Citrus Sinensis ID: 048542

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370---
Protein Sequence
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE
Secondary Structure (PSIPRED)
cEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEcccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccccccccccccccccccccccccccccEEEEcccccccccccHHccccccccccccccHHHHHHHHHHHccccccccccccccccccHHHHHHHHHccccEEcccccHHHHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHcccccccccEEcHHHHHHHHHcHHHcccccccccEEccccccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEEccccccEEEcccccccHcHHcHHHEccccccEEEEEEEEEcEccccHHHHHHccccEEEccHHHHHHEEEEEHHcccccccccccccccccHHHHHHHHHHcccccEEcccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccEEEcccccccccccccccccc
Coil and Loop (DISEMBL)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQqswmpkrysypqiIAMTNHFthklgqggfgsvykgqlqtgGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYeympngsldrhvfpkesrgqslcWEKLHEVALGTARGIEylhngcdvcilhfdikphnilldhnfipkvsdfglakfhpkendfvsisatrgtigyiapelisrnfgtvscksdvYGFGMVLLEMaggrrnsnmnatrsskayfpswvydqlnkggdlelqNVTEIESMIARKLCMIGLWCiqvkaadrpsMTKVLEMLEGsiddlqmpprpffsssrhisgtgreiesdssae
Flexible Loop (DISEMBL)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIApelisrnfgtvSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFfsssrhisgtgreiesdssae
Low Complexity Region (SEG)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE
Disordered region (IsUnstruct)
**TVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG*************KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAAD**********************************************
Disordered Region (DISOPRED)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLK*******FLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENS****EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS******SS*AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFF********************
Disordered Region (DISEMBL)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRH***************
Disordered Region (DISPRO)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLK**DNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSR****************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVTVRYGFLAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	373	2.2.26 [Sep-21-2011]
Q3ECH2	892	Probable receptor-like pr	no	no	0.978	0.409	0.462	4e-87
Q9FID5	806	Probable receptor-like pr	no	no	0.817	0.378	0.503	2e-85
Q9FID6	813	Probable receptor-like pr	no	no	0.831	0.381	0.479	2e-85
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.782	0.334	0.463	2e-72
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.865	0.393	0.462	2e-72
O64477	828	G-type lectin S-receptor-	no	no	0.766	0.345	0.462	1e-68
Q9XID3	829	G-type lectin S-receptor-	no	no	0.809	0.364	0.433	3e-66
Q39203	797	G-type lectin S-receptor-	no	no	0.745	0.348	0.45	7e-62
O65238	872	G-type lectin S-receptor-	no	no	0.764	0.326	0.407	6e-59
C0LGH3	1033	Probable LRR receptor-lik	no	no	0.788	0.284	0.403	3e-57

>sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2

 Score =  322 bits (824), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 179/387 (46%), Positives = 243/387 (62%), Gaps = 22/387 (5%)

Query: 4   VRYGFLA-GMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMP-KRYSYPQ 61
           VRY F+A G    V+      L   F V      KT D +   L+  ++ +P K Y+Y +
Sbjct: 493 VRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR--LQKLKALIPLKHYTYAE 550

Query: 62  IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHV 120
           +  MT  FT  +G+GGFG VY G L    ++AVK+L++SK +  E+FINEV+++ +  HV
Sbjct: 551 VKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHV 610

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           N+V LLGFC EGS+RA++YE++ NGSLD+ +  K S    L  + L+ +ALG ARG+EYL
Sbjct: 611 NIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDL--KTLYGIALGVARGLEYL 668

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+
Sbjct: 669 HYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEM 728

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-TRS--SKAYFPSWVYDQLNKG--- 294
           ISR +G+VS KSDVY +GM++LEM G R+    +  +RS  S  YFP W+Y  L K    
Sbjct: 729 ISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIK 788

Query: 295 -------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
                  G L    ++  E  IARK+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++
Sbjct: 789 DIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 848

Query: 348 PPRPFFS--SSRHISGTGREIESDSSA 372
           PPRP     S+  +S +    E  SSA
Sbjct: 849 PPRPVLQQISASSVSDSFWNSEESSSA 875

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1

 Score =  316 bits (810), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 162/322 (50%), Positives = 221/322 (68%), Gaps = 17/322 (5%)

Query: 57  YSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR 116
           Y+Y ++  +T  F++ +G+GGFG+VY G L  G  +AVK+L++ K SAE+FINEV+++ +
Sbjct: 488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query: 117 IHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE--KLHEVALGTA 174
             HVN+V LLGFC EGSKRA+VYE++ NGSLD+ +    SR +SL  +   L+ +ALG A
Sbjct: 548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFM----SRNKSLTQDVTTLYGIALGIA 603

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG+EYLH GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+  TRGTIG
Sbjct: 604 RGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIG 663

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--SKAYFPSWVYDQLN 292
           YIAPE+ SR +G VS KSDVY FGM++++M G R    +    S  S  YFP W+Y  L 
Sbjct: 664 YIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLE 723

Query: 293 KGGDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPR 350
            G    +    +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++PP+
Sbjct: 724 DGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPK 783

Query: 351 PFFSSSRHISGTGREIESDSSA 372
           P    S HIS    E+ ++SS+
Sbjct: 784 P----SMHIS---TEVITESSS 798

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1

 Score =  316 bits (809), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 155/323 (47%), Positives = 219/323 (67%), Gaps = 13/323 (4%)

Query: 55  KRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTI 114
           K+Y Y ++  +T  F+H +G+GGFG+VY+G L  G  +AVK+L++ K + ++FINEV+++
Sbjct: 484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC--WEKLHEVALG 172
            +  HVN+V LLGFC EGSKRA++ E++ +GSLD+ +    SR +SL      L+ +ALG
Sbjct: 544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGIALG 599

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            ARG+EYLH GC   I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGT
Sbjct: 600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 292
           IGYIAPE++SR +G +S KSDVY +GM++L+M G R          S AYFP W+Y  L 
Sbjct: 660 IGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLE 719

Query: 293 KGGDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPR 350
            G    +    + E ++ I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PP+
Sbjct: 720 NGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPK 779

Query: 351 PFFSSSRHISGTGREIESDSSAE 373
           P    SRHIS T   +ES S ++
Sbjct: 780 P----SRHIS-TELVLESSSLSD 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  273 bits (698), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 141/304 (46%), Positives = 195/304 (64%), Gaps = 12/304 (3%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE-EFINEVS 112
           P  ++Y  +   TN+F+  LG GGFG+VYKG +    L+AVK L+ +    E EFI EV+
Sbjct: 517 PVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVN 576

Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
           TIG +HH+N+V+L G+CSE S R LVYEYM NGSLD+ +F  E     L W    E+A+ 
Sbjct: 577 TIGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVA 636

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
           TA+GI Y H  C   I+H DIKP NILLD NF PKVSDFGLAK   +E+  V ++  RGT
Sbjct: 637 TAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHV-VTMIRGT 695

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 292
            GY+APE +S     ++ K+DVY +GM+LLE+ GGRRN +M +  +   ++P W Y +L 
Sbjct: 696 RGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDM-SYDAEDFFYPGWAYKELT 752

Query: 293 KGGDLE-----LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
            G  L+     LQ V E E ++  K   +  WCIQ + + RPSM +V+++LEG+ D++ +
Sbjct: 753 NGTSLKAVDKRLQGVAEEEEVV--KALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINL 810

Query: 348 PPRP 351
           PP P
Sbjct: 811 PPMP 814

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  272 bits (696), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 155/335 (46%), Positives = 209/335 (62%), Gaps = 12/335 (3%)

Query: 43  EKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF 102
           + FL N  S MP R++Y  + + TN+F+ KLGQGGFGSVY+G L  G  +AVK LE    
Sbjct: 470 DNFLENL-SGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQ 528

Query: 103 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC 162
             +EF  EVS IG IHH+++V+L GFC+EG+ R L YE++  GSL+R +F K+     L 
Sbjct: 529 GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLD 588

Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
           W+    +ALGTA+G+ YLH  CD  I+H DIKP NILLD NF  KVSDFGLAK   +E  
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
            V  +  RGT GY+APE I+ N+  +S KSDVY +GMVLLE+ GGR+N + + T S K +
Sbjct: 649 HV-FTTMRGTRGYLAPEWIT-NYA-ISEKSDVYSYGMVLLELIGGRKNYDPSET-SEKCH 704

Query: 283 FPSWVYDQLNKGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           FPS+ + ++ +G      D +++NV   +  + R +    LWCIQ     RPSM+KV++M
Sbjct: 705 FPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAM-KTALWCIQEDMQTRPSMSKVVQM 763

Query: 338 LEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSA 372
           LEG    +Q PP      SR  S   + I  D  A
Sbjct: 764 LEGVFPVVQ-PPSSSTMGSRLYSSFFKSISEDGGA 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  260 bits (664), Expect = 1e-68,   Method: Compositional matrix adjust.
 Identities = 141/305 (46%), Positives = 192/305 (62%), Gaps = 19/305 (6%)

Query: 57  YSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR 116
           +SY ++   T +F+ KLG GGFGSV+KG L     IAVK LE      ++F  EV TIG 
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query: 117 IHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ-SLCWEKLHEVALGTAR 175
           I HVN+V+L GFCSEGSK+ LVY+YMPNGSLD H+F  +   +  L W+   ++ALGTAR
Sbjct: 543 IQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTAR 602

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIG 234
           G+ YLH+ C  CI+H DIKP NILLD  F PKV+DFGLAK   +  DF  +  T RGT G
Sbjct: 603 GLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR--DFSRVLTTMRGTRG 660

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 294
           Y+APE IS     ++ K+DVY +GM+L E+  GRRN+  +     + +FPSW    L K 
Sbjct: 661 YLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFPSWAATILTKD 717

Query: 295 GDLEL-------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
           GD+          +  +IE +   + C +  WCIQ + + RP+M++V+++LEG    L++
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVT--RACKVACWCIQDEESHRPAMSQVVQILEGV---LEV 772

Query: 348 PPRPF 352
            P PF
Sbjct: 773 NPPPF 777

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  252 bits (644), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 136/314 (43%), Positives = 195/314 (62%), Gaps = 12/314 (3%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVST 113
           P +++Y ++   T  F  KLG GGFG+VY+G L    ++AVK LE  +   ++F  EV+T
Sbjct: 471 PVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVAT 530

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT 173
           I   HH+N+V+L+GFCS+G  R LVYE+M NGSLD  +F  +S  + L WE    +ALGT
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDS-AKFLTWEYRFNIALGT 589

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGT 232
           A+GI YLH  C  CI+H DIKP NIL+D NF  KVSDFGLAK  +PK+N + ++S+ RGT
Sbjct: 590 AKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRY-NMSSVRGT 648

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 292
            GY+APE ++     ++ KSDVY +GMVLLE+  G+RN ++ + +++   F  W Y++  
Sbjct: 649 RGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDV-SEKTNHKKFSIWAYEEFE 705

Query: 293 KGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
           KG      D  L     ++     ++     WCIQ +   RP+M KV++MLEG I +++ 
Sbjct: 706 KGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG-ITEIKN 764

Query: 348 PPRPFFSSSRHISG 361
           P  P   S    SG
Sbjct: 765 PLCPKTISEVSFSG 778

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  238 bits (606), Expect = 7e-62,   Method: Compositional matrix adjust.
 Identities = 135/300 (45%), Positives = 179/300 (59%), Gaps = 22/300 (7%)

Query: 55  KRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVST 113
           K +S+ ++ + TN F+ K+G GGFG+V+KG L  +   +AVK LE       EF  EV T
Sbjct: 449 KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCT 508

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT 173
           IG I HVN+V+L GFCSE   R LVY+YMP GSL  ++    +  + L WE    +ALGT
Sbjct: 509 IGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL--SRTSPKLLSWETRFRIALGT 566

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGT 232
           A+GI YLH GC  CI+H DIKP NILLD ++  KVSDFGLAK   +  DF  + AT RGT
Sbjct: 567 AKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGR--DFSRVLATMRGT 624

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-------TRSSKAYFPS 285
            GY+APE IS     ++ K+DVY FGM LLE+ GGRRN  +N+       T   K +FP 
Sbjct: 625 WGYVAPEWISGL--PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPP 682

Query: 286 WVYDQLNKGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
           W   ++ +G      D  L      E +   ++  + +WCIQ     RP+M  V++MLEG
Sbjct: 683 WAAREIIQGNVDSVVDSRLNGEYNTEEVT--RMATVAIWCIQDNEEIRPAMGTVVKMLEG 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  228 bits (581), Expect = 6e-59,   Method: Compositional matrix adjust.
 Identities = 127/312 (40%), Positives = 182/312 (58%), Gaps = 27/312 (8%)

Query: 53  MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA-EEFINEV 111
           +P+++ + ++   T +F  ++G GGFGSVYKG L    LIAVK + N      +EF  E+
Sbjct: 501 LPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEI 560

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
           + IG I H N+V+L GFC+ G +  LVYEYM +GSL++ +F     G  L W++  ++AL
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF--SGNGPVLEWQERFDIAL 618

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
           GTARG+ YLH+GCD  I+H D+KP NILL  +F PK+SDFGL+K   +E   +  +  RG
Sbjct: 619 GTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSL-FTTMRG 677

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA---------- 281
           T GY+APE I+     +S K+DVY +GMVLLE+  GR+N +  +  +S            
Sbjct: 678 TRGYLAPEWITN--AAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSST 735

Query: 282 --------YFPSWVYDQLNKGGDLELQNVT---EIESMIARKLCMIGLWCIQVKAADRPS 330
                   YFP +  D   +G  +EL +      + S  A KL  I L C+  + A RP+
Sbjct: 736 TTTSTGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPT 795

Query: 331 MTKVLEMLEGSI 342
           M  V+ M EGSI
Sbjct: 796 MAAVVGMFEGSI 807

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2

 Score =  222 bits (566), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 123/305 (40%), Positives = 181/305 (59%), Gaps = 11/305 (3%)

Query: 54  PKRYSYPQIIAMTNHF--THKLGQGGFGSVYKGQLQTGGLIAVKMLE-NSKFSAEEFINE 110
           P  ++Y ++ + T  F  ++KLG+GGFG VYKG+L  G  +AVK+L   S+    +F+ E
Sbjct: 678 PYTFTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAE 737

Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
           +  I  + H N+V+L G C EG  R LVYEY+PNGSLD+ +F +++    L W   +E+ 
Sbjct: 738 IVAISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT--LHLDWSTRYEIC 795

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           LG ARG+ YLH    + I+H D+K  NILLD   +PKVSDFGLAK +  +   +S +   
Sbjct: 796 LGVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHIS-TRVA 854

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           GTIGY+APE   R  G ++ K+DVY FG+V LE+  GR NS+ N     K Y   W ++ 
Sbjct: 855 GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDEN-LEDEKRYLLEWAWNL 911

Query: 291 LNKGGDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 348
             KG ++EL    +TE      +++  I L C Q   A RP M++V+ ML G ++   + 
Sbjct: 912 HEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVT 971

Query: 349 PRPFF 353
            +P +
Sbjct: 972 SKPGY 976

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
255570697	631	kinase, putative [Ricinus communis] gi|2	0.919	0.543	0.654	1e-133
224108395	348	predicted protein [Populus trichocarpa]	0.900	0.965	0.673	1e-132
224101781	348	predicted protein [Populus trichocarpa]	0.900	0.965	0.676	1e-131
357135051	680	PREDICTED: probable receptor-like protei	0.860	0.472	0.636	1e-118
326508416	666	predicted protein [Hordeum vulgare subsp	0.892	0.5	0.608	1e-118
13377503	708	TAK33 [Triticum aestivum]	0.852	0.449	0.634	1e-118
225455537	598	PREDICTED: probable receptor-like protei	0.863	0.538	0.603	1e-117
326500022	355	predicted protein [Hordeum vulgare subsp	0.852	0.895	0.625	1e-117
326516936	691	predicted protein [Hordeum vulgare subsp	0.852	0.460	0.628	1e-117
326509433	685	predicted protein [Hordeum vulgare subsp	0.892	0.486	0.592	1e-117

>gi|255570697|ref|XP_002526303.1| kinase, putative [Ricinus communis] gi|223534384|gb|EEF36092.1| kinase, putative [Ricinus communis]

 Score =  481 bits (1238), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 227/347 (65%), Positives = 279/347 (80%), Gaps = 4/347 (1%)

Query: 28  FLVSR-RTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQL 86
           FL+ + RT  KT ++ E  L N+ S MP+RYSY  IIA+TN+F  K+G+GGFG+VYKGQL
Sbjct: 277 FLIHKYRTQKKTEESKENLLPNEPSMMPRRYSYSDIIAITNNFKDKIGKGGFGTVYKGQL 336

Query: 87  QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS 146
             G L+AVKML +SKFS ++FI+EVSTIG+IHH NVVQL+GFCSEGS  AL++EY+  GS
Sbjct: 337 PDGFLVAVKMLGDSKFSDKDFIDEVSTIGKIHHANVVQLVGFCSEGSYHALLFEYIARGS 396

Query: 147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP 206
           LD+H+F +E+  Q   WEK  ++A+GTARGIE+LH GCDVCILHFDIKPHN+LL HNFIP
Sbjct: 397 LDKHIFSREAEFQPFSWEKRLQIAIGTARGIEHLHVGCDVCILHFDIKPHNVLLHHNFIP 456

Query: 207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 266
           KVSDFGLAKF+PKENDFVS+S  RGTIGYIAPELIS+N G+VSCKSDVY +G++LLEM G
Sbjct: 457 KVSDFGLAKFYPKENDFVSVSTARGTIGYIAPELISKNLGSVSCKSDVYSYGILLLEMVG 516

Query: 267 GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAA 326
           GRRN N N   S K +F SWVYD LN+GGDLEL++V E E+ IA+KLC++GLWCI   ++
Sbjct: 517 GRRNINPNGNSSGKVHFASWVYDHLNEGGDLELESVNEAEAAIAKKLCIVGLWCINKNSS 576

Query: 327 DRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE 373
           DRPSMTKV+EMLEG IDDLQ+PP P  S   H++  G   +SDSS E
Sbjct: 577 DRPSMTKVVEMLEGKIDDLQLPPSP-LSFPDHVAAEGP--QSDSSTE 620

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224108395|ref|XP_002314832.1| predicted protein [Populus trichocarpa] gi|222863872|gb|EEF01003.1| predicted protein [Populus trichocarpa]

 Score =  476 bits (1225), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 229/340 (67%), Positives = 275/340 (80%), Gaps = 4/340 (1%)

Query: 34  TTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIA 93
           TT K IDN ++FLR QQ  MP+RYSY  IIA+TN+F +KLGQGGFG+VYKGQL+ G  +A
Sbjct: 2   TTKKAIDNEQRFLRRQQHSMPRRYSYSDIIAITNNFENKLGQGGFGTVYKGQLRDGFSVA 61

Query: 94  VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFP 153
           VKML+N K + E+FINEVS IGRIH VN+V L+GFCSEG  RALV+EYM NGSLD+ +F 
Sbjct: 62  VKMLDNPKCNDEDFINEVSIIGRIHQVNIVWLMGFCSEGCHRALVFEYMANGSLDKLLFS 121

Query: 154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
           +E+    + WEKL ++ALGTARGIE+LH GC+VCILH DIKP N+LLD+NFIPKVSDFGL
Sbjct: 122 REAERHLVGWEKLLQIALGTARGIEHLHGGCNVCILHSDIKPQNVLLDNNFIPKVSDFGL 181

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 273
           +KF+P+E DFVSIS TRGTIGYIAPE+ISRN G VSCKSDVY FGM+LLEMAG RRNSN 
Sbjct: 182 SKFYPEEKDFVSISTTRGTIGYIAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRNSNS 241

Query: 274 NATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK 333
               SS+ YFPSWVYD L +  DL+L+NVTEIE+ I RKLC++GLWCIQ  A+DRPSMTK
Sbjct: 242 KGNCSSEVYFPSWVYDHLIERADLQLENVTEIEAGIPRKLCLVGLWCIQKAASDRPSMTK 301

Query: 334 VLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE 373
           V+EMLE ++DDLQ+PP    S  + IS   +E +SDSS E
Sbjct: 302 VVEMLEANVDDLQLPPNA-LSFPQSIS---KEPQSDSSTE 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224101781|ref|XP_002312418.1| predicted protein [Populus trichocarpa] gi|222852238|gb|EEE89785.1| predicted protein [Populus trichocarpa]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 230/340 (67%), Positives = 270/340 (79%), Gaps = 4/340 (1%)

Query: 34  TTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIA 93
           TT K   N E FL NQQ  MPKRY++  IIA+TN+F  KLGQGGFG+VYKGQL+   L+A
Sbjct: 2   TTKKASGNEEIFLVNQQHLMPKRYTFSDIIAITNNFKDKLGQGGFGNVYKGQLRDAFLVA 61

Query: 94  VKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFP 153
           VKML N+K + E+FINEVS IGRIHHVN+V+L+GFCSEGS RALV+EYM NGSLD+ +F 
Sbjct: 62  VKMLGNAKCNDEDFINEVSIIGRIHHVNIVRLVGFCSEGSYRALVFEYMANGSLDKLLFS 121

Query: 154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
           +E+    + WEKL ++A+GTARGIE+LH GC VCILH DIKPHN+LLD NFIPKVSDFGL
Sbjct: 122 RETELLLVSWEKLLQIAVGTARGIEHLHGGCSVCILHLDIKPHNVLLDSNFIPKVSDFGL 181

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 273
           AKF+P E DFVSIS TRGTIGY APE+ISRN G VSCKSDVY FGM+LLEMAG RR SN 
Sbjct: 182 AKFYPSEKDFVSISTTRGTIGYFAPEMISRNLGAVSCKSDVYSFGMLLLEMAGRRRKSNS 241

Query: 274 NATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK 333
               SS  YFPSWVYD L++GGDLEL+NVTEIE+ IARKLC+ GLWCIQ  A+DRP+MTK
Sbjct: 242 KGNCSSDVYFPSWVYDHLSEGGDLELENVTEIEAAIARKLCIAGLWCIQKAASDRPTMTK 301

Query: 334 VLEMLEGSIDDLQMPPRPFFSSSRHISGTGREIESDSSAE 373
           V+EML  +IDDLQ+P     S  + IS   +E +SDSS E
Sbjct: 302 VVEMLGANIDDLQLPSNA-LSFPQSIS---KEPQSDSSTE 337

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357135051|ref|XP_003569125.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Brachypodium distachyon]

 Score =  431 bits (1108), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 208/327 (63%), Positives = 257/327 (78%), Gaps = 6/327 (1%)

Query: 35  TLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IA 93
           T  TID +EKFLR QQ   P RY+Y  I A+T HF  KLGQGG+GSVYKG L  G + +A
Sbjct: 336 TRITIDVVEKFLRIQQMIGPTRYAYTDITAITGHFRDKLGQGGYGSVYKGVLLPGDVHVA 395

Query: 94  VKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           VKMLE NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  KRALVYEYMP+GSLD+++F
Sbjct: 396 VKMLEGNSSCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMKRALVYEYMPHGSLDKYIF 455

Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
             E   +S  W+KL+E+ALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFG
Sbjct: 456 SAE---KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVADFG 512

Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 272
           LAK +P++N FV +SA RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++
Sbjct: 513 LAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNAD 572

Query: 273 MNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 332
            NA RSS+AY+PSWVYDQL +    E+    ++  +  +KLC++GLWCIQ+K+ DRP+M+
Sbjct: 573 PNAARSSQAYYPSWVYDQLTQQEAGEISPAADMHEL-EKKLCVVGLWCIQMKSHDRPTMS 631

Query: 333 KVLEMLEGSIDDLQMPPRPFFSSSRHI 359
           +V+E+LE     LQMP RPFF    HI
Sbjct: 632 EVIEVLEAGAHGLQMPSRPFFCDEEHI 658

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326508416|dbj|BAJ99475.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  431 bits (1107), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 213/350 (60%), Positives = 264/350 (75%), Gaps = 17/350 (4%)

Query: 35  TLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IA 93
           T  TID +EKFLR QQ   P RY+Y  I A+T+HF  KLGQGG+GSV+KG L  G + +A
Sbjct: 316 TRITIDAVEKFLRMQQMLGPMRYAYTDITAITSHFRDKLGQGGYGSVFKGVLLPGNVHVA 375

Query: 94  VKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           VKMLE N   + E+FINEVSTIGRIHHVNVV+L+GFCSE  +RALVYEYMP GSLD+++F
Sbjct: 376 VKMLEGNPNCNGEDFINEVSTIGRIHHVNVVRLMGFCSEEMRRALVYEYMPQGSLDKYIF 435

Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
              S G+S CW+KL E+ALG ARGI+YLH GCD+ ILHFDIKPHNILLD+NF+PKV+DFG
Sbjct: 436 ---SSGKSFCWDKLAEIALGIARGIDYLHQGCDMQILHFDIKPHNILLDNNFVPKVADFG 492

Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 272
           LAK +P++N FV   A RGTIGYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++
Sbjct: 493 LAKLYPRDNSFVPSRALRGTIGYIAPEMISRSFGAISSKSDVYSFGMLLLEMAGGRRNAD 552

Query: 273 MNATRSSKAYFPSWVYDQLNKG---GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP 329
            NA  +S+AY+PSWVYD+L +    G++     TE+  +  RKLC++GLWCIQ++  DRP
Sbjct: 553 PNAANTSQAYYPSWVYDRLTQQDHVGEIFAHVYTEMHEL-ERKLCIVGLWCIQMRCQDRP 611

Query: 330 SMTKVLEMLEGSIDDLQMPPRPFFS--------SSRHISGTGREIESDSS 371
           +M+ V+EMLEG I  LQMP RPFF          + H+S    EI  D S
Sbjct: 612 TMSDVIEMLEGGIHSLQMPSRPFFCDEGHNHAEDTYHLSSELTEISEDMS 661

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|13377503|gb|AAK20741.1| TAK33 [Triticum aestivum]

 Score =  430 bits (1106), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 205/323 (63%), Positives = 256/323 (79%), Gaps = 5/323 (1%)

Query: 39  IDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKML 97
           ID +EKFLR QQ   P RYSY  I+A+T+HF  KLGQGG+GSVYKG L  GG+ +AVKML
Sbjct: 360 IDAVEKFLRIQQMIGPARYSYTDIVAVTSHFRDKLGQGGYGSVYKGVLLPGGVHVAVKML 419

Query: 98  E-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKES 156
           E NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE   RALVYEYMPNGSLD+++F  E 
Sbjct: 420 EGNSNCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMLRALVYEYMPNGSLDKYIFSTE- 478

Query: 157 RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
             +S  WEKL+E+ALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFGLAK 
Sbjct: 479 --KSFSWEKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVADFGLAKL 536

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 276
           +P+ + FV +SA RGT+GYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ N  
Sbjct: 537 YPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNMG 596

Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            SS+AY+PSWVYD+L +    E+ +V      + +KLC++GLWCIQ+++ DRP+M++V+E
Sbjct: 597 SSSQAYYPSWVYDRLTQEEAGEISDVAADMHELEKKLCVVGLWCIQMRSRDRPTMSEVIE 656

Query: 337 MLEGSIDDLQMPPRPFFSSSRHI 359
           +LE  +D LQMP RPFF    HI
Sbjct: 657 ILEAGVDGLQMPSRPFFCDEGHI 679

Source: Triticum aestivum

Species: Triticum aestivum

Genus: Triticum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455537|ref|XP_002267723.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera]

 Score =  429 bits (1102), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 195/323 (60%), Positives = 262/323 (81%), Gaps = 1/323 (0%)

Query: 32  RRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL 91
           RR  L    +IE+F+++  + MP RYSY  I  MT +F  KLG+GGFGSV+KG+LQ+G L
Sbjct: 268 RRRNLWIYSDIEEFIQSHNNLMPIRYSYSNIKKMTKNFKEKLGEGGFGSVFKGKLQSGRL 327

Query: 92  IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +AVKM+ NSK + ++FINEV+TIGRIHHVNVVQL+GFC++GSKRALV+++MPNGSLD+++
Sbjct: 328 VAVKMV-NSKANGQDFINEVATIGRIHHVNVVQLIGFCAKGSKRALVFDFMPNGSLDKYI 386

Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
           FP+     SL +EK++E++LG A GIEYLH GCD+ ILHFDIKPHNILLD NF PKVSDF
Sbjct: 387 FPRTEANISLNFEKMYEISLGVAHGIEYLHRGCDMQILHFDIKPHNILLDKNFSPKVSDF 446

Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS 271
           GLAK +P ++  VS++A RGT+GY+APEL+ +N G VS K+DVY FGM+L+EMAG R+N 
Sbjct: 447 GLAKLYPTDHSIVSVTAARGTMGYMAPELVYKNIGGVSYKADVYSFGMLLMEMAGRRKNL 506

Query: 272 NMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
           N+ A  SS+ YFPSWVYDQ ++G D+E+ + TE E  +A+K+ ++ LWCIQ+K +DRPSM
Sbjct: 507 NVFAEHSSQMYFPSWVYDQFSEGKDIEMGDATEEEQKLAKKMIIVALWCIQLKPSDRPSM 566

Query: 332 TKVLEMLEGSIDDLQMPPRPFFS 354
           +KV+EMLEG+++ LQMPP+PF +
Sbjct: 567 SKVVEMLEGNVELLQMPPKPFLT 589

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326500022|dbj|BAJ90846.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 202/323 (62%), Positives = 256/323 (79%), Gaps = 5/323 (1%)

Query: 39  IDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKML 97
           ID +EKFLR QQ+  P RYSY  I+A+T+HF  KLGQGG+G+VYKG L  GG+ +AVKML
Sbjct: 7   IDAVEKFLRIQQTIGPTRYSYTDIVAVTSHFRDKLGQGGYGTVYKGILLPGGVHVAVKML 66

Query: 98  E-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKES 156
           E NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYEYMP+GSLD+++F  E 
Sbjct: 67  EGNSNCNGEDFISEVSTIGRIHHVNVVRLVGFCSEEMRRALVYEYMPHGSLDKYIFSAE- 125

Query: 157 RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
             +S  W+KL+E+ALG ARGI YLH GCD+ ILHFDIKPHNILLD NF+PKV+DFGLAK 
Sbjct: 126 --KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDSNFVPKVADFGLAKL 183

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 276
           +P+ + FV +SA RGT+GYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ N  
Sbjct: 184 YPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNMG 243

Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            SS+AY+PSWVYD+L +    E+  V      + +KLC++GLWCIQ+++ DRPSM +V+E
Sbjct: 244 SSSQAYYPSWVYDRLTQEEAGEISAVAADMHELEKKLCVVGLWCIQMRSRDRPSMGEVIE 303

Query: 337 MLEGSIDDLQMPPRPFFSSSRHI 359
           +LE  +D L+MP RPFF    HI
Sbjct: 304 ILESGVDGLEMPSRPFFCDEGHI 326

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326516936|dbj|BAJ96460.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326526275|dbj|BAJ97154.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 203/323 (62%), Positives = 255/323 (78%), Gaps = 5/323 (1%)

Query: 39  IDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKML 97
           ID +EKFLR QQ   P RY+Y  IIA+T HF  KLGQGG+G+VYKG L  G + +AVKML
Sbjct: 343 IDAVEKFLRIQQLIGPTRYAYTDIIAITRHFRDKLGQGGYGTVYKGVLLPGDVHVAVKML 402

Query: 98  E-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKES 156
           E NS  + E+FI+EVSTIGRIHHVNVV+L+GFCSE  +RALVYEYMPNGSLD+++F  E 
Sbjct: 403 EGNSNCNGEDFISEVSTIGRIHHVNVVRLMGFCSEELRRALVYEYMPNGSLDKYIFSTE- 461

Query: 157 RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
             +S  W+KL+E+ALG ARGI YLH GCD+ ILHFDIKPHNILLD+NF+PKV+DFGLAK 
Sbjct: 462 --KSFSWDKLNEIALGIARGINYLHQGCDMQILHFDIKPHNILLDNNFVPKVADFGLAKL 519

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 276
           +P+ + FV +SA RGT+GYIAPE+ISR+FG +S KSDVY FGM+LLEMAGGRRN++ N  
Sbjct: 520 YPRGDSFVPLSAMRGTVGYIAPEMISRSFGVISSKSDVYSFGMLLLEMAGGRRNADPNMG 579

Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            SS+AY+PSWVYDQL +    E+  V      + +KLC++GLWCIQ+++ DRP+M++V+E
Sbjct: 580 SSSQAYYPSWVYDQLTREEAGEISPVAVDMHELEKKLCVVGLWCIQMRSRDRPTMSEVIE 639

Query: 337 MLEGSIDDLQMPPRPFFSSSRHI 359
           +LE  +D LQMP RPFF    HI
Sbjct: 640 ILEAGVDGLQMPSRPFFCDEGHI 662

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326509433|dbj|BAJ91633.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  427 bits (1099), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 214/361 (59%), Positives = 271/361 (75%), Gaps = 28/361 (7%)

Query: 9   LAGMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNH 68
           LA M VL+      +L   +L +R     TID +EKFLR QQ   P RY+Y  I A+T+H
Sbjct: 325 LAPMAVLI------FLGYKYLKTR----VTIDAVEKFLRLQQMLGPTRYAYTDITAITSH 374

Query: 69  FTHKLGQGGFGSVYKGQLQTGGL-IAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           F   LGQGG+GSV+KG L  G + +AVKMLE NS  + E+FI+EVSTIGRIHHVNVV+L+
Sbjct: 375 FRDMLGQGGYGSVFKGVLLPGNVHVAVKMLEGNSSCNGEDFISEVSTIGRIHHVNVVRLM 434

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           GFCSE  +RALVYEYMP GSLD+++F  E   +   W+KL+E+ALG ARGI YLH GCD+
Sbjct: 435 GFCSEEMRRALVYEYMPRGSLDKYIFSTE---KCFSWDKLNEIALGIARGINYLHQGCDM 491

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            ILHFDIKPHNILLD+NFIP+V+DFGLAK +P++N FV +SA RGTIGYIAPE+ISR+FG
Sbjct: 492 QILHFDIKPHNILLDNNFIPRVADFGLAKLYPRDNSFVPLSALRGTIGYIAPEMISRSFG 551

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE 306
            +S KSDVY FGM+LLEM+GGRRN++ NA  SS+AY+PSWVYD+L +      Q+V EI 
Sbjct: 552 AISSKSDVYSFGMLLLEMSGGRRNADSNAATSSQAYYPSWVYDRLTQ------QDVGEIS 605

Query: 307 SMIA-------RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHI 359
           + IA       RKLC++GLWCIQ+++ DRP+M++V+EMLEG  + LQMP RPFF    H 
Sbjct: 606 APIATEMHELERKLCIVGLWCIQMRSHDRPTMSEVIEMLEGGFEGLQMPSRPFFCDEEHT 665

Query: 360 S 360
           +
Sbjct: 666 A 666

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	373
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.847	0.475	0.504	1.9e-83
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.839	0.366	0.492	8.3e-83
TAIR|locus:2019713	892	AT1G67000 [Arabidopsis thalian	0.978	0.409	0.465	3.6e-82
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.833	0.466	0.487	1.2e-81
TAIR|locus:2019688	674	AT1G66930 [Arabidopsis thalian	0.790	0.437	0.526	2e-81
TAIR|locus:2177152	806	AT5G39030 [Arabidopsis thalian	0.823	0.380	0.5	5.4e-79
TAIR|locus:2177142	813	AT5G39020 [Arabidopsis thalian	0.831	0.381	0.479	8.7e-79
TAIR|locus:2176717	638	AT5G38260 [Arabidopsis thalian	0.849	0.496	0.481	3e-78
TAIR|locus:2020583	799	AT1G70250 [Arabidopsis thalian	0.793	0.370	0.5	6.2e-78
TAIR|locus:2176697	588	AT5G38240 [Arabidopsis thalian	0.780	0.494	0.501	7.3e-75

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
 Identities = 164/325 (50%), Positives = 221/325 (68%)

Query:    53 MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEV 111
             M KRYSY ++  MTN F H LG+GGFG+VYKG+L   G  +AVK+L+ S+ + EEFINEV
Sbjct:   317 MLKRYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGEEFINEV 376

Query:   112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
             +++ R  HVN+V LLGFC E +KRA++YE+MPNGSLD+++    S      WE+L++VA+
Sbjct:   377 ASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTKME--WERLYDVAV 434

Query:   172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             G +RG+EYLHN C   I+HFDIKP NIL+D N  PK+SDFGLAK    +   +S+   RG
Sbjct:   435 GISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRG 494

Query:   232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--YFPSWVYD 289
             T GYIAPE+ S+NFG VS KSDVY +GMV+LEM G +    +  + S+    YFP WVY 
Sbjct:   495 TFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPEWVYK 554

Query:   290 QLNKGGDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
                KG    +   ++T+ E  IA+KL ++ LWCIQ+  +DRP M KV+EMLEG+++ LQ+
Sbjct:   555 DFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQV 614

Query:   348 PPRPF-FSSSRHISGTGREIESDSS 371
             PP P  FS    +  T  E   D+S
Sbjct:   615 PPNPLLFSPEETVPDT-LEDSDDTS 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 812 (290.9 bits), Expect = 8.3e-83, Sum P(2) = 8.3e-83
 Identities = 161/327 (49%), Positives = 223/327 (68%)

Query:    53 MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSKFSAEEFINE 110
             M KRYS+ ++  MTN F H +G+GGFG+VYKG+L   +G  IA+K+L+ SK + EEFINE
Sbjct:   505 MLKRYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINE 564

Query:   111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
             + ++ R  HVN+V L GFC EGS+RA++YE+MPNGSLD+  F  E+    + W+ L+ +A
Sbjct:   565 LVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDK--FISENMSTKIEWKTLYNIA 622

Query:   171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
             +G ARG+EYLHN C   I+HFDIKP NIL+D +  PK+SDFGLAK   K+   +S+   R
Sbjct:   623 VGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISMLDAR 682

Query:   231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--NATRSSKAYFPSWVY 288
             GT+GYIAPE+ S+N+G VS KSDVY +GMV+LEM G  +   +  +AT  S  YFP WVY
Sbjct:   683 GTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPDWVY 742

Query:   289 DQLNKGGDLEL--QNVTEIES--MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS-ID 343
             + L +   + L   ++ E E    I +++ ++GLWCIQ   +DRP M KV+EMLEGS ++
Sbjct:   743 EDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGSRLE 802

Query:   344 DLQMPPRPFFSSSRHISGTGREIESDS 370
              LQ+PP+P  +   H+  T  E   DS
Sbjct:   803 ALQVPPKPLLNL--HVV-TDWETSEDS 826

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)]

 Score = 824 (295.1 bits), Expect = 3.6e-82, P = 3.6e-82
 Identities = 180/387 (46%), Positives = 247/387 (63%)

Query:     4 VRYGFLA-GMPVLVISNSATYLESNFLVSRRTTLKTIDNIEKFLRNQQSWMP-KRYSYPQ 61
             VRY F+A G    V+      L   F V      KT D +   L+  ++ +P K Y+Y +
Sbjct:   493 VRYTFIALGALTGVVIVFLVLLCPCFRVQIFRKRKTSDEVR--LQKLKALIPLKHYTYAE 550

Query:    62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHV 120
             +  MT  FT  +G+GGFG VY G L    ++AVK+L++SK +  E+FINEV+++ +  HV
Sbjct:   551 VKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINEVASMSQTSHV 610

Query:   121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
             N+V LLGFC EGS+RA++YE++ NGSLD+ +  K S    L  + L+ +ALG ARG+EYL
Sbjct:   611 NIVSLLGFCCEGSRRAIIYEFLGNGSLDKFISDKSSVNLDL--KTLYGIALGVARGLEYL 668

Query:   181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
             H GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTIGYIAPE+
Sbjct:   669 HYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILSLLDTRGTIGYIAPEM 728

Query:   241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA-TRS--SKAYFPSWVYDQLNKGG-- 295
             ISR +G+VS KSDVY +GM++LEM G R+    +  +RS  S  YFP W+Y  L K    
Sbjct:   729 ISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFPEWIYKDLEKANIK 788

Query:   296 DLE-------LQN-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
             D+E       ++N ++  E  IARK+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++
Sbjct:   789 DIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 848

Query:   348 PPRPFFS--SSRHISGTGREIESDSSA 372
             PPRP     S+  +S +    E  SSA
Sbjct:   849 PPRPVLQQISASSVSDSFWNSEESSSA 875

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 157/322 (48%), Positives = 228/322 (70%)

Query:    36 LKTIDNIEKFLRNQQSWMP-KRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAV 94
             ++T D+  +  +N ++ +P K YSY Q+ ++T  F   +G+GGFG+VY+G L  G  +AV
Sbjct:   318 MRTSDDSRQ--QNLKALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAV 375

Query:    95 KMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK 154
             K+L+ S+ + E+FINEV+++ +  HVN+V LLGFCSEG KRA++YE+M NGSLD+ +  K
Sbjct:   376 KVLKESQGNGEDFINEVASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFISSK 435

Query:   155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
             +S   ++ W +L+ +ALG ARG+EYLH+GC   I+HFDIKP N+LLD N  PKVSDFGLA
Sbjct:   436 KS--STMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLA 493

Query:   215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN 274
             K   ++   +S+  TRGTIGYIAPE+ SR +G VS KSDVY +GM++L++ G R  ++  
Sbjct:   494 KLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTE 553

Query:   275 ATRSSKA--YFPSWVYDQLNK---GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP 329
              T SS +  YFP W+Y  L K   G  +E   ++  E  IA+K+ ++GLWCIQ    DRP
Sbjct:   554 DTTSSTSSMYFPEWIYRDLEKAHNGKSIETA-ISNEEDEIAKKMTLVGLWCIQPWPLDRP 612

Query:   330 SMTKVLEMLEGSIDDLQMPPRP 351
             +M +V+EM+EG++D L++PPRP
Sbjct:   613 AMNRVVEMMEGNLDALEVPPRP 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)]

 Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
 Identities = 160/304 (52%), Positives = 214/304 (70%)

Query:    55 KRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-AEEFINEVST 113
             K Y+Y Q+  MT  F   +G+GGFG VY+G L  G ++AVK+L+ SK + +E+FINEVS+
Sbjct:   334 KHYTYAQVKRMTKSFAEVVGRGGFGIVYRGTLCDGRMVAVKVLKESKGNNSEDFINEVSS 393

Query:   114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT 173
             + +  HVN+V LLGFCSEGS+RA++YE++ NGSLD+ +  K S    L    L+ +ALG 
Sbjct:   394 MSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLT--ALYGIALGV 451

Query:   174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
             ARG+EYLH GC   I+HFDIKP N+LLD N  PKVSDFGLAK   K+   +S+  TRGTI
Sbjct:   452 ARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTI 511

Query:   234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM--NATRSSKAYFPSWVYDQL 291
             GYIAPE+ISR +G+VS KSDVY +GM++ EM G R+      N+   S  YFP W+Y  L
Sbjct:   512 GYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEWIYKDL 571

Query:   292 NKG--GDLE-LQ-NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
              K   GDLE ++  ++  E  IA+K+ ++GLWCIQ   +DRP M KV+EM+EGS+D L++
Sbjct:   572 EKADNGDLEHIEIGISSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEGSLDALEV 631

Query:   348 PPRP 351
             PPRP
Sbjct:   632 PPRP 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)]

 Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
 Identities = 160/320 (50%), Positives = 219/320 (68%)

Query:    57 YSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR 116
             Y+Y ++  +T  F++ +G+GGFG+VY G L  G  +AVK+L++ K SAE+FINEV+++ +
Sbjct:   488 YTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVASMSQ 547

Query:   117 IHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
               HVN+V LLGFC EGSKRA+VYE++ NGSLD+ +   +S  Q +    L+ +ALG ARG
Sbjct:   548 TSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVT--TLYGIALGIARG 605

Query:   177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             +EYLH GC   I+HFDIKP NILLD N  PKVSDFGLAK   K    +S+  TRGTIGYI
Sbjct:   606 LEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLSLMDTRGTIGYI 665

Query:   237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--SKAYFPSWVYDQLNKG 294
             APE+ SR +G VS KSDVY FGM++++M G R    +    S  S  YFP W+Y  L  G
Sbjct:   666 APEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWIYKDLEDG 725

Query:   295 GDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPF 352
                 +    +T+ E  IA+K+ ++GLWCIQ   +DRPSM +V+EM+EGS+D L++PP+P 
Sbjct:   726 EQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDALEIPPKP- 784

Query:   353 FSSSRHISGTGREIESDSSA 372
                S HIS    E+ ++SS+
Sbjct:   785 ---SMHIS---TEVITESSS 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2177142 AT5G39020 [Arabidopsis thaliana (taxid:3702)]

 Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
 Identities = 155/323 (47%), Positives = 219/323 (67%)

Query:    55 KRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTI 114
             K+Y Y ++  +T  F+H +G+GGFG+VY+G L  G  +AVK+L++ K + ++FINEV+++
Sbjct:   484 KQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEVTSM 543

Query:   115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE--KLHEVALG 172
              +  HVN+V LLGFC EGSKRA++ E++ +GSLD+ +    SR +SL      L+ +ALG
Sbjct:   544 SQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFI----SRNKSLTPNVTTLYGIALG 599

Query:   173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
              ARG+EYLH GC   I+HFDIKP NILLD NF PKV+DFGLAK   K    +S+  TRGT
Sbjct:   600 IARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILSLIDTRGT 659

Query:   233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 292
             IGYIAPE++SR +G +S KSDVY +GM++L+M G R          S AYFP W+Y  L 
Sbjct:   660 IGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIYKDLE 719

Query:   293 KGGDLEL--QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPR 350
              G    +    + E ++ I +K+ ++ LWCI+   +DRP M KV+EM+EGS+D L++PP+
Sbjct:   720 NGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALELPPK 779

Query:   351 PFFSSSRHISGTGREIESDSSAE 373
             P    SRHIS T   +ES S ++
Sbjct:   780 P----SRHIS-TELVLESSSLSD 797

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)]

 Score = 787 (282.1 bits), Expect = 3.0e-78, P = 3.0e-78
 Identities = 159/330 (48%), Positives = 218/330 (66%)

Query:    28 FLVSRRTT--LKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ 85
             F   RRT+  L+  DN  K L        K+YSY ++  +T  F+H LG+GGFG+VY G 
Sbjct:   285 FFQKRRTSHHLRPRDNNLKGLVQL-----KQYSYAEVRKITKLFSHTLGKGGFGTVYGGN 339

Query:    86 LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG 145
             L  G  +AVK+L++ K + E+FINEV+++ +  HVN+V LLGFC EGSKRA+VYE++ NG
Sbjct:   340 LCDGRKVAVKILKDFKSNGEDFINEVASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENG 399

Query:   146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 205
             SLD+  F  E +  +L    L+ +ALG ARG++YLH+GC   I+HFDIKP NILLD  F 
Sbjct:   400 SLDQ--FLSEKKSLNLDVSTLYRIALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFC 457

Query:   206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
             PKVSDFGLAK   K    +S+   RGTIGYIAPE+ S  +G VS KSDVY +GM++LEM 
Sbjct:   458 PKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMI 517

Query:   266 GGRRNS--NMNATRSSKAYFPSWVYDQLNKGGDLEL--QNVTEIESMIARKLCMIGLWCI 321
             G +        A+ SS AYFP W+Y  L  G D       ++  +  +A+K+ ++GLWCI
Sbjct:   518 GAKNKEIEETAASNSSSAYFPDWIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCI 577

Query:   322 QVKAADRPSMTKVLEMLEGSIDDLQMPPRP 351
             Q    +RP M +++EM+EGS+D L++PP+P
Sbjct:   578 QPSPLNRPPMNRIVEMMEGSLDVLEVPPKP 607

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)]

 Score = 784 (281.0 bits), Expect = 6.2e-78, P = 6.2e-78
 Identities = 153/306 (50%), Positives = 208/306 (67%)

Query:    53 MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEV 111
             M KR+SY Q+  MT  F + LG+GGFG+VYKG+L  G   +AVK+L+ S    E+FINE+
Sbjct:   445 MLKRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEI 504

Query:   112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
             +++ R  H N+V LLGFC EG K+A++YE MPNGSLD+  F  ++    + W+ L+ +A+
Sbjct:   505 ASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDK--FISKNMSAKMEWKTLYNIAV 562

Query:   172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             G + G+EYLH+ C   I+HFDIKP NIL+D +  PK+SDFGLAK        +S+   RG
Sbjct:   563 GVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIISMLHARG 622

Query:   232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFPSWVY 288
             TIGYIAPE+ S+NFG VS KSDVY +GMV+LEM G R   R  N  ++ +S  YFP W+Y
Sbjct:   623 TIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTSM-YFPDWIY 681

Query:   289 DQLNKGGDLEL--QNVTEIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
               L KG  +      +TE E   I +K+ ++GLWCIQ    DRP M+KV+EMLEGS++ L
Sbjct:   682 KDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGSLEAL 741

Query:   346 QMPPRP 351
             Q+PP+P
Sbjct:   742 QIPPKP 747

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)]

 Score = 755 (270.8 bits), Expect = 7.3e-75, P = 7.3e-75
 Identities = 153/305 (50%), Positives = 207/305 (67%)

Query:    73 LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
             +G+GGFG+VYKG L+ G  +AVK+L++S  + E+FINEV++I +  HVN+V LLGFC E 
Sbjct:   287 VGRGGFGTVYKGNLRDGRKVAVKILKDSNGNCEDFINEVASISQTSHVNIVSLLGFCFEK 346

Query:   133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
             SKRA+VYE++ NGSLD+          +L    L+ +ALG ARGIEYLH GC   I+HFD
Sbjct:   347 SKRAIVYEFLENGSLDQ--------SSNLDVSTLYGIALGVARGIEYLHFGCKKRIVHFD 398

Query:   193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 252
             IKP N+LLD N  PKV+DFGLAK   K+   +S+  TRGTIGYIAPEL SR +G VS KS
Sbjct:   399 IKPQNVLLDENLKPKVADFGLAKLCEKQESILSLLDTRGTIGYIAPELFSRVYGNVSHKS 458

Query:   253 DVYGFGMVLLEMAGGRRNSNM-NA-TRSSKAYFPSWVYDQLNKGGDLEL--QNVTEIESM 308
             DVY +GM++LEM G R    + NA + +S AYFP W++  L  G  ++L    +T  E  
Sbjct:   459 DVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPDWIFKDLENGDYVKLLADGLTREEED 518

Query:   309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSS--SRHISGTGREI 366
             IA+K+ ++GLWCIQ + +DRPSM KV+ M+EG++D L  PP+P        + + + +  
Sbjct:   519 IAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLDSLDPPPKPLLHMPMQNNNAESSQPS 578

Query:   367 ESDSS 371
             E DSS
Sbjct:   579 EEDSS 583

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	373
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	8e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-49
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-33
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-31
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-27
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-15
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	8e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	9e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	6e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-11
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.002
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.003
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  170 bits (433), Expect = 8e-51
 Identities = 86/281 (30%), Positives = 134/281 (47%), Gaps = 36/281 (12%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 121
              KLG+G FG VYKG L          +AVK L+        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +V+LLG C+E     +V EYMP G L  ++  +++R + L    L   AL  ARG+EYL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H D+   N L+  N + K+SDFGL++    ++D+  +   +  I ++APE  
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPE-- 174

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
           S   G  + KSDV+ FG++L E+   G      M+            V + L KG  L  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLPK 225

Query: 300 QNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                 E+  ++        L C      DRP+ ++++E+L
Sbjct: 226 PPNCPPELYKLM--------LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  166 bits (424), Expect = 2e-49
 Identities = 86/279 (30%), Positives = 133/279 (47%), Gaps = 33/279 (11%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-----LIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 121
              KLG+G FG VYKG+L+  G      +AVK L+        EEF+ E   + ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           VV+LLG C+E     +V EYM  G L  ++  +++R + L    L   AL  ARG+EYL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPK-LSLSDLLSFALQIARGMEYLE 119

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H D+   N L+  N + K+SDFGL++    + D+      +  I ++APE  
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE-- 173

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
           S   G  + KSDV+ FG++L E+   G +    M+            V + L  G  L  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLKNGYRL-- 222

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                       +L  + L C      DRP+ ++++E+L
Sbjct: 223 ----PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  164 bits (419), Expect = 9e-49
 Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 36/282 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHV 120
               KLG+G FG VYKG L      T   +AVK L+        EEF+ E S + ++ H 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           N+V+LLG C++G    +V EYMP G L   +      G+ L  + L ++AL  A+G+EYL
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                   +H D+   N L+  N + K+SDFGL++   +++ +      +  I ++APE 
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           +    G  + KSDV+ FG++L E+   G +    M+            V + L  G  L 
Sbjct: 176 L--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLELLEDGYRLP 224

Query: 299 -LQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
             +N   E+  ++ +        C      DRP+ ++++E L
Sbjct: 225 RPENCPDELYELMLQ--------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (410), Expect = 5e-48
 Identities = 67/196 (34%), Positives = 109/196 (55%), Gaps = 13/196 (6%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+GGFG+VY  +  +TG  +A+K++  E+S    EE + E+  + +++H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   LV EY   GSL   +   +     L  +++  + L    G+EYLH+     I+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 190 HFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           H D+KP NILLD  N   K++DFGL+K    +   +      GT  Y+APE++    G  
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGK-GYY 171

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++  G++L E+
Sbjct: 172 SEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (413), Expect = 6e-48
 Identities = 84/278 (30%), Positives = 134/278 (48%), Gaps = 32/278 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVV 123
               KLG G FG+VYK + + TG ++AVK+L+     +++      E+  + R+ H N+V
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-N 182
           +L+    +     LV EY   G L  ++    SRG  L  ++  ++AL   RG+EYLH N
Sbjct: 62  RLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           G    I+H D+KP NILLD N + K++DFGLAK   K +  ++     GT  Y+APE++ 
Sbjct: 118 G----IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAPEVLL 171

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
              G    K DV+  G++L E+  G+      N+             +  +   G  LE 
Sbjct: 172 GGNG-YGPKVDVWSLGVILYELLTGKPPFSGENILD--------QLQLIRR-ILGPPLEF 221

Query: 300 QNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVLE 336
                      A+ L      C+    + RP+  ++L+
Sbjct: 222 DEPKWSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 5e-44
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 21/203 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G FG VY  +  +TG L+A+K+++  K     E  + E+  + ++ H N+V+L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
             +  K  LV EY   G L   +     +   L  ++           +EYLH      I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLL----KKRGRLSEDEARFYLRQILSALEYLH---SKGI 118

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILLD +   K++DFGLA+      K   FV      GT  Y+APE++    
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV------GTPEYMAPEVLLGK- 171

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                  D++  G++L E+  G+
Sbjct: 172 -GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  152 bits (386), Expect = 6e-44
 Identities = 85/284 (29%), Positives = 138/284 (48%), Gaps = 39/284 (13%)

Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           KLG+G FG VYKG+L+        +AVK L+      E  +F+ E   + ++ H NVV+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 126 LGFCSEGSKRALVYEYMPNGSLD------RHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           LG C+E     LV EYM  G L       R VFP   +  +L  + L   A+  A+G+EY
Sbjct: 62  LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-STLSLKDLLSFAIQIAKGMEY 120

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L +      +H D+   N L+  + + K+SDFGL++    ++ +   +  +  I ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 297
            +    G  + KSDV+ FG++L E+   G      ++            V + L KG  L
Sbjct: 178 SL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---------VLEYLRKGYRL 226

Query: 298 EL-QNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              +    E+  ++        L C Q+   DRP+ ++++E LE
Sbjct: 227 PKPEYCPDELYELM--------LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 1e-37
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 27/211 (12%)

Query: 71  HKLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
             LG+G FGSVY    + TG L+AVK +E   +S+   E    E+  +  + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 127 GFCSEGSKRAL-VY-EYMPNGSLDRHVFPKESRGQSLCWEKLHE--VALGTA---RGIEY 179
           G   +  K  L ++ EY+  GSL   +   +  G      KL E  +   T     G+ Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFG------KLPEPVIRKYTRQILEGLAY 116

Query: 180 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           LH NG    I+H DIK  NIL+D + + K++DFG AK            + RGT  ++AP
Sbjct: 117 LHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           E+I          +D++  G  ++EMA G+ 
Sbjct: 173 EVIRG--EEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (310), Expect = 7e-33
 Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 15/201 (7%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            K+G+GGFG VYK    +TG  +A+K++   SK   E+ INE+  + +  H N+V+  G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDVC 187
             +  +  +V E+   GSL   +   +S  Q+L   ++  V     +G+EYLH NG    
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHSNG---- 118

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H DIK  NILL  +   K+ DFGL+          ++    GT  ++APE+I+     
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING--KP 173

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
              K+D++  G+  +E+A G+
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  118 bits (298), Expect = 3e-31
 Identities = 77/275 (28%), Positives = 128/275 (46%), Gaps = 32/275 (11%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
              ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C+E S   LV+E+M +G L    + +  RG     E L  + L    G+ YL +     +
Sbjct: 68  CTERSPICLVFEFMEHGCLSD--YLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NV 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFS--FSKY 178

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-----GDLELQNVT 303
           S KSDV+ FG+++ E+    +    N + S        V + +N G       L  Q+V 
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGFRLYKPRLASQSVY 231

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           E+              C + +  DRPS + +L  L
Sbjct: 232 ELMQ-----------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 1e-30
 Identities = 76/280 (27%), Positives = 134/280 (47%), Gaps = 41/280 (14%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L+  G     +A+K L+      +  +F+ E S +G+  H N+++L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ EYM NGSLD+  F +E+ G+     +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDK--FLRENDGK-FTVGQLVGMLRGIASGMKYL---SEM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   NIL++ N + KVSDFGL++         +    +  I + APE I+  + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA--YR 183

Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLEL 299
             +  SDV+ FG+V+ E M+ G R              P W      V   +  G    L
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGER--------------PYWDMSNQDVIKAVEDG--YRL 227

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +  S + +    + L C Q    +RP+ ++++  L+
Sbjct: 228 PPPMDCPSALYQ----LMLDCWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  115 bits (291), Expect = 4e-30
 Identities = 67/194 (34%), Positives = 101/194 (52%), Gaps = 10/194 (5%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
           KLG G FG V++G  +    +A+K+L+ +     ++F  EV  + R+ H +++ L   CS
Sbjct: 13  KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILH 190
            G    ++ E M  GSL    F +   GQ L    L ++A   A G+ YL    +   +H
Sbjct: 73  VGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   NIL+  + + KV+DFGLA+   KE D    S  +    + APE  S   GT S 
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL-IKE-DVYLSSDKKIPYKWTAPEAASH--GTFST 183

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L EM
Sbjct: 184 KSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 5e-29
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENS--KFSAEEFINEVSTIGRIHHVN 121
           F  +LG+G FG V   +       TG  +AVK L +S  +    +F  E+  +  + H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 122 VVQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           +V+  G C +   R+  L+ EY+P+GSL R    +     +L  ++L   +    +G++Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSL-RDYLQRHRDQINL--KRLLLFSSQICKGMDY 124

Query: 180 LHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIA 237
           L +       +H D+   NIL++   + K+SDFGLAK  P++ D+  +     + I + A
Sbjct: 125 LGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE +  +    S  SDV+ FG+ L E+
Sbjct: 181 PECLRTS--KFSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  111 bits (280), Expect = 1e-28
 Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 32/275 (11%)

Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 72  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE  S  +   S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE--SLAYNKFS 183

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNKGGDLEL-QNVTE 304
            KSDV+ FG++L E+          AT     Y P    S VY+ L KG  +E  +    
Sbjct: 184 IKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKGYRMERPEGCPP 232

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               + R        C Q   +DRPS  ++ +  E
Sbjct: 233 KVYELMRA-------CWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 1e-28
 Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 8/193 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G       +AVK L+    S E F+ E   + ++ H  +VQL   CSE
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ YL +      +H 
Sbjct: 73  EEPIYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   NIL+  N + K++DFGLA+   +++++ +    +  I + APE    N+G  + K
Sbjct: 128 DLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAA--NYGRFTIK 184

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 1e-28
 Identities = 58/196 (29%), Positives = 105/196 (53%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V+ G+ +    +A+KM+     S ++FI E   + ++ H N+VQL G 
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V EYM NG L  ++  ++ +  +   E L ++       +EYL +      
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGT---EWLLDMCSDVCEAMEYLESN---GF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  + + KVSDFGLA++   ++ + S   T+  + +  PE+   ++   
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVF--DYSRF 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (280), Expect = 7e-28
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 17/209 (8%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS----AEEFINEVSTIGRI-HHVNVVQLL 126
           KLG+G FG VY  + +   L+A+K+L     S     E F+ E+  +  + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV EY+  GSL   +  K  R   L   +   +       +EYLH     
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYLH---SK 120

Query: 187 CILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELI 241
            I+H DIKP NILLD +  + K+ DFGLAK  P      SI A      GT GY+APE++
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 242 SR-NFGTVSCKSDVYGFGMVLLEMAGGRR 269
              +    S  SD++  G+ L E+  G  
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-27
 Identities = 65/198 (32%), Positives = 103/198 (52%), Gaps = 15/198 (7%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V  G  + G  +AVK L++   +A+ F+ E S +  + H N+VQLLG
Sbjct: 9   KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDV 186
              +G+   +V EYM  GSL  ++    SRG++ +   +    AL    G+EYL      
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK--- 121

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N+L+  + + KVSDFGLAK   +  D     + +  + + APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALRE--K 174

Query: 247 TVSCKSDVYGFGMVLLEM 264
             S KSDV+ FG++L E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 4e-27
 Identities = 77/280 (27%), Positives = 135/280 (48%), Gaps = 43/280 (15%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGFC 129
           K+G+G FG VYKG L+    +AVK   ++       +F+ E   + +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            +     +V E +P GSL   +  K++R   L  +KL +++L  A G+EYL +    CI 
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEYLESKN--CI- 115

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI--GYIAPELISRNFG 246
           H D+   N L+  N + K+SDFG+++   +E   + ++S     I   + APE +  N+G
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEAL--NYG 170

Query: 247 TVSCKSDVYGFGMVLLEM--AGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
             + +SDV+ +G++L E    G      M+  ++          +++  G          
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------ERIESGY--------- 212

Query: 305 IESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
              M A +LC      + L C      +RPS +++   L+
Sbjct: 213 --RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 5e-27
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
              KLG G FG V++G       +AVK L+      ++F+ E   + ++ H  ++QL   
Sbjct: 10  LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGCDV 186
           C+      +V E M  GSL    + +   G++L   +L ++A   A G+ YL   N    
Sbjct: 70  CTLEEPIYIVTELMKYGSLLE--YLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---- 123

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N+L+  N I KV+DFGLA+   KE+ + +    +  I + APE     + 
Sbjct: 124 -YIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAA--LYN 179

Query: 247 TVSCKSDVYGFGMVLLEM 264
             S KSDV+ FG++L E+
Sbjct: 180 RFSIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  104 bits (261), Expect = 8e-26
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 28/220 (12%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE-----------FINEVSTIGRIHHV 120
           +G+G +G VY    + TG ++AVK +E     A               +E+ T+  + H+
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGS----LDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           N+VQ LGF +     ++  EY+P GS    L  +   +E   +    + L         G
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--------EG 120

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YLH+     ILH D+K  N+L+D + I K+SDFG++K      D     + +G++ ++
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNA 275
           APE+I       S K D++  G V+LEM  GRR  S+  A
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  103 bits (260), Expect = 9e-26
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 26/212 (12%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +K+G G FG VY    L TG L+AVK +   +N   + +E  +E+  +  + H N+V+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV-ALGTARGIEYLH-NGC 184
           G      K  +  EY   G+L+  +         +  E +  V  L    G+ YLH +G 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL-----EHGRILDEHVIRVYTLQLLEGLAYLHSHG- 119

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAPELIS 242
              I+H DIKP NI LDHN + K+ DFG A    +        + +  GT  Y+APE+I+
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 243 RN-----FGTVSCKSDVYGFGMVLLEMAGGRR 269
                          D++  G V+LEMA G+R
Sbjct: 177 GGKGKGHGRAA----DIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (260), Expect = 1e-25
 Identities = 78/296 (26%), Positives = 122/296 (41%), Gaps = 74/296 (25%)

Query: 71  HKLGQGGFGSVYKGQLQ-TGGLIAVK---MLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
             LGQG  G VYK + + TG + A+K   +  + +F  ++ + E+ T+       VV+  
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCY 65

Query: 127 G-FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA-----RGIEYL 180
           G F  EG    +V EYM  GSL   +             K+ E  L        +G++YL
Sbjct: 66  GAFYKEGEIS-IVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYL 115

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYI 236
           H      I+H DIKP N+L++     K++DFG++K       + N FV      GT+ Y+
Sbjct: 116 HT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV------GTVTYM 167

Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWV- 287
           +PE I   ++      +D++  G+ LLE A G+              FP       S+  
Sbjct: 168 SPERIQGESYSY---AADIWSLGLTLLECALGK--------------FPFLPPGQPSFFE 210

Query: 288 -YDQLNKGGDLELQNVT---EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +  G    L       E    I+         C+Q     RPS     E+L+
Sbjct: 211 LMQAICDGPPPSLPAEEFSPEFRDFISA--------CLQKDPKKRPS---AAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  103 bits (260), Expect = 1e-25
 Identities = 70/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           ++G+G FG VY  +    G L  +K ++ S  S +E    +NEV  + +++H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              E  K  +V EY   G L + +  ++  G+    E++ +  +     ++YLH      
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRK 123

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---N 244
           ILH DIKP NI L  N + K+ DFG++K     +         GT  Y++PEL      N
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
           +     KSD++  G VL E+   +      N+             +  ++ KG       
Sbjct: 182 Y-----KSDIWSLGCVLYELCTLKHPFEGENLLE-----------LALKILKG------Q 219

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
              I S  + +L  +    +Q    +RPS+ ++L+ 
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (260), Expect = 2e-25
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
              K+G+G  G VYK     TG  +A+K +   K + E  INE+  +    H N+V    
Sbjct: 23  NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 128 FCSEGSKRALVYEYMPNGSL----DRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLH- 181
               G +  +V EYM  GSL     ++     E +   +C E L        +G+EYLH 
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL--------QGLEYLHS 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIA 237
                  +H DIK  NILL  +   K++DFG A    K   K N  V      GT  ++A
Sbjct: 135 QNV----IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV------GTPYWMA 184

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           PE+I R       K D++  G++ +EMA G
Sbjct: 185 PEVIKRK--DYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  101 bits (253), Expect = 1e-24
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHH 119
               +LG+G FG V+ G+           L+AVK L+   S  + ++F  E   +    H
Sbjct: 8   VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRH-----------VFPKESRGQSLCWEKLHE 168
            N+V+  G C+EG    +V+EYM +G L++              P    G+ L   +L +
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQ 126

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A+  A G+ YL +   V   H D+   N L+ ++ + K+ DFG+++      D+  +  
Sbjct: 127 IAVQIASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYYRVGG 182

Query: 229 TRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                I ++ PE I   +   + +SDV+ FG+VL E+
Sbjct: 183 HTMLPIRWMPPESIM--YRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 79/291 (27%), Positives = 128/291 (43%), Gaps = 51/291 (17%)

Query: 73  LGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV +GQL     +   +AVK ++    +    EEF++E + +    H NV++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 126 LGFCSEGSKRA------LVYEYMPNGSLDRHVFPKESRGQS--LCWEKLHEVALGTARGI 177
           +G C E S         ++  +M +G L   +      G    L  + L +  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           EYL N      +H D+   N +L  +    V+DFGL+K     + +      +  + +IA
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNK 293
            E ++    T   KSDV+ FG+ + E+          ATR    Y P      +YD L  
Sbjct: 184 IESLADRVYTS--KSDVWAFGVTMWEI----------ATRGQTPY-PGVENHEIYDYLRH 230

Query: 294 GGDLELQNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
           G  L+             + C+  L+     C +    DRP+ TK+ E+LE
Sbjct: 231 GNRLK-----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 25/202 (12%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLG 127
            +G+G FG VYKG  L+TG  +A+K +   K   E     + E+  +  + H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDV 186
                    ++ EY  NGSL + +       +SL    +++V     +G+ YLH  G   
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV----LQGLAYLHEQG--- 119

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELIS 242
            ++H DIK  NIL   + + K++DFG+A         +   V      GT  ++APE+I 
Sbjct: 120 -VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV------GTPYWMAPEVI- 171

Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
                 S  SD++  G  ++E+
Sbjct: 172 -EMSGASTASDIWSLGCTVIEL 192

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (249), Expect = 2e-24
 Identities = 63/193 (32%), Positives = 102/193 (52%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G       +AVK L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K+  G++L    L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+    + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 5e-24
 Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 21/212 (9%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
           KLG+G +GSVYK    +TG ++A+K++   +   +E I E+S + +     +V+  G   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV-EEDLQEIIKEISILKQCDSPYIVKYYGSYF 68

Query: 131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           + +   +V EY   GS+   +   +   ++L  E++  +   T +G+EYLH+      +H
Sbjct: 69  KNTDLWIVMEYCGAGSVSDIM---KITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIH 122

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IG---YIAPELISRNFG 246
            DIK  NILL+     K++DFG++             A R T IG   ++APE+I     
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSG------QLTDTMAKRNTVIGTPFWMAPEVIQEI-- 174

Query: 247 TVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
             + K+D++  G+  +EMA G+   S+++  R
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR 206

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 98.6 bits (245), Expect = 8e-24
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 98.3 bits (245), Expect = 1e-23
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 47/279 (16%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVK--MLENSKFSAEEFIN----EVSTIGRIHHVNVVQL 125
           LG G FGSVY+G  L  G   AVK   L +   + +E +     E++ + ++ H N+VQ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR---GIEYLHN 182
           LG   E     +  E +P GSL + +    S  + +       + L T +   G+EYLH+
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-------IRLYTRQILLGLEYLHD 120

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                 +H DIK  NIL+D N + K++DFG+AK    E  F    + +G+  ++APE+I+
Sbjct: 121 RN---TVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSF--AKSFKGSPYWMAPEVIA 174

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-----VYDQLNKGGDL 297
           +  G     +D++  G  +LEMA G+               P W     V      G   
Sbjct: 175 QQ-GGYGLAADIWSLGCTVLEMATGK---------------PPWSQLEGVAAVFKIGRSK 218

Query: 298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           EL  + +  S  A+   +    C+Q   + RP+  ++LE
Sbjct: 219 ELPPIPDHLSDEAKDFILK---CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.0 bits (244), Expect = 1e-23
 Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G       +A+K L+    S E F+ E + + ++ H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 132 GSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                ++ EYM NGSL D   F K   G  L   KL ++A   A G+ ++        +H
Sbjct: 73  -EPIYIITEYMENGSLVD---FLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+GT + 
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI--NYGTFTI 182

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L E+
Sbjct: 183 KSDVWSFGILLTEI 196

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 43/272 (15%)

Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L    S  + +E ++E   +  + H +VV+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG-----QSLCWEKLHEVALGTARGIEYL 180
           LG C   S+  L+ + MP G L  +V  +  +        L W       +  A+G+ YL
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +  ++H D+   N+L+      K++DFGLAK    +         +  I ++A E 
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           I       + KSDV+ +G+ + E+   G +    + A           + D L KG  L 
Sbjct: 183 I--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---------IPDLLEKGERLP 231

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
              +  I+      + M+ + C  + A  RP+
Sbjct: 232 QPPICTID------VYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 97.6 bits (243), Expect = 2e-23
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   + ++ H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V EYM NG L  ++      G+     +L E+      G+ YL +      
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+D     KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--LYSKF 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 70/216 (32%), Positives = 118/216 (54%), Gaps = 24/216 (11%)

Query: 67  NHFTHK--LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIH 118
           +H T +  +G G FG V++G L+  G     +A+K L+   ++   ++F++E S +G+  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           H N+++L G  ++     ++ EYM NG+LD+++   +    S    +L  +  G A G++
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMK 121

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGY 235
           YL    D+  +H D+   NIL++ N   KVSDFGL++    E+D      T G    I +
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPIRW 176

Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            APE I+ R F +    SDV+ FG+V+ E M+ G R
Sbjct: 177 TAPEAIAYRKFTSA---SDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 96.9 bits (241), Expect = 5e-23
 Identities = 65/208 (31%), Positives = 115/208 (55%), Gaps = 20/208 (9%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L+  G     +A+K L++  ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ E+M NG+LD   F +++ GQ     +L  +  G A G++YL    ++
Sbjct: 72  GVVTKSRPVMIITEFMENGALDS--FLRQNDGQ-FTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++F      +  + S    +  I + APE I+ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+V+ E M+ G R
Sbjct: 186 RKF---TSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 7e-23
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 71  HKLGQGGFGSVYKGQLQTGGL----IAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQ 124
            +LG G FGSV KG           +AVK L+    +A  +EF+ E S + ++ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L+G C +G    LV E  P G L    + K+ R   +    L E+A   A G+ YL    
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPL--LKYLKKRREIPV--SDLKELAHQVAMGMAYLE--- 112

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 243
               +H D+   N+LL +    K+SDFG+++      + + + +A R  + + APE I  
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-- 170

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
           N+G  S KSDV+ +G+ L E 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 26/210 (12%)

Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLE---NSKFSAE----EFINEVSTIGRIHHVNVVQL 125
           LG+G +G+VY G    G LIAVK +E   ++  +AE    +   EV  +  + HVN+VQ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C + +  ++  E++P GS+   +    +R   L      +       G+ YLHN   
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNN-- 121

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTIGYIAPE 239
            C++H DIK +N++L  N I K+ DFG A+       H   ++   + +  GT  ++APE
Sbjct: 122 -CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM--LKSMHGTPYWMAPE 178

Query: 240 LISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           +I+ + +G    KSD++  G  + EMA G+
Sbjct: 179 VINESGYGR---KSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 95.6 bits (239), Expect = 1e-22
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 36/212 (16%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           KLG+G +G VYK +  +TG ++A+K   L+N +   E      + E+S +  + H N+V+
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE---EGIPSTALREISLLKELKHPNIVK 62

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYL 180
           LL       K  LV+EY        LD+   P   +  +S+ ++ L        RG+ Y 
Sbjct: 63  LLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLL--------RGLAYC 114

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      ILH D+KP NIL++ + + K++DFGLA+ F      +        T+ Y APE
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPE 168

Query: 240 LI--SRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
           ++  S+++ T V    D++  G +  EM  G+
Sbjct: 169 ILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 95.4 bits (237), Expect = 2e-22
 Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 46/286 (16%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+   ++    +F++E S +G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD   F ++  GQ     +L  +  G A G++YL    D+
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLD--AFLRKHDGQ-FTVIQLVGMLRGIASGMKYL---SDM 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + APE I+ 
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
           R F   +  SDV+ +G+V+ E M+ G R              P W  +  N+  D+ ++ 
Sbjct: 184 RKF---TSASDVWSYGIVMWEVMSYGER--------------PYW--EMSNQ--DV-IKA 221

Query: 302 VTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSI 342
           + E   + A   C   L      C Q    +RP   +++ +L+  I
Sbjct: 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 59/193 (30%), Positives = 101/193 (52%), Gaps = 8/193 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+ G       +AVK L+    S + F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                ++ EYM  GSL    F K   G  +   KL + +   A G+ Y+        +H 
Sbjct: 73  EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHR 127

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 184

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 185 SDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.9 bits (233), Expect = 4e-22
 Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 27/201 (13%)

Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FC 129
             +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG   
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCI 188
            E     +V EYM  GSL  ++    SRG+S L  + L + +L     +EYL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPE-LISR 243
           +H D+   N+L+  + + KVSDFGL K           S+T+ T    + + APE L  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLPVKWTAPEALREK 174

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
            F T   KSDV+ FG++L E+
Sbjct: 175 KFST---KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 45/277 (16%)

Query: 72  KLGQGGFGSVYKGQL----QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           KLG+G +GSVYK +     Q   L  V +   S+   E+ +NE+  +  ++H N++    
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +G+K  +V EY P G L + +  ++ + + +  +++  + +   RG++ LH   +  
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQK 123

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILH D+K  NILL  N + K+ D G++K   K      I    GT  Y+APE+       
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKGR--P 177

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMNA-------TRSSKAYFP--SWVYDQLNKGGDLE 298
            S KSD++  G +L EMA         A        +  +  +P    +Y Q       +
Sbjct: 178 YSYKSDIWSLGCLLYEMATFA--PPFEARSMQDLRYKVQRGKYPPIPPIYSQ-------D 228

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
           LQN                   +QVK   RP+  K+L
Sbjct: 229 LQNF-----------IR---SMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 93.0 bits (231), Expect = 8e-22
 Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 9/196 (4%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V+ G+ +    +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V E+M NG L    + ++ +G+ L  + L  +      G+EYL        
Sbjct: 68  CTQQKPLYIVTEFMENGCLLN--YLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SF 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+    + KVSDFG+ ++   ++++ S S  +  + +  PE+   NF   
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVF--NFSKY 178

Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 179 SSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 93.2 bits (231), Expect = 8e-22
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+      E F+ E   + ++ H  +V L    SE
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V E+M  GSL    F KE  G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 73  -EPIYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + K++DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 184 SDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 72/218 (33%), Positives = 116/218 (53%), Gaps = 43/218 (19%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVV 123
            ++G+G +G VYK +  +TG L+A+K   +EN K   E F    I E+  + ++ H N+V
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK---EGFPITAIREIKLLQKLRHPNIV 61

Query: 124 QLLGFCSEGSKRA--LVYEYMP---NGSLDRHVFPKESRGQSLCWEK-LHEVALGTARGI 177
           +L    +   K +  +V+EYM     G LD     K +  Q  C+ K L E       G+
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQLLE-------GL 113

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVS--ISATRGT 232
           +YLH NG    ILH DIK  NIL++++ + K++DFGLA+ + K N  D+ +  I     T
Sbjct: 114 QYLHSNG----ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----T 164

Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           + Y  PEL+  +  +G    + D++  G +L E+  G+
Sbjct: 165 LWYRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 2e-21
 Identities = 61/194 (31%), Positives = 106/194 (54%), Gaps = 17/194 (8%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
            +G+G FG+V +G+  TG  +AVK ++    +A+ F+ E + + ++HH N+V+LLG    
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLC-WEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V E M  G+L   +    +RG++L    +L + +L  A G+EYL +     ++H
Sbjct: 71  NGLY-IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123

Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   NIL+  + + KVSDFGLA+      D      ++  + + APE +       S 
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHK--KFSS 176

Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ +G++L E+
Sbjct: 177 KSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 17/205 (8%)

Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S      +F  E+  +  + H N+
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   LV EY+P GSL  ++     R   L   KL   A    +G+EYL
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL 124

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    + H D+   NIL++     K+ DFGL K  P++ ++  +       I + APE
Sbjct: 125 --GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 182 SLTES--KFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 33/220 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG------LIAVKML--ENSKFSAEEFINEVSTIGRIHHV 120
           F  +LG+G FG VYKG+L           +A+K L         +EF  E   +  + H 
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF--------------PKESRGQSLCWEKL 166
           N+V LLG C++     +++EY+ +G L  H F                E+   SL     
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDL--HEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126

Query: 167 HEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             +A+  A G+EYL  H+      +H D+   N L+      K+SDFGL++     + + 
Sbjct: 127 LHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR 181

Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             S +   + ++ PE I   +G  + +SD++ FG+VL E+
Sbjct: 182 VQSKSLLPVRWMPPEAIL--YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 73  LGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 124
           LGQG FG VY+G        +    +A+K +  +    E  EF+NE S +   +  +VV+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKE---SRGQSLCWEKLHEVALGTARGIE 178
           LLG  S G    +V E M  G L    R   P+            +K  ++A   A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YL        +H D+   N ++  +   K+ DFG+ +   + + +         + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA 265
           E  S   G  + KSDV+ FG+VL EMA
Sbjct: 191 E--SLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 7e-21
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 38/213 (17%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN--EVSTIGRI-HHVNVVQLLG 127
           +LG G FGSVY  +  +TG L+A+K ++   +S EE +N  EV ++ ++  H N+V+L  
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65

Query: 128 FCSEGSKRALVYEYMPNGSL-------DRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
              E  +   V+EYM  G+L           F  ES  +S+ ++          +G+ ++
Sbjct: 66  VFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQ--------ILQGLAHI 115

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN----DFVSISATRGTIGY 235
           H +G      H D+KP N+L+    + K++DFGLA+   +      D+VS   TR    Y
Sbjct: 116 HKHG----FFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDYVS---TR---WY 164

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            APE++ R+  + S   D++  G ++ E+   R
Sbjct: 165 RAPEILLRS-TSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 90.3 bits (224), Expect = 1e-20
 Identities = 75/286 (26%), Positives = 130/286 (45%), Gaps = 46/286 (16%)

Query: 73  LGQGGFGSVYKGQLQTGG--LIAVK--MLENSKF---------SAEEFINEVSTIG-RIH 118
           LG G FG VYK + +  G  L+A+K   + N  F         S  + ++EV+ I  ++ 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           H N+V+      E  +  +V + +    L  H    + + Q    E++  + +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YLH   +  I+H D+ P+NI+L  +    ++DFGLAK    E+   S+    GTI Y  P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV---GTILYSCP 182

Query: 239 ELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNM--NATRSSKAYFPSWVYDQLN 292
           E++ +  +G    K+DV+ FG +L +M   +    ++NM   AT+  +A     VY+ L 
Sbjct: 183 EIVKNEPYGE---KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA-----VYEPLP 234

Query: 293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                        E M +  +  +   C+   A  RP + +V  M+
Sbjct: 235 -------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 40/203 (19%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS-AEEFIN-----EVSTIGRIHHVNVV 123
            KLG+G +  VYK    +TG ++A+K ++  +   A++ IN     E+  +  + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 124 QLLGFCSEGSKRALVYEYMP--------NGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            LL      S   LV+E+M         + S+   V    +      +       L T R
Sbjct: 66  GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VL---TPADIKSY------MLMTLR 113

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+EYLH+     ILH D+KP+N+L+  + + K++DFGLA+     N  ++      T  Y
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWY 168

Query: 236 IAPELISRNFGTVSCKSDVYGFG 258
            APEL+   FG    +   YG G
Sbjct: 169 RAPELL---FG---ARH--YGVG 183

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.0 bits (221), Expect = 3e-20
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 72  KLGQGGFGSVYKGQLQTGGLI-AVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           +LG+G  GSV K +L+  G+I A+K    + +    ++ + E+          +V+  G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 128 FCSEGSKR-ALVYEYMPNGSLDRHVFPKESRGQS-LCWEK-LHEVALGTARGIEYLHNGC 184
           F  E S    +  EY   GSLD     K+ + +     EK L ++A    +G+ YLH   
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDS--IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--- 122

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISAT-RGTIGYIAPELIS 242
              I+H DIKP NILL      K+ DFG++       + V S++ T  GT  Y+APE I 
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVS------GELVNSLAGTFTGTSFYMAPERIQ 176

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
                 S  SDV+  G+ LLE+A  R
Sbjct: 177 G--KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V K   + TG ++AVK +      A   + + E+  + + +   +V   G 
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                  ++  EYM  GSLD     KE +G+ +    L ++A+   +G+ YLH      I
Sbjct: 68  FYNNGDISICMEYMDGGSLD--KILKEVQGR-IPERILGKIAVAVLKGLTYLHE--KHKI 122

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++    +     FV      GT  Y+APE I  N  
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------GTSSYMAPERIQGNDY 176

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           +V  KSD++  G+ L+E+A GR
Sbjct: 177 SV--KSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 88.4 bits (219), Expect = 5e-20
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 126
           LG G FG + +G L+        +A+  L       +   F+ E  T+G+  H N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  + G+   +V EYM NG+LD   F ++  GQ L   +L  +  G A G++YL    ++
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDS--FLRKHEGQ-LVAGQLMGMLPGLASGMKYL---SEM 126

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H  +  H +L++ + + K+S F   +    E  + ++S  +  + + APE I   + 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSG-KSPVLWAAPEAI--QYH 183

Query: 247 TVSCKSDVYGFGMVLLE-MAGGRR 269
             S  SDV+ FG+V+ E M+ G R
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 37/214 (17%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
             +G+G +G V K +   TG ++A+K     E+ +   +  + EV  + ++ H N+V L 
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRG-------QSLCWEKLHEVALGTARGIEY 179
                  +  LV+EY+    L+     + S G       +S  W+ L        + I Y
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLE---LLEASPGGLPPDAVRSYIWQLL--------QAIAY 115

Query: 180 LH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYI 236
            H +     I+H DIKP NIL+  + + K+ DFG A+       +      ATR    Y 
Sbjct: 116 CHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---WYR 168

Query: 237 APELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           APEL+    N+G      DV+  G ++ E+  G 
Sbjct: 169 APELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 6e-20
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 43/237 (18%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG V   +   TG L A+K+L+  K       E  + E + + RI+H  +V+L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--------GI 177
             +  ++  L  V EY P G L  H              K    +   AR         +
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSH------------LSKEGRFSEERARFYAAEIVLAL 106

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           EYLH+   + I++ D+KP NILLD +   K++DFGLAK     ++    +   GT  Y+A
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLA 161

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           PE++       +   D +  G++L EM  G+      +              FP ++
Sbjct: 162 PEVLLGKGYGKAV--DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.5 bits (219), Expect = 7e-20
 Identities = 83/309 (26%), Positives = 142/309 (45%), Gaps = 55/309 (17%)

Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFINEVST 113
           YP +      F   +G+G FG V K +++  GL    A+K ++   SK    +F  E+  
Sbjct: 1   YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60

Query: 114 IGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESR--------------G 158
           + ++ HH N++ LLG C       L  EY P+G+L    F ++SR               
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTA 118

Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
            +L  ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++   
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--- 172

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNAT 276
            +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M   
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230

Query: 277 RSSKAYFPSWVYDQLNKGGDLE--LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
                     +Y++L +G  LE  L    E+  ++ +        C + K  +RPS  ++
Sbjct: 231 E---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSFAQI 273

Query: 335 L----EMLE 339
           L     MLE
Sbjct: 274 LVSLNRMLE 282

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.2 bits (216), Expect = 1e-19
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 33/211 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY  + L T   IA+K +   +S++  +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE--KLHEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W   K +E  +         G++YLH 
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMA 177

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 86.3 bits (214), Expect = 2e-19
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 72  KLGQGGFGSVYKGQLQTGGL----IAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 125
           KLG G FG V +G+  T G     +AVK L++ K S   ++F+ E + +  + H N+++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            G         +V E  P GSL DR    ++          L + A+  A G+ YL +  
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELISR 243
               +H D+   NILL  +   K+ DFGL +  P+  D   +         + APE  S 
Sbjct: 118 ---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE--SL 172

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
              T S  SDV+ FG+ L EM
Sbjct: 173 RTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 85.7 bits (213), Expect = 4e-19
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 73  LGQGGFGSVYKGQLQTGGLI-AVKMLENSKFSAEEFINEVS----TIGRI-HHVNVVQLL 126
           +G+G F +V   + +      A+K+L+  +   E+ +  V      + R+  H  +++L 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 127 G-FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGC 184
             F  E      V EY PNG L +++    S  +        E+ L     +EYLH  G 
Sbjct: 69  YTFQDE-ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA----LEYLHSKG- 122

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATR--------- 230
              I+H D+KP NILLD +   K++DFG AK       P+ N   + +            
Sbjct: 123 ---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 231 ----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
               GT  Y++PEL++         SD++  G ++ +M  G+
Sbjct: 180 ASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.4 bits (211), Expect = 4e-19
 Identities = 62/196 (31%), Positives = 106/196 (54%), Gaps = 17/196 (8%)

Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G FG V+KG L+    +AVK  +      E   +F++E   + +  H N+V+L+G C
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           ++     +V E +P G     +  K+     L  ++L + AL  A G+ YL +    CI 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLES--KNCI- 115

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA--TRGTIGYIAPELISRNFGT 247
           H D+   N L+  N + K+SDFG+++   +E+D +  S+   +  I + APE +  N+G 
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEAL--NYGR 170

Query: 248 VSCKSDVYGFGMVLLE 263
            S +SDV+ +G++L E
Sbjct: 171 YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 73/254 (28%), Positives = 123/254 (48%), Gaps = 28/254 (11%)

Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+V+KG     G      +A+K +++   + + +E  + +  +G + H  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C  G+   LV +  P GSL  HV  ++ R  SL  ++L    +  A+G+ YL    +
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHV--RQHRD-SLDPQRLLNWCVQIAKGMYYLE---E 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H ++   NILL  + I +++DFG+A     ++     S  +  I ++A E I   F
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI--LF 185

Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           G  + +SDV+ +G+ + EM   G    + M          P  V D L KG  L    + 
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR---------PHEVPDLLEKGERLAQPQIC 236

Query: 304 EIES-MIARKLCMI 316
            I+  M+  K  MI
Sbjct: 237 TIDVYMVMVKCWMI 250

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 6e-19
 Identities = 70/231 (30%), Positives = 106/231 (45%), Gaps = 34/231 (14%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG G FG V   +   +G   A+K+L  +K       E  +NE   +  I H  +V L G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH--EVALGTARGIEYLHNGCD 185
              + S   LV EY+P G L  H+  ++S        + +  +V L     +EYLH+  D
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPVARFYAAQVVLA----LEYLHS-LD 121

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRN 244
             I++ D+KP N+LLD +   K++DFG AK               GT  Y+APE+I S+ 
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSKG 174

Query: 245 FGTVSCKS-DVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           +G    K+ D +  G+++ EM  G     + N           K  FPS+ 
Sbjct: 175 YG----KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF 221

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 85.7 bits (212), Expect = 6e-19
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L  E  + +   +  E++ +  ++H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 126 LGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G CSE   +   L+ EY+P GSL R   PK     +    +L   A     G+ YLH+ 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL-RDYLPKHKLNLA----QLLLFAQQICEGMAYLHSQ 126

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELIS 242
                +H D+   N+LLD++ + K+ DFGLAK  P+ +++  +       + + A E + 
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
            N    S  SDV+ FG+ L E+
Sbjct: 184 EN--KFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 9/193 (4%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLG G FG V+         +AVK ++    S E F+ E + +  + H  +V+L    ++
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                ++ E+M  GSL    F K   G      KL + +   A G+ ++        +H 
Sbjct: 73  -EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 126

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIK 183

Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L+E+
Sbjct: 184 SDVWSFGILLMEI 196

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.9 bits (210), Expect = 8e-19
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 72  KLGQGGFGSVYKGQLQTGGLI-AVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG V+K   +    + A+K ++ SK +    EE I+E   + ++    +++   
Sbjct: 7   KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  K  +V EY  NG L  H   K  RG+ L  +++    +    G+ +LH+     
Sbjct: 67  SFLDKGKLNIVMEYAENGDL--HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--- 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILH DIK  N+ LD     K+ D G+AK      +F   +   GT  Y++PEL       
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDK--P 177

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            + KSDV+  G+VL E   G+
Sbjct: 178 YNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 34/223 (15%)

Query: 69  FTHKLGQGGFGSVY----KGQLQTGG-----------LIAVKML--ENSKFSAEEFINEV 111
              KLG+G FG V+    +G  +  G           L+AVKML  + +K +  +F+ E+
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ--------SLCW 163
             + R+ + N+++LLG C       ++ EYM NG L++ +  +E            S+  
Sbjct: 69  KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128

Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
             L  +A+  A G++YL     +  +H D+   N L+ +++  K++DFG+++ +    D+
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR-NLYSGDY 184

Query: 224 VSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             I   R    I ++A E I    G  +  SDV+ FG+ L EM
Sbjct: 185 YRIQG-RAVLPIRWMAWESIL--LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 38/218 (17%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----------EEFINEVSTIGRIHHVN 121
           +G G FGSVY G    +G L+AVK +E    SA          +    E++ +  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGS----LDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           +VQ LG   +     +  EY+P GS    L+ +   +E+  ++   + L        +G+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL--------KGL 119

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR------- 230
            YLHN     I+H DIK  NIL+D+    K+SDFG++K   K       + T        
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           G++ ++APE++ +   T   K+D++  G +++EM  G+
Sbjct: 174 GSVFWMAPEVVKQTSYTR--KADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            +G+G FG+V K +    G ++  K ++    + +E    ++EV+ +  + H N+V+   
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              + S + L  V EY   G L + +   +   + +  E +  +       +   HN  D
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 186 V--CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               +LH D+KP NI LD N   K+ DFGLAK    ++ F       GT  Y++PE ++ 
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV--GTPYYMSPEQLNH 184

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
              +   KSD++  G ++ E+    
Sbjct: 185 M--SYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 70/233 (30%), Positives = 102/233 (43%), Gaps = 51/233 (21%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHV 120
               KLG+G FG VYK  Q++TG ++A+K  ++ N K   + F    + E+  + ++ H 
Sbjct: 11  EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK---DGFPITALREIKILKKLKHP 67

Query: 121 NVVQLLGFCSEGS-----KRALVYEYMP------NGSLDRHVFPKESRGQSLCWEKLHEV 169
           NVV L+    E       KR  VY   P      +G L+                +L E 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE- 126

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH------------ 217
                 GI YLH   +  ILH DIK  NIL+D+  I K++DFGLA+ +            
Sbjct: 127 ------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 218 PKENDFVSISATRGTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                + ++  TR    Y  PEL+   R + T     D++G G V  EM   R
Sbjct: 178 GGTRKYTNLVVTR---WYRPPELLLGERRYTT---AVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 49/227 (21%)

Query: 73  LGQGGFGSVYK--------GQLQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 122
           +GQG FG V++         +  T  ++AVKML  E S     +F  E + +    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPK--ESRGQS-------------LCWE 164
           V+LLG C+ G    L++EYM  G L+   RH  P+   S   S             L   
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------FH 217
           +   +A   A G+ YL    +   +H D+   N L+  N + K++DFGL++       + 
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             END + I        ++ PE I   +   + +SDV+ +G+VL E+
Sbjct: 188 ASENDAIPIR-------WMPPESIF--YNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 83.2 bits (205), Expect = 4e-18
 Identities = 83/293 (28%), Positives = 129/293 (44%), Gaps = 56/293 (19%)

Query: 73  LGQGGFGSVYKGQLQTGGLI---AVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FGSV +GQL     I   AVK ++    ++   E+F++E   +    H NV++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 127 GFCSEGSKR------ALVYEYMPNGSLDRHVFPKESR----GQSLCWEKLHEVALGTARG 176
           G C +  +        ++  +M +G L  H F   SR     Q L  + L +     A G
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDL--HSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +EYL +      +H D+   N +L+ N    V+DFGL+K     + +      +  + +I
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 237 APE-LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQL 291
           A E L  R + T   KSDV+ FG+ + E+          ATR    Y P    S +YD L
Sbjct: 182 AIESLADRVYTT---KSDVWSFGVTMWEI----------ATRGQTPY-PGVENSEIYDYL 227

Query: 292 NKGGDLELQNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
            +G  L+               C+ GL+     C  +   DRPS   +   LE
Sbjct: 228 RQGNRLK-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 39/214 (18%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG+ + TG ++A+K +      AEE      I E+S +  + H N+V+L
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG-------QSLCWEKLHEVALGTARGIE 178
                  +K  LV+EYM +  L +++     RG       +S  ++ L        +GI 
Sbjct: 64  HDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL--------KGIA 114

Query: 179 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 236
           + H N     +LH D+KP N+L++     K++DFGLA+ F    N F   S    T+ Y 
Sbjct: 115 FCHENR----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF---SNEVVTLWYR 167

Query: 237 APELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           AP+++  SR   T S   D++  G ++ EM  GR
Sbjct: 168 APDVLLGSR---TYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 43/282 (15%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            +G G    VY    L     +A+K   LE  + S +E   EV  + + +H NVV+    
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 129 CSEGSKRALVYEYMPNGS-LD--RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGC 184
              G +  LV  Y+  GS LD  +  +P+    +++    L EV     +G+EYLH NG 
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV----LKGLEYLHSNG- 122

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--------HPKENDFVSISATRGTIGYI 236
               +H DIK  NILL  +   K++DFG++                FV      GT  ++
Sbjct: 123 ---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV------GTPCWM 173

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 296
           APE++ +  G    K+D++ FG+  +E+A G       A  S   Y P  V     +   
Sbjct: 174 APEVMEQVHGYDF-KADIWSFGITAIELATGA------APYSK--YPPMKVLMLTLQNDP 224

Query: 297 LELQNVTEIE--SMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             L+   + +  S   RK  MI L C+Q   + RP+  ++L+
Sbjct: 225 PSLETGADYKKYSKSFRK--MISL-CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 83.2 bits (206), Expect = 5e-18
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 32/218 (14%)

Query: 71  HKLGQGGFGSVYKGQLQT------GGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
             LG+G FG V K +            +AVKML++     +  + ++E+  +  I  H N
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL------DRHVFPKESR------GQSLCWEKLHEV 169
           ++ LLG C++     +V EY  +G+L       R      S        ++L  + L   
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISA 228
           A   ARG+E+L +    CI H D+   N+L+  + + K++DFGLA+  H    D+     
Sbjct: 138 AYQVARGMEFLAS--KKCI-HRDLAARNVLVTEDHVMKIADFGLARDIH--HIDYYR-KT 191

Query: 229 TRG--TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           T G   + ++APE +     T   +SDV+ FG++L E+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 69  FTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ +  S+E    ++E+  +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+V LLG C+ G    ++ EY   G L    F +  R   L  E L   +   A+G+ +
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L +    CI H D+   N+LL H  I K+ DFGLA+    ++++V     R  + ++APE
Sbjct: 157 LAS--KNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            I     T   +SDV+ +G++L E+
Sbjct: 214 SIFNCVYTF--ESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 45/236 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     S+   +  + E+  +  ++H N+++LL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 128 FCSEGSKRALVYEYMPNGSLD-----RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH- 181
                    LV+E+M           +   P ES  +S  ++ L        +G+ + H 
Sbjct: 66  VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLP-ESLIKSYLYQLL--------QGLAFCHS 116

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
           +G    ILH D+KP N+L++   + K++DFGLA+ F      +     TR    Y APEL
Sbjct: 117 HG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR---WYRAPEL 169

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 293
           +   + + T     D++  G +  E+   R              FP     DQL K
Sbjct: 170 LLGDKGYST---PVDIWSVGCIFAELLSRR------------PLFPGKSEIDQLFK 210

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 8e-18
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVN 121
           F  +LG+  FG +YKG L   G     L+A+K L+  N+     EF  E S +  +HH N
Sbjct: 9   FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK--------------LH 167
           +V LLG  ++     +++EY+  G L   +  +       C                 LH
Sbjct: 69  IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128

Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            +A+  A G+EYL +      +H D+   NIL+      K+SD GL++     + +    
Sbjct: 129 -IAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +   I ++ PE I   +G  S  SD++ FG+VL E+
Sbjct: 185 KSLLPIRWMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 8e-18
 Identities = 71/250 (28%), Positives = 106/250 (42%), Gaps = 30/250 (12%)

Query: 75  QGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV-----NVVQLLGF 128
           +G FGSVY  + + TG   A+K+L+ S   A+  +  V     I  +      V +L   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK--LHEVALGTARGIEYLH-NGCD 185
                   LV EY+  G     +  K   G    W K  + EV LG    +E LH  G  
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLG----VEDLHQRG-- 117

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I+H DIKP N+L+D     K++DFGL++   +   FV      GT  Y+APE I    
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVG 169

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
                  D +  G V+ E   G    +     +  A F + +  ++N   +++     E 
Sbjct: 170 DDKMS--DWWSLGCVIFEFLFGYPPFHAE---TPDAVFDNILSRRINWPEEVKEFCSPEA 224

Query: 306 ESMIARKLCM 315
             +I R LCM
Sbjct: 225 VDLINRLLCM 234

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNV 122
           F   +G+G FG V +  ++  GL    A+KML+   S+    +F  E+  + ++ HH N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL-----------DRHVFPKE-SRGQSLCWEKLHEVA 170
           + LLG C       +  EY P G+L               F KE     +L  ++L + A
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A G++YL    +   +H D+   N+L+  N   K++DFGL++    E  +V  +  R
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGR 179

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++A E  S N+   + KSDV+ FG++L E+
Sbjct: 180 LPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 34/221 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
           LG G FG VYK Q  +TG   A K+++  S+   E+F+ E+  +    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 131 EGSKRALVYEYMPNGSLD------RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
             +K  ++ E+   G+LD            E + + +C + L          + +LH+  
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGL-TEPQIRYVCRQML--------EALNFLHSHK 123

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H D+K  NILL  +   K++DFG          K + F+      GT  ++APE+
Sbjct: 124 ---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI------GTPYWMAPEV 174

Query: 241 IS-RNFGT--VSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
           ++   F       K+D++  G+ L+E+A     +  +N  R
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 27/213 (12%)

Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHV--------FPKESRGQS---LCWEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +                +   L   ++  +A   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TRGT 232
           A G+ YL     +  +H D+   N L+    + K+ DFG+++      D+  +   T   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTDYYRVGGRTMLP 187

Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           I ++ PE ++ R F T   +SD++ FG+VL E+
Sbjct: 188 IRWMPPESILYRKFTT---ESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 72  KLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 127
           ++G+G  G V+K    +TG  +A+K +   +       + + E+  +    H  VV+LL 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDV 186
               GS   LV EYMP   L   V   E R       K +   L   +G+ Y+H NG   
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSE-VLRDEERPLPEAQVKSYMRML--LKGVAYMHANG--- 119

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRN 244
            I+H D+KP N+L+  + + K++DFGLA+   +E      S    T  Y APEL+  +R 
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARK 177

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +       D++  G +  E+  G 
Sbjct: 178 YDP---GVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 47/289 (16%)

Query: 73  LGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV + QL+    +   +AVKML+   FS+   EEF+ E + +    H NV++L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 126 LGFC--SEGSKR----ALVYEYMPNGSLDRHVFPKESR-GQ---SLCWEKLHEVALGTAR 175
           +G    S    R     ++  +M +G L  H F   SR G+   +L  + L    +  A 
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+EYL +      +H D+   N +L+ N    V+DFGL+K     + +    A++  + +
Sbjct: 125 GMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---PSWVYDQLN 292
           +A E ++ N  T    SDV+ FG+ + E+           TR    Y     S +Y+ L 
Sbjct: 182 LALESLADNVYTT--HSDVWAFGVTMWEI----------MTRGQTPYAGVENSEIYNYLI 229

Query: 293 KGGDLE--LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           KG  L+     + ++  ++ +        C   +   RPS   + + LE
Sbjct: 230 KGNRLKQPPDCLEDVYELMCQ--------CWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 40/222 (18%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEF---INEVSTIGRIHHVNVVQL 125
            ++G G FG+VY  + ++T  ++A+K M  + K S E++   I EV  + ++ H N ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 126 LGFCSEGSKRALVYEYMPNGS----LDRHVFPKESRGQSLCWEKLHEVAL-----GTARG 176
            G         LV EY   GS    L+ H  P            L EV +     G  +G
Sbjct: 81  KGCYLREHTAWLVMEYCL-GSASDILEVHKKP------------LQEVEIAAICHGALQG 127

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YLH+      +H DIK  NILL      K++DFG A      N FV      GT  ++
Sbjct: 128 LAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWM 178

Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 275
           APE+I + + G    K DV+  G+  +E+A  R+    NMNA
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVYKGQLQTGGLI----AVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG VY G L          AVK L         E+F+ E   +    H NV+ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 127 GFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           G C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+EYL +  
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL-RNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK 118

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGT---IGYIAPE- 239
            V   H D+   N +LD +F  KV+DFGLA+  + KE  + S+    G    + ++A E 
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKE--YYSVHNHTGAKLPVKWMALES 173

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
           L ++ F T   KSDV+ FG++L E+
Sbjct: 174 LQTQKFTT---KSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.3 bits (195), Expect = 6e-17
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG V+ G+L+     +AVK    +       +F+ E   + +  H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V E +  G     +    + G  L  ++L ++    A G+EYL +    CI
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH--CI 116

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT----IGYIAPELISRN 244
            H D+   N L+    + K+SDFG+++   +E D V  ++T G     + + APE +  N
Sbjct: 117 -HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV-YASTGGMKQIPVKWTAPEAL--N 169

Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +G  S +SDV+ FG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 37/222 (16%)

Query: 73  LGQGGFGSVYKG-QLQTGGL-----IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K    +  G      +AVKML+ +  S+E  + ++E + + +++H +V++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----------------------QSLC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++L 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSL--RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   +RG++YL    ++ ++H D+   N+L+      K+SDFGL++   +E+ 
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTT--QSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 30/212 (14%)

Query: 73  LGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFINEVSTIGRI-HHVNVVQLL 126
           +G+G FG V K +++  GL    A+K ++   SK    +F  E+  + ++ HH N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESR--------------GQSLCWEKLHEVALG 172
           G C       L  EY P+G+L    F ++SR                +L  ++L   A  
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            ARG++YL        +H D+   NIL+  N++ K++DFGL++    +  +V  +  R  
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E  S N+   +  SDV+ +G++L E+
Sbjct: 175 VRWMAIE--SLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 83/307 (27%), Positives = 135/307 (43%), Gaps = 74/307 (24%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            +G+G +G V K +  +TG ++A+K     E+ K   +  + E+  + ++ H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 128 FCSEGSKRALVYEYMPNGSLDR-HVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNG 183
                 +  LV+E++ +  LD    +P    ESR +   ++ L        RGIE+ H+ 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL--------RGIEFCHSH 119

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKE--NDFVSISATRGTIGYIAPE 239
               I+H DIKP NIL+  + + K+ DFG A+    P E   D+V   ATR    Y APE
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV---ATR---WYRAPE 170

Query: 240 LISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV-YDQLNK--- 293
           L+  +  +G      D++  G ++ EM  G            +  FP     DQL     
Sbjct: 171 LLVGDTKYGR---AVDIWAVGCLVTEMLTG------------EPLFPGDSDIDQLYHIIK 215

Query: 294 ------------------GGDLELQNVTEIESMIAR--KLCMIGL----WCIQVKAADRP 329
                                + L  V EIE +  R  KL  + L     C+++   DRP
Sbjct: 216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275

Query: 330 SMTKVLE 336
           S +++L 
Sbjct: 276 SSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 9e-17
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 31/207 (14%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            +G+G FG VYK    +T  ++A+K+  LE ++   E+   E+  + +     + +  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 129 CSEGSKRALVYEYMPNGS----LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
             +GSK  ++ EY   GS    L      +           L EV      G+EYLH   
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA-----FILREVL----LGLEYLHEEG 118

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  NILL      K++DFG    L     K N FV      GT  ++APE+
Sbjct: 119 KI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV------GTPFWMAPEV 169

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           I +       K+D++  G+  +E+A G
Sbjct: 170 IKQ--SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.0 bits (195), Expect = 9e-17
 Identities = 80/295 (27%), Positives = 119/295 (40%), Gaps = 60/295 (20%)

Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQ 124
           LG G FG VY+G  +          +AVK L  S    +E  F+ E   + + +H N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           L+G   E   R ++ E M  G L    R   P+  R  SL  + L   A   A+G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 182 -NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRG------ 231
            N      +H DI   N LL       + K++DFG+A+      D    S  R       
Sbjct: 134 ENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMAR------DIYRASYYRKGGRAML 183

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYFP 284
            I ++ PE      G  + K+DV+ FG++L E+         GR N              
Sbjct: 184 PIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229

Query: 285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             V + +  GG L+          + R    I   C Q    DRP+   +LE ++
Sbjct: 230 --VMEFVTGGGRLDPP--KGCPGPVYR----IMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V       TG  +AVK ++  K    E + NEV  +    H N+V++    
Sbjct: 26  KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   V    +R      E++  V L   + + +LH      ++
Sbjct: 86  LVGDELWVVMEFLEGGALTDIV--THTRMNE---EQIATVCLAVLKALSFLHAQG---VI 137

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN- 244
           H DIK  +ILL  +   K+SDFG    ++K  P+    V      GT  ++APE+ISR  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPEVISRLP 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 192 YGT---EVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 69/217 (31%), Positives = 110/217 (50%), Gaps = 34/217 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLQ-TGGLIAVK----MLENSKFSAEEFINEVSTIGRIHHVNVV 123
              +LG+G +GSVYK   + TG  +A+K     L+ SKF+  + I E+  + +     +V
Sbjct: 5   VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN--QIIMELDILHKAVSPYIV 62

Query: 124 QLLG-FCSEGSKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
              G F  EG+    VY   EYM  GSLD+ ++      + +  + L  +     +G+++
Sbjct: 63  DFYGAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 180 L---HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGY 235
           L   HN     I+H D+KP N+L++ N   K+ DFG++      N   S++ T  G   Y
Sbjct: 118 LKEEHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSG-----NLVASLAKTNIGCQSY 167

Query: 236 IAPELIS----RNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +APE I         T + +SDV+  G+ +LEMA GR
Sbjct: 168 MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 49/289 (16%)

Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQ 124
           LG+G FG V+  + +         L+ VK L+ +K      EF  E+    ++ H NVV+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL---HEVALGT--ARGIEY 179
           LLG C E     ++ EY   G L + +   +S+ + L    L    +VAL T  A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSISATRGTI 233
           L N      +H D+   N L+      KVS   L+K      ++   N  + +       
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------ 183

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ-LN 292
            ++APE +  +    S KSDV+ FG+++ E+               +  F     ++ LN
Sbjct: 184 -WLAPEAVQED--DFSTKSDVWSFGVLMWEV-----------FTQGELPFYGLSDEEVLN 229

Query: 293 --KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             + G LEL     +      +L  +   C  V   DRPS ++++  L 
Sbjct: 230 RLQAGKLELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 30/215 (13%)

Query: 72  KLGQGGFGSVYKGQ------LQTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       +   L+AVK L++   +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVF-------------PKESRGQSLCWEKLHEVAL 171
             G C +G    +V+EYM +G L++ +              P++++G+    + LH +A 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TR 230
             A G+ YL +      +H D+   N L+  N + K+ DFG+++      D+  +   T 
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTM 186

Query: 231 GTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
             I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 187 LPIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.8 bits (189), Expect = 6e-16
 Identities = 58/215 (26%), Positives = 105/215 (48%), Gaps = 36/215 (16%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVVQ 124
           LG G F S Y+ + ++TG L+AVK +   + ++       E    E+  + R++H ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           +LG   E S   L  E+M  GS+   +    +  +++      ++     RG+ YLH   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL----LRGLSYLH--- 120

Query: 185 DVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---------GTIG 234
           +  I+H D+K  N+L+D      +++DFG A         ++   T          GTI 
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA-------RLAAKGTGAGEFQGQLLGTIA 173

Query: 235 YIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++APE++    +G  SC  DV+  G V++EMA  +
Sbjct: 174 FMAPEVLRGEQYGR-SC--DVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 51/201 (25%), Positives = 101/201 (50%), Gaps = 20/201 (9%)

Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           + +G  G+ YKG+    G+   VK + +         +E++ +G++ H N+V+L+G C  
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIGLCRS 754

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                L++EY+   +L   +       ++L WE+  ++A+G A+ + +LH  C   ++  
Sbjct: 755 EKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           ++ P  I++D    P +    L      +      SA      Y+APE  +R    ++ K
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPE--TRETKDITEK 858

Query: 252 SDVYGFGMVLLEMAGGRRNSN 272
           SD+YGFG++L+E+  G+  ++
Sbjct: 859 SDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 21/201 (10%)

Query: 72  KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  +   +   +AVK+L+N        +E + E + + ++ +  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNG 183
           +G C E     LV E    G L++ +   +   +    E +H+V++G    ++YL   N 
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN- 115

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 242
                +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE + 
Sbjct: 116 ----FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170

Query: 243 RNFGTVSCKSDVYGFGMVLLE 263
            N+   S KSDV+ FG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 25/218 (11%)

Query: 74  GQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQL-LG 127
           G+G FG V   Q   T  + A+K +   K     S    +NE   +  ++H  +V L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           F  E     LV + +  G L  H+  K   S  Q   W  + E+ L     +EYLH+   
Sbjct: 69  FQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW--ICEIVLA----LEYLHSKG- 120

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISRN 244
             I+H DIKP NILLD      ++DF +A K  P        ++T GT GY+APE++ R 
Sbjct: 121 --IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTSTSGTPGYMAPEVLCRQ 174

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
               S   D +  G+   E   G+R    ++       
Sbjct: 175 --GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 68/281 (24%), Positives = 124/281 (44%), Gaps = 45/281 (16%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLL 126
           K+G+G F  VYK   L  G ++A+K ++  +       ++ + E+  + ++ H NV++ L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHV--FPKESR--GQSLCWEKLHEVALGTARGIEYLHN 182
               E ++  +V E    G L R +  F K+ R   +   W+   ++       +E++H+
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I 
Sbjct: 125 KR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIH 179

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMN----ATRSSKAYFPSWVYDQLNKGG 295
            N    + KSD++  G +L EMA  +       MN      +  K  +P    D  +   
Sbjct: 180 EN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS--- 234

Query: 296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                   E+  +++R        CI      RP ++ VL+
Sbjct: 235 -------EELRDLVSR--------CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 29/210 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQL 125
               ++G G +G VYK + + TG L+A+K+++       E I  E+S +    H N+V  
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65

Query: 126 LGFCSEGSKRALVYEYMPNGSLDR--HVFP---KESRGQSLCWEKLHEVALGTARGIEYL 180
            G      K  +V EY   GSL     V      E +   +C E L        +G+ YL
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL--------KGLAYL 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYI 236
           H       +H DIK  NILL  +   K++DFG++        K   F+      GT  ++
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI------GTPYWM 168

Query: 237 APELISRNF-GTVSCKSDVYGFGMVLLEMA 265
           APE+ +    G    K D++  G+  +E+A
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIELA 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 31/208 (14%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +  +TG L A K++E  S+   E+++ E+  +   +H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 130 SEGSKRALVYEYMPNGSLDRHVFP-----KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
               K  ++ E+ P G++D  +        E + Q +C + L          ++YLH+  
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML--------EALQYLHS-- 128

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            + I+H D+K  N+LL  +   K++DFG++    K   + + F+      GT  ++APE+
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI------GTPYWMAPEV 181

Query: 241 I---SRNFGTVSCKSDVYGFGMVLLEMA 265
           +   +        K+D++  G+ L+EMA
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 43/232 (18%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-----------------LIAVKML--ENSKFSAEEFIN 109
           F  KLG+G FG V+  ++                     L+AVK+L  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD-----RHVFPKESRGQ----- 159
           EV  + R+   N+++LLG C +     ++ EYM NG L+      H+  KE  G      
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 160 -----SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
                ++ +  L  VAL  A G++YL +   +  +H D+   N L+  N   K++DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 215 KFHPKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + +    D+  I   R    I ++A E I    G  +  SDV+ FG+ L E+
Sbjct: 186 R-NLYAGDYYRIQG-RAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ-- 135

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN- 244
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKA 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +G    K D++  G++ +EM  G
Sbjct: 192 YGP---KVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 38/211 (18%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEE-----FINEVSTIGRIHHVNVV 123
           K+G+G +G VYKG+  +TG ++A+K   LE    S EE      I E+S +  + H N+V
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLE----SEEEGVPSTAIREISLLKELQHPNIV 62

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            L     + S+  L++E++ +  L +++   PK   GQ +  E +        +GI + H
Sbjct: 63  CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCH 118

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYI 236
           +     +LH D+KP N+L+D+  + K++DFGLA+          ++ V       T+ Y 
Sbjct: 119 SRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-------TLWYR 168

Query: 237 APELISRNFGTV--SCKSDVYGFGMVLLEMA 265
           APE++    G+   S   D++  G +  EMA
Sbjct: 169 APEVL---LGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 44/215 (20%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--------FINEVSTIGRIHHVNV 122
           K+G+G +G V+K +  +TG ++A+K     KF   E         + E+  + ++ H N+
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 123 VQLLGFCSEGSKRALVYEYMPN---GSLDRHVFPK---ESRGQSLCWEKLHEVALGTARG 176
           V L+       K  LV+EY  +     L+++  P+   E   + + W+        T + 
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQ--------TLQA 112

Query: 177 IEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG 234
           + + H + C    +H D+KP NIL+      K+ DFG A+      +D+    ATR    
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---W 165

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           Y APEL+     +G      DV+  G V  E+  G
Sbjct: 166 YRAPELLVGDTQYGP---PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEE---FINEVSTIGRIHHVNVVQL 125
           LGQG FG VY    + TG  +AVK +    +S  + +E      E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   +    ++  EYMP GS+   +    +  +++  +   ++      G+EYLH    
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH---S 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPELI 241
             I+H DIK  NIL D     K+ DFG +K             S++   GT  +++PE+I
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT---GTPYWMSPEVI 179

Query: 242 S-RNFGTVSCKSDVYGFGMVLLEM 264
           S   +G    K+DV+  G  ++EM
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 38/211 (18%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLLG 127
           + +G +G V+  +   TG + A+K+++ +    +  +++V T    + +     VV+L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 128 FCSEGSKRAL--VYEYMPNG---SLDRHV--FPKESRGQSLCWEKLH--EVALGTARGIE 178
           + S   K+ L  V EY+P G   SL  +V    ++         +++  E+ L     +E
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAEIVLA----LE 107

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------HPKENDFVSISATRGT 232
           YLH+     I+H D+KP NIL+D N   K++DFGL+K           +D        GT
Sbjct: 108 YLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
             YIAPE+I    G  S   D +  G +L E
Sbjct: 165 PDYIAPEVI-LGQGH-SKTVDWWSLGCILYE 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 28/207 (13%)

Query: 73  LGQGGFGSVY------KGQLQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG+G FG V       +G   TG  +AVK L  E+      +   E+  +  ++H N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 125 LLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
             G C+E       L+ E++P+GSL  ++ P+     +L  ++  + A+   +G++YL +
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINL--KQQLKYAVQICKGMDYLGS 127

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELI 241
              V   H D+   N+L++     K+ DFGL K    + ++ ++     + + + APE +
Sbjct: 128 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 242 SRNFGTVSCK----SDVYGFGMVLLEM 264
                 +  K    SDV+ FG+ L E+
Sbjct: 185 ------IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.2 bits (179), Expect = 9e-15
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 129
           +G G +G VYKG+ ++TG L A+K+++ +    EE   E++ + +  HH N+    G F 
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 130 SEG-----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +       +  LV E+   GS+   +  K ++G +L  E +  +     RG+ +LH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHK 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 132 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 182

Query: 241 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 267
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 42/212 (19%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN--EVSTIGRI-HHVNVVQLL 126
            K+G+G F  V K Q  +TG   A+K ++    S E+  N  E+  + R+  H N+++L+
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 127 G--FCSEGSKRALV--------YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
              F  +  + ALV        YE +      +   P E R +S  ++ L          
Sbjct: 65  EVLFDRKTGRLALVFELMDMNLYELIKG---RKRPLP-EKRVKSYMYQLLK--------S 112

Query: 177 IEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGT 232
           ++++H NG    I H DIKP NIL+  + + K++DFG  +     P   +++S   TR  
Sbjct: 113 LDHMHRNG----IFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS---TR-- 162

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             Y APE +  + G    K D++  G V  E+
Sbjct: 163 -WYRAPECLLTD-GYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.9 bits (179), Expect = 9e-15
 Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 37/275 (13%)

Query: 73  LGQGGFGS--VYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           LG+G FG   +Y+ + +   L+  K +  ++ S +E    +NE+  +  + H N++    
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              + +   +  EY   G+L   +     +GQ    E +          + Y+H      
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPEL---ISR 243
           ILH DIK  NI L    + K+ DFG++K         S++ T  GT  Y++PEL   +  
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           NF     KSD++  G VL E+        +   R+  A  P  +  ++ +G      N T
Sbjct: 179 NF-----KSDIWALGCVLYEL--------LTLKRTFDATNPLNLVVKIVQG------NYT 219

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
            + S+ + +L  +    +Q     RP+  +VL+  
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 17/202 (8%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +V+KG+ + T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV+EY+ +  L +++   ++ G  +    +        RG+ Y H      I
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---I 124

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++    G+ 
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVL---LGST 179

Query: 249 --SCKSDVYGFGMVLLEMAGGR 268
             S   D++G G +L EMA GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 26/210 (12%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           +G G +G VYKG+ ++TG L A+K+++ ++   EE   E++ + +  HH N+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 131 EGSKRA------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           + S         LV E+   GS+   V  K ++G +L  + +  +     RG+ +LH   
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICREILRGLAHLHAHK 141

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 142 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 192

Query: 241 ISRNF---GTVSCKSDVYGFGMVLLEMAGG 267
           I+ +     T   +SD++  G+  +EMA G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGF 128
           ++G G  G+VYK   + TG L A+K++  +       +   E+  +  ++H NVV+    
Sbjct: 81  RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                +  ++ E+M  GSL+      E        + L +VA     GI YLH      I
Sbjct: 141 FDHNGEIQVLLEFMDGGSLEGTHIADE--------QFLADVARQILSGIAYLHRRH---I 189

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NFG 246
           +H DIKP N+L++     K++DFG+++   +  D  + S   GTI Y++PE I+   N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSPERINTDLNHG 247

Query: 247 TVS-CKSDVYGFGMVLLEMAGGR 268
                  D++  G+ +LE   GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 73/241 (30%), Positives = 111/241 (46%), Gaps = 53/241 (21%)

Query: 71  HKLGQGGFGSVYKGQLQ-TGGLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
            KLG+G + +VYKG+ + TG L+A+K +     E + F+A   I E S +  + H N+V 
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IREASLLKDLKHANIVT 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT---ARGIEYLH 181
           L           LV+EY+ +  L +++   +  G  L    +H V L      RG+ Y H
Sbjct: 68  LHDIIHTKKTLTLVFEYL-DTDLKQYM---DDCGGGL---SMHNVRLFLFQLLRGLAYCH 120

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYI 236
                 +LH D+KP N+L+      K++DFGLA+          N+ V       T+ Y 
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-------TLWYR 170

Query: 237 APE--LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP--SWVYDQLN 292
            P+  L S  + T     D++G G +  EMA GR              FP  + V DQL+
Sbjct: 171 PPDVLLGSTEYST---SLDMWGVGCIFYEMATGR------------PLFPGSTDVEDQLH 215

Query: 293 K 293
           K
Sbjct: 216 K 216

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 30/213 (14%)

Query: 73  LGQGGFGSVYKGQLQ------TGGL-IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           LG G FG VY+G         +G + +AVK L       E  EF+ E   +   +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQS-----LCWEKLHEVALGTARGIE 178
           +LLG C     + ++ E M  G L    + +++R +      L  ++L ++ L  A+G  
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDL--LSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 179 YLHNGCDVCILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRG-T 232
           YL     +  +H D+   N L+     D + + K+ DFGLA+   K +D+          
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK-SDYYRKEGEGLLP 176

Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE L+   F T   +SDV+ FG+++ E+
Sbjct: 177 VRWMAPESLLDGKFTT---QSDVWSFGVLMWEI 206

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +  TG  +AVK ++  K    E + NEV  +   HH NVV +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   V    +R      E++  V L   R + YLHN     ++
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV--THTRMNE---EQIATVCLSVLRALSYLHNQG---VI 140

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV------GTPYWMAPEVISRLP 194

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 195 YGT---EVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)

Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGV--------- 137

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 138 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV------GTPYWMAPELIS 189

Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 190 RLPYGP---EVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 29/219 (13%)

Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIH 118
             +   +       +    +          L+AVK+L  + S  + E+F+ EV  + R+ 
Sbjct: 21  VHLCEADGLQDFSEKAFAENDNADAPV---LVAVKVLRPDASDNAREDFLKEVKILSRLS 77

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLD----RHVFPKESR---GQSLCWEKLHEVAL 171
             N+ +LLG C+      ++ EYM NG L+    +HV          +SL +  L  +A 
Sbjct: 78  DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT 137

Query: 172 GTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
             A G+ YL   N      +H D+   N L+  N+  K++DFG+++ +   +D+  +   
Sbjct: 138 QIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSSDYYRV--- 188

Query: 230 RGT----IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +G     I ++A E +    G  + KSDV+ FG+ L E+
Sbjct: 189 QGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 17/199 (8%)

Query: 72  KLGQGGFGSVYKG--QLQTGGL-IAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FG V KG  +++   + +A+K+L  EN K   +E + E   + ++ +  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRH-VFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           G C E     LV E    G L++     K+    S   E +H+V++G    ++YL     
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEGKNF 116

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
           V   H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 117 V---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI--N 171

Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 143 TYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 200 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 35/224 (15%)

Query: 69  FTHKLGQGGFGSVY----KGQLQTGG-------------LIAVKML--ENSKFSAEEFIN 109
           F  KLG+G FG V+    +G  +                L+AVKML  + +K +  +F+ 
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD----RHVFPK---ESRGQSLC 162
           E+  + R+   N+++LL  C       ++ EYM NG L+    RH   +   ++   ++ 
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
           +  L  +A   A G++YL +   +  +H D+   N L+  N+  K++DFG+++ +    D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSR-NLYSGD 184

Query: 223 FVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +  I   R    I +++ E I    G  +  SDV+ FG+ L E+
Sbjct: 185 YYRIQG-RAVLPIRWMSWESIL--LGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 73  LGQGGFGSVY------KGQLQTGGLIAV-KMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +G+G FG V+        +L     I V +M ++ + +A+   NE   +  + H N+++ 
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK--LH---EVALGTARGIEYL 180
                E     +V EY P G+L  ++   + R  SL  E   LH   ++ L     + ++
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDTILHFFVQILLA----LHHV 117

Query: 181 HNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG---YI 236
           H      ILH D+K  NILLD H  + K+ DFG++K         S S     +G   YI
Sbjct: 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI------LSSKSKAYTVVGTPCYI 168

Query: 237 APELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           +PEL   + +     KSD++  G VL E+A  +R
Sbjct: 169 SPELCEGKPYNQ---KSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  H++   + G     E+    A     G+E LH      
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLHREN--- 122

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            ++ D+KP NILLD     ++SD GLA   P+     SI    GT+GY+APE+++    T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYT 179

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
           +S   D +G G ++ EM  G+
Sbjct: 180 LS--PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 24/210 (11%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGF-- 128
           +G+G +G VYK    +TG L+A+K+++  +   EE   E + + +  +H N+    G   
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73

Query: 129 ----CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
                    +  LV E    GS+   V     +G+ L  E +  +   T RG+ YLH   
Sbjct: 74  KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  NILL  N   K+ DFG    L     + N F+      GT  ++APE+
Sbjct: 134 ---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI------GTPYWMAPEV 184

Query: 241 ISRNFG---TVSCKSDVYGFGMVLLEMAGG 267
           I+ +     +   +SDV+  G+  +E+A G
Sbjct: 185 IACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 23/210 (10%)

Query: 72  KLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  +VV
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKE--SRGQSL-CWEKLHEVALGTARGI 177
           +LLG  S+G    ++ E M  G L    R + P+   +  Q+    +K+ ++A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TIGY 235
            YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   + +
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPVRW 187

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           ++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 188 MSPE--SLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 14/204 (6%)

Query: 72  KLGQGGFGSVYKGQLQTG---GLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 126
           ++G G FG V  G+   G     + VK L  S    E+  F+ EV     ++H NV+Q L
Sbjct: 2   EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           G C E     LV E+ P G L  ++   +    Q    + L  +A   A G+ +LH    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS--- 242
              +H D+   N  L  +   K+ D+GLA     E+ +++       + ++APEL+    
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 243 RNFGTV--SCKSDVYGFGMVLLEM 264
           ++      + KS+++  G+ + E+
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 70/260 (26%), Positives = 107/260 (41%), Gaps = 74/260 (28%)

Query: 73  LGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  +   +AVKML+    ++E    + E+  +  I HH+NVV
Sbjct: 15  LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74

Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLD------RHVF-----PKESRGQS----------- 160
            LLG C++ G    ++ EY   G+L       R  F         + +            
Sbjct: 75  NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134

Query: 161 -----------------------------------LCWEKLHEVALGTARGIEYLHNGCD 185
                                              L  E L   +   ARG+E+L     
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--ASR 192

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
            CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  + ++APE I   F
Sbjct: 193 KCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI---F 248

Query: 246 GTV-SCKSDVYGFGMVLLEM 264
             V + +SDV+ FG++L E+
Sbjct: 249 DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+++  +A ++F  E   +  + H ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRH---------VFPKESRGQSLCWEKLHEVALGTAR 175
             G C EG    +V+EYM +G L++          +  + +R   L   ++  +A   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TRGTIG 234
           G+ YL +      +H D+   N L+  N + K+ DFG+++      D+  +   T   I 
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSR-DVYSTDYYRVGGHTMLPIR 187

Query: 235 YIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           ++ PE ++ R F T   +SDV+  G+VL E+
Sbjct: 188 WMPPESIMYRKFTT---ESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 54/205 (26%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIH---HVNVVQ 124
           ++G G +G+VYK +   +G  +A+K +    N        + EV+ + R+    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 125 LLGFCS-----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           L+  C+       +K  LV+E++     D   +  +     L  E + ++     RG+++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y APE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPE 177

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
           ++ ++  T +   D++  G +  EM
Sbjct: 178 VLLQS--TYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEYLHNGCD 185
                    LV   M  G L  H++     G    +E+   V  A     G+E LH    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLEDLHQER- 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+APE++    
Sbjct: 123 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNER 177

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
            T S   D +  G +L EM  G+
Sbjct: 178 YTFS--PDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 36/214 (16%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +  +T  ++A+K   +EN K   E F    + E+  +  + H NVV 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 75

Query: 125 LLGFCS-----EGSKRA---LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           L+  C          +    LV+E+  +    L  +   K +  +      + +V     
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE------IKKVMKMLL 129

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  NIL+  + I K++DFGLA+ F   +N   +    R  T
Sbjct: 130 NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + ++E+  +  I  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L ++ L   
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 140 AYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 197 RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 23/205 (11%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +VYKG+ + T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL---GTARGIEYLHNGCD 185
                   LV+EY+ +  L +++   +  G S+    +H V L      RG+ Y H    
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNSI---NMHNVKLFLFQLLRGLNYCHRRK- 124

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SR 243
             +LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++  S 
Sbjct: 125 --VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++ T   + D++G G +  EM+ GR
Sbjct: 181 DYST---QIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 32/217 (14%)

Query: 73  LGQGGFGSVYKGQL--------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V + +              +AVKML+++    +  + I+E+  +  I  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHV-------------FPKESRGQSLCWEKLHE 168
           ++ LLG C++     ++ EY   G+L   +               K    Q L ++ L  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ-LSFKDLVS 138

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            A   ARG+EYL +    CI H D+   N+L+  + + K++DFGLA+     + +   S 
Sbjct: 139 CAYQVARGMEYLES--RRCI-HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 229 TRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 196 GRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 72  KLGQGGFGSVYKGQLQTG---GLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQLL 126
           ++G G FG V  G++ +G     + VK L  S    E+  F+ E      + H N++Q L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE--KLHEVALGTARGIEYLHNGC 184
           G C+E +   LV E+ P G L  ++     + + +  +   L  +A   A G+ +LH   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
               +H D+   N LL  +   K+ D+GL+    KE+ +V+       + +IAPEL+   
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 245 FGTV-----SCKSDVYGFGMVLLEM 264
            G +     + +S+V+  G+ + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 15/201 (7%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K L+  +    +     +NE   + ++    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  H++     G        +   +    G+E+LH      
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI--ICGLEHLHQ---RR 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP N+LLD +   ++SD GLA           I    GT GY+APE++      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG--EV 170

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
                D +  G  L EM  GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 8e-14
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 31/209 (14%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENS---KFSAEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE     K   E   +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARGIEY 179
           +  E +K AL  V   M  G L  H++        E R          E+  G    +E 
Sbjct: 67  YAYE-TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA----AEITCG----LED 117

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH      I++ D+KP NILLD     ++SD GLA     E +  +I    GT+GY+APE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE--TIRGRVGTVGYMAPE 171

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++     T S   D +G G ++ EM  G+
Sbjct: 172 VVKNERYTFS--PDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.5 bits (173), Expect = 8e-14
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 72  KLGQGGFGSVYKG--QLQTGGLI--AVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQL 125
            +G+G FG VY+G         I  AVK  +N  S    E+F+ E   + +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G  +E +   +V E  P G L R          SL    L   +   +  + YL +   
Sbjct: 73  IGVITE-NPVWIVMELAPLGEL-RSYLQVNK--YSLDLASLILYSYQLSTALAYLESKRF 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V   H DI   N+L+      K+ DFGL+++  ++  +   S  +  I ++APE I  NF
Sbjct: 129 V---HRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESI--NF 182

Query: 246 GTVSCKSDVYGFGMVLLEM 264
              +  SDV+ FG+ + E+
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.8 bits (173), Expect = 9e-14
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 22/213 (10%)

Query: 71  HKLGQGGFGSVY-KGQLQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 125
           H++G G FG+VY      T  ++AVK +  S     E     I EV  + ++ H N ++ 
Sbjct: 27  HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   +     LV EY    + D      E   + L   ++  +  G  +G+ YLH+   
Sbjct: 87  KGCYLKEHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 141

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRN 244
             ++H DIK  NILL      K++DFG A      N FV      GT  ++APE+I + +
Sbjct: 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVILAMD 193

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 275
            G    K DV+  G+  +E+A  R+    NMNA
Sbjct: 194 EGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 26/208 (12%)

Query: 68  HFTHKLGQGGFGSVY--KGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNV 122
               K+G+G FG +Y  K +  +   + +K ++ +K   +E      EV  + ++ H N+
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIE 178
           V       E  +  +V EY   G L + +  +     S  Q L W    +++L    G++
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GLK 115

Query: 179 YLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYI 236
           ++H   D  ILH DIK  NI L  N  + K+ DFG+A+   + ND + ++ T  GT  Y+
Sbjct: 116 HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDSMELAYTCVGTPYYL 169

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           +PE+        + K+D++  G VL E+
Sbjct: 170 SPEICQNR--PYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 59/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVSTIGR-IHHVNVVQLLGF 128
           LG+G +G V K + + TG ++AVK +  +  S E+   + ++    R +     V   G 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68

Query: 129 CSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                   +  E M + SLD   + V+    +G ++  + L ++A+   + +EYLH+   
Sbjct: 69  LFREGDVWICMEVM-DTSLDKFYKKVY---DKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS--R 243
           V  +H D+KP N+L++ N   K+ DFG++ +     D V+ +   G   Y+APE I+   
Sbjct: 125 V--IHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPEL 179

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
           N      KSDV+  G+ ++E+A GR
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 30/217 (13%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG V+KG   +T  ++A+K+  LE ++   E+   E++ + +     V +  G 
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 129 CSEGSKRALVYEYMPNGS---LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             +G+K  ++ EY+  GS   L R     E +  ++  E L        +G++YLH+   
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--------KGLDYLHSEKK 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 241
           +   H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 123 I---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
            ++      K+D++  G+  +E+A G   NS+M+  R
Sbjct: 174 QQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 45/217 (20%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQ 124
           K+G+G +G VYK +   TG ++A+K +   +   E+       I E+S +  ++H N+V+
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKI---RLETEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           LL      +K  LV+E++ +  L +++   P       L    L+++     +GI Y H+
Sbjct: 63  LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHS 117

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-F--------HPKENDFVSISATRGTI 233
                +LH D+KP N+L+D     K++DFGLA+ F        H    + V       T+
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH----EVV-------TL 163

Query: 234 GYIAPE--LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            Y APE  L SR + T     D++  G +  EM   R
Sbjct: 164 WYRAPEILLGSRQYST---PVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)

Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLEN--SKFSAEEFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++  ++    + I+E+  +  I  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G   C+                  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 146 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 203 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 68/232 (29%), Positives = 114/232 (49%), Gaps = 37/232 (15%)

Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQ 124
           LGQG FG V+      G    G L A+K+L+ +     + +    E   +  ++H  +V+
Sbjct: 4   LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 125 L-LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK----LHEVALGTARGIEY 179
           L   F +EG K  L+ +++  G L    F + S+      E     L E+AL     +++
Sbjct: 63  LHYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA----LDH 113

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH+   + I++ D+KP NILLD     K++DFGL+K    +++  + S   GT+ Y+APE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFC-GTVEYMAPE 168

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFP 284
           +++R   T S  +D + FG+++ EM  G        R   M     +K   P
Sbjct: 169 VVNRRGHTQS--ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 52/187 (27%), Positives = 89/187 (47%), Gaps = 37/187 (19%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE------FINEVSTIGRI---HHVNV 122
           +G+G +G+VYK + L TG  +A+K +   +    E       + E++ + ++    H N+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 123 VQLLGFC-----SEGSKRALVYEYMP---NGSLDRHVFP--KESRGQSLCWEKLHEVALG 172
           V+LL  C         K  LV+E++       L +   P       + L  + L      
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL------ 117

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
             RG+++LH+     I+H D+KP NIL+  +   K++DFGLA+ +  E    S+     T
Sbjct: 118 --RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV---T 169

Query: 233 IGYIAPE 239
           + Y APE
Sbjct: 170 LWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 30/217 (13%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG VYKG   +T  ++A+K+  LE ++   E+   E++ + +     + +  G 
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             +G+K  ++ EY+  GS    + P   +E+   ++  E L        +G++YLH+   
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL--------KGLDYLHSERK 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 241
           +   H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 123 I---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
            ++      K+D++  G+  +E+A G   NS+++  R
Sbjct: 174 KQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +V+KG+ + T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV+EY+ +  L +++   +  G  +    +        RG+ Y H      +
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFLYQILRGLAYCHRRK---V 125

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 246
           LH D+KP N+L++     K++DFGLA+   K     + S    T+ Y  P+++  S  + 
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T   + D++G G +  EMA GR
Sbjct: 184 T---QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLL-GF 128
           +LG G FG VYK Q  +TG L A K+++  S+   E+++ E+  +    H N+V+LL  F
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
             E +   L+ E+   G++D  +   E   + L   ++  V   T   + YLH   +  I
Sbjct: 72  YYENNLWILI-EFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKI 124

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPELI--- 241
           +H D+K  NIL   +   K++DFG++  +     + + F+      GT  ++APE++   
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCE 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA 265
           +        K+DV+  G+ L+EMA
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 24/203 (11%)

Query: 72  KLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +  +G  +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  ++ E++  G+L   V   ++R   L  E++  V     + + YLH+     ++
Sbjct: 88  LVGEELWVLMEFLQGGALTDIV--SQTR---LNEEQIATVCESVLQALCYLHSQG---VI 139

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRN- 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTP 193

Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +GT   + D++  G++++EM  G
Sbjct: 194 YGT---EVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 68.6 bits (167), Expect = 6e-13
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 20/211 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENS-KFSAEEF---INEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + ++T  ++A+K +  S K S E++   I EV  + RI H N ++  
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   + L   ++  +  G  +G+ YLH+    
Sbjct: 92  GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 145

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H DIK  NILL      K++DFG A      N FV      GT  ++APE+I + + 
Sbjct: 146 -MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVILAMDE 198

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRN-SNMNA 275
           G    K DV+  G+  +E+A  +    NMNA
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPPLFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEF-INEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K L+  +    S E+  + E   + +++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G L  H++    RG  +  E++   +     GI +LH    + 
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM--ERVIHYSAQITCGILHLH---SMD 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP N+LLD     ++SD GLA       D  +I+   GT GY+APE++      
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELK---DGKTITQRAGTNGYMAPEILKEE--P 170

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D +  G  + EM  GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 72  KLGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           +LGQG FG VY        KG+ +T   +AVK +  S    E  EF+NE S +      +
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHH 70

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEV---ALGTAR 175
           VV+LLG  S+G    +V E M +G L    R + P+           L E+   A   A 
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 233
           G+ YL+    V   H D+   N ++ H+F  K+ DFG+ +    E D+      +G   +
Sbjct: 131 GMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 185

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 186 RWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 22/202 (10%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A+K +   +   +E I NE+  +    + N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   V      E +  ++C E L        + +++LH+    
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALDFLHSNQ-- 135

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNF 245
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK- 190

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                K D++  G++ +EM  G
Sbjct: 191 -AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 75/311 (24%), Positives = 129/311 (41%), Gaps = 50/311 (16%)

Query: 73  LGQGGFGSVYKGQLQTGGL-----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   S   L+ + MP G L  +V   +     +  + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE---E 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    +         +  I ++A E I    
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR- 186

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--FP-SWVYDQLNKGGDLELQNV 302
              + +SDV+ +G+ + E+           T  SK Y   P S +   L KG  L    +
Sbjct: 187 -IYTHQSDVWSYGVTVWEL----------MTFGSKPYDGIPASEISSILEKGERLPQPPI 235

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE-------------MLEGSIDDLQMPP 349
             I+      + MI + C  + A  RP   +++              +++G  D+    P
Sbjct: 236 CTID------VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG--DERMHLP 287

Query: 350 RPFFSSSRHIS 360
            P  S+     
Sbjct: 288 SPTDSNFYRAL 298

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 22/202 (10%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+V+    + TG  +A+K +   K   +E I NE+  +  + + N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   V      E++  ++C E L        + +E+LH     
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL--------QALEFLHAN--- 134

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNF 245
            ++H DIK  N+LL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK- 190

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                K D++  G++ +EM  G
Sbjct: 191 -AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 25/204 (12%)

Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVN---VVQLLG 127
           LG G  GSV K   + TG ++A K++   +K S  + I  +  +  +H      +V   G
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70

Query: 128 -FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F +E +   +  E+M  GSLDR ++ K   G  +  E L ++A+    G+ YL+N    
Sbjct: 71  AFLNENNI-CMCMEFMDCGSLDR-IYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VH 123

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 244
            I+H DIKP NIL++     K+ DFG++    +   + FV      GT  Y++PE I   
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV------GTSTYMSPERIQG- 176

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
            G  + KSDV+  G+ ++E+A G+
Sbjct: 177 -GKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 29/206 (14%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G FG V+KG   +T  ++A+K+  LE ++   E+   E++ + +     V +  G 
Sbjct: 11  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+   
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEKK 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 241
           +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 123 I---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEVI 173

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            ++      K+D++  G+  +E+A G
Sbjct: 174 KQS--AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 9e-13
 Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V K Q +  GLI  + L   E       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ +  KE++   +  E L +V++   RG+ YL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ-- 124

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +    
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ--- 175

Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+E+A GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 60/190 (31%), Positives = 93/190 (48%), Gaps = 38/190 (20%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKF----------SAEEFINEVSTIGRIH 118
           LG+GG+G V++ +  TG     + A+K+L+ +             AE  I E      + 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA-----VK 58

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----QSLCWEKLHEVALGTA 174
           H  +V L+     G K  L+ EY+  G L  H+   E  G     + C+  L E++L   
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACF-YLSEISLA-- 112

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTI 233
             +E+LH      I++ D+KP NILLD     K++DFGL K    E    +++ T  GTI
Sbjct: 113 --LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCGTI 164

Query: 234 GYIAPELISR 243
            Y+APE++ R
Sbjct: 165 EYMAPEILMR 174

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 35/210 (16%)

Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG+ +  G L+A+K++     E + F+A   I E S +  + H N+V L
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IREASLLKGLKHANIVLL 68

Query: 126 LGFCSEGSKRALVYEYMPNG---SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
                      LV+EY+       +D+H          L  E +        RG+ Y+H 
Sbjct: 69  HDIIHTKETLTLVFEYVHTDLCQYMDKH-------PGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----HPKENDFVSISATRGTIGYIA 237
                ILH D+KP N+L+      K++DFGLA+      H   N+ V       T+ Y  
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-------TLWYRP 171

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           P+++  +    +C  D++G G + +EM  G
Sbjct: 172 PDVLLGSTEYSTC-LDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQLQT---GGLIAVKMLENSKFSAEEF----INEVSTIGRIHHV 120
                +G+G +G VYK + +    G   A+K  +  K            E++ +  + H 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62

Query: 121 NVVQLLGFCSEGSKRA--LVYEYMPNGSL---------DRHVFPKESRGQSLCWEKLHEV 169
           NVV L+    E + ++  L+++Y  +             R   P  S  +SL W+ L+  
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-PSMVKSLLWQILN-- 119

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKENDFV 224
                 G+ YLH+     +LH D+KP NIL+        + K+ D GLA  F+       
Sbjct: 120 ------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 225 SISATRGTIGYIAPELI 241
            +     TI Y APEL+
Sbjct: 171 DLDPVVVTIWYRAPELL 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.1 bits (163), Expect = 1e-12
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 22/202 (10%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+    
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ-- 136

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRNF 245
            ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R  
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRK- 191

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                K D++  G++ +EM  G
Sbjct: 192 -AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 73/275 (26%), Positives = 130/275 (47%), Gaps = 37/275 (13%)

Query: 73  LGQGGFGSVYKGQLQTGGL-----IAVKML-ENSKFSA-EEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L EN+   A +E ++E   +  +    V +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   S   LV + MP G L  +V  +E++ + +  + L    +  A+G+ YL    +
Sbjct: 75  LGICLT-STVQLVTQLMPYGCLLDYV--RENKDR-IGSQDLLNWCVQIAKGMSYLE---E 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRN 244
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E ++ R 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--FPSW-VYDQLNKGGDLELQN 301
           F   + +SDV+ +G+ + E+           T  +K Y   P+  + D L KG  L    
Sbjct: 188 F---THQSDVWSYGVTVWEL----------MTFGAKPYDGIPAREIPDLLEKGERLPQPP 234

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +  I+      + MI + C  + +  RP   ++++
Sbjct: 235 ICTID------VYMIMVKCWMIDSECRPRFRELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 39/224 (17%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 7   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++ +  L + +      G  L   K +   L   +G+ + H+     
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHSHR--- 120

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK-----FHPKENDFVSISATRGTIGYIAPELI- 241
           +LH D+KP N+L++     K++DFGLA+          ++ V       T+ Y APE++ 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRAPEILL 173

Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 284
             + + T     D++  G +  EM           TR  +A FP
Sbjct: 174 GCKYYSTA---VDIWSLGCIFAEM----------VTR--RALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 36/232 (15%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHH-VNVVQLLG- 127
           +G+G FG+V K     +G ++AVK       +   +  + ++  + R      +V+  G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 128 -FCSEGSKRALV-YEYMPNGSLDR-HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            F  EG     +  E M + SLD+ + +  E     +  E L ++A+ T + + YL    
Sbjct: 72  LF-REGD--CWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-- 125

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELIS 242
           ++ I+H D+KP NILLD N   K+ DFG++     +    SI+ TR  G   Y+APE I 
Sbjct: 126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISG-QLVD----SIAKTRDAGCRPYMAPERID 180

Query: 243 RNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW--VYDQL 291
            +       +SDV+  G+ L E+A G            K  +P W  V+DQL
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATG------------KFPYPKWNSVFDQL 220

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 20/203 (9%)

Query: 72  KLGQGGFGSVYKGQL----QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQLL 126
           K+G+G F  VY+       +   L  V++ E     A ++ + E+  + +++H NV++ L
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHV--FPKESR--GQSLCWEKLHEVALGTARGIEYLHN 182
               E ++  +V E    G L + +  F K+ R   +   W+    V L +A  +E++H+
Sbjct: 69  DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF--VQLCSA--VEHMHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I 
Sbjct: 125 RR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIH 179

Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
            N    + KSD++  G +L EMA
Sbjct: 180 EN--GYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 33/271 (12%)

Query: 73  LGQGGFGSVYKGQLQTGGL-----IAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  +V   K++ G  L    L    +  A+G+ YL    
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 126

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 184

Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 236

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 237 TID------VYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 22/212 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + ++   ++A+K +  S   + E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   + L   ++  V  G  +G+ YLH+    
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 188

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNS--NMNA 275
           G    K DV+  G+  +E+   R+    NMNA
Sbjct: 189 GQYDGKVDVWSLGITCIEL-AERKPPLFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 33/223 (14%)

Query: 66  TNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA--EEFINEVSTIGRI 117
           T  F  +LG+  FG VYKG L      +    +A+K L++       EEF +E     R+
Sbjct: 6   TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF-----PKESRGQS---------LCW 163
            H N+V LLG  ++    ++++ Y  +   D H F     P    G +         L  
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHS--DLHEFLVMRSPHSDVGSTDDDKTVKSTLEP 123

Query: 164 EKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
                +    A G+E+L  H+       H D+   N+L+      K+SD GL +     +
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  +  +   I +++PE I   +G  S  SD++ +G+VL E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           K+G+G F  VY+   L  G  +A+K ++     ++K +  + I E+  + +++H NV++ 
Sbjct: 9   KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 67

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHV--FPKESR--GQSLCWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R +  F K+ R   +   W+    V L +A  +E++H
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF--VQLCSA--LEHMH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 124 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAG 266
             N    + KSD++  G +L EMA 
Sbjct: 179 HEN--GYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE  +    +     +NE   + +++   VV L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +  E +K AL  V   M  G L  H++   + G     ++    A     G+E L     
Sbjct: 67  YAYE-TKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQRER- 122

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+KP NILLD     ++SD GLA   P+     ++    GT+GY+APE+I+   
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEK 177

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
            T S   D +G G ++ EM  G+
Sbjct: 178 YTFS--PDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 42/216 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF-INEVSTIGRIHHVNVVQLLG 127
           K+G+G +G+V+K +  +T  ++A+K   L++         + E+  +  + H N+V+L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 128 FCSEGSKRALVYEYMP----------NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
                 K  LV+EY            NG +D  +       +S  ++ L        +G+
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV------KSFMFQLL--------KGL 112

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGY 235
            + H+     +LH D+KP N+L++ N   K++DFGLA+    P        SA   T+ Y
Sbjct: 113 AFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR----CYSAEVVTLWY 165

Query: 236 IAPELISRNFGT--VSCKSDVYGFGMVLLEMAGGRR 269
             P+++   FG    S   D++  G +  E+A   R
Sbjct: 166 RPPDVL---FGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLL 126
            +G+G +G V       TG  +A+K +  S F  + F    + E+  + R  H N++ +L
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKI--SPFEHQTFCQRTLREIKILRRFKHENIIGIL 69

Query: 127 GFCSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                 S  +     +V E M     D +   K  + Q L  + +        RG++Y+H
Sbjct: 70  DIIRPPSFESFNDVYIVQELMET---DLY---KLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-------FVSISATRGTIG 234
              +V  LH D+KP N+LL+ N   K+ DFGLA+    E+D       +V   ATR    
Sbjct: 124 -SANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV---ATR---W 174

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y APE I  N    +   D++  G +L EM   R
Sbjct: 175 YRAPE-IMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 27/205 (13%)

Query: 73  LGQGGFGSVYKGQLQTGGLI-AVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG-- 127
           LG G  G V K   +  GLI A K+  LE       + I E+  +   H  N   ++G  
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGFY 65

Query: 128 --FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             F S+G + ++  E+M  GSLD+ V  K  R   +    L ++++   RG+ YL     
Sbjct: 66  GAFYSDG-EISICMEHMDGGSLDQ-VLKKAGR---IPENILGKISIAVLRGLTYLREKHK 120

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISR 243
             I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +  
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQG 172

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
              TV   SD++  G+ L+EMA GR
Sbjct: 173 THYTVQ--SDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 36/214 (16%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVV 123
           +++G+G +G VY+ +   +G ++A+K   ++N +     S+   + E++ +  + H N+V
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS---LREITLLLNLRHPNIV 69

Query: 124 QLLGFCSEGSKRA----LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           +L        K      LV EY      SL  ++    S  Q  C      + L   RG+
Sbjct: 70  ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC------LMLQLLRGL 121

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 236
           +YLH   +  I+H D+K  N+LL      K++DFGLA+ +         ++    T+ Y 
Sbjct: 122 QYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTPKVVTLWYR 175

Query: 237 APELISRNFG-TVSCKS-DVYGFGMVLLEMAGGR 268
           APEL+    G T    + D++  G +L E+   +
Sbjct: 176 APELL---LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.5 bits (157), Expect = 9e-12
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 24/201 (11%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG G  G+VYK   L T  ++AVK+  L+ +    ++ ++E+  + +     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              ++ ++  E+M  GSLD +        + +    L  +A+   +G+ YL +   + IL
Sbjct: 69  FVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATR-GTIGYIAPELISRNFGT 247
           H D+KP N+L++     K+ DFG++         V SI+ T  GT  Y+APE IS     
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVST------QLVNSIAKTYVGTNAYMAPERISGE--Q 169

Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
               SDV+  G+  +E+A GR
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 70  THKLGQGGFGSVYKGQLQ-TGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
             K+G+G +G VYK + + T   IA+K +   +  +      I E+S +  + H N+V+L
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
                   +  LV+EY+ +  L +H+   P  ++   L    L+++     RGI Y H+ 
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL----RGIAYCHSH 121

Query: 184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
               +LH D+KP N+L+D      K++DFGLA+ F      F        T+ Y APE++
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEIL 175

Query: 242 --SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             SR++ T     D++  G +  EM   +
Sbjct: 176 LGSRHYST---PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 63/239 (26%), Positives = 94/239 (39%), Gaps = 71/239 (29%)

Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVV 123
           +G+G FG V    L     TG + A+K+L           A     E   +       +V
Sbjct: 9   IGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIV 64

Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSL-----DRHVFPKESRGQSLCWEKLH--EVALGTA 174
           +L  + S   +  L  V EYMP G L      + VFP+E         + +  E+ L   
Sbjct: 65  KL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-------TARFYIAELVLA-- 113

Query: 175 RGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK------------------ 215
             ++ +H  G     +H DIKP NIL+D +   K++DFGL K                  
Sbjct: 114 --LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167

Query: 216 ---------FHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
                        +   V  ++T GT  YIAPE L    +G    + D +  G++L EM
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 66/245 (26%), Positives = 101/245 (41%), Gaps = 52/245 (21%)

Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLL 126
            LG+G  G V+  +L+ TG L A+K+L+  +      +  V T    +  + H  +  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK----LHEVALGTARGIEYLH- 181
                 +   LV +Y P G L      +   G+ L  E       EV L     +EYLH 
Sbjct: 68  ASFQTETYLCLVMDYCPGGEL--FRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLHL 121

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---------------------FHPKE 220
            G    I++ D+KP NILL  +    +SDF L+K                      +   
Sbjct: 122 LG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 221 NDFVS-ISATR-----GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNS 271
           ++  S   + R     GT  YIAPE+IS +    +   D +  G++L EM  G    + S
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYGTTPFKGS 235

Query: 272 NMNAT 276
           N + T
Sbjct: 236 NRDET 240

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 34/202 (16%)

Query: 87  QTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL--GFCSEGSKRALVYE 140
            TG  +A+K+L       E     F  E +   R++H N+V LL  G    G   A V+E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFA-VFE 59

Query: 141 YMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 195
           Y+P  +L          P    G+ L  + L  +A    +GI           +H D+KP
Sbjct: 60  YVPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGI-----------VHRDLKP 107

Query: 196 HNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELISRNFGT 247
            NI++         KV DFG+    P   D    + TR     GT  Y APE + R    
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RG-EP 165

Query: 248 VSCKSDVYGFGMVLLEMAGGRR 269
           V+  SD+Y +G++ LE   G+R
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 69/266 (25%), Positives = 103/266 (38%), Gaps = 75/266 (28%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
                LG G FG V +          +   +AVKML+    ++E    ++E+  +  I +
Sbjct: 10  RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69

Query: 119 HVNVVQLLG--------------FCSEG-------SKRALVYEY---------------- 141
           H+NVV LLG              FC  G       +KR     Y                
Sbjct: 70  HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVE 129

Query: 142 ------MPNGSLDRHVFPKESRGQS----------------LCWEKLHEVALGTARGIEY 179
                          +F +     S                L  E L   +   ARG+E+
Sbjct: 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEF 189

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V   + R  + ++APE
Sbjct: 190 L--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246

Query: 240 LISRNFGTV-SCKSDVYGFGMVLLEM 264
            I   F  V + +SDV+ FG++L E+
Sbjct: 247 SI---FDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHV---NVVQLL 126
           +G+G +G+VY+G  + TG ++A+K+  L+       +   EV+ + ++      N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G   +G +  ++ EY   GS+ R +       +      + EV +     ++Y+H    V
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVA----LKYIHK---V 120

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELIS 242
            ++H DIK  NIL+ +    K+ DFG+A            S+ R    GT  ++APE+I 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAA------LLNQNSSKRSTFVGTPYWMAPEVI- 173

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
                   K+D++  G+ + EMA G
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG  +  G L+A+K++     E   F+A   I E S +  + H N+V L
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTA---IREASLLKGLKHANIVLL 68

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                       V+EYM +  L +++  +   G      +L    L   RG+ Y+H    
Sbjct: 69  HDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRLFMFQL--LRGLAYIHGQH- 123

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ILH D+KP N+L+ +    K++DFGLA+   K     + S+   T+ Y  P+++    
Sbjct: 124 --ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVL---L 176

Query: 246 GTV--SCKSDVYGFGMVLLEMAGGR 268
           G    S   D++G G + +EM  G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 63.7 bits (156), Expect = 3e-11
 Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 64/252 (25%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQ 124
               +G G +G V      +TG  +A+K + N       A+  + E+  +  + H N++ 
Sbjct: 4   LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63

Query: 125 LLG-FCSEGSKR----ALVYEYMPNGSLDRHVFPK------ESRGQSLCWEKLHEVALGT 173
           LL        +      +V E M     D H   K      +   Q   ++ L       
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELME---TDLHKVIKSPQPLTDDHIQYFLYQIL------- 113

Query: 174 ARGIEYLH--NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF----HPKENDFVSIS 227
            RG++YLH  N     ++H D+KP NIL++ N   K+ DFGLA+       ++       
Sbjct: 114 -RGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 228 ATRGTIGYIAPELISRNFGTVSCKS-----DVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
            TR    Y APEL+      +S        D++  G +  E+               K  
Sbjct: 168 VTR---WYRAPELL------LSSSRYTKAIDIWSVGCIFAELLTR------------KPL 206

Query: 283 FP-SWVYDQLNK 293
           FP     DQLN 
Sbjct: 207 FPGRDYIDQLNL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 31/229 (13%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKF 102
           N+  W +P+RY+             ++G G +GSV      +TG  +A+K L     S+ 
Sbjct: 7   NKTVWELPERYTSL----------KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI 56

Query: 103 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQ 159
            A+    E++ +  + H NV+ LL  F S  S       Y  MP    D     ++  G 
Sbjct: 57  FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL----QKIMGH 112

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            L  +K+  +      G++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADA 169

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E        TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 170 E--MTGYVVTR---WYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V+K   +  GLI  + L   E       + I E+  +   +   +V   G 
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       
Sbjct: 72  FYSDG-EISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-- 124

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +    
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQ--- 175

Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+EMA GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 23/167 (13%)

Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH 167
             E   +  I+H +++QL G  +      L+   +P    D + +    R  ++C   + 
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DIL 185

Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            +     R I+YLH      I+H DIK  NI ++H     + DFG A F       V I+
Sbjct: 186 AIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP------VDIN 236

Query: 228 ATR-----GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           A +     GTI   APEL++R+ +G      D++  G+VL EMA   
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 61.6 bits (149), Expect = 7e-11
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKML-------ENSK-FSAEEFINEVSTIGRIHHVNVV 123
           LGQG FG VY    + TG  +A K +       E SK  SA E   E+  +  + H  +V
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67

Query: 124 QLLGFCSEGSKRALV--YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           Q  G   + +++ L    EYMP GS+   +    +  +S+  +   ++      G+ YLH
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
           +     I+H DIK  NIL D     K+ DFG +K           I +  GT  +++PE+
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 241 IS-RNFGTVSCKSDVYGFGMVLLEM 264
           IS   +G    K+DV+  G  ++EM
Sbjct: 181 ISGEGYGR---KADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 52/209 (24%), Positives = 106/209 (50%), Gaps = 30/209 (14%)

Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKMLENSKFSAEEFINEVSTIGRI---------HHV 120
           ++G+G +G V+K + L+ GG  +A+K +   +    E    +STI  +          H 
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHP 64

Query: 121 NVVQLLGFCS-----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
           NVV+L   C+       +K  LV+E++     D   +  +     +  E + ++     R
Sbjct: 65  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +   +++++   T+ Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            APE++ ++  + +   D++  G +  EM
Sbjct: 176 RAPEVLLQS--SYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 72/265 (27%), Positives = 104/265 (39%), Gaps = 78/265 (29%)

Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------L 147
            LLG              FC  G       SKR     Y    +               L
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134

Query: 148 DRHVFPKESRGQS----------------------------LCWEKLHEVALGTARGIEY 179
            R +    S   S                            L  E L   +   A+G+E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           L      CI H D+   NILL  N + K+ DFGLA+   K+ D+V     R  + ++APE
Sbjct: 195 L--ASRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            I     T+  +SDV+ FG++L E+
Sbjct: 252 TIFDRVYTI--QSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 71  HKLGQGGFGSVYKGQLQTGGLIA---VKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
            ++G G FG V   ++ T   +A   VK L+ +  S E  EF+ +      + H N++Q 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESR---GQSLCWEKLHEVALGTARGIEYLHN 182
           LG C E     LV+EY   G L  ++  ++      Q L    L  +A   A G+ ++H 
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEIAAGVTHMHK 117

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
                 LH D+   N  L  +   KV D+G+     KE+   +       + ++APEL+ 
Sbjct: 118 ---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 242 SRNFGTVSCK----SDVYGFGMVLLEM 264
             + G ++ +    S+V+  G+ L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 52/216 (24%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFI---NEVS----------TIGRIH 118
           LG+G FG V   + + TG L A+K L+      +  I   +EV           T     
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK------KGDIIARDEVESLMCEKRIFETANSER 60

Query: 119 HVNVVQLLGFCSEGSKRA-LVYEYMPNGSLDRH----VFPKESRGQSLCWEKLHEVALGT 173
           H  +V L   C +       V EY   G L  H    VF  E R           V LG 
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYA----ACVVLG- 113

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISA 228
              ++YLH N     I++ D+K  N+LLD     K++DFGL K    F  + + F     
Sbjct: 114 ---LQYLHENK----IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC---- 162

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             GT  ++APE+++    T +   D +G G+++ EM
Sbjct: 163 --GTPEFLAPEVLTETSYTRAV--DWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           +G+G +G VYK    + G L AVK+L+      EE   E + +  + +H NVV+  G   
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89

Query: 131 E-----GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +     G +  LV E    GS+   V      GQ L    +  +  G   G+++LHN   
Sbjct: 90  KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR- 148

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAP 238
             I+H D+K +NILL      K+ DFG++           +++TR       GT  ++AP
Sbjct: 149 --IIHRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRNTSVGTPFWMAP 197

Query: 239 ELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 267
           E+I+   +   +   + DV+  G+  +E+  G
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 21/203 (10%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE--EFIN----EVSTIGRIHHVNVVQL 125
           LGQG FG VY      TG  +AVK ++    S E  + +N    E+  +  + H  +VQ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G   +  +R L    E+MP GS+   +   +S G +L      +       G+ YLH+ 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYG-ALTENVTRKYTRQILEGVSYLHSN 125

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELIS 242
               I+H DIK  NIL D     K+ DFG +K           + +  GT  +++PE+IS
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 243 -RNFGTVSCKSDVYGFGMVLLEM 264
              +G    K+D++  G  ++EM
Sbjct: 183 GEGYGR---KADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 63/218 (28%), Positives = 91/218 (41%), Gaps = 51/218 (23%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFI-NEVSTIGRIHHVNVVQLLG 127
           LG GGFG V   +++      A+K ++         +E I +E   +   +H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 128 FCSEGSKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL---GTAR------ 175
           + +    +  +Y   EY   G L               W  L +  L    TAR      
Sbjct: 59  YRTF-KDKKYIYMLMEYCLGGEL---------------WTILRDRGLFDEYTARFYIACV 102

Query: 176 --GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATR 230
               EYLHN     I++ D+KP N+LLD N   K+ DFG AK      K   F       
Sbjct: 103 VLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------ 153

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           GT  Y+APE+I  N G      D +  G++L E+  GR
Sbjct: 154 GTPEYVAPEIIL-NKGY-DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 20/205 (9%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG L A K L   +       E  + E   + ++H   +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR---GIEYLHNGC 184
                +   LV   M  G L  H++  +                 TA+   G+E+LH   
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF---PEPRACFYTAQIISGLEHLHQRR 117

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISR 243
              I++ D+KP N+LLD++   ++SD GLA +    ++         GT G++APEL+  
Sbjct: 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQG 171

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                S   D +  G+ L EM   R
Sbjct: 172 EEYDFSV--DYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
            ++G G +G VYK + L TG L AVK+++      FS  +   E+  +    H N+V   
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIVAYF 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDR--HVFPKESRGQ--SLCWEKLHEVALGTARGIEYLHN 182
           G      K  +  EY   GSL    HV    S  Q   +C E L        +G+ YLH+
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL--------QGLAYLHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGY 235
                 +H DIK  NILL  N   K++DFG+A           I+AT        GT  +
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVA---------AKITATIAKRKSFIGTPYW 172

Query: 236 IAPEL--ISRNFGTVSCKSDVYGFGMVLLEMA 265
           +APE+  + +N G  +   D++  G+  +E+A
Sbjct: 173 MAPEVAAVEKN-GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 44/280 (15%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG---LIAVKMLENS----KFSAEEFINEVSTIGRIHHVN 121
           F   +G+G +G V   + +T G   +I    L N+    + +AE+   E   + ++ H N
Sbjct: 4   FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPN 60

Query: 122 VVQLL-GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +V     +  E     +V  +   G L   +  KE +G+ L   ++ E  +  A  ++YL
Sbjct: 61  IVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H   +  ILH D+K  N+ L    I KV D G+A+    + D    S   GT  Y++PEL
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPEL 173

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN---MNAT--RSSKAYFPSWVYDQLNKGG 295
            S      + KSDV+  G  + EMA  +   N   MN+   R  +   P    D   + G
Sbjct: 174 FSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231

Query: 296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
           +L       I +M+++            +   RPS+  +L
Sbjct: 232 EL-------IATMLSK------------RPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 53/232 (22%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEF---------------INEVSTIGR 116
           LG+G +G V K     TG ++A+K ++  + S +                 + E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 117 IHHVNVVQLLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALG 172
           I H N++ L+    EG    LV + M    L    DR +   ES+ + +  + L      
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQIL------ 129

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK------FHPKENDFVSI 226
              G+  LH       +H D+ P NI ++   I K++DFGLA+      +    +   ++
Sbjct: 130 --NGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 227 SATRG------TIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
                      T+ Y APEL+    G      +   D++  G +  E+  G+
Sbjct: 185 QRREEMTSKVVTLWYRAPELL---MGAEKYHFAV--DMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 65/231 (28%), Positives = 96/231 (41%), Gaps = 53/231 (22%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKM----LENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
            +G+GG G VY          +A+K     L  +    + F+ E      + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 127 GFCSEGSKRALVYEYMP--NG----SLDRHVFPKESRGQSLCWEKLHE-VALGT------ 173
             CS+G     VY  MP   G    SL + V+ KES  +     +L E  ++G       
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSK-----ELAEKTSVGAFLSIFH 120

Query: 174 --ARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISAT 229
                IEY+H+ G    +LH D+KP NILL       + D+G A F   +E D + I   
Sbjct: 121 KICATIEYVHSKG----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176

Query: 230 R---------------GTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEM 264
                           GT  Y+APE   R  G   S  +D+Y  G++L +M
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 42/235 (17%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG G FG V   + + TG   A+K L+  +       +    E S +  + H  +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 128 FCSEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLH--EVALGTARGIEYL 180
              + ++   + E++  G L  H+     FP +         K +  E+ L      EYL
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV-------AKFYHAELVLA----FEYL 134

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+  D  I++ D+KP N+LLD+    KV+DFG AK  P +  F       GT  Y+APE+
Sbjct: 135 HS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTLC----GTPEYLAPEV 186

Query: 241 I-SRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNATR---SSKAYFPSWV 287
           I S+  G      D +  G++L E   G      ++         + +  FP+W 
Sbjct: 187 IQSKGHGKA---VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWF 238

Length = 329

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 31/210 (14%)

Query: 73  LGQGGFGSVYKGQLQTGG-----------LIAVKMLENSKFSAEEFINEVSTIGRIHHVN 121
           LGQG F ++YKG L+               + +K+L +    +  F    S + ++ H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +V+L G C    +  +V EY+  G LD  +  +E    SL W KL +VA   A  + YL 
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFL-HREKNNVSLHW-KL-DVAKQLASALHYLE 118

Query: 182 NGCDVCILHFDIKPHNILL-----DHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIG 234
              D  ++H ++   NIL+     +  ++P  K+SD G+        + V        I 
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +IAPE I     +++  +D + FG  LLE+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 75  QGGFGSVYKGQL--QTGGL---IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           +G FG ++ G L  +  G    + VK +++  S+      + E   +  + H N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 128 FCSEGSKRALV-YEYMPNGSLDRHVFPKESR------GQSLCWEKLHEVALGTARGIEYL 180
            C E  +   V Y YM  G+L   +F ++ R       Q+L  ++L  +A+  A G+ YL
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      ++H DI   N ++D     K++D  L++   P +   +  +  R  + ++A E
Sbjct: 134 HK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALE 189

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA 265
            +       S  SDV+ FG++L E+ 
Sbjct: 190 SLVNKE--YSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)

Query: 72  KLGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG ++     + G    +K +  SK S    EE   EV+ +  + H N+VQ   
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              E     +V +Y   G L + +     RG     +++ +  +     ++++H   D  
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRK 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELI-SRNF 245
           ILH DIK  NI L  +   K+ DFG+A+     N  V ++ T  GT  Y++PE+  +R +
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPEICENRPY 178

Query: 246 GTVSCKSDVYGFGMVLLEM 264
                KSD++  G VL EM
Sbjct: 179 NN---KSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +L+ T  L AVK+L+      ++ +    T  R+      H  + QL 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL- 61

Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEY 179
                 +K  L  V EY+  G L  H+     F  E R +        E+ LG    +++
Sbjct: 62  -HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD-EPRARFYA----AEIVLG----LQF 111

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           LH   +  I++ D+K  N+LLD     K++DFG+     KE     V+ S   GT  YIA
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC----KEGILGGVTTSTFCGTPDYIA 164

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE++S      +   D +  G++L EM  G+
Sbjct: 165 PEILSYQPYGPAV--DWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)

Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L+  +   ++        G    +N   +L   S 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 53

Query: 132 GS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           G                K + + + M  G L  H+    S+       ++   A     G
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILG 109

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           APE++ +     S  +D +  G +L ++  G      + T+  
Sbjct: 163 APEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           RG++YLH+     ILH DIKP N+L++ N + K+ DFGLA+   + ++   ++    T  
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQY 169

Query: 235 YIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y APE++  SR++ +     D++  G +  E+ G R
Sbjct: 170 YRAPEILMGSRHYTS---AVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 22/154 (14%)

Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF-PKESR----GQSLCWEKLHEVA 170
            ++H +V+++      G+   +V   +P+ S D + +  K SR     Q+L  EK     
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEK----- 164

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
                G+ YLH      I+H D+K  NI ++      + D G A+F      F+ ++   
Sbjct: 165 -QILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--- 217

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           GT+   APE+++R+    + K+D++  G+VL EM
Sbjct: 218 GTVETNAPEVLARD--KYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  +G   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY+  G L  H+    SR +    ++           ++YLH+G    
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSGK--- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           I++ D+K  N++LD +   K++DFGL K      D  ++    GT  Y+APE++  N +G
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +L ++G L AVK+L+      ++ +    T  RI     +H  + QL 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 127 GFCSEGSKRAL-VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             C +   R   V E++  G L  H+  ++SR       + +   + +A  + +LH   D
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSA--LMFLH---D 114

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I++ D+K  N+LLDH    K++DFG+ K         + S   GT  YIAPE++    
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEML 172

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
              S   D +  G++L EM  G
Sbjct: 173 YGPSV--DWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 38/212 (17%)

Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G+GGFG VY   +  TG + A+K L+  +   ++        G    +N   +L   S 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVST 53

Query: 132 GS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           G                K   + + M  G L  H+    S+      +++   A     G
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILG 109

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S+    GT GY+
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 162

Query: 237 APELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
           APE++ +  GT     +D +  G +L ++  G
Sbjct: 163 APEVLQK--GTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V K +  +T  ++A+K  ++S+ +    E  + E+  +  +   N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                K  LV+EY+    L+      E     +  EK+        + I + H      I
Sbjct: 69  FRRRGKLYLVFEYVEKNMLEL----LEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---I 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFG 246
           +H DIKP N+L+ HN + K+ DFG A+   + ++  +    ATR    Y +PEL+    G
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR---WYRSPELL---LG 175

Query: 247 TVSCKS-DVYGFGMVLLEMAGGR 268
               K+ D++  G +L E++ G+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQLL 126
            ++G G +G VYK + + TG L A+K+++      E+F     E+  +    H N+V   
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 127 GFCSEGSKRALVYEYMPNGSLDR--HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           G      K  +  E+   GSL    HV    S  Q      +  V+  T +G+ YLH+  
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLHSKG 126

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIA 237
            +   H DIK  NILL  N   K++DFG++           I+AT        GT  ++A
Sbjct: 127 KM---HRDIKGANILLTDNGHVKLADFGVS---------AQITATIAKRKSFIGTPYWMA 174

Query: 238 PELIS-RNFGTVSCKSDVYGFGMVLLEMA 265
           PE+ +    G  +   D++  G+  +E+A
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 54/170 (31%), Positives = 81/170 (47%), Gaps = 35/170 (20%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQL 125
           +G+G +G VYK + + TG L+A+K   L+N K   E F    I E+  + +++H N+V L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKILRQLNHRNIVNL 71

Query: 126 ----------LGFCSEGSKRALVYEYMPN---GSLDRH-VFPKESRGQSLCWEKLHEVAL 171
                     L F  +     LV+EYM +   G L+   V   E   +S   + L     
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN 221
               G+ Y H       LH DIK  NILL++    K++DFGLA+ +  E 
Sbjct: 128 ----GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)

Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKF-----SAEEFINEVSTIGRIHHVNVV 123
           LG G +G V+     G    G L A+K+L+ +       +AE    E   +  +     +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 124 QLL--GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR---GIE 178
             L   F ++ +K  L+ +Y+  G L  H++ +E            EV +  A     ++
Sbjct: 68  VTLHYAFQTD-TKLHLILDYVNGGELFTHLYQREHF-------TESEVRVYIAEIVLALD 119

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           +LH    + I++ DIK  NILLD      ++DFGL+K    E +  + S   GTI Y+AP
Sbjct: 120 HLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAP 175

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E+I    G      D +  G++  E+  G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 15/201 (7%)

Query: 71  HKLGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVV 123
            +LG+G FG+VY    K  +    L  +K +   + +  E +    E   + ++ H  +V
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +      E     ++ EY     LD  +   +  G++L   ++ E  +    G+ Y+H  
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-- 123

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ILH D+K  NI L +N + K+ DFG+++      D    +   GT  Y++PE +  
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA--TTFTGTPYYMSPEALKH 179

Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
                  KSD++  G +L EM
Sbjct: 180 Q--GYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFIN----EVSTIGRIHHVNVVQ 124
           LG+G FG VY      TG  +AVK +    +S+ +++E +N    E+  +  + H  +VQ
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68

Query: 125 LLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
             G   +  ++ L    EYMP GS+   +    +  +++      ++     +G+ YLH+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI 241
                I+H DIK  NIL D     K+ DFG +K           I +  GT  +++PE+I
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181

Query: 242 S-RNFGTVSCKSDVYGFGMVLLEM 264
           S   +G    K+DV+     ++EM
Sbjct: 182 SGEGYGR---KADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.1 bits (136), Expect = 6e-09
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 46/214 (21%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQL- 125
           ++ +G +G VY+ +  +TG ++A+K L+  K   E F    + E++ + ++ H N+V + 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 126 ---LGFCSEGSKRALVYEYMPN---GSLDRHVFPKESRGQSLCWEKLHEVA---LGTARG 176
              +G  S   K  +V EY+ +     ++     K+   QS       EV    L    G
Sbjct: 71  EVVVG--SNLDKIYMVMEYVEHDLKSLMETM---KQPFLQS-------EVKCLMLQLLSG 118

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KF-HPKENDFVSISATRG--T 232
           + +LH   D  ILH D+K  N+LL++  I K+ DFGLA ++  P +        T+   T
Sbjct: 119 VAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP------YTQLVVT 169

Query: 233 IGYIAPELISRNFGT--VSCKSDVYGFGMVLLEM 264
           + Y APEL+    G    S   D++  G +  E+
Sbjct: 170 LWYRAPELL---LGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           ++YLH+  +V 
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 117

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 118 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 174

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 175 RA---VDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V      +T   +A+K + N+   +  A+  + E+  +  + H NV+ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 129 CSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
                + A     +VYE M     D H   + S  Q+L  +          RG++Y+H+ 
Sbjct: 73  MPPPHREAFNDVYIVYELM---DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELI- 241
               +LH D+KP N+LL+ N   K+ DFGLA+   ++ DF++    TR    Y APEL+ 
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---WYRAPELLL 181

Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
               + T     DV+  G +  E+ G +
Sbjct: 182 NCSEYTTA---IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 24/222 (10%)

Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQL 125
           LG G +G V+      G   +G L A+K+L+ +    +    E +   R  + H+     
Sbjct: 8   LGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 126 L-----GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           L      F ++ +K  L+ +Y+  G L  H+  +E   +        E+ L     +E+L
Sbjct: 67  LVTLHYAFQTD-TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA----LEHL 121

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H    + I++ DIK  NILLD N    ++DFGL+K FH  E +     +  GTI Y+AP+
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE--RAYSFCGTIEYMAPD 176

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 281
           ++    G      D +  G+++ E+  G     ++  ++S+A
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 27/204 (13%)

Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLG 127
           +G G FG V+  + +       L  + + E  +   E+ + NE   +  + H  +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           F +E  +R L  + EY+P G L  ++  + S   S      +   +  A  +EYLH+   
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCA--LEYLHS--- 119

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI-SR 243
             I++ D+KP NILLD     K++DFG AK           + T  GT  Y+APE+I S+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                    D +  G+++ EM  G
Sbjct: 174 GHNKA---VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           +G G +G+V      +TG  +A+K L     S+  A+    E+  +  + H NV+ LL  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 128 FCSEGS--KRALVYEYMPN-----GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           F  + S  +    Y  MP      G L +H    E R Q L ++ L        +G++Y+
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML--------KGLKYI 134

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H      I+H D+KP N+ ++ +   K+ DFGLA+    +++      TR    Y APE+
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTR---WYRAPEV 186

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I  N+   +   D++  G ++ EM  G+
Sbjct: 187 I-LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 73  LGQGGFGSVYKGQLQTGG--------LIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVV 123
           LGQG F  ++KG  +  G         + +K+L+ S +  +E F    S + ++ H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
              G C  G +  +V EY+  GSLD ++  K     ++ W KL EVA   A  + +L   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINISW-KL-EVAKQLAWALHFLE-- 117

Query: 184 CDVCILHFDIKPHNILLDHN---------FIPKVSDFGLA-KFHPKENDFVSISATRGTI 233
            D  + H ++   N+LL            FI K+SD G++    PKE     I   R  I
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKE-----ILLER--I 168

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            ++ PE I  N   +S  +D + FG  L E+  G
Sbjct: 169 PWVPPECI-ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 73/262 (27%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE------FINEVSTIGRIHHVN-VV 123
           K+G+G +G VYK +   TG L+A+K    ++   +E       + E+S +  +     +V
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 124 QLLGFCSEGSKRA-----LVYEYMP---------NGSLDRHVFPKESRGQSLCWEKLHEV 169
           +LL       K       LV+EY+          NG       P ++  +S  ++ L   
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKT-IKSFMYQLL--- 120

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
                +G+ + H      ++H D+KP N+L+D    + K++D GL +        + + +
Sbjct: 121 -----KGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-----AFSIPVKS 167

Query: 229 TRG---TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF 283
                 T+ Y APE++  S ++ T     D++  G +  EM+  R+             F
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYST---PVDIWSVGCIFAEMS--RKQ----------PLF 212

Query: 284 PSWVYDQLNKGGDLELQNVTEI 305
           P          GD ELQ +  I
Sbjct: 213 P----------GDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 54/243 (22%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V+  +L+ T    A+K L+      ++ +       R+      H  +  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--------G 176
            +C+  +K  L  V EY+  G L  H+            +  H+  L  A         G
Sbjct: 62  -YCTFQTKENLFFVMEYLNGGDLMFHI------------QSCHKFDLPRATFYAAEIICG 108

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGT 232
           +++LH+     I++ D+K  NILLD +   K++DFG+ K +     K   F       GT
Sbjct: 109 LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC------GT 159

Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFP 284
             YIAPE L+ + + T     D + FG++L EM  G+             + R     +P
Sbjct: 160 PDYIAPEILLGQKYNT---SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP 216

Query: 285 SWV 287
            W+
Sbjct: 217 RWL 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----VVQ 124
           +G+G FG V   Q+     TG + A+K+++ S   A+E ++       I  ++    + Q
Sbjct: 9   VGRGHFGEV---QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ 65

Query: 125 LLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           L     +     LV EY P G L    +R+    +        E + +  L  A  +  +
Sbjct: 66  LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD--------EDMAQFYL--AELVLAI 115

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+   +  +H DIKP N+L+D     K++DFG A          S     GT  YIAPE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEV 174

Query: 241 ISRNFGTVSCKSDV----YGFGMVLLEMAGGR 268
           ++   G       V    +  G++  EM  GR
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           ARG+E+L      C+ H D+   N+LL    I K+ DFGLA+    ++++VS  +T   +
Sbjct: 247 ARGMEFL--ASKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I  N  T    SDV+ +G++L E+
Sbjct: 304 KWMAPESIFDNLYTT--LSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V   + +  G   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           + YLH+ CD  
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALGYLHS-CD-- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ D+K  N++LD +   K++DFGL K    +    ++    GT  Y+APE++  N +G
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 115

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 174 RA---VDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 74/243 (30%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFIN---------EVSTIGRI-HH 119
            KLG+G +G V+K    +T  ++A+K +    F A  F N         E+  +  +  H
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKI----FDA--FRNATDAQRTFREIMFLQELGDH 66

Query: 120 VNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPK-----ESRGQSLCWEKLH 167
            N+V+LL        +A       LV+EYM     D H   +     +   + + ++ L 
Sbjct: 67  PNIVKLLNVI-----KAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRYIMYQLL- 117

Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK---------FHP 218
                  + ++Y+H+G    ++H D+KP NILL+ +   K++DFGLA+          +P
Sbjct: 118 -------KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 219 KENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRR----NS 271
              D+V   ATR    Y APE++  S  +   V    D++  G +L EM  G+      S
Sbjct: 168 VLTDYV---ATR---WYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGKPLFPGTS 217

Query: 272 NMN 274
            +N
Sbjct: 218 TLN 220

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 34/214 (15%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 127
           +G+G +G V       TG  +A+K + +  F     A   + E+  +  + H ++V++  
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 128 FCSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL-GTARGIEYLH 181
                S+R      +V+E M +   D H   K +    L  E  H+  L    R ++Y+H
Sbjct: 67  IMLPPSRREFKDIYVVFELMES---DLHQVIKAN--DDLTPEH-HQFFLYQLLRALKYIH 120

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-------NDFVSISATRGTIG 234
                 + H D+KP NIL + +   K+ DFGLA+    +        D+V   ATR    
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV---ATR---W 171

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           Y APEL    F   +   D++  G +  E+  G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 40/216 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL--IAVKMLENSKFSAEEFINEV----STIGRIHHVN 121
           +F   LG G FG V     +      +A+K  E SK   ++ ++ V      +  I+H  
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGS----LDRHV-FPKESRGQSLCWEKLHEVALGTARG 176
            V L G   + S   LV E++  G     L R+  FP +      C+     V +     
Sbjct: 93  CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG----CFYAAQIVLI----- 143

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----G 231
            EYL +   + I++ D+KP N+LLD +   K++DFG AK          +  TR     G
Sbjct: 144 FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK----------VVDTRTYTLCG 190

Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           T  YIAPE++  N G     +D +  G+ + E+  G
Sbjct: 191 TPEYIAPEIL-LNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 31/225 (13%)

Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLL 126
           LG G +G V+         TG L A+K+L+ +    +    E +   R  + HV     L
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 127 -----GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                 F +E +K  L+ +Y+  G +  H++ +++  +        E+ L     +E+LH
Sbjct: 68  VTLHYAFQTE-AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHLH 122

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGYI 236
               + I++ DIK  NILLD      ++DFGL+K      +F+S    R     GTI Y+
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYM 173

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 281
           APE+I R  G      D +  G+++ E+  G     +   R++++
Sbjct: 174 APEII-RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 33/247 (13%)

Query: 36  LKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSV----YKGQLQTGGL 91
           L+   NI+ FL N+   + ++    Q+ A        +G+G FG V    +K   +   +
Sbjct: 15  LRKNKNIDNFL-NRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAM 73

Query: 92  IAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRAL--VYEYMPNGSL- 147
             +   E  K S   F  E   I    +   VVQL  FC+    + L  V EYMP G L 
Sbjct: 74  KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLV 131

Query: 148 ---DRHVFPKESRGQSLCWEKLH--EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH 202
                +  P++       W K +  EV L     ++ +H+   + ++H D+KP N+LLD 
Sbjct: 132 NLMSNYDVPEK-------WAKFYTAEVVLA----LDAIHS---MGLIHRDVKPDNMLLDK 177

Query: 203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMV 260
           +   K++DFG       E   V      GT  YI+PE++    G      + D +  G+ 
Sbjct: 178 HGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 261 LLEMAGG 267
           L EM  G
Sbjct: 237 LFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 51/277 (18%)

Query: 80  SVYKGQLQTGGLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLGF----CSE 131
           S+YKG       + ++  +      K   +   NE+  + RI   N++++ GF      +
Sbjct: 35  SIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
             + +L+ EY   G L R V  KE   + L ++   ++A+   +G+  L+         +
Sbjct: 94  LPRLSLILEYCTRGYL-REVLDKE---KDLSFKTKLDMAIDCCKGLYNLYK--------Y 141

Query: 192 DIKPH------NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             KP+      + L+  N+  K+   GL K       F +++     + Y + ++++  F
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-PFKNVN----FMVYFSYKMLNDIF 196

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL---NKGGDLELQNV 302
              + K D+Y  G+VL E+  G+     N T          +YD +   N    L L   
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKE-------IYDLIINKNNSLKLPLDCP 248

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            EI+ ++          C    +  RP++ ++L  L 
Sbjct: 249 LEIKCIVEA--------CTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENS----KFSAEEFINEVST-IGRIHHVNVVQLL 126
           +G+G FG V   +    G   AVK+L+      K   +  + E +  +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                  K   V +Y+  G L  H+     FP E R +    E         A  + YLH
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFP-EPRARFYAAE--------IASALGYLH 113

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   + I++ D+KP NILLD      ++DFGL K   + +   + S   GT  Y+APE++
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVL 168

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +     +   D +  G VL EM  G
Sbjct: 169 RKQPYDRTV--DWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 34/233 (14%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGF 128
           LG+G FG V   +L+  G   AVK L+      ++ +       R+  +   N      +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 129 CSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR---GIEYLHNG 183
           C+  +K  L  V E++  G L  H+   + +G+      L+      A    G+++LH+ 
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRF----DLYRATFYAAEIVCGLQFLHSK 115

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELI 241
               I++ D+K  N++LD +   K++DFG+     KEN F    A+   GT  YIAPE++
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMC----KENVFGDNRASTFCGTPDYIAPEIL 168

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 287
                T S   D + FG++L EM  G+        +    + R    ++P W+
Sbjct: 169 QGLKYTFSV--DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 73  LGQGGFGSVYKGQLQTGGLI-AVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+    I A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V E++  G L  H+     R + L  E     +   +  + +LH     
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHM----QRQRKLPEEHARFYSAEISLALNFLHERG-- 116

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+K  N+LLD     K++D+G+ K   +  D  S     GT  YIAPE++     
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC--GTPNYIAPEIL----- 168

Query: 247 TVSCKSDVYGF-------GMVLLEMAGGR 268
               + + YGF       G+++ EM  GR
Sbjct: 169 ----RGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 54/271 (19%)

Query: 20  SATYLESNFLVSRRTTLKTIDNIEKFL-RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGF 78
           +A   + +    R+       NI+ FL R +++         ++ A        +G+G F
Sbjct: 4   TALVYDCDIPALRKNK-----NIDNFLSRYEKAAEKITKL--RMKAEDFDVIKVIGRGAF 56

Query: 79  GSVYKGQL----QTGGLIAVKMLENSKF-----SAEEFINEVSTIGRIHHVN---VVQLL 126
           G V   QL     +  + A+K+L  SKF     S   F  E   I  + H N   +VQL 
Sbjct: 57  GEV---QLVRHKSSKQVYAMKLL--SKFEMIKRSDSAFFWEERDI--MAHANSEWIVQL- 108

Query: 127 GFCSEGSKRAL--VYEYMPNGSL----DRHVFPKESRGQSLCWEKLH--EVALGTARGIE 178
              +    + L  V EYMP G L      +  P++       W + +  EV L     ++
Sbjct: 109 -HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-------WARFYTAEVVLA----LD 156

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
            +H+   +  +H D+KP N+LLD +   K++DFG        N  V      GT  YI+P
Sbjct: 157 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISP 212

Query: 239 ELI--SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++      G    + D +  G+ L EM  G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 24/203 (11%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 127
           +G G FG V   + Q TG  +A+K +    FS    A+    E+  +  + H N++ L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISLSD 76

Query: 128 -FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F S       V E +     D H        +    + +        RG++Y+H+    
Sbjct: 77  IFISPLEDIYFVTELL---GTDLHRLLTSRPLEK---QFIQYFLYQILRGLKYVHSAG-- 128

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH-PKENDFVSISATRGTIGYIAPELISRNF 245
            ++H D+KP NIL++ N   K+ DFGLA+   P+   +VS      T  Y APE I   +
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS------TRYYRAPE-IMLTW 180

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
                + D++  G +  EM  G+
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 12/99 (12%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSIS--AT 229
           RG++Y+H+     ++H D+KP N+L++ +   ++ DFG+A+     P E+ +      AT
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           R    Y APEL+  +    +   D++  G +  EM G R
Sbjct: 175 R---WYRAPELL-LSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +     A   E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 85  FTP----ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 191

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 8/91 (8%)

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--F 245
           ++H D+KP NILLD +   K+ DFG++       D  + + + G   Y+APE I      
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPPDPN 192

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR---RNSNM 273
                ++DV+  G+ L+E+A G+   +N   
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKT 223

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 34/231 (14%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAE 105
           N+  W +P RY     +          G G +G V       TG  +A+K L +  F + 
Sbjct: 7   NKTVWEVPDRYQNLSPV----------GSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSA 55

Query: 106 EF----INEVSTIGRIHHVNVVQLLG-FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRG 158
                   E+  +  + H NV+ LL  F    S      VY        D +      + 
Sbjct: 56  IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLN---NIVKC 112

Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           Q L  + +  +     RG++Y+H+     I+H D+KP NI ++ +   K+ DFGLA+   
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169

Query: 219 KE-NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            E   +V   ATR    Y APE++  N+   +   D++  G ++ E+  G+
Sbjct: 170 DEMTGYV---ATR---WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 69/303 (22%)

Query: 73  LGQGGFGSVYKGQLQTGG-------------------------LIAVKMLENSKFS-AEE 106
           LGQG   ++Y G+L+  G                          + +K+L+ S    A  
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ-SLCWEK 165
           F    S + ++ H+++  + G C  GS+  +V E++ +G LD  V  ++ +G+  + W+ 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD--VCLRKEKGRVPVAWKI 120

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--------FIPKVSDFGLAKFH 217
              VA   A  + YL    D  ++H ++   NILL           FI K+SD G++   
Sbjct: 121 T--VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFI-KLSDPGVS--- 171

Query: 218 PKENDFVSISATRGT--IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA 275
                F ++S       I +IAPE +     ++S  +D + FG  LLE+           
Sbjct: 172 -----FTALSREERVERIPWIAPECV-PGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225

Query: 276 TRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
           T S K  F    Y++ ++   L   +  E+ ++I++        C+  +   RPS   +L
Sbjct: 226 TPSEKERF----YEKKHR---LPEPSCKELATLISQ--------CLTYEPTQRPSFRTIL 270

Query: 336 EML 338
             L
Sbjct: 271 RDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 62/242 (25%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLLG 127
           +G+G FG V   Q + TG + A+K L  S+   +E +  V      +    +  VV+L  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL-- 66

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL----GTARGIEYLH 181
           + S   +  L  + EY+P G +   +  K++           E        T   I+ +H
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT--------EEETRFYIAETILAIDSIH 118

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK--------------FHPKENDFVSIS 227
               +  +H DIKP N+LLD     K+SDFGL                 H   ++F+   
Sbjct: 119 K---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 228 A----------------------TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +                      T GT  YIAPE+  +      C  D +  G+++ EM 
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC--DWWSLGVIMYEML 233

Query: 266 GG 267
            G
Sbjct: 234 VG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 36/212 (16%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVS-TIGRIHHVNVVQLLGFC- 129
           +G+G FG VY+ + + T  + A+K+L   +  A++   EV+ TIG   ++ V  LL    
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK---EVAHTIGE-RNILVRTLLDESP 56

Query: 130 ---------SEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTAR 175
                       S   LV +YM  G L  H+     F  E R +      + E+ L    
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFY----IAELVLA--- 108

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
            +E+LH      I++ D+KP NILLD      + DFGL+K +  +N   +     GT  Y
Sbjct: 109 -LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC--GTTEY 162

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +APE++    G      D +  G+++ EM  G
Sbjct: 163 LAPEVLLDEKGYTK-HVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 62/253 (24%), Positives = 96/253 (37%), Gaps = 77/253 (30%)

Query: 73  LGQGGFGSVY-KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN---------- 121
           +G G FG V    ++ T  L A+K L  +         +V    +  HV           
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKA---------DVLMRNQAAHVKAERDILAEAD 59

Query: 122 ---VVQLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
              VV+L  + S   K  L  V +Y+P G +   +       + L    + E+       
Sbjct: 60  NEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA---- 113

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL---------AKF-----HPKEND 222
           IE +H    +  +H DIKP NIL+D +   K++DFGL         +K+     H +++ 
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170

Query: 223 F------VSISATR---------------------GTIGYIAPELISRNFGTVSCKSDVY 255
                    I   R                     GT  YIAPE++ R   T  C  D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWW 228

Query: 256 GFGMVLLEMAGGR 268
             G++L EM  G+
Sbjct: 229 SVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+ T  + A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R + L  E     +   +  + YLH   + 
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 173

Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 174 GF---SVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 11/159 (6%)

Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
           +E+  +    H  +V+         K  L+ EY   G L++ +  K+   + L +++ +E
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQE-YE 170

Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-- 226
           V L   + +  L       ++H D+K  NI L    I K+ DFG +K   + +D VS+  
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDV 227

Query: 227 -SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            S+  GT  Y+APEL  R     S K+D++  G++L E+
Sbjct: 228 ASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 63/244 (25%), Positives = 105/244 (43%), Gaps = 56/244 (22%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGR------IHHVNVVQL 125
           LG+G FG V   +L+ T    A+K L+      ++ + E + + R        H  +  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDV-ECTMVERRVLALAWEHPFLTHL 61

Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR-------- 175
             FC+  +K  L  V EY+  G L  H+            +         AR        
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHI------------QSSGRFDEARARFYAAEIIC 107

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATR 230
           G+++LH  G    I++ D+K  N+LLD +   K++DFG+ K +     K + F       
Sbjct: 108 GLQFLHKKG----IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------ 157

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 283
           GT  YIAPE++       S   D + FG++L EM  G+        +   ++  + + +F
Sbjct: 158 GTPDYIAPEILKGQKYNESV--DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF 215

Query: 284 PSWV 287
           P W+
Sbjct: 216 PRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 49/222 (22%)

Query: 67  NHFT--HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-FSAEEFINEVSTIGRI----H 118
             F    ++GQGG+G V+  + + TG ++A+K ++ S  F   E +  V T   I     
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTK 59

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK--LHEVALGTAR- 175
              +V+LL    +     L  EY+P G             ++L      L E     AR 
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDF-----------RTLLNNLGVLSE---DHARF 105

Query: 176 -------GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS- 227
                   ++ LH   ++  +H D+KP N L+D +   K++DFGL+K        V+ + 
Sbjct: 106 YMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK------GIVTYAN 156

Query: 228 ATRGTIGYIAPELI-SRNFG-TVSCKSDVYGFGMVLLEMAGG 267
           +  G+  Y+APE++  + +  TV    D +  G +L E   G
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTV----DYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 7/111 (6%)

Query: 155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           E    +L  E L   +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 261

Query: 215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           +    ++++V     R  + ++APE I   F  V + +SDV+ +G++L E+
Sbjct: 262 RDIRNDSNYVVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 50.0 bits (119), Expect = 9e-07
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   + + T  L A+K+L+      ++ +       R+  ++     
Sbjct: 3   NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L   +   +  G+   +++ H V  A   A G+ +
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI---QQVGR---FKEPHAVFYAAEIAIGLFF 116

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           LH+     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFCGTPDYIA 169

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 170 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQL-L 126
           +G+G FG V + + + T  + A+K +      S+      + E + + +++   +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F S   K  LV  ++  G L  H+  +E R   L   + +   L  A  +E LH     
Sbjct: 61  SFQSPE-KLYLVLAFINGGELFHHL-QREGRF-DLSRARFYTAELLCA--LENLH---KF 112

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            +++ D+KP NILLD+     + DFGL K + K++D    +   GT  Y+APEL+    G
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLL-GHG 169

Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
                 D +  G++L EM  G
Sbjct: 170 YTKA-VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 47/233 (20%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           +G+G FG V   Q + TG + A+K+L  +    +E +  +     I      + VV++  
Sbjct: 9   IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +     L+ E++P G +   +  K++    L  E+       T   I+ +H    + 
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQ---LG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSISATR- 230
            +H DIKP N+LLD     K+SDFGL     K H            P +  F ++++ R 
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181

Query: 231 ----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
                           GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 66  TNHFTHKLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVV 123
           T      +G+G +G V+K    + G   AVK+L+      EE   E + +  +  H NVV
Sbjct: 19  TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVV 78

Query: 124 QLLGF-----CSEGSKRALVYEYMPNGSLDRHVFPKESRG----QSLCWEKLHEVALGTA 174
           +  G         G +  LV E    GS+   V     RG    + +    LHE  +G  
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG-- 136

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---- 230
             +++LH    +   H D+K +NILL      K+ DFG++           +++TR    
Sbjct: 137 --LQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVS---------AQLTSTRLRRN 182

Query: 231 ---GTIGYIAPELIS---RNFGTVSCKSDVYGFGMVLLEMAGG 267
              GT  ++APE+I+   +   T   + DV+  G+  +E+  G
Sbjct: 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 53/197 (26%), Positives = 92/197 (46%), Gaps = 29/197 (14%)

Query: 88  TGGLIAVKM--LEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN 144
           TG L+ V++  LEN ++   +   NEV       H N++      + GS   ++  +M  
Sbjct: 24  TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 145 GS---LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILL 200
           GS   L +  FP E   ++L    +  +  G  RG+ YLH NG     +H +IK  +IL+
Sbjct: 84  GSANSLLKTYFP-EGMSEAL----IGNILFGALRGLNYLHQNGY----IHRNIKASHILI 134

Query: 201 DHNFIPKVSDFGLAKFHPKEN---------DFVSISATRGTIGYIAPELISRNFGTVSCK 251
             + +  +S  GL+  +             DF   S +   + +++PEL+ ++    + K
Sbjct: 135 SGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS--VLPWLSPELLRQDLYGYNVK 190

Query: 252 SDVYGFGMVLLEMAGGR 268
           SD+Y  G+   E+A GR
Sbjct: 191 SDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)

Query: 69  FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVV 123
           F   LG+G FG V   + + T  L A+K+L+      ++ +     E   +        +
Sbjct: 4   FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63

Query: 124 QLLGFCSEGSKRA-LVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYL 180
             L  C +   R   V EY+  G L  H+    K    Q++ +      A   + G+ +L
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFL 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H      I++ D+K  N++LD     K++DFG+ K H  +   V+     GT  YIAPE+
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEI 172

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I+  +       D + +G++L EM  G+
Sbjct: 173 IA--YQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNV 122
           +G+G FG V   QL     T  + A+K+L  SKF       +  F  E   +   +   V
Sbjct: 51  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 105

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH--EVALGTARGIEYL 180
           VQL     +     +V EYMP G L   +   +   +   W + +  EV L     ++ +
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLA----LDAI 158

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H+   +  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+PE+
Sbjct: 159 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEV 214

Query: 241 ISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           +    G      + D +  G+ L EM  G
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 31/210 (14%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
           +G G FG VY+   + T   +A+K +L++ ++   E +     +  ++H+N++ L  +  
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYY 129

Query: 131 EGSKRA--------LVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYL 180
               +         +V E++P  ++ +++  + + +    L   KL+   L   R + Y+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H+     I H D+KP N+L+D N    K+ DFG AK        VS   +R    Y APE
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR---FYRAPE 240

Query: 240 LI--SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           L+  + N+ T     D++  G ++ EM  G
Sbjct: 241 LMLGATNYTT---HIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 75/324 (23%), Positives = 124/324 (38%), Gaps = 72/324 (22%)

Query: 53  MPKRYSYPQIIAMTNHFTHKLGQGGFGSVY-KGQLQTGGLIAVKMLENSKFSAEE---FI 108
           MP +Y   +          K+G G FG V+     +T      K +        E    +
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60

Query: 109 NEVSTIGRIHHVNVVQ---------------LLGFCSEGS-KRALVYEYMPNGSLDRHVF 152
            EV+ +  + H N+V+               L+ FC  G   R +   Y   G ++ H  
Sbjct: 61  IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCD----VCILHFDIKPHNILLDHNF---- 204
              +R      + LH +A        Y HN  D      +LH D+KP NI L        
Sbjct: 121 VDITR------QLLHALA--------YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166

Query: 205 -------------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
                        I K+ DFGL+K    E+      +  GT  Y +PEL+     +   K
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDK 223

Query: 252 SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIAR 311
           SD++  G ++ E+  G+       T   KA   S +  +L +G DL ++  ++  +++ +
Sbjct: 224 SDMWALGCIIYELCSGK-------TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIK 276

Query: 312 KLCMIGLWCIQVKAADRPSMTKVL 335
            L       + + A +RPS  + L
Sbjct: 277 NL-------LNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)

Query: 73  LGQGGFGSVYKGQLQT-GGLIAVKMLENSKFSAEEFINEVST-----IGRIHHVNVVQLL 126
           +G+G FG V   + ++ G   AVK+L+      ++  N +       +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  K   V +Y+  G L  H+     R +     +    A   A  I YLH+   +
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS---L 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD      ++DFGL K   +  +  + S   GT  Y+APE++ +   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE-- 171

Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 10/98 (10%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FH--PKEND-FVSISATR 230
            G++Y+H+  +V  LH D+KP N+L++ +   K+ DFGLA+ F   P EN  F++     
Sbjct: 116 CGLKYIHSA-NV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA- 171

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            T  Y APE I  +F + +   DV+  G +L E+ G +
Sbjct: 172 -TRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 73  LGQGGFGSVYKGQLQTG-GLIAVKMLENS----KFSAEEFINEVSTIGR-IHHVNVVQLL 126
           +G+G FG V   + +      AVK+L+      K   +  ++E + + + + H  +V L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  K   V +Y+  G L  H+     R +     +    A   A  + YLH+   +
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++ +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ-- 171

Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
                 D +  G VL EM  G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 55/237 (23%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG---- 127
           +G+G FG V   Q + TG + A+K+L  +    +E +  +    R     +V+  G    
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI----RAERDILVEADGAWVV 64

Query: 128 --FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
             F S   KR L  + E++P G +   +  K++  +      + E  L     I+ +H  
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA----IDAIHQ- 119

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFH------------PKENDFVSIS 227
             +  +H DIKP N+LLD     K+SDFGL     K H            P +  F +++
Sbjct: 120 --LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 228 ATR-----------------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           + R                 GT  YIAPE+  +      C  D +  G+++ EM  G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC--DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 73  LGQGGFGSV----YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL-G 127
           +G+G FG      +    Q   +  ++ L  S  + E+   E   + ++ H N+V     
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ------SLCWEKLHEVALGTARGIEYLH 181
           F ++G    +V EY   G L + +  K  RG+       L W    ++ LG    ++++H
Sbjct: 67  FEADG-HLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTILQW--FVQMCLG----VQHIH 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATR-GTIGYIAP 238
              +  +LH DIK  NI L  N   K+ DFG A+    P      + + T  GT  Y+ P
Sbjct: 118 ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-----GAYACTYVGTPYYVPP 169

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E I  N    + KSD++  G +L E+
Sbjct: 170 E-IWENM-PYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 26/216 (12%)

Query: 73  LGQGGFGSVYKGQLQTGGLI-AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ--LLGF- 128
           +G+G +  V   +L+    I A+K+++      +E I+ V T   +         L+G  
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 129 -CSEGSKRA-LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            C + + R  LV EY+  G L  H+     R + L  E     A      + +LH   + 
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHM----QRQRKLPEEHARFYAAEICIALNFLH---ER 115

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD +   K++D+G+ K      D  + S   GT  YIAPE++    +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEY 173

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR-------NSNMN 274
           G      D +  G+++ EM  GR        N +MN
Sbjct: 174 GF---SVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A+G+++L      CI H D+   N+LL    + K+ DFGLA+    ++++V     R  +
Sbjct: 222 AQGMDFL--ASKNCI-HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++APE I     TV  +SDV+ +G++L E+
Sbjct: 279 KWMAPESIFDCVYTV--QSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 61/232 (26%), Positives = 100/232 (43%), Gaps = 38/232 (16%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +    +AVK L     S   A     E+  +  + H NV+ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 129 CS------EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
            +        ++  LV   M    L+  V     + Q L  E +  +     RG++Y+H+
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIV-----KCQKLSDEHVQFLIYQLLRGLKYIHS 136

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H D+KP N+ ++ +   ++ DFGLA+    +++     ATR    Y APE I 
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATR---WYRAPE-IM 187

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 293
            N+   +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKG------------KALFPGNDYIDQLKR 227

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 17/100 (17%)

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--- 230
           A G+ +LH+     I++ D+K  N++LD     K++DFG+ K +           TR   
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFC 162

Query: 231 GTIGYIAPELIS-RNFGTVSCKS-DVYGFGMVLLEMAGGR 268
           GT  YIAPE+I+ + +G    KS D + FG++L EM  G+
Sbjct: 163 GTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 11/137 (8%)

Query: 136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP 195
           ALV +Y   G L + +   +SR ++    + HE  L   + +  +H+     ++H DIK 
Sbjct: 115 ALVLDYANAGDLRQEI---KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171

Query: 196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKS 252
            NILL  N + K+ DFG +K +      VS    R   GT  Y+APE+  R     S K+
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRK--PYSKKA 226

Query: 253 DVYGFGMVLLEMAGGRR 269
           D++  G++L E+   +R
Sbjct: 227 DMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 7/126 (5%)

Query: 139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 198
           Y         R     ES   +L +  L   +   A G+E+L      C+ H D+   N+
Sbjct: 216 YLPSAPERTRRDTLINES--PALSYMDLVGFSYQVANGMEFL--ASKNCV-HRDLAARNV 270

Query: 199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG 258
           L+    + K+ DFGLA+   ++++++S  +T   + ++APE I  N  T    SDV+ FG
Sbjct: 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL--SDVWSFG 328

Query: 259 MVLLEM 264
           ++L E+
Sbjct: 329 ILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 73  LGQGGFGSVYKGQLQTGG------LIAVKMLENSKFSAEEF-------INEVSTIGRIH- 118
           +G GGFG VY+ Q  +        +  ++ LEN     E         I++++    IH 
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 119 --HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF-PKESRGQSLCWEK--LHEVALGT 173
             H+ + +  G C    +  + Y ++    L++ V   KE   +  C  K  +  +    
Sbjct: 80  IDHLGIPKYYG-CGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKNKKLIKNIMKDM 135

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISAT- 229
              +EY+H   +  I H DIKP NI++D N    + D+G+A     H K  ++       
Sbjct: 136 LTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192

Query: 230 -RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG 266
            RGT+ Y    L + N   V+ + D+   G  +L+ AG
Sbjct: 193 HRGTLYYAG--LDAHNGACVTRRGDLESLGYCMLKWAG 228

Length = 294

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 31/213 (14%)

Query: 72  KLGQGGFGSVYKGQLQTG---GLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           K+G+G +G VYK + + G      A+K +E +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-CREIALLRELKHPNVIALQKV 66

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHVFPKESRG--------QSLCWEKLHEVALGTARGIE 178
           F S   ++  L+++Y  +       F + S+         +S+    L+++      GI 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI----LDGIH 122

Query: 179 YLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTI 233
           YLH      +LH D+KP NIL+          K++D G A+ F+        +     T 
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y APEL+  +R++   +   D++  G +  E+
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 72  KLGQGGFGSVYKGQLQTG---GLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           K+G+G +G VYK + + G      A+K +E +  S      E++ +  + H NV+ L   
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKV 66

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
           F S   ++  L+++Y  +       F + S+      +K  ++  G  +        GI 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQILDGIH 122

Query: 179 YLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTI 233
           YLH      +LH D+KP NIL+          K++D G A+ F+        +     T 
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y APEL+  +R++   +   D++  G +  E+
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 35/210 (16%)

Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V   + +  G   AVK+L+     N K            +  + H  +V L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                  K   V +++  G L  H+     FP E R       + +   + +A G  YLH
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-EPRA------RFYAAEIASALG--YLH 113

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIA 237
           +   + I++ D+KP NILLD      ++DFGL K      + ++ S T     GT  Y+A
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLA 164

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           PE+I +         D +  G VL EM  G
Sbjct: 165 PEVIRKQ--PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 44/218 (20%)

Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI---NEVSTIGRIHHVNVVQLLGFC 129
                   + K +  T  L+AVK +     S E+      E+ T  ++ H N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 130 SEGSKRALVYEYMPNGS---LDRHVFPKESRGQSLCWEKLHEVAL-----GTARGIEYLH 181
              S+  +V   M  GS   L +  FP          E L E+A+          ++Y+H
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFP----------EGLPELAIAFILKDVLNALDYIH 118

Query: 182 -NGCDVCILHFDIKPHNILLD----------HNFIPKVS-DFGLAKFHPKENDFVSISAT 229
             G     +H  +K  +ILL              +  +         H    DF   S+ 
Sbjct: 119 SKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH----DF-PKSSV 169

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +  + +++PE++ +N    + KSD+Y  G+   E+A G
Sbjct: 170 K-NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 37/203 (18%)

Query: 77  GFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKR 135
           G  S  +G+ +   LIA K ++    +A +  NE+  +GR++H N++++     SE +  
Sbjct: 181 GVNSTNQGKPKCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTY 239

Query: 136 AL-------VYEYMPNGSLDRHVFP--KESRG---QSLCWEKLHEVALGTARGIEYLHNG 183
            +       +Y +M + + D    P  K++R    Q LC              +EY+H  
Sbjct: 240 MITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLC-------------AVEYIH-- 284

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELIS 242
            D  ++H DIK  NI L+ +    + DFG A   P E +  +      GT+   +PE+++
Sbjct: 285 -DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM--PFEKEREAFDYGWVGTVATNSPEILA 341

Query: 243 RNFGTVSCK-SDVYGFGMVLLEM 264
            +     C+ +D++  G++LL+M
Sbjct: 342 GD---GYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +L+ T  + A+K+L+      ++ ++   T  RI      H  +  L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL- 61

Query: 127 GFCSEGSKRAL--VYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
             C   +K  L  V EY+  G L     R     E R +        EV L     + +L
Sbjct: 62  -HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYA----AEVTLA----LMFL 112

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIA 237
           H +G    +++ D+K  NILLD     K++DFG+     KE     ++ T   GT  YIA
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMC----KEGILNGVTTTTFCGTPDYIA 164

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE++       S   D +  G+++ EM  G+
Sbjct: 165 PEILQELEYGPSV--DWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 32/155 (20%)

Query: 128 FCSEGSKRAL--VYEYMPNG---SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           FCS  +KR L  V EY+  G   +L +++         L  +        T   +EYLHN
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGA-------LPVDMARMYFAETVLALEYLHN 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-----------HPKENDFVSISATR- 230
                I+H D+KP N+L+      K++DFGL+K               E D       + 
Sbjct: 120 ---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 231 -GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLE 263
            GT  YIAPE+I R  +G      D +  G++L E
Sbjct: 177 CGTPEYIAPEVILRQGYGK---PVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 23/111 (20%)

Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           Q LC             GI++LH+     I+H D+KP NI++  +   K+ DFGLA+   
Sbjct: 126 QMLC-------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 166

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
                  ++    T  Y APE+I    G       D++  G ++ EM  G 
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVI---LGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 27/82 (32%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 63/246 (25%), Positives = 96/246 (39%), Gaps = 59/246 (23%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLLG 127
           LG G FG V    ++ T  L A+K L          +  V      +    +  VV+L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +      V +Y+P G +   +   E   + L    + E+ L     IE +H    + 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA----IESVHK---MG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGL---------AKFHPKEN-------------DFVS 225
            +H DIKP NIL+D +   K++DFGL         +K++ K +             D VS
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 226 ------------ISATR-----------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLL 262
                         AT+           GT  YIAPE++ R   T  C  D +  G++L 
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC--DWWSVGVILF 239

Query: 263 EMAGGR 268
           EM  G+
Sbjct: 240 EMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 16/148 (10%)

Query: 75  QGGFGSVYKGQLQTGG-LIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +G FG VY G+ +    L AVK+++ +    K    +   E   +       +V L    
Sbjct: 14  RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73

Query: 130 SEGSKRALVYEYMPNGSLDR--HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +   LV EY+  G +    H++       ++ +  + EVAL     ++YLH      
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALA----LDYLHRHG--- 124

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           I+H D+KP N+L+ +    K++DFGL+K
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 34/114 (29%), Positives = 51/114 (44%), Gaps = 13/114 (11%)

Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S    E    ++E+  +  + +H
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC--WEKLHEVAL 171
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C   E   E AL
Sbjct: 99  INIVNLLGACTVGGPTLVITEYCCYGDLLN--FLRRKRDSFICPKHEDHAEAAL 150

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 4/82 (4%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR---NF 245
           +H DIKP NIL+D N   +++DFG +     E+  V  S   GT  YI+PE++       
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           G    + D +  G+ + EM  G
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 15/95 (15%)

Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIH-HVNVV 123
           LG G FG V +         Q+   +AVKML+++  S+E+   ++E+  +  +  H+N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL------DRHVF 152
            LLG C++G    ++ EY   G L      ++H F
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 14/100 (14%)

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKF---HPKENDFVSISATR 230
           RG++Y+H+     +LH D+KP N+ ++  + + K+ DFGLA+    H     ++S     
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 231 GTIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            T  Y +P L+    N+       D++  G +  EM  G+
Sbjct: 181 -TKWYRSPRLLLSPNNYTKA---IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 28/88 (31%), Positives = 42/88 (47%), Gaps = 9/88 (10%)

Query: 69  FTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HH 119
           F   LG G FG V +      G+      +AVKML+ S  + E    ++E+  +  +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL 147
            N+V LLG C+ G    ++ EY   G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 69/251 (27%)

Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVST----IGRIHHVNVVQLLG 127
           LG G FG V    ++ T  L A+K L          +  V      +    +  VV+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 128 FCSEGSKRALVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
              +      V +Y+P G +        +FP     + L    + E+       +E +H 
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFP-----EDLARFYIAELTCA----VESVHK 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGL---------AKF-----HPKEN--DF--- 223
              +  +H DIKP NIL+D +   K++DFGL         +K+     H +++  DF   
Sbjct: 120 ---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 224 ---------------VSISATR-----------GTIGYIAPELISRNFGTVSCKSDVYGF 257
                          +   A R           GT  YIAPE++ R   T  C  D +  
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC--DWWSV 234

Query: 258 GMVLLEMAGGR 268
           G++L EM  G+
Sbjct: 235 GVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 27/114 (23%), Positives = 40/114 (35%), Gaps = 20/114 (17%)

Query: 155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           E RG+ L  E++  V L     +  LH            K  NILL  + +  +   G  
Sbjct: 8   EVRGRPLNEEEIWAVCLQCLGALRELHRQ---------AKSGNILLTWDGL--LKLDGSV 56

Query: 215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            F   E                APE+I     + + K+D+Y  G+ L E     
Sbjct: 57  AFKTPEQSRPDPYFM-------APEVIQG--QSYTEKADIYSLGITLYEALDYE 101

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 14/117 (11%)

Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
            + R+H V   + L       +R  +   +    L R V  +     +  WE+L    L 
Sbjct: 101 LLARLHSVPP-EALPLARRLRRRLKLLRQLAAA-LRRLVAAELLDRLAELWERLLAALLA 158

Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS---DFGLAKFHPKENDFVSI 226
               +          ++H D+ P N+L+D     +V+   DF  A       D  S+
Sbjct: 159 LLPALPL-------VLVHGDLHPGNLLVDPG--GRVTGVIDFEDAGLGDPAYDLASL 206

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 14/156 (8%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSK-FSAEEFIN---EVSTIGRIHHVNVVQLLG 127
           +G+G FG V   Q   TG + A+K L  S+ F  ++  +   E   +       VV L  
Sbjct: 9   IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +     L+ E++P G L   +   ++  + +    + E  L     IE +H    + 
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLA----IEAVHK---LG 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEND 222
            +H DIKP NIL+D     K+SDFGL+  FH K++D
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFH-KQHD 156

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 37/127 (29%)

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           GI++LH+     I+H D+KP NI++  +   K+ DFGLA+             T GT   
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------------TAGTSFM 181

Query: 236 IAPELISRNFGTVSC--------KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV 287
           + P +++R +               D++  G ++ EM  G               FP   
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG------------GVLFPGTD 229

Query: 288 Y-DQLNK 293
           + DQ NK
Sbjct: 230 HIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 22/166 (13%)

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           E+  +  I H  ++ L+      S   +V   MP    D  +F    R   L  E+   +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCD--LFTYVDRSGPLPLEQAITI 190

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA------KFHPKENDF 223
                  + YLH      I+H D+K  NI LD      + DFG A         P+   +
Sbjct: 191 QRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247

Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                  GT+   +PEL++ +      K+D++  G+VL EM+    
Sbjct: 248 S------GTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 20/53 (37%), Positives = 31/53 (58%), Gaps = 1/53 (1%)

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +H DIKP N+LLD N   +++DFG +      +  V  +   GT  YI+PE++
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.4 bits (87), Expect = 0.003
 Identities = 29/157 (18%), Positives = 57/157 (36%), Gaps = 15/157 (9%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV--QLLGFC 129
            L  G    VY    +    + +K+  + +  A+    EV+ +  +    +   ++L   
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
                  L+ E++   +LD     +E +             L     +  LH    + + 
Sbjct: 63  ESDGWSYLLMEWIEGETLDE--VSEEEKEDIAE-------QLAEL--LAKLHQLPLLVLC 111

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
           H D+ P NIL+D   I  + D+  A + P   D  + 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAA 148

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	373
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.83
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
KOG1243	690	consensus Protein kinase [General function predict	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.05
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.76
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.56
PRK09902	216	hypothetical protein; Provisional	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.41
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.32
PLN02876	822	acyl-CoA dehydrogenase	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.2
PRK10593	297	hypothetical protein; Provisional	98.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.11
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.09
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.99
PRK05231	319	homoserine kinase; Provisional	97.91
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.88
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.83
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.79
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.73
KOG2270	520	consensus Serine/threonine protein kinase involved	97.62
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.61
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.38
PLN02236	344	choline kinase	97.22
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.17
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.16
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.93
COG2334	331	Putative homoserine kinase type II (protein kinase	96.93
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.91
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.85
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.8
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.67
PRK11768	325	serine/threonine protein kinase; Provisional	96.66
PLN02756	418	S-methyl-5-thioribose kinase	96.61
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.35
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.22
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.01
PRK06148	1013	hypothetical protein; Provisional	95.95
PTZ00384	383	choline kinase; Provisional	95.93
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.52
PTZ00296	442	choline kinase; Provisional	95.09
PRK12396	409	5-methylribose kinase; Reviewed	94.92

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-51  Score=378.99  Aligned_cols=284  Identities=44%  Similarity=0.778  Sum_probs=237.1

Q ss_pred             CCCccChhHHHHHHhhhh--cccCCCCcEEEEEEEEcCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           53 MPKRYSYPQIIAMTNHFT--HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        53 ~~~~~~~~~i~~~~~~~~--~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      ....|++.++..+|..|.  +.||+|+||.||+|...+|..||||.+...... ..+|.+|+.++.+++|||+++++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999999  699999999999999998899999988876655 66799999999999999999999999


Q ss_pred             eeCC-eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          130 SEGS-KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       130 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .+.+ ..++|+|||++|+|.+.++.....  +++|..+.+|+.++|+||+|||+.+.+.|+||||||+|||+|+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 599999999999999999765433  8999999999999999999999987778999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecc-cCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||+|.........  .... .||.+|+|||.+..  +..+.|+||||||+++.||++|+.+.+..... ....+..|.
T Consensus       219 sDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~  293 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWA  293 (361)
T ss_pred             cCccCcccCCccccc--eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHH
Confidence            999999655431111  1122 79999999999865  58899999999999999999999888765422 222367777


Q ss_pred             HHHHhcCCCcccCcc----chhhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          288 YDQLNKGGDLELQNV----TEIES-MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~----~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ...+..+...++.+.    .+.+. .....+..++.+|++.+|.+||+|.||++.|+....
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            777776543333221    22222 455679999999999999999999999999976543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-52  Score=381.72  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=213.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEecc----CccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .+|...+.||+|||+.||.++. .+|+.||+|++.+    .....+...+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4677889999999999999997 7899999999987    4455688999999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |+|..++|..++    ...+++++.+++.+..||+.||.|||+.   +|+|||||..|+|++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~----Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELL----KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHH----HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999888    3568899999999999999999999998   999999999999999999999999999998875


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      +.+.  -...+|||.|.|||++...  ..+..+||||+||++|.||.|++||......+        ....++...    
T Consensus       171 ~~Er--k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~----  234 (592)
T KOG0575|consen  171 DGER--KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNE----  234 (592)
T ss_pred             cccc--cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcC----
Confidence            5332  2457899999999999865  67889999999999999999999998654321        222222221    


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ...|..++.+..+||.++|+.||.+|||+++|+.
T Consensus       235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               2334567889999999999999999999999985

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-52  Score=368.90  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=211.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCcc--------CHHHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      .....|.+.+.||+|+||.|-+|.. ++|+.||||++.+...        ......+|+++|++|+|||||+++++++..
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3556677889999999999999985 4899999999976332        223457999999999999999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEe
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVS  209 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~  209 (373)
                      ...|+||||++||.|.+.+.    .++.+.+.....+++|++.|+.|||++   ||+||||||+|||++.+   -.+||+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            99999999999999999984    345677788889999999999999999   99999999999999765   679999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcC-cccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      |||+|+..+..   ..+...|||+.|.|||++.+....+. .++|+||+||++|-+++|.+||........       ..
T Consensus       322 DFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------l~  391 (475)
T KOG0615|consen  322 DFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------LK  391 (475)
T ss_pred             ccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------HH
Confidence            99999987633   35678899999999999977644444 488999999999999999999986654431       22


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.+..+..   ...+.....++.+..+|+.+||..||++|||++|+++
T Consensus       392 eQI~~G~y---~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  392 EQILKGRY---AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHHhcCcc---cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            33333322   2223455678899999999999999999999999886

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-51  Score=373.61  Aligned_cols=259  Identities=29%  Similarity=0.487  Sum_probs=227.1

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.....++.+.||+|-||.||.|.++....||+|.++......++|.+|+.+|++|+|+|||+++++|..+..+||||||
T Consensus       203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            44556678899999999999999999888999999999988999999999999999999999999999998899999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |+.|+|.+++..  ..+..+.......++.|||+||+||+++   ++|||||.++||||+++..+||+|||+++... ++
T Consensus       283 m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~  356 (468)
T KOG0197|consen  283 MPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG-DD  356 (468)
T ss_pred             cccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC-CC
Confidence            999999999954  3467788899999999999999999999   99999999999999999999999999999443 34


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .+.......-+..|.|||.+..  +.++.||||||||++||||+| |+.|++.....        .+.+.+.+|.++..+
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------ev~~~le~GyRlp~P  426 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------EVLELLERGYRLPRP  426 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHH--------HHHHHHhccCcCCCC
Confidence            4444455567789999999965  489999999999999999998 77777766543        367788888877655


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      .      .++..+.++|..||+.+|++|||++.+...|+...
T Consensus       427 ~------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  427 E------GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             C------CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            4      35678999999999999999999999999998754

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-50  Score=367.68  Aligned_cols=263  Identities=32%  Similarity=0.495  Sum_probs=217.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC-eeEEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVY  139 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~  139 (373)
                      .....+.+.||+|+||+||+|.++....||||++......   .++|.+|+.+|.+++||||++++|+|.+.. ..++||
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            3344556779999999999999994444999999875544   458999999999999999999999999887 799999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCcCCCCeeeeCCC-ceEEeeccCcccC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  217 (373)
                      ||+++|+|.+++...  .+..+++..+..++.|||+||.|||++   + |+||||||+|||++.++ ++||+|||+++..
T Consensus       120 Ey~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            999999999999654  467899999999999999999999998   7 99999999999999997 9999999999865


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ....  ...+...||+.|||||++.+....|+.|+||||||+++|||+||+.||......       .........+.++
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLRP  265 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCC
Confidence            4322  223446799999999999842247999999999999999999999999876541       1122333344444


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      .++.      .++..+..|+.+||+.||..||++.+++..|+.+.....
T Consensus       266 ~~p~------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  266 PIPK------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCc------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            4332      256788999999999999999999999999998766443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-50  Score=352.68  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=206.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC--ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCe-eEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~e~  141 (373)
                      ..+..+.||+|..|+||++.++ ++..+|+|.+...  ....+++.+|+++++..+|||||++||.|..+.. .+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3345688999999999999987 7888999999543  3344789999999999999999999999998884 9999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |.+|||++.+    ...+.+++.....++.++++||.|||+.  .+|+||||||+|||++..|.+||||||.+..+.+. 
T Consensus       160 MDgGSLd~~~----k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDIL----KRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999988    3346799999999999999999999962  39999999999999999999999999999866443 


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                         ......||..|||||.+.+.  .|+.++||||||+.++|+.+|+.|+.........   .......+-.+..+.   
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~---~~~Ll~~Iv~~ppP~---  301 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD---IFELLCAIVDEPPPR---  301 (364)
T ss_pred             ---hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCCCC---HHHHHHHHhcCCCCC---
Confidence               34567799999999999886  8999999999999999999999999876221110   011122222222222   


Q ss_pred             cchhhH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIES-MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~-~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         +|. .++.++++++..||+.||.+|||++|+++
T Consensus       302 ---lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 ---LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               223 47889999999999999999999999976

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-51  Score=344.43  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=217.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEee-EeeeCC-eeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG-FCSEGS-KRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~-~~~~~~-~~~l  137 (373)
                      .+.|++.++||+|+||.||++. ..+|..+|.|.++-...+.   .+...|+.+|++|+||||+++++ .+.++. -.++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            4568889999999999999997 4589999999998655544   56889999999999999999998 444444 4899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD-VCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      |||+|.+|+|...+......++.+++..+|.++.|++.||.++|+.-+ .-|.||||||.||+++.+|.+||+|||+++.
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999999987766778889999999999999999999998311 1399999999999999999999999999998


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      +.....+  ....+|||.||+||.+.+.  .|+.|+||||+||++|||+.-.+||.+..-        ....+.+..+..
T Consensus       178 l~s~~tf--A~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~~L~~KI~qgd~  245 (375)
T KOG0591|consen  178 LSSKTTF--AHSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------LSLCKKIEQGDY  245 (375)
T ss_pred             hcchhHH--HHhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCcccccH--------HHHHHHHHcCCC
Confidence            8665443  3456799999999999886  899999999999999999999999987631        223445555533


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +.++.     ..+|.++..|+..|+..||+.||+.-.++..+...++
T Consensus       246 ~~~p~-----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l~  287 (375)
T KOG0591|consen  246 PPLPD-----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSELD  287 (375)
T ss_pred             CCCcH-----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHhc
Confidence            22221     5788999999999999999999997666666665433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=349.10  Aligned_cols=247  Identities=25%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|.+.++||+|+||+||+|+++ ++..||||.+.+...+   .+.+..|+.+|+.++|||||.+++++..++..|+||||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            4556778999999999999976 6889999999876543   36678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC------CceEEeeccCcc
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN------FIPKVSDFGLAK  215 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~------~~~kl~Dfg~~~  215 (373)
                      |.||+|.+++.    +.+.+++..+..++.|+|.||++||++   +|+||||||.|||++..      -.+||+|||+|+
T Consensus        91 C~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   91 CNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999994    345799999999999999999999999   99999999999999764      468999999999


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .+....   .....+|++.|||||++..+  +|+.|+|+||+|+++|++++|+.||......+        .....+++.
T Consensus       164 ~L~~~~---~a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k~~  230 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKKGN  230 (429)
T ss_pred             hCCchh---HHHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhccc
Confidence            876433   23467899999999999764  89999999999999999999999998655332        222333332


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...    ...+...+..+.+|+...++.+|.+|.+..+-..
T Consensus       231 ~~~----~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~  267 (429)
T KOG0595|consen  231 EIV----PVLPAELSNPLRELLISLLQRNPKDRISFEDFFD  267 (429)
T ss_pred             ccc----CchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence            221    2233445566778888888888888887776543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=333.16  Aligned_cols=241  Identities=25%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...+++.+.||+|+||+|+.++.+ +++.||+|++++...    ..+....|..+|..++||+||+++..|.+...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            345577899999999999999855 788999999987543    346678999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +||+.||.|...+    ++.+.+++..+.-++..|+.||.|||+.   +|+|||+||+|||+|.+|+++|+|||+++..-
T Consensus       104 ld~~~GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999998888    4457799999999999999999999998   99999999999999999999999999998543


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  .....+||+.|||||++.+.  .++..+|+||+|+++|+|++|.+||...+...        ..+.+..+... 
T Consensus       177 ~~~~--~t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~~-  243 (357)
T KOG0598|consen  177 KDGD--ATRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKLP-  243 (357)
T ss_pred             cCCC--ccccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcCC-
Confidence            3322  23457899999999999886  88999999999999999999999998776432        23333333311 


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRP  329 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  329 (373)
                           ..+..++.+.++++...|+.||++|.
T Consensus       244 -----~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 -----LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence                 12233567899999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-47  Score=322.72  Aligned_cols=260  Identities=24%  Similarity=0.330  Sum_probs=202.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|+-..++|+|+||.||+|+++ +|+.||||++..++.+.   +-.++|+++|++++|+|+|.++++|......++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            3555678999999999999977 79999999998766543   4468999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |+..-|+++-    .....++.+.+.+++.|++.|+.|||++   +++||||||+|||++.+|.+||||||.|+.+...+
T Consensus        83 ~dhTvL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   83 CDHTVLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             cchHHHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9775444432    2234588899999999999999999999   99999999999999999999999999999876433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------chHHHHHHHhc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYDQLNK  293 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~  293 (373)
                      .  .++....|-.|.|||.+.|. .+|+..+||||+||++.||++|.+.|++.+....-..        ++.- ......
T Consensus       156 d--~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q~iF~~  231 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-QSIFSS  231 (396)
T ss_pred             c--hhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-HHHhcc
Confidence            2  24556689999999999875 5889999999999999999999998886553211000        0000 001111


Q ss_pred             -----CC-CcccCccchhh---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 -----GG-DLELQNVTEIE---SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 -----~~-~~~~~~~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           |. .++......+.   +.++.-+.+++..||+.||++|++.++++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 11 11222222222   345567899999999999999999999864

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-47  Score=338.21  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=212.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHH--HHHHHHHhcccC-CCceeeEeeEeeeCC-eeEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE--FINEVSTIGRIH-HVNVVQLLGFCSEGS-KRAL  137 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~e~~~l~~l~-h~ni~~~~~~~~~~~-~~~l  137 (373)
                      .-.+|.+.++||.|+||.||+|+.+ +|+.||||.++..-...++  -++|+..|++++ ||||+++.+++.+.. .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3458899999999999999999855 7899999999876655544  368999999998 999999999998877 9999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||| ..+|++++..   ++..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+..+||+|||+|+-.
T Consensus        88 VfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            99999 5599988843   368899999999999999999999998   9999999999999999999999999999976


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc---------cccchHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS---------KAYFPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~---------~~~~~~~~~  288 (373)
                      .....   ++..+.|-.|+|||++... +.|+.+.|+||+||+++|+.+-++.|++......         ......|..
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            55443   4556688999999999876 7899999999999999999999999987653211         000111111


Q ss_pred             -HHHhcCCCcccCc-----cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          289 -DQLNKGGDLELQN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       289 -~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       ..+.......++.     ...+-...+.++.+|+.+|+.+||.+|||++|.++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence             1111111122211     122333477899999999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=328.23  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=211.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCH--HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|++...||.|..++||+|+ ...++.||||++...+.+.  +.+.+|+..|..++||||++++..|..+..+|+||+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4567888999999999999998 4578999999998765544  788999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||.+||+.+.+...-.  ..+.+..+..|.+++++||.|||.+   |.+|||||+.|||++.+|.+||+|||.+..+...
T Consensus       105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999998854433  3389999999999999999999999   9999999999999999999999999987655433


Q ss_pred             CCce--eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          221 NDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       221 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      +...  ..+...||++|||||++..+...|+.|+||||||+...||.+|..||...-+        ..+.-.-- .+.+.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tL-qn~pp  250 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTL-QNDPP  250 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHh-cCCCC
Confidence            3221  1255689999999999766667899999999999999999999999974432        11111111 11111


Q ss_pred             c----CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 L----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .    ....+-...++..+++++..||+.||++|||++++++
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0    1122334567789999999999999999999999975

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-46  Score=341.53  Aligned_cols=248  Identities=26%  Similarity=0.376  Sum_probs=205.9

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----cc--CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  135 (373)
                      ...|.+.+.||+|+||+|+.|.+. ++..||+|++...    ..  ..+.+.+|+.+++.++ ||||+++++++......
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            346778899999999999999755 7899999987764    21  2356678999999998 99999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA  214 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~  214 (373)
                      ++||||+.+|+|.+++.    ..+++.+..+..++.|++.|++|||+.   ||+||||||+|||++.+ +++||+|||++
T Consensus        96 ~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999994    356788999999999999999999998   99999999999999999 99999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      .....  ........+||+.|+|||++.+....-+.++||||+|++||.|++|+.||......       . ....+..+
T Consensus       169 ~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~-------~-l~~ki~~~  238 (370)
T KOG0583|consen  169 AISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP-------N-LYRKIRKG  238 (370)
T ss_pred             cccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH-------H-HHHHHhcC
Confidence            97741  11234677899999999999886223357899999999999999999999874321       1 22222222


Q ss_pred             CCcccCccchhhHHH-HHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          295 GDLELQNVTEIESMI-ARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      .       ..++..+ +.+++.|+.+|+..||.+|+|+.+++
T Consensus       239 ~-------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 E-------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             C-------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1       1223344 78899999999999999999999999

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-46  Score=335.86  Aligned_cols=264  Identities=23%  Similarity=0.326  Sum_probs=208.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l  137 (373)
                      ...|+-.++||+|+||.||+|+. .+|+.||+|.++.....   ..-..+|+.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            45667778999999999999984 58999999999875533   34568999999999999999999988776  68999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |+|||++ +|.-++.   ..+..+++.++..++.|++.||.|||++   +|+|||||.+|||+|.+|.+||+|||+|+++
T Consensus       196 VFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            9999976 7777773   3356799999999999999999999998   9999999999999999999999999999977


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc---------chHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY---------FPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~---------~~~~~~  288 (373)
                      ..... ..++..+-|..|.|||.+.|. ..|+.++|+||.|||+.||+.|++.|.....-+.-..         ...|..
T Consensus       269 ~~~~~-~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~  346 (560)
T KOG0600|consen  269 TPSGS-APYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV  346 (560)
T ss_pred             cCCCC-cccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence            54432 235677789999999999987 6899999999999999999999999876553211100         111111


Q ss_pred             HHHhcCCC--ccc---CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGD--LEL---QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~--~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+.....  +..   ....+.-..++....+|+..+|..||.+|.|+.++++
T Consensus       347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11110000  000   0112223445678899999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=329.63  Aligned_cols=258  Identities=29%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCC--eeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~e~  141 (373)
                      .+...+.||+|+||.||++... +|...|||.+...... .+.+.+|+.+|.+++|||||+++|......  ..+++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            3456789999999999999866 5899999998765322 466889999999999999999999754444  68999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~  220 (373)
                      +++|+|.+++...   +.++++..+..+..|+++||+|||++   |++||||||+|||++. ++.+||+|||++......
T Consensus        98 ~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   98 APGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999433   22799999999999999999999998   9999999999999999 799999999999865531


Q ss_pred             C-CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 N-DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      . .........||+.|||||++.+. .....++||||+||++.||+||+.||... .     ....+..........   
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~-----~~~~~~~~ig~~~~~---  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEF-F-----EEAEALLLIGREDSL---  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhh-c-----chHHHHHHHhccCCC---
Confidence            1 11122346799999999999741 23335899999999999999999999753 1     011222222222211   


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                         +.++..++.+.++++.+|++.||.+|||++++++..--..
T Consensus       242 ---P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  242 ---PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ---CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence               2555668889999999999999999999999998665443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=345.63  Aligned_cols=245  Identities=25%  Similarity=0.353  Sum_probs=209.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +++++.||+|+.|.|-+|++. +|+.+|||++.+..    .....+.+|+-+|+.+.|||++.+|+++++..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            467799999999999999865 89999999997652    2336678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|.|.+++    ...+++++.++.+++.||+.|+.|||..   +|+|||+||+|+|+|..+++||+|||+|..-..+.
T Consensus        94 v~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   94 VPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             cCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999    4567899999999999999999999998   99999999999999999999999999998654433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                         .....||++.|.+||++.|. ...+.++||||+|+|||.||+|+.||++.....        +...+..|.      
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~--------LLlKV~~G~------  228 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV--------LLLKVQRGV------  228 (786)
T ss_pred             ---cccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCccHHH--------HHHHHHcCc------
Confidence               34567899999999999987 445779999999999999999999998655321        223333332      


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       -+.|..++.++++|+.+|+..||+.|+|++||++.
T Consensus       229 -f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 -FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence             23335667889999999999999999999999983

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.6e-45  Score=340.02  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=204.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeC-C
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEG-S  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~  133 (373)
                      ..+|++.+.||+|+||.||+|.+      .++..||+|+++.....  ...+.+|+.++..+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            34678889999999999999974      23568999998754322  35688999999999 899999999988654 4


Q ss_pred             eeEEEEeccCcCCccccccCCCC---------------------------------------------------------
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES---------------------------------------------------------  156 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  156 (373)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            58899999999999888753211                                                         


Q ss_pred             -CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCc
Q 048542          157 -RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY  235 (373)
Q Consensus       157 -~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y  235 (373)
                       ...++++..+..++.|+++||+|||+.   +++||||||+|||++.++.+||+|||++................++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence             023578888999999999999999998   9999999999999999999999999999765433222222233466789


Q ss_pred             ccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHH
Q 048542          236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLC  314 (373)
Q Consensus       236 ~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (373)
                      +|||.+.+.  .++.++|||||||++|+|++ |..||.......       .....+..+.....      +..++..+.
T Consensus       243 ~aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRMRA------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCCCC------CCCCCHHHH
Confidence            999998764  78899999999999999997 999987543221       12222333322221      123456789


Q ss_pred             HHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          315 MIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       315 ~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +|+.+||+.||.+|||+.++++.|+.++.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-46  Score=337.10  Aligned_cols=247  Identities=24%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH----HHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .+.|++.||.|+|++|++|+.+ ++..||||++.+.....    +-...|-.+|.+| .||.|++++.-|.++..+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            4678899999999999999855 78999999987643322    3456788888888 7999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++    .+-+.+++...+.++.+|+.||+|||++   |||||||||+|||+|++++++|+|||.|..+..
T Consensus       154 e~A~nGdll~~i----~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  154 EYAPNGDLLDLI----KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             EecCCCcHHHHH----HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            999999999999    4457799999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCc---------ee--eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          220 ENDF---------VS--ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       220 ~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ....         ..  ....+||..|.+||++...  ..+..+|+|+|||++|+|+.|.+||.....        ..++
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF  296 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF  296 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence            2211         11  1446799999999999775  778899999999999999999999986543        1122


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.+...   +    .++++.++..+.+|+.+.|..||.+|+|.++|-+
T Consensus       297 qkI~~l---~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  297 QKIQAL---D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHHh---c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            222221   1    2333445578899999999999999999999865

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.1e-46  Score=355.29  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=219.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...-.+.+.||+|+||+||+|+..      +...||||.++.....  ..+|.+|++++..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            334456789999999999999743      3457999999986655  37899999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc
Q 048542          136 ALVYEYMPNGSLDRHVFPKES------R----GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~  205 (373)
                      ++|+|||..|+|.++|.....      .    ..+++..+.+.|+.|||.||.||-++   .+|||||-.+|+||+++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence            999999999999999954321      1    23488999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccch
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  284 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~  284 (373)
                      +||+|||+++..-..+.+..-....-+.+|||||.+..  +.||.+||||||||+|||+++ |..||....++       
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------  712 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------  712 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchH-------
Confidence            99999999986544433332223345679999999864  599999999999999999997 88898876654       


Q ss_pred             HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                       .+.+.+..+..+.-+      .+++.++++||..||+.+|++||+++||-..|+...+.
T Consensus       713 -EVIe~i~~g~lL~~P------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 -EVIECIRAGQLLSCP------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -HHHHHHHcCCcccCC------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence             367777777764443      45567899999999999999999999999999987654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-45  Score=305.27  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|.-.+++|+|.||.||+|+. ++|+.||||.++..+..   .....+|++.|+.++|+||+.++++|...+...+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            566678999999999999984 58999999999876554   35678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |+. +|...+.   .+...++...+..++.++++|++|||++   .|.||||||.|+|++.+|.+||+|||+++......
T Consensus        83 m~t-dLe~vIk---d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   83 MPT-DLEVVIK---DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ccc-cHHHHhc---ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            954 8888873   4467899999999999999999999998   99999999999999999999999999999887665


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc------------ccchHHHH-
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK------------AYFPSWVY-  288 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~------------~~~~~~~~-  288 (373)
                      ....  ....|-.|.|||.+.|. ..|+..+|+||.||++.||+-|.+-|.+....+.-            ...+++.. 
T Consensus       156 ~~~~--~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQT--HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             cccc--cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            4332  23678899999999886 68899999999999999999998777654432110            00010000 


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ....+-...+.+....+-...+.++.+|+..||..||.+|+|++|+++.
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0000000001111111223346678999999999999999999999873

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=338.37  Aligned_cols=264  Identities=26%  Similarity=0.464  Sum_probs=215.6

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      +|......+...||+|.||+||+|.|.  +.||||+++...-+.   +.|++|+.++++-+|.||+-+.|+|..+.. .|
T Consensus       388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            344455567799999999999999986  679999998765444   679999999999999999999999988777 99


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |+.+|+|.+|+.+++..+   .++.......|+.||++|+.|||.+   +|+|||||..||++.++++|||+|||++..-
T Consensus       465 iTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             eehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeee
Confidence            999999999999996544   5688889999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCCceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ..-..........|...|||||++..+ ...|+..+||||||+++|||++|..||.....++-          .+..++.
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----------ifmVGrG  608 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----------IFMVGRG  608 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----------EEEeccc
Confidence            433333344556788999999998532 34789999999999999999999999984332211          0112222


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ...++........++++++|+..||..++++||++.+|+..|+.++.
T Consensus       609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            22233344445667899999999999999999999999999988754

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=333.58  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             hhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCH-HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           67 NHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      |.-..+||+|+.|.||.+. ..+++.||||.+....... +-+++|+.+|+..+|+|||.+++.|...+.+++|||||+|
T Consensus       275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~g  354 (550)
T KOG0578|consen  275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEG  354 (550)
T ss_pred             hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCC
Confidence            3444789999999999997 4478899999998766655 5678999999999999999999999888999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+.+     ....+++.++..|+..++.||+|||.+   +|+|||||.+|||++.+|.+||+|||+|..+.....  
T Consensus       355 gsLTDvV-----t~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--  424 (550)
T KOG0578|consen  355 GSLTDVV-----TKTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--  424 (550)
T ss_pred             Cchhhhh-----hcccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence            9999988     244589999999999999999999999   999999999999999999999999999987654432  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      .-....||+.|||||+....  .|+.|.||||||++++||+.|.+||-....-.        ....+...+.+.+...  
T Consensus       425 KR~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr--------AlyLIa~ng~P~lk~~--  492 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNGTPKLKNP--  492 (550)
T ss_pred             ccccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHH--------HHHHHhhcCCCCcCCc--
Confidence            12356799999999999876  89999999999999999999999997643211        1122233333443332  


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ..++..+++++.+||+.|+.+|+|+.|+|+
T Consensus       493 --~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 --EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              446788999999999999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=306.64  Aligned_cols=234  Identities=27%  Similarity=0.362  Sum_probs=203.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+++.+.||.|+||.|.+++.+ +|..+|+|++.+...    +.+...+|..+|+.+.||+++++++.+.+.+..|+|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            4567899999999999999976 678999999987543    33667899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |.+||.|..++    .+.+++++..++-++.+|+.|++|||+.   +|++||+||+|||+|.+|.+||+|||.|......
T Consensus       125 yv~GGElFS~L----rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  125 YVPGGELFSYL----RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             ccCCccHHHHH----HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999    4567899999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                           +-..||||.|+|||+++..  .++.++|+||||+++|||+.|.+||...+.        ..+++.+-.+.     
T Consensus       198 -----T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~-----  257 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGK-----  257 (355)
T ss_pred             -----EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCc-----
Confidence                 2356799999999999876  788899999999999999999999987765        22444444332     


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADR  328 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~R  328 (373)
                        ...|.-++..+++|+...|+.|-.+|
T Consensus       258 --v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 --VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence              23345567789999999999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.8e-45  Score=332.88  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=214.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+...+.   +.+.+|+++++.++||||+.++++|+...+.++|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            4667789999999999999866 78899999998866655   4578899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +.| +|..++    ..++.++++.+..++.+++.||.|||++   +|.|||+||.|||++.++.+|++|||+++.+....
T Consensus        83 a~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   83 AVG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            976 999988    4567899999999999999999999998   99999999999999999999999999999776533


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                        ...+...|||.|||||...+.  .|+..+|.||+||++||+.+|++||.....       ...+.......       
T Consensus       155 --~vltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d~-------  216 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKDP-------  216 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcCC-------
Confidence              234566799999999999875  889999999999999999999999974432       11122221111       


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCCcc
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSIDDLQMPPRPFF  353 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~~~~~~~~p~~  353 (373)
                       ...+...+..+.+++...|..||.+|.|..+++.  ++++.......|..|-.
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence             1222366888999999999999999999999975  45554443333444333

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=318.81  Aligned_cols=254  Identities=20%  Similarity=0.340  Sum_probs=214.4

Q ss_pred             ChhHHHHHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCH----HHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           58 SYPQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        58 ~~~~i~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      +..--..-+|++.+.||+|.||+|-+|.. ..|+.||||.++++....    -.+.+|+++|..|+||||+.+|++|++.
T Consensus        46 hhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk  125 (668)
T KOG0611|consen   46 HHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK  125 (668)
T ss_pred             CcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC
Confidence            33344566899999999999999999984 689999999998866543    3478999999999999999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      +...+||||..+|.|++++    ...+.+++.++..++.||..|+.|||.+   +++|||||.+|||+|.++++||+|||
T Consensus       126 dKIvivMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             ceEEEEEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence            9999999999999999999    4567899999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++..+....   ..+..||++.|.+||+..|. ..-++.+|.||||++||.|+.|..||++.+...        +...+.
T Consensus       199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs  266 (668)
T KOG0611|consen  199 LSNLYADKK---FLQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQIS  266 (668)
T ss_pred             hhhhhcccc---HHHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhh
Confidence            998776544   24567899999999999876 344678999999999999999999998765321        223333


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      .+...+..        -+.+..-||++||..||++|.|++++...+
T Consensus       267 ~GaYrEP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 RGAYREPE--------TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cccccCCC--------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            33322221        134678899999999999999999997654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=328.73  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+++.+.||+|+||.||+|+.+ +|..+|+|+++++...    .+....|-.+|....+|+||++|..|.+...+|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            3566789999999999999855 7999999999986553    3667889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC-
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK-  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-  219 (373)
                      |++||++..+|    .+...+++..+..++.+++-|+..+|+.   |++||||||+|+|+|..|++||+|||++.-... 
T Consensus       222 ylPGGD~mTLL----~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  222 YLPGGDMMTLL----MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             ecCCccHHHHH----HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            99999999998    3457799999999999999999999998   999999999999999999999999999852211 


Q ss_pred             --------------------CCCce------e------------------eecccCCCCcccccccccccCCcCcccchH
Q 048542          220 --------------------ENDFV------S------------------ISATRGTIGYIAPELISRNFGTVSCKSDVY  255 (373)
Q Consensus       220 --------------------~~~~~------~------------------~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvw  255 (373)
                                          .....      .                  .....|||.|+|||++.+.  .|+..+|+|
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwW  372 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWW  372 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHH
Confidence                                00000      0                  0123599999999999986  688999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC-CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC---H
Q 048542          256 GFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS---M  331 (373)
Q Consensus       256 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~  331 (373)
                      |||||+||||.|.+||....+.+        .+..+.... .+.++...    .++.+..+||.+|+. ||.+|..   +
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~l~fP~~~----~~s~eA~DLI~rll~-d~~~RLG~~G~  439 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRETLKFPEEV----DLSDEAKDLITRLLC-DPENRLGSKGA  439 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhhccCCCcC----cccHHHHHHHHHHhc-CHHHhcCcccH
Confidence            99999999999999998776543        333333322 22222222    234789999999999 9999986   5


Q ss_pred             HHHH
Q 048542          332 TKVL  335 (373)
Q Consensus       332 ~ell  335 (373)
                      +||-
T Consensus       440 ~EIK  443 (550)
T KOG0605|consen  440 EEIK  443 (550)
T ss_pred             HHHh
Confidence            5553

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-43  Score=321.37  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC-----------------CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT-----------------GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQ  124 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~  124 (373)
                      ...|.+.++||+|+||.||+|.+++                 +..||+|.+......  ..++.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3467788999999999999997532                 236999998764322  357889999999999999999


Q ss_pred             EeeEeeeCCeeEEEEeccCcCCccccccCCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 048542          125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKE---------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL  189 (373)
Q Consensus       125 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~iv  189 (373)
                      +++++.+....+++|||+++++|.+++....               .....+++..+..++.|++.||.|||+.   +++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999988774321               1123578888999999999999999998   999


Q ss_pred             ecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcC--
Q 048542          190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG--  267 (373)
Q Consensus       190 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g--  267 (373)
                      ||||||+|||++.++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|+++  
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999765433322222234467889999998654  688899999999999999974  


Q ss_pred             CCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          268 RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      ..||.......    ..................   ..+..++..+.+|+.+||+.||.+|||++++.+.|++
T Consensus       239 ~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         239 EQPYGELTDEQ----VIENAGEFFRDQGRQVYL---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCcCCHHH----HHHHHHHHhhhccccccc---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            45555432211    001111111111110000   0112335678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-43  Score=316.88  Aligned_cols=246  Identities=19%  Similarity=0.274  Sum_probs=198.9

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCH----HHHHHHHHHhcccCCCceeeEeeEeee----CCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~e~~  142 (373)
                      ..||+|++|.||+|... |+.||+|.++......    +.+.+|+.++++++||||+++++++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            56999999999999984 8899999998654433    567799999999999999999999866    35688999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++|+|.+++..    ...+++.....++.+++.||.|||+.  .+++||||||+||+++.++.+||+|||++....... 
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999843    35688999999999999999999973  278899999999999999999999999987553321 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                          ....|+..|+|||.+.+....++.++|||||||++|+|++|..||......       ...............+  
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~--  244 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------EIYDLIINKNNSLKLP--  244 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCCCCCC--
Confidence                134588999999998764357899999999999999999999999754321       1111222222222221  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          ...+..+.+++.+||+.||++|||++++++.|+..
T Consensus       245 ----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        245 ----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                23456799999999999999999999999999864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.3e-43  Score=327.98  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=203.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  135 (373)
                      ..+++.+.||+|+||.||+|.+      .++..||+|+++....  ..+.+.+|+.++..+ +||||+++++++......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            3577889999999999999963      2456899999875433  235688999999999 899999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC-----------------------------------------------------------
Q 048542          136 ALVYEYMPNGSLDRHVFPKES-----------------------------------------------------------  156 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  156 (373)
                      ++|||||++|+|.+++.....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999888743211                                                           


Q ss_pred             ------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          157 ------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       157 ------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                                  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++..........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                        123578889999999999999999998   99999999999999999999999999998654333222


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......       ......+..+.....+   
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~---  339 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLSP---  339 (375)
T ss_pred             ccCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCCC---
Confidence            12223456789999998764  78899999999999999998 78887644321       1122233333222111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                         ...+.++.+|+.+||+.||++|||+.++++.|+..
T Consensus       340 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               12345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.6e-43  Score=301.81  Aligned_cols=272  Identities=21%  Similarity=0.263  Sum_probs=209.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeee--CCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv  138 (373)
                      ..|+..++|++|+||.||+|+++ +++.||+|.++.+....   -.-++|+.+|.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            35666789999999999999966 78999999998765322   245799999999999999999988743  4579999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||||+. +|..++...   ..++...++..+..|+++|++|||.+   .|+||||||+|+|++..|.+||+|||+|+.++
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999976 888777443   36799999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ...  ..++...-|..|.|||.+.+. ..|+...|+||+|||+.||+++++.|.+......-..    ++..+.......
T Consensus       229 sp~--k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~----If~llGtPte~i  301 (419)
T KOG0663|consen  229 SPL--KPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK----IFKLLGTPSEAI  301 (419)
T ss_pred             CCc--ccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH----HHHHhCCCcccc
Confidence            653  245666789999999999986 6899999999999999999999998876654321111    111111100000


Q ss_pred             c--------------C------ccchhhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCc
Q 048542          299 L--------------Q------NVTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPF  352 (373)
Q Consensus       299 ~--------------~------~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~p~  352 (373)
                      .              .      ....++.. ++..-.+|+..+|..||.+|.|++|.|+  .+...+.+.|..|.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~  374 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPS  374 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChh
Confidence            0              0      00011111 4567889999999999999999999876  34444444444443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=341.82  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=216.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CC---ceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TG---GLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      -.+.+.||.|.||.|++|+++ .|   ..||||.++....  ...+|+.|..+|.+++||||+++.|+........+|+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            345588999999999999976 23   4799999997544  44789999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|+.+|..+   .+.+.+.++.-+.+.||.|+.||-+.   ++|||||.++|||++.+..+|++|||+++.+.++
T Consensus       711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999999543   45688899999999999999999998   9999999999999999999999999999977544


Q ss_pred             C-CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          221 N-DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       221 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      . ......+-.-+.+|.|||.+.-.  +++.++||||+|+++||.++ |.+|+.++.+.+        +.+.++.+.++.
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--------VIkaIe~gyRLP  854 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VIKAIEQGYRLP  854 (996)
T ss_pred             CCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCcccccchHH--------HHHHHHhccCCC
Confidence            3 22222333345799999999654  89999999999999999986 999999887643        566677776655


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .+      .+++..|..||..||++|-.+||.+.+|+..|..+..
T Consensus       855 pP------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  855 PP------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             CC------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            43      4567789999999999999999999999999998654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-45  Score=322.75  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      |.-.+.||+|+||.||+|... +++.||||++.....  ..+++.+|+.++..++++||.++|+.+..+..++++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            334478999999999999854 889999999986544  44789999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      ||++.+.+    ..+..+.+..+..++.++..|+.|||..   +.+|||||+.|||+..+|.+||+|||.+..+......
T Consensus        95 gGsv~~lL----~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   95 GGSVLDLL----KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             Ccchhhhh----ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999998    3345557888888999999999999998   9999999999999999999999999999866543322


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....||+.|||||++.+.  .|+.|+||||||++.+||.+|.+|+....+...  .+            .......+
T Consensus       168 --r~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--lf------------lIpk~~PP  229 (467)
T KOG0201|consen  168 --RKTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--LF------------LIPKSAPP  229 (467)
T ss_pred             --cccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceE--EE------------eccCCCCC
Confidence              2567799999999999865  889999999999999999999999876554211  00            00111112


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+...+++.+++++..||+.||+.|||+.++++
T Consensus       230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            233467888999999999999999999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=350.13  Aligned_cols=267  Identities=27%  Similarity=0.467  Sum_probs=215.7

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc--CCc----eeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeee
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ--TGG----LIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE  131 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~--~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  131 (373)
                      +++....-.+.+.||+|+||.||.|...  +|.    .||||.++...  ....+|.+|..+|++++||||++++|+|.+
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            3344455566789999999999999855  333    48999988753  344789999999999999999999999999


Q ss_pred             CCeeEEEEeccCcCCccccccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKE---SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      ....++++|||++|+|..++...+   .....++......++.|||+|+.||+++   ++|||||..+|+|+++...+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEE
Confidence            999999999999999999996542   1245688999999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||+|+.+.....+.......-+..|||||.+..  +.++.|+||||||+++||+++ |..||+...+.+        +
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v  913 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------V  913 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------H
Confidence            99999994433322221111234568999999976  589999999999999999998 677777655432        4


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ...+..+.+++.+      ..++..+.++|.+||+.+|++||++..+++.+..+.+.+
T Consensus       914 ~~~~~~ggRL~~P------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  914 LLDVLEGGRLDPP------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HHHHHhCCccCCC------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            4445555544433      455678899999999999999999999999998876644

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.3e-43  Score=318.13  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=199.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |+..+.||+|+||.||+|... +++.||+|.+.....    ....+.+|+.++..++|+||+++++++.+++..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            556789999999999999864 789999999875432    224577899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+.+...  ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999998776432  234688999999999999999999998   99999999999999999999999999998653322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                         ......||..|+|||.+.+.  .++.++|||||||++|+|++|+.||........    ...........       
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~~~-------  220 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVKED-------  220 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhhcc-------
Confidence               12345689999999999764  788999999999999999999999976543211    01111111111       


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                      ....+..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11223345678999999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=321.33  Aligned_cols=243  Identities=23%  Similarity=0.253  Sum_probs=199.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|..+ +++.||+|++.....    ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            4667899999999999999876 788999999875332    23567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          82 YVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999998883    345688999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .     ....|++.|+|||.+.+.  .++.++|||||||++|+|++|..||......        .....+..+. .   
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~-~---  215 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAGK-L---  215 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-c---
Confidence            1     234589999999998765  6788999999999999999999999754321        1222222221 1   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLEM  337 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~~  337 (373)
                         ..+..++..+.+|+.+||+.||.+||+     ++++++.
T Consensus       216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               112234567899999999999999995     8887753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-42  Score=325.34  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=203.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ...|++.+.||+|+||.||+|...      ++..||+|.++.....  .+.+.+|+.+++.+ +|+||+++++++.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346778899999999999998743      2347999999764332  35678999999999 89999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCC-----------------------------------------------------------
Q 048542          135 RALVYEYMPNGSLDRHVFPKE-----------------------------------------------------------  155 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  155 (373)
                      .++|||||++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999988774321                                                           


Q ss_pred             -------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeec
Q 048542          156 -------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (373)
Q Consensus       156 -------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (373)
                             ....++++..+..++.|+++||.|||++   +++||||||+||+++.++.+||+|||++..............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                   1123578889999999999999999998   999999999999999999999999999876543322222223


Q ss_pred             ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ..++..|+|||.+.+.  .++.++|||||||++|+|++ |+.||.......       ........+.....+      .
T Consensus       274 ~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~~~~~~------~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGYQMSRP------D  338 (374)
T ss_pred             CCCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHcccCccCC------C
Confidence            3456789999998654  78899999999999999997 999987543221       111222222111111      1


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.6e-43  Score=312.30  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=203.6

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ....+++.+.||+|+||.||+|.++    .+..||+|.++.....  ...+.+|+..++.++||||+++++++..+...+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3456788899999999999999754    3568999998865332  356889999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999888432   34689999999999999999999998   999999999999999999999999998764


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....... ......++..|+|||.+.+.  .++.++|||||||++|++++ |..||......        .....+..+.
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~  225 (266)
T cd05064         157 DKSEAIY-TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGF  225 (266)
T ss_pred             ccccchh-cccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCC
Confidence            3222111 11122356789999998764  78889999999999999775 99998754321        1222233322


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...      .+..++..+.+++.+||+.+|++|||++++++.|+..
T Consensus       226 ~~~------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 RLP------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCC------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            211      1233556789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=313.44  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---------------CHHHHHHHHHHhcccCCCceeeEee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---------------SAEEFINEVSTIGRIHHVNVVQLLG  127 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~h~ni~~~~~  127 (373)
                      ...|++.+.||+|.||.|-+|+.. +++.||||++.+.+.               ..++..+|+.+|++++|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            346788899999999999999865 789999999965322               2367889999999999999999999


Q ss_pred             EeeeC--CeeEEEEeccCcCCccccccCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          128 FCSEG--SKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       128 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      +..+.  +..|||+|||..|.+...-     ...+ +.+.++++++.++..||.|||.+   ||+||||||+|+|++.+|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence            99764  5799999999988874332     2344 99999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCC---CceeeecccCCCCccccccccccc--CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc
Q 048542          205 IPKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  279 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~  279 (373)
                      ++||+|||.+.......   .........|||.|+|||...+..  ...+.+.||||+|++||.|+.|+.||......  
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--  325 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--  325 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence            99999999987552211   111223467999999999886631  23356789999999999999999999755431  


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                            ..++.+... .+.++..    +++...+++|+.+||+.||++|.+..+|....
T Consensus       326 ------~l~~KIvn~-pL~fP~~----pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  326 ------ELFDKIVND-PLEFPEN----PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ------HHHHHHhcC-cccCCCc----ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                  122222221 1122221    24567899999999999999999999987643

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.7e-42  Score=306.32  Aligned_cols=252  Identities=25%  Similarity=0.433  Sum_probs=204.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..+++.+.||+|+||.||++.++++..+|+|.+.......+++.+|+.+++.++||||+++++++......+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            35677789999999999999988888999999887766778899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||.+........ .
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~  156 (256)
T cd05114          84 GCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T  156 (256)
T ss_pred             CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence            9999887432   23588999999999999999999998   999999999999999999999999999876533221 1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......        .....+..+.....+   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~---  223 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRLYRP---  223 (256)
T ss_pred             ccCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCC---
Confidence            12233456689999998764  67889999999999999999 88888654321        122222222221111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                         ...+..+.+++.+||+.+|++|||++++++.|.
T Consensus       224 ---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 ---KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               123457899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-43  Score=325.35  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=199.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|..+ +++.||+|++....    ...+.+.+|+.+++.++||||+++++++.++...+++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            35678899999999999999976 68899999987543    22356889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+.+.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        98 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999998883    345688999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..     ....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......        .....+..+. ...
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~-~~~  234 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGR-LKF  234 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCC-cCC
Confidence            22     234689999999999765  6788999999999999999999999654321        1222222221 111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                            +..++..+.+|+.+||+.||.+||+     +++++.
T Consensus       235 ------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        235 ------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  2234567899999999999999997     677763

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-43  Score=323.22  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=195.3

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||+|..+ +|+.||+|+++...    .....+.+|+.+++.++||||+++++++..+...++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78899999987532    22356778999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|.+.+.    .+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++........  .
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  151 (323)
T cd05571          81 ELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence            9988873    345689999999999999999999998   999999999999999999999999999875322211  1


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....||+.|+|||.+.+.  .++.++||||+||++|+|++|..||......        ......... ..      ..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~-~~------~~  214 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILME-EI------RF  214 (323)
T ss_pred             ccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcC-CC------CC
Confidence            2345699999999999764  6788999999999999999999999754321        111111111 11      12


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      +..++..+.+|+.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            234567899999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-42  Score=308.78  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=207.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...+++.+.||+|++|.||+|..++++.||+|.++......+++.+|+.+++.++||||+++++++...+..+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            34677889999999999999998778889999998776667889999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++....  +..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....... .
T Consensus        85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~  158 (261)
T cd05068          85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-Y  158 (261)
T ss_pred             CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-c
Confidence            999999884332  45689999999999999999999998   99999999999999999999999999998664221 1


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      ........+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||.....        ......+........   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~---  225 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPC---  225 (261)
T ss_pred             cccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCC---
Confidence            111222234579999988764  77889999999999999999 8888864322        112222322222111   


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                         +...+..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       226 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 ---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence               12345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-42  Score=311.75  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=205.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC-C-----ceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT-G-----GLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..+++.+.||+|+||.||+|.... +     ..||+|.++.....  ..++.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            356788999999999999998642 2     57999988754332  356889999999999999999999999989999


Q ss_pred             EEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          137 LVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      ++|||+++++|.+++.....            ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999988854311            125688899999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccc
Q 048542          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  283 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~  283 (373)
                      .++|+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......      
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH------
Confidence            9999999998765433322222334567889999988654  68889999999999999998 99998754321      


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        .....+..+....      .+..++..+.+|+.+||+.||.+||+++++++.|++
T Consensus       234 --~~~~~i~~~~~~~------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         234 --EVIEMIRSRQLLP------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHHcCCcCC------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              1222333322221      224556789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=300.97  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=205.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ...|++.+.||+|.|+.|+++.+. +|+.+|+|++.....   ..+++.+|+.+.+.|+||||+++.+...+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            346778899999999999999754 899999999875433   4478899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee---CCCceEEeeccCccc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKF  216 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~  216 (373)
                      |+|.|++|...+..    ...+++..+...+.||++||.|+|.+   +|+|||+||+|+++.   ...-+||+|||++..
T Consensus        90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999776632    24577888899999999999999999   999999999999995   344689999999987


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....   ....+..|||.|+|||++...  .|+..+|||+.|++||-|+.|..||.+.+...        +++.+..+..
T Consensus       163 l~~g---~~~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~y  229 (355)
T KOG0033|consen  163 VNDG---EAWHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAY  229 (355)
T ss_pred             eCCc---cccccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhcccc
Confidence            6622   235677899999999999775  89999999999999999999999998754321        3333333321


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .  -......+++++.++|+++||..||.+|+|+.|.++
T Consensus       230 -d--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 -D--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -C--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence             1  112233456778999999999999999999988764

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-44  Score=296.01  Aligned_cols=268  Identities=25%  Similarity=0.341  Sum_probs=211.9

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----e
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----K  134 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~  134 (373)
                      |...+|++.+++|+|||+.||+++ ..+++.||+|++.... .+.+..++|++..++++|||+++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345678899999999999999998 5578999999987665 45578899999999999999999998875433     4


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|++++|+..|+|.+.+.....++..+++.+++.|+.++++||.+||+. ..+++||||||.|||+++.+.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999999987777788899999999999999999999987 345999999999999999999999999998


Q ss_pred             ccCCCCC-------CceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH
Q 048542          215 KFHPKEN-------DFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       215 ~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  286 (373)
                      +...-.-       ..........|..|.|||.+.-+ ....++++|||||||++|.|+.|..||+..-...+...+   
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL---  253 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL---  253 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE---
Confidence            7543111       01112233478899999998643 235788999999999999999999999744332211110   


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          ........+++..    .++..+.+++.+|++.||.+||++.+++..+..+
T Consensus       254 ----Av~n~q~s~P~~~----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 ----AVQNAQISIPNSS----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----eeeccccccCCCC----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                0000111122211    2678999999999999999999999999988764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=326.04  Aligned_cols=242  Identities=26%  Similarity=0.455  Sum_probs=201.6

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcccc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRH  150 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~  150 (373)
                      +-||+|+.|.||+|+.+ ++.||||.++.-+      ..+++.|++|+||||+.+.|+|.....+|||||||..|-|...
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            45999999999999988 7889999876432      3578999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeeccc
Q 048542          151 VFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  230 (373)
Q Consensus       151 l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  230 (373)
                      +    ..+.++......+|..+||.|+.|||.+   .|+|||||.-||||+.+..+||+|||-++......   .....+
T Consensus       203 L----ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFa  272 (904)
T KOG4721|consen  203 L----KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFA  272 (904)
T ss_pred             H----hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhh
Confidence            9    4567899999999999999999999998   99999999999999999999999999987554332   233567


Q ss_pred             CCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHH
Q 048542          231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIA  310 (373)
Q Consensus       231 gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (373)
                      ||..|||||++.++  ..++|+||||||++|||||||.-||.+-+...-       +|   ..+..   ......+..++
T Consensus       273 GTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------Iw---GVGsN---sL~LpvPstcP  337 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------IW---GVGSN---SLHLPVPSTCP  337 (904)
T ss_pred             hhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhee-------EE---eccCC---cccccCcccCc
Confidence            99999999999886  889999999999999999999999875442210       00   11110   00123345667


Q ss_pred             HHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          311 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       311 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      +.++-|+++||+..|.+||++.+++..|.=...+
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            7899999999999999999999999998754443

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.5e-42  Score=308.29  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=207.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...+++.++||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++.+......+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            45677889999999999999998888899999988766667889999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            99999888432  245688889999999999999999998   999999999999999999999999999986543221 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+.........  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  226 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGYRMPRM--  226 (261)
T ss_pred             eccCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            112233456789999988654  67889999999999999998 88888643321        122222222211111  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                          ..++..+.+++.+||+.+|++|||++++.+.|+.
T Consensus       227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                1245678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-42  Score=310.95  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=206.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ..+|.+.+.||+|+||.||+|...      ++..||+|.++.....  .+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            456788899999999999999864      2468999998765443  36789999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc
Q 048542          136 ALVYEYMPNGSLDRHVFPKE----------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~  205 (373)
                      +++|||+++++|.+++....          .....+++..+..++.|++.|+.|||++   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999885432          2234578899999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccch
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  284 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~  284 (373)
                      ++|+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------  232 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------  232 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence            999999998754332221112233457789999998764  78889999999999999998 999986543321      


Q ss_pred             HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        .......+.....      +..++..+.+++.+||+.||++|||+.|+++.|+.
T Consensus       233 --~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         233 --VIECITQGRLLQR------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              1222222222111      12345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=326.79  Aligned_cols=294  Identities=27%  Similarity=0.410  Sum_probs=224.3

Q ss_pred             EEEEEeecchhhhhHHHHHhhhcCCC-CCc------cChh--HHHHHHhhhhcccCCCCcEEEEEEEEcC--C---ceeE
Q 048542           28 FLVSRRTTLKTIDNIEKFLRNQQSWM-PKR------YSYP--QIIAMTNHFTHKLGQGGFGSVYKGQLQT--G---GLIA   93 (373)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~--~i~~~~~~~~~~ig~G~~g~V~~~~~~~--~---~~va   93 (373)
                      ++.....++.++.++..+........ ...      ..-.  ++....-.+.++||+|+||.||+|+++.  +   ..||
T Consensus       111 ~~~~~~~~F~si~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VA  190 (474)
T KOG0194|consen  111 FFFEGLRKFPTISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVA  190 (474)
T ss_pred             eEEeccccCCcHHHHHHHHHhcccceeccceeecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeE
Confidence            34444567777777766655432111 111      1111  2223333456999999999999998652  2   2389


Q ss_pred             EEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHH
Q 048542           94 VKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV  169 (373)
Q Consensus        94 iK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  169 (373)
                      +|..+.+.    ....++.+|.++|++++||||+++||++......++|||+|.||+|.+++...   ...++..+...+
T Consensus       191 vK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~  267 (474)
T KOG0194|consen  191 VKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRF  267 (474)
T ss_pred             EEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHH
Confidence            99988522    23477899999999999999999999999999999999999999999999432   236999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee-cccCCCCcccccccccccCCc
Q 048542          170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNFGTV  248 (373)
Q Consensus       170 ~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~  248 (373)
                      +.+.|.||+|||++   +++||||-.+|+|++.++.+||+|||+++...   .+.... ...-+..|+|||.+..  +.|
T Consensus       268 ~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~--~~~  339 (474)
T KOG0194|consen  268 CYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNT--GIF  339 (474)
T ss_pred             HHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhcc--Ccc
Confidence            99999999999998   99999999999999999999999999987543   111111 2246679999999976  489


Q ss_pred             CcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHH-hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCC
Q 048542          249 SCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL-NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAA  326 (373)
Q Consensus       249 s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  326 (373)
                      +.++|||||||++||+++ |..||......        .+...+ ..+.....+.      ..+..+..++.+||..+|+
T Consensus       340 s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~~~~------~~p~~~~~~~~~c~~~~p~  405 (474)
T KOG0194|consen  340 SFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMPIPS------KTPKELAKVMKQCWKKDPE  405 (474)
T ss_pred             ccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCCCCC------CCHHHHHHHHHHhccCChh
Confidence            999999999999999998 78888776543        233333 4444444333      2346788899999999999


Q ss_pred             CCCCHHHHHHHHhcCCCCCC
Q 048542          327 DRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       327 ~Rps~~ell~~L~~~~~~~~  346 (373)
                      +||||.++.+.|+.+.+...
T Consensus       406 ~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  406 DRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             hccCHHHHHHHHHHHHhccc
Confidence            99999999999998766544

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-43  Score=322.32  Aligned_cols=250  Identities=20%  Similarity=0.267  Sum_probs=202.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|... +++.||+|+++....    ....+.+|+.++..++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            3667899999999999999976 688999999875422    23567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..... 
T Consensus        82 ~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          82 YVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999883    345688999999999999999999998   999999999999999999999999999975533 


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC-CCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  299 (373)
                          ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ....+... .....
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~~~  219 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETLQR  219 (333)
T ss_pred             ----ccCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccccC
Confidence                12345699999999999765  78899999999999999999999997543221        11111111 11111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      +........++..+.+++.+||+.+|.+||+++++++.
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            11111112456789999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.6e-42  Score=318.81  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=199.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||.||++... ++..+|+|.+.....  ..+++.+|+.+++.++||||+++++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            45677899999999999999876 678899999876432  236789999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          85 MDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999883    234688999999999999999999974  269999999999999999999999999987553321


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-----------------
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-----------------  284 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-----------------  284 (373)
                          .....|+..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+.                 
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcc
Confidence                2234689999999999764  68889999999999999999999996433211000000                 


Q ss_pred             ---------------------HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          285 ---------------------SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       285 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                                           ......+.........     ...++.++.+|+.+||+.||++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-----NGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCC-----CccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 0000000000000000     11246789999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=323.92  Aligned_cols=239  Identities=24%  Similarity=0.359  Sum_probs=203.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ...+.+.||+|+||+|+++..+ +++.+|||++++..    ...+....|-+++...+ ||.++.++..|...++.|+||
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            4567799999999999999976 78899999999854    34577788888888774 999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+.||++....     ....+++..+.-++..++.||.|||++   +|++||||.+|||+|.+|.+||+|||+++-.-.
T Consensus       449 ey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  449 EYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC
Confidence            999999965444     346799999999999999999999999   999999999999999999999999999984332


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      .+.  .....+||+.|+|||++.+.  .|+..+|+|||||++||||.|..||...+.++        +.+.+..      
T Consensus       521 ~g~--~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee--------~FdsI~~------  582 (694)
T KOG0694|consen  521 QGD--RTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE--------VFDSIVN------  582 (694)
T ss_pred             CCC--ccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHhc------
Confidence            221  34678899999999999886  89999999999999999999999999776543        2222222      


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                       +...+|..++.+..+++.++|..+|++|..+
T Consensus       583 -d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 -DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             2245567788999999999999999999976

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-42  Score=333.32  Aligned_cols=252  Identities=19%  Similarity=0.218  Sum_probs=202.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-C-CceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-T-GGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|.+.+.||+|+||.||+|... + +..||+|.+...... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3778899999999999999754 3 678888877544332 355778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++|+|.+++........++++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999887754434456789999999999999999999998   999999999999999999999999999986543322


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      ........||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        ........+....    
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--------~~~~~~~~~~~~~----  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQR--------EIMQQVLYGKYDP----  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCC----
Confidence            2223345699999999998764  7888999999999999999999999654321        1122222222111    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .+..++..+.+++.+||+.||++||++++++.
T Consensus       291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              12234568999999999999999999999864

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.7e-42  Score=324.07  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=204.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc--CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF--SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~  135 (373)
                      ..+.+.+.||+|+||.||+|...      ++..||||+++....  ..+.+.+|+.+++.+. ||||+++++++.+....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            35667799999999999999753      234699999975433  2367889999999996 99999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC-----------------------------------------------------------
Q 048542          136 ALVYEYMPNGSLDRHVFPKES-----------------------------------------------------------  156 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  156 (373)
                      ++|||||++|+|.+++.....                                                           
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            999999999999887643210                                                           


Q ss_pred             ---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC
Q 048542          157 ---------------------------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  203 (373)
Q Consensus       157 ---------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~  203 (373)
                                                       ....+++..+..++.|+++||.|||+.   +++||||||+||+++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence                                             123478888999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccccc
Q 048542          204 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  282 (373)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~  282 (373)
                      +.+||+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......     
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-----  346 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-----  346 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence            99999999999865433322222334467889999998764  67889999999999999997 88888654321     


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        .........+.....      +..++..+.+++.+||+.||++|||+.++.+.|+.+++
T Consensus       347 --~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 --STFYNKIKSGYRMAK------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --HHHHHHHhcCCCCCC------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              112222333222211      12346688999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-43  Score=305.55  Aligned_cols=259  Identities=22%  Similarity=0.288  Sum_probs=202.5

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEecc---CccCHHHHHHHHHHhcccCCCceeeEeeEeee-----CCeeEEEE
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLEN---SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKRALVY  139 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~~lv~  139 (373)
                      ..+.||+|+||.|+.+..+ +|+.||||.+..   .....++..+|+++++.++|+||+.+++++..     -...|+|+
T Consensus        26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~  105 (359)
T KOG0660|consen   26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF  105 (359)
T ss_pred             ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence            3578999999999999865 889999999874   33345788999999999999999999998855     35689999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |+| +.+|+..+    .++..++...+..+++|++.||.|+|+.   +++|||+||+|+|++.+..+||+|||+|+....
T Consensus       106 elM-etDL~~ii----k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  106 ELM-ETDLHQII----KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             hHH-hhHHHHHH----HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccc
Confidence            999 56888888    4455699999999999999999999998   999999999999999999999999999997754


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHH----
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVY----  288 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~----  288 (373)
                      ......++....|-.|.|||++... ..|+.+.||||+||++.||++|++-|.+.+.-..-..       .+....    
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3333345667789999999998654 6899999999999999999999999987653211000       001111    


Q ss_pred             -----HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 -----DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ..+..-...........-++.+....+|+.+||..||.+|+|++|.++
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                 111111111111112222355678899999999999999999999986

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=318.31  Aligned_cols=239  Identities=23%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||+|+||.||+|... +++.||+|++....    .....+.+|+.+++.++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 67899999987532    2335678899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~  151 (312)
T cd05585          81 FHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN  151 (312)
T ss_pred             HHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence            98883    245689999999999999999999998   999999999999999999999999999875432221  123


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...||+.|+|||.+.+.  .++.++||||+||++|+|++|..||......       . ........ ..      ..+.
T Consensus       152 ~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~-~~~~~~~~-~~------~~~~  214 (312)
T cd05585         152 TFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------E-MYRKILQE-PL------RFPD  214 (312)
T ss_pred             cccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcC-CC------CCCC
Confidence            45699999999999764  7888999999999999999999999754321       1 11122111 11      1223


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .++..+.+++.+||+.||.+||++..+.+.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~  244 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEI  244 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence            456788999999999999999864433333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-43  Score=320.56  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=212.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCe-eEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSK-RALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv~  139 (373)
                      ..|.+.+++|+|+||.++.++++ ++..+++|.+.....+.   ....+|+.++++++||||+.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            35778899999999999999866 67799999997654433   467899999999999999999999988887 99999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      +||+||++.+.+...  ++.-++++.+..++.|++.|+.|||++   .|+|||||+.||+++.++.+||+|||+|+.+..
T Consensus        84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            999999999988543  367799999999999999999999988   999999999999999999999999999998876


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ....  .....||+.|+.||++.+.  .|..|+|+|||||++|||++-+++|...+..       ..+.+.. .+.    
T Consensus       159 ~~~~--a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-------~Li~ki~-~~~----  222 (426)
T KOG0589|consen  159 EDSL--ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-------ELILKIN-RGL----  222 (426)
T ss_pred             chhh--hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccchH-------HHHHHHh-hcc----
Confidence            5422  3456799999999999886  8999999999999999999999999765532       1122222 211    


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        ...++..++.++..|+..|++.+|..||++.+++..
T Consensus       223 --~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 --YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              234556788999999999999999999999999875

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.5e-43  Score=295.78  Aligned_cols=250  Identities=24%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-----cCH----HHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-----FSA----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~----~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      .|+-.+.+|.|..+.|.++.++ +|+.+|+|++....     .+.    +.-..|+.+|+++ .||+|+++.++++.+..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            4455678999999999999865 78899999986421     112    4456799999998 59999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++|+|.|+.|.|.+++    ++...++++....|+.|+.+|+.|||.+   +|||||+||+|||++++.++||+|||.+
T Consensus        98 ~FlVFdl~prGELFDyL----ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYL----TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhcccchHHHHh----hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence            99999999999999999    5667899999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccc----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      +.+.....   ....+|||+|+|||.+...    ...|+..+|.|++|+++|.|+.|.+||.-..        ...+...
T Consensus       171 ~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------QmlMLR~  239 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QMLMLRM  239 (411)
T ss_pred             eccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHHHHHH
Confidence            98766553   3567899999999988543    2358889999999999999999999987332        1223333


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +..|.- .+  ..+-..+++...++|+.+||+.||.+|.|++|.+.
T Consensus       240 ImeGky-qF--~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKY-QF--RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhccc-cc--CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            333321 11  22334567888999999999999999999999875

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-42  Score=321.69  Aligned_cols=246  Identities=24%  Similarity=0.270  Sum_probs=200.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcC--CceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQT--GGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~--~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ....|++.+.||+|+||.||+|.++.  +..||+|.+....    ...+.+.+|+.+++.++||||+++++++.++...+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44567888999999999999998553  3589999986532    23356788999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++|+|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999998883    345689999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .....     ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+..+..
T Consensus       181 ~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~  245 (340)
T PTZ00426        181 VDTRT-----YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGII  245 (340)
T ss_pred             cCCCc-----ceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCC
Confidence            54321     234699999999998764  6788999999999999999999999754321        12222322221


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  337 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~  337 (373)
                             ..+..++..+.+++.+||+.||.+|+     +++++++.
T Consensus       246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                   11223456789999999999999995     89988764

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-42  Score=308.84  Aligned_cols=249  Identities=32%  Similarity=0.558  Sum_probs=194.5

Q ss_pred             hhcccCCCCcEEEEEEEEc-----CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.+.||.|.||.||+|.++     .+..|+||.++.....  .+.+.+|++.+++++||||+++++++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999876     3567999999654332  47899999999999999999999999988889999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+++...  ....+++..+..++.|++.||+|||++   +++|+||+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999998543  246789999999999999999999998   99999999999999999999999999998763333


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .............|+|||.+.+.  .++.++||||||+++|||++ |+.||.....        ......+..+.....+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~  227 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPIP  227 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTSB
T ss_pred             ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc--------ccccccccccccceec
Confidence            22222334577789999998765  68899999999999999999 6788754422        1122333333332222


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                            ..++..+.+++.+||+.||++|||++++++.|
T Consensus       228 ------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 ------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  23456789999999999999999999999976

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-41  Score=303.56  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=204.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|.+.+.||+|+||.||+|..+++..+|+|.++......+++.+|+.+++.++||||+++++++......+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            45678899999999999999887777899999987766678899999999999999999999999988899999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+....... ..
T Consensus        84 ~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~  156 (256)
T cd05113          84 GCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YT  156 (256)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc-ee
Confidence            9999888432   23689999999999999999999998   99999999999999999999999999987654322 11


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ........+......   
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  223 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRP---  223 (256)
T ss_pred             ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCC---
Confidence            12233456789999998754  67889999999999999998 88888643321        122222222221111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                         ...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 ---HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               123568899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.3e-42  Score=306.59  Aligned_cols=255  Identities=30%  Similarity=0.446  Sum_probs=205.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..+.+.+.||+|+||.||+|..+ ++..+|+|.+.......+++.+|+.+++.++|+||+++++++..+...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            34667789999999999999865 68899999988766566788999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||++........ 
T Consensus        86 ~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-  159 (263)
T cd05052          86 YGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-  159 (263)
T ss_pred             CCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence            99999888432  234588999999999999999999998   999999999999999999999999999876543221 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        ..............   
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~---  226 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRMER---  226 (263)
T ss_pred             eccCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCC---
Confidence            111122345689999988664  77889999999999999998 88888643321        12222332222211   


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                         +..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               223456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-42  Score=304.11  Aligned_cols=251  Identities=29%  Similarity=0.453  Sum_probs=203.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..+++.+.||+|+||.||+|.++++..+|+|.+.......+++.+|+.+++.++||||+++++++......+++|||+++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            34677899999999999999988778999999887666777889999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++...   ...+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~  156 (256)
T cd05059          84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T  156 (256)
T ss_pred             CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence            9999988432   23688999999999999999999998   999999999999999999999999999876543221 1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......        ..............+   
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  223 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRLYRP---  223 (256)
T ss_pred             ccCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcCCCC---
Confidence            11222345679999998764  67889999999999999998 78888643321        112222222221111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                         ..++..+.+++.+||+.+|++|||++++++.|
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 ---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               22466899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.1e-42  Score=311.48  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|.+.+.||.|+||.||+|..+ ++..||+|.++....  ....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            4677899999999999999865 788999999875432  2356789999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++ +|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        86 ~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          86 DS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             Cc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            64 88877732   234578899999999999999999998   999999999999999999999999999875432221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhcC-
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKG-  294 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~-  294 (373)
                        ......+++.|+|||.+.+. ..++.++||||+||++|+|++|+.||............       +...+...... 
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence              12334588999999988653 35788999999999999999999999754432110000       00000000000 


Q ss_pred             --CCcccCc-----cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 --GDLELQN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 --~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .....+.     .......++.++.+|+.+||+.||.+|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              0000000     00111224567899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=290.29  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=207.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..++.+.||+|-||.||.|+.+ ++..||+|++.++..    ...++.+|+++-..|+||||+++|++|.+....|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            3467899999999999999855 778999999987543    23678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |.++|++...+...  ....+.+.....++.|+|.|+.|+|..   +++||||||+|+|++..+.+|++|||.+......
T Consensus       103 ya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  103 YAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN  177 (281)
T ss_pred             ecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence            99999999998532  356688888999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .+    ...+||..|.|||...+.  ..+..+|+|++|++.||++.|.+||.....        ...++.+.+...    
T Consensus       178 kR----~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k~~~----  239 (281)
T KOG0580|consen  178 KR----KTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRKVDL----  239 (281)
T ss_pred             Cc----eeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHHccc----
Confidence            22    356799999999999876  678899999999999999999999986552        223333433221    


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .++..++..+.+++.+|+..+|.+|.+..|++.
T Consensus       240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ---cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence               223556778999999999999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-42  Score=316.25  Aligned_cols=259  Identities=24%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||.||+|..+ +++.||+|++.....  ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            35778899999999999999976 788999999875432  235678899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +. ++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          85 VH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            95 577666632   235588899999999999999999998   99999999999999999999999999987543222


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC-------
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-------  294 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  294 (373)
                      .  ......+++.|+|||++.+. ..++.++||||+||++|+|++|..||.........  +. .........       
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~  231 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LE-RIFLVLGTPNEDTWPG  231 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HH-HHHHHhCCCChhhccc
Confidence            1  12345688999999988653 35788899999999999999999999754321100  00 000000000       


Q ss_pred             ------CC---cccCccchhhH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 ------GD---LELQNVTEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ------~~---~~~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            ..   ...........     .++..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                  00   00000000000     12356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=305.07  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=204.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|.++.    ...||+|.++.....  ..++.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            456778999999999999998752    357999988764333  35788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999988432   24689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ............
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYRL  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            32222222233456789999998764  67889999999999999998 98888643321        122222222221


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ..      +..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       228 ~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11      123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-42  Score=317.94  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=193.9

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||++..+ +|..||+|+++...    .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999865 78899999987532    22356778999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|..++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  151 (323)
T cd05595          81 ELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT  151 (323)
T ss_pred             cHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence            9987773    345689999999999999999999998   99999999999999999999999999987432221  11


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ......... .      ..
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~~-~------~~  214 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEE-I------RF  214 (323)
T ss_pred             cccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCC-C------CC
Confidence            2345699999999998764  77889999999999999999999997543211        111111111 1      12


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      +..++..+.+++.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            234567889999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-42  Score=313.06  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.+.||+|+||.||+|+.+ +++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            4677899999999999999976 678899999875432   236678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      ++++++..+.    .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          82 VEKNMLELLE----EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9887765443    2234688999999999999999999998   99999999999999999999999999998654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHHhcC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNKG  294 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~  294 (373)
                      . .......|+..|+|||.+.+.  .++.++||||+||++|+|++|+.||...........       .+..........
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN  231 (287)
T ss_pred             c-ccccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence            1 112234689999999998764  678899999999999999999999976432110000       000000000000


Q ss_pred             C---CcccCc---c----chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 G---DLELQN---V----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~---~~~~~~---~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .   ....+.   .    ......++..+.+|+.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0   000000   0    1112235678999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-42  Score=319.76  Aligned_cols=262  Identities=19%  Similarity=0.252  Sum_probs=194.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRAL  137 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~l  137 (373)
                      |++.+.||+|+||.||+|..+ ++..||||.+....   ....++.+|+.+++.++||||+++++++...     ...|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            677899999999999999865 78899999987532   2235688999999999999999999987543     24799


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||. ++|.+++.    ....+++..+..++.|+++||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        82 v~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          82 VFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            999995 68887773    345689999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHH
Q 048542          218 PKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYD  289 (373)
Q Consensus       218 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~  289 (373)
                      ..... ........||..|+|||.+.+....++.++|||||||++|+|++|+.||...........       .+.....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            32221 112234568999999999865334778899999999999999999999975432110000       0000000


Q ss_pred             HHh---------cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          290 QLN---------KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       290 ~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+.         ................++..+.+++.+||+.||++|||++|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000         00000000000111123456889999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.7e-42  Score=313.13  Aligned_cols=257  Identities=24%  Similarity=0.387  Sum_probs=202.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...|+..+.||+|+||.||+|.+. ++.    .||+|.++....  ...++.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            345777899999999999999864 333    389999875432  236788999999999999999999998764 577


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999988432   34588899999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ..............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGE  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence            6543332222333456789999998764  78899999999999999997 89888643221        1222223322


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+      ..++.++.+++.+||+.+|.+|||+.+++..|....+
T Consensus       229 ~~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 RLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             CCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            22211      1234578999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.2e-41  Score=314.53  Aligned_cols=257  Identities=23%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ....|++.++||+|+||.||++.+. ++..+|+|.+.....  ....+.+|+++++.++||||+++++++.++...++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3457888899999999999999876 678899998876432  2367889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    ....+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            9999999999883    234688999999999999999999963  2799999999999999999999999999875432


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc----------------
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF----------------  283 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~----------------  283 (373)
                      ..    .....|+..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+                
T Consensus       157 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         157 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hc----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            21    1234689999999998764  6788999999999999999999998754321100000                


Q ss_pred             -----------------h---HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 -----------------P---SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 -----------------~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                       .   ................     ...++.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLP-----SGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCC-----CCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                             0   0000000000000000     0113467899999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-41  Score=318.55  Aligned_cols=256  Identities=21%  Similarity=0.203  Sum_probs=194.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..|.+.+.||+|+||.||+|... +++.||+|....     ..+.+|+.+++.++||||+++++++......++++|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            45888899999999999999865 788999996542     356789999999999999999999999999999999994


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                       ++|..++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus       167 -~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-  237 (391)
T PHA03212        167 -TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA-  237 (391)
T ss_pred             -CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence             67877763    234688999999999999999999998   999999999999999999999999999875332211 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH-------------
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ-------------  290 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------------  290 (373)
                      .......||+.|+|||++.+.  .++.++|||||||++|+|++|..||...................             
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             cccccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence            112345699999999998764  78899999999999999999998876433211100000000000             


Q ss_pred             ------------HhcCCCcccCcc--chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 ------------LNKGGDLELQNV--TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ------------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                  ............  ......++.++.+|+.+||+.||.+|||++|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        000000000000  0111234668999999999999999999999985

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-42  Score=331.65  Aligned_cols=255  Identities=23%  Similarity=0.282  Sum_probs=203.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------  133 (373)
                      ..+|.+.+.||+|+||+||+|... +++.||||++.....+   ...+.+|+..+..++|+|++++++.+....      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            347888899999999999999854 7899999998765443   256778999999999999999987764322      


Q ss_pred             --eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          134 --KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       134 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                        ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence              36799999999999998865544566799999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |+++...............||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......       . .....
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-------~-~~~~~  257 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENME-------E-VMHKT  257 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHH
Confidence            999765432222222345699999999999764  7889999999999999999999999754321       1 12222


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ..+....      .+..++..+.+++.+||+.||.+||++.++++.
T Consensus       258 ~~~~~~~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAGRYDP------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcCCCCC------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            2221111      223456789999999999999999999999763

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.4e-41  Score=301.93  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=207.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..|.+.++||.|+||.||+|...++..+++|.+..... ...++.+|+.+++.++|+||+++++++.+....+++|||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            45788899999999999999988889999999887655 45778899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  .+..+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||.+........ 
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999998543  245689999999999999999999998   999999999999999999999999999976543221 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                       ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......        ........+.....   
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---  225 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPC---  225 (261)
T ss_pred             -cccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCC---
Confidence             11233466789999988654  67889999999999999998 78888654321        12222222222211   


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                         +..++..+.+++.+||+.||++|||++++++.|++
T Consensus       226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         226 ---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               12345678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-41  Score=301.53  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=208.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |...+|++.++||+|+||.||+|..++++.+|+|.+.......+++.+|+.+++.++|+||+++++++. ....+++|||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            455678899999999999999999888899999999887777789999999999999999999999874 4568999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999887432  245688999999999999999999998   99999999999999999999999999987654222


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      . .......++..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||......        .....+..+..... 
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-  224 (260)
T cd05067         157 Y-TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYRMPR-  224 (260)
T ss_pred             c-ccccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCCCCC-
Confidence            1 111233466789999988654  67889999999999999998 99998654321        12222332222221 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                           +...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 12235679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-42  Score=317.28  Aligned_cols=241  Identities=22%  Similarity=0.319  Sum_probs=195.0

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||++..+ +++.||+|++....    .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 68899999987532    22356788999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|.+.+.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......  ..
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  151 (328)
T cd05593          81 ELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT  151 (328)
T ss_pred             CHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence            9988773    345689999999999999999999998   99999999999999999999999999987532211  12


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ........ .      ...
T Consensus       152 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--------~~~~~~~~-~------~~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-D------IKF  214 (328)
T ss_pred             cccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHHH--------HHHHhccC-C------ccC
Confidence            2345699999999998764  67889999999999999999999997543211        11111111 1      112


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  337 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~  337 (373)
                      +..++..+.+++.+||+.||++||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            234567889999999999999997     88988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5e-42  Score=309.63  Aligned_cols=246  Identities=23%  Similarity=0.316  Sum_probs=196.2

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||+|+||+||++... +++.+|+|.+......    .+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999865 7889999998754322    24567899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+.+......+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            877754444456799999999999999999999998   999999999999999999999999999876543321  123


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...||+.|+|||.+.+.  .++.++|+|||||++|+|++|+.||.........    .........       .....+.
T Consensus       156 ~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~-------~~~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRILN-------DSVTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhhcc-------cCCCCcc
Confidence            44689999999999764  7788999999999999999999999754432110    001111110       0112223


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      .++..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            4567899999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.5e-42  Score=298.31  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=201.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCc-eeeEeeEeeeCC------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVN-VVQLLGFCSEGS------  133 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~------  133 (373)
                      ..|...++||+|+||+||+|+.+ +|+.||+|.++....   ......+|+.+++.++|+| |+.+++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34566678999999999999965 788999999987654   3356789999999999999 999999998776      


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..++|+||+ .-+|..++.........++...+..++.|++.||+|||++   +|+||||||.|||++.+|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            889999999 4588888854433224577788999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      |+...-+..  .++...+|..|.|||++.+. ..|+...|+||+||++.||++++.-|.+......-    .-+...+..
T Consensus       167 Ara~~ip~~--~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql----~~If~~lGt  239 (323)
T KOG0594|consen  167 ARAFSIPMR--TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL----FRIFRLLGT  239 (323)
T ss_pred             HHHhcCCcc--cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH----HHHHHHcCC
Confidence            986543322  24455688999999999887 46899999999999999999999888765532100    001111110


Q ss_pred             C-------------CCcccCc---cchhh---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          294 G-------------GDLELQN---VTEIE---SMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       294 ~-------------~~~~~~~---~~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .             ....+..   .....   +....+..+++.+|++.+|.+|.|++.+++.
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0             0001110   11111   1122478999999999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9e-42  Score=309.24  Aligned_cols=261  Identities=24%  Similarity=0.404  Sum_probs=205.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...+.+.+.||+|+||.||++...      ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            345677899999999999999742      345689998875432 2467899999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          137 LVYEYMPNGSLDRHVFPKE---------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                      ++|||+++++|.+++....         .+...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            9999999999988874322         1234589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++................++..|+|||.+.+.  .++.++|+|||||++|+|++ |..||......        .
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~  230 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------E  230 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence            9999999765433222222233457789999998764  77889999999999999998 88887644321        1


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .......+......      ..++..+.+|+.+||+.||.+|||++++++.|+.+.+
T Consensus       231 ~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         231 VIECITQGRVLQRP------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHHcCCcCCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            22223332222111      2235678999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-41  Score=317.40  Aligned_cols=248  Identities=26%  Similarity=0.379  Sum_probs=194.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..+++.++||+|+||.||+|.+. +++.||||++......  ...+.+|+.+++.++|+||+++++++......++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34567789999999999999865 6889999998654332  36788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+..        ...+..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999985432        345677889999999999999998   99999999999999999999999999997654322


Q ss_pred             CceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          222 DFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .  ......||..|+|||.+...   ....+.++|||||||++|+|++|+.||........    .. ..........  
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~-~~~~~~~~~~--  293 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW----AS-LMCAICMSQP--  293 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH----HH-HHHHHhccCC--
Confidence            1  12345689999999987432   12345689999999999999999999974332211    00 0111111111  


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ...+..++..+.+|+.+||+.||++|||++|+++
T Consensus       294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1122345678999999999999999999999987

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-41  Score=301.64  Aligned_cols=254  Identities=28%  Similarity=0.435  Sum_probs=205.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...|++.++||+|+||.||+|..+++..+|+|.+.......+++.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            4567888999999999999999888889999999877777788999999999999999999999875 456899999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  ....+++..+..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            99999988432  234588999999999999999999998   999999999999999999999999999976543221 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......        .....+.......    
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  223 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMP----  223 (260)
T ss_pred             ccccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCC----
Confidence            111223356689999988654  67889999999999999999 88888643321        1222222222211    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        .+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 --CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              122345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=315.03  Aligned_cols=261  Identities=29%  Similarity=0.459  Sum_probs=203.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeee-CCe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSE-GSK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~~  134 (373)
                      .+|++.+.||+|+||.||+|...      +++.||+|+++.....  ...+..|+.++..+ +|+||+++++++.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            46888999999999999999632      3468999998754322  24677899999999 89999999998754 467


Q ss_pred             eEEEEeccCcCCccccccCCCCC---------------------------------------------------------
Q 048542          135 RALVYEYMPNGSLDRHVFPKESR---------------------------------------------------------  157 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  157 (373)
                      .+++|||+++++|.+++......                                                         
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999998887432110                                                         


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCccc
Q 048542          158 GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA  237 (373)
Q Consensus       158 ~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a  237 (373)
                      ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++................++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            23688999999999999999999998   999999999999999999999999999986543322222223446678999


Q ss_pred             ccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHH
Q 048542          238 PELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMI  316 (373)
Q Consensus       238 PE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  316 (373)
                      ||.+.+.  .++.++|||||||++|+|++ |..||......+       .....+..+.....      +...+.++.++
T Consensus       244 PE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-------EFCRRLKEGTRMRA------PEYATPEIYSI  308 (337)
T ss_pred             cHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-------HHHHHHhccCCCCC------CccCCHHHHHH
Confidence            9988764  78889999999999999997 998886533211       12222222222211      12335678999


Q ss_pred             HHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          317 GLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       317 i~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +.+||+.+|++||+++|+++.|+.++.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-41  Score=302.92  Aligned_cols=258  Identities=21%  Similarity=0.336  Sum_probs=206.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|..+ +++.||||.+.....    ....+.+|+.+++.++||||+++++++......++++|
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            4677899999999999999865 788999998764221    22567899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.........+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999888754444455688999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.......     .. ....+........ 
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~~~-  228 (267)
T cd08228         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FS-LCQKIEQCDYPPL-  228 (267)
T ss_pred             hH--HHhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HH-HHHHHhcCCCCCC-
Confidence            21  12234588899999998764  67889999999999999999999986543211     11 1122222221111 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          ....++..+.+++.+||+.+|++|||++++++.++++
T Consensus       229 ----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         229 ----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                1234567799999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.7e-41  Score=306.54  Aligned_cols=258  Identities=23%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...+++.+.||+|+||.||+|...      ++..||+|.+......  .+.+.+|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            346788899999999999999854      2468999998755432  25688899999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC
Q 048542          136 ALVYEYMPNGSLDRHVFPK------------ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  203 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~  203 (373)
                      ++++||+++++|.+++...            ......+++..+..++.|++.||.|||+.   +++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            9999999999998887421            11234588889999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccccc
Q 048542          204 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  282 (373)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~  282 (373)
                      +.+||+|||++................+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.....      
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  232 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            99999999998765433322222334467899999988653  67889999999999999998 7777754322      


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        ......+..+.....      +..++..+.+++.+||+.+|.+||++++++..|+.
T Consensus       233 --~~~~~~i~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 --QDVIEMIRNRQVLPC------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              112223333222211      22345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-41  Score=301.73  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=205.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..+|++.++||+|+||.||+|.+.++..||+|.++......+++.+|+.+++.++||||+++++++.+ ...+++|||++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            34688899999999999999998777789999998766667889999999999999999999998754 56799999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  .+..+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          84 KGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            99999888432  234578999999999999999999998   9999999999999999999999999999765433211


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                       ......++..|+|||...+.  .++.++|+|||||++|+|++ |..||......        .............    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~----  223 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMP----  223 (262)
T ss_pred             -cccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCCC----
Confidence             11233466789999988654  68889999999999999999 77777644321        1222222222111    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                        .+..++..+.+++.+|++.||++||++.++++.|+..
T Consensus       224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              1234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-41  Score=304.06  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=200.9

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....|++.+.||+|+||.||+|..+      ++..+|+|.+.....  ...++.+|+.+++.++||||+++++++..+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3456788899999999999999753      346799998865332  23568899999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          135 RALVYEYMPNGSLDRHVFPKESR------GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999887432211      23467888999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--------~~  230 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--------QV  230 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence            999998755433222111223457789999998764  68889999999999999999 67787543221        11


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      ............+      ...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2222222222211      2234578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-41  Score=307.19  Aligned_cols=260  Identities=24%  Similarity=0.424  Sum_probs=206.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..+.+.+.||+|+||.||+|...      ++..+++|.+...... .+.+.+|+..++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35667789999999999999743      3456889988754433 3578899999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc
Q 048542          138 VYEYMPNGSLDRHVFPKE------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI  205 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~  205 (373)
                      ||||+++++|.+++....            .....+++..+..++.|++.|++|||++   +++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999885432            1234588999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccch
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFP  284 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~  284 (373)
                      ++|+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......      
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------  233 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence            999999999765433222222334467889999988764  67889999999999999998 999886543211      


Q ss_pred             HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        ..+....+......      ..++..+.+++.+||+.+|++|||++++++.|+.+.+
T Consensus       234 --~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         234 --VIECITQGRVLERP------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HHHHHhCCCCCCCC------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              22222332222211      2245678999999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-41  Score=314.17  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=195.2

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ ++..||+|+++....    ....+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999865 688999999976432    224577899999888 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--  151 (329)
T cd05588          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence            99987773    345699999999999999999999998   999999999999999999999999999874322111  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc-cccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......||+.|+|||.+.+.  .++.++|+|||||++|+|++|+.||........ ......+..+...... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~------  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-I------  222 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-C------
Confidence            12345689999999999764  678899999999999999999999975432211 1111223333332221 1      


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPS------MTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps------~~ell~  336 (373)
                      ..+..++..+.+++.+||+.||.+|||      ++++++
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            122334667899999999999999998      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-41  Score=299.42  Aligned_cols=247  Identities=23%  Similarity=0.402  Sum_probs=194.7

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      +.||+|+||.||+|..+ +++.+|+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999865 788999998765332  236789999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++..   .+..+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            988832   234688999999999999999999998   99999999999999999999999999987543221111111


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhh
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE  306 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (373)
                      ....+..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ..............      +
T Consensus       155 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~------~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLPC------P  218 (252)
T ss_pred             CCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCCC------c
Confidence            11234579999998664  67889999999999999997 77777543221        12222222222111      1


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       307 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-41  Score=313.14  Aligned_cols=243  Identities=22%  Similarity=0.321  Sum_probs=190.8

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +++.+|+|+++....    ....+.+|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46899999999999866 678999999976422    224567888888776 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|...+.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--  151 (329)
T cd05618          81 GDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--  151 (329)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence            99987773    345689999999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-ccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-AYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......||..|+|||.+.+.  .++.++|||||||++|+|++|+.||......... .....+......... .      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-~------  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I------  222 (329)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-C------
Confidence            12345689999999998764  7788999999999999999999999643222111 111222333222221 1      


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                      .++..++..+.+++.+||+.||++||++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1223446678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.6e-41  Score=302.78  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=202.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-----CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..+++.+.||+|+||.||+|...     ++..+++|.+......  ...+.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45677899999999999999742     4578999998753332  2568889999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          138 VYEYMPNGSLDRHVFPKE-------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~-------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      +|||+++++|.+++....             .....+++..+..++.|++.||.|||++   +++|+||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999988874221             1123578889999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccc
Q 048542          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  283 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~  283 (373)
                      .+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....       
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------  232 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            9999999999765433322222333466789999998654  67889999999999999998 8888864321       


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                       ...............      +..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus       233 -~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 -QEVIEMVRKRQLLPC------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             112222222222211      12345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-42  Score=309.00  Aligned_cols=247  Identities=19%  Similarity=0.317  Sum_probs=210.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .-|.+.+.||+|.|+.|-+|++- +|.+||||++.+.+.+   ...+..|++.|+.++|||||++|++......+|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34677899999999999999865 8999999999876554   3678999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~  219 (373)
                      .-.+|+|++++..++   ..+.+..+.+++.||+.|+.|||+.   .+|||||||+|+.+. .-|-+||+|||++..+..
T Consensus        98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999997654   4589999999999999999999998   999999999999876 568999999999987665


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...   .+..+|+..|.|||++.|. ....+++||||||++||.|++|+.||......+.        ...+.       
T Consensus       172 G~k---L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------LTmIm-------  232 (864)
T KOG4717|consen  172 GKK---LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------LTMIM-------  232 (864)
T ss_pred             cch---hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------hhhhh-------
Confidence            543   3567899999999999886 2334678999999999999999999986654321        11111       


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......|..++.++++||..||..||++|.|.+||+.
T Consensus       233 DCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 DCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            2224567888999999999999999999999999875

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.9e-42  Score=316.26  Aligned_cols=240  Identities=22%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||++... ++..||+|+++...    .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999865 78899999987532    22356678999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      +|..++.    ....+++..+..++.|++.||+|||+ .   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--  151 (325)
T cd05594          81 ELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--  151 (325)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence            9988773    34568999999999999999999996 6   999999999999999999999999999874322221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......        ........ ..      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--------~~~~i~~~-~~------~  214 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILME-EI------R  214 (325)
T ss_pred             ccccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHHH--------HHHHHhcC-CC------C
Confidence            12344699999999998764  77889999999999999999999996543211        11111111 11      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      .+..++..+.+++.+||+.||++|+     ++.++++
T Consensus       215 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            1223466789999999999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=319.62  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=202.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|.+.+.||+|+||.||+|... +++.||+|++....    .....+.+|+.++..++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            4677899999999999999976 78899999987542    233567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          82 YMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            9999999998843    35689999999999999999999998   9999999999999999999999999999765433


Q ss_pred             C---------------------------CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          221 N---------------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       221 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                      .                           .........||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCCC
Confidence            2                           00112344689999999999775  788999999999999999999999976


Q ss_pred             CcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 048542          274 NATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLEM  337 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~ell~~  337 (373)
                      .....        ....+.. ......+...    .++..+.+++.+|++ ||.+||+ ++++++.
T Consensus       233 ~~~~~--------~~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQE--------TYNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHHH--------HHHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            54211        1111111 1111121111    146788999999998 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-41  Score=312.88  Aligned_cols=235  Identities=23%  Similarity=0.298  Sum_probs=189.6

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +++.||+|+++...    ...+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999876 67899999987532    2335667888888776 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--  151 (320)
T cd05590          81 GDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--  151 (320)
T ss_pred             chHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence            99988773    345689999999999999999999998   999999999999999999999999999875322211  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+.....       .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~-------~  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEV-------V  214 (320)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCC-------C
Confidence            12345699999999998764  6788999999999999999999999754321        12222222111       1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                      .+..++..+.+++.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            122346688999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.9e-41  Score=311.02  Aligned_cols=243  Identities=25%  Similarity=0.342  Sum_probs=192.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHh---cccCCCceeeEeeEeeeCCeeEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTI---GRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l---~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      |++.+.||+|+||.||+|..+ +++.||||+++...    ...+.+.+|..++   +.++||||+++++++......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999865 68899999997532    2234566666554   566899999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|...+.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            99999999987762     24689999999999999999999998   99999999999999999999999999987432


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+..+..  
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~~--  218 (324)
T cd05589         153 GFGD--RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--------VFDSIVNDEV--  218 (324)
T ss_pred             CCCC--cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC--
Confidence            2211  12345689999999998764  67889999999999999999999997543211        1122222111  


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                           ..+..++..+.+++.+||+.||.+||     ++.++++
T Consensus       219 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 -----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 11223466789999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-41  Score=313.07  Aligned_cols=240  Identities=25%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             cccCCCCcEEEEEEEEc----CCceeEEEEeccCc-----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.||+|+||.||++...    +++.||+|+++...     .....+.+|+.+++.++||||+++++++..+...|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999753    57889999987532     2234567899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+.+.    ....+.+..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999988873    345678888999999999999999998   99999999999999999999999999987432222


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .  ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+..+. .    
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~--------~~~~~~~~~~-~----  217 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK--------KTIDKILKGK-L----  217 (323)
T ss_pred             C--cccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-C----
Confidence            1  12334689999999998764  6788999999999999999999999754321        1112222221 1    


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                        ..+..++..+.+++.+||+.||++||     +++++++
T Consensus       218 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 --NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              11223456789999999999999999     7888766

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-42  Score=328.83  Aligned_cols=258  Identities=21%  Similarity=0.223  Sum_probs=200.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCC-ceeEEEEeccCcc-CHHHHHHHHHHhcccC-CCceeeEeeEe-ee------CCee
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTG-GLIAVKMLENSKF-SAEEFINEVSTIGRIH-HVNVVQLLGFC-SE------GSKR  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~-~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-h~ni~~~~~~~-~~------~~~~  135 (373)
                      +.++.+.|.+|||+.||+|....+ ..||+|++-..+. ..+...+|+.+|++|+ |+|||.+++.. ..      ....
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345668999999999999997755 8999998765433 3377899999999997 99999999932 11      1245


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      .|+||||++|+|-+++..+..  ..|++.++++|+.|+++|+++||.. ..+|+|||||-+|||++.+++.||||||.++
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            689999999999999965543  3399999999999999999999986 6679999999999999999999999999997


Q ss_pred             cCCCCCC-cee------eecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH
Q 048542          216 FHPKEND-FVS------ISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       216 ~~~~~~~-~~~------~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      ..-...+ ...      .-...-|+.|+|||++.-. .-..++|+|||+|||+||-||....||+....-.         
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---------  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---------  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---------
Confidence            4322221 100      0122378999999987432 1367899999999999999999999998663211         


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        .+. + ...++.    .+.++..+.+||..||+.||.+||++-++++.+-.+..
T Consensus       266 --Iln-g-~Y~~P~----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 --ILN-G-NYSFPP----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --EEe-c-cccCCC----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence              000 0 011111    14678899999999999999999999999998887543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=310.86  Aligned_cols=252  Identities=24%  Similarity=0.319  Sum_probs=212.3

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCe
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK  134 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~  134 (373)
                      +-....|.+.+.||.|.||.||++..+ +|+.+|+|.+.+...    ..+...+|+.+|+.++ ||||+.+++++++...
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~  110 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS  110 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence            334557888899999999999999977 599999999987544    3468899999999998 9999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC----CCceEEee
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSD  210 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~----~~~~kl~D  210 (373)
                      .++|||+|.||.|.+.+...     .+++..+..++.|++.++.|||+.   |++|||+||+|+|+..    ++.+|++|
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEee
Confidence            99999999999999998544     299999999999999999999998   9999999999999963    35799999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ||++......   ......+||+.|+|||++...  .|+..+|+||+|+++|.|++|..||........        ...
T Consensus       183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~  249 (382)
T KOG0032|consen  183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLA  249 (382)
T ss_pred             CCCceEccCC---ceEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHH
Confidence            9999987662   235677899999999999764  889999999999999999999999987764321        112


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +..+..   ....+....++..+.+++..|+..||..|+|+.++++
T Consensus       250 i~~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            222211   2223334566889999999999999999999999999

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.9e-41  Score=301.20  Aligned_cols=254  Identities=28%  Similarity=0.426  Sum_probs=196.7

Q ss_pred             hhcccCCCCcEEEEEEEEcCCc---eeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC------CeeE
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGG---LIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRA  136 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~---~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~  136 (373)
                      +.+.||+|+||.||+|.+..+.   .+|+|.++....   ..+.+.+|+.+++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            5688999999999999876433   589998876432   236788899999999999999999987432      2468


Q ss_pred             EEEeccCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          137 LVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      ++|||+++|+|.+++....  .....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999988764322  2234589999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhc
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ................+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.....        .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~  229 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLRQ  229 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc
Confidence            865433221111223466789999998764  67889999999999999999 7788764322        112233333


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      +......      ..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       230 ~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 GNRLKQP------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            3222211      23456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-41  Score=298.62  Aligned_cols=255  Identities=29%  Similarity=0.481  Sum_probs=207.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...|.+.+.||+|+||.||+|..+++..+|+|.+.......+++.+|+.+++.++|+||+++++++......+++|||++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS   84 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence            45677889999999999999998878889999998877777889999999999999999999999998889999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  .+..+++..+..++.+++.|+.|||++   +++|+||||+||+++.++.++|+|||++....... .
T Consensus        85 ~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          85 KGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             CCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999888442  235689999999999999999999998   99999999999999999999999999987654321 1


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......++..|+|||.+.+.  .++.++|+||+|+++|+|++ |+.||......        ........+.....+  
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  226 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYRMPRP--  226 (261)
T ss_pred             hhhhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            111222355689999988764  67889999999999999998 88888543321        122222222211111  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                          ...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       227 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         227 ----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                1225678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-41  Score=302.47  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=204.2

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....+.+.+.||+|+||.||+|..+      ++..+|+|.+......  ...+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3456777899999999999999864      2368999998754322  3568899999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          135 RALVYEYMPNGSLDRHVFPKES------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .+++|||+++++|.+++.....      ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence            9999999999999988854321      123478889999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~  230 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--------V  230 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHHH--------H
Confidence            999998765433322222233467889999988654  67889999999999999998 888886433211        2


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      ......+.....+      ..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       231 ~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         231 LKFVIDGGHLDLP------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            2222332222222      2235688999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.3e-41  Score=301.53  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=199.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .+++.+.||+|+||.||+|.+. ++.    .+++|.+.....  ...++..|+..+..++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence            4567789999999999999865 344    478887754322  22567788889999999999999998764 557899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        87 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          87 TQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999998843   235689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ............++..|+|||.+.+.  .++.++||||||+++|||++ |..||......        ...+.+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence            33322223344577889999998654  78899999999999999998 99888654321        122333333322


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....      .++..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       231 ~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 AQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            2221      123467889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.6e-42  Score=315.32  Aligned_cols=250  Identities=24%  Similarity=0.306  Sum_probs=196.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCc-----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  136 (373)
                      |++.+.||+|+||.||+++..    ++..||+|++....     ...+.+..|+.+++.+ +|+||+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            567899999999999999753    67899999986532     2235677899999999 5899999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        82 lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          82 LILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999988883    345689999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....... ......||..|+|||.+.+. ..++.++|||||||++|+|++|..||........    ............ 
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~~~~-  227 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRILKCD-  227 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHhcCC-
Confidence            4332211 12234699999999998754 3467899999999999999999999975432211    111111111111 


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      .      ..+..++..+.+++.+||+.||++||     +++++++
T Consensus       228 ~------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         228 P------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             C------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            1      11223456789999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-41  Score=333.99  Aligned_cols=270  Identities=23%  Similarity=0.356  Sum_probs=208.6

Q ss_pred             CCccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           54 PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        54 ~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      |..+...+.....|.+.+.||+|+||+||+|... ++..+|+|.+......   ...+..|+.+++.++||||+++++++
T Consensus         2 p~~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f   81 (1021)
T PTZ00266          2 PGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRF   81 (1021)
T ss_pred             CccccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence            3445556666778899999999999999999876 6778999998754332   36688999999999999999999988


Q ss_pred             ee--CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----CCCeEecCcCCCCeeeeC-
Q 048542          130 SE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC----DVCILHFDIKPHNILLDH-  202 (373)
Q Consensus       130 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----~~~ivH~dikp~Nil~~~-  202 (373)
                      ..  ....|+||||+++++|.+++.........+++..++.|+.||+.||.|||+..    ..+|+||||||+|||++. 
T Consensus        82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~  161 (1021)
T PTZ00266         82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG  161 (1021)
T ss_pred             EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence            54  45789999999999999988544334467999999999999999999999841    125999999999999964 


Q ss_pred             ----------------CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc
Q 048542          203 ----------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG  266 (373)
Q Consensus       203 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~  266 (373)
                                      .+.+||+|||++........   .....||+.|+|||++.+....++.++|||||||++|+|++
T Consensus       162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             ccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                            23589999999976543221   23446999999999986554568889999999999999999


Q ss_pred             CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH--HHHhc
Q 048542          267 GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL--EMLEG  340 (373)
Q Consensus       267 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell--~~L~~  340 (373)
                      |..||......       ..+...+........       ...+..+.+|+..||+.+|.+||++.+++  ..+..
T Consensus       239 Gk~PF~~~~~~-------~qli~~lk~~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        239 GKTPFHKANNF-------SQLISELKRGPDLPI-------KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             CCCCCCcCCcH-------HHHHHHHhcCCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            99999643321       112222322221111       12356789999999999999999999998  44543

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.9e-41  Score=305.10  Aligned_cols=260  Identities=25%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ...|++.+.||+|+||.||++...      ....+|+|.+......  ..++.+|+.+++.+ +|+||+++++++..+..
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            345677799999999999999864      2357999988754332  25678999999999 79999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC
Q 048542          135 RALVYEYMPNGSLDRHVFPKE------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~  202 (373)
                      .+++|||+++|+|.+++....            .....+++..+..++.|++.||+|||+.   +++||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence            999999999999998874321            2345689999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccc
Q 048542          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKA  281 (373)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~  281 (373)
                      ++.+||+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......    
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----  241 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----  241 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH----
Confidence            999999999999865443322222233456789999988654  67889999999999999997 88887643321    


Q ss_pred             cchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                          ........+.....      +...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       242 ----~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         242 ----ELFKLLKEGYRMEK------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                12233333322221      1223567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-42  Score=303.92  Aligned_cols=258  Identities=25%  Similarity=0.329  Sum_probs=194.4

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----eeEEEEec
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYEY  141 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e~  141 (373)
                      .-.+.+|.|+||.||.|... +++.||||.+..+..-.   .+|+.+|+.+.||||+++..+|....     ...+||||
T Consensus        27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley  103 (364)
T KOG0658|consen   27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY  103 (364)
T ss_pred             EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence            34588999999999999865 67899999887654322   36999999999999999988874422     34589999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~  220 (373)
                      |+. +|.+.+......+..++...+.-+..||.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus       104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            976 89888855444567788888889999999999999998   99999999999999955 99999999999987665


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH----HHHHhcCC-
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV----YDQLNKGG-  295 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~-  295 (373)
                      ....++   ..|-.|+|||.+.|. ..|+.+.||||.||++.||+-|++-|.+.+....-..+-...    .+.+.... 
T Consensus       180 epniSY---icSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  180 EPNISY---ICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             CCceeE---EEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            544332   367789999999886 689999999999999999999999998755321100000000    00111000 


Q ss_pred             ---CcccCcc------chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 ---DLELQNV------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ---~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ....+..      .-.....+.+..+|+.++|+.+|.+|.++.|++.
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               0000000      0122345678999999999999999999998864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.1e-41  Score=310.72  Aligned_cols=239  Identities=23%  Similarity=0.295  Sum_probs=189.3

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|... +++.||+|+++...    ...+....|..++... +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999865 67889999987532    2234455666666644 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|..++.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.......  .
T Consensus        81 g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~  151 (316)
T cd05592          81 GDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence            99988873    235689999999999999999999998   99999999999999999999999999997543222  1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......        .....+... ..      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~-~~------~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILND-RP------H  214 (316)
T ss_pred             ccccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC-CC------C
Confidence            22345699999999998764  6788999999999999999999999754321        122222211 11      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell  335 (373)
                      .+..++..+.+++.+||+.||.+||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            2233466789999999999999999875 453

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=307.39  Aligned_cols=250  Identities=26%  Similarity=0.347  Sum_probs=199.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +|++.+.||+|+||.||++... +++.||+|.+......    ...+.+|+.+++.++||||+++++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3667789999999999999865 6889999998754322    2456789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+.+...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999998777432  234689999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..   .....|+..|+|||.+.+.  .++.++||||+||++|+|++|..||........    .......+....     
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~-----  221 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRVKEDQ-----  221 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHhhhcc-----
Confidence            21   2334689999999998764  678899999999999999999999975432110    011111111111     


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                        ...+..++..+.+|+.+||+.||.+||     +++++++
T Consensus       222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              122234567889999999999999999     8888855

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-41  Score=300.12  Aligned_cols=256  Identities=29%  Similarity=0.447  Sum_probs=200.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCe-----
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-----  134 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-----  134 (373)
                      +++.+.||+|+||.||+|...    .+..||+|.++.....   .+.+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            356789999999999999864    2367999998764333   3578899999999999999999998865443     


Q ss_pred             -eEEEEeccCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          135 -RALVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       135 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                       .++++||+++++|..++....  .....+++..+..++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999988874432  2234689999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      |++................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        ...+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~  227 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDY  227 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence            999865433322222223356789999988654  67889999999999999999 77887543321        12233


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...+.....      +..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       228 ~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         228 LRHGNRLKQ------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHcCCCCCC------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            333322221      233466899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.6e-41  Score=304.89  Aligned_cols=258  Identities=26%  Similarity=0.404  Sum_probs=203.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      +++.+.||+|+||.||+|...      ....+++|.+......  ..++.+|+.+++.++||||+++++.+......+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456789999999999999753      2346889888754332  35788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          139 YEYMPNGSLDRHVFPKE--------------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      +||+.+++|.+++....                    .....+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni  158 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV  158 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence            99999999988874321                    1124588999999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCc
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  277 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~  277 (373)
                      ++++++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||..... 
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-  235 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-  235 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence            9999999999999999765433322222333466789999988664  67889999999999999998 8888864322 


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                             ...............      +..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus       236 -------~~~~~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 -------ERLFNLLKTGYRMER------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -------HHHHHHHhCCCCCCC------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                   123333333322221      12345678999999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.5e-41  Score=318.11  Aligned_cols=251  Identities=22%  Similarity=0.237  Sum_probs=194.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |++.+.||+|+||+||+|... +++.||+|++.....    ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            566789999999999999865 678999999976432    235678899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+++.    +...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||++.......
T Consensus        83 ~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          83 IPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999998883    345688999999999999999999998   99999999999999999999999999975321100


Q ss_pred             Cc---------------------------------------------eeeecccCCCCcccccccccccCCcCcccchHH
Q 048542          222 DF---------------------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (373)
Q Consensus       222 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  256 (373)
                      ..                                             .......||+.|+|||.+.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCccceee
Confidence            00                                             001124699999999998764  6788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHh--hcCCCCCCCCCHHHH
Q 048542          257 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLW--CIQVKAADRPSMTKV  334 (373)
Q Consensus       257 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dp~~Rps~~el  334 (373)
                      |||++|+|++|..||.......       ..............+..    ..++..+.+|+.+  |+..+|..||+++++
T Consensus       234 lG~il~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTE-------TQLKVINWENTLHIPPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHH-------HHHHHHccccccCCCCC----CCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999999997644321       11111111111122211    1245678888887  556666679999999


Q ss_pred             HHH
Q 048542          335 LEM  337 (373)
Q Consensus       335 l~~  337 (373)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-41  Score=312.15  Aligned_cols=241  Identities=20%  Similarity=0.272  Sum_probs=192.7

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +++.||+|++....    ...+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999876 67899999987632    2234567888888766 799999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|...+.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--  151 (321)
T cd05591          81 GDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--  151 (321)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence            99988773    345688999999999999999999998   999999999999999999999999999875332221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++||||+||++|+|++|+.||.......        ....+.....       .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--------~~~~i~~~~~-------~  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--------LFESILHDDV-------L  214 (321)
T ss_pred             cccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC-------C
Confidence            12345689999999998764  77889999999999999999999997544211        1222222111       1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRP-------SMTKVLEM  337 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rp-------s~~ell~~  337 (373)
                      .+..++..+.+++.+||+.||++||       +++++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1123456789999999999999999       77887643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.2e-41  Score=299.81  Aligned_cols=258  Identities=22%  Similarity=0.347  Sum_probs=206.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|..+ ++..+++|.+.....    ...++.+|+.+++.++|+||+++++++.++...+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            5677899999999999999864 789999998765322    23578899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.........+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999988754334456789999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......      ............... 
T Consensus       160 ~~--~~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~-  228 (267)
T cd08229         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPL-  228 (267)
T ss_pred             Cc--ccccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH------HHHhhhhhcCCCCCC-
Confidence            21  12234588899999998664  67889999999999999999999986433211      011111111111111 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          .+..++..+.+++.+||+.||++|||+.+|++.++.+
T Consensus       229 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 ----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                1123567899999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2e-41  Score=310.81  Aligned_cols=239  Identities=22%  Similarity=0.286  Sum_probs=190.6

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +|..||+|.++...    ........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999987642    2334566777777654 899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|..++.    .+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++........  
T Consensus        81 g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05620          81 GDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence            99988873    245688999999999999999999998   999999999999999999999999999864322111  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++||||+||++|+|++|..||......        .....+.... .      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~-~------~  214 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDT-P------H  214 (316)
T ss_pred             ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C------C
Confidence            22345699999999999764  7888999999999999999999999754321        1222222211 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell  335 (373)
                      .+..++.++.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1223466789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=318.28  Aligned_cols=250  Identities=23%  Similarity=0.259  Sum_probs=197.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|... +++.||||++....    .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            3567799999999999999976 68899999997542    223557789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    .+..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          82 YLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999883    245689999999999999999999998   9999999999999999999999999998754321


Q ss_pred             CCce------------------------------------eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHH
Q 048542          221 NDFV------------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM  264 (373)
Q Consensus       221 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~l  264 (373)
                      ....                                    ......||+.|+|||++.+.  .++.++|||||||++|+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el  232 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHHh
Confidence            1000                                    00123589999999998764  688999999999999999


Q ss_pred             HcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 048542          265 AGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  336 (373)
Q Consensus       265 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~ell~  336 (373)
                      ++|..||.......       ..............+..    ..++..+.+|+.+|+. +|.+|++   ++++++
T Consensus       233 ~~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         233 LVGYPPFCSDNPQE-------TYRKIINWKETLQFPDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             hcCCCCCCCCCHHH-------HHHHHHcCCCccCCCCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999997544211       11111111111111111    1245678899999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.1e-41  Score=302.98  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=206.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcC-----CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeee-CCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQT-----GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~  134 (373)
                      ...+|.+.+.||+|+||.||+|.+..     +..|++|.+.....  ..+.+.+|+.+++.++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34577788999999999999998764     67899998875432  23668899999999999999999998765 567


Q ss_pred             eEEEEeccCcCCccccccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEee
Q 048542          135 RALVYEYMPNGSLDRHVFPKESR----GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~D  210 (373)
                      .+++++|+++++|.+++......    +..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999887543221    25689999999999999999999998   999999999999999999999999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      ||+++...............++..|+|||.+.+.  .++.++|||||||++|++++ |+.||......        ....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~  230 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAA  230 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHH
Confidence            9999765433221112233466789999998764  67889999999999999998 99998654321        1222


Q ss_pred             HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+.....      +..++..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       231 ~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         231 YLKDGYRLAQ------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHcCCCCCC------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            2222222111      11234678999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=296.19  Aligned_cols=250  Identities=32%  Similarity=0.513  Sum_probs=205.0

Q ss_pred             cccCCCCcEEEEEEEEcC----CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|....    +..+++|.+......  .+.+.+|+..+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999998763    778999999876544  47889999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          145 GSLDRHVFPKESR-----GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       145 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ++|.+++......     ...+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999998543211     46799999999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ...........++..|+|||.+.+.  .++.++||||+|+++|+|++ |..||.....        .........+....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            4322233445678899999988764  78889999999999999999 5888875532        11223333322221


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                            .+..++..+.+++.+||+.+|++|||++++++.|+
T Consensus       228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  12334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.8e-41  Score=297.40  Aligned_cols=246  Identities=24%  Similarity=0.429  Sum_probs=196.1

Q ss_pred             ccCCCCcEEEEEEEEc---CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           72 KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      .||+|+||.||+|.++   ++..+|+|+++.....   .+++.+|+.+++.++||||+++++++.. ...+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999643   5788999998754332   3678899999999999999999998864 5678999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce-
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-  224 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-  224 (373)
                      +|.+++.    ....+++..+..++.|++.|++|||++   +++||||||+||+++.++.+||+|||++.......... 
T Consensus        81 ~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            9998883    234688999999999999999999998   99999999999999999999999999998664433221 


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++|+|||||++|+|++ |..||......        .....+..+.....+   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~---  220 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYY--KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECP---  220 (257)
T ss_pred             ecCCCCCCccccCHhHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCC---
Confidence            11222345789999988653  67889999999999999998 89998754321        122333333322222   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                         ..++..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       221 ---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 ---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               23456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-40  Score=297.40  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=203.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|.+.+.||+|++|.||+|.++.+..+|+|.+.......+.+.+|+.+++.++|+|++++++++.. ...+++|||+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   84 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGK   84 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCC
Confidence            4577889999999999999998877789999988766666788999999999999999999998754 568899999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ .
T Consensus        85 ~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05069          85 GSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence            9999888532  234588999999999999999999998   999999999999999999999999999976543221 1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||...+.  .++.++|+||||+++|+|++ |..||......        .............     
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-----  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMP-----  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC-----
Confidence            11233466789999988654  67889999999999999999 88888653321        1122222221111     


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                       .+...+..+.+++.+||+.||++||+++++++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             123446789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.5e-41  Score=305.60  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=191.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc--CCceeEEEEeccCcc---CHHHHHHHHHHhccc---CCCceeeEeeEee-----eC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCS-----EG  132 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~--~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~h~ni~~~~~~~~-----~~  132 (373)
                      +|++.+.||+|+||.||+|...  ++..||+|.++....   ....+.+|+.+++.+   +||||+++++++.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            4677899999999999999863  467899998875332   224556777776665   6999999999885     34


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++||||+. ++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            56899999995 58888774322  34588999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++.......   ......|++.|+|||.+.+.  .++.++|||||||++|+|++|..||.........    ........
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~----~~i~~~~~  226 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL----GKILDVIG  226 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH----HHHHHHhC
Confidence            997654321   22345689999999998664  6788999999999999999999999765432100    00000000


Q ss_pred             cC-------------CCc---ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KG-------------GDL---ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~-------------~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..             ...   ...........++..+.+|+.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00             000   000011122235667899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-41  Score=309.29  Aligned_cols=239  Identities=23%  Similarity=0.300  Sum_probs=190.6

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcc-cCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|... +++.||+|+++...    ........|..++.. ++||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999999876 57899999987642    223456677777775 4899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  151 (316)
T cd05619          81 GDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--  151 (316)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence            99988883    235688999999999999999999998   999999999999999999999999999874322111  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++||||+||++|+|++|..||......        .....+.... .      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~-~------~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDN-P------C  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C------C
Confidence            12345689999999998764  6788999999999999999999999754321        1222222211 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell  335 (373)
                      .+..++..+.+++.+||+.||++||++. ++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            1223456789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-41  Score=307.50  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=205.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCS  130 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  130 (373)
                      +....|.+.+.||+|+||.||++...        +...+|+|.++....  ...++.+|+.+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            33467888999999999999999753        234699999876432  235688899999999 7999999999999


Q ss_pred             eCCeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          131 EGSKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       131 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      .....++||||+++++|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            99999999999999999999854321            123588899999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCc
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  277 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~  277 (373)
                      +++.++.+||+|||.+................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||..... 
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence            9999999999999998755432221111222345689999988764  67889999999999999998 7778754321 


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                             ...............      +...+..+.+|+.+||+.+|++|||+.++++.|+.+..
T Consensus       249 -------~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         249 -------EELFKLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -------HHHHHHHHcCCCCCC------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                   112223333322221      12345688999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-40  Score=297.12  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|... +|+.+|+|.++...    ...+.+.+|+.+++.++|+|++++++++......+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4677899999999999999976 88999999886422    224678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++......+..+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999988855444456789999999999999999999998   9999999999999999999999999998755332


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......      .........+.....+
T Consensus       160 ~~--~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~  229 (267)
T cd08224         160 TT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEKCDYPPLP  229 (267)
T ss_pred             Cc--ccceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCccH------HHHHhhhhcCCCCCCC
Confidence            21  11234588899999998764  67889999999999999999999986443210      0111122222111111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                           ...++..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       230 -----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 -----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 1245668899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3e-41  Score=311.76  Aligned_cols=252  Identities=21%  Similarity=0.228  Sum_probs=200.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||++..+ +++.||+|+++....    ....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            3667899999999999999865 788999999986433    33567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          82 YQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999988432   25689999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCceeeecccCCCCcccccccccc----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          221 NDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ... ......||+.|+|||.+...    ...++.++|||||||++|+|++|..||.......       ...........
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~  227 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------TYNNIMNFQRF  227 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-------HHHHHHcCCCc
Confidence            322 22334689999999998631    2357789999999999999999999997543211       11111111111


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...+..    ..++..+.+|+..||+ +|.+|||++++++
T Consensus       228 ~~~~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            122211    1245678999999998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.4e-41  Score=314.31  Aligned_cols=254  Identities=20%  Similarity=0.253  Sum_probs=202.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ....|++.+.||+|+||.||++..+ +++.||+|++....    .....+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457788899999999999999866 68899999986532    223457789999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++|+|.+++.     +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999998873     23578888999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCCceeeecccCCCCcccccccccc--cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-C
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-G  294 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~  294 (373)
                      ..... .......||+.|+|||.+.+.  ...++.++|||||||++|+|++|..||......       . ....+.. .
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~  263 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMDHK  263 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcCC
Confidence            43221 122345699999999998653  134788999999999999999999999754421       1 1122222 1


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  337 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~~  337 (373)
                      .....+..    ..++..+.+|+.+||+.+|.+  |||++++++.
T Consensus       264 ~~~~~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 NSLTFPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CcCCCCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            12222221    134678899999999999987  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-41  Score=303.67  Aligned_cols=259  Identities=26%  Similarity=0.395  Sum_probs=198.0

Q ss_pred             hhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEE
Q 048542           68 HFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALV  138 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv  138 (373)
                      ++.+.||+|+||+||++..     .++..||+|.++....  ....+.+|+.+++.++||||+++++++...  ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6778999999999988653     3577899999876533  346788999999999999999999987653  467899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++.     ...+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        87 ~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999998883     23589999999999999999999998   99999999999999999999999999988654


Q ss_pred             CCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-------ccchHHHHHH
Q 048542          219 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWVYDQ  290 (373)
Q Consensus       219 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~~~~  290 (373)
                      ....... .....++..|+|||.+.+.  .++.++||||||+++|+|++|..|+.........       ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            3322111 1122356679999988654  6788999999999999999999997643321000       0000001111


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      .......      ..+..++..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       237 ~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRL------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCC------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111111      112334568999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-41  Score=304.74  Aligned_cols=264  Identities=23%  Similarity=0.379  Sum_probs=197.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC---------------CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT---------------GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLL  126 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~  126 (373)
                      ..+|++.+.||+|+||.||++....               ...||+|.+......  .+.+.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3467888999999999999987542               124899998764322  35688999999999999999999


Q ss_pred             eEeeeCCeeEEEEeccCcCCccccccCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          127 GFCSEGSKRALVYEYMPNGSLDRHVFPKES--------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       127 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      +++......++||||+++++|.+++.....        ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999888743211        123478889999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc--CCCCCCCCcC
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT  276 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~--g~~p~~~~~~  276 (373)
                      +++.++.+||+|||++................++..|+|||.+.+.  .++.++|+|||||++|+|++  +..||.....
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            9999999999999998755433222112223456789999988654  68899999999999999998  4556554322


Q ss_pred             ccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ...   + ................   ..+...+..+.+|+.+||+.||++|||++++++.|+
T Consensus       239 ~~~---~-~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQV---I-ENTGEFFRNQGRQIYL---SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHH---H-HHHHHhhhhccccccC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            110   0 0001111111111100   011123568999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4e-41  Score=310.10  Aligned_cols=239  Identities=23%  Similarity=0.283  Sum_probs=191.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      |++.+.||+|+||.||+|..+ +++.||+|++....    ...+.+..|..++..++| ++|+.+++++...+..|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567799999999999999866 67789999987532    233567789999998876 468889999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          82 YVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999988873    345688999999999999999999998   9999999999999999999999999998643221


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .....+.... .   
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~-~---  218 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHN-V---  218 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-C---
Confidence            11  12345699999999999764  6788999999999999999999999754321        1112222211 1   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                         ..+..++..+.+++.+||+.||.+|++.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               1123346678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.6e-41  Score=312.92  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=194.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||+||+|... +++.||+|++.....    ....+.+|+.++..++|+||+++++.+.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            3567789999999999999865 688999999975322    23567789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          82 FLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999883    345689999999999999999999998   9999999999999999999999999998754321


Q ss_pred             CCc---------------------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcC
Q 048542          221 NDF---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG  267 (373)
Q Consensus       221 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g  267 (373)
                      ...                                 ......+||+.|+|||++.+.  .++.++|||||||++|+|++|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHhC
Confidence            100                                 001234699999999998764  688899999999999999999


Q ss_pred             CCCCCCCcCccccccchHHHHHHHhcC-CCcccCccchhhHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHH
Q 048542          268 RRNSNMNATRSSKAYFPSWVYDQLNKG-GDLELQNVTEIESMIARKLCMIGLWCIQ--VKAADRPSMTKVLEM  337 (373)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rps~~ell~~  337 (373)
                      ..||......        .....+... .....+...    .++..+.+++.+|+.  .++..||+++|+++.
T Consensus       233 ~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         233 YPPFCSETPQ--------ETYKKVMNWKETLIFPPEV----PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCCHH--------HHHHHHHcCcCcccCCCcC----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9999754321        122222221 112222111    235567788887554  233456899999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.2e-41  Score=309.88  Aligned_cols=240  Identities=24%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +++.||+|+++...    .....+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999876 67899999987542    2235567888888877 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|...+.    +...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  151 (318)
T cd05570          81 GDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--  151 (318)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence            99988773    345689999999999999999999998   999999999999999999999999999864322211  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......|+..|+|||.+.+.  .++.++|+|||||++|+|++|+.||......        .....+.... .      .
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~-~------~  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDE-V------R  214 (318)
T ss_pred             cccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCC-C------C
Confidence            12234589999999999764  7888999999999999999999999654321        1122222211 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ell~  336 (373)
                      .+..++..+.+|+.+||+.||.+|||+     .++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            123346688999999999999999999     88765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-40  Score=313.20  Aligned_cols=263  Identities=24%  Similarity=0.410  Sum_probs=204.6

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeC
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEG  132 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  132 (373)
                      +....+.+.++||+|+||.||+|++.      ++..||+|+++.....  .+.+.+|+.++..+. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34445667799999999999999854      3457999999764332  356889999999997 99999999999998


Q ss_pred             CeeEEEEeccCcCCccccccCCCC--------------------------------------------------------
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKES--------------------------------------------------------  156 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  156 (373)
                      ...++||||+++|+|.+++.....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999888753211                                                        


Q ss_pred             --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          157 --------------------------------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       157 --------------------------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                                                            ....+++..+..++.|++.||.|||+.   +++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence                                                  113467778889999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCc
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  277 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~  277 (373)
                      |++.++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|||++ |..||......
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999764332221112233467889999998764  67889999999999999998 88887643221


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                             ......+..+.....      +..++..+.+|+.+||+.+|.+||+++++++.|+.++
T Consensus       349 -------~~~~~~~~~~~~~~~------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -------EQFYNAIKRGYRMAK------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -------HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                   112222333322221      1234568999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-40  Score=306.60  Aligned_cols=261  Identities=25%  Similarity=0.424  Sum_probs=203.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  132 (373)
                      ..+|++.+.||+|+||.||+|...        ++..+|+|.++....  ..+++.+|+.+++++ +||||+++++++..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            446788899999999999999742        123689998875432  236788999999999 799999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      ...++++||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   +++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            999999999999999988854321            234578889999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~  279 (373)
                      +.++.+||+|||+++...............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......  
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  243 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  243 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence            99999999999998765433222222223345679999998764  67889999999999999998 77777543211  


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                            .....+..+......      ..++..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus       244 ------~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 ------ELFKLLKEGHRMDKP------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             ------HHHHHHHcCCCCCCC------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                  122222222222211      2334578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-40  Score=299.96  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=201.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...+++.+.||+|+||.||+|.+. ++.    .||+|.++....  ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            345667799999999999999854 444    489998875433  23678899999999999999999999875 4578


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999888432   34689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ..............++..|+|||...+.  .++.++|||||||++|||++ |..||......        .....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~  228 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGE  228 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCC
Confidence            6433322222233456789999998664  68889999999999999998 88887543221        1222233332


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .....      ..++..+.+++.+||+.||++||++.++++.|+.+..
T Consensus       229 ~~~~~------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 RLPQP------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             cCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            22211      2345678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.9e-41  Score=313.59  Aligned_cols=255  Identities=22%  Similarity=0.276  Sum_probs=199.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      +....|++.+.||+|+||.||++..+ +++.+|+|++.....    ....+.+|..+++.++||||+++++.+.++...+
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence            34467888899999999999999876 678999999864321    2345778999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++|+|.+++.     ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         120 MVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            9999999999998873     23478888999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCccccccccccc--CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-  293 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  293 (373)
                      ...... .......||+.|+|||++.+..  +.++.++|||||||++|+|++|..||......        .....+.. 
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~  262 (371)
T cd05622         192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMNH  262 (371)
T ss_pred             cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC
Confidence            543221 1223456999999999986542  24788999999999999999999999754321        11222222 


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  337 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~~  337 (373)
                      ......+.    ...++..+.+++.+|++.++.+  |++++++++.
T Consensus       263 ~~~~~~~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         263 KNSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCcccCCC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            11222221    1235677899999999844433  7799998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.9e-41  Score=301.49  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..+.+.++||+|+||.||++...      ++..+++|.+...... .+.+.+|+++++.++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45567799999999999999642      3557899987754332 3678999999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCce
Q 048542          138 VYEYMPNGSLDRHVFPKES-----------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  206 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~  206 (373)
                      +|||+++++|.+++.....           ....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999988854321           113588899999999999999999998   99999999999999999999


Q ss_pred             EEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchH
Q 048542          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~  285 (373)
                      ||+|||++................+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.......       
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------  232 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------  232 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------
Confidence            99999998755332221112223356789999988764  67889999999999999998 888886433211       


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                       .......+.....      +..++..+.+++.+||+.||.+||+++++++.|+.
T Consensus       233 -~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 -AIECITQGRELER------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HHHHHHcCccCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             1122222221111      12345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-41  Score=316.21  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=194.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|.+.+.||+|+||.||++..+ +++.||||++.....    ..+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            3567799999999999999865 788999999865322    23567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          82 FLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999998883    345688999999999999999999998   9999999999999999999999999998632110


Q ss_pred             CCc------------e---------------------------------eeecccCCCCcccccccccccCCcCcccchH
Q 048542          221 NDF------------V---------------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVY  255 (373)
Q Consensus       221 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvw  255 (373)
                      ...            .                                 ......||+.|+|||++.+.  .++.++|||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Diw  232 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceeeE
Confidence            000            0                                 00123589999999998764  788999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCC---CCH
Q 048542          256 GFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADR---PSM  331 (373)
Q Consensus       256 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~  331 (373)
                      ||||++|+|++|..||.......        ....+.. .....++..    ..++..+.+|+.+|++ +|.+|   +|+
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSHE--------TYRKIINWRETLYFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCccCCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            99999999999999996543211        1111111 111222211    1245678999999998 77765   599


Q ss_pred             HHHHHH
Q 048542          332 TKVLEM  337 (373)
Q Consensus       332 ~ell~~  337 (373)
                      .++++.
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-41  Score=301.71  Aligned_cols=251  Identities=29%  Similarity=0.462  Sum_probs=198.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHH---HHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~---~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||+||++... +++.+|+|++.........   ..+|+.+++.++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999977 5668999999887654433   345999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.    ....+++..+..++.|+++||.+||+.   +++|+||||+||+++.++.++|+|||.+.....  .
T Consensus        81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N  151 (260)
T ss_dssp             TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred             cccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence            9999998884    356689999999999999999999998   999999999999999999999999999875421  1


Q ss_pred             ceeeecccCCCCcccccccc-cccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      ........++..|+|||.+. +  ...+.++|+||+|+++|+|++|..||.......................       
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  222 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-------  222 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-------
T ss_pred             cccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-------
Confidence            12334566899999999987 3  3788899999999999999999999986621111111100000000000       


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ..........+.+++.+||+.||++|||++++++
T Consensus       223 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 -SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000011268999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.6e-41  Score=312.38  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...|++.+.||+|+||.||++..+ +++.+|+|++....    .....+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            456788899999999999999976 67899999986522    2234577899999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         122 MEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999883     23578889999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCccccccccccc--CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ... ........||+.|+|||++.+..  +.++.++|+||+||++|+|++|..||......       ............
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~  265 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNS  265 (370)
T ss_pred             cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcc
Confidence            322 12233556999999999986542  24778999999999999999999999754321       111122222222


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  337 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~~  337 (373)
                      ...+..    ..++..+.+++..|++.++.+  |+|++|+++.
T Consensus       266 ~~~p~~----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPED----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCCc----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            222211    234667889999999865543  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.4e-41  Score=323.00  Aligned_cols=261  Identities=19%  Similarity=0.250  Sum_probs=191.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeC--------Cee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------SKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~  135 (373)
                      ..|++.+.||+|+||.||+|... +++.||||.+....   ....+|+.+++.++||||+++++++...        ...
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            35778899999999999999865 68899999886543   2335799999999999999998876332        246


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLA  214 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~  214 (373)
                      ++||||+++ +|.+++......+..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            789999965 67666644334456799999999999999999999998   999999999999998654 7999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWV  287 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~  287 (373)
                      ........   .....||+.|+|||++.+. ..++.++||||+||++|+|++|..||............       ....
T Consensus       219 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~  294 (440)
T PTZ00036        219 KNLLAGQR---SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ  294 (440)
T ss_pred             hhccCCCC---cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            86543322   1234689999999988653 36788999999999999999999999765422110000       0000


Q ss_pred             HHHHhcC-CCcccCc--c----chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 YDQLNKG-GDLELQN--V----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ~~~~~~~-~~~~~~~--~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....... ....++.  .    ..++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0000000 0000010  0    1112234568999999999999999999999874

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.2e-40  Score=301.19  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=200.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC-----------------CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT-----------------GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL  125 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~  125 (373)
                      ..|++.+.||+|+||.||+|....                 +..||+|.+.....  ..+.+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            456788999999999999997542                 23589999876543  24678899999999999999999


Q ss_pred             eeEeeeCCeeEEEEeccCcCCccccccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKES-------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      ++++..+...+++|||+++++|.+++.....       ....+++..++.++.|++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999988854321       123689999999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc--CCCCCCCCcC
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT  276 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~--g~~p~~~~~~  276 (373)
                      +++.++.++|+|||++................++..|+|||.+.+.  .++.++|||||||++|+|++  +..||.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            9999999999999998765433322222334467789999998764  68889999999999999998  5566643321


Q ss_pred             ccccccchHHHHHHHhcC-CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          277 RSSKAYFPSWVYDQLNKG-GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                              .......... ...........+..++.++.+++.+||+.||.+|||+.++++.|+.
T Consensus       240 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 --------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                    1111111111 0000000011122345689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1e-40  Score=304.62  Aligned_cols=262  Identities=23%  Similarity=0.413  Sum_probs=205.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCc--cCHHHHHHHHHHhccc-CCCceeeEeeEee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCS  130 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~  130 (373)
                      +....|.+.+.||+|+||.||+|...        ++..+|+|.+....  ....++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44567788899999999999999641        23479999887543  2236788999999999 8999999999999


Q ss_pred             eCCeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          131 EGSKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       131 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      .....+++|||+++++|.+++.....            ....+++..+..++.|+++||.|||++   +++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999998854321            123578888999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCc
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  277 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~  277 (373)
                      +++.++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||..... 
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-  245 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-  245 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCH-
Confidence            9999999999999999866443322222333466789999998764  67889999999999999998 6777753321 


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                             .........+.....      +..++..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       246 -------~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 -------EELFKLLKEGHRMDK------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             -------HHHHHHHHcCCcCCC------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                   112233333322211      1234567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.7e-42  Score=313.68  Aligned_cols=237  Identities=24%  Similarity=0.320  Sum_probs=191.4

Q ss_pred             cccCCCCcEEEEEEEE----cCCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           71 HKLGQGGFGSVYKGQL----QTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~----~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +.||+|+||.||++..    .+|+.+|+|++.....   ....+.+|+.+++.++||||+++++++..+...|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    3678999999976432   23456789999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.    +...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            999988873    345689999999999999999999998   999999999999999999999999999875433221 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+.... .      
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~-~------  215 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAK-L------  215 (318)
T ss_pred             -ceecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCC-C------
Confidence             12345689999999998764  6788999999999999999999999754321        1111121111 1      


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTK  333 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  333 (373)
                      ..+..++..+.+|+.+||+.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            122334667899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-40  Score=303.57  Aligned_cols=260  Identities=25%  Similarity=0.436  Sum_probs=203.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  133 (373)
                      .++.+.+.||+|+||.||++...        .+..+|+|.++.....  ..++.+|+.+++.+ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            46678899999999999999742        2456899998754332  35688999999999 6999999999999989


Q ss_pred             eeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ..+++|||+++|+|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999998854321            234588999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccc
Q 048542          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  280 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~  280 (373)
                      .++.+||+|||++................++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999765432221111222345679999998764  68889999999999999999 7888754322    


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          .........+.....      +..++..+.+++.+||+.+|++|||+.++++.|.....
T Consensus       243 ----~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 ----EELFKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ----HHHHHHHHcCCCCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                112223333222221      12335578899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-40  Score=307.40  Aligned_cols=239  Identities=25%  Similarity=0.302  Sum_probs=187.9

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHH-HhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|... +|+.+|+|++.....    ....+..|.. +++.++||||+++++.+..+...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999865 788999999875322    2234455554 46778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|...+.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--  151 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--  151 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence            99987773    345689999999999999999999998   999999999999999999999999999874322111  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ......... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~-~~------  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKP-LV------  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCC-cc------
Confidence            12345699999999998764  67889999999999999999999997543211        112222211 11      


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      .+...+..+.+++.+|++.+|.+||++.+.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            1122456788999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-40  Score=299.54  Aligned_cols=261  Identities=24%  Similarity=0.399  Sum_probs=202.2

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ...+|++.+.||+|+||.||+|..+      .+..||+|.+......  ...+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3457788899999999999999753      2447999988754432  2467889999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          135 RALVYEYMPNGSLDRHVFPKES------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .+++|||+++|+|.+++.....      .....++..+..++.|++.||.|||++   +++||||||+||+++.++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999853221      123456778889999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||+++...............++..|+|||.+.+.  .++.++|+|||||++|+|++ |..||......       . .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-------~-~  230 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------Q-V  230 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-H
Confidence            999998755332221111223356789999998764  67889999999999999998 67777543321       1 2


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ......+......      ...+..+.+++.+||+.||++|||+.++++.|+..+
T Consensus       231 ~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         231 LKFVMDGGYLDQP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHcCCCCCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            2222222222211      123467999999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-40  Score=297.01  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=191.9

Q ss_pred             cccCCCCcEEEEEEEEc---CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||+|...   ++..+|+|.++.....  ...+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999865   3457999988765432  246888999999999999999999999988999999999999


Q ss_pred             CccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          146 SLDRHVFPKES-RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       146 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      +|.+++..... .....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99988854322 223466778888999999999999998   99999999999999999999999999987543332222


Q ss_pred             eeecccCCCCcccccccccccC-----CcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          225 SISATRGTIGYIAPELISRNFG-----TVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~-----~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ......++..|+|||.+.+..+     .++.++|+||||+++|+|++ |..||.......        ............
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--------VLTYTVREQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHhhcccCC
Confidence            2223457788999999864311     35779999999999999996 999986543221        101111111111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ... .......+..+.+++..|| .+|++|||+++|++.|+
T Consensus       230 ~~~-~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPK-PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCC-CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            110 1111123456788999999 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-40  Score=296.59  Aligned_cols=255  Identities=24%  Similarity=0.429  Sum_probs=205.1

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ...++++.++||+|+||.||++...++..+++|.+.......+.+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            345678889999999999999998778889999988766566788999999999999999999999877 7789999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++...  .+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||.+....... 
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  156 (260)
T cd05073          83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  156 (260)
T ss_pred             CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence            999999988432  245678889999999999999999998   99999999999999999999999999987553322 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      ........++..|+|||.+.+.  .++.++|+||||+++|++++ |..||.......        .......+.....  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~--  224 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYRMPR--  224 (260)
T ss_pred             cccccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCCCCC--
Confidence            1112233456789999998654  67889999999999999998 888886443211        1122222221111  


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                          +...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                12345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-40  Score=304.83  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=196.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +|.+.+.||+|+||.||+|..+ +++.+|+|.++....  ....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            5677899999999999999866 678899999875432  2356778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++ +|.+++..   .+..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        87 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          87 DK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            65 77766632   234578899999999999999999998   999999999999999999999999999875433221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhc--
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNK--  293 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~--  293 (373)
                        ......++..|+|||.+.+. ..++.++||||+||++|+|++|+.||............       ....+.....  
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence              12234578899999988653 35788999999999999999999999765432110000       0000000000  


Q ss_pred             ----CCCcccC--ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 ----GGDLELQ--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ----~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .......  ........++..+.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                0000000  000111235667899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-40  Score=298.88  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=199.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...+.+.+.||+|++|.||+|.+.      .+..|++|.+......  ...+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            345677899999999999999865      3567899988654332  35688999999999999999999999888899


Q ss_pred             EEEEeccCcCCccccccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---ceEEe
Q 048542          136 ALVYEYMPNGSLDRHVFPKES---RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVS  209 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~~kl~  209 (373)
                      +++|||+++++|.+++.....   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999998844321   123588999999999999999999998   999999999999998654   58999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      |||++.................+..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------~~  231 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------VM  231 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HH
Confidence            99999865332211111122345679999998654  78899999999999999997 888886543211        12


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ...........      +..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       232 ~~~~~~~~~~~------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGGGRLDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCcCCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            22222222221      2234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-40  Score=307.20  Aligned_cols=242  Identities=21%  Similarity=0.307  Sum_probs=191.2

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|... +++.+|+|+++....    ..+.+.+|..++..+ +||||+.+++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999865 678899999986432    234577899998888 699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|...+.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--  151 (327)
T cd05617          81 GDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--  151 (327)
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence            99987773    335699999999999999999999998   999999999999999999999999999874322211  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......... ...+......... .      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~-~------~  221 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKP-I------R  221 (327)
T ss_pred             ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCC-C------C
Confidence            12345699999999998764  77889999999999999999999996543222111 1122222222211 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                      .+..++..+.+++.+||+.||++||++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            223345678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-40  Score=297.81  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46778899999999999999964 678999999875433 3356788999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.    ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          89 GGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999988873    235688999999999999999999998   999999999999999999999999999976532211


Q ss_pred             ceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                        ......++..|+|||.+.+. ...++.++|+||+||++|+|++|..||..........        ..... ......
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--------~~~~~-~~~~~~  230 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--------LMSKS-NFQPPK  230 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--------eeecC-CCCCCC
Confidence              11234588899999987532 2356789999999999999999999986443211100        00000 001000


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                       ......++..+.+++.+||+.+|++|||++++++.|
T Consensus       231 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 -LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             011123467899999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-40  Score=299.78  Aligned_cols=247  Identities=25%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||+|+||.||++..+ +|+.||+|.+.....    ....+..|+++++.++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999865 689999999865322    123456799999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+.+...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            8777432  234588899999999999999999998   99999999999999999999999999987654322   223


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...|+..|+|||.+.+.  .++.++||||+||++|+|++|+.||.........    ..+........ ...     ...
T Consensus       153 ~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~-~~~-----~~~  220 (277)
T cd05607         153 QRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK----EELKRRTLEDE-VKF-----EHQ  220 (277)
T ss_pred             ccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH----HHHHHHhhccc-ccc-----ccc
Confidence            45689999999998765  5888999999999999999999998754321110    01111111110 000     012


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .++..+.+|+.+||+.||++||++.|+++.+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            35667899999999999999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-40  Score=300.48  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=204.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  133 (373)
                      ....+.+.+.||+|+||.||++...      ++..+|+|.++.....  .+.+.+|+.+++++ +||||+++++++....
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3456778899999999999999742      3457999988764332  35688999999999 7999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..+++|||+++++|.+++....  ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||+
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            9999999999999998884322  23489999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHh
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      +................++..|+|||.+.+.  .++.++||||+||++|+|++ |..||.......       .......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------~~~~~~~  258 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------KFYKLIK  258 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------HHHHHHH
Confidence            9865443322222233467789999988664  67889999999999999998 888886543211       1122222


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .+.....      +...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus       259 ~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 EGYRMAQ------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCcCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2221111      112346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.9e-41  Score=317.39  Aligned_cols=251  Identities=24%  Similarity=0.259  Sum_probs=195.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....    .....+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            3677899999999999999865 68899999987532    233567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          82 YIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999883    235688899999999999999999998   9999999999999999999999999997532100


Q ss_pred             CC-----------------------------------------ceeeecccCCCCcccccccccccCCcCcccchHHHHH
Q 048542          221 ND-----------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM  259 (373)
Q Consensus       221 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~  259 (373)
                      ..                                         ........||+.|+|||++.+.  .++.++|||||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGv  232 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeeccc
Confidence            00                                         0001134699999999999765  6788999999999


Q ss_pred             HHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHH
Q 048542          260 VLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP---SMTKVLE  336 (373)
Q Consensus       260 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---s~~ell~  336 (373)
                      ++|+|++|+.||.......       ..............+..    ..++..+.+++.+|+ .+|.+|+   |+.++++
T Consensus       233 ilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAE-------TQLKVINWETTLHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeeehhhCCCCCCCCCHHH-------HHHHHhccCccccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999999997654321       11111111111111111    124567788888876 5999999   8888875


Q ss_pred             H
Q 048542          337 M  337 (373)
Q Consensus       337 ~  337 (373)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=313.08  Aligned_cols=252  Identities=30%  Similarity=0.453  Sum_probs=216.5

Q ss_pred             hhcccCCCCcEEEEEEEEcC-CceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           69 FTHKLGQGGFGSVYKGQLQT-GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ..++||-|.||.||.|.|+. .-.||||.++.+.+..++|+.|..+|+.++|||+|+++|+|..+..+|||+|||..|+|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL  350 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL  350 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence            34899999999999999873 55799999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++...  ....++....+.++.||+.|+.||..+   +++||||..+|+|+.++..+|++|||+++++..+ .+....
T Consensus       351 LdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHA  424 (1157)
T KOG4278|consen  351 LDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHA  424 (1157)
T ss_pred             HHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCC-ceeccc
Confidence            9999543  234577788899999999999999998   9999999999999999999999999999987644 333334


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhh
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE  306 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (373)
                      +..-+..|.|||.+.-  ..++.|+|||+||++|||+.| |-.||..-+.        ..++..++++.+.+-+      
T Consensus       425 GAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgyRM~~P------  488 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGYRMDGP------  488 (1157)
T ss_pred             CccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhccccccCC------
Confidence            4556778999998854  489999999999999999997 6677765432        4477888888766544      


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       307 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ..++..+.+||+.||+++|.+||++.|+-+.++.+.
T Consensus       489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            345678999999999999999999999998888654

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-40  Score=305.97  Aligned_cols=236  Identities=26%  Similarity=0.333  Sum_probs=187.1

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHH-HhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||+||+|..+ +|+.||+|++.....    ....+..|.. +++.++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999976 788999999875322    2234455544 56778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (323)
T cd05575          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--  151 (323)
T ss_pred             CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence            99988873    345688999999999999999999998   999999999999999999999999999874322211  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ......... .      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~-~------~  214 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNKP-L------R  214 (323)
T ss_pred             ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCC-C------C
Confidence            12345689999999998764  68889999999999999999999997543211        112221111 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      .+..++..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1123466789999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-40  Score=315.15  Aligned_cols=258  Identities=20%  Similarity=0.224  Sum_probs=195.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..|.+.+.||+|+||.||+|.+. +++.||||....     ..+.+|+.++++++|+||+++++++..+...+++||++.
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            35778899999999999999876 578899995432     345789999999999999999999999999999999994


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                       ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       244 -~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        244 -SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             -CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence             688777632   234689999999999999999999998   9999999999999999999999999999765432221


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc--ccCc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL--ELQN  301 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  301 (373)
                      .......||..|+|||++.+.  .++.++|||||||++|||++|..|+...............+...+......  .+..
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            122245699999999999765  688899999999999999998876644332222222222222222221100  0000


Q ss_pred             -----------------------cchhh--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 -----------------------VTEIE--SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 -----------------------~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                             .....  ..++..+.+|+.+||+.||.+|||+.|+++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence                                   00000  123347889999999999999999999987

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-40  Score=313.08  Aligned_cols=262  Identities=21%  Similarity=0.213  Sum_probs=199.3

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc---CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      .+...+|++.+.||+|+||.||+|...   ++..||+|.+....    ...+|+.+++.++||||+++++++......++
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            344556888999999999999999753   45689999876542    34579999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +||++. ++|.+++    .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++...
T Consensus       164 v~e~~~-~~l~~~l----~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYV----DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 5787777    2346789999999999999999999998   9999999999999999999999999999765


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH------
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL------  291 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------  291 (373)
                      .............||..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+.. +...+      
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~  312 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLE  312 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccc
Confidence            443332223345699999999998764  788899999999999999999999976543221110000 00000      


Q ss_pred             ----------------hcCCCcccCccch-hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          292 ----------------NKGGDLELQNVTE-IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       292 ----------------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                                      ............. ....++.++.+++.+||+.||++|||+.|++..
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                            0000000000000 001234578899999999999999999999874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.6e-40  Score=292.17  Aligned_cols=251  Identities=28%  Similarity=0.485  Sum_probs=203.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..+++.+.||.|+||.||++.+.++..+|+|.+........++.+|+.+++.++|||++++++++......+++|||+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            35667899999999999999987788999999987777778899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++...   ...+++..+..++.+++.|++|||+.   +++|+||||+||+++.++.++|+|||.+........ .
T Consensus        84 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  156 (256)
T cd05112          84 GCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T  156 (256)
T ss_pred             CcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence            9998887432   34578999999999999999999998   999999999999999999999999999875533211 1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ........+.....+   
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  223 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKP---  223 (256)
T ss_pred             ccCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCCC---
Confidence            11223356789999988754  67889999999999999998 88888643321        122223322222111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                         ...+..+.+|+.+||+.+|++|||++++++.|
T Consensus       224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               11346799999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.8e-40  Score=291.30  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=195.1

Q ss_pred             ccCCCCcEEEEEEEEc---CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           72 KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      .||+|+||.||+|.+.   ++..||+|++......  .+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999764   3456999998765332  3568899999999999999999998864 57899999999999


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee-
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-  225 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~-  225 (373)
                      |.+++..   ....+++..+..++.|++.||+|||++   +++|+||||+||+++.++.+||+|||++........... 
T Consensus        81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9988742   234689999999999999999999998   999999999999999999999999999975543322211 


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      .....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+..+.....+    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~----  220 (257)
T cd05115         155 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGKRLDCP----  220 (257)
T ss_pred             cCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCCCCC----
Confidence            1222345789999988654  67889999999999999996 99998654321        122333333322221    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                        ...+..+.+++.+||+.+|++||++.++.+.|+..
T Consensus       221 --~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 --AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              23356889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.9e-41  Score=316.38  Aligned_cols=249  Identities=22%  Similarity=0.237  Sum_probs=192.9

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |.+.+.||+|+||.||+|... +++.||+|++.....    ....+.+|+.+++.++||||+++++.+.++...++||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            566789999999999999865 678999999875432    235678899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          83 IPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999988832    34688999999999999999999998   99999999999999999999999999975321000


Q ss_pred             C---------------------------------------------ceeeecccCCCCcccccccccccCCcCcccchHH
Q 048542          222 D---------------------------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (373)
Q Consensus       222 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  256 (373)
                      .                                             ........||+.|+|||++.+.  .++.++||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwS  233 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEEe
Confidence            0                                             0001124689999999998764  6888999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC---HHH
Q 048542          257 FGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTK  333 (373)
Q Consensus       257 lG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~e  333 (373)
                      +||++|+|++|+.||.......       ..............+..    ..++..+.+++.+|+ .+|.+|++   +++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLE-------TQMKVINWQTSLHIPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHH-------HHHHHHccCCCcCCCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            9999999999999997543211       11111111111222211    234567788888876 59999997   777


Q ss_pred             HHH
Q 048542          334 VLE  336 (373)
Q Consensus       334 ll~  336 (373)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-40  Score=294.14  Aligned_cols=249  Identities=29%  Similarity=0.458  Sum_probs=204.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..+++.+.||.|+||.||+|... |+.||+|.+.......+++.+|+.+++.++|+||+++++++.+....++||||+++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            45677899999999999999876 88999999987665567889999999999999999999999988999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++....  ...+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||.+.......   
T Consensus        85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            99999884322  23689999999999999999999998   99999999999999999999999999998653221   


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....+..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.....        .........+.....    
T Consensus       157 --~~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~----  220 (256)
T cd05039         157 --DSGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEA----  220 (256)
T ss_pred             --ccCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCC----
Confidence              123356689999988653  67889999999999999997 8888854321        112223332222211    


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        +..++..+.+++.+||+.+|++|||++++++.|++
T Consensus       221 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 --PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              12345688999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.9e-41  Score=307.61  Aligned_cols=239  Identities=23%  Similarity=0.281  Sum_probs=191.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      |++.+.||+|+||.||+|... ++..||+|++.....    ..+.+..|..++..+ +|++|+.+++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566789999999999999866 677999999875422    224566777887777 58999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+.+.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          82 YVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999988873    235688999999999999999999998   9999999999999999999999999998743322


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......        .....+.... .   
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~-~---  218 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN-V---  218 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C---
Confidence            11  12345689999999999764  7889999999999999999999999754321        1122222211 1   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                         ..+..++.++.+++.+||+.||.+|++.
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               1123456788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-40  Score=300.73  Aligned_cols=257  Identities=26%  Similarity=0.424  Sum_probs=201.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|..+      ++..+|+|.+......  ..++.+|+.+++.++||||+++++++.++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            35667799999999999999853      4678999998754332  356889999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          137 LVYEYMPNGSLDRHVFPKE------------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      ++|||+++++|.+++....                  .....+++..++.++.|++.||+|||++   +++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            9999999999988885321                  1123578889999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCc
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATR  277 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~  277 (373)
                      +++.++.++|+|||++.................+..|+|||.+.+.  .++.++|||||||++|+|++ |..||......
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999998754333221112223356679999988664  78889999999999999997 77787543221


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                              ........+.....      +..++..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       240 --------~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 --------EVIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             --------HHHHHHhcCCCCCC------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                    12222332222211      12345679999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.2e-40  Score=291.75  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=201.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |.+.+.||+|++|.||+|..+ ++..|++|.+....   .....+.+|+.+++.++|||++++++++.+....+++|||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            456788999999999999875 68899999987543   23467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++...  .+..+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          82 ENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            999999988543  245688999999999999999999998   999999999999999999999999999886543322


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....|++.|+|||...+.  .++.++|+||||+++|+|++|+.||......        ........+...     
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-----  219 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIRGVFP-----  219 (256)
T ss_pred             h--hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC-----
Confidence            1  1234588899999998764  6788999999999999999999999754421        111222222211     


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       ..+..++..+.+++.+||+.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             1222456789999999999999999999999873

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-40  Score=292.89  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=196.3

Q ss_pred             cccCCCCcEEEEEEEEc-C---CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-T---GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ++||+|+||.||+|.+. +   +..+|+|.+.....  ..+++.+|+.+++.+.|+|++++++++. ....+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999754 2   26899999887655  3467889999999999999999999876 4567999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999998843    34689999999999999999999998   99999999999999999999999999998664333221


Q ss_pred             -eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          225 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                       ......++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......        .....+.......    
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  218 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERLP----  218 (257)
T ss_pred             ccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcCC----
Confidence             11122245679999988654  68889999999999999998 89998654321        1222222222211    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                        .+..++..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              1223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.3e-40  Score=306.29  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=201.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeee-CC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSE-GS  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~  133 (373)
                      ..+|++.+.||+|+||.||+|..      .+++.||||+++.....  ...+.+|+.++..+ +||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            34678899999999999999973      25678999999764332  35678999999999 68999999998765 45


Q ss_pred             eeEEEEeccCcCCccccccCCCC---------------------------------------------------------
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES---------------------------------------------------------  156 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  156 (373)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999888743211                                                         


Q ss_pred             ------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeeccc
Q 048542          157 ------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR  230 (373)
Q Consensus       157 ------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  230 (373)
                            ....+++..+..++.|+++||+|||++   +++||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  012467888899999999999999998   99999999999999999999999999987653332222222234


Q ss_pred             CCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHH
Q 048542          231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI  309 (373)
Q Consensus       231 gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (373)
                      ++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......       ........+.....+      ...
T Consensus       243 ~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~------~~~  307 (343)
T cd05103         243 LPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAP------DYT  307 (343)
T ss_pred             CCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HHHHHHhccCCCCCC------CCC
Confidence            56789999988654  67889999999999999997 888886543211       122222232222221      123


Q ss_pred             HHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       310 ~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            4578999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-40  Score=295.95  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=190.4

Q ss_pred             cccCCCCcEEEEEEEEcC---CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQT---GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||+|...+   ...+++|.+......  ...+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            468999999999997543   346888877644322  256789999999999999999999999999999999999999


Q ss_pred             CccccccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          146 SLDRHVFPKESR-GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       146 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      +|.+++...... ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999988544321 23356778889999999999999998   99999999999999999999999999986543322222


Q ss_pred             eeecccCCCCcccccccccc-----cCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          225 SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ......++..|+|||++...     ...++.++|||||||++|+|++ |..||......       ........ .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~-~~~~~  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVR-EQDIK  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhh-ccCcc
Confidence            22233466789999987431     1256789999999999999999 67777543221       11111111 11111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .+. ...+..++..+.+++..|| .||++|||+++|++.|.
T Consensus       230 ~~~-~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPK-PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC-CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111 1222345667788999999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.2e-40  Score=299.46  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=197.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-----------------CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-----------------TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL  125 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~  125 (373)
                      .+|++.+.||+|+||.||++...                 ++..+|+|.+.....  ...++.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            35678899999999999998532                 234689999875432  23678899999999999999999


Q ss_pred             eeEeeeCCeeEEEEeccCcCCccccccCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKES-------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                      ++++..+...+++|||+++++|.+++.....       ....+++..+..++.|++.||+|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            9999999999999999999999988854321       123477889999999999999999998   999999999999


Q ss_pred             eeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc--CCCCCCCCcC
Q 048542          199 LLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNAT  276 (373)
Q Consensus       199 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~--g~~p~~~~~~  276 (373)
                      +++.++.++|+|||++................++..|+|||...+.  .++.++|+|||||++|+|++  |..||.....
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC--CccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999998765433221112223346789999987653  78899999999999999998  6667653322


Q ss_pred             ccccccchHHHHHHHhcC-CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          277 RSSKAYFPSWVYDQLNKG-GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ...   . .......... .....+    .+..++..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       240 ~~~---~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQV---I-ENTGEFFRDQGRQVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH---H-HHHHHHHhhccccccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            110   0 0000111111 111111    11223467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.1e-40  Score=297.18  Aligned_cols=255  Identities=26%  Similarity=0.448  Sum_probs=200.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CC---ceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TG---GLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..+++.+.||+|+||.||+|... ++   ..||+|.+.....  ...++..|+.+++.++||||+++++++.++...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45678899999999999999865 33   3599999876432  236789999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++...   ...+++..+..++.|++.|+.|||++   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999888432   34588999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCceeeeccc---CCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          219 KENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       219 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ............   .+..|+|||.+.+.  .++.++||||+||++|||++ |..||.......        ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQD  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcC
Confidence            322211111111   24579999998754  77889999999999999886 999986543211        11222222


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .....      +..++..+.+++.+||+.+|.+||++++++..|+..
T Consensus       228 ~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLPP------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCCC------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111      123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-40  Score=304.14  Aligned_cols=260  Identities=26%  Similarity=0.445  Sum_probs=200.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCc--eeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGG--LIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  135 (373)
                      +....|++.+.||+|+||.||+|.++ ++.  .+++|.++....  ....+.+|+.++.++ +|+||+++++++..+...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            34456778899999999999999865 444  457777664322  235788899999999 899999999999999999


Q ss_pred             EEEEeccCcCCccccccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC
Q 048542          136 ALVYEYMPNGSLDRHVFPKE------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  203 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~  203 (373)
                      +++|||+++++|.+++....            .....+++..+..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence            99999999999998885332            1234688999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccccc
Q 048542          204 FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  282 (373)
Q Consensus       204 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~  282 (373)
                      +.+||+|||++......   .......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......    
T Consensus       161 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----  231 (303)
T ss_pred             CcEEeCccccCcccchh---hhcccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChHH----
Confidence            99999999998632111   111112245679999988654  67889999999999999998 999886443211    


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          .......+.....      +...+..+.+|+.+||+.+|++||+++++++.|+.++.
T Consensus       232 ----~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 ----LYEKLPQGYRLEK------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             ----HHHHHhcCCcCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                1222222211111      12235678999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.8e-40  Score=294.00  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      |++.+.||.|+||.||++... +++.+|+|.++...  ...+.+.+|+.+++.++|+||+++++.+..+...+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            567789999999999999866 78899999886433  234678889999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  .+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+.........
T Consensus        82 ~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          82 GGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99998877432  345688999999999999999999998   9999999999999999999999999998765433221


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||......       . .......+....     
T Consensus       157 --~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~-----  219 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSWK-------N-LILKVCQGSYKP-----  219 (255)
T ss_pred             --cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCHH-------H-HHHHHhcCCCCC-----
Confidence              2234588899999998764  6788999999999999999999999643321       1 111222222111     


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       .+..++..+.+++.+||+.||++|||+.+++..
T Consensus       220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             123345678999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4e-40  Score=295.15  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=201.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-C---CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-T---GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|.+. +   +..+|+|.++.....  .+.+.+|+.+++.++||||+++++++..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778899999999999999864 2   237999998764332  35788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999988432   34588999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          219 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       219 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....... .....++..|+|||.+.+.  .++.++|+||||+++|++++ |..||.......        ....+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            4322111 1122235679999998764  68889999999999999886 999986543211        1122222211


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...      +..++..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       228 ~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPA------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCC------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            111      123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.9e-40  Score=290.55  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=196.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      +.||+|+||.||+|...++..+|+|.+......  ...+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999999888889999998764332  346889999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeec
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (373)
                      +++...   ...+.+..+..++.+++.||.|+|+.   +++|+||||+||+++.++.+||+|||++........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~  153 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL  153 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence            887432   34578999999999999999999998   999999999999999999999999999875432211 11112


Q ss_pred             ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ..++..|+|||.+.+.  .++.++||||||+++|++++ |..||......        ........+.....      +.
T Consensus       154 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~------~~  217 (250)
T cd05085         154 KQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSC------PQ  217 (250)
T ss_pred             CCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCC------CC
Confidence            2345679999998654  67889999999999999998 88898654321        12222222222211      12


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            24568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.4e-40  Score=296.08  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=201.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeC--Cee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~  135 (373)
                      ..|++.+.||+|+||.||++..     .++..||+|.++....  ....+.+|+.+++.++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567789999999999999974     2577899999875432  236788999999999999999999998765  568


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999887322   23588999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcc-------ccccchHHH
Q 048542          216 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-------SKAYFPSWV  287 (373)
Q Consensus       216 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~  287 (373)
                      ......... ......++..|+|||.+.+.  .++.++|||||||++|+|++++.|........       .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            664433221 12234467789999988664  67889999999999999999877653321110       000001111


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ......+....      .+..++..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus       236 ~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRLP------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccCC------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11222222111      1123467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.6e-40  Score=306.15  Aligned_cols=241  Identities=25%  Similarity=0.321  Sum_probs=188.5

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHH-HhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ +++.||+|++.....    ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46899999999999876 677899999875322    1233444444 56778999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++.    ....+.+..+..++.|+++||.|||+.   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 ~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--  151 (325)
T cd05602          81 GELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--  151 (325)
T ss_pred             CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence            99988883    345678888999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||++.+.  .++.++||||+||++|+|++|..||.......        ....+.... .      .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~-~------~  214 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKP-L------Q  214 (325)
T ss_pred             CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCC-c------C
Confidence            12345699999999998764  78889999999999999999999997543211        111111111 1      1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .+..++..+.+++.+||+.||.+||++.+.+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            112346678999999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.7e-40  Score=301.05  Aligned_cols=261  Identities=20%  Similarity=0.268  Sum_probs=187.8

Q ss_pred             hcccCCCCcEEEEEEEEc---CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee--CCeeEEEEeccCc
Q 048542           70 THKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEYMPN  144 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~  144 (373)
                      .++||+|+||.||+|..+   ++..+|+|.+..... ...+.+|+.+++.++||||+++++++..  +...+++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999865   467899999876443 3457789999999999999999998854  456889999985 


Q ss_pred             CCccccccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee----eCCCceEEeeccCcc
Q 048542          145 GSLDRHVFPKE-----SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  215 (373)
Q Consensus       145 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~~~  215 (373)
                      ++|.+++....     .....+++..+..++.|++.||.|||++   +++||||||+|||+    +.++.+||+|||++.
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            47766653221     1234588999999999999999999998   99999999999999    456789999999998


Q ss_pred             cCCCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc--cchHHHHHHHh
Q 048542          216 FHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--YFPSWVYDQLN  292 (373)
Q Consensus       216 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~  292 (373)
                      ....... ........||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||..........  ...........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            6543221 1122345689999999998763 357889999999999999999999997544321110  00000000000


Q ss_pred             cCCCc------------------------ccC--cc----chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDL------------------------ELQ--NV----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~------------------------~~~--~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....                        ...  ..    .......+..+.+|+.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000                        000  00    0000011245789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.6e-40  Score=294.27  Aligned_cols=255  Identities=28%  Similarity=0.442  Sum_probs=200.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCc---eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGG---LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..++..+.||+|+||.||+|..+ +++   .+|+|.++....  ..+++.+|+.+++.++|||++++.+++......+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            35566789999999999999865 333   699999876432  236788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999888843   235688999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          219 KENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       219 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....... ......+..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~~  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGFR  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCCC
Confidence            3222111 1112234579999998764  67889999999999999997 99998643321        12222222221


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...      +..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~~------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 LPA------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111      112356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-40  Score=301.31  Aligned_cols=258  Identities=24%  Similarity=0.426  Sum_probs=200.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCc--eeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGG--LIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|++.+.||+|+||.||+|..+ ++.  .+++|.++....  ..+.+.+|+.++.++ +||||+++++++......++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            4677899999999999999875 333  468888774322  235788999999999 7999999999999989999999


Q ss_pred             eccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          140 EYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                      ||+++++|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence            99999999988843221            123588999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++......   ........+..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        
T Consensus       160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------  226 (297)
T cd05089         160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------  226 (297)
T ss_pred             ECCcCCCccccce---eccCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence            9999998632211   111112235579999988654  67889999999999999997 999986543211        


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .......+.....      +..++..+.+|+.+||+.+|.+|||++++++.|+.+....
T Consensus       227 ~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 LYEKLPQGYRMEK------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHhcCCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1222222222111      1234567899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-39  Score=294.24  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=195.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +++.+.||+|+||.||+|... +++.||+|.+......  ..++.+|+.++++++||||+++++.+......+++|||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            466789999999999999864 7889999998654322  3568899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|..+        ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--  149 (279)
T cd06619          83 GGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--  149 (279)
T ss_pred             CCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence            9988543        2467888899999999999999998   99999999999999999999999999987543321  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||........... .................   
T Consensus       150 --~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---  221 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-PLQLLQCIVDEDPPVLP---  221 (279)
T ss_pred             --ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-hHHHHHHHhccCCCCCC---
Confidence              2234689999999998764  678899999999999999999999975432221111 11111111111111111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        ....+.++.+++.+||+.+|++||+++++++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              11235578999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-40  Score=312.30  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=194.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----eeEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAL  137 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~l  137 (373)
                      +++.+.||+|+||.||++... +++.||+|.+.....   ...++.+|+.+++.++|+||+++++++....     ..|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            356789999999999999865 789999999865322   2357889999999999999999999997766     7899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |+||+. ++|.+.+.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        82 v~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          82 VTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             Eeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            999996 57776662    345689999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc---------hHH--
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---------PSW--  286 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~---------~~~--  286 (373)
                      ..... .......++..|+|||.+.+. ..++.++||||+||++|+|++|+.||...........+         ..+  
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            32221 112334578899999998764 35788999999999999999999999755422100000         000  


Q ss_pred             ----HHHHHhcC-CCcc-cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          287 ----VYDQLNKG-GDLE-LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       287 ----~~~~~~~~-~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ....+... .... ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                00001000 0000 00000111223567899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.2e-40  Score=302.91  Aligned_cols=236  Identities=25%  Similarity=0.342  Sum_probs=185.8

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHH-HhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|+.. +++.||+|++.....    ....+..|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999976 678999999875322    1234455554 57888999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|...+.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  151 (321)
T cd05603          81 GELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--  151 (321)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence            99987773    345688899999999999999999998   999999999999999999999999999875322211  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......       . ....+.... ..      
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~~-~~------  214 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-------Q-MYDNILHKP-LQ------  214 (321)
T ss_pred             ccccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCHH-------H-HHHHHhcCC-CC------
Confidence            12345689999999998764  6888999999999999999999999754321       1 112222111 11      


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      .+...+..+.+++.+||+.||.+||+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1123356789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=308.43  Aligned_cols=265  Identities=25%  Similarity=0.356  Sum_probs=210.2

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      +-.....+.++||+|-||.|.+|....+.+||+|+++.....  ..+|.+|+++|.+++||||+.++|+|..++.+++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            334445677999999999999999887899999999875443  378999999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||++|+|..++..++-..  +..+....|+.||+.|++||.+.   ++||||+.+.|+|+++++++||+|||+++.+-.
T Consensus       615 EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence            9999999999996553222  34455667999999999999998   999999999999999999999999999986655


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc--CCCCCCCCcCccccccchHHHHHHHhcCC-C
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG--GRRNSNMNATRSSKAYFPSWVYDQLNKGG-D  296 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  296 (373)
                      .+.+.......-+.+|||+|.+..  ++++.++|||+||+.+||+++  ...||.....++        +.+...... .
T Consensus       690 g~yy~vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------vven~~~~~~~  759 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------VVENAGEFFRD  759 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------HHHhhhhhcCC
Confidence            544444344556789999998865  489999999999999999975  556776443321        222211110 0


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ....-....|..++..+.+++.+||+.|-++|||++++...|...
T Consensus       760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111111233455677899999999999999999999999988753

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.9e-40  Score=306.09  Aligned_cols=258  Identities=21%  Similarity=0.232  Sum_probs=192.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCC------
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------  133 (373)
                      ...|++.+.||+|+||.||++... +|..||+|.+.....   ....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            456788899999999999999865 688999999875422   2356789999999999999999999886443      


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..|+||||+++ +|...+      ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus       100 ~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876         100 DVYLVMELMDA-NLCQVI------HMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             eeEEEEeCCCc-CHHHHH------hccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence            47999999965 555544      13478888999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc-----------c
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-----------Y  282 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~-----------~  282 (373)
                      +.......   ......||..|+|||.+.+.  .++.++||||+||++|+|++|+.||..........           .
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  244 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE  244 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence            87543221   12334689999999999764  78889999999999999999999997543211000           0


Q ss_pred             c----hHHHHHHHhcCCCcc------------cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 F----PSWVYDQLNKGGDLE------------LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 ~----~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +    ...............            .+.........+..+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0    000000000000000            00001111223567899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.9e-40  Score=296.74  Aligned_cols=262  Identities=25%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ....|++.+.||+|+||+||++... ++..||+|++.....  ..+++.+|+.+++.++||||+++++++......++||
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            3457788899999999999999865 688899998765432  2467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    ....+++..+..++.+++.||.|||+.  .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          83 EFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             ecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999988773    235689999999999999999999962  2899999999999999999999999999864422


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..    .....|+..|+|||.+.+.  .++.++|+|||||++|+|++|..||............................
T Consensus       157 ~~----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd06620         157 SI----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP  230 (284)
T ss_pred             hc----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence            21    1234688999999998654  77889999999999999999999998654322111111111111111111111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      ....  ...++..+.+|+.+||+.||++|||++|+++..
T Consensus       231 ~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1000  012456789999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-40  Score=289.55  Aligned_cols=266  Identities=22%  Similarity=0.269  Sum_probs=212.7

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ..+-....++.+.||+|.-|+||+++.+ ++..+|+|++.+....    ..+...|-++|..++||.++.+|..++.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            3344556678899999999999999977 5689999999875443    2556779999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|++||||+||+|+.+...  +.+..+++..++-++..++-||+|||..   |||.|||||+|||+.++|++-|+||.++
T Consensus       152 ~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             eEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccc
Confidence            9999999999999888744  4467799999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCC---------------------------------CC---------------------ceeeecccCCCCcccccc
Q 048542          215 KFHPKE---------------------------------ND---------------------FVSISATRGTIGYIAPEL  240 (373)
Q Consensus       215 ~~~~~~---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~  240 (373)
                      ......                                 ..                     .......+||-.|+|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            532110                                 00                     011223469999999999


Q ss_pred             cccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhh
Q 048542          241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWC  320 (373)
Q Consensus       241 ~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  320 (373)
                      +.|.  ..+.++|+|+||+++|||+.|..||.+....+.       ....+.+  .+.++...    .++..+++||++.
T Consensus       307 I~G~--GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------l~NIv~~--~l~Fp~~~----~vs~~akDLIr~L  371 (459)
T KOG0610|consen  307 IRGE--GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------LRNIVGQ--PLKFPEEP----EVSSAAKDLIRKL  371 (459)
T ss_pred             eecC--CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------HHHHhcC--CCcCCCCC----cchhHHHHHHHHH
Confidence            9987  557799999999999999999999988776542       1111211  12222221    5677899999999


Q ss_pred             cCCCCCCCCC----HHHHHH--HHhcCCCCC
Q 048542          321 IQVKAADRPS----MTKVLE--MLEGSIDDL  345 (373)
Q Consensus       321 l~~dp~~Rps----~~ell~--~L~~~~~~~  345 (373)
                      |.+||.+|..    +.||-+  +.++..+++
T Consensus       372 LvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             hccChhhhhccccchHHhhcCccccCCChhh
Confidence            9999999998    888754  566766655

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-40  Score=292.62  Aligned_cols=250  Identities=25%  Similarity=0.308  Sum_probs=199.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .|.+.+.||+|++|.||+|... ++..+|+|.+......      ...+.+|+.+++.++||||+++++++.++...+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            3567789999999999999864 6889999988754321      24678899999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +||+++++|.+.+.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          83 MEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999988873    234688899999999999999999998   99999999999999999999999999987553


Q ss_pred             CCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ...... ......++..|+|||.+.+.  .++.++||||+|+++|+|++|+.||......       ............ 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~-  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTN-  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCC-
Confidence            321111 11234578899999999775  5888999999999999999999998654221       111111111111 


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                           ...+..++..+.+++.+||+.+|.+|||+.++++.
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                 12223456688999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=294.38  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=203.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...+++.+.||+|+||.||+|.++ +|.    .+|+|.......  ...++.+|+..++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            356678899999999999999865 333    589998876543  23678899999999999999999999987 7889


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|||+++|+|.+++...   ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999988432   34589999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ..............++..|+|||.+...  .++.++|+||||+++|++++ |..||......        .....+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~  228 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGE  228 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCC
Confidence            6533322222223346689999988653  67889999999999999998 99998654321        1222333332


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+      ...+..+.+++.+||..+|.+||++.++++.|+.+.+
T Consensus       229 ~~~~~------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 RLPQP------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCC------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22221      1233568899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.9e-40  Score=291.34  Aligned_cols=248  Identities=30%  Similarity=0.458  Sum_probs=198.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEe-eeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~~  143 (373)
                      ..+++.+.||+|+||.||++... |..+|+|.++... ..+.+.+|+.+++.++|+|++++++++ ..+...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            45677899999999999999766 7889999886543 356788999999999999999999975 45567899999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......  
T Consensus        84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          84 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999987432  234588999999999999999999998   99999999999999999999999999987543222  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                         ....++..|+|||.+.+.  .++.++|||||||++|+|++ |+.||......        .....+..+....    
T Consensus       157 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~----  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMD----  219 (256)
T ss_pred             ---CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhcCCCCC----
Confidence               122355689999998664  67889999999999999997 88887643221        1122222222211    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        .+..++..+.+++.+||+.+|++|||++++++.|+.
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              112345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.8e-40  Score=292.53  Aligned_cols=253  Identities=22%  Similarity=0.267  Sum_probs=198.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|.+.+.||+|+||.||+|... ++..||+|.++..... ...+.+|+.+++.++||||+++++.+......+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            36778899999999999999865 6889999998765332 356788999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.    ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....... 
T Consensus        89 ~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          89 GGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999998873    345689999999999999999999998   99999999999999999999999999987553221 


Q ss_pred             ceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                       .......|+..|+|||.+.. ..+.++.++|+||+||++|+|++|..||.......       .............  .
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-------~~~~~~~~~~~~~--~  230 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-------ALFLMTKSNFQPP--K  230 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-------hHHhhhccCCCCC--c
Confidence             11234468999999998742 12357889999999999999999999986543211       0111111111111  0


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ... ...++..+.+++.+||+.+|++|||++++++
T Consensus       231 ~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000 1124557899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-40  Score=293.30  Aligned_cols=250  Identities=27%  Similarity=0.453  Sum_probs=194.1

Q ss_pred             cccCCCCcEEEEEEEEc-CCc--eeEEEEeccCc--cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGG--LIAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~--~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|..+ ++.  .+++|.++...  ...+.+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            35899999999999876 343  46888887532  2336788999999999 799999999999999999999999999


Q ss_pred             CCccccccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          145 GSLDRHVFPKE------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       145 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ++|.+++....            .....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99998885432            1223578999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      ++......   ........+..|+|||.+.+.  .++.++|+||||+++|+|++ |..||......        ......
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~  224 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKL  224 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHH
Confidence            98532111   111112345679999988654  67889999999999999997 99998643321        112222


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ..+......      ...+..+.+++.+||+.+|.+|||+.+++..|+.++
T Consensus       225 ~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCCCCCCCC------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            222222111      223457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-39  Score=292.38  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=188.7

Q ss_pred             cccCCCCcEEEEEEEEcCCc---eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQTGG---LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||+|+||.||+|...++.   .+++|.+.....  ..+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            36999999999999755433   456676654332  3467899999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|.+++..........++..+..++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99998854433334567778889999999999999998   999999999999999999999999999864322211111


Q ss_pred             eecccCCCCcccccccccc-----cCCcCcccchHHHHHHHHHHHcC-CCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          226 ISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      .....++..|+|||.+...     ...++.++||||||+++|+|+++ ..||......       ......... .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~-~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIKD-QQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhh-ccccc
Confidence            2344578899999987532     12356789999999999999975 5566432211       111111111 11111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .. ......++..+.+++..|| .+|++||+++++++.|.
T Consensus       230 ~~-~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FK-PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC-CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11 1112234567888999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.4e-40  Score=304.70  Aligned_cols=239  Identities=23%  Similarity=0.289  Sum_probs=190.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +++.+.||+|+||.||+|..+ +|+.||+|++....    ...+.+..|..++..+. |++|+++++++......|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            456789999999999999865 68899999987532    22345678888888875 5778889999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        82 y~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999988873    345689999999999999999999998   9999999999999999999999999998753222


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......||+.|+|||.+.+.  .++.++|+||+||++|+|++|..||......        .....+.... .   
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~-~---  218 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHN-V---  218 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-C---
Confidence            11  12334589999999998764  6788999999999999999999999754321        1122222211 1   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                         ..+..++..+.+++.+||+.+|.+|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               1223345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-39  Score=300.48  Aligned_cols=263  Identities=16%  Similarity=0.229  Sum_probs=194.0

Q ss_pred             hhcccCCC--CcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           69 FTHKLGQG--GFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        69 ~~~~ig~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +.+.||+|  +|++||++..+ +|+.||+|.++.....   .+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78899999865 7899999999765332   245778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++....  ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999884332  24588999999999999999999998   999999999999999999999999986543221111


Q ss_pred             ce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-----ccchH------H
Q 048542          223 FV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-----AYFPS------W  286 (373)
Q Consensus       223 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-----~~~~~------~  286 (373)
                      ..     ......++..|+|||.+.+....++.++|||||||++|+|++|+.||.........     ...+.      .
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            00     01123466789999998764346788999999999999999999999743221100     00000      0


Q ss_pred             HHHHHh-----cCCCc---------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          287 VYDQLN-----KGGDL---------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       287 ~~~~~~-----~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......     .+...               ...........++..+.+|+.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000000     00000               000001122345678999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-39  Score=294.37  Aligned_cols=262  Identities=28%  Similarity=0.432  Sum_probs=197.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-----CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeee--CCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l  137 (373)
                      .+++.+.||+|+||.||++..+     ++..||+|.+...... .+.+.+|+.+++.++||||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            4567799999999999999742     5778999998765432 3678899999999999999999998743  346889


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999988422   34588999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCceee-ecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc-----c---ccchHHHH
Q 048542          218 PKENDFVSI-SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-----K---AYFPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-----~---~~~~~~~~  288 (373)
                      ......... ....++..|+|||.+.+.  .++.++|+||||+++|+|++|..|+........     .   ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            443322111 112234569999998654  678899999999999999998876543221100     0   00001111


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      +.+.......      .+..++..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLP------APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCC------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1122221111      1123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=9.3e-40  Score=290.62  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=202.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .|++.+.||+|+||.||+|... ++..+++|.+..... .+++.+|+..++.++||||+++++++..+...++++||+++
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            5677889999999999999976 478999999876543 67899999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++..   .+..+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus        83 ~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          83 GSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            999988732   245689999999999999999999998   999999999999999999999999999886543321  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||........        ..........    ...
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~----~~~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--------IFMIPNKPPP----TLS  220 (256)
T ss_pred             ccccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--------hhhhccCCCC----CCC
Confidence            12234478899999998765  678899999999999999999999875432211        0001111111    111


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+..++..+.+++.+||+.||++|||++++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            22345678999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-40  Score=298.58  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=197.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |+..+.||+|+||.||++... +++.||+|.+......    ...+.+|+.+++.++|+|++.+++.+.+....+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            456688999999999999865 7889999998754322    24567899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999988874322  34588999999999999999999998   99999999999999999999999999987543322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .   .....|+..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.........    .......... .     
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~----~~~~~~~~~~-~-----  221 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEV-Q-----  221 (285)
T ss_pred             c---ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH----HHHHhhhhhh-h-----
Confidence            1   1234689999999998764  6888999999999999999999999754322110    0011111100 0     


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                       ...+..++..+.+|+.+||+.||++|||     ++|+++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence             1112334567899999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-39  Score=290.11  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=185.6

Q ss_pred             cccCCCCcEEEEEEEEcC-------------CceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           71 HKLGQGGFGSVYKGQLQT-------------GGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      +.||+|+||.||+|...+             ...+++|.+...... ...+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997532             225888987654433 256788999999999999999999999988999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc-------eEEe
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-------PKVS  209 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~-------~kl~  209 (373)
                      ++|||+++++|..++..   ....+++..+..++.|+++||+|||++   +++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999877632   235689999999999999999999998   9999999999999986654       8999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHH-cCCCCCCCCcCccccccchHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll-~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      |||++......      ....++..|+|||.+... ..++.++|||||||++|+|+ .|..|+.......        ..
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~  219 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KE  219 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HH
Confidence            99998654322      233478889999988632 46788999999999999998 5777765432111        11


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                       ....... ..  .    ...+..+.+|+.+||+.||.+||++.++++.|+
T Consensus       220 -~~~~~~~-~~--~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 -RFYEGQC-ML--V----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -HHHhcCc-cC--C----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             1111110 00  0    112357899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.7e-40  Score=328.24  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=200.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +|++.++||+|+||.||+|.+. +++.||+|++.....    ..+++.+|+.+++.++||||+++++++.+++..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4677899999999999999865 688999999875422    23578899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          141 YMPNGSLDRHVFPKE-------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~-------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      |+++++|.+++....       ......++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence            999999988874321       1123456678889999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCc----------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc
Q 048542          214 AKFHPKENDF----------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR  277 (373)
Q Consensus       214 ~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~  277 (373)
                      +.........                .......||+.|+|||.+.+.  .++.++||||+||++|+|++|..||......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            9765211100                001124599999999998765  6788999999999999999999999753321


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCC
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSID  343 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~  343 (373)
                      ..       ...    ......... .....++..+.+++.+||+.||++|| +++++++.|+..+.
T Consensus       238 ki-------~~~----~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 KI-------SYR----DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hh-------hhh----hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            10       000    000000000 00123456788999999999999995 67888888876544

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-39  Score=296.52  Aligned_cols=247  Identities=26%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +|.+.+.||.|+||.||+|... +++.+++|.+...... .+.+.+|+.+++.++|+|++++++.+..+...++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            5667789999999999999864 6889999988764433 4678899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.     ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus       101 ~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            999998873     23578899999999999999999998   9999999999999999999999999998754332211


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....+++.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......       ...... ........   
T Consensus       173 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~-~~~~~~~~---  237 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIA-TNGTPELQ---  237 (296)
T ss_pred             --cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHh-cCCCCCCC---
Confidence              1234588899999998764  67889999999999999999999997544311       111111 11111111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .+..++..+.+++.+||+.+|++|||++++++
T Consensus       238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             12345667899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.4e-40  Score=293.96  Aligned_cols=251  Identities=25%  Similarity=0.436  Sum_probs=196.6

Q ss_pred             cccCCCCcEEEEEEEEcC-------CceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQT-------GGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.||+|+||.||+|..++       +..+|+|.+....  .....+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998642       2578999886543  2346788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-----ceEEeeccC
Q 048542          142 MPNGSLDRHVFPKES---RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-----IPKVSDFGL  213 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-----~~kl~Dfg~  213 (373)
                      +++++|.+++.....   ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999998854321   234578899999999999999999998   999999999999999877     899999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHh
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      +................++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~  227 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHVT  227 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHHh
Confidence            8755433221111223456789999998764  78899999999999999998 898886433211        112222


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      .+....      .+..++..+.+++.+||+.+|.+||+++++++.|+.
T Consensus       228 ~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         228 AGGRLQ------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cCCccC------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            222111      123346788999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-39  Score=287.73  Aligned_cols=247  Identities=27%  Similarity=0.456  Sum_probs=196.6

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      ++||.|+||.||++...+++.||+|.+......  ...+.+|+.+++.++|+||+++++++.+....+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999999777999999998765443  467889999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeec
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (373)
                      +++...   ...+++..+..++.+++.|+.|||++   +++||||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            887432   34578899999999999999999998   999999999999999999999999999875542211111112


Q ss_pred             ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ..++..|+|||.+.+.  .++.++|+||||+++|+|++ |..||.......        ............      .+.
T Consensus       155 ~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~~~~~------~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESGYRMP------APQ  218 (251)
T ss_pred             CcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcCCCCC------CCc
Confidence            2245679999988654  67889999999999999999 777775543211        112222221111      122


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..+..+.+++.+||+.+|++|||++|+++.|+
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            34567999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-40  Score=305.48  Aligned_cols=257  Identities=22%  Similarity=0.262  Sum_probs=191.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC------Ce
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~  134 (373)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            46778899999999999999865 778999999875432   235677899999999999999999987543      34


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++++++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence            68999988 778877662     34689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWV  287 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~  287 (373)
                      ......     .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||............       ....
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            865432     1234689999999998653 36788999999999999999999999754321100000       0000


Q ss_pred             HHHH---------hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 YDQL---------NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ~~~~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...+         ..................+..+.+|+.+||+.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000         000000000000111122345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-39  Score=292.08  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=198.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeC------CeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG------SKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~------~~~~  136 (373)
                      ..|++.+.||+|+||.||+|... +++.+|+|.+.........+.+|+.+++.+ +|+|++++++++...      ...+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            35677789999999999999865 678999999987666667888999999998 699999999998653      4678


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999988432  235688999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......  ......|+..|+|||.+.+.   ...++.++|+||+||++|+|++|..||.......        .......
T Consensus       161 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~~  230 (272)
T cd06637         161 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  230 (272)
T ss_pred             cccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhc
Confidence            432211  12334588999999988532   2357789999999999999999999986433211        0111111


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......     ....++..+.+|+.+||+.+|.+|||++++++
T Consensus       231 ~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 NPAPRL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            111111     11234567899999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.9e-40  Score=306.66  Aligned_cols=258  Identities=21%  Similarity=0.223  Sum_probs=192.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC------Ce
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~  134 (373)
                      .+|++.+.||+|+||.||++... +++.+|+|.+......   ...+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            46778899999999999999865 6889999998754322   35677899999999999999999988543      35


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++|||+++ ++.+.+      ...+++..+..++.|+++||.|||++   +++||||||+|||++.++.+||+|||++
T Consensus        97 ~~lv~e~~~~-~l~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          97 VYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             eEEEhhhhcc-cHHHHH------hhcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence            7999999965 565555      13478889999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc--------cch--
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFP--  284 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~--------~~~--  284 (373)
                      .......   ......||..|+|||.+.+.  .++.++|||||||++|+|++|+.||..........        ..+  
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         167 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccCCCcc---ccCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            7543322   12334689999999998764  68889999999999999999999997543211000        000  


Q ss_pred             -----HHHHHHHhcCCCc---c---------cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          285 -----SWVYDQLNKGGDL---E---------LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       285 -----~~~~~~~~~~~~~---~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                           .............   .         .+.....+...+..+.+|+.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                 0000011100000   0         000011122235678999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-39  Score=290.36  Aligned_cols=247  Identities=29%  Similarity=0.452  Sum_probs=196.6

Q ss_pred             cccCCCCcEEEEEEEEcC--Cc--eeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQT--GG--LIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|++|.||+|.+.+  +.  .+|+|.+.....  ..+++.+|+.+++.++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998653  22  589999987655  34678899999999999999999999988 889999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++.....  ..+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.+||+|||++..........
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999998854321  4689999999999999999999998   99999999999999999999999999998664432221


Q ss_pred             -eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHh-cCCCcccCc
Q 048542          225 -SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLN-KGGDLELQN  301 (373)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  301 (373)
                       ......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ...... ......   
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~---  221 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------ILKKIDKEGERLE---  221 (257)
T ss_pred             ecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhcCCcCC---
Confidence             11234477889999988764  67889999999999999998 999986433211        111111 111111   


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                         .+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       222 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               11234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.5e-40  Score=299.51  Aligned_cols=254  Identities=22%  Similarity=0.311  Sum_probs=196.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      |++.+.||+|+||.||++.+. ++..+|+|.+.....  ...++.+|+++++.++||||+++++++.++...+++|||++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~   82 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD   82 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence            567789999999999999865 678899998875422  23568899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.    +...+++..+..++.|+++||.|||+.  .+++|+||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  154 (308)
T cd06615          83 GGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  154 (308)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc--
Confidence            999999883    235688999999999999999999972  289999999999999999999999999986543221  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH-----------------
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-----------------  286 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-----------------  286 (373)
                        .....++..|+|||.+.+.  .++.++|+||||+++|+|++|+.||...........+...                 
T Consensus       155 --~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             --cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence              1234688999999998664  6788999999999999999999998643321100000000                 


Q ss_pred             -----------HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          287 -----------VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       287 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                                 ..........+..+     ...++..+.+++.+||+.+|++|||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLP-----SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCc-----CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       00000000000000     01245679999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.7e-40  Score=295.94  Aligned_cols=262  Identities=23%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |.+.+.||+|++|.||+|..+ ++..||+|.+.....   ....+.+|+.+++.++|||++++++++.++...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            566789999999999999875 688999999865422   2367789999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++.... .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          82 S-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             C-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            6 57877764322 235689999999999999999999998   999999999999999999999999999875433221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc---------chHHH----HH
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY---------FPSWV----YD  289 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~---------~~~~~----~~  289 (373)
                        ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........         ...|.    ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              12233578899999988653 3567899999999999999999999875432110000         00000    00


Q ss_pred             HHhcCC-CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          290 QLNKGG-DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       290 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...... .............++.++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000 00000001111235678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=306.05  Aligned_cols=251  Identities=25%  Similarity=0.419  Sum_probs=206.6

Q ss_pred             hhhcccCCCCcEEEEEEEEc---CCc--eeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ---TGG--LIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~---~~~--~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+.+.||.|-||.||+|...   .|+  .||||..+.+.  .+.+.|+.|..+|++++||||++++|+|.+ ...++|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            45588999999999999854   233  58999887643  345889999999999999999999999986 57899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      .++-|.|..++.   .+...++......++.||+.||+|||+.   .+|||||..+|||+.....+||+|||+++++.+.
T Consensus       471 L~~~GELr~yLq---~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  471 LAPLGELREYLQ---QNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             cccchhHHHHHH---hccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999994   3446688888899999999999999998   9999999999999999999999999999988776


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..+... ...-+..|||||.+.-  ..++.++|||.||+.+||++. |..||..-.+..        +...+++|.++  
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iEnGeRl--  611 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIENGERL--  611 (974)
T ss_pred             chhhcc-ccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEecCCCCC--
Confidence            655443 4446778999998854  489999999999999999985 889987544322        11223344333  


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                          +.|+.++..+..|+.+||..+|.+||++.++...|+.++
T Consensus       612 ----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  612 ----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                344566788999999999999999999999988877543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.4e-40  Score=297.45  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=189.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhccc---CCCceeeEeeEeee-----CCe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCSE-----GSK  134 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----~~~  134 (373)
                      |++.+.||+|+||.||+|..+ +++.||+|.++....   ....+.+|+.+++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            667789999999999999866 788999999875322   223456777777665   69999999998754     345


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++|||+++ +|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             EEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            7899999964 787776432  234589999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-  293 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  293 (373)
                      ........   .....|+..|+|||.+.+.  .++.++||||+||++|+|++|.+||..........    ........ 
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~----~~~~~~~~~  226 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG----KIFDLIGLP  226 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH----HHHHHhCCC
Confidence            76543221   1234578999999998764  68899999999999999999999986543211000    00000000 


Q ss_pred             -------CC-----Cc---ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 -------GG-----DL---ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 -------~~-----~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                             ..     ..   ...........++..+.+++.+||+.||++|||+.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   00     00   000011222345667899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-39  Score=295.36  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=199.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEee-----eCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-----~~~~~~l  137 (373)
                      .+|++.+.||+|+||.||++... +++.+|+|++.........+.+|+.+++.+ +||||+++++++.     .+...++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            35677799999999999999865 678999998876555556788899999999 6999999999873     3456899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +|||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  174 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL  174 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeec
Confidence            9999999999887754333456688999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      .....  ......|+..|+|||.+...   ...++.++||||+||++|+|++|+.||........       . ......
T Consensus       175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~-~~~~~~  244 (286)
T cd06638         175 TSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------L-FKIPRN  244 (286)
T ss_pred             ccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------H-hhcccc
Confidence            43221  12234589999999987532   13578899999999999999999999875432110       0 011111


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ......    .+..++..+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         245 PPPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            111111    112234578999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-40  Score=307.30  Aligned_cols=248  Identities=23%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |++.+.||+|+||.||++..+ +++.||+|+++...    .....+.+|..++..++||||+++++.+.+....++||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            566789999999999999865 68899999987532    2235678899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+++.    +...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.......
T Consensus        83 ~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          83 LPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            99999999883    345689999999999999999999998   99999999999999999999999999987442211


Q ss_pred             Cc---------------------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCC
Q 048542          222 DF---------------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (373)
Q Consensus       222 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~  268 (373)
                      ..                                 .......||+.|+|||++.+.  .++.++|||||||++|+|++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccCC
Confidence            00                                 001134699999999998765  6888999999999999999999


Q ss_pred             CCCCCCcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 048542          269 RNSNMNATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE  336 (373)
Q Consensus       269 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~ell~  336 (373)
                      .||.......        ....+.. ......+..    ..++..+.+|+.+|+ .||.+|++   ++++++
T Consensus       234 ~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQE--------TYRKVMNWKETLVFPPE----VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHHH--------HHHHHHcCCCceecCCC----CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9997544321        1122221 111111111    124567888998876 49999996   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.9e-40  Score=296.05  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=196.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |+..+.||+|+||+||+|... +++.+|+|.+......    ...+.+|+.+++.++|+|++.+++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            445688999999999999865 7889999998754322    24567899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+.+...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            9999998777432  234689999999999999999999998   99999999999999999999999999987543322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .   .....|+..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........    ............      
T Consensus       157 ~---~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~------  221 (285)
T cd05632         157 S---IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE------  221 (285)
T ss_pred             c---ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc------
Confidence            1   2334689999999998764  688899999999999999999999975432110    001111111111      


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                       ...+..++..+.+|+..||+.||++||+     +++++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             0112334567899999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.7e-39  Score=292.03  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.++||.|+||.||+|... ++..+++|.+..... ....+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            46788899999999999999876 588999999875433 2367888999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|...+..   ....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++....... 
T Consensus        92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999776632   234589999999999999999999998   99999999999999999999999999886532221 


Q ss_pred             ceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          223 FVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                       .......++..|+|||.+.+.   ...++.++|+|||||++|+|++|..||......        ..............
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  235 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL  235 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCccC
Confidence             112334588899999988532   234677899999999999999999998654321        11111111111111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ..+..++.++.+++.+||+.||++||+++++++
T Consensus       236 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 ----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                112345567899999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=301.23  Aligned_cols=255  Identities=19%  Similarity=0.205  Sum_probs=195.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||++... +++.||+|++....    .....+.+|..++..++|+||+++++++.++...++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            4677899999999999999865 68899999987522    223557889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          82 YYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             cCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999988832   235688999999999999999999998   9999999999999999999999999998755432


Q ss_pred             CCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          221 NDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ... ......||+.|+|||++.+.   .+.++.++||||+||++|+|++|+.||......       .............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~  227 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHF  227 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCcc
Confidence            221 11234589999999998631   235678999999999999999999999754321       1111111111111


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCC--CCCCHHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAA--DRPSMTKVLEM  337 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~Rps~~ell~~  337 (373)
                      .++..   ...++..+.+++.+|+..++.  .||+++++++.
T Consensus       228 ~~~~~---~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QFPPD---VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCCc---cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11111   122566788999998865433  37899888775

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-40  Score=295.19  Aligned_cols=239  Identities=25%  Similarity=0.363  Sum_probs=185.5

Q ss_pred             ccCCCCcEEEEEEEEcC-------------------------CceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeE
Q 048542           72 KLGQGGFGSVYKGQLQT-------------------------GGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQL  125 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~  125 (373)
                      .||+|+||.||+|.+..                         ...|++|.+...... ...+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         124889988754433 2567889999999999999999


Q ss_pred             eeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-
Q 048542          126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-  204 (373)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-  204 (373)
                      ++++..+...++||||+++|+|..++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999888732   235688999999999999999999998   999999999999997543 


Q ss_pred             ------ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHH-cCCCCCCCCcCc
Q 048542          205 ------IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATR  277 (373)
Q Consensus       205 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll-~g~~p~~~~~~~  277 (373)
                            .+|++|||++......      ....++..|+|||.+.+. ..++.++||||||+++|+|+ +|..||......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence                  4799999987643221      123477889999988653 46788999999999999995 688888654322


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .        ..........  .+      ......+.+++.+||+.+|++|||+.++++.|.
T Consensus       229 ~--------~~~~~~~~~~--~~------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 E--------KERFYEKKHR--LP------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H--------HHHHHHhccC--CC------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1        1111111111  11      112346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=305.75  Aligned_cols=240  Identities=24%  Similarity=0.323  Sum_probs=187.0

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc---CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ||+|+||+||+|... +++.||+|++.....    .......|..++...   .||||+++++.+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999866 688999999865322    123345566666555   699999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+.+.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++........  
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--  151 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--  151 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence            99988773    345689999999999999999999998   999999999999999999999999999875322221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||..|+|||.+.+. ..++.++||||+||++|+|++|..||......        .....+..+. ..++.   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~-~~~~~---  218 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGK-VRFPK---  218 (330)
T ss_pred             CccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCC-CCCCC---
Confidence            12345699999999998653 34788999999999999999999999754321        1222222221 11111   


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRP----SMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rp----s~~ell~  336 (373)
                        ..++..+.+++.+||+.||.+||    ++.++++
T Consensus       219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              12456789999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-40  Score=301.40  Aligned_cols=252  Identities=21%  Similarity=0.280  Sum_probs=200.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc---CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l  137 (373)
                      +....|++.++||+||.+.||++...+.+.||+|.+.....   ...-+.+|+..|.+|+ |.+|+.+++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34567888899999999999999988888899887765333   3467999999999995 8999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||- ..+|...+...   ....+.-.+..+..||+.|+.++|+.   ||||.||||.|+|+ -.|.+||+|||+|..+
T Consensus       438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAI  509 (677)
T ss_pred             Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence            99985 56888888432   22333237788999999999999998   99999999999999 6689999999999988


Q ss_pred             CCCCCceeeecccCCCCcccccccccccC---------CcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFG---------TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ..+.....-...+||+.||+||.+.....         ..+.++||||+||+||+|+.|+.||..-.+          .+
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~  579 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QI  579 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HH
Confidence            87776666667889999999998854211         266789999999999999999999864321          12


Q ss_pred             HHHhcC----CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKG----GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+...    ...+++...+   .  .++.+++..||..||++|||..|+|+
T Consensus       580 aKl~aI~~P~~~Iefp~~~~---~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 AKLHAITDPNHEIEFPDIPE---N--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHhhcCCCccccccCCCC---c--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            222222    2223333222   1  23899999999999999999999987

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-39  Score=291.93  Aligned_cols=258  Identities=27%  Similarity=0.322  Sum_probs=200.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeee--CCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~  141 (373)
                      ++..+.||.|++|.||++... +++.+|+|.+.....  ...++.+|+++++.++||||+++++++.+  ....++||||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            456689999999999999975 688999999876443  33678999999999999999999998854  3468999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999887644333456688999999999999999999998   99999999999999999999999999987543221


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .    ....++..|+|||.+.+.  .++.++|+||+||++|+|++|..||........   .+..............+..
T Consensus       160 ~----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (287)
T cd06621         160 A----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL---GPIELLSYIVNMPNPELKD  230 (287)
T ss_pred             c----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC---ChHHHHHHHhcCCchhhcc
Confidence            1    123478899999988664  778899999999999999999999976533111   1111122222212222221


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ........+..+.+++.+||+.+|.+|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11111234678999999999999999999999988

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.8e-40  Score=298.45  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=196.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|.+.+.||+|+||.||+|..+ +++.||+|.++....  ....+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            5677899999999999999865 678999999875432  3356788999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          87 D-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            6 588777632   234588999999999999999999998   999999999999999999999999999875432221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHH-hcC
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQL-NKG  294 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~-~~~  294 (373)
                        ......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+       ....+... ...
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             --cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence              12234578899999988653 35778999999999999999999999755432100000       00000000 000


Q ss_pred             --CCcccCc-----cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 --GDLELQN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 --~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .....+.     .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0000000     01111234667899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-39  Score=303.54  Aligned_cols=259  Identities=21%  Similarity=0.225  Sum_probs=193.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeC------C
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------S  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~  133 (373)
                      ..+|++.+.||+|+||.||++... +++.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            346788899999999999999865 68899999987532   2235678999999999999999999987543      3


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..|+||||+++ +|.+.+.      ..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            57999999965 6666552      3478888999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------chH
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPS  285 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~  285 (373)
                      +.......   ......+|..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........        .+.
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE  247 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            97653321   12334689999999999764  788899999999999999999999975442110000        000


Q ss_pred             H-------HHHHHhcCCCc------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          286 W-------VYDQLNKGGDL------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       286 ~-------~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      +       ...........            ..+.........+..+.+|+.+||+.||.+|||++++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0       00000000000            0000011111234578999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.8e-39  Score=291.26  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..++.+.+.||+|+||.||+|...+    ...++||.......  ..+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3456778999999999999998643    24689998875432  33678999999999999999999998875 45789


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +|||+++++|.+++...   ...+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999988432   34589999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ...... ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        .......+..
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~  226 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGER  226 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCc
Confidence            443221 11223345689999988654  67889999999999999986 999986544221        1122233222


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ...+      ..++..+.+++.+|+..+|++|||+.++++.|++..+
T Consensus       227 ~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 LPMP------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2211      2345678999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.5e-39  Score=287.09  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=201.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|+||.||.++.. ++..+++|.+.....   ...++.+|+.++++++|+||+++++++.+....+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            667899999999999999854 688999998875432   2356889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++....  ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          82 NGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             CCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999884322  45688999999999999999999998   999999999999999999999999999876543331


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......+++.|.|||.+.+.  .++.++|+||||+++|+|++|..||......       . .......+....    
T Consensus       157 --~~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~----  220 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N-LVVKIVQGNYTP----  220 (256)
T ss_pred             --cccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHcCCCCC----
Confidence              12344588999999998764  5778999999999999999999998653321       1 111222221111    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        .+..++..+.+++.+||+.+|++|||++++++.
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence              113446678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-39  Score=290.57  Aligned_cols=254  Identities=26%  Similarity=0.389  Sum_probs=198.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-----------HHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-----------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      |...+.||.|+||.||+|... +|+.+|+|.++.....           .+.+.+|+.+++.++|||++++++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            456688999999999999865 6889999987642111           2457789999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             eEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999988832    35688999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ................++..|+|||.+......++.++|+||||+++|++++|..||.......       .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------HHHHhhccc
Confidence            7654322222223345888999999987642247889999999999999999999986433211       011111111


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......  ......++..+.+++.+||+.+|++|||++++++
T Consensus       229 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            111111  1222345678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-39  Score=290.99  Aligned_cols=249  Identities=28%  Similarity=0.421  Sum_probs=197.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC-------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      |++.+.||+|+||.||+|...+++.+|+|.++.....       ...+.+|+.+++.++|+||+++++++.+....++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            4567889999999999999888899999988754321       245788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    +...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          82 EFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999883    234688999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC----ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          220 END----FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       220 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ...    ........++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......      . .. ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~-~~-~~~~~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------A-MF-YIGAHR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChHH------H-HH-Hhhhcc
Confidence            111    1112234588999999998764  67889999999999999999999996543211      0 00 111110


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...    ...+..++..+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLM----PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCC----CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000    1122335677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.3e-39  Score=291.53  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      |++.+.||.|+||.||+|... ++..+++|.+..... ..+.+.+|+.+++.++|||++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            577789999999999999876 577889998865432 346788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|...+..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........  
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            999877632   235689999999999999999999998   999999999999999999999999999875432211  


Q ss_pred             eeecccCCCCccccccccc---ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          225 SISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      ......++..|+|||.+..   ....++.++|+||+||++|+|++|+.||......        ..............  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL--  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCCCC--
Confidence            1233458899999998742   1235678999999999999999999998643321        01111111111111  


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ..+..++..+.+++.+||+.||.+||+++++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              112335668999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-39  Score=287.05  Aligned_cols=240  Identities=24%  Similarity=0.373  Sum_probs=188.7

Q ss_pred             cccCCCCcEEEEEEEEcCCc-----------eeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           71 HKLGQGGFGSVYKGQLQTGG-----------LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      +.||+|+||.||+|.+....           .+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46899999999999876333           57888776655446788999999999999999999999887 7789999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-------ceEEeecc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-------IPKVSDFG  212 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-------~~kl~Dfg  212 (373)
                      ||+++++|.+++...   ...+++..+..++.|++.||+|||++   +++||||||+||+++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999888432   22688999999999999999999998   999999999999999887       79999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcC-CCCCCCCcCccccccchHHHHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      ++......      ....++..|+|||.+.+....++.++|+||||+++|+|++| ..||.......        .....
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~~~~~  219 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------KERFY  219 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------HHHHH
Confidence            98765431      12346778999999876434678899999999999999995 66665443211        00111


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..........        ...+.+++.+||..+|.+|||+.++++.|+
T Consensus       220 ~~~~~~~~~~--------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQHRLPMPD--------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCCCCCCCC--------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111111        157899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-39  Score=288.56  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=190.1

Q ss_pred             cccCCCCcEEEEEEEEc----CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEee-eCCeeEEEEeccC
Q 048542           71 HKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVYEYMP  143 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~  143 (373)
                      +.||+|+||.||+|.+.    ++..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999854    234799998854322  2467889999999999999999999775 4556889999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...   .....+..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999988432   23467777888999999999999998   9999999999999999999999999998754322111


Q ss_pred             e--eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          224 V--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       224 ~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .  ......++..|+|||.+.+.  .++.++|||||||++|+|++|.. ||......        ........+.....+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  224 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLLQGRRLLQP  224 (262)
T ss_pred             eecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhcCCCCCCC
Confidence            1  11233466789999988664  67889999999999999999654 44432211        112222222222111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                            ..++..+.+++.+||+.+|++||++.++++.|+...
T Consensus       225 ------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         225 ------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                  223467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-39  Score=290.96  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||.|+||.||++... ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            35788899999999999999865 688999999875433 2367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..   ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          85 DGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999888743   235689999999999999999999998   999999999999999999999999998875433221


Q ss_pred             ceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          223 FVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                        ......++..|+|||.+...   ...++.++|+||||+++|+|++|..||.......        .......+.....
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  228 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--------VLLKILKSEPPTL  228 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--------HHHHHhcCCCCCc
Confidence              12334588999999987532   1346778999999999999999999987543211        1112222211111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ..+..++..+.+++.+||+.+|++||+++++++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 ----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence                112345667899999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-39  Score=290.76  Aligned_cols=263  Identities=26%  Similarity=0.444  Sum_probs=204.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-----CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeee--CCee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  135 (373)
                      ..+++.+.||+|+||.||+|.+.     ++..+|+|.+......  .+.+.+|+.+++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35667799999999999999854     4678999999876654  5789999999999999999999999877  5678


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||.+.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999988432   23589999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-------ccchHHH
Q 048542          216 FHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AYFPSWV  287 (373)
Q Consensus       216 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~  287 (373)
                      .......... .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..|+.........       .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            7653322211 1122355679999988664  6788999999999999999999987643321100       0001111


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...+........      +..++..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus       236 ~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPR------PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCC------CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            222222221111      122346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-39  Score=303.50  Aligned_cols=256  Identities=19%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ...|++.+.||+|+||.||+|... ++..||+|+.....     ...|+.+++.++||||+++++++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            345788899999999999999876 56789999754432     356899999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      . ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....... 
T Consensus       140 ~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        140 S-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             C-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            4 578777732   345689999999999999999999998   99999999999999999999999999987533221 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc---chHHHHHHHhcCC-C-c
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY---FPSWVYDQLNKGG-D-L  297 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~-~-~  297 (373)
                        ......||..|+|||.+.+.  .++.++|||||||++|+|+++..|+...........   ........+.... . .
T Consensus       212 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        212 --AFLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             --ccccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence              12345689999999998764  688999999999999999987665533221110000   0001111111000 0 0


Q ss_pred             ccC--ccc----------------------hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQ--NVT----------------------EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~--~~~----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .++  ...                      .....++..+.+|+.+||+.||.+|||++|+++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            000  000                      000123456678999999999999999999986

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=291.09  Aligned_cols=255  Identities=26%  Similarity=0.357  Sum_probs=202.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCC------eeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGS------KRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~------~~~  136 (373)
                      .+|++.+.||.|++|.||+|..+ +++.+++|++.......+++.+|+.+++++ +|+||+++++++....      ..+
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            46778899999999999999975 678999999987766667899999999999 6999999999986544      489


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|||+++++|.+++......+..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999988754443456789999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......  ......|+..|+|||.+...   ...++.++||||||+++|+|++|..||.......        .......
T Consensus       163 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~  232 (275)
T cd06608         163 LDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------ALFKIPR  232 (275)
T ss_pred             cccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------HHHHhhc
Confidence            433221  12334588899999987532   2346778999999999999999999996432211        1111111


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......    ..+..++..+.+++.+||..||++|||++++++
T Consensus       233 ~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NPPPTL----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cCCCCC----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111    112335678999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=289.05  Aligned_cols=246  Identities=24%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +|++.+.||.|++|.||+|... +++.+|+|.+.....  ....+.+|+.+++.++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            4677899999999999999866 688999999875432  2356889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          82 GGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            99999988832     2789999999999999999999998   999999999999999999999999999986643321


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......++..|+|||.+.+.  .++.++||||||+++|+|++|..||......        ................ 
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~-  220 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLEG-  220 (274)
T ss_pred             --ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCcc-
Confidence              12334588899999998765  5889999999999999999999998654321        1111222222111111 


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ..++..+.+++.+||..+|++|||++++++
T Consensus       221 ----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 ----NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                115667899999999999999999999977

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-39  Score=301.21  Aligned_cols=254  Identities=19%  Similarity=0.203  Sum_probs=195.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+++.+ +++.||+|++....    .....+.+|..++..++|+||+.+++++.+++..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4677899999999999999866 67889999987532    123457789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        82 y~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          82 YYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             CCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999988432   34688999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          221 NDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ... ......||+.|+|||.+.+.   .+.++.++|||||||++|+|++|+.||.......       ............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~  227 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHEERF  227 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------HHHHHHcCCCcc
Confidence            221 12335699999999988642   1356789999999999999999999997543211       111111111111


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~  336 (373)
                      .++.   ....++..+.+++.+|+..++++  |++++++++
T Consensus       228 ~~p~---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 QFPS---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1111   11234678899999999876544  467888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.9e-39  Score=290.28  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|...+.||+|+||.||+|.+. ++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45667788999999999999865 678899999875432  235788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.     ...+++..+..++.|+++|+.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999988873     24688999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .  ......++..|+|||.+.+.  .++.++|+|||||++|+|++|..|+.......        ...........    
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~----  219 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPP----  219 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCC----
Confidence            1  11233578899999998764  67889999999999999999999986433211        11111111111    


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .....++..+.+++.+||+.+|++|||+.++++
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 --TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence              112234567899999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-39  Score=292.98  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=197.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.+.||+|+||.||+|..+ +++.||+|.+.....   ..+.+.+|+.+++.++|+|++++++++......+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            4667789999999999999976 688999998865432   235678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.....    ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          82 CDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             cCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99988876652    234589999999999999999999998   99999999999999999999999999998664432


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH-------HHHHHHhc-
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS-------WVYDQLNK-  293 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~-  293 (373)
                      .  ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||......+.......       ........ 
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c--cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            1  12233578899999988653 3578899999999999999999999975443211000000       00000000 


Q ss_pred             ----C-CCcccCcc---chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 ----G-GDLELQNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ----~-~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          . ........   ......++..+.+|+.+||+.+|++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                0 00000000   1111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=286.58  Aligned_cols=253  Identities=24%  Similarity=0.293  Sum_probs=200.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|++.+.||.|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++.++||||+++++++.+....+++|||++
T Consensus         4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~   83 (262)
T cd06613           4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG   83 (262)
T ss_pred             ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence            4677789999999999999865 678899999876533 34678899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          84 GGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999888732   225689999999999999999999998   999999999999999999999999999876543211 


Q ss_pred             eeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                       ......++..|+|||.+.+. .+.++.++|+||||+++|+|++|..||........       ............   .
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~~~~~~~~~~---~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFLISKSNFPPP---K  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCCCc---c
Confidence             12234578899999988642 12567899999999999999999999875432110       111111100100   1


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......++..+.+++.+||+.+|.+|||+++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1122345678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.4e-39  Score=285.97  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~  141 (373)
                      |++.+.||+|++|.||++..+ +++.+|+|.+.....   ..+.+.+|+.+++.++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            678899999999999999865 578899999875433   23567889999999999999999988764 4568999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++...  ....+++..+..++.+++.|+++||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999998888432  245689999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .  ......+++.|+|||.+.+.  .++.++|+||+|+++++|++|..||......       .... ....+...    
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~-~~~~~~~~----  220 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDMN-------SLVY-RIIEGKLP----  220 (257)
T ss_pred             C--ccccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HHHH-HHHhcCCC----
Confidence            1  12334588999999998764  6788999999999999999999998643311       1111 12222111    


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.5e-39  Score=294.38  Aligned_cols=256  Identities=26%  Similarity=0.420  Sum_probs=198.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..++..+.||+|+||.||+|.+. ++.    .+|+|.+......  ..++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            34556688999999999999864 444    4788988754332  24678999999999999999999998654 4679


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            99999999999887432   34588999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .............++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .....+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~  229 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEKGER  229 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCC
Confidence            433322222234456789999998764  67889999999999999997 88888643211        12222333322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....      ...+..+.+++.+||..+|++||+++++++.|+.+..
T Consensus       230 ~~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         230 LPQP------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2211      1234578999999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4e-39  Score=293.01  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=199.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +|++.+.||.|++|.||+|... +++.|++|.+..... ..+.+.+|+..++.++|||++++++++..+...++|+||++
T Consensus        20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   99 (296)
T cd06655          20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA   99 (296)
T ss_pred             eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence            4567789999999999999854 788999998875433 34678899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.     ...+++..+..++.+++.|++|||+.   +++|+||||+||+++.++.++|+|||++.........
T Consensus       100 ~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655         100 GGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            999998773     23588999999999999999999998   9999999999999999999999999998754332211


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||.......       .. ............   
T Consensus       172 --~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------~~-~~~~~~~~~~~~---  236 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------AL-YLIATNGTPELQ---  236 (296)
T ss_pred             --CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH-HHHHhcCCcccC---
Confidence              1234588899999998764  67889999999999999999999997544311       01 111111111111   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .+..++..+.+++.+||+.||.+|||+.++++
T Consensus       237 -~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 -NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             12234567899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5e-39  Score=286.01  Aligned_cols=249  Identities=32%  Similarity=0.528  Sum_probs=199.3

Q ss_pred             hhhcccCCCCcEEEEEEEEcC-----CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           68 HFTHKLGQGGFGSVYKGQLQT-----GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+.+.||.|+||.||++.+..     +..+|+|.+.....  ....+.+|+..++.++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356889999999999998763     37899999976654  35788999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++....  ...+++..+..++.|++.|+++||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999998884322  12289999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..... ....+++.|+|||.+.+  ..++.++|+||+|+++++|++ |..||.....        .........+.....
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  225 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPK  225 (258)
T ss_pred             ccccc-ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCC
Confidence            22211 12337789999998854  477889999999999999998 6777754221        112223333332222


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      .      ...+..+.+++.+||+.||++|||+.++++.|
T Consensus       226 ~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 P------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            1      22567899999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-39  Score=288.69  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=199.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEcC--CceeEEEEeccCc-----------cCHHHHHHHHHHhcc-cCCCceeeEeeEeeeC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQT--GGLIAVKMLENSK-----------FSAEEFINEVSTIGR-IHHVNVVQLLGFCSEG  132 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~--~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~~  132 (373)
                      |++.+.||+|+||.||+|..+.  ++.+|+|.+....           ....++.+|+.++.+ ++||||+++++++..+
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            5677899999999999999764  6789999875321           122456778887765 7999999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      ...+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999988874433345678999999999999999999996 4   8999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |.+.......   ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||......       . .....
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~-~~~~~  225 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNML-------S-LATKI  225 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHH-------H-HHHHH
Confidence            9998654332   22345688999999998764  6788999999999999999999998643321       1 11111


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      .........     ...++..+.+++.+||+.||++||++.|+..+++
T Consensus       226 ~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 VEAVYEPLP-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hhccCCcCC-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111111111     1134567899999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4e-40  Score=293.68  Aligned_cols=240  Identities=23%  Similarity=0.320  Sum_probs=186.7

Q ss_pred             cccCCCCcEEEEEEEEc-C-------CceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQ-T-------GGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~-------~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.||+|+||.||+|... .       ...+++|.+...... .+.+.+|..+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36899999999999764 2       234888887654332 36788899999999999999999999998999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc--------eEEeeccC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------PKVSDFGL  213 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~--------~kl~Dfg~  213 (373)
                      +++|+|.+++...   +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.        ++++|||.
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999988432   33688999999999999999999998   9999999999999987664        69999998


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcCccccccchHHHHHHHh
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      +......      ....++..|+|||.+.+. ..++.++||||||+++|+|++|.. |+.......        ......
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~  219 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--------KLQFYE  219 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--------HHHHHH
Confidence            8654322      223578899999998753 357889999999999999999964 443222110        111111


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..  ..      .+...+.++.+++.+||+.||++|||++++++.|+
T Consensus       220 ~~--~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DR--HQ------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc--cc------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11  11      11223457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.8e-39  Score=288.63  Aligned_cols=247  Identities=26%  Similarity=0.402  Sum_probs=196.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----------HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      +.+...||+|++|.||+|... +++.+|+|.+......          .+.+.+|+.+++.++||||+++++++.+....
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            456688999999999999865 6789999988654322          14578899999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      +++|||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          82 NIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999998883    335688889999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCc----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          216 FHPKENDF----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       216 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      ........    .......|+..|+|||.+.+.  .++.++|+||+||++|+|++|..||.......       ... ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~-~~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-------AIF-KI  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-------HHH-HH
Confidence            65422111    011123578899999998764  67889999999999999999999997543211       011 11


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......      ..+..++..+.+++.+||+.||.+||++.++++
T Consensus       225 ~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GENASP------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hccCCC------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111111      122345678899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-38  Score=286.69  Aligned_cols=246  Identities=22%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|+..+.||.|+||.||+|.+. ++..+|+|.+.....  ....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4566788999999999999875 688999999875432  2367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.     ..++++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999998873     24588889999999999999999998   999999999999999999999999999876543221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......        ..........      
T Consensus       157 --~~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~------  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIPKNNP------  218 (277)
T ss_pred             --ccccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------HhhhhhcCCC------
Confidence              12234578889999998654  67889999999999999999999987543211        1111111111      


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ......++..+.+++.+||+.+|++||+++++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12334567789999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.9e-39  Score=293.90  Aligned_cols=260  Identities=20%  Similarity=0.279  Sum_probs=186.8

Q ss_pred             cccCCCCcEEEEEEEEc---CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEee--eCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~e~~~~g  145 (373)
                      .+||+|+||.||+|..+   ++..||+|.+..... ...+.+|+.+++.++||||+++++++.  .+...+++|||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            67999999999999865   456899998875443 346778999999999999999999884  35678999999864 


Q ss_pred             CccccccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee----eCCCceEEeeccCccc
Q 048542          146 SLDRHVFPK-----ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKF  216 (373)
Q Consensus       146 sL~~~l~~~-----~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~~~~  216 (373)
                      +|.+++...     ......+++..+..++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||++..
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            666655321     11234588999999999999999999998   99999999999999    4567899999999986


Q ss_pred             CCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc--ccchHHHHHHHhc
Q 048542          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK--AYFPSWVYDQLNK  293 (373)
Q Consensus       217 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~  293 (373)
                      ....... .......||..|+|||.+.+. ..++.++|||||||++|+|++|..||.........  .............
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            5433211 122344688999999998653 35788999999999999999999999754422110  0000000000000


Q ss_pred             CC------------------------CcccCcc------chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GG------------------------DLELQNV------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~------------------------~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..                        .......      .......+..+.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            00                        0000000      0000112346889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=304.39  Aligned_cols=240  Identities=26%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH----HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||.|+||.||.|++. +.+.||||.+..+....    .+++.|+..|+.++|||++.+.|+|..+...|+|||||- |
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence            67999999999999855 78899999987654332    578899999999999999999999999999999999994 4


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      |-.|++.   ...+++.+.++..|..+.+.||+|||+.   +.+|||||..|||+++.|.+||+|||.+......+    
T Consensus       111 SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----  180 (948)
T KOG0577|consen  111 SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----  180 (948)
T ss_pred             cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh----
Confidence            7777763   3357899999999999999999999998   99999999999999999999999999998765543    


Q ss_pred             eecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          226 ISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                        ..+|||.|||||++.-. -|.|+-|+||||||+...||.-.++|...+..-       ...+....+. .+.+.    
T Consensus       181 --sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYHIAQNe-sPtLq----  246 (948)
T KOG0577|consen  181 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-SPTLQ----  246 (948)
T ss_pred             --cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHHHHhcC-CCCCC----
Confidence              45699999999987432 368999999999999999999999998765431       1222222221 11111    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ..+.+..++.++..||+.-|.+|||.+++++
T Consensus       247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             2456888999999999999999999988764

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-39  Score=287.14  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee--CCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e  140 (373)
                      |++.+.||.|+||.||++... ++..+|+|.+......   .+++.+|+.+++.++|+||+++++++..  +...+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            567789999999999999865 7789999998754432   3567889999999999999999997753  456899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-----~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+++++|.+++........++++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999888654444677999999999999999999999     66   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ........  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||......        ........+.
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~  226 (265)
T cd08217         159 ILGHDSSF--AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQL--------QLASKIKEGK  226 (265)
T ss_pred             cccCCccc--ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCHH--------HHHHHHhcCC
Confidence            66543321  2234588999999998764  6788999999999999999999998754321        1222222222


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..      ..+..++..+.+++.+||+.+|++|||++++++
T Consensus       227 ~~------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         227 FR------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CC------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            11      223345678999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=308.36  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             ccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccc
Q 048542           72 KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR  149 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~  149 (373)
                      .||+|.||+||-|++. +...+|||.+..... ...-+.+|+.+.+.|+|.|||+++|.+.++++.-+.||-.+||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            5999999999999966 566899998875443 33567899999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceEEeeccCcccCCCCCCceee
Q 048542          150 HVFPKESRGQSL--CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSI  226 (373)
Q Consensus       150 ~l~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (373)
                      ++...   =+++  ++...--+.+||++||.|||++   .|||||||-+|+|++ -.|.+||+|||-++++..-+.  ..
T Consensus       662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T  733 (1226)
T KOG4279|consen  662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT  733 (1226)
T ss_pred             HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence            99533   3445  7788888999999999999998   999999999999997 578999999999987654432  34


Q ss_pred             ecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhh
Q 048542          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE  306 (373)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (373)
                      ....||..|||||++......|+.++|||||||.+.||.||++||...+...-         ...+.|..   ..-+++|
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVGmy---KvHP~iP  801 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVGMY---KVHPPIP  801 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhcce---ecCCCCc
Confidence            56679999999999987767899999999999999999999999976554321         11222211   1124667


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          307 SMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       307 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..++.+++.++.+|+.+||.+||+++++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            888999999999999999999999999986

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-39  Score=293.57  Aligned_cols=260  Identities=20%  Similarity=0.258  Sum_probs=195.0

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||.||+|..+ +|..+|+|.++....   ....+.+|+.+++.++||||+++++++.+....++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            567789999999999999876 788999999875422   2256778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++..   .+..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          82 D-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             C-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            6 477766632   235689999999999999999999998   999999999999999999999999999875533221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------chHHHHHHHhcC
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYDQLNKG  294 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~  294 (373)
                        ......++..|+|||.+.+. ..++.++|||||||++|+|++|..|+...........        .+...+......
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence              12234578899999988653 3468899999999999999999998654332110000        000000000000


Q ss_pred             -C---CcccCcc---chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 -G---DLELQNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 -~---~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .   .......   .+....++..+.+++.+||+.||.+|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             0   0000000   1122345678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.5e-39  Score=292.83  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=199.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|.+.+.||.|+||.||+|... +++.||+|.+...... .+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            56778899999999999999864 7899999998764433 366788999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999998873     24578889999999999999999998   999999999999999999999999999875433221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....+++.|+|||.+.+.  .++.++|+|||||++|+|++|..||.........       .. .........   
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~~-~~~~~~~~~---  235 (297)
T cd06656         171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATNGTPEL---  235 (297)
T ss_pred             C--cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------ee-eccCCCCCC---
Confidence            1  1234588899999998764  6788999999999999999999999654322110       00 001111111   


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ..+..++..+.+++.+||+.+|++||+++++++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 -QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             112334567899999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-39  Score=295.34  Aligned_cols=261  Identities=22%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.+.||+|+||.||+|..+ +++.+|+|.+.....   ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            4667799999999999999976 688999998765432   235678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|..+..    ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          82 VDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             CCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99988877652    234589999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHHh--
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLN--  292 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~--  292 (373)
                      .  ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...........       +.........  
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            1  22334578899999988653 3567889999999999999999988864432110000       0000000000  


Q ss_pred             ----cCCCcccCc---cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 ----KGGDLELQN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .........   .......++..+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                000000000   01112245678999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-39  Score=294.01  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      |++.+.||+|++|.||+|... +++.||+|.+......      ...+.+|+.+++.++|+||+++++++.+....++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            566788999999999999865 6889999999765433      245678999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+ +++|.+++...   ...+++..+..++.|+++||.|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          82 EFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             ccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            999 88999888432   23689999999999999999999998   999999999999999999999999999986644


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-------HHHHHHHh
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQLN  292 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~~  292 (373)
                      ...  ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||.............       ...+....
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            321  12233467889999988543 356889999999999999999977775433211000000       00000000


Q ss_pred             ---cCCC---cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 ---KGGD---LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ---~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ....   .............+..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               0000   0000011122334678999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.4e-39  Score=303.87  Aligned_cols=201  Identities=26%  Similarity=0.354  Sum_probs=172.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCHHHHHHHHHHhcccC-C-----CceeeEeeEeeeCCe
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-H-----VNVVQLLGFCSEGSK  134 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-----~ni~~~~~~~~~~~~  134 (373)
                      .+.-+|.+.+.||+|+||.|.+|.+ ++++.||||+++....-..+...|+.+|..|+ |     -|+|+++++|...++
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            3444778889999999999999985 48999999999987776678889999999996 3     389999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC--CCceEEeecc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFG  212 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~--~~~~kl~Dfg  212 (373)
                      .|||+|.+ +.+|++++..+.  -..++...++.++.||+.||.+||+.   +|||+||||+|||+.+  ...+||+|||
T Consensus       263 lciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999 569999996544  34588999999999999999999988   9999999999999964  3479999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      +++.....-    + ....+-.|.|||++.|.  .|+.+.|+||||||+.||++|.+.|.+..
T Consensus       337 SSc~~~q~v----y-tYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  337 SSCFESQRV----Y-TYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cccccCCcc----e-eeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence            998764432    1 33466789999999986  89999999999999999999987776544

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.6e-39  Score=288.03  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------  133 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------  133 (373)
                      |.+.+.||+|+||.||+|...    ++..+|||++......   .+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            356688999999999999753    4678999998764332   356889999999999999999999885432      


Q ss_pred             eeEEEEeccCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          134 KRALVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      ..++++||+.+|+|.+++....  .....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999987764322  1223578899999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      |++................++..|++||.+.+.  .++.++|||||||++|+|++ |..||......        .....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~  227 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNY  227 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHH
Confidence            998865433222112223456789999988654  67889999999999999999 77877543221        11222


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ..........      ...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       228 ~~~~~~~~~~------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 LIKGNRLKQP------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHcCCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2222211111      22356899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.4e-39  Score=311.29  Aligned_cols=257  Identities=17%  Similarity=0.273  Sum_probs=186.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC------CCceeeEeeEeeeC-CeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH------HVNVVQLLGFCSEG-SKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~------h~ni~~~~~~~~~~-~~~~  136 (373)
                      ..|++.++||+|+||+||+|... +++.||||+++.......+...|+.+++.++      |.+++.+++++..+ .+.+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            46778899999999999999865 6788999999754433445566777776664      44688898888654 5788


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCC-----------
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNF-----------  204 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~-----------  204 (373)
                      +|||++ +++|.+++.    +...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++           
T Consensus       209 iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccccc
Confidence            999998 678877773    23568999999999999999999996 5   999999999999998665           


Q ss_pred             -----ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc
Q 048542          205 -----IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  279 (373)
Q Consensus       205 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~  279 (373)
                           .+||+|||.+......     .....||+.|+|||++.+.  .++.++|||||||++|||++|+.||........
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             CCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 4999999987643221     2345699999999999775  788899999999999999999999975442110


Q ss_pred             ccc-------ch-HHHH--------HHHhcCCCcccC-cc---------chh-hHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          280 KAY-------FP-SWVY--------DQLNKGGDLELQ-NV---------TEI-ESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       280 ~~~-------~~-~~~~--------~~~~~~~~~~~~-~~---------~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      ...       ++ .|..        ............ ..         ... .......+.+|+.+||+.||.+|||++
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            000       00 0100        000000000000 00         000 001134678999999999999999999


Q ss_pred             HHHH
Q 048542          333 KVLE  336 (373)
Q Consensus       333 ell~  336 (373)
                      |+++
T Consensus       434 e~L~  437 (467)
T PTZ00284        434 QMTT  437 (467)
T ss_pred             HHhc
Confidence            9987

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-39  Score=299.02  Aligned_cols=255  Identities=19%  Similarity=0.201  Sum_probs=195.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||++..+ +++.+|+|++....    .....+.+|..++..++|+||+++++.+.+....++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            4667899999999999999876 57789999986422    222457789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        82 y~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          82 YYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             ccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999843   234688999999999999999999998   9999999999999999999999999998754332


Q ss_pred             CCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          221 NDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .. .......||+.|+|||++.+.   .+.++.++|||||||++|+|++|+.||.......       ............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~~~  227 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHKERF  227 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCccc
Confidence            22 122335699999999988631   2357889999999999999999999997543211       111111111111


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  337 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~~  337 (373)
                      ..+.   ....++..+.+|+.+|+..++.+  |++++++++.
T Consensus       228 ~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111   11234677899999988654444  6889988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.6e-39  Score=284.69  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=197.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|++.+.||+|+||.||++.. ++..+|+|.++... ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            4577889999999999999875 57889999886533 446788999999999999999999998654 47999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++....  ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          83 GNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999885332  34588999999999999999999998   99999999999999999999999999987543221   


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....+..|+|||.+.+.  .++.++|+||||+++|+|++ |+.||.......        .......+......   
T Consensus       155 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~---  219 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VKECVEKGYRMEPP---  219 (254)
T ss_pred             --CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhCCCCCCCC---
Confidence              123345679999988653  78889999999999999997 888886543211        22223333222211   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                         ..++..+.+++.+||+.+|++||+++++++.|+.
T Consensus       220 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 ---EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               2345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-38  Score=289.18  Aligned_cols=254  Identities=26%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeC-----CeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG-----SKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-----~~~~lv  138 (373)
                      .|.+.+.||+|+||.||++..+ +++.+|+|.+.........+.+|+.+++++ +|||++++++++...     ...++|
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            4667789999999999999865 688999999876655567788899999998 799999999998653     358999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++......+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999988754333456789999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCceeeecccCCCCccccccccccc---CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNF---GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .....  .....|+..|+|||.+....   ..++.++|+|||||++|+|++|+.||.......        .........
T Consensus       180 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--------~~~~~~~~~  249 (291)
T cd06639         180 STRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--------TLFKIPRNP  249 (291)
T ss_pred             ccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--------HHHHHhcCC
Confidence            32211  12345888999999875421   136789999999999999999999986543211        111111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......    +..++..+.+++.+||+.+|++||++.++++
T Consensus       250 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         250 PPTLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111    1234457899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.9e-39  Score=286.53  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=193.4

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      ..||+|+||.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++..+...++++||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            57999999999999865 677899998876543 3467889999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCCCCCCcee
Q 048542          149 RHVFPKESRGQSL--CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       149 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +++...   ...+  ++..+..++.|++.||+|||+.   +++||||||+||+++. ++.++|+|||++........  .
T Consensus        94 ~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~  165 (268)
T cd06624          94 ALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--C  165 (268)
T ss_pred             HHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--c
Confidence            988432   1234  7788889999999999999998   9999999999999976 67999999999875533221  1


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....++..|+|||.+.+....++.++|+||+|+++|+|++|..||.........      .........      ...+
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~~~~------~~~~  233 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGMFKI------HPEI  233 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------Hhhhhhhcc------CCCC
Confidence            2233578899999998654335788999999999999999999998643321100      000000011      1122


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +..++..+.+++.+||+.+|++|||+.++++
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            3345678999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=303.87  Aligned_cols=249  Identities=24%  Similarity=0.420  Sum_probs=208.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc--CCc--eeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ--TGG--LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ...+.++||+|.||.|++|.|.  +|.  .||||+++.....  ..+|++|+.+|.+|+|+|++++||+..+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3456689999999999999876  343  6899999987655  4899999999999999999999999987 7788999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |.++.|||.+.+..  .....+.......++.|||.||.||.++   ++||||+-.+|+|+.....+||+|||+.+.++.
T Consensus       190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999965  3456688888899999999999999998   999999999999999999999999999998876


Q ss_pred             CCCceeeec-ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          220 ENDFVSISA-TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       220 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ......+.. ..-...|.|||.+..  ..++.++|||+||+.+|||++ |..||.+...        ..+.+.++++..+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILKNIDAGERL  334 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHHhccccccC
Confidence            665544433 335678999999976  489999999999999999998 6678765543        2345555544443


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..      ++.+++++++++.+||..+|.+|||+..|.+
T Consensus       335 pR------Pk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  335 PR------PKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CC------CCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            33      3456789999999999999999999999974

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.8e-39  Score=287.06  Aligned_cols=250  Identities=26%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      |++.+.||.|++|.||++.++ +++.+++|.+.....  ...++.+|++.++.++||||+++++.+..+...++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            567789999999999999876 688999999876533  33678899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      +++|.+++...   ...+++..+..++.|++.|++|||+ .   +++|+||||+||+++.++.++|+|||.+........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          83 GGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999888432   2678899999999999999999999 7   999999999999999999999999999875532211


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                          ....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.........  ... ..+............ 
T Consensus       157 ----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~-  226 (265)
T cd06605         157 ----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFE-LLQYIVNEPPPRLPS-  226 (265)
T ss_pred             ----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHH-HHHHHhcCCCCCCCh-
Confidence                115588899999998765  7888999999999999999999999755321111  011 111111111111111 


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ..++..+.+++.+||..||++|||+.++++
T Consensus       227 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 ----GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                115678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.2e-39  Score=284.36  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=199.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||.+|++... +++.+|+|.+.....   ...++.+|+.+++.++||||+++++++......++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            567789999999999999865 688999999875432   3357889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+.+...  ....+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          82 EGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999998887432  234578899999999999999999998   999999999999999999999999999876543221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....|++.|+|||.+.+.  ..+.++|+||||+++++|++|..||......       . .......+....    
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~-~~~~~~~~~~~~----  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------N-LVLKIIRGSYPP----  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCHH-------H-HHHHHhcCCCCC----
Confidence            1  1233578899999998764  6788999999999999999999998644321       1 112222222211    


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .+..++..+.+++.+||+.+|++||++.++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              12334667999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=286.83  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      -+.+..+||+|+||.||++.++ +|+.+|||.+... .+..++..|+.+|++++.|++|++||.+.....+++|||||..
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            3456789999999999999866 7999999998754 3557889999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |++.+.+.   .+++++++.++..++...++||+|||..   .-+|||||..|||++.+|.+||+|||.+..+.+.  ..
T Consensus       113 GSiSDI~R---~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA  184 (502)
T KOG0574|consen  113 GSISDIMR---ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA  184 (502)
T ss_pred             CcHHHHHH---HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence            99999884   4568899999999999999999999987   7899999999999999999999999998754321  12


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      .-+...||+.|||||+++.-  .|.+++||||||+...||..|++|+.+-.+-.  ..+        .  .....+.--.
T Consensus       185 KRNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR--AIF--------M--IPT~PPPTF~  250 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMR--AIF--------M--IPTKPPPTFK  250 (502)
T ss_pred             hhCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccc--eeE--------e--ccCCCCCCCC
Confidence            23456799999999999875  68889999999999999999999987543211  000        0  0001111123


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      -+...+.++.+++++||-.+|++|-|+-++++
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            34667889999999999999999999988875

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-38  Score=283.80  Aligned_cols=257  Identities=24%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||.|+||.||+|... ++..+++|++.....  ....+.+|+..++.++|+|++++++.+..+...++++|++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            4667899999999999999865 678899999875443  3467899999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..... ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          82 SGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999988843221 24688999999999999999999998   999999999999999999999999999876544332


Q ss_pred             ce--eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          223 FV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       223 ~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......|+..|+|||.+... ..++.++|+||||+++|+|++|..||.......       ...... ........
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~~  228 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTL-QNDPPSLE  228 (267)
T ss_pred             ccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHh-cCCCCCcC
Confidence            21  11233588899999998654 357889999999999999999999986543211       011111 11111111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .. .....++..+.+++.+||+.||++|||++++++
T Consensus       229 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             Cc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            10 001345678899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.8e-38  Score=285.60  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..++..+.||+|+||.||+|+.+      +...+++|.+......  .+.+.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            34566789999999999999864      2457999988764433  367899999999999999999999999989999


Q ss_pred             EEEeccCcCCccccccCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          137 LVYEYMPNGSLDRHVFPKESR-----GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      +||||+++++|.+++......     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999988543321     12689999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      |++....... ........++..|+|||.+.+.  ..+.++||||||+++|+|++ |..||......        .....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~~~~~  230 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------EVLNR  230 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH--------HHHHH
Confidence            9986442221 1122333467789999988654  67789999999999999998 77777533211        11122


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ...+. .....    +..++..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       231 ~~~~~-~~~~~----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGK-LELPV----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCC-cCCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            22111 11111    1224567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-38  Score=288.07  Aligned_cols=253  Identities=25%  Similarity=0.343  Sum_probs=198.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||+|+||.||++..+ ++..||+|.+.....  ....+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4678899999999999999876 789999998875422  2357889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|..++.... ....+++..+..++.+++.||.|||+.  .+++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999988774321 134689999999999999999999962  289999999999999999999999999987543221 


Q ss_pred             ceeeecccCCCCccccccccccc----CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                         .....++..|+|||.+.+..    ..++.++|+|||||++|+|++|..||.......        ....+.......
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~  226 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAIVDGD  226 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHHhhcC
Confidence               12345788999999885431    235789999999999999999999986432211        111111111101


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ....+..++.++.+++.+||+.+|++||++++++.
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 ---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence               01222346778999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9e-39  Score=289.03  Aligned_cols=257  Identities=23%  Similarity=0.331  Sum_probs=198.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|++|.||+|... +|+.||+|.+.....   ..+.+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            667889999999999999865 688999999876542   2367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                       +++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence             99999887432   35689999999999999999999998   999999999999999999999999999886544321


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc---------
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---------  293 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  293 (373)
                       .......++..|+|||.+.+. ..++.++||||+|+++|+|++|.+||........   + .........         
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---L-AIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---H-HHHHHHcCCCChHHHhhc
Confidence             122345688999999988653 3568899999999999999999777754332110   0 000000000         


Q ss_pred             -----CCCcccCcc-----chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 -----GGDLELQNV-----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 -----~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           .........     .......+..+.+++.+||+.+|.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 000000000     1111234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.8e-39  Score=289.44  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=197.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeee------CCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~------~~~~~  136 (373)
                      ..|++.+.||.|+||.||+|... +++.+|+|++........++..|+.+++.+ +|+||+++++++..      ....+
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            45677899999999999999865 688999999877655567788899999998 69999999998843      45789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|||+++|+|.+++....  +..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            9999999999998884322  34588888999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......  ......|+..|+|||.+...   ...++.++|+|||||++|+|++|..||.......        .......
T Consensus       171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--------~~~~~~~  240 (282)
T cd06636         171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  240 (282)
T ss_pred             hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--------hhhhHhh
Confidence            432211  12234588899999987531   2357789999999999999999999986543211        0011111


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....     .....++..+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 NPPPK-----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             CCCCC-----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            11111     111235668999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-38  Score=283.37  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      |+..+.||+|++|.||+|... +++.|++|.+.....      ..+.+.+|+.+++.++|+||+++++++.++...++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            456688999999999999876 789999998865331      2357889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    +...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          82 ELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999998883    234588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..   ......++..|+|||.+... ..++.++|+||||+++|+|++|..||......       ............   
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~---  220 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKEL---  220 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccC---
Confidence            32   12345588899999998654 13788999999999999999999998654311       111111110111   


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ...+..++..+.+++.+||+.+|++||+++++++
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               1122335678899999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-38  Score=288.99  Aligned_cols=244  Identities=26%  Similarity=0.356  Sum_probs=194.9

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ...||+|+||.||++... ++..||||.+...... .+.+.+|+..++.++|+||+++++.+..+...+++|||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            467999999999999865 6889999998654332 35688999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++........  ...
T Consensus       107 ~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         107 TDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            88772     23588999999999999999999998   999999999999999999999999999875432221  112


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...|+..|+|||.+.+.  .++.++|+||||+++|+|++|+.||.......        ...............    ..
T Consensus       177 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~----~~  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDNLPPRVKD----SH  242 (292)
T ss_pred             eeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCcccc----cc
Confidence            34588999999998654  67889999999999999999999987543211        111122111111111    12


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .++..+.+++.+||+.||.+|||++++++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            345678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=284.76  Aligned_cols=246  Identities=22%  Similarity=0.366  Sum_probs=196.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      |++.+.||.|+||.||+|.+. +++.+|+|.+....  ...+++.+|+.+++.++   |||++++++++..+...+++||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            566788999999999999964 78899999987542  23467888999999986   9999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.     ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          83 YAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             cCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999988873     23688999999999999999999998   9999999999999999999999999998866443


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||........       . ..........+.
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~-~~~~~~~~~~~~  223 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------M-MLIPKSKPPRLE  223 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------h-hccccCCCCCCC
Confidence            31  12334588899999988643 3568899999999999999999999965432110       0 011111111111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .     ..++..+.+++.+||+.||++||++.++++
T Consensus       224 ~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 D-----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             c-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1     114567899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-39  Score=290.72  Aligned_cols=261  Identities=24%  Similarity=0.345  Sum_probs=193.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||+|++|.||+|..+ +++.||+|.+.....  ....+.+|+.+++.++|+||+++++++.++...++||||+
T Consensus         6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            5677799999999999999876 688999999875432  2245678999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++ +|.+++...   ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        86 ~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          86 DT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            74 888777422   34688999999999999999999998   999999999999999999999999999875432111


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------chHHHHHHHhcC
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYDQLNKG  294 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~  294 (373)
                        ......++..|+|||.+.+. ..++.++||||+|+++|+|++|..||...........        .....+......
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             --cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence              11223467889999987653 3577899999999999999999999965431100000        000000000000


Q ss_pred             ---CC--cccCccchh---hHHHH--HHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 ---GD--LELQNVTEI---ESMIA--RKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ---~~--~~~~~~~~~---~~~~~--~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ..  .........   ...+.  ..+.+++.+||+.+|++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               00  000000000   01122  67789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=296.28  Aligned_cols=274  Identities=21%  Similarity=0.259  Sum_probs=199.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~  136 (373)
                      ..|++.+.||+|+||.||+|... +|+.||+|.+.....  ...++.+|+.+++.++|+||+++++++...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            35777899999999999999865 788999999864322  335678899999999999999999887543     3579


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+.+ +|.+.+.     ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          85 IVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence            99999964 7766652     34689999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc--------hHHH
Q 048542          217 HPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF--------PSWV  287 (373)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~--------~~~~  287 (373)
                      ........ ......|+..|+|||.+.+. ..++.++||||+||++|+|++|+.||............        ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            54322211 12234688999999987543 35788999999999999999999999654321100000        0000


Q ss_pred             HH--------HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcCCCCCCCC
Q 048542          288 YD--------QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSIDDLQMP  348 (373)
Q Consensus       288 ~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~~~~~~~~  348 (373)
                      ..        ....................+..+.+++.+||+.+|.+|||+.++++.  ++...+....|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcc
Confidence            00        000000000000011112346779999999999999999999999986  66665543333

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-38  Score=281.35  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=197.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||.||++... +++.+|+|.+.....   ....+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            567789999999999999865 788999999876432   2367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~  221 (373)
                      ++++|.+++...  .+..+++..+..++.+++.|++|||++   +++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          82 PGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999988432  245589999999999999999999998   99999999999999854 468999999998654332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .   .....++..|+|||.+.+.  ..+.++||||||+++|+|++|..||......       ..... ........   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~-~~~~~~~~---  220 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLK-IMSGTFAP---  220 (256)
T ss_pred             c---ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHH-HHhcCCCC---
Confidence            1   1234588899999998764  6788999999999999999999998654321       11111 11111111   


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .+..++..+.+++.+||+.+|++|||++|+++
T Consensus       221 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ---ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ---CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               11234667899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.2e-38  Score=285.51  Aligned_cols=247  Identities=26%  Similarity=0.326  Sum_probs=192.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc------CHHHHHHHHHHhcccCCCceeeEeeEeee--CCeeEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRAL  137 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l  137 (373)
                      |+..+.||+|+||.||+|... ++..|++|.+.....      ....+.+|+.+++.++||||+++++++.+  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            566789999999999999865 688999998864321      12467889999999999999999998865  357889


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ++||+++++|.+++.    ....+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          84 FMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            999999999998883    234588899999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ..... ........++..|+|||.+.+.  .++.++|+||+||++|+|++|+.||......       ........... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~-  226 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPT-  226 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCC-
Confidence            32111 1112234588899999998764  6788999999999999999999998643221       11111111111 


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ....+..++..+.+++ +||..+|++||+++|+++
T Consensus       227 -----~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 -----NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -----CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                 1222344556777887 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-38  Score=288.20  Aligned_cols=242  Identities=27%  Similarity=0.370  Sum_probs=197.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|.+.+.||+|+||.||++... +++.+|+|.+....    ...+.+.+|+++++.++||||+++++++.++...+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            3667799999999999999866 68899999987533    233668899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        82 ~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          82 YVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             cCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999998883    335689999999999999999999998   9999999999999999999999999998865433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                           .....+++.|+|||.+.+.  ..+.++|+||||+++|+|++|..||......        ........+. .   
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~---  215 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNPI--------QIYEKILEGK-V---  215 (290)
T ss_pred             -----CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-c---
Confidence                 1234588999999998664  6778999999999999999999998654411        1122222111 1   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                         ..+..++..+.+++.+||+.||.+|+     +++|+++
T Consensus       216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               11223457889999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.5e-38  Score=329.94  Aligned_cols=265  Identities=22%  Similarity=0.447  Sum_probs=199.8

Q ss_pred             cChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           57 YSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        57 ~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      +++.++.. .+...+.||+|+||.||+|... ++..||+|.++......   ..|++.+++++||||++++++|.++...
T Consensus       683 ~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~  758 (968)
T PLN00113        683 ITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGA  758 (968)
T ss_pred             hhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence            34444432 3445578999999999999874 78899999987543322   3568899999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++|+|.+++.       .++|..+..++.|+++|++|||..+..+++||||||+||+++.++..++. ||...
T Consensus       759 ~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        759 YLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             EEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            99999999999999882       37899999999999999999995545599999999999999988887775 55543


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC-
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-  294 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-  294 (373)
                      .....      ....++..|+|||.+.+.  .++.++|||||||++|||++|+.||......  ......|........ 
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCH  900 (968)
T ss_pred             ccccC------CCccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccc
Confidence            22111      123578999999998764  7899999999999999999999998543221  112233332221111 


Q ss_pred             ----CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          295 ----GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       295 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          ...........+.....++.+++.+||+.||++|||++|+++.|+....
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence                0111111112233445678899999999999999999999999998754

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-39  Score=286.69  Aligned_cols=245  Identities=23%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |++.+.||.|+||.||+|..+ +++.+|+|.+....    ...+.+.+|+.+++.++||||+++++.+.++...++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            567899999999999999876 68899999987543    2346788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +.+++|.+.+.    ...++++..+..++.|+++||.|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          82 LLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999998883    235789999999999999999999998   99999999999999999999999999987654332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                         ......|+..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......     ..+....... .      
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~------  217 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET-A------  217 (258)
T ss_pred             ---cccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-c------
Confidence               12345588899999998765  57889999999999999999999987654321     1122222111 1      


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSM--TKVL  335 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~--~ell  335 (373)
                      ....+...+..+.+++.+||+.||.+||++  +|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            112223456789999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-38  Score=287.48  Aligned_cols=261  Identities=21%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |+..+.||.|++|.||+|... +++.||||.+.....   ....+.+|+.+++.++||||+++++++.++...+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            456788999999999999875 688999998875432   2257889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      . ++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          82 H-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             c-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            5 5787776432  245689999999999999999999998   999999999999999999999999999875533221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHh---
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLN---  292 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~---  292 (373)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|++|+.||............       ....+....   
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence              12233467889999988653 34578899999999999999999998754321100000       000000000   


Q ss_pred             ----cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 ----KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ................++..+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                00000000011112234567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.5e-38  Score=281.93  Aligned_cols=246  Identities=23%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||+|+||.||+|... ++..+|+|.+.....  ....+.+|+.++..++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4667789999999999999865 678999998865433  2357889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.     ...+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          85 GGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999988873     24588999999999999999999998   999999999999999999999999999875533221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ............     
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-----  219 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPP-----  219 (277)
T ss_pred             --hhccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCCC-----
Confidence              12234578899999988653  6788999999999999999999998643221        111112222111     


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       ..+..++..+.+++.+||+.+|.+||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             1223345678999999999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=292.03  Aligned_cols=265  Identities=21%  Similarity=0.283  Sum_probs=196.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc---CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRAL  137 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~l  137 (373)
                      |++.+.||+|+||.||+|..+   ++..||+|.+....    ...+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            567788999999999999865   47899999988633    2235678899999999999999999999887  78999


Q ss_pred             EEeccCcCCccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC----CCceEEeecc
Q 048542          138 VYEYMPNGSLDRHVFPKES-RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFG  212 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~----~~~~kl~Dfg  212 (373)
                      ||||+++ ++.+.+..... ....+++..++.++.|++.||.|||+.   +++||||||+||+++.    ++.+||+|||
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            9999965 66555533222 234789999999999999999999998   9999999999999998    8999999999


Q ss_pred             CcccCCCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-c-hHH---
Q 048542          213 LAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-F-PSW---  286 (373)
Q Consensus       213 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-~-~~~---  286 (373)
                      ++........ ........++..|+|||.+.+. ..++.++||||||+++|+|++|..||........... . ...   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            9886543322 1122344678899999987653 3567899999999999999999999976544321000 0 000   


Q ss_pred             HHHHH---------------------hcCCCcccCcc---chhhH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          287 VYDQL---------------------NKGGDLELQNV---TEIES--MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       287 ~~~~~---------------------~~~~~~~~~~~---~~~~~--~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....+                     ...........   .....  ..+.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000                     00000001100   00111  34567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.3e-38  Score=289.34  Aligned_cols=253  Identities=20%  Similarity=0.211  Sum_probs=198.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |++.+.||+|+||.||++... +++.|++|.+.....    ....+.+|+.+++.++||||+++++.+..+...+++|||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY   82 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence            567789999999999999876 678999999876532    235677899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.    ....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          83 VEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            99999999883    235689999999999999999999998   99999999999999999999999999886321100


Q ss_pred             C-------------ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          222 D-------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       222 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      .             ........++..|+|||.+.+.  .++.++|+|||||++|+|++|..||......        ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--------~~~  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELF  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            0             0001123478889999998664  6788999999999999999999998643321        112


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      .......... +.   ....++..+.+++.+||+.||++||+..++.+.|+.
T Consensus       226 ~~~~~~~~~~-~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIEW-PE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccCC-CC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            2222111111 10   011345678999999999999999998877777775

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.9e-38  Score=280.84  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=200.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||.||+|... +++.+++|.++....   ....+.+|+.+++.++|+||+++++++......++++||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            567789999999999999865 788999999887655   3467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.    .+..+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999883    234578899999999999999999998   999999999999999999999999999886644332


Q ss_pred             cee--eecccCCCCccccccccccc-CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          223 FVS--ISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       223 ~~~--~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...  .....++..|+|||.+.+.. ...+.++||||||+++|+|++|+.||.......      .... ....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~-~~~~~~~~~~  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMF-HVGAGHKPPI  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHH-HHhcCCCCCC
Confidence            111  12345788999999987642 237789999999999999999999996443211      0111 1111111122


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +..    ..++..+.+++.+||+.+|++|||+++++.
T Consensus       228 ~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 PDS----LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Ccc----cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            211    123567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.8e-38  Score=287.55  Aligned_cols=244  Identities=25%  Similarity=0.352  Sum_probs=195.0

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ...||.|+||.||++... +++.||+|.+..... ..+.+.+|+..+..++|||++++++++..+...++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            457999999999999865 688999999865433 346788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      ...+.     ...+++..+..++.|++.||+|||++   +++|+||||+||+++.++.++|+|||++........  ...
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  175 (297)
T cd06659         106 TDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK  175 (297)
T ss_pred             HHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence            88662     24588999999999999999999998   999999999999999999999999999875433221  122


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...|+..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......        ....+.........    ...
T Consensus       176 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~----~~~  241 (297)
T cd06659         176 SLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLK----NAH  241 (297)
T ss_pred             ceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCCCcc----ccC
Confidence            34588999999998764  67889999999999999999999987443211        11111111111111    112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .++..+.+++.+||+.+|++||+++++++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            345678999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8e-38  Score=285.97  Aligned_cols=247  Identities=26%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|...+.||+|+||.||+|... +++.||+|.+.....    ...++.+|+.+++.++||||+++++++.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34677799999999999999865 688999998864322    1246889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+. |++.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9996 566665532   234689999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ..      ...++..|+|||.+.+ ..+.++.++||||||+++|+|++|..||.......       .... ........
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~~~  233 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNDSPT  233 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcCCCCC
Confidence            22      2357889999998743 12467889999999999999999999986543211       0111 11111111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ..     ...++..+.+++.+||+.+|++||++.+++..
T Consensus       234 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         234 LS-----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC-----chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            11     12356689999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-38  Score=282.22  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=197.8

Q ss_pred             hhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      |+..+.||+|++|.||++.. .+++.+|+|.+.....       ..+.+.+|+.+++.++|+||+++++++.+....++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            45568899999999999986 4788999999875331       135688999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  217 (373)
                      +||+++++|.+++.    ...++++..+..++.|++.||.|||++   +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        82 ~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          82 VEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999998883    235688999999999999999999998   999999999999998765 6999999998765


Q ss_pred             CCCCCce--eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          218 PKENDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       218 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .......  ......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||........    ............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~  228 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIASATT  228 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHhccCC
Confidence            4321110  11223578899999998664  678899999999999999999999864432111    111111111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            ....+..++..+.+++.+||+.+|++|||+.++++
T Consensus       229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  12233456778999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.6e-38  Score=284.73  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=193.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHH-hcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||+|+||.||++..+ +|..||+|.++.....  ..++..|+.. ++.++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            566789999999999999876 6899999998765432  2455566664 56668999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++......+..+++..++.++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++....... 
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            6 678777644333446799999999999999999999974  279999999999999999999999999987653221 


Q ss_pred             ceeeecccCCCCcccccccccc--cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          223 FVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                        ......++..|+|||.+.+.  ...++.++|+|||||++|+|++|+.||.......      ..... .........+
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~~~~  229 (283)
T cd06617         159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF------QQLKQ-VVEEPSPQLP  229 (283)
T ss_pred             --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH------HHHHH-HHhcCCCCCC
Confidence              11234578899999988642  1356789999999999999999999986432210      11111 1111111111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .     ..++..+.+++.+||..+|++|||++++++
T Consensus       230 ~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         230 A-----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             c-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1     235678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=273.92  Aligned_cols=250  Identities=21%  Similarity=0.253  Sum_probs=201.8

Q ss_pred             Hhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeee----CCeeEEE
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALV  138 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~~lv  138 (373)
                      .|.+. ++||-|-.|+|..+..+ +|+++|+|++..+.    ...+|+++.-.. .|||||.+++++.+    ..++.+|
T Consensus        62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            44444 78999999999999866 89999999987653    345788876666 59999999998854    4567799


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~  215 (373)
                      ||.|+||.|...+..+  ....+++.++.+|+.||+.|+.|||+.   +|.||||||+|+|...   +..+||+|||.|+
T Consensus       138 mE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccccc
Confidence            9999999999888543  356799999999999999999999998   9999999999999964   5579999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .....   ......+-|+.|.|||++..+  .|+..+|+||+|+++|-|++|.+||.......    ++..+...+..+.
T Consensus       213 ~t~~~---~~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gq  283 (400)
T KOG0604|consen  213 ETQEP---GDLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQ  283 (400)
T ss_pred             ccCCC---ccccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccC
Confidence            65432   234567899999999999765  78888999999999999999999998765432    2223334444433


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      - .++  .+-...+|+..+++++.+|+.+|.+|.|+++++.
T Consensus       284 y-~FP--~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 Y-EFP--EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c-cCC--ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2 222  2334678899999999999999999999999976

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.3e-38  Score=279.62  Aligned_cols=248  Identities=27%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +++.+.||+|++|.||+|..+ +++.+++|++.....  ....+.+|+..+..++|+|++++++++......+++|||++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            566789999999999999876 589999999876543  34778999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      +++|.+++..    ...+++..+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          83 GGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999998832    3668999999999999999999999 8   999999999999999999999999999886543322


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......    ... ............    
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~-~~~~~~~~~~~~----  222 (264)
T cd06623         156 Q--CNTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQPS----FFE-LMQAICDGPPPS----  222 (264)
T ss_pred             c--ccceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCccccccC----HHH-HHHHHhcCCCCC----
Confidence            1  1234578899999998664  77889999999999999999999987654311    111 112222211111    


Q ss_pred             chhhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .+.. ++..+.+++.+||+.+|++|||+.++++
T Consensus       223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence              1222 5678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=289.59  Aligned_cols=267  Identities=25%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcc--cCCCceeeEeeEeeeCC----eeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSEGS----KRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~~~----~~~lv~e  140 (373)
                      -++.+.||+|.||.||+|.+. ++.||||++....  ...|.+|-+++..  ++|+||+++++.-....    .++||++
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            356688999999999999988 6999999997543  4567777777665  48999999998765444    7889999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC------DVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      |.+.|||.+++     +...++|....+++..+++||+|||+..      +++|+|||||.+|||+..++++.|+|||+|
T Consensus       289 fh~kGsL~dyL-----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  289 FHPKGSLCDYL-----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eccCCcHHHHH-----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999     3566999999999999999999999742      468999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcC-----cccchHHHHHHHHHHHcCCCCCCCCcCcccc---------
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-----CKSDVYGFGMVLLEMAGGRRNSNMNATRSSK---------  280 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-----~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~---------  280 (373)
                      ..+..........+..||.+|||||++.+. -++.     .+.||||+|.++|||++...-+......+..         
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            987655544445567899999999999774 2222     3589999999999999876544321111111         


Q ss_pred             -ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          281 -AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       281 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                       ..+.....-.+.+..++.+++.=.- -....-+++.+..||+.||+-|.|+.=+-+++..+..
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~-h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRK-HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhc-CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence             1122222223334444444321111 1234568999999999999999999999998887644

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-38  Score=288.51  Aligned_cols=251  Identities=25%  Similarity=0.297  Sum_probs=198.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|++|.||+|... ++..+|+|.+......    ...+.+|+.+++.++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            3567789999999999999876 5889999998765432    3568889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+.+++|.+++...  .+..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          82 YCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             ecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999887422  245689999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCce---------------------------eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          221 NDFV---------------------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       221 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                      ....                           ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            1100                           01123578899999998764  678899999999999999999999975


Q ss_pred             CcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 048542          274 NATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS----MTKVLE  336 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ell~  336 (373)
                      .....       .........  ......    ..++..+.+++.+||+.||++|||    +++++.
T Consensus       235 ~~~~~-------~~~~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         235 SNRDE-------TFSNILKKE--VTFPGS----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CchHH-------HHHHHhcCC--ccCCCc----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            54321       011111111  111111    115678999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-39  Score=296.85  Aligned_cols=245  Identities=21%  Similarity=0.329  Sum_probs=206.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      -|.+.+.||+|.|++|.+|++. ++..||||++.+...+.   ..+.+|+.+|+.++||||++++.+......+|+||||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey  136 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY  136 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence            4566799999999999999865 79999999998865544   4578999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +.+|.+++++.    +.....+..+..++.|+..|++|||++   +|+|||||++|+|++.+.++||+|||++..+....
T Consensus       137 a~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  137 ASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             ccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccc
Confidence            99999999994    345566688899999999999999998   99999999999999999999999999998776433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                         .....+|++.|.|||++.+. ...++++|+||+|+++|.|+.|..||++....+....+       +.        .
T Consensus       210 ---~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------l~--------g  270 (596)
T KOG0586|consen  210 ---MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------LR--------G  270 (596)
T ss_pred             ---cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCcccccccchh-------ee--------e
Confidence               23467899999999999987 46678999999999999999999999876543322110       11        1


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...++.-++.++.+|+++++-.+|.+|++++++.+
T Consensus       271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            12233344678999999999999999999999865

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-38  Score=285.50  Aligned_cols=261  Identities=20%  Similarity=0.263  Sum_probs=195.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~  139 (373)
                      .|++.+.||.|+||.||+|..+ ++..+++|.++.....   ...+.+|+.+++.++||||+++++++...  ...+++|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            5777899999999999999976 6789999998754322   24567899999999999999999998777  8899999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||++ ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9996 4887777432   23689999999999999999999998   999999999999999999999999999886544


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-------HHHHHHHh
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQLN  292 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~~  292 (373)
                      ...  ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...........+.       ...+....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            321  12334578899999988653 346789999999999999999999987543211100000       00000000


Q ss_pred             c---CC--C-cccC---ccchhhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 K---GG--D-LELQ---NVTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~---~~--~-~~~~---~~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .   ..  . ....   .....+.. ++..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0   00  0 0000   00111111 3667899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.6e-38  Score=280.00  Aligned_cols=248  Identities=23%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc------CHHHHHHHHHHhcccCCCceeeEeeEeee--CCeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~  136 (373)
                      .|++.+.||+|+||.||+|... ++..||+|.+.....      ..+.+.+|+.+++.++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            3566789999999999999865 688999998764221      12567889999999999999999998865  35678


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|||+++++|.+++.    +...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          83 IFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            9999999999998873    234578888999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....... .......++..|+|||.+.+.  .++.++|||||||++|+|++|+.||.......       ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPT  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCC
Confidence            4321111 112334588899999998764  67889999999999999999999986432111       0111111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            ....+..++..+.+++.+|+. +|++||+++++++
T Consensus       227 ------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                  112334566788999999995 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=269.08  Aligned_cols=249  Identities=22%  Similarity=0.322  Sum_probs=198.1

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccC
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ++...||.|+.|.||+++.+ +|..+|||.+......  .++++..+.++.+.+ +|+||+.+|+|..+...++.||.| 
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence            34577999999999999966 6889999999875433  367778888777665 899999999999999999999998 


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +..+..++.   ....++++..+-++...+++||.||..+  .+|+|||+||+|||+|+.|++||||||++-++-+... 
T Consensus       174 s~C~ekLlk---rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-  247 (391)
T KOG0983|consen  174 STCAEKLLK---RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-  247 (391)
T ss_pred             HHHHHHHHH---HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence            445555552   2346799999999999999999999976  5999999999999999999999999999986644332 


Q ss_pred             eeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        .+...|.+.|||||.+.-. ...|+.++||||||+.++||.||..||.....+       ..+...+.+...+.++. 
T Consensus       248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP~L~~-  317 (391)
T KOG0983|consen  248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPPLLPG-  317 (391)
T ss_pred             --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCCCCCc-
Confidence              2344588999999998654 457888999999999999999999999876643       12333333322222221 


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ...++..+++++..||+.|+.+||...++++
T Consensus       318 ---~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 ---HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             ---ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence               1237888999999999999999999999876

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-38  Score=285.29  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .+|.+.+.||+|+||.||++... ++..+++|.+..... ..+.+.+|+.+++.++|||++++++.+......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            46778899999999999999864 678999999865433 3467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.     ...+++..+..++.|++.|+.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999998873     23578889999999999999999998   999999999999999999999999998875543322


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....+++.|+|||.+.+.  .++.++|+||||+++|++++|..||..........        ...........  
T Consensus       171 ~--~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~~~~~~--  236 (293)
T cd06647         171 K--RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGTPELQ--  236 (293)
T ss_pred             c--cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCCCCCCC--
Confidence            1  1234588899999998664  67889999999999999999999997544321100        00111111111  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        .+..++..+.+++.+||+.+|++||++++++..
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              122345678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=299.07  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=200.7

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEecc-----CccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCe--eEEEE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLEN-----SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK--RALVY  139 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~~lv~  139 (373)
                      ++...||+|+|-+||+|.+. +|-.||--.++.     +....++|.+|+++|+.|+||||+++|+++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34478999999999999865 676776544332     22233789999999999999999999999977554  77899


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  218 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~  218 (373)
                      |.+..|+|..+.    .+.+......+..|+.||++||.|||++ +++|+|||||.+||+|++ .|.+||+|+|+|....
T Consensus       123 EL~TSGtLr~Y~----kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYR----KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHH----HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999998    4456688889999999999999999997 789999999999999984 5899999999999765


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ...    .....|||.|||||+...   .|+..+||||||+.++||.|+..||....+.       ..+++.+..|..+.
T Consensus       198 ~s~----aksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  198 KSH----AKSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPA  263 (632)
T ss_pred             ccc----cceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHH
Confidence            433    233679999999999873   7899999999999999999999999877653       44667777776554


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .-..-.     ...++++|.+|+.. .++|||+.|+|+
T Consensus       264 sl~kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 ALSKVK-----DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HhhccC-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            221111     25789999999999 999999999986

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=284.85  Aligned_cols=261  Identities=23%  Similarity=0.289  Sum_probs=195.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|++|.||+|..+ +|..||+|++.....   ..+.+.+|+.+++.++|||++++++++.++...+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            356788999999999999865 789999999875432   2356889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++....  ...+++..+..++.|+++||+|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            4 68888774322  24689999999999999999999998   999999999999999999999999999875432211


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHH----
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQL----  291 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~----  291 (373)
                        ......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........       .....+...    
T Consensus       155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence              11223468899999987653 3568899999999999999999999875432110000       000000000    


Q ss_pred             ---hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 ---NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .................++..+.+++.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000000001111222345578999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=285.60  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=197.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.+.||+|+||.||+|.++ +++.||+|.++....   ..+.+.+|+.+++.++|+||+++++++..+...+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            4677899999999999999876 678999998875432   236788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      ++++.+..+.    .+...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          82 VERTLLELLE----ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             CCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9887766544    2234588999999999999999999998   99999999999999999999999999988654433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHHhc-
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNK-  293 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~-  293 (373)
                      . .......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........       .+......... 
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            2 112234578889999998653 2677899999999999999999999875432110000       00000000000 


Q ss_pred             ----C-CCcccCccc----hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 ----G-GDLELQNVT----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ----~-~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          + .........    ..+..++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                0 000000000    112234678999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.5e-38  Score=284.81  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCe-----e
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSK-----R  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~-----~  135 (373)
                      .|++.+.||+|+||.||+|... +++.||+|.++....   ....+.+|+.+++.++ ||||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            3567789999999999999865 688999998865432   2356788999999995 6999999999876655     8


Q ss_pred             EEEEeccCcCCccccccCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccC
Q 048542          136 ALVYEYMPNGSLDRHVFPKESR-GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGL  213 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~  213 (373)
                      +++|||+++ +|.+++...... +..+++..+..++.||+.||.|||+.   +++||||+|+||+++. ++.+||+|||+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence            999999975 787777443222 45689999999999999999999998   9999999999999998 88999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      +........  ......+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.........   .. ....+..
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~-~~~~~~~  230 (295)
T cd07837         158 GRAFSIPVK--SYTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LH-IFKLLGT  230 (295)
T ss_pred             ceecCCCcc--ccCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH-HHHHhCC
Confidence            875432211  11223467889999988653 35788999999999999999999998754321100   00 0000000


Q ss_pred             CCC---------------c--ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGD---------------L--ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~---------------~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...               .  ...........++..+.+++.+||+.||.+|||++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000               0  000001111235678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.8e-38  Score=283.52  Aligned_cols=242  Identities=24%  Similarity=0.332  Sum_probs=186.8

Q ss_pred             ccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhc---ccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           72 KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIG---RIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~---~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .||+|+||.||++... +++.+|+|.+......    ...+.+|..+++   ..+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999865 6889999988754322    123344444333   3479999999999999899999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999988773    335689999999999999999999998   99999999999999999999999999986543222  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....|+..|+|||.+.+. ..++.++|+||+||++|+|++|..||........     .... ......      ..
T Consensus       152 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~~------~~  216 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEID-RMTLTV------NV  216 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHH-HHhhcC------Cc
Confidence              1234589999999987542 3578899999999999999999999975432211     0111 111111      11


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEM  337 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~  337 (373)
                      ..+..++.++.+++.+||+.||++||     |++++++.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            22344567899999999999999999     59988773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.5e-38  Score=283.69  Aligned_cols=262  Identities=23%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      |++.+.||.|++|.||+|..+ +|..||+|.++....  ....+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            567789999999999999976 688999999876432  34667889999999999999999999999999999999997


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      + +|.+++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........ 
T Consensus        82 ~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          82 K-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             c-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            5 7877764332 235689999999999999999999998   999999999999999999999999999875432211 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhcCC-
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKGG-  295 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~-  295 (373)
                       ......++..|++||.+.+. ..++.++|+||||+++|+|++|..||............       ....+..+.... 
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             11233478889999988653 35678999999999999999999998755432110000       000011111000 


Q ss_pred             -CcccC-----ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 -DLELQ-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 -~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....+     .........+..+.+++.+||+.||.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             00000     011122344678899999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.2e-38  Score=290.94  Aligned_cols=265  Identities=21%  Similarity=0.276  Sum_probs=197.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC---ccCHHHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~  136 (373)
                      +|.+.+.||+|+||.||+|... ++..||||.+...   ......+.+|+.+++.++|+||+++++++...     ...+
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            5677889999999999999865 7889999998753   22345677899999999999999999987644     3479


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+. ++|.+++.    .+..+++..+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          86 IVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            9999995 68877773    345689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------------
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------------  283 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------------  283 (373)
                      ......  ......++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||............             
T Consensus       158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         158 TSEKGD--FMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cCCCcc--cccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            543321  12234578899999987643 35788999999999999999999999654311000000             


Q ss_pred             ---hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcC
Q 048542          284 ---PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGS  341 (373)
Q Consensus       284 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~  341 (373)
                         .........................++..+.+++.+||+.+|++|||++++++.  ++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               000000000000000001111223457789999999999999999999999876  6554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=287.27  Aligned_cols=261  Identities=18%  Similarity=0.237  Sum_probs=183.8

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCccCH------------HHHHHHHHHhcccCCCceee
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFSA------------EEFINEVSTIGRIHHVNVVQ  124 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~------------~~~~~e~~~l~~l~h~ni~~  124 (373)
                      ++....|++.+.||+|+||.||+|...+    +..+|+|+........            .....+...+..+.|+|++.
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3445578889999999999999998663    3466777543322211            11223445566778999999


Q ss_pred             EeeEeeeCC----eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          125 LLGFCSEGS----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       125 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      +++.+....    ..+++++++. .++.+.+.    .....++..+..++.|++.||+|||+.   +++||||||+|||+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill  159 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFK----RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV  159 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhc-cCHHHHHH----hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            998765443    3467778763 35544442    123356788899999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      +.++.++|+|||+++........     .......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||....
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999765322211     111234699999999998765  78899999999999999999999997653


Q ss_pred             Ccccccc-chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          276 TRSSKAY-FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       276 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ....... ........+..+. ...       ...+..+.+++..||+.+|++||+++++++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEGK-IKI-------KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhhh-hcc-------CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            2211000 0000111111111 011       123467899999999999999999999999763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=284.08  Aligned_cols=261  Identities=22%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e  140 (373)
                      |++.+.||.|++|.||+|... +++.+|+|.+....   .....+.+|+.+++.++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999876 57899999998653   2335688999999999999999999999887  88999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++ +|.+++...   ...+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9964 887777322   25689999999999999999999998   9999999999999999999999999999866443


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH-------HHHHH--
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-------VYDQL--  291 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------~~~~~--  291 (373)
                      .. .......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+...       .+...  
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             Cc-ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence            21 112334567889999987653 35788999999999999999999998754421100000000       00000  


Q ss_pred             ---hcCCCcccCc---cchhhHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 ---NKGGDLELQN---VTEIESM-IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ---~~~~~~~~~~---~~~~~~~-~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ..........   ..+.... ++..+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0000000000   0011111 2678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.6e-38  Score=283.85  Aligned_cols=258  Identities=22%  Similarity=0.276  Sum_probs=192.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeC--CeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv~e  140 (373)
                      |++.+.||+|+||.||+|... +++.+|+|.++.....  .....+|+..+.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999865 6889999998764322  234457888888885 99999999999887  88999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |++ +++.+.+..   ....+++..+..++.|++.||+|||+.   +++|+||+|+||+++. +.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 577776632   234689999999999999999999998   9999999999999999 99999999999865433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHHhc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNK  293 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~  293 (373)
                      ...   ....++..|+|||.+.+. +.++.++|+||+||++|+|++|..||...........       ...........
T Consensus       153 ~~~---~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         153 PPY---TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             CCc---CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence            221   233578899999976543 3567899999999999999999999975442110000       00000111111


Q ss_pred             CCCcc--cCc-----cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGDLE--LQN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~~~--~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....  .+.     .......++..+.+++.+||+.+|++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            11110  100     01122345788999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.7e-38  Score=278.57  Aligned_cols=247  Identities=28%  Similarity=0.415  Sum_probs=201.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|+||.||++..+ +++.+++|.+.....   ...++.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            566789999999999999865 778999999876433   2356778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++......+..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-  157 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-  157 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence            99999988855434456789999999999999999999998   99999999999999999999999999998664431 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                         .....++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.......        .......+...     
T Consensus       158 ---~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~-----  219 (256)
T cd08530         158 ---AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--------LRYKVQRGKYP-----  219 (256)
T ss_pred             ---cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCCC-----
Confidence               1234588899999998764  67889999999999999999999986543211        11122222211     


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ..+..++.++.+++.+||+.+|++|||+.++++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 -PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             122345678999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=307.05  Aligned_cols=269  Identities=18%  Similarity=0.247  Sum_probs=185.8

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc--CCceeEEE------------------EeccCccCHHHHHHHHHHhcccCCC
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVK------------------MLENSKFSAEEFINEVSTIGRIHHV  120 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vaiK------------------~~~~~~~~~~~~~~e~~~l~~l~h~  120 (373)
                      +.....|++.+.||+|+||+||+|..+  ++...+.|                  .+.........+.+|+.+++.++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            344567889999999999999998754  22222222                  1222222235678999999999999


Q ss_pred             ceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCee
Q 048542          121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKES-RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (373)
Q Consensus       121 ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil  199 (373)
                      ||+++++++......|++++++. ++|.+++..... .........+..++.|++.||.|||++   +|+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            99999999999999999999984 466666533211 122234566778999999999999998   9999999999999


Q ss_pred             eeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCC-CcCcc
Q 048542          200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NATRS  278 (373)
Q Consensus       200 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~-~~~~~  278 (373)
                      ++.++.+||+|||++.......... .....||..|+|||++.+.  .++.++|||||||++|+|++|..++.. .....
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence            9999999999999998664332211 1234699999999999764  688899999999999999998754432 22111


Q ss_pred             cccc-------------ch---HHHHHHHhcCCCcccC-ccchh--hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          279 SKAY-------------FP---SWVYDQLNKGGDLELQ-NVTEI--ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       279 ~~~~-------------~~---~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....             ++   ...++.+......... .....  ...++.++.+++.+||+.||.+|||+.|++.
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000             00   0001111100000000 00000  0113456788899999999999999999986

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-37  Score=280.44  Aligned_cols=249  Identities=28%  Similarity=0.376  Sum_probs=201.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .|.+.+.||.|++|.||+|.++ ++..+++|.+.......+.+.+|+..++.++|+|++++++.+......++++||+++
T Consensus        20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            4566788999999999999976 688999999987655567788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++....   ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........  
T Consensus       100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614         100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            99999984321   3789999999999999999999998   999999999999999999999999998875543221  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||.......       ... ...........    
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~-~~~~~~~~~~~----  237 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALF-LITTKGIPPLK----  237 (286)
T ss_pred             hhccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHH-HHHhcCCCCCc----
Confidence            11233478899999998764  67889999999999999999999986433211       011 11111111111    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....++..+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            11234567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-37  Score=276.43  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=203.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |.+.+.||.|+||.||++... ++..+++|.+.....   ....+.+|+++++.++|+|++++++.+......++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            566788999999999999866 688999999876543   3467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+.+......+..+++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            99999988855433457799999999999999999999998   999999999999999999999999999886544331


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......|++.|+|||...+.  .++.++|+||+|+++++|++|..||......        .............+   
T Consensus       159 --~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---  223 (258)
T cd08215         159 --LAKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPI---  223 (258)
T ss_pred             --eecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCC---
Confidence              22334688899999987664  6788999999999999999999998654321        12222222221111   


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         +..++..+.+++.+||+.+|++|||+.++++
T Consensus       224 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ---PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               2244568899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-37  Score=276.21  Aligned_cols=240  Identities=24%  Similarity=0.320  Sum_probs=193.6

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||.|++|.||+|... +++.+|+|.+.....    ..+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999976 588999999876432    236788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            998832    34588999999999999999999998   99999999999999999999999999998664432   112


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-CCCcccCccchhh
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIE  306 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  306 (373)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......      ......... .....      .+
T Consensus       151 ~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP------MEIYNDILKGNGKLE------FP  216 (262)
T ss_pred             cccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH------HHHHHHHhccCCCCC------CC
Confidence            33578899999998654  67889999999999999999999997654311      111112221 11111      12


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          307 SMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       307 ~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                      ...+..+.+++.+||+.+|++||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            223568999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-37  Score=282.18  Aligned_cols=255  Identities=25%  Similarity=0.324  Sum_probs=192.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +...+.||+|+||.||++... +++.+|+|.+......  ...+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            445678999999999999865 6889999998754332  356788999999996 999999999999888999999998


Q ss_pred             CcCCccccccC-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      .. ++.++... .......+++..+..++.+++.||+|||+.  .+++||||||+||+++.++.++|+|||++.......
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            53 55443211 112236689999999999999999999963  289999999999999999999999999987543322


Q ss_pred             CceeeecccCCCCccccccccccc-CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .   .....|+..|+|||.+.+.. ..++.++||||+||++|+|++|+.||......      .. .......+......
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~-~~~~~~~~~~~~~~  232 (288)
T cd06616         163 A---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV------FD-QLTQVVKGDPPILS  232 (288)
T ss_pred             c---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH------HH-HHhhhcCCCCCcCC
Confidence            1   12335888999999986531 25788999999999999999999998644310      00 11111111111111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ...+..++..+.+|+.+||+.+|++|||++++++
T Consensus       233 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         233 --NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             --CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              1112345678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3e-37  Score=273.29  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=200.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      |.+.+.||+|++|.||++... ++..+++|++..... ....+.+|+..++.++|+|++++++++..+...++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            456688999999999999976 688999999977654 457889999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++...   ...+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||.+........  
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          82 GSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999887432   25689999999999999999999998   999999999999999999999999999886654331  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                       .....++..|+|||.+.+.  ..+.++|+||||+++|+|++|..||.......       ... ............   
T Consensus       154 -~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~-~~~~~~~~~~~~---  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALF-KIATNGPPGLRN---  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHH-HHHhcCCCCcCc---
Confidence             2234588899999998764  57889999999999999999999987543211       111 111111111111   


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ...++..+.+++.+||+.||++|||+.++++
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 -PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1123567999999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.6e-37  Score=279.63  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=194.7

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      .+.||+|++|.||++... +++.+++|.+..... ..+.+.+|+.+++.++|||++++++++......++++||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            478999999999999864 688999998865433 235678999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++..     ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+........  ...
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~  173 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRK  173 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccc
Confidence            988732     4588999999999999999999998   999999999999999999999999998765433221  112


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||......        ................    +.
T Consensus       174 ~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~  239 (285)
T cd06648         174 SLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPKLKN----LH  239 (285)
T ss_pred             cccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCCCcc----cc
Confidence            34588999999998664  6788999999999999999999998653321        1111222221111111    12


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .++..+.+++.+||+.+|++|||++++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            24568999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.4e-38  Score=284.87  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=191.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|.+.+.||+|+||.||+|... +++.||+|.+......  ...+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            4667799999999999999865 6889999998754322  246778999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      . +++.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        86 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          86 H-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             c-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            5 677666532   224577888899999999999999998   999999999999999999999999999875432221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH---------HHHHHhc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW---------VYDQLNK  293 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~  293 (373)
                        ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||........ .....+         .+.....
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             --CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhh
Confidence              11233478899999988653 3467789999999999999999999975432100 000000         0000000


Q ss_pred             --CCCccc---Cccchh---hH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 --GGDLEL---QNVTEI---ES--MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 --~~~~~~---~~~~~~---~~--~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ......   ......   ..  ..+..+.+++.+|++.||.+|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              000000   000000   00  11357889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-37  Score=290.36  Aligned_cols=259  Identities=21%  Similarity=0.218  Sum_probs=193.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC------C
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------S  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~  133 (373)
                      ...|+..+.||+|+||.||+|... +++.||+|.+.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            456778899999999999999865 788999999865322   235677899999999999999999987543      3


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..++||||+. ++|.+.+.      ..++...+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQ------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             cEEEEEeccC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            5799999995 47777662      2278889999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc--------cchH
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFPS  285 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~  285 (373)
                      +........   .....++..|+|||.+.+.  .++.++|||||||++|+|++|+.||...+......        ....
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  239 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE  239 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            986543221   2234578899999998764  78889999999999999999999997543211000        0000


Q ss_pred             -------HHHHHHhcCCCcc---c----------CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          286 -------WVYDQLNKGGDLE---L----------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       286 -------~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                             .............   +          ......+...+..+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000000000000   0          00000112345678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.3e-37  Score=275.17  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=201.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~e  140 (373)
                      |...+.||+|++|.||+|... ++..+++|.+.....   ..+.+.+|+..+++++|+||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            455688999999999999976 788999999876553   357788999999999999999999999888  88999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..    ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          82 YVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             ecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999988842    23789999999999999999999998   9999999999999999999999999998866544


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..........++..|+|||.+.+.  ..+.++||||||+++++|++|..||......      ............     
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-----  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGE-----  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccccCC-----
Confidence            321112345688899999998764  5788999999999999999999998765411      011111111011     


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....+...+..+.+++.+|++.+|++||++.++++
T Consensus       222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             11223344678999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.8e-38  Score=282.68  Aligned_cols=243  Identities=26%  Similarity=0.347  Sum_probs=191.6

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||+|+||+||+|..+ +|+.+|+|.+.....    ....+.+|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 688999999875332    234567899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++....  ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            98884332  24689999999999999999999998   99999999999999999999999999987554321   122


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...++..|+|||.+.+.  .++.++|+||+|+++|+|++|+.||.........        ..+......   .....+.
T Consensus       153 ~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~---~~~~~~~  219 (277)
T cd05577         153 GRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK--------EELKRRTLE---MAVEYPD  219 (277)
T ss_pred             cccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH--------HHHHhcccc---ccccCCc
Confidence            34578899999998764  5788999999999999999999999654432110        011111110   1112223


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      .++..+.+++.+||+.||.+||     ++.+++.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            4467889999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-37  Score=288.55  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhccc-CCCceeeEeeEeee--CCee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE--GSKR  135 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~  135 (373)
                      ....|.+.+.||+|+||.||+|... +++.+|+|.+....   .....+.+|+.+++.+ +||||+++++++..  ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3456788899999999999999876 67899999885432   2235577899999999 99999999998854  3468


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||++ ++|..++..     ..+.+..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999996 588777621     2678888999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc---eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hH
Q 048542          216 FHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PS  285 (373)
Q Consensus       216 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~  285 (373)
                      ........   .......|+..|+|||.+.+. ..++.++|+||||+++|+|++|+.||............       ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            65433221   122234588899999987653 45778999999999999999999998654322110000       00


Q ss_pred             H---------HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          286 W---------VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       286 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .         ....+.................++..+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0         000000000000011111112256789999999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-37  Score=286.94  Aligned_cols=260  Identities=20%  Similarity=0.305  Sum_probs=191.7

Q ss_pred             cccCCC--CcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQG--GFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..||+|  +||+||++.+. +|+.||+|++......   .+.+.+|+.+++.++||||+++++++..+...++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  99999999865 7899999998765433   25678899999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      +++.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99998874432  23588899999999999999999998   99999999999999999999999998654322111100


Q ss_pred             e-----eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------------chH
Q 048542          225 S-----ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------------FPS  285 (373)
Q Consensus       225 ~-----~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------------~~~  285 (373)
                      .     .....++..|+|||.+.+....++.++||||+||++|+|++|..||...........              .+.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence            0     011234567999999876544678899999999999999999999975432110000              000


Q ss_pred             HHHHHH-------hc---------C---CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 WVYDQL-------NK---------G---GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 ~~~~~~-------~~---------~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       -....       ..         .   ..............++..+.+|+.+||+.||++|||++|+++
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 -EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             -hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             00000       00         0   000000011223456778999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-40  Score=323.10  Aligned_cols=248  Identities=27%  Similarity=0.340  Sum_probs=200.8

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      ..+||.|.||.||.|... +|...|+|-++....   ....+.+|..++..++|||++++||+-.+.+..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            367999999999999854 788899998764322   3366889999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc--
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--  223 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  223 (373)
                      +|.+.+    ..++..++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.|.........  
T Consensus      1320 sLa~ll----~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLL----EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             cHHHHH----HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999988    3455566777778889999999999998   9999999999999999999999999999876544211  


Q ss_pred             eeeecccCCCCccccccccccc-CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......||+.|||||++.+.. ..-.-+.||||+||++.||.||++||...+..-       .+.-.+..+..+.++  
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-------aIMy~V~~gh~Pq~P-- 1463 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-------AIMYHVAAGHKPQIP-- 1463 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-------HHHhHHhccCCCCCc--
Confidence            1233556999999999997753 223457899999999999999999997655421       112233344444433  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                          ..++..-.+++.+||..||++|-++.|+++.
T Consensus      1464 ----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                4478889999999999999999999888764

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.4e-38  Score=289.98  Aligned_cols=263  Identities=18%  Similarity=0.243  Sum_probs=195.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeee----CCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~  136 (373)
                      ..|.+.+.||.|+||.||+|..+ ++..||+|.+....   .....+.+|+.+++.++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            45667789999999999999865 78999999987542   234667889999999999999999988753    35689


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+. ++|.+++.    .+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          85 VVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            9999995 58887773    345589999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------ch---
Q 048542          217 HPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FP---  284 (373)
Q Consensus       217 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~---  284 (373)
                      .......  .......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........       .+   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            4332211  111234688899999987653 3578899999999999999999999965432110000       00   


Q ss_pred             ------HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 ------SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            .........................+..+.+++.+||+.+|++|||+++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  0000000000000000011122335678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=281.06  Aligned_cols=260  Identities=21%  Similarity=0.276  Sum_probs=198.9

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|++|.||+|..+ +++.+++|.+......   ...+.+|+.+++.++|+||+++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            355688999999999999865 7889999998765433   467888999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++ ++.+.+..   ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            65 77777633   235789999999999999999999998   99999999999999999999999999987664433 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhc--
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNK--  293 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~--  293 (373)
                       .......++..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||............       ....+.....  
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             -ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence             112234578889999998653 36788999999999999999999998654421100000       0000000000  


Q ss_pred             ------CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 ------GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            ...............++..+.+++.+||+.||.+||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  0000011112333456788999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=297.98  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=199.0

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccC--ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC------eeEEEEe
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVYE  140 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~e  140 (373)
                      .+.||+|+||.||+|+++ +|+.||||.++..  ....+.+.+|++++++++|+|||+++++-++..      ...++||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            467999999999999955 8999999998863  445688999999999999999999998765543      4679999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCC--ceEEeeccCccc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNF--IPKVSDFGLAKF  216 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~--~~kl~Dfg~~~~  216 (373)
                      ||.+|||...+...++ ...+++.+++.+..+++.||.|||++   +|+||||||.||++-  .+|  ..||+|||.|+-
T Consensus        98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            9999999999987765 45699999999999999999999998   999999999999984  223  579999999997


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC--
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--  294 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--  294 (373)
                      ..+..   .+....||..|++||.+..+ +.|+..+|.|||||++|+..||..||........... -.|  ....+.  
T Consensus       174 l~d~s---~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~-~~~--~~~tkkp~  246 (732)
T KOG4250|consen  174 LDDNS---LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE-IMW--HIITKKPS  246 (732)
T ss_pred             CCCCC---eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch-hhh--hhhccCCC
Confidence            76554   45667899999999999853 4788899999999999999999999986655432111 111  111110  


Q ss_pred             ---------CC------cccCccchhhHHHHHHHHHHHHhhcCCCCCCCC--CHHHHHHHHh
Q 048542          295 ---------GD------LELQNVTEIESMIARKLCMIGLWCIQVKAADRP--SMTKVLEMLE  339 (373)
Q Consensus       295 ---------~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp--s~~ell~~L~  339 (373)
                               ..      ..++......+.....+.+.+..+|..+|++|-  .+.+....+.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~  308 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD  308 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence                     00      011112223344455677778888888888887  5444444333

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.5e-38  Score=288.59  Aligned_cols=262  Identities=21%  Similarity=0.293  Sum_probs=193.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|.++.....   .....+|+.+++.++|+||+++++++...  ...++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            35677899999999999999875 6899999998754322   23456899999999999999999998654  568999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+.+ +|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        87 ~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          87 MEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            999964 777776432   35689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH-------HHHHHH
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS-------WVYDQL  291 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~~~~~~  291 (373)
                      ....  ......++..|+|||.+.+. ..++.++||||+||++|+|++|..||...........+..       ..+...
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            3321  12233457789999988653 3578899999999999999999999975432210000000       000000


Q ss_pred             hcC---CCccc-----CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKG---GDLEL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~---~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...   .....     ..........+..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000   00000     0000111224677899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.9e-37  Score=281.03  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=195.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|...+.||+|+||.||++... ++..+|+|.+......    ...+.+|+.+++.++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3556788999999999999865 6889999998654221    2468889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+.+ ++.+.+..   ...++++..+..++.+++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            9964 77666532   245689999999999999999999998   9999999999999999999999999988754322


Q ss_pred             CCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                            ....++..|+|||.+.. ..+.++.++|||||||++|+|++|..||.......       ... ..........
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-------~~~-~~~~~~~~~~  244 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQNESPTL  244 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-------HHH-HHHhccCCCC
Confidence                  23458889999998742 12467889999999999999999999986542211       111 1111111111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      .     ...++..+.+++.+||+.+|.+||++.++++.+--
T Consensus       245 ~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         245 Q-----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             C-----CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            1     12345678999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.7e-37  Score=280.71  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=193.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.+.||+|++|.||+|..+ +++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            4667789999999999999876 688999999865432   235678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~  220 (373)
                      ++ ++|.+.+...  ....+++..+..++.|++.||+|||++   +++|+||+|+||+++. ++.+||+|||++......
T Consensus        83 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         83 LD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            95 5777666322  223467888889999999999999998   9999999999999985 567999999999754332


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc---C---
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---G---  294 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~---  294 (373)
                      ..  ......++..|+|||.+.+. ..++.++||||+|+++|+|++|..||.......       ........   .   
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-------~~~~~~~~~~~~~~~  226 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-------ELFKIFRILGTPNEE  226 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhCCCChh
Confidence            11  12233578899999988653 357889999999999999999999997543211       01110000   0   


Q ss_pred             ---------------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 ---------------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                     ..............++..+.+++.+||+.+|++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           000000001112234667899999999999999999999986

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=268.35  Aligned_cols=261  Identities=24%  Similarity=0.331  Sum_probs=206.6

Q ss_pred             Hhhhh-cccCCCCcEEEEEEE-EcCCceeEEEEeccCccC-HHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      -|++. +.||+|+++.|-.+. ..+|..||||++.+...- ..+..+|++++...+ |+||+.++++|+++...|+|||.
T Consensus        78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            45554 679999999999997 668999999999876543 467899999999995 99999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---ceEEeeccCcccCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHP  218 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~~kl~Dfg~~~~~~  218 (373)
                      |.||+|...+    .+...+++.++.++..+|+.||.+||.+   ||.|||+||+|||.....   -+||+||.+..-..
T Consensus       158 m~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k  230 (463)
T KOG0607|consen  158 MRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK  230 (463)
T ss_pred             ccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccc
Confidence            9999998888    3456799999999999999999999998   999999999999996544   47999998876432


Q ss_pred             CCCC-----ceeeecccCCCCccccccc---ccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc-------cccccc
Q 048542          219 KEND-----FVSISATRGTIGYIAPELI---SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR-------SSKAYF  283 (373)
Q Consensus       219 ~~~~-----~~~~~~~~gt~~y~aPE~~---~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~-------~~~~~~  283 (373)
                      ....     .......+|+..|||||+.   .++...|+.++|.||||+++|-||+|.+||.+.-..       +.-...
T Consensus       231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C  310 (463)
T KOG0607|consen  231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC  310 (463)
T ss_pred             cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence            2221     1123456789999999975   334456888999999999999999999999653221       111223


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...+++.+..+. .++++  .-...++....+|+...+..|+.+|.++.+++.
T Consensus       311 Q~~LFesIQEGk-YeFPd--kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  311 QNKLFESIQEGK-YEFPD--KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHhccC-CcCCh--hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            334444444443 23332  333578889999999999999999999999887

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.9e-38  Score=277.71  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=197.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |.+.+.||+|+||.||+|..+ +|..+|+|.+....   ...+.+.+|+.+++.++|+||+++++.+......++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            566789999999999999876 67889999986542   23467789999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  221 (373)
                      ++++|.+++...  .+..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++ .++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          82 DGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999888432  234578999999999999999999998   999999999999998875 46999999987654332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      ..  .....|++.|+|||...+.  .++.++|+||||+++|+|++|..||......       ....... .....    
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~----  220 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-------QLVLKIC-QGYFA----  220 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHh-cccCC----
Confidence            21  1234588899999988654  6788999999999999999999998643321       1121111 11111    


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .....++..+.+++.+||+.+|++|||+.++++
T Consensus       221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              111234567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.9e-37  Score=283.62  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=190.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCC--------
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--------  133 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--------  133 (373)
                      .|++.+.||+|+||.||+|..+ +++.||+|.+.....   ....+.+|+.+++.++||||+++++++....        
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   92 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG   92 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence            5778899999999999999865 688999998864322   2245678999999999999999999986544        


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ..++||||+. ++|.+.+..   ....+++..+..++.|+++||+|||++   +++|+||||+||+++.++.+||+|||+
T Consensus        93 ~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          93 SFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             eEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence            4599999996 477766632   234689999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------h
Q 048542          214 AKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------P  284 (373)
Q Consensus       214 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~  284 (373)
                      +.........  .......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+       +
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9765432211  112234577889999987653 34678999999999999999999998654321100000       0


Q ss_pred             HHHHHHH---hcCCCcccCcc--chhhH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 SWVYDQL---NKGGDLELQNV--TEIES-----MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ~~~~~~~---~~~~~~~~~~~--~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...+...   ........+..  .....     ..+..+.+++.+||+.||.+|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000000   00000000000  00000     11346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=302.37  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=213.8

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +-.++||+|+||+||+|.+- .|+    +||||++......  ..++++|+..|.++.|||+++++++|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34478999999999999854 343    6899988765433  578999999999999999999999997655 789999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||+.|+|.+++..   .+..+..+..+.|..|||+||.|||.+   .++||||-.+|+|+..-..+|+.|||+++....+
T Consensus       778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            9999999999954   346688899999999999999999998   9999999999999999999999999999988776


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..........-.+.|+|-|.+...  .++.++||||||+.+||++| |..|+......        .+.+.++.+.++. 
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------eI~dlle~geRLs-  920 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------EIPDLLEKGERLS-  920 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------HhhHHHhccccCC-
Confidence            655555555667889999998764  89999999999999999997 88888765543        2445555555433 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                           .|+..+.++..++.+||..|++.||+++++...+.+...+..
T Consensus       921 -----qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  921 -----QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             -----CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence                 234566789999999999999999999999999998766553

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3e-37  Score=283.07  Aligned_cols=262  Identities=17%  Similarity=0.177  Sum_probs=192.8

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.+.+|.|+++.++++.. ++..||+|++....   ...+.+.+|+.+++.++|+||+++++++.+....+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            445566666666666554 68999999987542   23467899999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc--
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF--  223 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--  223 (373)
                      +|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||.+.........  
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9998885332  34588899999999999999999998   9999999999999999999999999988654322111  


Q ss_pred             ---eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc-----cchHH----HHHHH
Q 048542          224 ---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-----YFPSW----VYDQL  291 (373)
Q Consensus       224 ---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~-----~~~~~----~~~~~  291 (373)
                         .......++..|+|||.+.+....++.++|+||+||++|+|++|..||..........     ..+.+    .....
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence               0112334777899999987643457889999999999999999999997543211000     00000    00000


Q ss_pred             hcCC----------CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKGG----------DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....          .............++..+.+++.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000          00001112233456778999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=273.23  Aligned_cols=238  Identities=24%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.+.+.||+|.||+|.+++.+ +++.||+|++++.-.    ....-+.|-++|+..+||.+..+...|...+++|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            467799999999999999866 789999999987533    224456789999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      ..||.|.-.+    ++...+++....-+...|+.||.|||++   +||.||+|.+|.++|.+|++||+|||+++---...
T Consensus       250 anGGeLf~HL----srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  250 ANGGELFFHL----SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             ccCceEeeeh----hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            9999998777    3456688888888999999999999998   99999999999999999999999999997422211


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                        ..+...+|||.|+|||++...  .|+.++|+|.+|+++|||++|+.||...+...        .++.+.       ..
T Consensus       323 --~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------LFeLIl-------~e  383 (516)
T KOG0690|consen  323 --DTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------LFELIL-------ME  383 (516)
T ss_pred             --ceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccchhH--------HHHHHH-------hh
Confidence              235678999999999999875  88999999999999999999999998766532        111111       11


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                      ....|+.++++.+.|+...|..||.+|..
T Consensus       384 d~kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  384 DLKFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             hccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            12345667788999999999999999973

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-39  Score=296.27  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcC-CceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQT-GGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..++...||.|+||+||+|..+. +-..|-|++.... ...++++-|+++|..+.||+|+++++.|..++.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            34667889999999999998773 4456778776543 344889999999999999999999999988899999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      ||-.+..+.   .-+..+.+..+..+++|++.||.|||++   +|+|||||+.|||++-+|.++|+|||.+.......  
T Consensus       113 GGAVDaiml---EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  113 GGAVDAIML---ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             CchHhHHHH---HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence            999887763   3367899999999999999999999999   99999999999999999999999999986433211  


Q ss_pred             eeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          224 VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..-....|||.|||||+....   ...|+.++||||||+.|.+|..+.+|-..-.        ++-+.-.+.+...+.  
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMRVllKiaKSePPT--  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSEPPT--  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHHHHHHHhhcCCCc--
Confidence            122456799999999987543   3478899999999999999999988754222        111221222211111  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .-.|...+..+.+++.+||..||+.||++.++++
T Consensus       255 --LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 --LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             --ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence              1223566788999999999999999999999876

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.5e-38  Score=284.71  Aligned_cols=262  Identities=22%  Similarity=0.270  Sum_probs=194.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC----
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----  133 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----  133 (373)
                      .....|++.+.||+|+||.||+|..+ +++.||+|.++...   .....+.+|+.+++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34557788899999999999999976 67899999987543   22356778999999999999999999886654    


Q ss_pred             ------eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          134 ------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       134 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                            ..++++||+++ ++...+..   ....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 66665532   234689999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      |+|||++........ .......++..|+|||.+.+. ..++.++||||+||++|+|++|+.||...........    +
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~----~  230 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL----I  230 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----H
Confidence            999999886543321 112223467789999987543 3467899999999999999999999875432110000    0


Q ss_pred             HHHHhcCCC---ccc----------------CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 YDQLNKGGD---LEL----------------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ~~~~~~~~~---~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .........   ...                .........++..+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000   000                0000011124568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-37  Score=276.53  Aligned_cols=243  Identities=24%  Similarity=0.275  Sum_probs=188.4

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH----HHHHHHHHH-hcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVST-IGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||.|+||.||+|... +++.||+|.+.......    ..+..|... ....+|+|++++++++..+...++++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999865 68899999987543221    233444443 3445899999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......    
T Consensus        82 ~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----  150 (260)
T cd05611          82 GDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----  150 (260)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence            99998883    235688999999999999999999998   9999999999999999999999999988754321    


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                        ....++..|+|||.+.+.  .++.++||||+|+++|+|++|..||......        ........+... .  ...
T Consensus       151 --~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-~--~~~  215 (260)
T cd05611         151 --KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRIN-W--PEE  215 (260)
T ss_pred             --ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccC-C--CCc
Confidence              233578899999998765  5788999999999999999999999644321        122222221111 1  111


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ....++..+.+++.+||+.+|++||++.++.+.|+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            12245678999999999999999998876666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-37  Score=279.00  Aligned_cols=242  Identities=27%  Similarity=0.366  Sum_probs=193.3

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      .+||+|+||.||++..+ ++..+|+|.+..... ....+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            67999999999999875 788999998865433 3356889999999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeec
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA  228 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (373)
                      +++.     ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||++........  ....
T Consensus       106 ~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~  175 (292)
T cd06657         106 DIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS  175 (292)
T ss_pred             HHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence            8762     23578999999999999999999998   999999999999999999999999998875433221  1223


Q ss_pred             ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHH
Q 048542          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESM  308 (373)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (373)
                      ..++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||.......        ................    ..
T Consensus       176 ~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~----~~  241 (292)
T cd06657         176 LVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLPPKLKNL----HK  241 (292)
T ss_pred             cccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhhCCcccCCc----cc
Confidence            4588899999988653  67889999999999999999999986433211        1111211111111111    12


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          309 IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       309 ~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ++..+.+++.+||+.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3557889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.6e-37  Score=277.33  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=195.2

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||.|+||.||++... +|+.+++|.+.....    ..+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 589999999876543    236788899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC-----
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-----  222 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----  222 (373)
                      .+++..    ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            888832    23689999999999999999999998   999999999999999999999999999875433211     


Q ss_pred             -ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 -FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 -~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                       ........++..|+|||...+.  ..+.++|+||||+++|+|++|..||......        ........+. ...+.
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~  222 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGK-IEWPE  222 (265)
T ss_pred             ccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-cCCCc
Confidence             1122334578899999998764  5788999999999999999999998754421        1122222211 11111


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..    .++..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       223 ~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         223 DV----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cc----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            11    13567899999999999999999966666665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=306.98  Aligned_cols=274  Identities=22%  Similarity=0.218  Sum_probs=214.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...|.+.+.||+|+||.|..++.+ +++.||+|++.+..    .....|..|-.+|..-+.+-|+.++..|.++.++|+|
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV  153 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV  153 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence            556788899999999999999976 78899999998733    3346688888899888899999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||||+||+|-.++.    +-.++++..+.-++..|+-||.-+|+.   |+|||||||+|||+|..|++||+|||.|-.+.
T Consensus       154 MdY~pGGDlltLlS----k~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  154 MDYMPGGDLLTLLS----KFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             EecccCchHHHHHh----hcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            99999999999883    233799999999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          219 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .++ ...+...+|||.|.+||+++..   .+.|+..+|+||+|+++|||+.|..||.....-       .-.-..+....
T Consensus       227 ~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------eTY~KIm~hk~  298 (1317)
T KOG0612|consen  227 ADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------ETYGKIMNHKE  298 (1317)
T ss_pred             CCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH-------HHHHHHhchhh
Confidence            544 3456778899999999998542   267899999999999999999999999855421       11112222223


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH--HHhcCCC----CCCCCCCCccccCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS---MTKVLE--MLEGSID----DLQMPPRPFFSSSR  357 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---~~ell~--~L~~~~~----~~~~~~~p~~~~~~  357 (373)
                      .+.++..    ..+|..+++||++.+. +|+.|..   ++++-.  +++++-+    +..+|-.|...++.
T Consensus       299 ~l~FP~~----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~  364 (1317)
T KOG0612|consen  299 SLSFPDE----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDD  364 (1317)
T ss_pred             hcCCCcc----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCC
Confidence            3334422    2367788999988775 6778887   887754  2333322    33445555554443

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-37  Score=281.03  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=195.2

Q ss_pred             hhhhcccCCCCcEEEEEEEE----cCCceeEEEEeccCc-----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeE
Q 048542           67 NHFTHKLGQGGFGSVYKGQL----QTGGLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~----~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  136 (373)
                      |++.+.||+|+||.||++..    .+|..||+|++....     ...+.+.+|+.+++.+ +|+||+++++.+..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56678999999999999985    368899999987532     2235678899999999 5899999999999989999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          82 LILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999998883    235688999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....... ......|+..|+|||.+.+....++.++||||||+++|+|++|..||........   ... ......... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~-~~~~~~~~~-  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAE-ISRRILKSE-  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHH-HHHHhhccC-
Confidence            5332211 1123458889999999865434567889999999999999999999864322111   111 111111111 


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      .      ..+..++..+.+++.+||+.||++||     +++++++
T Consensus       229 ~------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 P------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             C------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            1      11233456789999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.6e-37  Score=277.64  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=186.6

Q ss_pred             ccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHH---HhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           72 KLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVS---TIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~---~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .||+|+||.||++... +++.||+|.+......    ...+.+|..   .+....||||+.+++.+......++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 6889999998764322    122334433   3444579999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++.    ....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999988773    345699999999999999999999998   99999999999999999999999999987543222  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....|+..|+|||.+.+. ..++.++|+||+|+++|+|++|+.||.........     ... ........      
T Consensus       152 --~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~-~~~~~~~~------  216 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EID-RMTLTMAV------  216 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHH-HHhhccCC------
Confidence              1234689999999998643 25788999999999999999999999765322110     011 11111111      


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      ..+..++..+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            12223467899999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.5e-37  Score=280.58  Aligned_cols=248  Identities=26%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .+|...+.||+|+||.||+|... ++..+|+|.+.....    ...++.+|+.+++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999965 678899998864322    2356788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+. |++.+.+..   .+..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 577666532   234588999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .      ....++..|+|||.+.+ ..+.++.++|||||||++|+|++|..||.......       ... ....+....
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~-~~~~~~~~~  233 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALY-HIAQNESPA  233 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-------HHH-HHhhcCCCC
Confidence            2      23357889999998753 12357789999999999999999999986533211       111 111111111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      ..     ...++..+.+++.+||+.+|++||+++++++.-
T Consensus       234 ~~-----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cC-----cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            11     123466789999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1e-36  Score=273.13  Aligned_cols=240  Identities=19%  Similarity=0.262  Sum_probs=185.5

Q ss_pred             hhhhcc--cCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHK--LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~--ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +.+.+.  ||+|+||.||++..+ ++..+|+|.+........    |......+ +|||++++++.+..++..++||||+
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~   91 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI   91 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence            344455  499999999999865 788899999876433221    22222222 6999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~  221 (373)
                      ++++|.+++.    .+..+++..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||++.......
T Consensus        92 ~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~  164 (267)
T PHA03390         92 KDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS  164 (267)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc
Confidence            9999999883    234789999999999999999999998   999999999999999888 99999999987654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                            ...++..|+|||.+.+.  .++.++||||+|+++|+|++|..||........  ....+.     ......   
T Consensus       165 ------~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~~~~---  226 (267)
T PHA03390        165 ------CYDGTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLL-----KRQQKK---  226 (267)
T ss_pred             ------cCCCCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHH-----Hhhccc---
Confidence                  23588999999998764  678899999999999999999999974432210  011111     111111   


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~ell~  336 (373)
                       ......++..+.+++.+||+.+|.+||+ ++++++
T Consensus       227 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        227 -LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             1122346678999999999999999996 688874

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-37  Score=285.90  Aligned_cols=255  Identities=22%  Similarity=0.298  Sum_probs=193.0

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---------------HHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---------------EEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---------------~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      +.+.||.|+||.||+|..+ +++.||+|.+.......               ..+.+|+.+++.++|+||+++++++..+
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4477999999999999865 68899999986543221               2467899999999999999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...+++|||+. ++|.+++.    ....+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCcc
Confidence            99999999996 58888773    345688999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCC------------CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc
Q 048542          213 LAKFHPKEN------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  280 (373)
Q Consensus       213 ~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~  280 (373)
                      ++.......            .........++..|+|||.+.+. ..++.++|+||+||++|+|++|..||........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-  242 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ-  242 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence            987654110            00111233467889999998653 3468899999999999999999999975543210 


Q ss_pred             ccchHHHHHHHhcCCCc-----------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          281 AYFPSWVYDQLNKGGDL-----------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ...+..........                 ............+..+.+++.+||+.+|++|||+++++.
T Consensus       243 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             ---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence               00011111000000                 000011111234567899999999999999999999987

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=271.69  Aligned_cols=245  Identities=24%  Similarity=0.373  Sum_probs=199.7

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |.+.+.||+|++|.||++... +++.|++|.+.....   ..+.+.+|++++..++|+|++++++++.+....+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            566789999999999999866 678999999987654   3467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          82 ENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999988832    35689999999999999999999998   999999999999999999999999999986654332


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .  .....++..|+|||...+.  ..+.++|+||+|+++|+|++|..||......       ...... ......     
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~-----  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRI-VQDDHP-----  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHH-hccCCC-----
Confidence            1  2234588899999998664  4788999999999999999999998643311       011111 111111     


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ..+..++..+.+++.+||+.+|++|||+.+++.
T Consensus       218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             112234568899999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=281.48  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=202.1

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .-+.||+|+||.||-+..+ +|..||+|.+.+....    ....++|-.++.+++.+.||.+-..|+..+.+|+|+..|.
T Consensus       189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN  268 (591)
T KOG0986|consen  189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN  268 (591)
T ss_pred             eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence            3478999999999999855 8999999988764332    2456789999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      ||+|.-.+.+..+  ..+++..+.-++.+|+.||++||+.   +||.||+||+|||+|+.|+++|+|.|+|.-+....  
T Consensus       269 GGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--  341 (591)
T KOG0986|consen  269 GGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--  341 (591)
T ss_pred             CCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC--
Confidence            9999888866543  5699999999999999999999998   99999999999999999999999999999775544  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       ......||.+|||||++.+.  .|+...|+||+||++|+|+.|+.||.......        .++.++...   +....
T Consensus       342 -~~~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------k~eEvdrr~---~~~~~  407 (591)
T KOG0986|consen  342 -PIRGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------KREEVDRRT---LEDPE  407 (591)
T ss_pred             -ccccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhh--------hHHHHHHHH---hcchh
Confidence             23455799999999999886  68889999999999999999999997544322        111222211   12234


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      +++..+++++++|.+..|+.||.+|....
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            56677889999999999999999998654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-37  Score=280.34  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=198.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCc-----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  136 (373)
                      |++.+.||+|++|.||++...    ++..+|+|.++...     ...+.+.+|+.++..+ +||||+++++.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            456789999999999999743    56789999987532     1235678899999999 5999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++.    ....+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999988873    234688999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....... ......|+..|+|||.+.+.....+.++|+||||+++|+|++|..||........   ... ......... 
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~-~~~~~~~~~-  228 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSE-ISRRILKSK-  228 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHH-HHHHHHccC-
Confidence            4332211 1123458889999999866433467899999999999999999999864332110   011 111111111 


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                            ...+..++..+.+++.+||+.||++|||+.++.+.|+-
T Consensus       229 ------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                  11223345678999999999999999999988887764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-37  Score=279.00  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..|++.+.||+|+||.||+|.++ +++.||+|.++.....  ...+..|+.++.+.. ||||+++++++.+....+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            34677899999999999999977 4889999998764332  245667777676664 9999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |++ +++.++...   ....+++..+..++.|++.|++|||+ .   +++||||+|+||+++.++.+||+|||++.....
T Consensus        95 ~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            985 466655522   13478999999999999999999996 5   899999999999999999999999999876543


Q ss_pred             CCCceeeecccCCCCccccccccccc--CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ...   .....++..|+|||.+.+..  +.++.++|+||||+++|+|++|+.||.......      . ...........
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~  237 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------E-VLTKILQEEPP  237 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------H-HHHHHhcCCCC
Confidence            221   12334778999999986542  347889999999999999999999986432210      0 11111111111


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .....    ..++.++.+++.+||+.||++||+++++++.
T Consensus       238 ~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPPN----EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111    1245678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4e-38  Score=268.89  Aligned_cols=268  Identities=21%  Similarity=0.263  Sum_probs=199.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-C----CceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee-CCeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-T----GGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~  136 (373)
                      .|+....||+|.||.||+|..+ +    ...+|||.++..+..   .....+|+.+++.++|||++.+..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            5677899999999999999533 2    237899999865332   2456899999999999999999998866 88999


Q ss_pred             EEEeccCcCCccccccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC----CceEEeec
Q 048542          137 LVYEYMPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDF  211 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~----~~~kl~Df  211 (373)
                      +++||.+. +|...+.-+ ..+...++...+..|+.||+.|+.|||++   =|+||||||.|||+..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999977 676666433 23346799999999999999999999998   79999999999999877    89999999


Q ss_pred             cCcccCCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc--cccchHHHH
Q 048542          212 GLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--KAYFPSWVY  288 (373)
Q Consensus       212 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~  288 (373)
                      |+++.+...-.. ......+.|..|.|||.+.|. ..|+.+.||||+||++.||++-.+.|........  ..+-.+.+.
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999976544322 234455689999999999886 6899999999999999999999887765442211  122122222


Q ss_pred             HHHhcCCCc---ccCc---cch-----------------hh------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          289 DQLNKGGDL---ELQN---VTE-----------------IE------SMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       289 ~~~~~~~~~---~~~~---~~~-----------------~~------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      ..++--+.+   ..+.   ..+                 +.      ..-+....+|+.++|..||-+|.|+++.++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            222111110   0000   000                 00      00123478999999999999999999998754

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.7e-37  Score=285.75  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=191.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeC----------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEG----------  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----------  132 (373)
                      .+|.+.+.||.|+||.||+|... +++.||+|.+...... .+.+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            45677899999999999999865 6889999998765433 36688999999999999999999776543          


Q ss_pred             ----CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceE
Q 048542          133 ----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPK  207 (373)
Q Consensus       133 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~k  207 (373)
                          ...+++|||++ ++|.+++.     ...+++..+..++.|+++||.|||+.   +++||||||+||+++ .++.++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence                35789999996 58877662     24588999999999999999999998   999999999999997 456789


Q ss_pred             EeeccCcccCCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc----
Q 048542          208 VSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----  282 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~----  282 (373)
                      |+|||++.......... ......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........    
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999987553221111 11223478899999987542 3577899999999999999999999975432110000    


Q ss_pred             -----------chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 -----------FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                 ..........................++..+.+++.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                       000000000000000000011112235677899999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-37  Score=275.68  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=195.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEecc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      |++.+.||.|++|.||+|... +++.++||.+......  .....+|+..++.++ |+|++++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456788999999999999976 5788999998764332  234567999999998 999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                       +++|.+.+....  +..+++..+..++.|++.+|.|||++   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             788888774322  34689999999999999999999998   999999999999999999999999999876543222


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc---------cchHHHHH-HHh
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA---------YFPSWVYD-QLN  292 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~---------~~~~~~~~-~~~  292 (373)
                         .....++..|+|||.+.+. ..++.++|+||||+++++|++|+.||..........         .-..|... ...
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             ---cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence               1234578899999988543 357889999999999999999999986554221100         00001000 000


Q ss_pred             cCCCcccCc-----cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDLELQN-----VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .........     ........+..+.+++.+||+.+|++|||++|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000000     01111122467999999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-37  Score=272.89  Aligned_cols=271  Identities=24%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc--CCCceeeEeeEeeeC----Ce
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI--HHVNVVQLLGFCSEG----SK  134 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~~~~~~~----~~  134 (373)
                      .-.+.+-.+.+.||+|.||.||+|.++ |+.||||++...  +...+.+|.++++..  +|+||+.+++.=..+    ..
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            334455567789999999999999999 999999998643  457788888888764  899999998764332    35


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG-----CDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~-----~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      ++||++|.+.|||+|++.     ...++.+...+++..+|.||++||..     ..+.|.|||||..|||+..++.+.|+
T Consensus       284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            789999999999999993     36688899999999999999999963     35789999999999999999999999


Q ss_pred             eccCcccCCCCCCce--eeecccCCCCcccccccccccC--Cc-C-cccchHHHHHHHHHHHcCC----------CCCCC
Q 048542          210 DFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFG--TV-S-CKSDVYGFGMVLLEMAGGR----------RNSNM  273 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~--~~-s-~~~DvwslG~~l~~ll~g~----------~p~~~  273 (373)
                      |+|+|..........  ..+..+||.+|||||++.....  .+ + ..+||||||.++||+....          .||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            999998766543322  2345679999999999865311  11 1 2589999999999998542          45544


Q ss_pred             CcCccccccchHHHHHHH-hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          274 NATRSSKAYFPSWVYDQL-NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .-+...  .+.+ +.+.+ .+..++..++ ..........+.+||+.||..+|.-|.|+--+-+.|..+.+
T Consensus       439 ~Vp~DP--s~ee-MrkVVCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  439 VVPSDP--SFEE-MRKVVCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCC--CHHH-HhcceeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            332111  0100 11111 1112222222 22223445678999999999999999999999999987654

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-36  Score=276.51  Aligned_cols=245  Identities=26%  Similarity=0.352  Sum_probs=191.8

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +...+.||+|+||.||+|... ++..|++|.+.....    ....+.+|+.+++.++|||++++++++.+....+++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            444578999999999999865 688999999865332    225678899999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +. +++.+.+..   ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++...... 
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-  174 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-  174 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence            95 577666532   245689999999999999999999998   9999999999999999999999999988643221 


Q ss_pred             CceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                           ....|+..|+|||.+.. ..+.++.++||||||+++|+|++|..||.......       ...... ....... 
T Consensus       175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~-~~~~~~~-  240 (313)
T cd06633         175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIA-QNDSPTL-  240 (313)
T ss_pred             -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHH-hcCCCCC-
Confidence                 23458889999999753 12467889999999999999999999986543211       111111 1111111 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                          ....++..+.+++.+||+.+|.+||++.++++.
T Consensus       241 ----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 ----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                112334578999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-37  Score=304.31  Aligned_cols=249  Identities=27%  Similarity=0.359  Sum_probs=185.0

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----------
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----------  133 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----------  133 (373)
                      +-.+.||+||||.||+++++ +|+.||||++....  .....+.+|+.++.+|+|||||+++..+.+..           
T Consensus       482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~  561 (1351)
T KOG1035|consen  482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS  561 (1351)
T ss_pred             HHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence            33478999999999999988 89999999998763  33467889999999999999999885441100           


Q ss_pred             --------------------------------------------------------------------------------
Q 048542          134 --------------------------------------------------------------------------------  133 (373)
Q Consensus       134 --------------------------------------------------------------------------------  133 (373)
                                                                                                      
T Consensus       562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~  641 (1351)
T KOG1035|consen  562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI  641 (1351)
T ss_pred             chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence                                                                                            


Q ss_pred             ----------------------------eeEEEEeccCcCCccccccCCCCCCCCC-CHHHHHHHHHHHHHHHHHHHcCC
Q 048542          134 ----------------------------KRALVYEYMPNGSLDRHVFPKESRGQSL-CWEKLHEVALGTARGIEYLHNGC  184 (373)
Q Consensus       134 ----------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~i~~al~~LH~~~  184 (373)
                                                  .+||-||||+..++.+++..+    ... ....+|+++.+|++||+|+|++ 
T Consensus       642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaYIH~~-  716 (1351)
T KOG1035|consen  642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAYIHDQ-  716 (1351)
T ss_pred             cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHHHHhC-
Confidence                                        134566777666665555221    111 4678899999999999999998 


Q ss_pred             CCCeEecCcCCCCeeeeCCCceEEeeccCcccCC----------------CCCCceeeecccCCCCcccccccccccC-C
Q 048542          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP----------------KENDFVSISATRGTIGYIAPELISRNFG-T  247 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~  247 (373)
                        |++||||||.||+++.++.+||+|||+++...                ........+...||.-|+|||.+.+... .
T Consensus       717 --giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  717 --GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             --ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence              99999999999999999999999999998621                0011113456679999999999987632 6


Q ss_pred             cCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCC
Q 048542          248 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAAD  327 (373)
Q Consensus       248 ~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  327 (373)
                      |+.|+|+||+|++++||+.   ||...-.       ...+...++.+..+..   ..+...-...-.+++.+|++.||.+
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsME-------Ra~iL~~LR~g~iP~~---~~f~~~~~~~e~slI~~Ll~hdP~k  861 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSME-------RASILTNLRKGSIPEP---ADFFDPEHPEEASLIRWLLSHDPSK  861 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHH-------HHHHHHhcccCCCCCC---cccccccchHHHHHHHHHhcCCCcc
Confidence            9999999999999999994   4543322       2224445554433332   2222222344578999999999999


Q ss_pred             CCCHHHHHH
Q 048542          328 RPSMTKVLE  336 (373)
Q Consensus       328 Rps~~ell~  336 (373)
                      |||+.|+|.
T Consensus       862 RPtA~eLL~  870 (1351)
T KOG1035|consen  862 RPTATELLN  870 (1351)
T ss_pred             CCCHHHHhh
Confidence            999999986

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=270.76  Aligned_cols=248  Identities=23%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc------cCHHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK------FSAEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~  136 (373)
                      .|++.+.||+|+||.||+|... ++..+|+|.+....      .....+.+|+.+++.++|+||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            4667899999999999999865 68899999875321      1225788899999999999999999988654  4678


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          83 IFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            9999999999988873    234578899999999999999999998   999999999999999999999999999975


Q ss_pred             CCCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ...... ........++..|+|||.+.+.  .++.++|+|||||++|+|++|+.||......       ....+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  226 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPT  226 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCC
Confidence            432111 1112234588899999998764  6788999999999999999999998643221       11111111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .      ...+..++..+.+++.+||+ +|..||++.+++.
T Consensus       227 ~------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         227 K------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1      12334566789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-37  Score=284.00  Aligned_cols=266  Identities=21%  Similarity=0.265  Sum_probs=200.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----eeEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRAL  137 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~l  137 (373)
                      |++.+.||.|++|.||+|... +++.+|+|.+....   ...+.+.+|+.+++.++|+||+++++++....     ..|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            667899999999999999976 58899999987643   23467889999999999999999999987765     7899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +|||++ ++|.+.+.    .+..+++..+..++.+++.||+|||+.   +++|+||||+||+++.++.++|+|||++...
T Consensus        82 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          82 VTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             Eecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            999997 47877773    234799999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc---------hHH-
Q 048542          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---------PSW-  286 (373)
Q Consensus       218 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~---------~~~-  286 (373)
                      ...... .......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||...........+         ..+ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            443210 112334578899999998764 26788999999999999999999999755422100000         000 


Q ss_pred             ------HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcC
Q 048542          287 ------VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGS  341 (373)
Q Consensus       287 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~  341 (373)
                            ....+.................++..+.+++.+||+.+|.+|||++++++.  +++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                  000000000000000111223356789999999999999999999999873  5554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=274.12  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=191.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhccc---CCCceeeEeeEeeeCCe-----
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRI---HHVNVVQLLGFCSEGSK-----  134 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~-----  134 (373)
                      |++.+.||+|+||.||+|.++ ++..+|+|.++.....   ...+.+|+.+++.+   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999977 5889999998754322   24566777776665   59999999999987766     


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++|||+. ++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999996 47877764322  23589999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-  293 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  293 (373)
                      ........   .....++..|+|||.+.+.  .++.++|+|||||++|+|++|..||........   .... ...... 
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~-~~~~~~~  225 (287)
T cd07838         155 RIYSFEMA---LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKI-FDVIGLP  225 (287)
T ss_pred             eeccCCcc---cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHH-HHHcCCC
Confidence            76543321   1223478899999998764  678899999999999999999988875432210   0000 000000 


Q ss_pred             -------C--------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 -------G--------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 -------~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                             .        ..............++..+.+++.+||+.||++||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   0        000000112222345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.3e-37  Score=275.92  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=198.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|.+.+.||+|+||.||+|... +++.+|+|++.....    ....+.+|..+++.++ ||||+++++++..+...+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            3667789999999999999865 789999999876322    2356788999999998 999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    +...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          82 EYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999998883    334799999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCc------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc
Q 048542          220 ENDF------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA  281 (373)
Q Consensus       220 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~  281 (373)
                      ....                  .......++..|+|||.+.+.  ..+.++|+||||++++++++|..||......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----  228 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----  228 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH----
Confidence            2211                  112233578899999988764  6788999999999999999999998755421    


Q ss_pred             cchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHH
Q 048542          282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM----TKVLE  336 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~----~ell~  336 (373)
                          ......... .      ...+..++..+.+++.+||+.+|.+|||+    +++++
T Consensus       229 ----~~~~~~~~~-~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 ----LTFQKILKL-E------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHHHHHhc-C------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                111111111 1      11122336678999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-36  Score=282.64  Aligned_cols=262  Identities=21%  Similarity=0.258  Sum_probs=194.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------e
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~  134 (373)
                      .+|++.+.||+|+||.||+|... ++..||+|.+......   ...+.+|+.+++.++||||+++++++..+.      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            35667799999999999999855 7889999998653222   356789999999999999999999886543      3


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        95 ~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            58999998 778877762     24688999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc-------cchHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------YFPSWV  287 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~  287 (373)
                      .......     ....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||..........       ..+...
T Consensus       166 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         166 RQTDSEM-----TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             cccccCc-----cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            7553321     234578899999988653 357889999999999999999999997543210000       000000


Q ss_pred             HHHHhcC---------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH--HHHhcC
Q 048542          288 YDQLNKG---------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL--EMLEGS  341 (373)
Q Consensus       288 ~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell--~~L~~~  341 (373)
                      ...+...         ..............++..+.+++.+|++.||++|||+.+++  ..++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence            0000000         00000000111223456789999999999999999999998  445444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.2e-37  Score=272.84  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=193.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC------ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      +|.+.+.||+|+||.||++... .+..+++|+++..      .....++..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            3667899999999999999865 3445666665432      12234567789999999999999999999988999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +||+++++|.+++......+..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999888754334456799999999999999999999998   9999999999999975 569999999987654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  ......|+..|+|||.+.+.  .++.++|+||||+++|+|++|..||......        ........+... 
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~-  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTP-  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCC-
Confidence            3222  12234578899999988654  6778899999999999999999998643211        111111112111 


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ..+..++..+.+++.+||+.+|++||++.++++
T Consensus       224 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 -----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                 122455678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-36  Score=279.71  Aligned_cols=258  Identities=22%  Similarity=0.256  Sum_probs=192.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~  139 (373)
                      ..|++.+.||.|+||.||+|... ++..||+|.+....   .....+.+|+.+++.++||||+++++++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            45677899999999999999865 78899999876432   234677899999999999999999998865 56789999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+ +++|.+++.     ...+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        90 e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          90 ELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             ehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            998 568877762     34578888899999999999999998   999999999999999999999999999875432


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHHHHHh
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVYDQLN  292 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~  292 (373)
                      ..     ....++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||...........       .+........
T Consensus       161 ~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         161 QM-----TGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             Cc-----CCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            11     233578889999987542 3578899999999999999999999865432110000       0000000000


Q ss_pred             cCCCc---------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          293 KGGDL---------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       293 ~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .....         ......+....++..+.+++.+||+.+|++|||+++++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000         0000011112345789999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-36  Score=282.78  Aligned_cols=261  Identities=22%  Similarity=0.289  Sum_probs=191.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC------Cee
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKR  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~  135 (373)
                      .|.+.+.||+|+||.||+|... +|+.||+|.+.....   ....+.+|+.+++.++||||+++++++...      ...
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   95 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF   95 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence            4556789999999999999865 789999999875322   235678999999999999999999988654      246


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++++||+.. +|....      +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        96 ~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          96 YLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             EEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            899999853 665443      24588999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------chHHHH
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FPSWVY  288 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~~~  288 (373)
                      ......     ....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........       ......
T Consensus       166 ~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         166 HADAEM-----TGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCCCCC-----CCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            543221     234578889999988652 3578899999999999999999999975432110000       000000


Q ss_pred             HHHhcC-------CCcccC--ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcCC
Q 048542          289 DQLNKG-------GDLELQ--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSI  342 (373)
Q Consensus       289 ~~~~~~-------~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~  342 (373)
                      ......       ......  .........+..+.+++.+||+.||.+||++++++.  .+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            000000       000000  000111234567899999999999999999999984  366543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-36  Score=277.75  Aligned_cols=264  Identities=24%  Similarity=0.282  Sum_probs=190.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC--------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG--------  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------  132 (373)
                      ..|++.+.||.|+||.||+|..+ +++.+|+|.+.....   ....+.+|+++++.++||||+++++++.+.        
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            46778899999999999999866 688999998865332   224567899999999999999999987443        


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++++||+.+ ++...+..   ....+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence            346899999965 56555532   235699999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCc---------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc
Q 048542          213 LAKFHPKENDF---------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF  283 (373)
Q Consensus       213 ~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~  283 (373)
                      ++.........         .......+++.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99754332211         111233467889999987653 35788999999999999999999998654322100000


Q ss_pred             -------hHHHHHHHh---cCC--C--cccC-ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 -------PSWVYDQLN---KGG--D--LELQ-NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 -------~~~~~~~~~---~~~--~--~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                             ....+....   ...  .  .... ...+....+...+.+++.+||+.||++|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                   000000000   000  0  0000 000111123467899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.2e-36  Score=279.48  Aligned_cols=261  Identities=21%  Similarity=0.226  Sum_probs=189.0

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-C--CceeEEEEeccCcc---CHHHHHHHHHHhccc-CCCceeeEeeEeee----CCee
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-T--GGLIAVKMLENSKF---SAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKR  135 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~--~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~  135 (373)
                      |++.+.||+|+||.||++... +  +..||+|.+.....   ....+.+|+.+++.+ +||||+++++.+..    ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            567789999999999999865 4  67899998875322   235678899999999 59999999987532    2457


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      +++++|+. ++|.+.+.    .+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          82 YLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            88999985 68887773    345689999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCCCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc--------cchH
Q 048542          216 FHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA--------YFPS  285 (373)
Q Consensus       216 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~--------~~~~  285 (373)
                      ........  .......|+..|+|||.+.+. ..++.++|+||+|+++|+|++|..||..........        ....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            55432211  112234688999999987543 357889999999999999999999987543210000        0000


Q ss_pred             HHHH--------HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 WVYD--------QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 ~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....        ....................+..+.+++.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000        00000000000001111123567899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=299.99  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=209.3

Q ss_pred             hhhcccCCCCcEEEEEEEEc----C----CceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ----T----GGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~----~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  136 (373)
                      .+.+.+|+|.||.|++|..+    .    ...||||.++.....  .+.+..|+++|+.+ +|+||+.++|+|......+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            55679999999999999743    1    347999998865444  47889999999999 6999999999999999999


Q ss_pred             EEEeccCcCCccccccCCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          137 LVYEYMPNGSLDRHVFPKE---S-------RG--QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      +|+||+..|+|.+++...+   .       ..  ..++....+.++.|||.|++||++.   +++|||+-.+|||+..+.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence            9999999999999996554   0       01  2388999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCCCceeeeccc--CCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccc
Q 048542          205 IPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKA  281 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~  281 (373)
                      .+||+|||+++.......+.. ....  -+..|||||.+...  .|+.++||||||+++||+++ |..|++....     
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----  527 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----  527 (609)
T ss_pred             EEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCCc-----
Confidence            999999999986555444332 2222  34569999999764  89999999999999999998 6677754221     


Q ss_pred             cchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        ...+.+.+..|.+.+.+.      .++.++.++|+.||+.+|++||++.++.+.++..+.
T Consensus       528 --~~~l~~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 --TEELLEFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             --HHHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence              122355677777766553      345688999999999999999999999999998543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-36  Score=279.53  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=189.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC------Ce
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~  134 (373)
                      .+|.+.+.||+|+||.||+|... +++.||+|.+......   .+.+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            35666789999999999999854 7889999998754322   35678899999999999999999988543      34


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++++++ +++|.+.+.     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        97 ~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~  167 (345)
T cd07877          97 VYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  167 (345)
T ss_pred             EEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccc
Confidence            67888887 778877662     23588999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWV  287 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~  287 (373)
                      ......     .....++..|+|||.+.+. ..++.++||||+||++|+|++|+.||...........+       +...
T Consensus       168 ~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T cd07877         168 RHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  241 (345)
T ss_pred             cccccc-----ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            754322     1234578899999987653 35788999999999999999999998654321100000       0000


Q ss_pred             HHHHhcC---------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          288 YDQLNKG---------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       288 ~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ...+...         ...............+..+.+++.+|++.||.+|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000000         0000000000001235678999999999999999999998863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=282.32  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=193.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------  134 (373)
                      ..|.+.+.||+|++|.||+|... ++..||+|.+.....   ....+.+|+.+++.++|||++++++++.....      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            35677899999999999999976 678999998865322   23567789999999999999999987765544      


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++|+||+ +++|.+++.     ...+++..+..++.|+++||+|||+.   +++|+||||+||+++.++.++|+|||++
T Consensus        95 ~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          95 VYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             EEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence            89999998 668888773     24689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHH
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWV  287 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~  287 (373)
                      ......     .....++..|+|||.+.+. ..++.++||||+|+++|+|++|+.||...........+       +...
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            765332     2234578899999988653 35678999999999999999999999754321100000       0000


Q ss_pred             HHHHh--------c-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 YDQLN--------K-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ~~~~~--------~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....        . ...............++..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000        0 0000000001111234678999999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-36  Score=263.73  Aligned_cols=235  Identities=29%  Similarity=0.385  Sum_probs=190.4

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      ||.|+||.||++... +++.+++|.+.....    ..+.+.+|+.+++.++|||++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 588999999876543    335788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      .+++..    ...+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN  151 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence            988832    34689999999999999999999998   999999999999999999999999999876543321  123


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...++..|+|||...+.  ..+.++|+||||+++|+|++|..||......        ........ ....      .+.
T Consensus       152 ~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~------~~~  214 (250)
T cd05123         152 TFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--------EIYEKILK-DPLR------FPE  214 (250)
T ss_pred             CCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHhc-CCCC------CCC
Confidence            44578899999998764  5778999999999999999999998644321        11111211 1111      112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTK  333 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~e  333 (373)
                      ..+..+.+++.+||..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            23567899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-36  Score=270.75  Aligned_cols=259  Identities=24%  Similarity=0.322  Sum_probs=195.5

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ++.+.||+|++|.||+|... +++.+|+|.+....   ...+.+.+|+.+++.++|+|++++++++.+....++|+||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            45678999999999999876 58999999988643   233677889999999999999999999999999999999997


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                       ++|.+++...   ...+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        82 -~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          82 -MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             -cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence             5898888432   14689999999999999999999998   999999999999999999999999999876543321 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhcC--
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNKG--  294 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~--  294 (373)
                       ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||............       ....+......  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence             12233467789999988653 36788999999999999999999988654321100000       00000000000  


Q ss_pred             CCcccC-----ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 GDLELQ-----NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....+     .........+..+.+++.+||+.||++||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000     001111223668999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=283.02  Aligned_cols=238  Identities=22%  Similarity=0.304  Sum_probs=192.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++...+|.|+|+.|-.+... +++..++|++.....   +..+|+.++... +||||+++++.+.++...|+|||.+
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            45777888999999999999855 788999999987632   224567666555 7999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee-eCCCceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~-~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      .++-+.+.+..    ..... .++.+|+.+|+.|+.|||++   |++|||+||+|||+ +..++++|+|||.++..... 
T Consensus       399 ~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  399 DGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             cccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            98887766632    22233 67788999999999999998   99999999999999 58899999999999865443 


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                          +...+-|..|.|||++...  .++.++|+||||++||+||+|+.||......       ..+...+..+       
T Consensus       470 ----~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~-------  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMP-------  529 (612)
T ss_pred             ----hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCC-------
Confidence                3455678899999999865  8999999999999999999999998754432       1122222111       


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .....+|...++|+.+||+.||.+||++.++..
T Consensus       530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              122567889999999999999999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=268.91  Aligned_cols=269  Identities=22%  Similarity=0.315  Sum_probs=207.6

Q ss_pred             CCccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH--------HHHHHHHHHhcccCCCceee
Q 048542           54 PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA--------EEFINEVSTIGRIHHVNVVQ  124 (373)
Q Consensus        54 ~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------~~~~~e~~~l~~l~h~ni~~  124 (373)
                      ...|........+|-+.+.||+|||+.||+|.+- .++.||+|+-...+.-.        +...+|..+.+.|.||.||+
T Consensus       452 nSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  452 NSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             hhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            3445555567788889999999999999999744 57788999865432211        34678999999999999999


Q ss_pred             EeeEee-eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-
Q 048542          125 LLGFCS-EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-  202 (373)
Q Consensus       125 ~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-  202 (373)
                      +|+++. +...+|-|+|||+|.+|+-++    ...+.++++++..|+.||+.||.||... ..+|+|.||||.|||+-. 
T Consensus       532 lYDyfslDtdsFCTVLEYceGNDLDFYL----KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G  606 (775)
T KOG1151|consen  532 LYDYFSLDTDSFCTVLEYCEGNDLDFYL----KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG  606 (775)
T ss_pred             eeeeeeeccccceeeeeecCCCchhHHH----HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence            999985 456788999999999998888    4567799999999999999999999986 678999999999999953 


Q ss_pred             --CCceEEeeccCcccCCCCCCc-----eeeecccCCCCccccccccc--ccCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          203 --NFIPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       203 --~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                        -|.+||+|||++..+..+...     .......||..|++||++--  .....+.|+||||+|+++|..+.|+.||+.
T Consensus       607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence              467999999999987654322     22345579999999998743  245788999999999999999999999987


Q ss_pred             CcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          274 NATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......-.     ....+-+.....++.    .+.++.+...+|++||+..-++|....++..
T Consensus       687 nqsQQdIL-----qeNTIlkAtEVqFP~----KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  687 NQSQQDIL-----QENTILKATEVQFPP----KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             chhHHHHH-----hhhchhcceeccCCC----CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            65432110     011111111111221    1345678899999999999999999888754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=270.98  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=205.9

Q ss_pred             ccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCC--C----ceeeEeeE
Q 048542           56 RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHH--V----NVVQLLGF  128 (373)
Q Consensus        56 ~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~----ni~~~~~~  128 (373)
                      .|..+++...+|.+.+.+|+|.||.|-.+.++ ++..||+|+++.-..-.+..+-|++++.++.+  |    -++.+.++
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            46677888899999999999999999999755 57899999998766556677889999999942  3    37788889


Q ss_pred             eeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC------
Q 048542          129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH------  202 (373)
Q Consensus       129 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~------  202 (373)
                      |+-.++.|+|+|.+ |.|+.+++..  ++-.+++...+..++.|+++++++||+.   +++|.||||+|||+-.      
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence            99999999999998 6699999843  3456789999999999999999999998   9999999999999821      


Q ss_pred             --------------CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCC
Q 048542          203 --------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (373)
Q Consensus       203 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~  268 (373)
                                    +..++++|||.|++.....     .....|-.|.|||++.+-  .++.++||||+||||+||.+|.
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~ElytG~  306 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELYTGE  306 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheecc--CcCCccCceeeeeEEEEeeccc
Confidence                          2358999999998765443     334578899999999986  7899999999999999999999


Q ss_pred             CCCCCCcCcccccc-------chHHHHH------HHhcCCCcccCccc-------------h------hhHHHHHHHHHH
Q 048542          269 RNSNMNATRSSKAY-------FPSWVYD------QLNKGGDLELQNVT-------------E------IESMIARKLCMI  316 (373)
Q Consensus       269 ~p~~~~~~~~~~~~-------~~~~~~~------~~~~~~~~~~~~~~-------------~------~~~~~~~~l~~l  316 (373)
                      ..|....+.+.-..       +|.-+..      ....+ .++.++..             .      ........+.+|
T Consensus       307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDL  385 (415)
T KOG0671|consen  307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDL  385 (415)
T ss_pred             eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHH
Confidence            98876654331111       1111111      11111 22211100             0      011234569999


Q ss_pred             HHhhcCCCCCCCCCHHHHHH
Q 048542          317 GLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       317 i~~cl~~dp~~Rps~~ell~  336 (373)
                      +++||..||.+|+|+.|++.
T Consensus       386 l~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  386 LRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHccCccccccHHHHhc
Confidence            99999999999999999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.5e-36  Score=262.07  Aligned_cols=219  Identities=20%  Similarity=0.145  Sum_probs=174.2

Q ss_pred             CCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCC
Q 048542           76 GGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK  154 (373)
Q Consensus        76 G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  154 (373)
                      |.+|.||++.++ +++.+|+|.+.....    ..+|...+....||||+++++++.+....+++|||+++|+|.+++.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence            899999999865 788999999876432    23444555556799999999999999999999999999999888732 


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCC
Q 048542          155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG  234 (373)
Q Consensus       155 ~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~  234 (373)
                         ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++.++++|||.+......     .....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence               34589999999999999999999998   9999999999999999999999999987654332     123346678


Q ss_pred             cccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHH
Q 048542          235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLC  314 (373)
Q Consensus       235 y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  314 (373)
                      |+|||...+.  .++.++|+||+|+++|+|++|..|+.......             .....      ...+..++..+.
T Consensus       148 y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~~------~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHTT------LNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccccc------cCCcccCCHHHH
Confidence            9999988653  67889999999999999999998765321110             00000      112234567889


Q ss_pred             HHHHhhcCCCCCCCCCH
Q 048542          315 MIGLWCIQVKAADRPSM  331 (373)
Q Consensus       315 ~li~~cl~~dp~~Rps~  331 (373)
                      +++.+||+.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=234.85  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=195.9

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .-.++||+|.||+||+|+.. +++.||+|.++.+..+   .....+|+-+++.++|.||++++++...+....+|+|||.
T Consensus         5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd   84 (292)
T KOG0662|consen    5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_pred             HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence            33578999999999999855 7889999998765433   3677899999999999999999999999999999999994


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                       .+|..+..   ..++.+..+.+..++.|+++|+.++|+.   ++.|||+||.|.|++.+|.+||+|||+++..+-+-  
T Consensus        85 -qdlkkyfd---slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   85 -QDLKKYFD---SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             -HHHHHHHH---hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence             47776662   3467789999999999999999999998   99999999999999999999999999998665433  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCC-CCCCcCccccccchHHHHHHHhcCCCc-----
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDL-----  297 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  297 (373)
                      ..++....|..|.+|.++.+. .-|+...|+||.||++.|+.....| |+..+..       +........-+.+     
T Consensus       156 rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvd-------dqlkrif~~lg~p~ed~w  227 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-------DQLKRIFRLLGTPTEDQW  227 (292)
T ss_pred             EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-------HHHHHHHHHhCCCccccC
Confidence            234455678999999999876 5788899999999999999975544 5444322       1122111111000     


Q ss_pred             ----ccCc------------cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ----ELQN------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ----~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .+++            ..++-+.+...=++|+.+.+.-+|.+|+++++.++
T Consensus       228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence                0000            01222334455689999999999999999999876

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=282.42  Aligned_cols=252  Identities=27%  Similarity=0.346  Sum_probs=207.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEee-----eCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS-----EGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~-----~~~~~~lv  138 (373)
                      +.+|...||.|.+|.||+++.. +++..|+|+........+++..|.++++.. .|||++.+++++.     .++.++||
T Consensus        20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            3456789999999999999854 788999999998888888899999999988 5999999999884     35679999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||||.+||..|++.+..  +..+.|..+..|+..++.|+.+||++   .++|||||-.|||++.++.+||+|||++..+.
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999996544  78899999999999999999999998   99999999999999999999999999987554


Q ss_pred             CCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          219 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....  .-....||+.|||||++...   ...|+.++|+||||++..||--|.+|+.++.+.          ...+.-..
T Consensus       175 sT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm----------raLF~IpR  242 (953)
T KOG0587|consen  175 STVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM----------RALFLIPR  242 (953)
T ss_pred             cccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh----------hhhccCCC
Confidence            3221  22456799999999998542   346778899999999999999999998776542          11111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+...  ..-+...+..+.++|..||..|..+||++.++++
T Consensus       243 NPPPk--Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  243 NPPPK--LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCcc--ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            11111  1224567889999999999999999999998875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=261.19  Aligned_cols=254  Identities=24%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      ...||.|+||+|++-.++ +|+..|||.++.....  ..+++.|..+..+- +.||||++||.+..++..++.||.| ..
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence            357999999999999866 7899999999876543  36778888876665 6899999999999999999999999 55


Q ss_pred             Ccccccc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          146 SLDRHVF-PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       146 sL~~~l~-~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ||+.+.. -...++..+++..+-.|......||.||-..  ..|+|||+||+|||++..|.+||||||++-.+...   .
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---i  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---I  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH---H
Confidence            6654331 1123356688998889999999999999875  69999999999999999999999999998754322   1


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ..+...|...|||||.+......|+.++||||||+.|||+.||+.|+..+...      -+ ....+..+..+.+... .
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv------fe-ql~~Vv~gdpp~l~~~-~  294 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV------FE-QLCQVVIGDPPILLFD-K  294 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH------HH-HHHHHHcCCCCeecCc-c
Confidence            22334577889999999876556899999999999999999999998765431      11 1122222322222211 1


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      -..+++..++.++.-|+..|-++||+..++.++
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            124578899999999999999999999998764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=264.90  Aligned_cols=244  Identities=24%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      .|....++|...||+|+||+|.+|..+ +.+.||||+++++-.    +.+.-..|-++|... +-|.++.++.+|..-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            355566788899999999999999866 677899999987532    223445677777766 46899999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      +|+||||+.||+|--.+    ++-+++.+..+.-++..||-||-+||++   ||+.||||.+||+++.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999997666    3446677788888999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      .-.--.  .......+||+.|+|||++.-+  .|+..+|+||+|++||||+.|++||+..+.++        +.+.+...
T Consensus       498 KEni~~--~~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI~eh  565 (683)
T KOG0696|consen  498 KENIFD--GVTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAIMEH  565 (683)
T ss_pred             cccccC--CcceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHHc
Confidence            732222  1234567899999999999654  88999999999999999999999998776543        33333222


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                      .       ..+|..+|.+...+....|..+|.+|..
T Consensus       566 n-------vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 N-------VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             c-------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence            1       3455677889999999999999999964

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=252.23  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeee-------
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE-------  131 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-------  131 (373)
                      ....|.-..+||+|.||.||+|+.+ +|++||+|++-..+.   -.....+|+.++..++|+|++.+++.|..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3445666688999999999999865 677889887644222   12556899999999999999999988843       


Q ss_pred             -CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEee
Q 048542          132 -GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (373)
Q Consensus       132 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~D  210 (373)
                       ....|+||++|+. +|.-++.   +...+++..++..++.++..||.|+|.+   .|+|||+||.|+|++.+|.+||+|
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLs---n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLS---NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhc---CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence             2347999999976 7777773   3346799999999999999999999998   999999999999999999999999


Q ss_pred             ccCcccCCCCCC--ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch----
Q 048542          211 FGLAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----  284 (373)
Q Consensus       211 fg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~----  284 (373)
                      ||+++.......  ...++....|..|.+||.+.|. ..++++.|+|..||++.+|+++.+-+........-..+.    
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999975543222  1235566679999999999886 688999999999999999999998877654332111110    


Q ss_pred             ---HHHHHHHh-----cCCCcc-cCcc-chhhHHH------HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 ---SWVYDQLN-----KGGDLE-LQNV-TEIESMI------ARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ---~~~~~~~~-----~~~~~~-~~~~-~~~~~~~------~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ..+|..+.     .....+ ++.. ...-++.      .....+|+.+++..||.+||.+++++.
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence               00110000     000000 1100 0000111      136789999999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-34  Score=288.61  Aligned_cols=143  Identities=25%  Similarity=0.357  Sum_probs=127.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|.+.++||+|+||.||+|.+. +++.||||+++.....    ...+..|+.+++.++||||+++++++......|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            4677899999999999999976 7889999998754322    2567889999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999988832    34578899999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=270.10  Aligned_cols=240  Identities=26%  Similarity=0.364  Sum_probs=195.1

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      +.||+|.||+||-|+++ +|+.||||++.+-+.   ...++.+|+.+|+++.||.||.+--.|+..+..++|||.+. |+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GD  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GD  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-ch
Confidence            78999999999999865 899999999976433   34778999999999999999999999999999999999995 46


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEeeccCcccCCCCCCc
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +.+.+..  ...+++++..-.-++.||+.||.|||.+   +|+|+||||+|||+...   ..+||||||.|+.++...  
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            5555543  3356788888888999999999999998   99999999999999643   479999999999886543  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       .-....||+.|+|||++.++  .|...-|+||.|+++|--++|.-||.......          +.+.   ...+....
T Consensus       722 -FRrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn----------dQIQ---NAaFMyPp  785 (888)
T KOG4236|consen  722 -FRRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN----------DQIQ---NAAFMYPP  785 (888)
T ss_pred             -hhhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccchh----------HHhh---ccccccCC
Confidence             22456799999999999886  67778899999999999999999997443211          1111   11222223


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV  334 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~el  334 (373)
                      .-..+++....+||...|+..-++|-|.+.-
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~  816 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKS  816 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence            3346778889999999999999999998764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=266.22  Aligned_cols=240  Identities=23%  Similarity=0.242  Sum_probs=201.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCc-eeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGG-LIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~-~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..+....||-|+||.|-+++.+... .+|+|++++.+.    +.+....|-.+|..+++|.||++|--|.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3345567999999999999877444 489999987543    34667899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      -|-||.|...+    ...+.+......-++..+++|+.|||++   +|+.|||||+|.+++.+|-+||.|||.|+.++..
T Consensus       501 aClGGElWTiL----rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  501 ACLGGELWTIL----RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             hhcCchhhhhh----hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999888    3456788888888999999999999998   9999999999999999999999999999987665


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..   .-..+||+.|.|||++.+.  ..+.++|.||||+++|||++|.+||...++        +..+..+-++...   
T Consensus       574 ~K---TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dp--------mktYn~ILkGid~---  637 (732)
T KOG0614|consen  574 RK---TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDP--------MKTYNLILKGIDK---  637 (732)
T ss_pred             Cc---eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCch--------HHHHHHHHhhhhh---
Confidence            42   3456899999999999876  456789999999999999999999987654        3344445444321   


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                        -+.|+.+.+...+|+++....+|.+|..
T Consensus       638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 --IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence              2445667788899999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=4.4e-33  Score=244.87  Aligned_cols=237  Identities=27%  Similarity=0.375  Sum_probs=190.6

Q ss_pred             CcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccC
Q 048542           77 GFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFP  153 (373)
Q Consensus        77 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  153 (373)
                      +||.||+|... +++.+++|++......  .+.+.+|+..++.++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999977 5889999998765443  47889999999999999999999999999999999999999999988743


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCC
Q 048542          154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI  233 (373)
Q Consensus       154 ~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  233 (373)
                      .    ..+++..+..++.+++.++.+||+.   +++|+||+|+||+++.++.++|+|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2    2388999999999999999999998   99999999999999999999999999998665432   223455888


Q ss_pred             CcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHH
Q 048542          234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKL  313 (373)
Q Consensus       234 ~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
                      .|++||.+.+.  .++.++|+||+|+++++|++|..||......       .................    ...++.++
T Consensus       151 ~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------~~~~~~~~~~~~~~~~~----~~~~~~~~  217 (244)
T smart00220      151 EYMAPEVLLGK--GYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------LELFKKIGKPKPPFPPP----EWKISPEA  217 (244)
T ss_pred             CCCCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHhccCCCCccc----cccCCHHH
Confidence            99999988753  6788999999999999999999998653211       11222222221111100    00145688


Q ss_pred             HHHHHhhcCCCCCCCCCHHHHHH
Q 048542          314 CMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       314 ~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+++.+||..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-34  Score=244.57  Aligned_cols=246  Identities=21%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +.+.+.||+|+|++|..++++ +.+.||+|++++.-.+    .+-...|-.+.... +||.++.++.+|..+..+++|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            456789999999999999865 7889999999874332    23345677777766 69999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |.+||+|--.+    .+..+++++.+.-+...|+-||.|||+.   ||+.||+|.+|+|+|..|++||+|+|+++-...+
T Consensus       332 yv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  332 YVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999996555    3457799999999999999999999998   9999999999999999999999999999854333


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ..+..+||+.|.|||++.+.  .|...+|+|++|++++||+.|+.||..-........-.++.++.+....     
T Consensus       405 gd--~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-----  475 (593)
T KOG0695|consen  405 GD--TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-----  475 (593)
T ss_pred             Cc--ccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-----
Confidence            33  24567899999999999886  7888999999999999999999999854322111112334444333221     


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                        ..+|+.++-+...++..-|+.||.+|..
T Consensus       476 --iriprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  476 --IRIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             --ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence              2344556677888899999999999964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2e-33  Score=274.25  Aligned_cols=264  Identities=21%  Similarity=0.225  Sum_probs=164.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-C----CceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeE------eeeCC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-T----GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF------CSEGS  133 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~------~~~~~  133 (373)
                      ..|.+.+.||+|+||.||+|.+. +    +..||+|.+..... .+.+.++  .+....+.++..+...      ...+.
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence            35677899999999999999875 4    68999998764332 1222121  1111122222222111      24566


Q ss_pred             eeEEEEeccCcCCccccccCCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES----------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~N  197 (373)
                      ..++|+||+++++|.+++.....                .+.......+..++.|++.||.|||+.   +|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence            78999999999999888743210                011122345668999999999999998   99999999999


Q ss_pred             eeeeC-CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccC--------------------CcCcccchHH
Q 048542          198 ILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG--------------------TVSCKSDVYG  256 (373)
Q Consensus       198 il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~~Dvws  256 (373)
                      ||++. ++.+||+|||++......... ......+++.|+|||.+.....                    .++.++||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             EEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99985 679999999999755332221 1234568999999996532211                    2345679999


Q ss_pred             HHHHHHHHHcCCCCCCCCcCc------cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          257 FGMVLLEMAGGRRNSNMNATR------SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       257 lG~~l~~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                      +||++|||+++..++......      ........|.. ........+.....+..........+|+.+||+.||++|||
T Consensus       365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t  443 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK-LVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS  443 (566)
T ss_pred             HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHH-hhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence            999999999876554321100      00000111110 00000000000000000111234568999999999999999


Q ss_pred             HHHHHH
Q 048542          331 MTKVLE  336 (373)
Q Consensus       331 ~~ell~  336 (373)
                      ++++++
T Consensus       444 a~e~L~  449 (566)
T PLN03225        444 AKAALA  449 (566)
T ss_pred             HHHHhC
Confidence            999987

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=247.08  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=203.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccC--ccCHHHHHHHHHHhcccCCCceeeEeeEee-eCCeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~  136 (373)
                      +.++...+-+|.||.||+|.+.      +.+.|.+|.++..  ..+...++.|-..+..+.|||+.++.+++. +....+
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~  364 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF  364 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence            3445567999999999999654      3456778877653  334577889999999999999999999885 456788


Q ss_pred             EEEeccCcCCccccccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          137 LVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      +++.++.-|+|..++...+    ...+.++..+...++.|++.|++|||+.   +++|.||..+|+++|+...+||+|=.
T Consensus       365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsa  441 (563)
T KOG1024|consen  365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSA  441 (563)
T ss_pred             EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccch
Confidence            9999999999998885221    2234567778889999999999999998   99999999999999999999999998


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      +++-+-..+..-.-.+...+..||+||.+++.  .|+.++||||||+++|||+| |+.|+..-+        |..+...+
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeID--------PfEm~~yl  511 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEID--------PFEMEHYL  511 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccC--------HHHHHHHH
Confidence            88754333221111223356789999999886  89999999999999999998 777765444        34466667


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ++|.++.-+      -++++++..+|..||..+|++||++++++.-|.+.
T Consensus       512 kdGyRlaQP------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  512 KDGYRLAQP------FNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             hccceecCC------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            777665433      34567899999999999999999999999988753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=272.44  Aligned_cols=242  Identities=24%  Similarity=0.298  Sum_probs=184.0

Q ss_pred             cccCCCCcEE-EEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGS-VYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      +.+|.|+.|+ ||+|... |+.||||.+-....  +-..+|+..++.- .||||+++|+.-.+.++.|+..|.| ..+|.
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~  590 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQ  590 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHH
Confidence            5689999987 7999987 88999998765332  3457899999988 6999999999888999999999999 56999


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---C--CceEEeeccCcccCCCCCC-
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---N--FIPKVSDFGLAKFHPKEND-  222 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~--~~~kl~Dfg~~~~~~~~~~-  222 (373)
                      +++...............+.+..|+++||++||+.   +|+||||||.||||+.   +  .+++|+|||+++.+..... 
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS  667 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS  667 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence            99965311111111145577899999999999997   9999999999999975   2  4789999999998765443 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcC-CCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      +....+..||.+|+|||++...  .-+.++|+||+||++|+.++| .+||+..-..+.          ++..+...... 
T Consensus       668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----------NIl~~~~~L~~-  734 (903)
T KOG1027|consen  668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----------NILTGNYTLVH-  734 (903)
T ss_pred             hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhh----------hhhcCccceee-
Confidence            2334566799999999999775  445689999999999999986 899986543321          12222111111 


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      .... .+  ....+||.+|++.+|..||++.+|+
T Consensus       735 L~~~-~d--~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 LEPL-PD--CEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             eccC-ch--HHHHHHHHHhcCCCcccCCCHHHHh
Confidence            1111 11  1688999999999999999999996

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-34  Score=229.04  Aligned_cols=202  Identities=27%  Similarity=0.384  Sum_probs=167.8

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      -...||+|++|.|-+-++. +|...|+|.++..-.+  .++.++|+.+..+. .+|.+|.+||........++.||.| .
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence            3477999999999888754 8999999999864333  35677888876665 6899999999999999999999999 5


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      .||+.+...--.++..+++..+-+|+..+..||.|||++  ..++|||+||+|||++.+|++|+||||++-.+.+.-   
T Consensus       129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---  203 (282)
T KOG0984|consen  129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---  203 (282)
T ss_pred             hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh---
Confidence            577766544445678899999999999999999999987  699999999999999999999999999997654322   


Q ss_pred             eeecccCCCCcccccccccc--cCCcCcccchHHHHHHHHHHHcCCCCCCCCcC
Q 048542          225 SISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT  276 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~  276 (373)
                      ..+...|...|+|||.+..+  ...|+.|+||||||+.+.||.+++.|++.+..
T Consensus       204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            22234588899999998653  23688999999999999999999999987664

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-33  Score=256.51  Aligned_cols=204  Identities=25%  Similarity=0.335  Sum_probs=169.0

Q ss_pred             cccCCCCcEEEEEEEE-cCCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.||-|+||.|.+++. .+...||.|.+++...    .......|-.+|....++-||++|..|.+.+.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            5699999999999974 4677899999886433    2345677889999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC-------
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-------  218 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~-------  218 (373)
                      ++-.+|.    +.+-+.+..++-++..+..|+++.|..   |++||||||+|||||.+|++||+|||+|+-+.       
T Consensus       715 DmMSLLI----rmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLI----RMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            9988884    345688999999999999999999998   99999999999999999999999999986211       


Q ss_pred             --CCCC-----------c--------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHH
Q 048542          219 --KEND-----------F--------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (373)
Q Consensus       219 --~~~~-----------~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll  265 (373)
                        ..+.           +                    ......+||+.|+|||++...  .++.-+|+||.|++||||+
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHHHh
Confidence              0000           0                    001123599999999999875  7788999999999999999


Q ss_pred             cCCCCCCCCcCccccccc
Q 048542          266 GGRRNSNMNATRSSKAYF  283 (373)
Q Consensus       266 ~g~~p~~~~~~~~~~~~~  283 (373)
                      .|+.||-.....+....+
T Consensus       866 ~g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  866 VGQPPFLADTPGETQYKV  883 (1034)
T ss_pred             hCCCCccCCCCCcceeee
Confidence            999999877665544333

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-32  Score=259.41  Aligned_cols=262  Identities=19%  Similarity=0.204  Sum_probs=176.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-----------------cCCceeEEEEeccCccC-HHH--------------HHHHH
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-----------------QTGGLIAVKMLENSKFS-AEE--------------FINEV  111 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~-~~~--------------~~~e~  111 (373)
                      ...|.+.++||+|+||.||+|..                 ..++.||||.+...... .++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            33567779999999999999963                 23467999998654321 122              23466


Q ss_pred             HHhcccCCCc-----eeeEeeEeee--------CCeeEEEEeccCcCCccccccCCCC--------------------CC
Q 048542          112 STIGRIHHVN-----VVQLLGFCSE--------GSKRALVYEYMPNGSLDRHVFPKES--------------------RG  158 (373)
Q Consensus       112 ~~l~~l~h~n-----i~~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~  158 (373)
                      ..+.+++|.+     +++++++|..        ....++||||+++++|.+++.....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            6666676554     3666776643        3467999999999999888753211                    11


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccc
Q 048542          159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP  238 (373)
Q Consensus       159 ~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP  238 (373)
                      ..+++..+..++.|++.+|.|||+.   +++||||||+||+++.++.+||+|||++......... ......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            2356778889999999999999998   9999999999999999999999999998754332211 11122357899999


Q ss_pred             cccccccC--------------------CcCcccchHHHHHHHHHHHcCCC-CCCCCcCcc--c---cccchHHHHHHHh
Q 048542          239 ELISRNFG--------------------TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRS--S---KAYFPSWVYDQLN  292 (373)
Q Consensus       239 E~~~~~~~--------------------~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~--~---~~~~~~~~~~~~~  292 (373)
                      |.+.....                    ....+.|+||+||++++|++|.. |+.......  .   ......|  .. .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~-~  456 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RM-Y  456 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hh-h
Confidence            98753210                    11234799999999999999875 554221100  0   0001111  11 1


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKA---ADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rps~~ell~  336 (373)
                      ......+.    .....+....+|+.+||..+|   .+|+|++|+++
T Consensus       457 ~~~~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111111    122346778999999999766   68999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.5e-32  Score=243.84  Aligned_cols=149  Identities=24%  Similarity=0.396  Sum_probs=126.2

Q ss_pred             hhhcCCCCCccChhHHHH-HHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCHHHHHHHHHHhcccC-----C
Q 048542           47 RNQQSWMPKRYSYPQIIA-MTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-----H  119 (373)
Q Consensus        47 ~~~~~~~~~~~~~~~i~~-~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h  119 (373)
                      .++..+......+++... .+|.+.++||-|.|++||+|.+ ++.+.||+|+.+...--.+..+.|+++|++++     |
T Consensus        59 ~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~  138 (590)
T KOG1290|consen   59 EDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPND  138 (590)
T ss_pred             hhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCC
Confidence            445666777788888888 8999999999999999999975 46788999999876666677889999999983     3


Q ss_pred             ---CceeeEeeEee----eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecC
Q 048542          120 ---VNVVQLLGFCS----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFD  192 (373)
Q Consensus       120 ---~ni~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~d  192 (373)
                         ..||++++.|.    ++.+.|+|+|++ |.+|..++....  .+.++...+.+|++||+.||.|||..+  +|+|.|
T Consensus       139 ~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTD  213 (590)
T KOG1290|consen  139 PGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTD  213 (590)
T ss_pred             CCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccC
Confidence               36999999984    467899999999 778888885544  345888899999999999999999874  999999


Q ss_pred             cCCCCeee
Q 048542          193 IKPHNILL  200 (373)
Q Consensus       193 ikp~Nil~  200 (373)
                      |||+|||+
T Consensus       214 lKPENvLl  221 (590)
T KOG1290|consen  214 LKPENVLL  221 (590)
T ss_pred             CCcceeee
Confidence            99999997

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=7.5e-33  Score=253.83  Aligned_cols=195  Identities=22%  Similarity=0.333  Sum_probs=168.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHH---------HHHHHHhcccC---CCceeeEeeEeeeC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEF---------INEVSTIGRIH---HVNVVQLLGFCSEG  132 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~---------~~e~~~l~~l~---h~ni~~~~~~~~~~  132 (373)
                      .|...+.+|.|+||.|++|.++ +...|+||.+.+.+.-.+.+         -.|+.+|..++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4555689999999999999977 56689999998766544433         35999999997   99999999999999


Q ss_pred             CeeEEEEecc-CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          133 SKRALVYEYM-PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       133 ~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      +.+|++||.- ++.+|.+++    .....+.+.++..|+.|++.|+++||++   +|+|||||-+|+.++.+|.+||+||
T Consensus       642 d~yyl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CeeEEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence            9999999986 567888888    4456799999999999999999999999   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      |.+.+.....    ....+||..|.|||++.|. ...+..-|||++|++||.++...+||.
T Consensus       715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCC----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9998765432    3456799999999999886 344667899999999999999998886

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-34  Score=239.31  Aligned_cols=259  Identities=23%  Similarity=0.320  Sum_probs=193.7

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-----eeEEEEe
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-----KRALVYE  140 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~~~lv~e  140 (373)
                      .+.||-|+||.||.+.+. +|+.||.|.+..-.   .+.+++.+|++++..++|.|++..++......     ..|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            477999999999999865 89999999886532   34478899999999999999999888764432     3578899


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      .| ..+|+..+.    +-..++...+.-+.+||++||.|||+.   +|.||||||.|.|++.+-.+||+|||+++....+
T Consensus       138 Lm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            98 458888884    446688888899999999999999998   9999999999999999999999999999865433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH-------------
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV-------------  287 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~-------------  287 (373)
                      . ...++....|..|.|||++.|. ..|+.+.||||.||++.||+..+-.|....+.+.-..+.+..             
T Consensus       210 ~-~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 D-RLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             h-hhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            2 2334455678899999999886 689999999999999999998887776554432211111110             


Q ss_pred             ---HHHHhcCCC-cccCccchh--hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          288 ---YDQLNKGGD-LELQNVTEI--ESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       288 ---~~~~~~~~~-~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                         ...++.+.+ +.+.....+  +.+-......+...++..||+.|.+.++.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence               011111111 111111111  112234567888999999999999999987654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.7e-32  Score=225.18  Aligned_cols=257  Identities=17%  Similarity=0.312  Sum_probs=192.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeC--CeeEEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEG--SKRALVY  139 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~--~~~~lv~  139 (373)
                      ...|++.+++|+|-++.||.|. ..++++++||+++.-+  .+.+.+|+.+|..|. ||||++++++..+.  ....+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            3468889999999999999998 4578899999998643  467889999999997 99999999998664  4578999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHP  218 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~  218 (373)
                      ||..+.+...+.       ..++...+...+.++++||.|||+.   ||.|||+||.|+++|. ...++|+|+|+|.+..
T Consensus       115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            999886665443       5577888999999999999999999   9999999999999995 5579999999999876


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-c-----hHHHHHH--
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-F-----PSWVYDQ--  290 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-~-----~~~~~~~--  290 (373)
                      ...++   +....+-.|--||.+-.- ..|+..-|+|||||++..|+..+.||.-......... +     .+.....  
T Consensus       185 p~~eY---nVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  185 PGKEY---NVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCcee---eeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            65533   334456667889988653 4677788999999999999999999975543321110 0     0001111  


Q ss_pred             -------------HhcCCCcccCc--cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 -------------LNKGGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 -------------~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                   +....+.....  ..+-..-.++++.+|+.+.|..|-.+|||++|.+.
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                         11111100000  00000113478899999999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=4.3e-33  Score=252.55  Aligned_cols=272  Identities=21%  Similarity=0.278  Sum_probs=209.0

Q ss_pred             CCccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCC------CceeeEe
Q 048542           54 PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHH------VNVVQLL  126 (373)
Q Consensus        54 ~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------~ni~~~~  126 (373)
                      ..++.++++...+|.+....|+|-|++|.+|..+ .|+.||||+|+.+..-.+.-+.|+++|++|+.      -|++.++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            3467788999999999999999999999999865 57899999999877666777899999999952      3789999


Q ss_pred             eEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-Cc
Q 048542          127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FI  205 (373)
Q Consensus       127 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~  205 (373)
                      ..|...+++|||+|-+ ..+|.+.+... ..+..+....+..++.|+.-||..|-..   +|+|.||||+|||+++. ..
T Consensus       501 r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            9999999999999988 66888887544 3456688889999999999999999998   99999999999999865 56


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~  285 (373)
                      +||||||.|........    +....+-.|.|||++.|.  .|+...|+||+||.||||.||+-.|++..+...-.++.+
T Consensus       576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             eeeccCccccccccccc----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            89999999987654331    112244579999999986  788899999999999999999988887654432111100


Q ss_pred             HH----HHHHhcCC--------Cc------------------------------ccCc---cchhhHHHHHHHHHHHHhh
Q 048542          286 WV----YDQLNKGG--------DL------------------------------ELQN---VTEIESMIARKLCMIGLWC  320 (373)
Q Consensus       286 ~~----~~~~~~~~--------~~------------------------------~~~~---~~~~~~~~~~~l~~li~~c  320 (373)
                      ..    ...+.++.        .+                              .+..   .+.-.......+.+|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            00    00011000        00                              0000   1111233456799999999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 048542          321 IQVKAADRPSMTKVLE  336 (373)
Q Consensus       321 l~~dp~~Rps~~ell~  336 (373)
                      |..||++|.|..+.|+
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=4.3e-30  Score=220.53  Aligned_cols=210  Identities=35%  Similarity=0.588  Sum_probs=180.6

Q ss_pred             cCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccc
Q 048542           73 LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR  149 (373)
Q Consensus        73 ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~  149 (373)
                      ||+|++|.||++... +++.+++|++......  .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999976 4889999999876553  5778999999999999999999999999899999999999899999


Q ss_pred             cccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCCCCCCceeeec
Q 048542          150 HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISA  228 (373)
Q Consensus       150 ~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~  228 (373)
                      ++....   ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            884321   4688999999999999999999998   9999999999999998 89999999999986544321  1223


Q ss_pred             ccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHH
Q 048542          229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESM  308 (373)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (373)
                      ..+...|++||..... ...+.+.|+|++|+++++|                                            
T Consensus       153 ~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            4577889999988653 2567789999999999999                                            


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          309 IARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       309 ~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        ..+.+++.+|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              367889999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-31  Score=220.22  Aligned_cols=254  Identities=20%  Similarity=0.281  Sum_probs=195.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeE-eeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGF-CSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~-~~~~~~~~lv~e  140 (373)
                      ...|.+.+.+|+|.||.+-++.++ +++.+++|.+........+|.+|...--.|. |.||+..|++ |...+...+++|
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            346788899999999999999976 6788999999998888899999999877774 8999998875 455667788999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCCceEEeeccCcccCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~~~kl~Dfg~~~~~~  218 (373)
                      |++.|+|..-+.     ...+.+.....++.|++.||.|+|++   ++||||||.+|||+.  +..++||||||+.+..+
T Consensus       103 ~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999988772     23477888889999999999999998   999999999999995  34589999999987543


Q ss_pred             CCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          219 KENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ..     ......+..|.+||.....   .....+.+|+|.||+++|..++|+.||.......    .+.|.+..+..+.
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d----~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD----KPYWEWEQWLKRK  245 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----chHHHHHHHhccc
Confidence            32     2233356778999976431   1234567899999999999999999998443322    2445555555555


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ....+.   .-..++..+..+.++-+..+|++|=-..++-++
T Consensus       246 ~~~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  246 NPALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             CccCch---hhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            444332   223456788889999999999999544444433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-31  Score=245.28  Aligned_cols=252  Identities=22%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|++.+++|+|++|.||+++++ +++..|+|+++..... ..-+..|+-+++..+||||+.+++.+......++.||||.
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg   95 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG   95 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence            4677899999999999999965 7899999999876543 3566789999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+.-+    -..++++.++..+++...+|++|||+.   +-+|||||-.|||+++.|.+|++|||.+..+...-  
T Consensus        96 ggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--  166 (829)
T KOG0576|consen   96 GGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--  166 (829)
T ss_pred             CCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--
Confidence            999988763    356789999999999999999999998   88999999999999999999999999886443211  


Q ss_pred             eeeecccCCCCcccccccc-cccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~-~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......||+.|||||+.. +..+.|.+++|+|++|+...|+---++|.....+        ......+.+. ....+..
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--------mr~l~LmTkS-~~qpp~l  237 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--------MRALFLMTKS-GFQPPTL  237 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--------HHHHHHhhcc-CCCCCcc
Confidence            1123567999999999863 3346788999999999999999877766543221        1122222221 1111111


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+ ....+..+.++++.|+..+|++|||++.++.
T Consensus       238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11 1223567899999999999999999987653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=223.19  Aligned_cols=245  Identities=22%  Similarity=0.268  Sum_probs=183.0

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC------eeEEEE
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALVY  139 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv~  139 (373)
                      .+.+|.|.- .|..+.+. .+++||+|......   ...++..+|..++..++|+||++++.++.-..      ..|+||
T Consensus        22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~  100 (369)
T KOG0665|consen   22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM  100 (369)
T ss_pred             ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence            366888888 56666543 68899999875432   23367789999999999999999999986543      478999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |+| ..+|...+.      -.+.-+.+..+..|++.|++|||+.   +|+||||||+||++..+..+||.|||+++....
T Consensus       101 e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen  101 ELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             Hhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCc
Confidence            999 568877773      3355678889999999999999998   999999999999999999999999999985433


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH-----------
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-----------  288 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------  288 (373)
                      .   ..++....|-.|.|||++.+.  .+.+.+||||+||++.||++|+-.|.+.+.      ++.|..           
T Consensus       171 ~---~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  171 D---FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGKDH------IDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             c---cccCchhheeeccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCchH------HHHHHHHHHHhcCCCHH
Confidence            2   234445678899999999886  488899999999999999999988874432      111111           


Q ss_pred             ---H-------HHhcC------------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 ---D-------QLNKG------------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ---~-------~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         +       .....            .+..+....+.++--+.-+++|+.+||-.||++|.|++++|+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence               0       00000            000011111111122345789999999999999999999987

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.1e-29  Score=225.82  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=192.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|...++||.|+|++||++...    .+..||+|.+.... ...++.+|++.|..+ -+.||+++.+++..++...+|+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            35677799999999999999744    35689999887543 346788999999999 5899999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceEEeeccCcccCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~  218 (373)
                      ||+++....++.       ..++...+..++..+..||+++|.+   ||+||||||+|+|.+ ..+.-.|+|||++....
T Consensus       115 p~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  115 PYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             cccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHH
Confidence            999998887776       3466788899999999999999999   999999999999998 55778999999997211


Q ss_pred             CC---------------------------------CCcee---------eecccCCCCcccccccccccCCcCcccchHH
Q 048542          219 KE---------------------------------NDFVS---------ISATRGTIGYIAPELISRNFGTVSCKSDVYG  256 (373)
Q Consensus       219 ~~---------------------------------~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvws  256 (373)
                      ..                                 ..+..         -....||++|.|||++.+. +..+.++||||
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws  263 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWS  263 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceee
Confidence            00                                 00000         0022499999999999875 56788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCcCccccccc------hHHHHHHHh-cCC--------------------Cc---ccC------
Q 048542          257 FGMVLLEMAGGRRNSNMNATRSSKAYF------PSWVYDQLN-KGG--------------------DL---ELQ------  300 (373)
Q Consensus       257 lG~~l~~ll~g~~p~~~~~~~~~~~~~------~~~~~~~~~-~~~--------------------~~---~~~------  300 (373)
                      .|+++..+++++.||.....+.....-      ...+.+... .+.                    ..   ...      
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            999999999999999754432111000      000000000 000                    00   000      


Q ss_pred             -ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 -NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 -~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ........++..+.+|+.+|+..||.+|.|+++.|+
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             001111223457899999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.5e-28  Score=213.81  Aligned_cols=197  Identities=33%  Similarity=0.500  Sum_probs=167.4

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .+.+.||.|++|.||++... ++..+++|.+.....  ..+.+.+|+..++.++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            45688999999999999976 488999999987654  357888999999999999999999999998999999999999


Q ss_pred             CCccccccCCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          145 GSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      ++|.+++...    .. +++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++|+|||.+.........
T Consensus        82 ~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       82 GDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            9999888432    22 78899999999999999999998   9999999999999999999999999998866543200


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                       ......++..|++||.+. ....++.++|+|+||+++++|++|+.||..
T Consensus       155 -~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             112345778899999884 224677799999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.5e-27  Score=198.67  Aligned_cols=166  Identities=23%  Similarity=0.231  Sum_probs=124.2

Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++..   .+..+++..++.++.|++.||.|||+.   +      ||+||+++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            577777732   245699999999999999999999987   5      999999999999999  99987654322   


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                          ..||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......      ..... +.............
T Consensus        64 ----~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~------~~~~~-~~~~~~~~~~~~~~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELS------AILEI-LLNGMPADDPRDRS  130 (176)
T ss_pred             ----CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhc------HHHHH-HHHHhccCCccccc
Confidence                2588999999999765  78889999999999999999999986543211      11111 11111111111111


Q ss_pred             hhHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          305 IESMIAR--KLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       305 ~~~~~~~--~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      .+..++.  .+.+++.+||+.+|.+||++.++++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            2233444  69999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-28  Score=205.08  Aligned_cols=249  Identities=21%  Similarity=0.375  Sum_probs=194.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..++..+|.....|..|+|+++ |..++.|++.....+.   .+|.+|.-.++.+.||||+++++.|.......++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3456678999999999999999 6667778876654433   68999999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe--eccCcccCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS--DFGLAKFHPKE  220 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~--Dfg~~~~~~~~  220 (373)
                      +.|||+..++.  ..+......++.+++.++++|++|||+. ++-|.---+....+++|++.+++|+  |--.+.     
T Consensus       270 p~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  270 PFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             cchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            99999998853  3445566778899999999999999986 3334445688999999999887765  311111     


Q ss_pred             CCceeeecccCCCCcccccccccccCCcC-cccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                          ...+..-.+.|++||.++....... .++|+|||++++|||.|...||.+..+-+              .+.+..+
T Consensus       342 ----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--------------cgmkial  403 (448)
T KOG0195|consen  342 ----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--------------CGMKIAL  403 (448)
T ss_pred             ----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh--------------hhhhhhh
Confidence                1123346789999999987533333 35799999999999999999997655422              2222222


Q ss_pred             C-ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          300 Q-NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       300 ~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      . ....+|+.++..+.+|+.-|++.||.+||.++.++-.||.+
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            1 22355667788999999999999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=5.9e-28  Score=246.89  Aligned_cols=195  Identities=18%  Similarity=0.205  Sum_probs=134.6

Q ss_pred             cCC-CceeeEeeEe-------eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 048542          117 IHH-VNVVQLLGFC-------SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI  188 (373)
Q Consensus       117 l~h-~ni~~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i  188 (373)
                      ++| .||..++++|       ......+.++|++ +++|.+++...   ...+++..+..++.||++||.|||++   +|
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            445 5777777776       2334567788987 66999998432   35689999999999999999999998   99


Q ss_pred             EecCcCCCCeeeeCCC-------------------ceEEeeccCcccCCCCCC--------------ceeeecccCCCCc
Q 048542          189 LHFDIKPHNILLDHNF-------------------IPKVSDFGLAKFHPKEND--------------FVSISATRGTIGY  235 (373)
Q Consensus       189 vH~dikp~Nil~~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y  235 (373)
                      +||||||+|||++..+                   .+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999996544                   455556665543211000              0001123578899


Q ss_pred             ccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHH
Q 048542          236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCM  315 (373)
Q Consensus       236 ~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  315 (373)
                      +|||.+.+.  .++.++|||||||++|||++|..|+.....          ....+.......     .. .........
T Consensus       182 ~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~~~-----~~-~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVLPP-----QI-LLNWPKEAS  243 (793)
T ss_pred             EChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhcCh-----hh-hhcCHHHHH
Confidence            999998764  688999999999999999998877542211          111111111000     00 011234568


Q ss_pred             HHHhhcCCCCCCCCCHHHHHH
Q 048542          316 IGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       316 li~~cl~~dp~~Rps~~ell~  336 (373)
                      ++.+||+.+|.+|||+.|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999976

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-25  Score=193.43  Aligned_cols=263  Identities=19%  Similarity=0.271  Sum_probs=198.6

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      +..-.|++.++||+|+||.++.|+ .-+++.||||.- ..+....++..|....+.|. .++|...|.+..++.+..+|+
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            344567889999999999999998 447999999954 44455577889999999985 689999999989999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-----CCceEEeeccCc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLA  214 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-----~~~~kl~Dfg~~  214 (373)
                      |.+ |.||.|++   .-.++.++.+.+..++.|++.-++|+|++   .+|.|||||+|+||..     ...+.++|||+|
T Consensus       104 dLL-GPSLEDLF---D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLF---DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHH---HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 77988877   34578899999999999999999999998   9999999999999963     345889999999


Q ss_pred             ccCCCCCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          215 KFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       215 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      +.+.+.....     .-....||.+||+-....|.  ..+.+.|+-|||-++++.|.|..||..-......     ..++
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK-----~kYe  249 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK-----EKYE  249 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcchH-----HHHH
Confidence            9776554322     12345699999999988775  7788999999999999999999999865433211     1122


Q ss_pred             HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .+...  ...-...++-..++.++..-+...-+.+-.+-|..+-+...+...
T Consensus       250 KIGe~--Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  250 KIGET--KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             Hhccc--cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            22111  111112222234455566666666667777778877666555543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.5e-25  Score=202.56  Aligned_cols=261  Identities=20%  Similarity=0.225  Sum_probs=193.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCC--ceeEEEEeccCccCH-HHHHHHHHHhcccCC----CceeeEeeEe-eeCCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTG--GLIAVKMLENSKFSA-EEFINEVSTIGRIHH----VNVVQLLGFC-SEGSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~--~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h----~ni~~~~~~~-~~~~~~~l  137 (373)
                      +|.+.++||+|+||.||.+.....  ..+|+|......... ..+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            677889999999999999997643  478888876543221 267788888888862    5889999888 57788999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-----CceEEeecc
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-----FIPKVSDFG  212 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-----~~~kl~Dfg  212 (373)
                      ||+.+ |.+|.++.....  ...++..++..++.|++.+|.++|+.   |++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99998 789988764333  57799999999999999999999998   99999999999999754     468999999


Q ss_pred             Ccc--cCCCCCC----ce-e-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch
Q 048542          213 LAK--FHPKEND----FV-S-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  284 (373)
Q Consensus       213 ~~~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~  284 (373)
                      +++  .......    .. . .....||..|.++.+..+.  ..+.+.|+||++.++.+++.|..||...........  
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~--  248 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK--  248 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH--
Confidence            998  3221111    01 1 1345699999999998875  778899999999999999999999965443221111  


Q ss_pred             HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                        ............      .....+..+.++...+-..+..++|....+...|+.....
T Consensus       249 --~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  249 --FEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             --HHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence              111111111100      0011234566666667779999999999999998776543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.2e-25  Score=202.58  Aligned_cols=164  Identities=21%  Similarity=0.214  Sum_probs=126.9

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc--CCceeEEEEeccCc------cCHHHHHHHHHHhcccCCCceee-EeeEeeeC
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSK------FSAEEFINEVSTIGRIHHVNVVQ-LLGFCSEG  132 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~~  132 (373)
                      .....|.+.+.||+|+||+||+|.++  +++.+|||++....      .....+.+|+++++.++|+|+++ ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34556888899999999999999865  56778999865321      12356889999999999999885 4432    


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCc-CCCCeeeeCCCceEEeec
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~di-kp~Nil~~~~~~~kl~Df  211 (373)
                      ...++||||+++++|.. ..   .    ..   ...++.++++||.|||+.   ||+|||| ||+|||++.++.+||+||
T Consensus        91 ~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            45799999999999862 21   0    01   135788999999999998   9999999 999999999999999999


Q ss_pred             cCcccCCCCCCcee------eecccCCCCccccccccc
Q 048542          212 GLAKFHPKENDFVS------ISATRGTIGYIAPELISR  243 (373)
Q Consensus       212 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  243 (373)
                      |++...........      .....+++.|+|||.+..
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99987654332211      235568889999999854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=5.4e-26  Score=221.63  Aligned_cols=252  Identities=21%  Similarity=0.242  Sum_probs=188.4

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEecc---CccCH----HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLEN---SKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~---~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ....+|.|++|.|+..... .....+.|....   .....    ..+..|+.+-..++|+|++.....+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            3467999999977777533 333344443321   11111    225567777888899999888777766555555599


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++ +|..++    .....+...++..++.|+..|+.|+|+.   |+.|||+|++|+++..+|.+||+|||.+....-+
T Consensus       402 ~~~~-Dlf~~~----~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLV----MSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHH----hcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 998888    3335688889999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCc--eeeecccCCCCcccccccccccCCcCc-ccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          221 NDF--VSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       221 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~-~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .+.  ....+.+|+..|+|||.+.+.  .|.+ ..||||.|+++..|.+|+.||..........      .........-
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRN  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccc
Confidence            333  445677899999999999875  5544 5799999999999999999998665432211      1111112222


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......+...++.+.+.++.+||+.||.+|.|+++|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            223334566777889999999999999999999999976

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-25  Score=183.64  Aligned_cols=259  Identities=19%  Similarity=0.258  Sum_probs=189.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEE-EcCCceeEEEEeccCccCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ....|++.++||+|+||.+|.|. ..+|..||||+-.. ...-.++..|..+.+.|++ ..|+.+..+..+.....+||+
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            34578899999999999999998 55899999996543 3333567789999999975 678888888889999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEeeccCcccC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFH  217 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~~~  217 (373)
                      .+ |.||.+++.-.   ...++.++++-++-|++.-++|+|..   +++||||||+|+|..-+   ..+.|+|||+++.+
T Consensus        92 LL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            98 78998887433   45688999999999999999999998   99999999999999643   46889999999876


Q ss_pred             CCCCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          218 PKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       218 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      .+.....     .-....||.+|.+-....+.  ..+.+.|+-|+|.++.++..|..||.+......     ....+.+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI~  237 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKIS  237 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHHH
Confidence            5433221     12345699999988877654  567789999999999999999999986543221     11111111


Q ss_pred             c-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          293 K-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       293 ~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      . ......   ..+=..++.++...+..|-..--++-|...-+-+.+.
T Consensus       238 EkK~s~~i---e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  238 EKKMSTPI---EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HhhcCCCH---HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            1 111110   0111223455666667777777777777655544443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=2.8e-22  Score=183.75  Aligned_cols=261  Identities=28%  Similarity=0.370  Sum_probs=195.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC----HHHHHHHHHHhcccCCC-ceeeEeeEeeeCCeeEEEEec
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHV-NVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~-ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      |.+.+.||.|+||.||++...  ..+++|.+......    ...+.+|..++..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            456688999999999999877  78899988764432    46788999999999988 799999999777778999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  220 (373)
                      +.++++.+.+...... ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999998655322111 3688999999999999999999998   999999999999999888 7999999999755433


Q ss_pred             CCce----eeecccCCCCccccccccccc-CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          221 NDFV----SISATRGTIGYIAPELISRNF-GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       221 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....    ......|+..|+|||.+.+.. ...+...|+||+|++++++++|..||......    .........+....
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence            3211    235567999999999987631 36777899999999999999999996554431    00111222222222


Q ss_pred             Cc--ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          296 DL--ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       296 ~~--~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ..  ...............+.+++..|+..+|..|.+..+....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11  0000000002223568899999999999999999887764

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2e-24  Score=211.76  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=181.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCc--cCHHHH---HHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSK--FSAEEF---INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~---~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+.+.+.||++.|=+|.+|+++.|. |+||++-+..  .+.+.+   +.|++ ...+++||.+++.-+...+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            3456688999999999999988666 8999875533  222333   44555 555689999999888788888899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc--CC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HP  218 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~--~~  218 (373)
                      |..+ +|+|.+    ..+.-+...+..-|+.|++.|+..+|..   ||+|||||.+|||++.-+-+.|+||..-+.  +.
T Consensus       102 yvkh-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9855 898888    4455677788889999999999999998   999999999999999999999999987653  22


Q ss_pred             CCC--Cce-eeecccCCCCccccccccccc---------CCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchH
Q 048542          219 KEN--DFV-SISATRGTIGYIAPELISRNF---------GTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       219 ~~~--~~~-~~~~~~gt~~y~aPE~~~~~~---------~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~  285 (373)
                      .++  ++. .......-.+|.|||.+....         ...+++.||||+||++.||++ |++||...+--.++     
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr-----  248 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR-----  248 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh-----
Confidence            221  111 122333446899999874321         125678899999999999998 56777643321111     


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                             .+......  .-...--...+++|+..|++.||++|.|+++.|+--.|.
T Consensus       249 -------~~~~~~~e--~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  249 -------SGNADDPE--QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -------ccCccCHH--HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                   11000000  000011124789999999999999999999999986654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=3.1e-23  Score=175.12  Aligned_cols=138  Identities=17%  Similarity=0.176  Sum_probs=107.4

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---------------------------HHHHHHHHHhcccCCCce
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---------------------------EEFINEVSTIGRIHHVNV  122 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---------------------------~~~~~e~~~l~~l~h~ni  122 (373)
                      ...||+|+||.||+|...+|+.||+|+++......                           .....|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36799999999999998889999999997642210                           112349999999987776


Q ss_pred             eeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCcCCCCeeee
Q 048542          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-HNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       123 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ivH~dikp~Nil~~  201 (373)
                      .....+..  ...++||||++++++.....    ....++...+..++.|++.+|.++ |+.   +++||||||+||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            43332222  22389999998876654431    235688899999999999999999 687   999999999999998


Q ss_pred             CCCceEEeeccCcccC
Q 048542          202 HNFIPKVSDFGLAKFH  217 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (373)
                       ++.++|+|||++...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=5.5e-23  Score=175.69  Aligned_cols=172  Identities=14%  Similarity=0.132  Sum_probs=130.9

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHH----------HHHHHHHhcccCCCceeeEeeEee
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE----------FINEVSTIGRIHHVNVVQLLGFCS  130 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~h~ni~~~~~~~~  130 (373)
                      ++...+|+..+.+|.|+||.||+... +++.+|+|++.......+.          +.+|+..+.++.|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            44556788889999999999999766 5778999999765433322          578899999999999999988865


Q ss_pred             eC--------CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC
Q 048542          131 EG--------SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (373)
Q Consensus       131 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~  202 (373)
                      ..        ...+++|||++|.+|.+..        .++.    ....+++.++..+|+.   |++|||++|+||+++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            33        3578999999999997653        1222    2456899999999998   9999999999999998


Q ss_pred             CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHH
Q 048542          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (373)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll  265 (373)
                      ++ ++|+|||...........              .......  .+..++|+||||+.+..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler--~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLER--HYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH--------------HHHHHHh--HhcccccccceeEeehHHH
Confidence            88 999999987644222110              0022222  4557899999999887664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.6e-22  Score=169.21  Aligned_cols=140  Identities=20%  Similarity=0.186  Sum_probs=110.0

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---------------------------HHHHHHHHHHhcccCCCce
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---------------------------AEEFINEVSTIGRIHHVNV  122 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~ni  122 (373)
                      ...||+|++|.||+|...+|+.||||+++.....                           ......|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3679999999999999778999999998764211                           1123578899999999887


Q ss_pred             eeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeee
Q 048542          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       123 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~  201 (373)
                      .....+...  ..++||||++++++.....    ....++......++.|++.++.++|+ .   |++||||||+||+++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            544443332  2489999998875543321    12457788889999999999999999 7   999999999999998


Q ss_pred             CCCceEEeeccCcccCCC
Q 048542          202 HNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~  219 (373)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=2.6e-22  Score=187.49  Aligned_cols=219  Identities=21%  Similarity=0.350  Sum_probs=167.8

Q ss_pred             hcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-EecC
Q 048542          114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI-LHFD  192 (373)
Q Consensus       114 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~i-vH~d  192 (373)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..   ....+++.....++.+++.||+|||+.   .+ .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            4678899999999999999999999999999999999954   356788999999999999999999987   44 9999


Q ss_pred             cCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccc--cC---CcCcccchHHHHHHHHHHHcC
Q 048542          193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--FG---TVSCKSDVYGFGMVLLEMAGG  267 (373)
Q Consensus       193 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~---~~s~~~DvwslG~~l~~ll~g  267 (373)
                      +++.|++++....+||+|||+.................-..-|.|||.+.+.  ..   ..+.+.|+||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            9999999999999999999998766432111222222344579999998653  11   146789999999999999999


Q ss_pred             CCCCCCCcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          268 RRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ..||.........    ..+...+.+ +.....+...... .....+..++.+||..+|.+||+++++-..++...+
T Consensus       155 ~~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCCh----HHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9999875544332    222223333 2222222222221 344478999999999999999999999999987655

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=5.1e-22  Score=174.82  Aligned_cols=232  Identities=21%  Similarity=0.271  Sum_probs=147.0

Q ss_pred             hhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccC----------CCceeeEeeEee---
Q 048542           69 FTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIH----------HVNVVQLLGFCS---  130 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~----------h~ni~~~~~~~~---  130 (373)
                      ..+.||.|+++.||.+++. +|+.+|+|+......    ..+++.+|.-....+.          |-.++..++...   
T Consensus        16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~   95 (288)
T PF14531_consen   16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred             EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence            3478999999999999977 689999998754332    2356666665555432          112222222221   


Q ss_pred             ------eC---C-----eeEEEEeccCcCCccccccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCc
Q 048542          131 ------EG---S-----KRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDI  193 (373)
Q Consensus       131 ------~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~di  193 (373)
                            ..   .     ..+++|+-+ .++|.+.+..   .......+.......+..|+++.+++||+.   |++|+||
T Consensus        96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi  171 (288)
T PF14531_consen   96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI  171 (288)
T ss_dssp             S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred             CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence                  11   1     235678877 5577766521   122122344455567778999999999998   9999999


Q ss_pred             CCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccc------cCCcCcccchHHHHHHHHHHHcC
Q 048542          194 KPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGG  267 (373)
Q Consensus       194 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslG~~l~~ll~g  267 (373)
                      +|+|++++.+|.++|+||+.....+..   .  .....+..|.+||.....      .-.++.+.|.|++|+++|.|.++
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR---Y--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE---E--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce---e--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            999999999999999999887654321   1  113355779999976432      12467889999999999999999


Q ss_pred             CCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCC
Q 048542          268 RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADR  328 (373)
Q Consensus       268 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  328 (373)
                      ..||+..........               .+   .... +++..++.|+..+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~---------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW---------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG---------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc---------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999987654332211               11   1222 567789999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=4.2e-21  Score=160.71  Aligned_cols=188  Identities=15%  Similarity=0.104  Sum_probs=139.1

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHH-----HHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEecc
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE-----EFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ....|++|+||+|+.+.. .+.+++.+.+.....-..     .+.+|+++|++++ |++++.++++    ...+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            357799999999997765 578888887776554322     5789999999995 5789999886    3469999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCc-CCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDI-KPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~di-kp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      .|.+|.....    .      . ...++.|++.++.++|+.   ||+|||| ||+|||++.++.++|+|||++.......
T Consensus        81 ~G~~L~~~~~----~------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         81 AGAAMYQRPP----R------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             cCccHHhhhh----h------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            9988854320    0      1 134678899999999998   9999999 7999999999999999999998554333


Q ss_pred             Cc----e--e-----eecccCCCCcccccccccccCCcC-cccchHHHHHHHHHHHcCCCCCCCCcC
Q 048542          222 DF----V--S-----ISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNAT  276 (373)
Q Consensus       222 ~~----~--~-----~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwslG~~l~~ll~g~~p~~~~~~  276 (373)
                      ..    .  .     ......++.|++|+...-. ...+ .+.++++-|+-+|.++|++.+...+..
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            11    0  0     0012267778888754221 1222 456999999999999999988765443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-21  Score=173.30  Aligned_cols=200  Identities=17%  Similarity=0.203  Sum_probs=138.2

Q ss_pred             CCCceeeEeeEeee---------------------------CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHH
Q 048542          118 HHVNVVQLLGFCSE---------------------------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA  170 (373)
Q Consensus       118 ~h~ni~~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  170 (373)
                      +||||+.+.++|.+                           +...|+||..++ .+|..++..+     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence            59999999887632                           224689998884 4898888532     24455667789


Q ss_pred             HHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCC--ceEEeeccCcccCCCCC---Ccee-eecccCCCCcccccccc
Q 048542          171 LGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNF--IPKVSDFGLAKFHPKEN---DFVS-ISATRGTIGYIAPELIS  242 (373)
Q Consensus       171 ~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~--~~kl~Dfg~~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~  242 (373)
                      .|+++|+.|||.+   |+.|||+|.+|||+.  +++  .++++|||++--.....   .+.+ ....-|.-..||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999998   999999999999994  333  57899999875322211   1111 11223677889999986


Q ss_pred             cccCCc----CcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHH
Q 048542          243 RNFGTV----SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGL  318 (373)
Q Consensus       243 ~~~~~~----s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  318 (373)
                      ...|..    -.|+|.|+.|.+.||+++..+||.....--    ++.-.   ....   +   ....+..++..+++|+.
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L~~r~---Yqe~---q---LPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----LDTRT---YQES---Q---LPALPSRVPPVARQLVF  491 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----echhh---hhhh---h---CCCCcccCChHHHHHHH
Confidence            543332    137999999999999999999998633210    00000   0111   1   12233445667899999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHh
Q 048542          319 WCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       319 ~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..|+.||++|++..-....|+
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999999876666554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.1e-20  Score=185.28  Aligned_cols=248  Identities=20%  Similarity=0.200  Sum_probs=176.5

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv  138 (373)
                      +-...+.+.+.||+|+||+||+|...+|+.||+|+-+....-  +|.--.+++.+|+   -+.|..+...+.-.+.-++|
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            334556777899999999999999888999999987664321  1111122222332   23455555555556677899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-------CCCceEEeec
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-------HNFIPKVSDF  211 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-------~~~~~kl~Df  211 (373)
                      +||.+.|+|.+++.    ..+.+++..+..++.|++..+.+||..   +|||+||||+|+++.       ...-++|+||
T Consensus       773 ~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  773 SEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             eeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence            99999999999994    456688999999999999999999998   999999999999994       2345899999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |.+--+.--.........++|-.+--+|+..|.  .++...|.|.++.+++-||.|+.--                   .
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y~q-------------------~  904 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKYME-------------------V  904 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHHHH-------------------h
Confidence            998754333333445677789999999999886  8899999999999999999997311                   2


Q ss_pred             hcCCCcccCc-cch-hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          292 NKGGDLELQN-VTE-IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       292 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ..+....... ... ..++++..   +...+|+.|-..=|...++...+++.+
T Consensus       905 ~~g~~~~~~~~~~Ry~~~~~W~~---~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  905 KNGSSWMVKTNFPRYWKRDMWNK---FFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             cCCcceeccccchhhhhHHHHHH---HHHHHhCcCcccchhHHHHHHHHHHHH
Confidence            2222222111 111 12333444   444455566666688888887777653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.3e-21  Score=183.03  Aligned_cols=231  Identities=23%  Similarity=0.253  Sum_probs=179.9

Q ss_pred             cCCCCcEEEEEEE----EcCCceeEEEEeccCccCH---HHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           73 LGQGGFGSVYKGQ----LQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        73 ig~G~~g~V~~~~----~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +|.|+||.|++++    ...|..+|+|..++.....   .....|..++...+ ||.+++++..+..+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999999875    2356778998876532211   13456777888886 99999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |.|...+    .+...+.+.........++-++.++|+.   +++|||+|++||+++.+|++++.|||+++..-...   
T Consensus        82 g~lft~l----~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   82 GDLFTRL----SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             chhhhcc----ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            9987766    3345566777777888899999999998   99999999999999999999999999988543322   


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                         ..+||..|||||++.+    ....+|.||||++.++|++|..||..           +.....+..        ...
T Consensus       152 ---~~cgt~eymApEI~~g----h~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~--------~~~  205 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIING----HLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA--------ELE  205 (612)
T ss_pred             ---hcccchhhhhhHhhhc----cCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh--------ccC
Confidence               1279999999999963    35578999999999999999999875           111111111        123


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCH--HHHHHHHh
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSM--TKVLEMLE  339 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~--~ell~~L~  339 (373)
                      .++..+..+.+++.+++..+|..|.-.  ..+.+..+
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            456778889999999999999999866  44544444

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=8.3e-20  Score=159.43  Aligned_cols=139  Identities=17%  Similarity=0.144  Sum_probs=108.7

Q ss_pred             hhhhcccCCCCcEEEEEEE--EcCCceeEEEEeccCccC-------------------------HHHHHHHHHHhcccCC
Q 048542           67 NHFTHKLGQGGFGSVYKGQ--LQTGGLIAVKMLENSKFS-------------------------AEEFINEVSTIGRIHH  119 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h  119 (373)
                      |.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                         ...+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            5677999999999999998  458999999998754210                         0234679999999975


Q ss_pred             C--ceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-eEecCcCCC
Q 048542          120 V--NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC-ILHFDIKPH  196 (373)
Q Consensus       120 ~--ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-ivH~dikp~  196 (373)
                      .  .+++++++    ...++||||+++++|.....    .........+..++.|++.++.+||+.   + ++||||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            3  34444443    23589999999988866542    223455666788999999999999998   8 999999999


Q ss_pred             CeeeeCCCceEEeeccCcccC
Q 048542          197 NILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       197 Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=7.8e-20  Score=155.87  Aligned_cols=132  Identities=17%  Similarity=0.221  Sum_probs=101.9

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCcc-CHHHHHHHHHHhccc-----CCCceeeEeeEeeeCC---eeE-EEEe
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF-SAEEFINEVSTIGRI-----HHVNVVQLLGFCSEGS---KRA-LVYE  140 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~---~~~-lv~e  140 (373)
                      +.||+|+||.||.  ++.....+||++..... ..+.+.+|+.+++.+     .||||+++++++.++.   ..+ +|+|
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            6799999999996  44333447998876432 346789999999999     5799999999998763   333 7899


Q ss_pred             c--cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEecCcCCCCeeeeC----CCceEEeeccC
Q 048542          141 Y--MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI-EYLHNGCDVCILHFDIKPHNILLDH----NFIPKVSDFGL  213 (373)
Q Consensus       141 ~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al-~~LH~~~~~~ivH~dikp~Nil~~~----~~~~kl~Dfg~  213 (373)
                      |  +.+++|.+++..     ..+++.  ..++.+++.++ +|||++   +|+||||||+|||++.    ++.++|+||+-
T Consensus        86 ~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         86 FDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             CCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            9  557999999932     235544  34577777777 999998   9999999999999974    34799999543


Q ss_pred             c
Q 048542          214 A  214 (373)
Q Consensus       214 ~  214 (373)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.3e-18  Score=148.65  Aligned_cols=134  Identities=21%  Similarity=0.191  Sum_probs=106.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC-----------------------HHHHHHHHHHhcccCCCc--
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-----------------------AEEFINEVSTIGRIHHVN--  121 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~n--  121 (373)
                      |.+.+.||+|+||.||++...+|+.+|||+++.....                       ......|+..+..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            6677899999999999999888999999987653211                       123567888888887774  


Q ss_pred             eeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       122 i~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ++..++    ....+++|||+++++|.....      .    .....++.+++.++.++|+.   +++|+||||+||+++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~----~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRV------L----EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhccc------c----ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            444443    234589999999998866541      0    23457888999999999998   999999999999999


Q ss_pred             CCCceEEeeccCcccC
Q 048542          202 HNFIPKVSDFGLAKFH  217 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (373)
                      .++.++|+|||++...
T Consensus       160 ~~~~~~liDfg~~~~~  175 (198)
T cd05144         160 DDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcEEEEECCccccC
Confidence            9999999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.3e-18  Score=150.23  Aligned_cols=133  Identities=21%  Similarity=0.286  Sum_probs=111.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccC---------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.||+|++|.||+|.. +|..+++|........         ...+.+|+.++..+.|+++.....++.+....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 5788999976543221         13577899999999999888777777777788999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|++|.+.+...       .. ....++.+++.++.++|+.   +++|+|++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999998887321       12 6788999999999999998   999999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=3.5e-18  Score=146.07  Aligned_cols=129  Identities=22%  Similarity=0.317  Sum_probs=103.7

Q ss_pred             ccCCCCcEEEEEEEEcCCceeEEEEeccCcc---------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           72 KLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .||+|+||.||+|.+. +..+++|.......         ...++.+|+.++..++|+++.....++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3899999999999854 78899998654221         1245678999999998887655555555666779999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +|++|.+.+...    ..       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998876221    10       7899999999999998   999999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.76  E-value=5.7e-19  Score=173.56  Aligned_cols=209  Identities=21%  Similarity=0.204  Sum_probs=139.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      ++.++.|..|++|.||..+++ +.+.+|+|+-+. +.-    .+.  ++....+|.++                     |
T Consensus        85 f~~IklisngAygavylvrh~~trqrfa~kiNkq-~li----lRn--ilt~a~npfvv---------------------g  136 (1205)
T KOG0606|consen   85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLI----LRN--ILTFAGNPFVV---------------------G  136 (1205)
T ss_pred             cceeEeeccCCCCceeeeeccccccchhhccccc-chh----hhc--cccccCCccee---------------------c
Confidence            344588999999999999877 567888854332 211    010  12222233322                     2


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC----
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN----  221 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  221 (373)
                      +-...+    ..-++++...        +.+++|||+.   +|+|||+||+|.++..-|++|++|||++.......    
T Consensus       137 Dc~tll----k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  137 DCATLL----KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             hhhhhc----ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence            222222    1123343332        6789999998   99999999999999999999999999986432110    


Q ss_pred             ---------CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          222 ---------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       222 ---------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                               ....-...+||+.|.|||++..+  .|+..+|+|++|+++|+.+.|..||.....++-.        ..+-
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--------g~vi  271 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--------GQVI  271 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--------hhhh
Confidence                     00112345799999999999876  7888999999999999999999999887654321        1111


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      .........    ...+..++++++.+.|+.+|.+|.-..
T Consensus       272 sd~i~wpE~----dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  272 SDDIEWPEE----DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             hhhcccccc----CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence            111111111    123356789999999999999996433

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4.7e-19  Score=162.96  Aligned_cols=173  Identities=21%  Similarity=0.284  Sum_probs=129.2

Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      .+|+.|++|...+|.+++..++ .....++.....++.|++.|+.|   +   +.+|+|+||.||++..+..+||.|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            4789999999999999996543 35567788899999999999999   5   899999999999999999999999999


Q ss_pred             cccCCCCC----CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcC-CCCCCCCcCccccccchHHHH
Q 048542          214 AKFHPKEN----DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       214 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g-~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ........    .....+...||..||+||.+.++  .|+.|+||||||++|+||+.- ..++.           .....
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~  469 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFE-----------RIATL  469 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhh
Confidence            88665443    22334556799999999999886  899999999999999999972 21111           01122


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      ..++.+..++     ....+++ .-..|+.+++...|.+||++.
T Consensus       470 ~d~r~g~ip~-----~~~~d~p-~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  470 TDIRDGIIPP-----EFLQDYP-EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hhhhcCCCCh-----HHhhcCc-HHHHHHHHhcCCCcccCchHH
Confidence            2233332221     1111112 235889999999999999443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=6.6e-18  Score=165.37  Aligned_cols=132  Identities=19%  Similarity=0.255  Sum_probs=107.1

Q ss_pred             hhhcccCCCCcEEEEEEEEcCCceeEEEE-eccCcc--------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQTGGLIAVKM-LENSKF--------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~-~~~~~~--------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...+.||+|+||.||+|.+.... +++|. +.....        ..+++.+|+++++.++|++++....++......++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            34688999999999999876443 44443 222111        124678999999999999998887777777778999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      |||+++++|.+++.            ....++.+++.+|.+||+.   +++|||+||+||++ .++.++|+|||++..
T Consensus       415 ~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999988772            3467899999999999998   99999999999999 577999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=2.5e-17  Score=139.36  Aligned_cols=135  Identities=20%  Similarity=0.221  Sum_probs=96.9

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHH---HH----------------------HHHHHHhcccCCC--ce
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE---EF----------------------INEVSTIGRIHHV--NV  122 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~---~~----------------------~~e~~~l~~l~h~--ni  122 (373)
                      .+.||+|+||.||+|...+++.||||+++.......   ..                      ..|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988899999999876432211   11                      2455555555433  24


Q ss_pred             eeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeee
Q 048542          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       123 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~  201 (373)
                      .+.++.    ...+++|||++++.+.......    .... .....++.+++.++.++|. .   +++|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444433    2358999999885543211100    0011 5677899999999999998 7   999999999999999


Q ss_pred             CCCceEEeeccCcccC
Q 048542          202 HNFIPKVSDFGLAKFH  217 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (373)
                       ++.++|+|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             899999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=2.5e-16  Score=127.99  Aligned_cols=134  Identities=21%  Similarity=0.207  Sum_probs=112.9

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC--CceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      .+.||.|.++.||++...+ ..+++|....... ...+.+|...++.++|  .++++++.+....+..+++|||++++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            4679999999999999764 7899999876544 5678899999999976  5889999888877889999999988776


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ..+           +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            433           4456677899999999999986444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.7e-18  Score=166.92  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=189.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcC--CceeEEEEeccCc---cCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQT--GGLIAVKMLENSK---FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|++.+.||+|+|+.|-......  ...+|.|.+....   ...+....|..+-+.+. |+|++.+++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            45677889999999998887543  3455666554432   22244555777777776 999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  217 (373)
                      ++..++++.+.+....  ....+...+...+.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|...
T Consensus       101 ~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             CcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999988773111  114555566778999999999999 77   999999999999999999 9999999999977


Q ss_pred             CC-CCCceeeecccC-CCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          218 PK-ENDFVSISATRG-TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       218 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .. .+........+| ++.|.|||...+. .......|+||.|+++..+++|..||.........  ...|....   +.
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~~~~~---~~  249 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSWKSNK---GR  249 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc--ceeecccc---cc
Confidence            66 444445556678 9999999998774 35567789999999999999999999876644321  11111110   00


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..     .......+....+++.+++..+|..|.+.+++..
T Consensus       250 ~~-----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 FT-----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cc-----cCccccCChhhhhcccccccCCchhccccccccc
Confidence            00     1111233456788888999999999999988754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=7e-16  Score=135.01  Aligned_cols=133  Identities=17%  Similarity=0.190  Sum_probs=101.9

Q ss_pred             cccC-CCCcEEEEEEEEcCCceeEEEEeccCc--------------cCHHHHHHHHHHhcccCCCce--eeEeeEeeeC-
Q 048542           71 HKLG-QGGFGSVYKGQLQTGGLIAVKMLENSK--------------FSAEEFINEVSTIGRIHHVNV--VQLLGFCSEG-  132 (373)
Q Consensus        71 ~~ig-~G~~g~V~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni--~~~~~~~~~~-  132 (373)
                      ..|| .|+.|+||.+... +..+++|.+....              .....+.+|+.++..++|+++  +..+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4577 8889999998875 7789999875321              122467889999999988774  6666664332 


Q ss_pred             C---eeEEEEeccCc-CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          133 S---KRALVYEYMPN-GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       133 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .   ..++|||++++ .+|.+++..     ..++..    .+.+++.++.+||+.   ||+|+||||.|||++.++.++|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            2   23599999987 688777621     234443    356889999999998   9999999999999998889999


Q ss_pred             eeccCccc
Q 048542          209 SDFGLAKF  216 (373)
Q Consensus       209 ~Dfg~~~~  216 (373)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998864

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=5.8e-14  Score=133.35  Aligned_cols=139  Identities=20%  Similarity=0.206  Sum_probs=96.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCH-----------------------------------------HHHHH
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA-----------------------------------------EEFIN  109 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~~~~  109 (373)
                      +.||+|++|.||+|++++|+.||||+.+......                                         -++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5699999999999999999999999986532100                                         02344


Q ss_pred             HHHHhcccC----CCceeeEeeEe-eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHcC
Q 048542          110 EVSTIGRIH----HVNVVQLLGFC-SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR-GIEYLHNG  183 (373)
Q Consensus       110 e~~~l~~l~----h~ni~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-al~~LH~~  183 (373)
                      |...+.++.    +.+-+.+-.++ ......++||||++|++|.+......   ....   ...++..++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHhC
Confidence            555555542    22222222222 22345789999999999987653211   1112   2345555555 46788887


Q ss_pred             CCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       184 ~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                         |++|+|++|.||+++.++.++++|||++....
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=2.2e-14  Score=125.00  Aligned_cols=204  Identities=22%  Similarity=0.266  Sum_probs=137.6

Q ss_pred             HhcccCCCceeeEeeEeeeC-----CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 048542          113 TIGRIHHVNVVQLLGFCSEG-----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC  187 (373)
Q Consensus       113 ~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~  187 (373)
                      -+..+-|.||++++.++.+.     ....++.|||..|++..++.........+....-.+|+.||..||.|||+. ++.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34445699999999988653     346789999999999999977777777888888889999999999999985 789


Q ss_pred             eEecCcCCCCeeeeCCCceEEeeccCcccCCC--CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHH
Q 048542          188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA  265 (373)
Q Consensus       188 ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll  265 (373)
                      ++|+++..+.|++..+|-+|+.--.-......  ...........+.++|.+||.=  ...+.+.++|||+||+...+|-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg--~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG--TTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC--cccccccchhhhhhhHHHHHHH
Confidence            99999999999999998888763211111000  0000011223467889999953  3346667899999999999998


Q ss_pred             cCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          266 GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       266 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+.--....    .........   ..+ ....+.+         ..-+.++..|++..|..||++.+++.
T Consensus       277 ilEiq~tns----eS~~~~ee~---ia~-~i~~len---------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNS----ESKVEVEEN---IAN-VIIGLEN---------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCC----cceeehhhh---hhh-heeeccC---------ccccCcCcccccCCCCCCcchhhhhc
Confidence            765321111    111111110   000 0011111         11245667799999999999998864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.7e-13  Score=112.66  Aligned_cols=130  Identities=20%  Similarity=0.157  Sum_probs=96.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCcCCccc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDR  149 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~gsL~~  149 (373)
                      +.++.|.++.||++... ++.+++|+..........+..|+..++.+.+.++ ++++.+.  ....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence            56889999999999876 7889999876554333456789999998865444 4455443  334589999999988754


Q ss_pred             cccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          150 HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       150 ~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ..         .   ....+..+++++++.||+..  ..+++|+|++|.||+++ ++.++++||+.+..
T Consensus        81 ~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            21         0   11235678999999999872  12359999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=9.2e-14  Score=130.61  Aligned_cols=252  Identities=21%  Similarity=0.200  Sum_probs=182.3

Q ss_pred             HHHHHHhhhhcccCC--CCcEEEEEEEE--c-CCceeEEEEeccCc---cCHHHHHHHHHHhccc-CCCceeeEeeEeee
Q 048542           61 QIIAMTNHFTHKLGQ--GGFGSVYKGQL--Q-TGGLIAVKMLENSK---FSAEEFINEVSTIGRI-HHVNVVQLLGFCSE  131 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~--G~~g~V~~~~~--~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  131 (373)
                      +....+..+.+.+|.  |.+|.+|.+..  . ++..+|+|.-+...   ....+-.+|+...+++ .|+|.++.+..+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            344445566788999  99999999975  3 67889998744322   1223335677777777 48999999999999


Q ss_pred             CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEecCcCCCCeeeeCC-Cce
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR----GIEYLHNGCDVCILHFDIKPHNILLDHN-FIP  206 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~  206 (373)
                      .+..++-+|+| +.+|..+..   .....++...++....+...    |+.++|+.   +++|-|+||.||+...+ ...
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~---~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCH---TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             CCcceeeeccc-cchhHHhhh---cccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence            99999999999 467776663   33455777888888888888    99999998   99999999999999988 889


Q ss_pred             EEeeccCcccCCCCCCc---eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc
Q 048542          207 KVSDFGLAKFHPKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF  283 (373)
Q Consensus       207 kl~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~  283 (373)
                      +++|||+...+....-.   .......|...|++||...+   .++...|+|++|.++.+-..+..+....-..      
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------  333 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNS------  333 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCC------
Confidence            99999999877654411   11122357788999999865   5677899999999999999887665433111      


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .|  ...+.+...     .++-...+.++...+.+|++.+|..|++.+.+..
T Consensus       334 -~W--~~~r~~~ip-----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 -SW--SQLRQGYIP-----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -Cc--cccccccCc-----hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             11  111111110     1111222445666889999999999999887653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=1.5e-13  Score=132.09  Aligned_cols=138  Identities=17%  Similarity=0.221  Sum_probs=89.7

Q ss_pred             cccCCCCcEEEEEEEEcC-CceeEEEEeccCccC---------------------------H--------H------HHH
Q 048542           71 HKLGQGGFGSVYKGQLQT-GGLIAVKMLENSKFS---------------------------A--------E------EFI  108 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~---------------------------~--------~------~~~  108 (373)
                      +.||+|++|.||+|++++ |+.||||++++.-..                           .        +      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999886 999999999754210                           0        1      133


Q ss_pred             HHHHHhcccC----CCceeeEeeEeee-CCeeEEEEeccCcCCccccccCCCCCC---CCCCHHHHHHHHHHHHHHHHHH
Q 048542          109 NEVSTIGRIH----HVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRHVFPKESRG---QSLCWEKLHEVALGTARGIEYL  180 (373)
Q Consensus       109 ~e~~~l~~l~----h~ni~~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~l~~~~~~~i~~~i~~al~~L  180 (373)
                      +|...+.++.    +.+.+.+-.++.+ ....++||||+.|+++.+..... ..+   ..+....+..++.|+.      
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~v~~~~~Qif------  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERGVEVFFTQVF------  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHHHHHHHHHHH------
Confidence            3444444442    3333333333322 34568999999999997642111 111   1233333334444443      


Q ss_pred             HcCCCCCeEecCcCCCCeeeeCCC----ceEEeeccCcccCCC
Q 048542          181 HNGCDVCILHFDIKPHNILLDHNF----IPKVSDFGLAKFHPK  219 (373)
Q Consensus       181 H~~~~~~ivH~dikp~Nil~~~~~----~~kl~Dfg~~~~~~~  219 (373)
                       ..   |++|+|++|.||+++.++    .++++|||++.....
T Consensus       278 -~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence             34   999999999999999887    999999999876644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=8.8e-12  Score=104.56  Aligned_cols=136  Identities=13%  Similarity=0.146  Sum_probs=98.0

Q ss_pred             cccCCCCcEEEEEEEEcC-------CceeEEEEeccCc----------------------cCH-HHH----HHHHHHhcc
Q 048542           71 HKLGQGGFGSVYKGQLQT-------GGLIAVKMLENSK----------------------FSA-EEF----INEVSTIGR  116 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------~~~vaiK~~~~~~----------------------~~~-~~~----~~e~~~l~~  116 (373)
                      ..||.|--+.||.|...+       +..+|||+.+.+.                      .+. ..+    .+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997543       4789999875311                      011 122    379999998


Q ss_pred             cCC--CceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEecCc
Q 048542          117 IHH--VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-HNGCDVCILHFDI  193 (373)
Q Consensus       117 l~h--~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~L-H~~~~~~ivH~di  193 (373)
                      +..  -+++.++++    ...++||||+.+..+....    -+...++......+..+++.+|..+ |..   +++|+|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~----Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK----LKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh----hhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            853  456666654    4568999999764332111    1122345556677889999999999 887   9999999


Q ss_pred             CCCCeeeeCCCceEEeeccCcccCC
Q 048542          194 KPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       194 kp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ++.||+++ ++.++|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.38  E-value=9.9e-12  Score=118.31  Aligned_cols=165  Identities=18%  Similarity=0.219  Sum_probs=123.4

Q ss_pred             EcCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHH
Q 048542           86 LQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE  164 (373)
Q Consensus        86 ~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~  164 (373)
                      ..++.+|.|...+.+... .+...+-++.++.++||||+++++.++.....|+|+|.+.  .|..++       ..+...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l-------k~l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL-------KELGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH-------HHhHHH
Confidence            446788888877765442 3556788899999999999999999999999999999873  344444       123356


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccc
Q 048542          165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN  244 (373)
Q Consensus       165 ~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  244 (373)
                      .+..-+.||+.||.+||+.  .+++|++|..+.|+++..|..||++|.++........  ......--..|..|+.+...
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence            6677889999999999964  3999999999999999999999999998864432221  00111122346677765432


Q ss_pred             cCCcCcccchHHHHHHHHHHHcC
Q 048542          245 FGTVSCKSDVYGFGMVLLEMAGG  267 (373)
Q Consensus       245 ~~~~s~~~DvwslG~~l~~ll~g  267 (373)
                          ....|.|.|||++++++.|
T Consensus       181 ----~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 ----EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ----ccchhhhhHHHHHHHHhCc
Confidence                1346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=3.3e-11  Score=104.59  Aligned_cols=141  Identities=21%  Similarity=0.239  Sum_probs=109.8

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCcc--CHHHHHHHHHHhcccCC--CceeeEeeEeeeCC---eeEEEEeccC
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS---KRALVYEYMP  143 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~---~~~lv~e~~~  143 (373)
                      +.|+.|..+.+|++...+|..+++|.......  ...++..|..+++.+++  .++++++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999887668999999776443  34677899999999975  34677777766532   5689999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC---------------------------------------  184 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------------------  184 (373)
                      |.++.+.+..     ..++......++.++++++..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765521     34667777788888899998888531                                       


Q ss_pred             --------------CCCeEecCcCCCCeeeeC--CCceEEeeccCccc
Q 048542          185 --------------DVCILHFDIKPHNILLDH--NFIPKVSDFGLAKF  216 (373)
Q Consensus       185 --------------~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~  216 (373)
                                    ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          135799999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.30  E-value=7e-11  Score=109.38  Aligned_cols=219  Identities=20%  Similarity=0.251  Sum_probs=157.8

Q ss_pred             CcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEee----eCCeeEEEEeccCc-CCccc
Q 048542           77 GFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRALVYEYMPN-GSLDR  149 (373)
Q Consensus        77 ~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~lv~e~~~~-gsL~~  149 (373)
                      -..+.|++..+ +|..|++|++...+. .......-++.++++.|+|+|++.+++.    .+..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34578999855 899999999943221 1223345678899999999999998875    35568899999875 56666


Q ss_pred             cccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          150 HVFPKE-----------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       150 ~l~~~~-----------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +.+...           ..+...++..+|.++.|+..||.++|+.   |+..+-+.|.+|+++++.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            554321           2356688999999999999999999998   99999999999999999999999888776554


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .+.         +       |-+.+     .++-|.=.||.++..|-+|...-...+...      .             
T Consensus       445 ~d~---------~-------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~------~-------------  484 (655)
T KOG3741|consen  445 EDP---------T-------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQ------S-------------  484 (655)
T ss_pred             CCC---------C-------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchH------H-------------
Confidence            332         0       11111     235699999999999999964311111100      0             


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                       .....+...++.++++++......++++ -+..+++.++-+
T Consensus       485 -s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~  524 (655)
T KOG3741|consen  485 -SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGS  524 (655)
T ss_pred             -HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHH
Confidence             0012344677888899999999888887 677877776543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1e-10  Score=95.06  Aligned_cols=130  Identities=21%  Similarity=0.248  Sum_probs=96.5

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEE-eccCccC--------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKM-LENSKFS--------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~-~~~~~~~--------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..+++|+-+.++.+.+. |.++++|. +++.-..        .++-.+|..++.++.--.|....=+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999775 44566664 3322111        24567899999988655554444455667778899999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      .+|..|.+.+...           ...++..+-.-+.-||..   +|+|+|++++||.++.++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888787322           145667777778889998   999999999999997654 99999999874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=2.3e-10  Score=95.63  Aligned_cols=124  Identities=27%  Similarity=0.280  Sum_probs=80.5

Q ss_pred             EEEEEEEcCCceeEEEEeccCccC---------------------------HHHHHHHHHHhcccCCC--ceeeEeeEee
Q 048542           80 SVYKGQLQTGGLIAVKMLENSKFS---------------------------AEEFINEVSTIGRIHHV--NVVQLLGFCS  130 (373)
Q Consensus        80 ~V~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~--ni~~~~~~~~  130 (373)
                      .||.|...+|..+|+|+.+....+                           .....+|.+.|.++...  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999997532110                           13456899999999755  566776542 


Q ss_pred             eCCeeEEEEeccC--cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          131 EGSKRALVYEYMP--NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY-LHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       131 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~-LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                         ..++||||++  |..+..+..      ..++......++.+++..+.. +|..   |++|+|+++.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKD------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHH------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHh------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  545543321      111123345567777775555 5777   99999999999999887 999


Q ss_pred             EeeccCcccC
Q 048542          208 VSDFGLAKFH  217 (373)
Q Consensus       208 l~Dfg~~~~~  217 (373)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.17  E-value=1.7e-10  Score=93.38  Aligned_cols=141  Identities=20%  Similarity=0.248  Sum_probs=101.8

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEecc-----C----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLEN-----S----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~-----~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..+-+|+-+.|+++.+. |+...||.=..     .    ..+..+..+|.+.+.++.--.|.-..-++.+.....++|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            56778999999999887 77777775321     1    11235678899999988655555444456677778899999


Q ss_pred             cCc-CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---ceEEeeccCcccC
Q 048542          142 MPN-GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  217 (373)
Q Consensus       142 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~~kl~Dfg~~~~~  217 (373)
                      +++ .++.+++...-  ...........++.+|-+.+.-||.+   +++|+||..+||++..++   .+.++|||++...
T Consensus        92 ~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   92 IDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            976 36666664321  12222333367888999999999998   999999999999997544   3589999998643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=7e-10  Score=100.49  Aligned_cols=266  Identities=13%  Similarity=0.122  Sum_probs=158.1

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeE------eee-CCeeEEEEe
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGF------CSE-GSKRALVYE  140 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~------~~~-~~~~~lv~e  140 (373)
                      ..+.||+|+-+.+|..-.- +.. +-|+.....-...  ......|... .||-+-.-+.+      ..+ ....-++|+
T Consensus        15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchh-hch-hheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4578999999999965322 222 3355544322111  1122223222 45432220110      111 222557788


Q ss_pred             ccCcCCccccccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          141 YMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       141 ~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      .+.+..--..+.+   ++.+.....|......+..++.+.+.||+.   |.+-+|++++|+|+++++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            7765422222222   233445578999999999999999999998   9999999999999999999999985443332


Q ss_pred             CCCCCceeeecccCCCCcccccccc-cc--cCCcCcccchHHHHHHHHHHHcC-CCCCCCCcCc-----cccccchHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELIS-RN--FGTVSCKSDVYGFGMVLLEMAGG-RRNSNMNATR-----SSKAYFPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~--~~~~s~~~DvwslG~~l~~ll~g-~~p~~~~~~~-----~~~~~~~~~~~  288 (373)
                      ...   .......|...|.+||.-. +.  .-..+...|.|.+|+++++|+.| ++||..-...     ..+..+....+
T Consensus       168 ~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            222   2334567899999999643 11  01345678999999999999987 8998753321     11111111111


Q ss_pred             HHHhcCCCcccCccchh-hHHHHHHHHHHHHhhcCCC--CCCCCCHHHHHHHHhcCCCC
Q 048542          289 DQLNKGGDLELQNVTEI-ESMIARKLCMIGLWCIQVK--AADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~d--p~~Rps~~ell~~L~~~~~~  344 (373)
                      ....+......+..... ...++.++..|..+|+...  +.-|||++.++..|..+-++
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            11111111111111111 1345667888999998653  67899999998887754443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.10  E-value=1.8e-11  Score=115.27  Aligned_cols=241  Identities=20%  Similarity=0.228  Sum_probs=165.4

Q ss_pred             hhhcccCCCCcEEEEEEEEc--CCceeEEEEeccCccCH-HH--HHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEec
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSKFSA-EE--FINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~~-~~--~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .+...||.|.|+.|+....+  ++..|++|.....-... .+  -..|+-+...+ .|.+++..+..+...+..|+--||
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~  347 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF  347 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence            44578999999999998744  67789999876644332 12  23455555555 488888887777777788899999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~  220 (373)
                      |.++++....    .....+.+...+.+..|++.++.++|+.   .++|+|++|+||++..+ +..++.|||+...+.-.
T Consensus       348 ~~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  348 CEGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             hcCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence            9998886655    2234466777889999999999999998   99999999999999875 78899999988642111


Q ss_pred             CCceeeecccCCCCccc-ccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIA-PELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~a-PE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      .     ....+..++.| +|++... ..+..+.|++|||.-+.+..++..--+....           +..+..+..+..
T Consensus       421 ~-----~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------~~~i~~~~~p~~  483 (524)
T KOG0601|consen  421 S-----GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------SLTIRSGDTPNL  483 (524)
T ss_pred             c-----ccccccccccccchhhccc-cccccccccccccccccccccCcccCccccc-----------ceeeecccccCC
Confidence            1     11223344452 5555443 4667789999999999999988643221110           001111111111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                             ......+..+...+...++..||++.++....+
T Consensus       484 -------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  484 -------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             -------CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                   112245677778899999999999988766543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=1.2e-09  Score=94.04  Aligned_cols=136  Identities=23%  Similarity=0.195  Sum_probs=98.2

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC-----------------------HHHHHHHHHHhcccCCC--c
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-----------------------AEEFINEVSTIGRIHHV--N  121 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~--n  121 (373)
                      +.+...||-|--+.||.|..+.|.++|||.-+....+                       .....+|.+.|..|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3566889999999999999999999999975432211                       12356899999999654  6


Q ss_pred             eeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       122 i~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      +++.+++    +..++|||+++|-.|...-         +..+....++..|++-+..+-..   |++|+|+++-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            6666654    5668999999886664332         11222333444444444444455   999999999999999


Q ss_pred             CCCceEEeeccCcccCC
Q 048542          202 HNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~  218 (373)
                      ++|.++++||-.+....
T Consensus       237 ~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         237 EDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             cCCCEEEEeCcccccCC
Confidence            99999999998776443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.05  E-value=1e-10  Score=116.30  Aligned_cols=242  Identities=18%  Similarity=0.166  Sum_probs=158.8

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .+-+-+|+++.++.+.-. +|...++|.......    ..+....+-.++-...+|.++....-+......+++++|..+
T Consensus       809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~  888 (1205)
T KOG0606|consen  809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG  888 (1205)
T ss_pred             cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence            356778888888877533 343444444332111    111222222222223456555554444556778999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC----
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE----  220 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~----  220 (373)
                      ++|...+++.    ...+.+.....+..+..+.++||+.   .+.|+|++|.|.+...++..+++|||.....+..    
T Consensus       889 ~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  889 GDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             CCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            9998877432    2455555666777788899999986   6899999999999999999999999843221100    


Q ss_pred             -----------------C---Cc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          221 -----------------N---DF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       221 -----------------~---~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                                       .   ..     ..-....||+.|.+||...+.  .....+|+|+.|+.+++.++|..||....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                             0   00     001233589999999999875  55667899999999999999999997665


Q ss_pred             CccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 048542          276 TRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT  332 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  332 (373)
                      ...        +++.+-++... .+   ..+...+....+++...+..+|.+|..+.
T Consensus      1040 pq~--------~f~ni~~~~~~-~p---~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQ--------IFENILNRDIP-WP---EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhh--------hhhccccCCCC-CC---CCccccChhhhhhhhhhhccCchhccCcc
Confidence            432        22222222211 11   22234466788899999999999998876

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=6.8e-09  Score=92.02  Aligned_cols=132  Identities=17%  Similarity=0.096  Sum_probs=93.1

Q ss_pred             EEEEEEEEcCCceeEEEEeccCcc------------CHHHHHHHHHHhcccCCCc--eeeEeeEeee-----CCeeEEEE
Q 048542           79 GSVYKGQLQTGGLIAVKMLENSKF------------SAEEFINEVSTIGRIHHVN--VVQLLGFCSE-----GSKRALVY  139 (373)
Q Consensus        79 g~V~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~-----~~~~~lv~  139 (373)
                      ..|.+.... |+.|.||.......            ....+.+|+..+..+...+  .+.++.+...     ....++|+
T Consensus        36 rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            346666554 77899997643221            1124678999888885333  2334444432     23578999


Q ss_pred             eccCcC-CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-------CCceEEeec
Q 048542          140 EYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-------NFIPKVSDF  211 (373)
Q Consensus       140 e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-------~~~~kl~Df  211 (373)
                      |++++. +|.+++....  ..+........++.+++..+.-||..   |++|+|++++|||++.       +..+.|+||
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            999875 7877763221  23345667778999999999999998   9999999999999975       467899999


Q ss_pred             cCccc
Q 048542          212 GLAKF  216 (373)
Q Consensus       212 g~~~~  216 (373)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=6e-10  Score=106.76  Aligned_cols=151  Identities=19%  Similarity=0.245  Sum_probs=101.7

Q ss_pred             HHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceee-------ecccCCCCccccccccc
Q 048542          171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-------SATRGTIGYIAPELISR  243 (373)
Q Consensus       171 ~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~  243 (373)
                      .+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+........+...       ........|.|||.+.+
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455999999976  59999999999999999999999999988755442222111       11224567999999877


Q ss_pred             ccCCcCcccchHHHHHHHHHHHcCCCC-CCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcC
Q 048542          244 NFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQ  322 (373)
Q Consensus       244 ~~~~~s~~~DvwslG~~l~~ll~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  322 (373)
                      .  ..+.++|+||+|+++|.+..|..+ +...........       .........    ..+...++.++++=+.+++.
T Consensus       184 ~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------~~~~~~~~~----~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 T--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------SRNLLNAGA----FGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             c--cccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------hhccccccc----ccccccCcHHHHHHHHHHhc
Confidence            4  667899999999999999955443 332221110000       000000000    11224456677788888999


Q ss_pred             CCCCCCCCHHHHHH
Q 048542          323 VKAADRPSMTKVLE  336 (373)
Q Consensus       323 ~dp~~Rps~~ell~  336 (373)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.76  E-value=3.8e-08  Score=94.48  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=90.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccC---------------------------H----H----------HHHH
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---------------------------A----E----------EFIN  109 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------------------------~----~----------~~~~  109 (373)
                      .-|+.++-|.||+|++++|+.||||+.+++-..                           .    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            568899999999999999999999998643211                           0    1          1334


Q ss_pred             HHHHhcccC-----CCceeeEeeEee-eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 048542          110 EVSTIGRIH-----HVNVVQLLGFCS-EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG  183 (373)
Q Consensus       110 e~~~l~~l~-----h~ni~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~  183 (373)
                      |...+.++.     .+++ .+-.++. -.....++|||++|..+.+......   ...+.+.+.....++.  +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            555554442     2332 2222232 2456789999999999888753222   2233333322222222  1122222


Q ss_pred             CCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       184 ~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                         |+.|.|..|.||+++.+|++.+.|||+......
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               899999999999999999999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=4e-07  Score=77.95  Aligned_cols=137  Identities=20%  Similarity=0.223  Sum_probs=93.3

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccC--------------------HHH-----HHHHHHHhcccC--CCcee
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS--------------------AEE-----FINEVSTIGRIH--HVNVV  123 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------------~~~-----~~~e~~~l~~l~--h~ni~  123 (373)
                      -.|++|--+.||+|...++..+|+|+++.....                    ..+     ...|+.-|+++.  +-.++
T Consensus        54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            357778888899999888999999998643211                    111     235777777773  34455


Q ss_pred             eEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC
Q 048542          124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  203 (373)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~  203 (373)
                      +.+.+.    ...+||||+.....    -...-+...+.......+..++++.+.-|-..  .++||+||+.-|||+. +
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~  202 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-D  202 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-C
Confidence            555543    34699999854311    11112233334445667777888888777762  2999999999999998 8


Q ss_pred             CceEEeeccCcccCC
Q 048542          204 FIPKVSDFGLAKFHP  218 (373)
Q Consensus       204 ~~~kl~Dfg~~~~~~  218 (373)
                      +.+.++|||.+....
T Consensus       203 ~~p~iID~~QaV~~~  217 (268)
T COG1718         203 GEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEECccccccC
Confidence            899999999887554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=6.4e-07  Score=77.76  Aligned_cols=132  Identities=20%  Similarity=0.254  Sum_probs=86.6

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEeeEeeeCCeeEEEEeccCcCC-c
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEYMPNGS-L  147 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~gs-L  147 (373)
                      ..||.|..+.||+.   .+..+++|.... ........+|.+++..+..-.  +++.+++........++||+++|.+ +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            46899999999984   255788888765 334566789999999886433  5677888777777889999998863 2


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc---------------------------------------C-CCCC
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN---------------------------------------G-CDVC  187 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~---------------------------------------~-~~~~  187 (373)
                      ...+.        .+......++.++++.+.-||+                                       . ....
T Consensus        83 ~~~~~--------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        83 SRIIS--------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhc--------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            11110        0011111122222222222221                                       1 1235


Q ss_pred             eEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          188 ILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       188 ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++|+|+.|.||++++++ +.++||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            78999999999999887 9999999775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=2.3e-07  Score=79.45  Aligned_cols=105  Identities=23%  Similarity=0.258  Sum_probs=79.4

Q ss_pred             HHHHHHHHHhcccCCC--ceeeEeeEeeeC----CeeEEEEeccCcC-CccccccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 048542          105 EEFINEVSTIGRIHHV--NVVQLLGFCSEG----SKRALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTARGI  177 (373)
Q Consensus       105 ~~~~~e~~~l~~l~h~--ni~~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al  177 (373)
                      ....+|...+..+...  ..++.+++....    ...++|+|++++. +|.+++....    ..+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence            4677888888877432  344455555442    2457999999874 7887773321    255566788999999999


Q ss_pred             HHHHcCCCCCeEecCcCCCCeeeeCCC---ceEEeeccCccc
Q 048542          178 EYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKF  216 (373)
Q Consensus       178 ~~LH~~~~~~ivH~dikp~Nil~~~~~---~~kl~Dfg~~~~  216 (373)
                      +-||..   |++|+|+++.|||++.++   .+.++||+-+..
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999998   999999999999999876   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=3.7e-07  Score=87.53  Aligned_cols=139  Identities=17%  Similarity=0.184  Sum_probs=90.2

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCH--------------------------------------HHHHHHHH
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA--------------------------------------EEFINEVS  112 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------~~~~~e~~  112 (373)
                      +.||..+.|.||+|+.++|+.||||+.++.-...                                      =+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999875432110                                      02334443


Q ss_pred             Hhccc----CCCc------eeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 048542          113 TIGRI----HHVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN  182 (373)
Q Consensus       113 ~l~~l----~h~n------i~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~  182 (373)
                      -..++    .|-+      |+++|..+  .....|+||||+|..+.+.-...   ...++...+..-+.+...-+-+.| 
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qIf~~-  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQIFKT-  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHHHhc-
Confidence            33332    3434      44444322  34678999999999887764322   223444444333333322222222 


Q ss_pred             CCCCCeEecCcCCCCeeee----CCCceEEeeccCcccCCC
Q 048542          183 GCDVCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       183 ~~~~~ivH~dikp~Nil~~----~~~~~kl~Dfg~~~~~~~  219 (373)
                          |++|+|-.|.||+++    .++.+.+-|||+......
T Consensus       321 ----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 ----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence                899999999999998    367899999999876543

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=1.5e-06  Score=73.29  Aligned_cols=135  Identities=16%  Similarity=0.126  Sum_probs=97.7

Q ss_pred             CCCCcEEEEEEEEcCCceeEEEEeccC-------ccCHHHHHHHHHHhcccCCC--ceeeEeeEeee-----CCeeEEEE
Q 048542           74 GQGGFGSVYKGQLQTGGLIAVKMLENS-------KFSAEEFINEVSTIGRIHHV--NVVQLLGFCSE-----GSKRALVY  139 (373)
Q Consensus        74 g~G~~g~V~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~~~-----~~~~~lv~  139 (373)
                      |+||-+.|++-... |..+-+|.....       ......|.+|+..+..+..-  .+++.. ++..     ...-+||+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            57888899987766 446888876521       22446789999999998532  244444 3321     12356899


Q ss_pred             eccCc-CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc--eEEeeccCcc
Q 048542          140 EYMPN-GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAK  215 (373)
Q Consensus       140 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~  215 (373)
                      |-+++ -+|.+++....  -.+.+......++.+++..++-||+.   |+.|+|+.+.||+++.++.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97743 57777763321  22456677788999999999999998   9999999999999986666  9999998665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=3.3e-06  Score=71.61  Aligned_cols=133  Identities=16%  Similarity=0.120  Sum_probs=81.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHH----------HHHHHHHhcccCC---CceeeEeeEee--
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE----------FINEVSTIGRIHH---VNVVQLLGFCS--  130 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~h---~ni~~~~~~~~--  130 (373)
                      .+...+.+-......|.+-..+ |+.+++|..+......++          ..+.+..+..+..   -....++.+.+  
T Consensus        32 ~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            4444455555555555555444 788999987654332222          1233333333322   22222222222  


Q ss_pred             ---eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          131 ---EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       131 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                         -....+++|||++|..|.+...        +.+    .+...+.+++.-+|+.   |++|+|..|.|++++.++ ++
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~  174 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IR  174 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EE
Confidence               2234568999999988866531        222    2445677889999998   999999999999998654 99


Q ss_pred             EeeccCcc
Q 048542          208 VSDFGLAK  215 (373)
Q Consensus       208 l~Dfg~~~  215 (373)
                      ++||+...
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.41  E-value=3.4e-06  Score=74.32  Aligned_cols=75  Identities=13%  Similarity=0.199  Sum_probs=53.5

Q ss_pred             cCCCCc-EEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccCcCCcccc
Q 048542           73 LGQGGF-GSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRH  150 (373)
Q Consensus        73 ig~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~  150 (373)
                      |..|.+ ..||+.... +..+.+|+.....  ..+...|+.+++.+. +--+++++++...++..++|||+++|.++...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444555 778998765 4788889876543  345677888888884 34466777777666678999999998777543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=2.2e-06  Score=74.69  Aligned_cols=77  Identities=23%  Similarity=0.315  Sum_probs=56.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCC--ceeeEeeEe---eeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLLGFC---SEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~---~~~~~~~lv~e~~~~g  145 (373)
                      +.++.|..+.||+....+ +.+++|..... .....+.+|..+++.+...  .++.++...   ......+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            568899999999999886 69999987665 4456778899998888532  355666544   2334578999999888


Q ss_pred             Cccc
Q 048542          146 SLDR  149 (373)
Q Consensus       146 sL~~  149 (373)
                      .+..
T Consensus        81 ~~~~   84 (239)
T PF01636_consen   81 PLDD   84 (239)
T ss_dssp             EHHH
T ss_pred             cccc
Confidence            7766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.38  E-value=2.5e-05  Score=65.61  Aligned_cols=105  Identities=24%  Similarity=0.204  Sum_probs=82.2

Q ss_pred             HHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 048542          108 INEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV  186 (373)
Q Consensus       108 ~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~  186 (373)
                      .+|.-+++.+++ +++++++|+|-.    .++.||...+++...-. .-..-...+|..+.+|+.++++.+.++++....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            357888888875 699999999944    67899998776642210 001123478999999999999999999986555


Q ss_pred             CeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       187 ~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      .+.-.|++++|+-+++++++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=5.5e-06  Score=67.23  Aligned_cols=130  Identities=18%  Similarity=0.212  Sum_probs=87.8

Q ss_pred             hhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceee-EeeEeeeCCeeEEEEeccCcCC
Q 048542           68 HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ-LLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~-~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      +..+.|++|++|.||+|.+. |..+|+|+-+. ......+..|.+++..++-.++.+ +|.+-.+    ++.|||+.|-+
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            34578999999999999988 66888886554 345577889999999997666544 4433222    35599998878


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcC-CCCeeeeCCCceEEeeccCcccC
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIK-PHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dik-p~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |.+....       ...    +-...+++.---|-..   ||-|+.|. |...++-.++.+.|+||..|+..
T Consensus        99 L~~~~~~-------~~r----k~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIG-------GDR----KHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhc-------ccH----HHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            7655411       112    2233455553444444   99999986 44444445559999999988743

>PLN02876 acyl-CoA dehydrogenase

Probab=98.30  E-value=1.4e-05  Score=82.57  Aligned_cols=78  Identities=15%  Similarity=0.304  Sum_probs=57.9

Q ss_pred             hcccCCCCcEEEEEEEEcCC---ceeEEEEeccCc--cCHHHHHHHHHHhcccC-CCce--eeEeeEeeeC---CeeEEE
Q 048542           70 THKLGQGGFGSVYKGQLQTG---GLIAVKMLENSK--FSAEEFINEVSTIGRIH-HVNV--VQLLGFCSEG---SKRALV  138 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-h~ni--~~~~~~~~~~---~~~~lv  138 (373)
                      .+.++.|.+..+|+....++   ..+++|+.....  .....+.+|..+++.+. |.++  ++++.+|.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            36789999999999876643   467888765433  23457889999999995 6654  7788887664   467899


Q ss_pred             EeccCcCCc
Q 048542          139 YEYMPNGSL  147 (373)
Q Consensus       139 ~e~~~~gsL  147 (373)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.21  E-value=3.2e-07  Score=87.67  Aligned_cols=184  Identities=19%  Similarity=0.171  Sum_probs=127.9

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc-eeeEeeEeeeCCeeEEEEeccCcC-C
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMPNG-S  146 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~~~~g-s  146 (373)
                      +-+..++|+++++++.+-........+.+...    ....-++++|.+++||| .+..++-+..+...++.++++.++ +
T Consensus       246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            34567899999999987443333335544332    34456899999999999 666666677778889999999766 2


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceee
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI  226 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  226 (373)
                      -.....   .....+...+...+...-+++++++|+.   .=+|+|    ||+..+ +..+..||+....+.+..   ..
T Consensus       322 ~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~  387 (829)
T KOG0576|consen  322 SALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP  387 (829)
T ss_pred             ccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence            222221   1122233444556666777889999975   457888    777754 678999999887654432   23


Q ss_pred             ecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      +...+++.|+|||+....  .+..+.|+|+.|.-..++--|.+|-.
T Consensus       388 ~t~~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccCCCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence            455699999999988764  67778999999987777777766643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.20  E-value=2.2e-05  Score=68.71  Aligned_cols=74  Identities=18%  Similarity=0.213  Sum_probs=47.6

Q ss_pred             cccCCCCcEE-EEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCC---ceeeEeeEeeeC---CeeEEEEeccC
Q 048542           71 HKLGQGGFGS-VYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCSEG---SKRALVYEYMP  143 (373)
Q Consensus        71 ~~ig~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~~~---~~~~lv~e~~~  143 (373)
                      +.|+.|+... ||+.    +..+++|.... .....++.+|.+.+..+...   .+...++.....   ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            4567777764 8875    34577886554 33456788999999887532   344445443332   23578999999


Q ss_pred             cCCccc
Q 048542          144 NGSLDR  149 (373)
Q Consensus       144 ~gsL~~  149 (373)
                      |.++.+
T Consensus        78 G~~l~~   83 (235)
T cd05155          78 GETATA   83 (235)
T ss_pred             CCCCCc
Confidence            877754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.17  E-value=5.3e-05  Score=68.69  Aligned_cols=75  Identities=11%  Similarity=0.085  Sum_probs=56.7

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC---CceeeEeeEeee---CCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH---VNVVQLLGFCSE---GSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~---~~~~~lv~e~~~~  144 (373)
                      +.||.|..+.||.....++ .+++|..+. ......+..|...++.+.-   -.++++++++..   .+..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            5799999999999876544 577777433 2244688899999998853   367888887754   3568999999988


Q ss_pred             CCc
Q 048542          145 GSL  147 (373)
Q Consensus       145 gsL  147 (373)
                      .++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=3.9e-05  Score=64.85  Aligned_cols=126  Identities=19%  Similarity=0.274  Sum_probs=88.8

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCc-----------------cCHHHHHHHHHHhcccC------CCceeeEee
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSK-----------------FSAEEFINEVSTIGRIH------HVNVVQLLG  127 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~ni~~~~~  127 (373)
                      ..||+|+.-.||.  ++++...+||+.....                 ....+..+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5699999999885  5566778999887655                 22356667777666665      778999999


Q ss_pred             EeeeCCeeEEEEeccCc--C----CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          128 FCSEGSKRALVYEYMPN--G----SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       128 ~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      +.+.+...-+|+|.+.+  |    +|.+++.     ...++. ...+.+   -+-..||-+.   .|+.+|++|.||++.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHH---HHHHHHHHHc---CCeecCCCcccEEEE
Confidence            99998888999998632  3    4555551     223444 333333   3445667766   899999999999996


Q ss_pred             CC--C--ceEEee
Q 048542          202 HN--F--IPKVSD  210 (373)
Q Consensus       202 ~~--~--~~kl~D  210 (373)
                      .+  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.11  E-value=1.5e-05  Score=81.52  Aligned_cols=198  Identities=20%  Similarity=0.192  Sum_probs=134.7

Q ss_pred             HHHHHHhcccCCCceeeEeeEeeeCCeeE----EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 048542          108 INEVSTIGRIHHVNVVQLLGFCSEGSKRA----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG  183 (373)
Q Consensus       108 ~~e~~~l~~l~h~ni~~~~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~  183 (373)
                      .-|...+.+..|+|+..++.|........    +..++|..-++...+    ..-..++....+.+..+..+|++|+|+.
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~----q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL----QSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH----hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            34667788889999999999886654433    345677777776666    3456688889999999999999999987


Q ss_pred             CCCCeEecCcCCC---CeeeeCCCceEEe--eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHH
Q 048542          184 CDVCILHFDIKPH---NILLDHNFIPKVS--DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFG  258 (373)
Q Consensus       184 ~~~~ivH~dikp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG  258 (373)
                         ...|.-+..+   +-..+..+....+  ||+.+.........   ....-+..|.+||.........+...|+|.+|
T Consensus       306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence               5666555555   4455566666666  88887765443321   12234456788888766544555567999999


Q ss_pred             HHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          259 MVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       259 ~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                      .....+..|..+-.......          ..+.              ......+.+....|+..++++|++..+++...
T Consensus       380 ll~~~~~~~~~i~~~~~~~~----------~~l~--------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPV----------SLLD--------------VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHhhhhhcCcccccccchh----------hhhc--------------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999998875533221110          0000              00011467778889999999999999998754


Q ss_pred             h
Q 048542          339 E  339 (373)
Q Consensus       339 ~  339 (373)
                      -
T Consensus       436 f  436 (1351)
T KOG1035|consen  436 F  436 (1351)
T ss_pred             h
Confidence            3

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.09  E-value=4.1e-05  Score=66.99  Aligned_cols=74  Identities=15%  Similarity=0.206  Sum_probs=48.7

Q ss_pred             cccCCCCcEEEEEEEEcC--CceeEEEEeccCccCHHHHHHHHHHhcccCCCc-eeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           71 HKLGQGGFGSVYKGQLQT--GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      +.|..|-...+|+....+  ++.|++|+........-+..+|..+++.+...+ .+++++.+.    ..++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence            457788888999998664  678999977653322223347888888885333 344444332    2489999988766


Q ss_pred             c
Q 048542          148 D  148 (373)
Q Consensus       148 ~  148 (373)
                      .
T Consensus        80 ~   80 (235)
T cd05157          80 E   80 (235)
T ss_pred             C
Confidence            3

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.99  E-value=7.2e-05  Score=66.40  Aligned_cols=139  Identities=12%  Similarity=0.104  Sum_probs=78.5

Q ss_pred             ccCCCCcEEEEEEEEcCCceeEEEEeccCccCH-HHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCcCCccc
Q 048542           72 KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDR  149 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~gsL~~  149 (373)
                      .+..|-.+.+|+... ++..+++|......... -+..+|..+++.+....+ ++++....    .++|+||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            355678888998874 46788899765432221 234678888888854333 34443322    368999998876643


Q ss_pred             cc-----------------cCCCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHcC-----CCCCeEecCcCCCC
Q 048542          150 HV-----------------FPKESRGQSLCWE-KLHEVALGT---------ARGIEYLHNG-----CDVCILHFDIKPHN  197 (373)
Q Consensus       150 ~l-----------------~~~~~~~~~l~~~-~~~~i~~~i---------~~al~~LH~~-----~~~~ivH~dikp~N  197 (373)
                      ..                 +.....+.++... .+.....++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            20                 1111111122211 111111111         1111112111     12368999999999


Q ss_pred             eeeeCCCceEEeeccCccc
Q 048542          198 ILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       198 il~~~~~~~kl~Dfg~~~~  216 (373)
                      |++++++ +.++||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.91  E-value=0.0002  Score=65.71  Aligned_cols=142  Identities=15%  Similarity=0.199  Sum_probs=77.7

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEee------EeeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLG------FCSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~------~~~~~~~~~lv~e~~  142 (373)
                      +.++.|....+|+....+| .+++|+..  ....+....|...+..|...+  +++.+.      +....+..+++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            4567788788999876644 78999876  233444455666666653211  333332      122345678999999


Q ss_pred             CcCCcccc----c----------cCCCC-------CCCCCCH-HHHHH------------HHHH-HHHHHHHHHcC----
Q 048542          143 PNGSLDRH----V----------FPKES-------RGQSLCW-EKLHE------------VALG-TARGIEYLHNG----  183 (373)
Q Consensus       143 ~~gsL~~~----l----------~~~~~-------~~~~l~~-~~~~~------------i~~~-i~~al~~LH~~----  183 (373)
                      +|..+...    .          +....       ....+.+ .....            ...+ +...+..+...    
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            88654211    0          00000       0001111 11110            1111 11122222211    


Q ss_pred             CCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       184 ~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ...+++|+|+.|.||+++.+...-++||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            23489999999999999876656899999875

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.88  E-value=0.00021  Score=64.81  Aligned_cols=143  Identities=19%  Similarity=0.195  Sum_probs=85.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEeeE------eeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGF------CSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~------~~~~~~~~lv~e~~  142 (373)
                      +.+..|....+|+.... ++.+++|+...  .+.+....|+.++..+.+.+  +++++..      ...++..+++++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~-~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTD-SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeC-CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            56777888899998765 45789998765  34566777888888874322  3444331      12345568999999


Q ss_pred             CcCCccccc--------------c----CCCC---CCCCCCHHHHH----------HHHHHHHHHHHHHHc----CCCCC
Q 048542          143 PNGSLDRHV--------------F----PKES---RGQSLCWEKLH----------EVALGTARGIEYLHN----GCDVC  187 (373)
Q Consensus       143 ~~gsL~~~l--------------~----~~~~---~~~~l~~~~~~----------~i~~~i~~al~~LH~----~~~~~  187 (373)
                      +|..+...-              +    ....   ......|....          .....+..++.++..    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            887654300              0    0000   00011111110          011122334444443    12347


Q ss_pred             eEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          188 ILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       188 ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++|+|+.|.|+++++++.+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            99999999999999887778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.83  E-value=0.00029  Score=64.38  Aligned_cols=143  Identities=20%  Similarity=0.253  Sum_probs=82.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCC--ceeeEeeEe------eeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV--NVVQLLGFC------SEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~--ni~~~~~~~------~~~~~~~lv~e~~  142 (373)
                      +.++.|....+|+.... ++.+++|+.... ...+....|.+++..|...  .+++++...      ...+..+++++|+
T Consensus        28 ~~~~~G~~n~~y~v~t~-~~~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTD-VGRYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeC-CCcEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            55777777899998765 446888977552 2345556677777777422  233443321      2245678999999


Q ss_pred             CcCCccccc--------------cC------CCCCC--CCCCHHHHH------------HHHHHHHHHHHHHHc----CC
Q 048542          143 PNGSLDRHV--------------FP------KESRG--QSLCWEKLH------------EVALGTARGIEYLHN----GC  184 (373)
Q Consensus       143 ~~gsL~~~l--------------~~------~~~~~--~~l~~~~~~------------~i~~~i~~al~~LH~----~~  184 (373)
                      +|..+....              +.      .....  ..-.|....            .....+.+.+.++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            886543110              00      00000  000111100            011122334544532    12


Q ss_pred             CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ..+++|+|+++.|++++.++...++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            3589999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.79  E-value=0.0002  Score=65.27  Aligned_cols=141  Identities=21%  Similarity=0.262  Sum_probs=83.5

Q ss_pred             cccCCCCcEEEEEEEEcC-------CceeEEEEeccCccCHHHHHHHHHHhcccCCCc-eeeEeeEeeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQT-------GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +.+..|-...+|+....+       ++.+++|+.........+..+|..++..+.... .+++++++..    ..|++|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            345567777899987654       578999997765433345678888888885333 3345554432    3689999


Q ss_pred             CcCCccccc-----------------cCCCCC--C---CCC--CHHHHHH--------------------------HHHH
Q 048542          143 PNGSLDRHV-----------------FPKESR--G---QSL--CWEKLHE--------------------------VALG  172 (373)
Q Consensus       143 ~~gsL~~~l-----------------~~~~~~--~---~~l--~~~~~~~--------------------------i~~~  172 (373)
                      +|.++....                 +.....  .   ...  -+.....                          ....
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            887664311                 000000  0   001  0111111                          1112


Q ss_pred             HHHHHHHHHc------CCCCCeEecCcCCCCeeeeCC----CceEEeeccCcc
Q 048542          173 TARGIEYLHN------GCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAK  215 (373)
Q Consensus       173 i~~al~~LH~------~~~~~ivH~dikp~Nil~~~~----~~~kl~Dfg~~~  215 (373)
                      +...+..+-.      .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            2222334432      134579999999999999874    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.0004  Score=65.10  Aligned_cols=73  Identities=14%  Similarity=0.158  Sum_probs=53.9

Q ss_pred             cccCCCCcEEEEEEEEcCC-ceeEEEEeccC--------ccCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEE
Q 048542           71 HKLGQGGFGSVYKGQLQTG-GLIAVKMLENS--------KFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~-~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv  138 (373)
                      +.||.|.+..||++...+| +.++||.-...        ....++...|.+.|+.+.   ..++++++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5789999999999998866 48999984311        234567778888888763   2457777766  44567899


Q ss_pred             EeccCcC
Q 048542          139 YEYMPNG  145 (373)
Q Consensus       139 ~e~~~~g  145 (373)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9998763

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.73  E-value=0.00043  Score=58.20  Aligned_cols=124  Identities=27%  Similarity=0.404  Sum_probs=86.0

Q ss_pred             HHhhhhcccCCCCc-EEEEEEEEcCCceeEEEEecc---Cc-------------------cCHHHHHHHHHHhcccC---
Q 048542           65 MTNHFTHKLGQGGF-GSVYKGQLQTGGLIAVKMLEN---SK-------------------FSAEEFINEVSTIGRIH---  118 (373)
Q Consensus        65 ~~~~~~~~ig~G~~-g~V~~~~~~~~~~vaiK~~~~---~~-------------------~~~~~~~~e~~~l~~l~---  118 (373)
                      ...++.+.||.|.- |.||+++.. |..||+|+++.   ..                   .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            45677899999999 999999987 77999999321   00                   00134778888888774   


Q ss_pred             CCce--eeEeeEeeeC------------------CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 048542          119 HVNV--VQLLGFCSEG------------------SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE  178 (373)
Q Consensus       119 h~ni--~~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~  178 (373)
                      +.++  ++.+||..-.                  ....||.||.+...             .++..    -+.+|.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence            4455  8889887322                  11346777765422             12223    3445666678


Q ss_pred             HHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       179 ~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+|..   ||+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89988   9999999999985     3478999854

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.62  E-value=0.00053  Score=62.34  Aligned_cols=139  Identities=19%  Similarity=0.234  Sum_probs=97.2

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCcc----------------------CHH-----HHHHHHHHhcccCCCce
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF----------------------SAE-----EFINEVSTIGRIHHVNV  122 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~----------------------~~~-----~~~~e~~~l~~l~h~ni  122 (373)
                      ...|..|--+.||.+...+|..+|||+++.+-.                      +..     -...|++-|++++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            356888888999999998999999999753211                      111     12458888888875554


Q ss_pred             eeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC
Q 048542          123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (373)
Q Consensus       123 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~  202 (373)
                      +-.--...  ....|||+|+....    .....-+...++...+..+-.+++.-+.-|.+.|  .+||.||+--|+|+ .
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdg----w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDG----WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCC----CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-E
Confidence            32211111  23469999995322    1222335666777788888888888888887664  89999999999999 5


Q ss_pred             CCceEEeeccCcccC
Q 048542          203 NFIPKVSDFGLAKFH  217 (373)
Q Consensus       203 ~~~~kl~Dfg~~~~~  217 (373)
                      +|.+.++|.+.+.-.
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            678999998877543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.61  E-value=7.6e-05  Score=66.53  Aligned_cols=134  Identities=16%  Similarity=0.108  Sum_probs=93.1

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH-----------------------HHHHHHHHHhcccCC--Cc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA-----------------------EEFINEVSTIGRIHH--VN  121 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~e~~~l~~l~h--~n  121 (373)
                      +.+.++||-|--+.+|.+....|++.++|+-+....+.                       -...+|+..|+.|..  --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            45678999999999999999999999999754322111                       123468888888742  22


Q ss_pred             eeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       122 i~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      +++.++    ...-++|||++.+-.|...-       ......   .+...+..-+.-|-.+   |++|+|..-=||++.
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~-------~v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVR-------HVEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeee-------ecCChH---HHHHHHHHHHHHHHHc---CceecccchheeEEe
Confidence            444443    35568999999887775432       111222   2333444445556666   999999999999999


Q ss_pred             CCCceEEeeccCcccC
Q 048542          202 HNFIPKVSDFGLAKFH  217 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~  217 (373)
                      +++.++++||-.+...
T Consensus       237 dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVST  252 (465)
T ss_pred             cCCCEEEeechHhhcc
Confidence            9999999999866543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.38  E-value=0.0011  Score=59.51  Aligned_cols=72  Identities=18%  Similarity=0.340  Sum_probs=46.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.++.|....+|+.. .+++.+.+|+-...  ....+..|..-|+.|.   .-.+++++++....+..++++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~--~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNSES--GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEEGG--GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecChh--hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            568888899999987 55788999987632  2356677888777773   446888888887777789999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.22  E-value=0.003  Score=58.56  Aligned_cols=142  Identities=18%  Similarity=0.254  Sum_probs=80.9

Q ss_pred             cccCCCCcEEEEEEEEcC-----CceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQT-----GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.+-.|-...+|+....+     +..+++|+........-+-.+|..+++.+...++ +++++.+..+    .|.+|+++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            445557788899987542     3678999876543222223678888888854333 3455555332    57999877


Q ss_pred             CCcccc-c----------------cCCC--CCCCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-C
Q 048542          145 GSLDRH-V----------------FPKE--SRGQSLCWEKLHEVALGT-----------------ARGIEYL----HN-G  183 (373)
Q Consensus       145 gsL~~~-l----------------~~~~--~~~~~l~~~~~~~i~~~i-----------------~~al~~L----H~-~  183 (373)
                      .++... +                +...  .......+..+..+..++                 ...+..|    .. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421 0                1100  001112233333332211                 1111122    21 1


Q ss_pred             CCCCeEecCcCCCCeeeeC-CCceEEeeccCccc
Q 048542          184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKF  216 (373)
Q Consensus       184 ~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~  216 (373)
                      ....++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2347899999999999986 46899999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.17  E-value=0.0058  Score=55.42  Aligned_cols=133  Identities=22%  Similarity=0.241  Sum_probs=85.0

Q ss_pred             CCCcEEEEEEEEcCCceeEEEEecc---CccCHHHHHHHHHHhcccCC--CceeeEeeEeeeCC--eeEEEEeccCcCCc
Q 048542           75 QGGFGSVYKGQLQTGGLIAVKMLEN---SKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGS--KRALVYEYMPNGSL  147 (373)
Q Consensus        75 ~G~~g~V~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~--~~~lv~e~~~~gsL  147 (373)
                      .|..-.+|..... +++++++ ...   ......+..+|+.+++.+.-  --+...+++|.++.  ..+.||+|++|..+
T Consensus        35 ~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~  112 (321)
T COG3173          35 GGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV  112 (321)
T ss_pred             CCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence            3333345555444 7888888 331   12233566778888888742  23455677776665  77999999988655


Q ss_pred             cccccCCCCCCCCCCHHHHHHHH-HHHHHHHHHHHcCC------------------------------------------
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVA-LGTARGIEYLHNGC------------------------------------------  184 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~-~~i~~al~~LH~~~------------------------------------------  184 (373)
                      .+.+....     .  .  .+.+ ..+++.|+-||+-.                                          
T Consensus       113 ~~~~~~~~-----~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         113 WSALPPES-----L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             cCcCCccc-----c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            43331110     1  1  1222 36666677777531                                          


Q ss_pred             -------------CCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          185 -------------DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       185 -------------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                                   ...++|+|+++.|++++.++-+=+.||+++..-.
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                         1359999999999999988889999999987543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.16  E-value=0.0053  Score=55.05  Aligned_cols=70  Identities=11%  Similarity=-0.003  Sum_probs=40.4

Q ss_pred             cCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC--Cc-eeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           73 LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH--VN-VVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        73 ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~n-i~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      .++|-...|+.....+|..+++|.-+. ........+|..++..+..  +- ++++..  .+  ..+++|++++|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~~--~~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRV--HT--PELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceee--ec--CceEEEeccCCCcc
Confidence            344444556665555688899987653 2234567889999998852  21 122221  11  22567777766544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.93  E-value=7.7e-05  Score=78.40  Aligned_cols=161  Identities=12%  Similarity=0.033  Sum_probs=113.9

Q ss_pred             HHHHHHHhcccCCCceeeEeeEeee--CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 048542          107 FINEVSTIGRIHHVNVVQLLGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC  184 (373)
Q Consensus       107 ~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~  184 (373)
                      ...|....+...|+++...+.-...  ....+..++|+.+|.+.+.+.+...+...+....+.....+...+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555556678887665544322  33467899999999999988766655555655555555555466666666543


Q ss_pred             C--CCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHH
Q 048542          185 D--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL  262 (373)
Q Consensus       185 ~--~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~  262 (373)
                      +  .-.+|+++|+-|.++..+.++|+.++|+.+...+....  .....+++-|++|++...-  .++.++|+|..|+.+|
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHH
Confidence            2  23689999999999999999999999999833222211  2234577788899987654  6777899999999999


Q ss_pred             HHHcCCCCC
Q 048542          263 EMAGGRRNS  271 (373)
Q Consensus       263 ~ll~g~~p~  271 (373)
                      .+..|..+|
T Consensus      1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred             HHhcccHHH
Confidence            999887665

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.93  E-value=0.016  Score=53.02  Aligned_cols=141  Identities=21%  Similarity=0.330  Sum_probs=83.5

Q ss_pred             ccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc------eeeEee----EeeeCCeeEEEEec
Q 048542           72 KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLG----FCSEGSKRALVYEY  141 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~----~~~~~~~~~lv~e~  141 (373)
                      .|.+ .-..+|+....+|+. ++|+.+.. .+..++..|...+..|.-..      +...=|    ....+.+.+-+++|
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3444 455688888776665 99999887 77788888888888883211      222211    11112377789999


Q ss_pred             cCcCCccc-ccc------------------C----CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcCC-
Q 048542          142 MPNGSLDR-HVF------------------P----KESRGQSLCWEK-------------LHEVALGTARGIEYLHNGC-  184 (373)
Q Consensus       142 ~~~gsL~~-~l~------------------~----~~~~~~~l~~~~-------------~~~i~~~i~~al~~LH~~~-  184 (373)
                      ++|..+.. .-.                  .    +........|..             -.....++...+..+.+.. 
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99887763 110                  0    001111122220             0012223334444444321 


Q ss_pred             ---CCC---eEecCcCCCCeeeeCCCc-eEEeeccCcc
Q 048542          185 ---DVC---ILHFDIKPHNILLDHNFI-PKVSDFGLAK  215 (373)
Q Consensus       185 ---~~~---ivH~dikp~Nil~~~~~~-~kl~Dfg~~~  215 (373)
                         ...   ++|+|+.|.||+++.+.. ..++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               123   999999999999998874 8899999775

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.91  E-value=0.011  Score=53.88  Aligned_cols=29  Identities=34%  Similarity=0.305  Sum_probs=25.6

Q ss_pred             CCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       186 ~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      .+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            48999999999999987 678899999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.85  E-value=0.0096  Score=54.91  Aligned_cols=143  Identities=13%  Similarity=0.214  Sum_probs=79.1

Q ss_pred             cccCCCCcEEEEEEEEcC----CceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCcC
Q 048542           71 HKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      +.|..|-...+|+....+    +..|++|+........-+-.+|..+++.+..-++ +++++++.. .   +|.+|+++.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g~   95 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINAR   95 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcCC
Confidence            445557777899886542    2379999876543222233578888888864444 345555432 2   588998776


Q ss_pred             Ccccc-------c----------cCCC--CCCCCCCHHHHHHHHHHH-------------------------HHHHHHHH
Q 048542          146 SLDRH-------V----------FPKE--SRGQSLCWEKLHEVALGT-------------------------ARGIEYLH  181 (373)
Q Consensus       146 sL~~~-------l----------~~~~--~~~~~l~~~~~~~i~~~i-------------------------~~al~~LH  181 (373)
                      .+...       +          +...  .....-.+..+..+..++                         +..+..+.
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            55321       0          0100  001111222222222111                         11111121


Q ss_pred             c--CCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccC
Q 048542          182 N--GCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFH  217 (373)
Q Consensus       182 ~--~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~  217 (373)
                      .  ..+..++|.|+.+.||++++ ++.++++||..|...
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            1  11235899999999999974 578999999988643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.80  E-value=0.017  Score=52.81  Aligned_cols=32  Identities=19%  Similarity=0.215  Sum_probs=28.5

Q ss_pred             CCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ..+++|+|+.++|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            35899999999999999998999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.67  E-value=0.0032  Score=54.08  Aligned_cols=123  Identities=17%  Similarity=0.236  Sum_probs=60.7

Q ss_pred             CceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCcCCcccc-ccC-------------
Q 048542           89 GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLDRH-VFP-------------  153 (373)
Q Consensus        89 ~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~-------------  153 (373)
                      ++.|++|+........-+...|..+++.+...++ +++++.+.++    .|.+|+++.+|... +..             
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678899888775555666788898888864443 4455544332    56799876655321 100             


Q ss_pred             ---C-C--CCCCCCCHHHHHHH----------------------HHHHHHHHHHHHc-----CCCCCeEecCcCCCCeee
Q 048542          154 ---K-E--SRGQSLCWEKLHEV----------------------ALGTARGIEYLHN-----GCDVCILHFDIKPHNILL  200 (373)
Q Consensus       154 ---~-~--~~~~~l~~~~~~~i----------------------~~~i~~al~~LH~-----~~~~~ivH~dikp~Nil~  200 (373)
                         . .  .......+..+..+                      ...+.+-+..+.+     ..+..++|+|+.|.||++
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence               0 0  00111111111111                      0111111111111     012368999999999999


Q ss_pred             -eCCCceEEeeccCcc
Q 048542          201 -DHNFIPKVSDFGLAK  215 (373)
Q Consensus       201 -~~~~~~kl~Dfg~~~  215 (373)
                       +.++.++++||..|.
T Consensus       158 ~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             TSSSSCEEE--GTT-E
T ss_pred             ccCCCeEEEecHHHHh
Confidence             888999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.66  E-value=0.062  Score=49.43  Aligned_cols=72  Identities=15%  Similarity=0.163  Sum_probs=47.4

Q ss_pred             CCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEe---e--EeeeCCeeEEEEeccCcCCc
Q 048542           76 GGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLL---G--FCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        76 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~---~--~~~~~~~~~lv~e~~~~gsL  147 (373)
                      +.-..||+....+++.+++|+.+....+...+..|...+..|....  ++...   |  +...++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            3445789988777888999988766666777788888887774211  22211   1  12234567789999877543

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.61  E-value=0.044  Score=51.55  Aligned_cols=71  Identities=15%  Similarity=0.212  Sum_probs=49.7

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEecc-----Cc---cCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEEE
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLEN-----SK---FSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      +.||.|....||+.... ++.++||.-..     +.   .+..+-..|.+.|+.+.   ..++++++.++.  ...+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence            67899999999998864 56799997652     11   23344455677776653   247888888776  3457889


Q ss_pred             eccCc
Q 048542          140 EYMPN  144 (373)
Q Consensus       140 e~~~~  144 (373)
                      |++++
T Consensus       115 E~L~~  119 (418)
T PLN02756        115 RYLEP  119 (418)
T ss_pred             eecCC
Confidence            99966

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.58  E-value=0.012  Score=49.95  Aligned_cols=151  Identities=16%  Similarity=0.232  Sum_probs=88.1

Q ss_pred             CCcEEEEEEEEcCCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccC
Q 048542           76 GGFGSVYKGQLQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFP  153 (373)
Q Consensus        76 G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  153 (373)
                      |+.++.-.+..+- .+..+|.++.....  ..-+.++..++.+++  .|+++..  .+.-..-++.|+|-....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------
Confidence            3444444444332 34455555554433  356778888888874  5666652  233345588898833111      


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCC
Q 048542          154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI  233 (373)
Q Consensus       154 ~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  233 (373)
                              ..   ..++.-=+++|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+...  .            .+.
T Consensus       142 --------~~---~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~------------~~V  195 (308)
T PF07387_consen  142 --------NF---SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E------------NQV  195 (308)
T ss_pred             --------ch---hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--h------------hee
Confidence                    00   11111114668888954 4589999999999999999999999965432  0            111


Q ss_pred             CcccccccccccCCcCcccchHHHHHHHHHHHcCC
Q 048542          234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR  268 (373)
Q Consensus       234 ~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~  268 (373)
                      .|.--|     +...++++.+-+|-.-++++....
T Consensus       196 ~~vN~~-----Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  196 NMVNIE-----YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             eEEeee-----ccccChHHHHHHHHHHHHHHHHHH
Confidence            122211     124566777777776667666543

The function of this family is unknown.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.35  E-value=0.038  Score=51.01  Aligned_cols=71  Identities=18%  Similarity=0.129  Sum_probs=48.1

Q ss_pred             ccCCCCcEEEEEEEEcCC-ceeEEEEecc--------CccCHHHHHHHHHHhcccC--CC-ceeeEeeEeeeCCeeEEEE
Q 048542           72 KLGQGGFGSVYKGQLQTG-GLIAVKMLEN--------SKFSAEEFINEVSTIGRIH--HV-NVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~-~~vaiK~~~~--------~~~~~~~~~~e~~~l~~l~--h~-ni~~~~~~~~~~~~~~lv~  139 (373)
                      .||.|....||++..++| +.++||.-..        ...+.++..-|.+.|+...  .| .+++++.  .++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            479999999999997654 5799997421        1344566667888887663  34 4555553  3445567899


Q ss_pred             eccCc
Q 048542          140 EYMPN  144 (373)
Q Consensus       140 e~~~~  144 (373)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.22  E-value=0.023  Score=51.99  Aligned_cols=107  Identities=15%  Similarity=0.106  Sum_probs=70.1

Q ss_pred             eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEee
Q 048542          131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (373)
Q Consensus       131 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~D  210 (373)
                      +....|++|++- |+++..        .....++++..++.+.+..+.-+..+  ...-|||+.-.|||++ +|++.|+|
T Consensus       297 e~~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CceEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEE
Confidence            344567777774 555532        23355778888998888877777764  5789999999999999 99999999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM  259 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~  259 (373)
                      |-+++... ......+      ...-.|-.+.|.   -+.+-|||-+--
T Consensus       365 fklsRl~~-~q~~isy------~rldhp~lF~G~---dd~QFeIYrlMr  403 (488)
T COG5072         365 FKLSRLSY-SQGIISY------NRLDHPDLFNGV---DDYQFEIYRLMR  403 (488)
T ss_pred             eeeeeccc-CCceeec------cccCchhhhcCc---cceeeeHHHHHH
Confidence            99998432 2211111      123345555543   244567776433

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.01  E-value=0.0044  Score=58.86  Aligned_cols=46  Identities=20%  Similarity=0.286  Sum_probs=36.1

Q ss_pred             HHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEEeccCcCCccccc
Q 048542          105 EEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRHV  151 (373)
Q Consensus       105 ~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~gsL~~~l  151 (373)
                      .++.-....++.+.|+|....+++-.. .....+|+|++ +.||.+.+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~   73 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDIL   73 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHH
Confidence            456677888999999999999887643 34578899998 66888777

>PRK06148 hypothetical protein; Provisional

Probab=95.95  E-value=0.13  Score=54.79  Aligned_cols=143  Identities=17%  Similarity=0.200  Sum_probs=78.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC-------CCceeeEe-e----Eeee-CC--ee
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-------HVNVVQLL-G----FCSE-GS--KR  135 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-------h~ni~~~~-~----~~~~-~~--~~  135 (373)
                      +.|+ |..-.+|+....+|..+++|+.+... .......|...+..|.       -|.+++.. |    .... +.  +.
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            4464 45577898887778899999988643 3333344555555442       23333321 1    1111 12  45


Q ss_pred             EEEEeccCcCCcccccc-----------------------CCCCCCCCCCHH-----------------HHHHHHHHHHH
Q 048542          136 ALVYEYMPNGSLDRHVF-----------------------PKESRGQSLCWE-----------------KLHEVALGTAR  175 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~-----------------------~~~~~~~~l~~~-----------------~~~~i~~~i~~  175 (373)
                      +-+++|++|..+.+...                       ........+.|.                 ....++.++.+
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            67899999877654110                       000001112221                 11122223332


Q ss_pred             HHH-----HHHcCCCCCeEecCcCCCCeeeeCCC--ceE-EeeccCccc
Q 048542          176 GIE-----YLHNGCDVCILHFDIKPHNILLDHNF--IPK-VSDFGLAKF  216 (373)
Q Consensus       176 al~-----~LH~~~~~~ivH~dikp~Nil~~~~~--~~k-l~Dfg~~~~  216 (373)
                      ...     .+. ....+++|+|+.+.|||++.++  .+. |+|||-+..
T Consensus       189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            221     121 2245899999999999999775  555 999998764

>PTZ00384 choline kinase; Provisional

Probab=95.93  E-value=0.093  Score=49.32  Aligned_cols=74  Identities=14%  Similarity=0.195  Sum_probs=44.3

Q ss_pred             cccCCCCcEEEEEEEEcCC--ce-----eEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTG--GL-----IAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +.|..|-...+|++...++  ..     |.++.........-+-.+|..+++.+...++ +++++.+..    .++.||+
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            4565688889999975532  22     4444322221111223578899998865444 445555542    5999999


Q ss_pred             CcCCcc
Q 048542          143 PNGSLD  148 (373)
Q Consensus       143 ~~gsL~  148 (373)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            887664

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.52  E-value=0.48  Score=40.83  Aligned_cols=73  Identities=19%  Similarity=0.340  Sum_probs=46.9

Q ss_pred             cCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc---CCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           73 LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI---HHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        73 ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      +.-|.--..|...+ ...++.+|+-....  ...|..|+.-|..|   +.-++.+++.+..+..+.|+|+||++-+.+.
T Consensus        24 v~gG~inea~~v~d-g~~~~FvK~n~~~~--~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          24 VSGGDINEAWRLRD-GTDPFFVKCNQREQ--LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cCCccccceeEeec-CCcceEEEecchhh--HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            33343333444433 24578888644322  24456666655555   4466888888888999999999999876664

>PTZ00296 choline kinase; Provisional

Probab=95.09  E-value=0.2  Score=48.04  Aligned_cols=73  Identities=14%  Similarity=0.164  Sum_probs=45.5

Q ss_pred             cccCCCCcEEEEEEEEcC---------CceeEEEEeccCccCHHHHHHHHHHhcccCCCcee-eEeeEeeeCCeeEEEEe
Q 048542           71 HKLGQGGFGSVYKGQLQT---------GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV-QLLGFCSEGSKRALVYE  140 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~e  140 (373)
                      +.|..|-.-.+|++...+         ++.|.+|+........-+-..|..+++.+...+|- ++++.+.    ...+.+
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~e  186 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEE  186 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEE
Confidence            456667777888887542         35788988765443322345688888877544433 3444432    346789


Q ss_pred             ccCcCCc
Q 048542          141 YMPNGSL  147 (373)
Q Consensus       141 ~~~~gsL  147 (373)
                      |++|.+|
T Consensus       187 fi~g~~l  193 (442)
T PTZ00296        187 WLYGDPL  193 (442)
T ss_pred             eeCCccC
Confidence            9987644

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.92  E-value=0.076  Score=49.71  Aligned_cols=72  Identities=15%  Similarity=0.134  Sum_probs=50.0

Q ss_pred             cccCCCCcEEEEEEEEcC-CceeEEEEecc-------CccCHHHHHHHHHHhcccC--CC-ceeeEeeEeeeCCeeEEEE
Q 048542           71 HKLGQGGFGSVYKGQLQT-GGLIAVKMLEN-------SKFSAEEFINEVSTIGRIH--HV-NVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~-------~~~~~~~~~~e~~~l~~l~--h~-ni~~~~~~~~~~~~~~lv~  139 (373)
                      +.||.|.-..||++...+ ++.++||.-..       ...+.++..-|.+.|+...  .| .+++++.  .++....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHHH
Confidence            678999999999999753 56789886421       2445577778888888763  34 4555653  3445567888


Q ss_pred             eccCc
Q 048542          140 EYMPN  144 (373)
Q Consensus       140 e~~~~  144 (373)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            88854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	373
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-40
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-33
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-31
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-25
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-25
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-23
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-23
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-23
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-23
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-20
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-20
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-20
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-20
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-19
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-19
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		7e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		8e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		8e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		9e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-13
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		9e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		9e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		8e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-06
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-06
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-06
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-06
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-06
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		9e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		9e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  192 bits (488), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 116/297 (39%), Positives = 167/297 (56%), Gaps = 15/297 (5%)
Query: 55  KRYSYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE--FINE 110
           KR+S  ++   +++F++K  LG+GGFG VYKG+L  G L+AVK L+  +    E  F  E
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
           V  I    H N+++L GFC   ++R LVY YM NGS+   +  +      L W K   +A
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           LG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 204
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NATRSSKAYFPSWVYD 289
           GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV  
Sbjct: 205 GTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 290 QLNKGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 341
            L +       D++LQ   + E +   +L  + L C Q    +RP M++V+ MLEG 
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 115/297 (38%), Positives = 165/297 (55%), Gaps = 15/297 (5%)
Query: 55  KRYSYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE--FINE 110
           KR+S  ++   +++F +K  LG+GGFG VYKG+L  G L+AVK L+  +    E  F  E
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
           V  I    H N+++L GFC   ++R LVY YM NGS+   +  +      L W K   +A
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
           LG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V   A R
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVX-XAVR 196
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM-NATRSSKAYFPSWVYD 289
           G IG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             WV  
Sbjct: 197 GXIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 290 QLNKGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS 341
            L +       D++LQ   + E +   +L  + L C Q    +RP M++V+ MLEG 
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEV--EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 105/285 (36%), Positives = 157/285 (55%), Gaps = 16/285 (5%)
Query: 66  TNHFTHK--LGQGGFGSVYKGQLQTGGLIAVKM-LENSKFSAEEFINEVSTIGRIHHVNV 122
           TN+F HK  +G G FG VYKG L+ G  +A+K     S    EEF  E+ T+    H ++
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V L+GFC E ++  L+Y+YM NG+L RH++  +    S+ WE+  E+ +G ARG+ YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H D+K  NILLD NF+PK++DFG++K   + +        +GT+GYI PE   
Sbjct: 158 R---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFI 214
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-----DL 297
           +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G      D 
Sbjct: 215 K--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
            L +    ES+  RK     + C+ + + DRPSM  VL  LE ++
Sbjct: 272 NLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/282 (37%), Positives = 154/282 (54%), Gaps = 16/282 (5%)
Query: 66  TNHFTHK--LGQGGFGSVYKGQLQTGGLIAVKM-LENSKFSAEEFINEVSTIGRIHHVNV 122
           TN+F HK  +G G FG VYKG L+ G  +A+K     S    EEF  E+ T+    H ++
Sbjct: 38  TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V L+GFC E ++  L+Y+YM NG+L RH++  +    S+ WE+  E+ +G ARG+ YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H D+K  NILLD NF+PK++DFG++K   +          +GT+GYI PE   
Sbjct: 158 R---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI 214
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-----DL 297
           +  G ++ KSDVY FG+VL E+    R++ + +          W  +  N G      D 
Sbjct: 215 K--GRLTEKSDVYSFGVVLFEVLCA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271
Query: 298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            L +    ES+  RK     + C+ + + DRPSM  VL  LE
Sbjct: 272 NLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 100/303 (33%), Positives = 148/303 (48%), Gaps = 35/303 (11%)
Query: 57  YSYPQIIAMTNHFT--------HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE-- 106
           +S+ ++  +TN+F         +K+G+GGFG VYKG +    +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHVFPKESRGQSLCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR           L W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNAT 276
           V  S   GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   
Sbjct: 190 VMXSRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +         + D ++K   +   + T +E+M +     +   C+  K   RP + KV +
Sbjct: 247 KEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQ 299
Query: 337 MLE 339
           +L+
Sbjct: 300 LLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 147/303 (48%), Gaps = 35/303 (11%)
Query: 57  YSYPQIIAMTNHFT--------HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE-- 106
           +S+ ++  +TN+F         +K+G+GGFG VYKG +    +   K+      + EE  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHVFPKESRGQSLCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR           L W
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 126
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 127 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNAT 276
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   
Sbjct: 184 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 240
Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +         + D ++K   +   + T +E+M +     +   C+  K   RP + KV +
Sbjct: 241 KEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQ 293
Query: 337 MLE 339
           +L+
Sbjct: 294 LLQ 296

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/303 (32%), Positives = 147/303 (48%), Gaps = 35/303 (11%)
Query: 57  YSYPQIIAMTNHFT--------HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE-- 106
           +S+ ++  +TN+F         +K+G+GGFG VYKG +    +   K+      + EE  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LDRHVFPKESRGQSLCW 163
             F  E+  + +  H N+V+LLGF S+G    LVY YMPNGS LDR           L W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR--LSCLDGTPPLSW 132
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG-------RRNSNMNAT 276
           V      GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G       R    +   
Sbjct: 190 VMXXRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +         + D ++K   +   + T +E+M +     +   C+  K   RP + KV +
Sbjct: 247 KEEIEDEEKTIEDYIDK--KMNDADSTSVEAMYS-----VASQCLHEKKNKRPDIKKVQQ 299
Query: 337 MLE 339
           +L+
Sbjct: 300 LLQ 302

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 138/296 (46%), Gaps = 21/296 (7%)
Query: 57  YSYPQIIAMTNHFT--------HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE-- 106
           +S+ ++  +TN+F         +K G+GGFG VYKG +    +   K+      + EE  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 107 --FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCW 163
             F  E+    +  H N+V+LLGF S+G    LVY Y PNGSL DR           L W
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDR--LSCLDGTPPLSW 123
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
               ++A G A GI +LH    +   H DIK  NILLD  F  K+SDFGLA+   K    
Sbjct: 124 HXRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF 283
           V  S   GT  Y APE +    G ++ KSD+Y FG+VLLE+  G    + +         
Sbjct: 181 VXXSRIVGTTAYXAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 237
Query: 284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              + D+     D   +   + +S        +   C+  K   RP + KV ++L+
Sbjct: 238 KEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ +    +KL ++A  TARG++YLH      
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHAKS--- 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGS--LSPDLSKV 238
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 239 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 143/286 (50%), Gaps = 25/286 (8%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ +   G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL R +    +R Q L   +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR- 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
               + KSDVY FG++L E+A  ++   N+N  +   A    +   +L    +L  Q   
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKCKRLEIPRNLNPQVAA 270
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 349
            IE             C   +   RPS   ++++L   I     PP
Sbjct: 271 IIEG------------CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 141/286 (49%), Gaps = 25/286 (8%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ +   G  +AVK+L    F AE   EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL R +    +R Q L   +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR- 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H D+K  N+L+D  +  KV DFGL++   K + F+      GT  ++APE++   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
               + KSDVY FG++L E+A  ++   N+N  +   A    +   +L    +L  Q   
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV--GFKCKRLEIPRNLNPQVAA 270
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 349
            IE             C   +   RPS   ++++L   I     PP
Sbjct: 271 IIEG------------CWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 145/274 (52%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + S   + A+V ++    SL  H+   E++ +    +KL ++A  TARG++YLH      
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHAKS--- 140
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGS--LSPDLSKV 250
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 146/274 (53%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ +    +KL ++A  TARG++YLH      
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHASETKFEM---KKLIDIARQTARGMDYLHAKS--- 140
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N            + + + +G      +++++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--------IIEMVGRGS--LSPDLSKV 250
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 129/275 (46%), Gaps = 22/275 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      +V EYMP G+L  ++  +E   + +    L  +A   +  +EYL        +
Sbjct: 98  TLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAMEYLEKK---NFI 152
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N  T S
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--TFS 209
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VYD L KG  +E           
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYDLLEKGYRMEQPE------GC 256
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
             K+  +   C +   ADRPS  +  +  E    D
Sbjct: 257 PPKVYELMRACWKWSPADRPSFAETHQAFETMFHD 291

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 141/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + S   + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 72  Y-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 234
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 239
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 234
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 239
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 240 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 151
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +     Y            +++++
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS---------PDLSKV 261
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 262 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 236
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 237 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +     Y            +++++
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS---------PDLSKV 262
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 14  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG     E L  + L    G+ YL    + C+
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 127
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 184
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 185 SSKSDVWSFGVLMWEV 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG     E L  + L    G+ YL    + C+
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 124
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 121/213 (56%), Gaps = 13/213 (6%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI---NEVSTIG 115
           Y +I A     + ++G G FG+VYKG+    G +AVK+L+    + E+F    NEV+ + 
Sbjct: 30  YWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
           +  HVN++  +G+ ++ +  A+V ++    SL +H+  +E++ Q     +L ++A  TA+
Sbjct: 88  KTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTAQ 143
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G++YLH      I+H D+K +NI L      K+ DFGLA    + +    +    G++ +
Sbjct: 144 GMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200
Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGG 267
           +APE+I  ++    S +SDVY +G+VL E+  G
Sbjct: 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG     E L  + L    G+ YL    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 179
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 180 SSKSDVWSFGVLMWEV 195

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFM---------VGRGYLSPDLSKV 234
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +           G      +++++
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMV---------GRGYLSPDLSKV 254
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 255 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 80/274 (29%), Positives = 142/274 (51%), Gaps = 24/274 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + ++   F NEV  + +  HVN++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           + ++  + A+V ++    SL  H+   E++ + +   KL ++A  TA+G++YLH      
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKS--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS-RNFG 246
           I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++  
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 247 TVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
             S +SDVY FG+VL E M G    SN+N  R    +     Y            +++++
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLS---------PDLSKV 262
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 263 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  F + +  +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-FTAHAGAKFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMERPE------GC 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 105/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K ++    S ++FI E   + ++ H  +VQL G 
Sbjct: 31  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG     E L  + L    G+ YL    + C+
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 144
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 201
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 202 SSKSDVWSFGVLMWEV 217

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV E+M +G L  ++  +  RG     E L  + L    G+ YL    + C+
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EACV 125
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 182
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 183 SSKSDVWSFGVLMWEV 198

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G FG VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMERPEGC------ 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 188
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A                  PS VY+ L K   +E           
Sbjct: 189 IKSDVWAFGVLLWEIA-------TYGMSPYPGIDPSQVYELLEKDYRMERPEGC------ 235
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 11  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +  RG     E L  + L    G+ YL    +  +
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGL-FAAETLLGMCLDVCEGMAYLE---EASV 124
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+ S  F   
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS--FSRY 181
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSDV+ FG+++ E+
Sbjct: 182 SSKSDVWSFGVLMWEV 197

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + +I H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES 307
            KSDV+ FG++L E+A  G      ++ ++         VY+ L K   +E         
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYRMERPE------ 240
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               K+  +   C Q   +DRPS  ++ +  E
Sbjct: 241 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 191
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 238
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 237
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 83  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 137
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 194
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 241
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 24/271 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 79  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 133
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 190
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTEIESM 308
            KSDV+ FG++L E+A    +       S        VY+ L K   +E  +   E    
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYE 243
Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + R        C Q   +DRPS  ++ +  E
Sbjct: 244 LMRA-------CWQWNPSDRPSFAEIHQAFE 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 78  -EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 188
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 189 SDVWSFGILLTEL 201

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAPAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 74  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 184
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 76  -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 186
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 187 SDVWSFGILLTEL 199

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 92  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 146
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 203
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERP------EGC 250
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + 
Sbjct: 4   KPQKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKL 117
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            ++A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ + 
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAR 173
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 174 EGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + 
Sbjct: 3   KPQKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 59
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKL 116
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            ++A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ + 
Sbjct: 117 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAR 172
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 173 EGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 208

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 81  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 135
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 192
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 239
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVCEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 334 -EPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 444
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 445 SDVWSFGILLTEL 457

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 251 -EPIYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 361
Query: 252 SDVYGFGMVLLEMAGGRR 269
           SDV+ FG++L E+    R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + 
Sbjct: 8   KPQKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 64
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL
Sbjct: 65  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKL 121
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            ++A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ + 
Sbjct: 122 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAR 177
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 178 EGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 75  -EPIXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 185
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 186 SDVWSFGILLTEL 198

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 84  TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 138
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 195
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 242
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 134
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   N L+  N + KV+DFGL++    +       A +  I + APE ++ N    S
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGA-KFPIKWTAPESLAYN--KFS 191
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMI 309
            KSDV+ FG++L E+A    +       S        VY+ L K   +E           
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPE------GC 238
Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L +++   A G+ Y+     +  +H 
Sbjct: 82  -EPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 193 SDVWSFGILLTEL 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  G L    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVMEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N+  +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 130/272 (47%), Gaps = 26/272 (9%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 397
Query: 250 CKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES 307
            KSDV+ FG++L E+A  G      ++ ++         VY+ L K   +E         
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYRMERP------E 442
Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               K+  +   C Q   +DRPS  ++ +  E
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  G L    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 85  -EPIYIVTEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 195
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 196 SDVWSFGILLTEL 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L +++   A G+ Y+     +  +H 
Sbjct: 82  -EPIYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPE--AALYGRFTIK 192
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG++L E+
Sbjct: 193 SDVWSFGILLTEL 205

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL    SE
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  +H 
Sbjct: 252 -EPIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D++  NIL+  N + KV+DFGL +   ++N++ +    +  I + APE  +  +G  + K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPE--AALYGRFTIK 362
Query: 252 SDVYGFGMVLLEMA 265
           SDV+ FG++L E+ 
Sbjct: 363 SDVWSFGILLTELT 376

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI 108
           Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+
Sbjct: 1   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 57
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL +
Sbjct: 58  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 114
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 115 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 170
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI 108
           Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+
Sbjct: 2   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 58
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL +
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 115
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 116 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 171
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 172 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 39/284 (13%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
              +LG G FG V+ G       +AVK L+    S + F+ E + +  + H  +V+L   
Sbjct: 17  LVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
            +      ++ EYM  GSL    F K   G  +   KL + +   A G+ Y+        
Sbjct: 77  VTREEPIYIITEYMAKGSL--LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NY 131
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG  
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI--NFGCF 188
Query: 249 SCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
           + KSDV+ FG++L E+         GR N+++    S     P     ++    D EL +
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP-----RVENCPD-ELYD 242
Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
           + ++              C + KA +RP+     + L+  +DD 
Sbjct: 243 IMKM--------------CWKEKAEERPT----FDYLQSVLDDF 268

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + 
Sbjct: 6   KPQKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 62
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKL 119
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            ++A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  + 
Sbjct: 120 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAR 175
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 176 EGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 211

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + 
Sbjct: 4   KPQKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKL 117
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            ++A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  + 
Sbjct: 118 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAR 173
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 174 EGAKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 209

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI 108
           Q+ W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+
Sbjct: 9   QKPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFL 65
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL +
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLD 122
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +   
Sbjct: 123 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREG 178
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 179 AKFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL----IAVKMLEN--SKFSAEEFINEVSTI 114
           +I A   H    +G G  G V  G+L+  G     +A+K L+   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ     +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D  + + T G I 
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD-AAXTTTGGKIP 217
Query: 235 --YIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
             + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 218 IRWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 113/217 (52%), Gaps = 16/217 (7%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL----IAVKMLEN--SKFSAEEFINEVSTI 114
           +I A   H    +G G  G V  G+L+  G     +A+K L+   ++    +F++E S +
Sbjct: 45  EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIM 104
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           G+  H N+++L G  + G    +V EYM NGSLD   F +   GQ     +L  +  G  
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD--TFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTI 233
            G+ YL    D+  +H D+   N+L+D N + KVSDFGL++    + D   + +  +  I
Sbjct: 162 AGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            + APE I+  F T S  SDV+ FG+V+ E +A G R
Sbjct: 219 RWTAPEAIA--FRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 50  QSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFIN 109
           + W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+ 
Sbjct: 1   KPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA 57
Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL ++
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDM 114
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N++ +    
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGA 170
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 203

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/288 (30%), Positives = 136/288 (47%), Gaps = 49/288 (17%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           +G G FG VYKG L+T        +A+K L+      +  +F+ E   +G+  H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G  S+     ++ EYM NG+LD+ +  K+     L   +L  +  G A G++YL N   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL---QLVGMLRGIAAGMKYLAN--- 165
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS 242
           +  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + APE IS
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 243 -RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW------VYDQLNKG 294
            R F   +  SDV+ FG+V+ E M  G R              P W      V   +N G
Sbjct: 224 YRKF---TSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 266
Query: 295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
               L    +  S I + +    + C Q + A RP    ++ +L+  I
Sbjct: 267 --FRLPTPMDCPSAIYQLM----MQCWQQERARRPKFADIVSILDKLI 308

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 30/274 (10%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG C
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +      ++ E+M  G+L  ++  +E   Q +    L  +A   +  +EYL        +
Sbjct: 325 TREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 379
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H ++   N L+  N + KV+DFGL++    +  + + +  +  I + APE ++ N    S
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN--KFS 436
Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----SWVYDQLNKGGDLELQNVTEI 305
            KSDV+ FG++L E+A               + +P    S VY+ L K   +E       
Sbjct: 437 IKSDVWAFGVLLWEIA-----------TYGMSPYPGIDLSQVYELLEKDYRMERP----- 480
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 K+  +   C Q   +DRPS  ++ +  E
Sbjct: 481 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 513

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 66  TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           T     +LG G FG V+ G       +AVK L+    S + F+ E + + ++ H  +V+L
Sbjct: 9   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 68
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
               ++     ++ EYM NGSL    F K   G  L   KL ++A   A G+ ++    +
Sbjct: 69  YAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 122
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
              +H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+
Sbjct: 123 RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NY 179
Query: 246 GTVSCKSDVYGFGMVLLEM 264
           GT + KSDV+ FG++L E+
Sbjct: 180 GTFTIKSDVWSFGILLTEI 198

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               KLG G FG V+ G       +AVK L+    S + F+ E + +  + H  +V+L  
Sbjct: 15  KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             ++     ++ E+M  GSL    F K   G  +   KL + +   A G+ Y+       
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---N 129
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  N+L+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG 
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAI--NFGC 186
Query: 248 VSCKSDVYGFGMVLLEMAG-------GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ 300
            + KS+V+ FG++L E+         GR N+++ +  S     P     ++    D EL 
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMP-----RMENCPD-ELY 240
Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
           ++ ++              C + KA +RP+     + L+  +DD 
Sbjct: 241 DIMKM--------------CWKEKAEERPT----FDYLQSVLDDF 267

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSRGSKFPVRWSPPEVLM--YSKF 183
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 9/202 (4%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL  
Sbjct: 12  QLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             SE     +V EYM  GSL    F K+  G++L    L ++A   A G+ Y+     + 
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MN 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  NIL+ +  I K++DFGLA+   ++N+  +    +  I + APE  +  +G 
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPE--AALYGR 182
Query: 248 VSCKSDVYGFGMVLLEMAGGRR 269
            + KSDV+ FG++L E+    R
Sbjct: 183 FTIKSDVWSFGILLTELVTKGR 204

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 12/215 (5%)
Query: 50  QSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFIN 109
           + W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+ 
Sbjct: 1   KPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA 57
Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL ++
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDM 114
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +    
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGA 170
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 125
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 182
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 183 SSKSDIWAFGVLMWEI 198

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 12/215 (5%)
Query: 50  QSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFIN 109
           + W    +  P+    T     +LG G FG V+ G       +AVK L+    S + F+ 
Sbjct: 1   KPWWEDEWEVPR---ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA 57
Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL ++
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDM 114
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++N+  +    
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGA 170
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 183
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 184 SSKSDIWAFGVLMWEI 199

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 121
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 178
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 179 SSKSDIWAFGVLMWEI 194

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 198
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 132
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +   
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLM--YSKF 189
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 190 SSKSDIWAFGVLMWEI 205

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 9/199 (4%)
Query: 66  TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           T     +LG G FG V+ G       +AVK L+    S + F+ E + + ++ H  +V+L
Sbjct: 10  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
               ++     ++ EYM NGSL    F K   G  L   KL ++A   A G+ ++    +
Sbjct: 70  YAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 123
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
              +H +++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+
Sbjct: 124 RNYIHRNLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NY 180
Query: 246 GTVSCKSDVYGFGMVLLEM 264
           GT + KSDV+ FG++L E+
Sbjct: 181 GTFTIKSDVWSFGILLTEI 199

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 56/291 (19%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+      +  +F++E S +G+  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ EYM NGSLD  +   + R   +   +L  +  G   G++YL    D+
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS---DM 150
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG    I + APE I+ 
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIA- 207
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
            +   +  SDV+ +G+V+ E M+ G R              P W         D+  Q+V
Sbjct: 208 -YRKFTSASDVWSYGIVMWEVMSYGER--------------PYW---------DMSNQDV 243
Query: 303 TE-----------IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
            +           ++  IA    M+  W  Q + +DRP   +++ ML+  I
Sbjct: 244 IKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLI 292

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 138/291 (47%), Gaps = 56/291 (19%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+      +  +F++E S +G+  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ EYM NGSLD  +   + R   +   +L  +  G   G++YL    D+
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS---DM 135
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG    I + APE I+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIA- 192
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
            +   +  SDV+ +G+V+ E M+ G R              P W         D+  Q+V
Sbjct: 193 -YRKFTSASDVWSYGIVMWEVMSYGER--------------PYW---------DMSNQDV 228
Query: 303 TE-----------IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
            +           ++  IA    M+  W  Q + +DRP   +++ ML+  I
Sbjct: 229 IKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLI 277

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 103/193 (53%), Gaps = 9/193 (4%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +LG G FG V  G+ +    +AVKM++    S +EF  E  T+ ++ H  +V+  G CS+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
                +V EY+ NG L  ++    S G+ L   +L E+      G+ +L +      +H 
Sbjct: 75  EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHR 128
Query: 192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK 251
           D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++   S K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYFKYSSK 185
Query: 252 SDVYGFGMVLLEM 264
           SDV+ FG+++ E+
Sbjct: 186 SDVWAFGILMWEV 198

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 139/292 (47%), Gaps = 58/292 (19%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+      +  +F++E S +G+  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     ++ EYM NGSLD  +   + R   +   +L  +  G   G++YL    D+
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI---QLVGMLRGIGSGMKYLS---DM 129
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFG+++    E+D  +   TRG    I + APE I+ 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
           R F +    SDV+ +G+V+ E M+ G R              P W         D+  Q+
Sbjct: 188 RKFTSA---SDVWSYGIVMWEVMSYGER--------------PYW---------DMSNQD 221
Query: 302 VTE-----------IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
           V +           ++  IA    M+  W  Q + +DRP   +++ ML+  I
Sbjct: 222 VIKAIEEGYRLPPPMDCPIALHQLMLDCW--QKERSDRPKFGQIVNMLDKLI 271

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 114/207 (55%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G L+  G     +A+K L++  ++    +F++E S +G+  H NV+ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++ +   ++ E+M NGSLD   F +++ GQ    + L  +  G A G++YL    D+
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQ-LVGMLRGIAAGMKYL---ADM 154
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-NDFVSISATRGTIG--YIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F   + +D    SA  G I   + APE I  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 212
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 110/201 (54%), Gaps = 19/201 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+   ++    +F+ E S +G+  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD   F K++ GQ    + L  +  G + G++YL    D+
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLD--TFLKKNDGQFTVIQ-LVGMLRGISAGMKYL---SDM 143
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + APE I+ 
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIA- 200
Query: 244 NFGTVSCKSDVYGFGMVLLEM 264
            F   +  SDV+ +G+V+ E+
Sbjct: 201 -FRKFTSASDVWSYGIVMWEV 220

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     ++ EYM NG L  ++     R Q+   ++L E+       +EYL +      
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESK---QF 141
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+   N L++   + KVSDFGL+++   + +  S+  ++  + +  PE++   +   
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV-GSKFPVRWSPPEVLM--YSKF 198
Query: 249 SCKSDVYGFGMVLLEM 264
           S KSD++ FG+++ E+
Sbjct: 199 SSKSDIWAFGVLMWEI 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 140/285 (49%), Gaps = 44/285 (15%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+  G     +A+K L+   ++    +F+ E S +G+  H NVV L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  + G    +V E+M NG+LD   F ++  GQ    + L  +  G A G+ YL    D+
Sbjct: 111 GVVTRGKPVMIVIEFMENGALD--AFLRKHDGQFTVIQ-LVGMLRGIAAGMRYL---ADM 164
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  ++  T G    + + APE I  
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRV--IEDDPEAVYTTTGGKIPVRWTAPEAI-- 220
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
            +   +  SDV+ +G+V+ E M+ G R              P W  D  N+  D+ ++ +
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMSYGER--------------PYW--DMSNQ--DV-IKAI 261
Query: 303 TEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSI 342
            E   + A   C  GL      C Q + A+RP   +++ +L+  I
Sbjct: 262 EEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 137/304 (45%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFI 108
           P    YP +      F   +G+G FG V K +++  GL    A+K ++   SK    +F 
Sbjct: 4   PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 63
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 64  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 123
Query: 156 SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +L  ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 124 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 180
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 181 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 235
Query: 274 NATRSSKAYFPSWVYDQLNKGGDLE--LQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 236 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 278
Query: 332 TKVL 335
            ++L
Sbjct: 279 AQIL 282

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 137/304 (45%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFI 108
           P    YP +      F   +G+G FG V K +++  GL    A+K ++   SK    +F 
Sbjct: 14  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 156 SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +L  ++L   A   ARG++YL        +H D+   NIL+  N++ K++DFGL++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245
Query: 274 NATRSSKAYFPSWVYDQLNKGGDLE--LQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 246 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 288
Query: 332 TKVL 335
            ++L
Sbjct: 289 AQIL 292

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G L+  G     +A+K L++  ++    +F++E S +G+  H NV+ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++ +   ++ E+M NGSLD   F +++ GQ    + L  +  G A G++YL    D+
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQ-LVGMLRGIAAGMKYL---ADM 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE-NDFVSISATRGTIG--YIAPELISR 243
             +H  +   NIL++ N + KVSDFGL++F   + +D    SA  G I   + APE I  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI-- 186
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+V+ E M+ G R
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 49  QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI 108
           Q+ W    +  P+    +     KLG G FG V+         +AVK ++    S E F+
Sbjct: 2   QKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFL 58
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E + +  + H  +V+L    ++     ++ E+M  GSL   +   E   Q L   KL +
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLID 115
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
            +   A G+ ++        +H D++  NIL+  + + K++DFGLA+   ++N++ +   
Sbjct: 116 FSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREG 171
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 172 AKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGLA+    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L+  G     +A+K L+   ++    EF++E S +G+  H N+++L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +      ++ E+M NG+LD   F + + GQ     +L  +  G A G+ YL    ++
Sbjct: 82  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 135
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F  + +   + +++ G    I + APE I+ 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA- 194
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            F   +  SD + +G+V+ E M+ G R
Sbjct: 195 -FRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 12/218 (5%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    +     KLG G FG V+         +AVK ++    S E 
Sbjct: 173 KPQKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 229
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + +  + H  +V+L    ++     ++ E+M  GSL   +   E   Q L   KL
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKL 286
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            + +   A G+ ++        +H D++  NIL+  + + K++DFGLA+   ++N++ + 
Sbjct: 287 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAR 342
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 343 EGAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 378

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 113/208 (54%), Gaps = 22/208 (10%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYLS---DM 154
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+VL E M+ G R
Sbjct: 213 RKF---TSASDVWSYGIVLWEVMSYGER 237

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 113/208 (54%), Gaps = 22/208 (10%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYLS---DM 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+VL E M+ G R
Sbjct: 196 RKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V +G+L+  G     +A+K L+   ++    EF++E S +G+  H N+++L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +      ++ E+M NG+LD   F + + GQ     +L  +  G A G+ YL    ++
Sbjct: 84  GVVTNSMPVMILTEFMENGALDS--FLRLNDGQ-FTVIQLVGMLRGIASGMRYL---AEM 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG--YIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++F     +D    S+  G I   + APE I+ 
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA- 196
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            F   +  SD + +G+V+ E M+ G R
Sbjct: 197 -FRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 137/304 (45%), Gaps = 47/304 (15%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL---IAVKMLEN--SKFSAEEFI 108
           P    YP +      F   +G+G FG V K +++  GL    A+K ++   SK    +F 
Sbjct: 11  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 70
Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 71  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 130
Query: 156 SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           S   +L  ++L   A   ARG++YL        +H ++   NIL+  N++ K++DFGL++
Sbjct: 131 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR 187
Query: 216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNM 273
               +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG     M
Sbjct: 188 ---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 242
Query: 274 NATRSSKAYFPSWVYDQLNKGGDLE--LQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                        +Y++L +G  LE  L    E+  ++ +        C + K  +RPS 
Sbjct: 243 TCAE---------LYEKLPQGYRLEKPLNCDDEVYDLMRQ--------CWREKPYERPSF 285
Query: 332 TKVL 335
            ++L
Sbjct: 286 AQIL 289

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 164
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 221
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 222 -YRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 12/215 (5%)
Query: 50  QSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFIN 109
           + W    +  P+    T     +LG G  G V+ G       +AVK L+    S + F+ 
Sbjct: 1   KPWWEDAWEVPR---ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA 57
Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           E + + ++ H  +V+L    ++     ++ EYM NGSL    F K   G  L   KL ++
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDM 114
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   A G+ ++    +   +H D++  NIL+      K++DFGLA+   ++ +  +    
Sbjct: 115 AAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGA 170
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +  I + APE I  N+GT + KSDV+ FG++L E+
Sbjct: 171 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEI 203

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V EYM NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL +    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +F  +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 22/208 (10%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V E M NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYLS---DM 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+VL E M+ G R
Sbjct: 196 RKF---TSASDVWSYGIVLWEVMSYGER 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 112/208 (53%), Gaps = 22/208 (10%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V E M NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELIS- 242
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 243 RNFGTVSCKSDVYGFGMVLLE-MAGGRR 269
           R F   +  SDV+ +G+VL E M+ G R
Sbjct: 225 RKF---TSASDVWSYGIVLWEVMSYGER 249

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGL----IAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G FG V  G+L+        +A+K L+   ++    +F+ E S +G+  H N+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  ++     +V E M NGSLD  +   +++   +   +L  +  G A G++YL    D+
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---QLVGMLRGIASGMKYL---SDM 166
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG---TIGYIAPELISR 243
             +H D+   NIL++ N + KVSDFGL++    E+D  +   TRG    I + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTSPEAIA- 223
Query: 244 NFGTVSCKSDVYGFGMVLLE-MAGGRR 269
            +   +  SDV+ +G+VL E M+ G R
Sbjct: 224 -YRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 13  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 72
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 73  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 130 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 187 SLTES--KFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 12  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 71
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 72  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 128
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 129 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 186 SLTES--KFSVASDVWSFGVVLYEL 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 18  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 77
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 78  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 134
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 135 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 192 SLTES--KFSVASDVWSFGVVLYEL 214

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 19  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 78
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 79  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 135
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 136 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 193 SLTES--KFSVASDVWSFGVVLYEL 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 161
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 162 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 219 SLTES--KFSVASDVWSFGVVLYEL 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 20  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 79
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 80  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 136
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 137 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 194 SLTES--KFSVASDVWSFGVVLYEL 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 130
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 131 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 188 SLTES--KFSVASDVWSFGVVLYEL 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 21  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 80
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 81  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 137
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 138 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 195 SLTES--KFSVASDVWSFGVVLYEL 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 148
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 149 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 206 SLTES--KFSVASDVWSFGVVLYEL 228

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   ++  + +   KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 15  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 74
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 75  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI---KLLQYTSQICKGMEYL 131
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H ++   NIL+++    K+ DFGL K  P++ ++  +       I + APE
Sbjct: 132 --GTKRYI-HRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 189 SLTES--KFSVASDVWSFGVVLYEL 211

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 131
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V EYM  GSL  ++    SRG+S L  + L + +L     +EYL        +H
Sbjct: 87  KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   N+L+  + + KVSDFGL K      D       +  + + APE +       S 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK--KFST 193
Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L E+
Sbjct: 194 KSDVWSFGILLWEI 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 19/195 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 131
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V EYM  GSL  ++    SRG+S L  + L + +L     +EYL        +H
Sbjct: 72  KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVS 249
            D+   N+L+  + + KVSDFGL K      D       +  + + APE L  + F T  
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFST-- 178
Query: 250 CKSDVYGFGMVLLEM 264
            KSDV+ FG++L E+
Sbjct: 179 -KSDVWSFGILLWEI 192

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 19/195 (9%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 131
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V EYM  GSL  ++    SRG+S L  + L + +L     +EYL        +H
Sbjct: 259 KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVS 249
            D+   N+L+  + + KVSDFGL K      D   +      + + APE L  + F T  
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALREKKFST-- 365
Query: 250 CKSDVYGFGMVLLEM 264
            KSDV+ FG++L E+
Sbjct: 366 -KSDVWSFGILLWEI 379

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 17/194 (8%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG-FCSE 131
           +G+G FG V  G  + G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG    E
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 77
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQS-LCWEKLHEVALGTARGIEYLHNGCDVCILH 190
                +V EYM  GSL  ++    SRG+S L  + L + +L     +EYL        +H
Sbjct: 78  KGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC 250
            D+   N+L+  + + KVSDFGL K      D       +  + + APE +       S 
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE--AAFST 184
Query: 251 KSDVYGFGMVLLEM 264
           KSDV+ FG++L E+
Sbjct: 185 KSDVWSFGILLWEI 198

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKG-----QLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV        Q  TG ++AVK L++S +    +F  E+  +  + H N+
Sbjct: 17  FLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 76
Query: 123 VQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ E++P GSL  ++   + R   +   KL +      +G+EYL
Sbjct: 77  VKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHI---KLLQYTSQICKGMEYL 133
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPE 239
             G    I H D+   NIL+++    K+ DFGL K  P++ +   +       I + APE
Sbjct: 134 --GTKRYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ +    S  SDV+ FG+VL E+
Sbjct: 191 SLTES--KFSVASDVWSFGVVLYEL 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 47  RNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
           + Q+ W    +  P+    +     KLG G FG V+         +AVK ++    S E 
Sbjct: 167 KPQKPWEKDAWEIPR---ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA 223
Query: 107 FINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
           F+ E + +  + H  +V+L    ++     ++ E+M  GSL   +   E   Q L   KL
Sbjct: 224 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKL 280
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            + +   A G+ ++        +H D++  NIL+  + + K++DFGLA+           
Sbjct: 281 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV---------- 327
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              +  I + APE I  NFG+ + KSDV+ FG++L+E+
Sbjct: 328 -GAKFPIKWTAPEAI--NFGSFTIKSDVWSFGILLMEI 362

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 69  FTHKLGQGGFGSVYKGQL-QTGGLIAVK--MLENSKFSAE------EFINEVSTIGRIHH 119
           +  ++G+GGFG V+KG+L +   ++A+K  +L +S+   E      EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+V+L G      +  +V E++P G L   +     +   + W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 180 LHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + N  +  I+H D++  NI L   D N     KV+DFGL+     +    S+S   G   
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNFQ 191
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           +G GGFG VY+     G  +AVK       E+   + E    E      + H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
            C +     LV E+   G L+R +      G+ +  + L   A+  ARG+ YLH+   V 
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 188 ILHFDIKPHNILLDH--------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           I+H D+K  NIL+          N I K++DFGLA    +E    +  +  G   ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPE 184
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +I  +    S  SDV+ +G++L E+  G
Sbjct: 185 VIRASM--FSKGSDVWSYGVLLWELLTG 210

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 192 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 249 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 280

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 127/261 (48%), Gaps = 38/261 (14%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+V+KG     G      + +K++E+   + S +   + +  IG + H ++V+L
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C  GS   LV +Y+P GSL  HV  ++ RG +L  + L    +  A+G+ YL    +
Sbjct: 99  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 151
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 209
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           G  + +SDV+ +G+ + E+   G    + +             V D L KG         
Sbjct: 210 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKG--------- 251
Query: 304 EIESMIARKLCMIGLWCIQVK 324
             E +   ++C I ++ + VK
Sbjct: 252 --ERLAQPQICTIDVYMVMVK 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 16/199 (8%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+V+KG     G      + +K++E+   + S +   + +  IG + H ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C  GS   LV +Y+P GSL  HV  ++ RG +L  + L    +  A+G+ YL    +
Sbjct: 81  LGLCP-GSSLQLVTQYLPLGSLLDHV--RQHRG-ALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E I  +F
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI--HF 191
Query: 246 GTVSCKSDVYGFGMVLLEM 264
           G  + +SDV+ +G+ + E+
Sbjct: 192 GKYTHQSDVWSYGVTVWEL 210

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +       TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R   L   +L   +    +G+EY
Sbjct: 87  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 142
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 143 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 200 ESLSDNI--FSRQSDVWSFGVVLYEL 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +       TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 14  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 73
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R   L   +L   +    +G+EY
Sbjct: 74  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 129
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 130 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 187 ESLSDNI--FSRQSDVWSFGVVLYEL 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 20/203 (9%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG+G +GSVYK    +TG ++A+K +   +   +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   +V EY   GS+   +     R ++L  +++  +   T +G+EYLH    +  +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHF---MRKI 147
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPELISRNF 245
           H DIK  NILL+     K++DFG+A             A R    GT  ++APE+I +  
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVA------GQLTDXMAKRNXVIGTPFWMAPEVI-QEI 200
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G  +C +D++  G+  +EMA G+
Sbjct: 201 G-YNCVADIWSLGITAIEMAEGK 222

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 146 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 203 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 234

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +       TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 15  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 74
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R   L   +L   +    +G+EY
Sbjct: 75  VKYRGV-SYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEY 130
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D+  +    +  I + AP
Sbjct: 131 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 187
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 188 ESLSDNI--FSRQSDVWSFGVVLYEL 211

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHVFPKESR--------GQSLCWEKLHEVALGTA 174
            LLG C++ G    ++ E+   G+L  ++  K +            L  E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           +G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V     R  + 
Sbjct: 155 KGMEFLASRKXI---HRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 117/237 (49%), Gaps = 26/237 (10%)
Query: 42  IEKFLRNQQSWMPK-----RYSYPQIIAMTNH----FTHKLGQGGFGSVYKGQLQTGG-L 91
           I+  L  QQ    K       + P+   + NH       ++G+G FG V+ G+L+    L
Sbjct: 82  IDHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTL 141
Query: 92  IAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
           +AVK    +       +F+ E   + +  H N+V+L+G C++     +V E +  G  D 
Sbjct: 142 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG--DF 199
Query: 150 HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
             F + + G  L  + L ++    A G+EYL + C  CI H D+   N L+    + K+S
Sbjct: 200 LTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKC--CI-HRDLAARNCLVTEKNVLKIS 255
Query: 210 DFGLAKFHPKENDFVSISA---TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
           DFG+++   +E D V  ++    +  + + APE +  N+G  S +SDV+ FG++L E
Sbjct: 256 DFGMSR---EEADGVXAASGGLRQVPVKWTAPEAL--NYGRYSSESDVWSFGILLWE 307

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 69  FTHKLGQGGFGSVYKGQL-QTGGLIAVK--MLENSKFSAE------EFINEVSTIGRIHH 119
           +  ++G+GGFG V+KG+L +   ++A+K  +L +S+   E      EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+V+L G      +  +V E++P G L   +     +   + W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 180 LHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + N  +  I+H D++  NI L   D N     KV+DFG +     +    S+S   G   
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-----QQSVHSVSGLLGNFQ 191
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHV------------FPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  ++             P++     L  E L   +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D+V     R
Sbjct: 157 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 245

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 69  FTHKLGQGGFGSVYKGQL-QTGGLIAVK--MLENSKFSAE------EFINEVSTIGRIHH 119
           +  ++G+GGFG V+KG+L +   ++A+K  +L +S+   E      EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+V+L G      +  +V E++P G L   +     +   + W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEY 137
Query: 180 LHNGCDVCILHFDIKPHNILL---DHN--FIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + N  +  I+H D++  NI L   D N     KV+DF L+     +    S+S   G   
Sbjct: 138 MQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-----QQSVHSVSGLLGNFQ 191
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           ++APE I     + + K+D Y F M+L  +  G 
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLD------RHVF----PKESRGQSLCWEKLHEVALG 172
            LLG C++ G    ++ E+   G+L       R+ F    P++     L  E L   +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D V     R  
Sbjct: 157 VAKGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 214 LKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 27/214 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEKLHEVA 170
            LLG C++ G    ++ E+   G+L  +            V P++     L  E L   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
              A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R
Sbjct: 155 FQVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 19/206 (9%)
Query: 69  FTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFSAE-EFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +       TG L+AVK L++S    + +F  E+  +  +H   +
Sbjct: 11  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 70
Query: 123 VQLLGFCSEGSKRA---LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+  G  S G  R    LV EY+P+G L   +    +R  +    +L   +    +G+EY
Sbjct: 71  VKYRGV-SYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA---SRLLLYSSQICKGMEY 126
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAP 238
           L  G   C+ H D+   NIL++     K++DFGLAK  P + D   +    +  I + AP
Sbjct: 127 L--GSRRCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAP 183
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEM 264
           E +S N    S +SDV+ FG+VL E+
Sbjct: 184 ESLSDNI--FSRQSDVWSFGVVLYEL 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 105/198 (53%), Gaps = 17/198 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG V+ G+L+    L+AVK    +       +F+ E   + +  H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C++     +V E +  G  D   F + + G  L  + L ++    A G+EYL + C  CI
Sbjct: 181 CTQKQPIYIVMELVQGG--DFLTFLR-TEGARLRVKTLLQMVGDAAAGMEYLESKC--CI 235
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA---TRGTIGYIAPELISRNF 245
            H D+   N L+    + K+SDFG+++   +E D V  ++    +  + + APE +  N+
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVKWTAPEAL--NY 289
Query: 246 GTVSCKSDVYGFGMVLLE 263
           G  S +SDV+ FG++L E
Sbjct: 290 GRYSSESDVWSFGILLWE 307

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 136/290 (46%), Gaps = 44/290 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G+G FG V K + +    +A+K +E S+   + FI E+  + R++H N+V+L G C   
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 72
Query: 133 SKRALVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +   LV EY   GSL          P  +   ++ W       L  ++G+ YLH+     
Sbjct: 73  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 126
Query: 188 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 179
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE-I 305
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPI 234
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEML-------EGSIDDLQMP 348
           ES++ R        C     + RPSM ++++++        G+ + LQ P
Sbjct: 235 ESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 276

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 136/290 (46%), Gaps = 44/290 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G+G FG V K + +    +A+K +E S+   + FI E+  + R++H N+V+L G C   
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 133 SKRALVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +   LV EY   GSL          P  +   ++ W       L  ++G+ YLH+     
Sbjct: 72  NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSMQPKA 125
Query: 188 ILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A      +    ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS-- 178
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE-I 305
             S K DV+ +G++L E+   R+  +        A+   W     N      ++N+ + I
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFD---EIGGPAFRIMWAVH--NGTRPPLIKNLPKPI 233
Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEML-------EGSIDDLQMP 348
           ES++ R        C     + RPSM ++++++        G+ + LQ P
Sbjct: 234 ESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHV-----------FPKESRGQSLCWEKLHEVAL 171
            LLG C++ G    ++ E+   G+L  ++            P++     L  E L   + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
             A+G+E+L      CI H D+   NILL    + K+ DFGLA+   K+ D V     R 
Sbjct: 156 QVAKGMEFL--ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            + ++APE I     T+  +SDV+ FG++L E+
Sbjct: 213 PLKWMAPETIFDRVYTI--QSDVWSFGVLLWEI 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLGFCSE-GSKRALVYEYMPNGSLDRHVFPKESR--------GQSLCWEKLHEVALGTA 174
            LLG C++ G    ++ E+   G+L  ++  K +            L  E L   +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           +G+E+L +   +   H D+   NILL    + K+ DFGLA+   K+ D+V     R  + 
Sbjct: 155 KGMEFLASRKXI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           ++APE I     T+  +SDV+ FG++L E+
Sbjct: 212 WMAPETIFDRVYTI--QSDVWSFGVLLWEI 239

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   EG+ + L  EY   G L   + P     +       H++  G      YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 123
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                  DV+  G+VL  M  G
Sbjct: 184 FHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 9   LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 121
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 179 RREFHAE-PVDVWSCGIVLTAMLAG 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   EG+ + L  EY   G L   + P     +       H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                  DV+  G+VL  M  G
Sbjct: 183 FHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   EG+ + L  EY   G L   + P     +       H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                  DV+  G+VL  M  G
Sbjct: 183 FHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL 125
               LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+ 
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   EG+ + L  EY   G L   + P     +       H++  G      YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 123
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                  DV+  G+VL  M  G
Sbjct: 184 FHAE-PVDVWSCGIVLTAMLAG 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 15/213 (7%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL-IAVKML----ENSKFSAEEFINEVSTIG 115
           +II        KLG GG  +VY  +     + +A+K +       + + + F  EV    
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
           ++ H N+V ++    E     LV EY+   +L  ++   ES G  L  +           
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG-PLSVDTAINFTNQILD 122
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           GI++ H   D+ I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQY 178
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            +PE  ++   T  C +D+Y  G+VL EM  G 
Sbjct: 179 FSPEQ-AKGEATDEC-TDIYSIGIVLYEMLVGE 209

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 27/204 (13%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLE-NSKFSAEEFIN-----EVSTIGRIHHVNVVQL 125
           LG+G F +VYK + + T  ++A+K ++   +  A++ IN     E+  +  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA--LGTARGIEYLHNG 183
           L      S  +LV+++M     D  V  K++   SL     H  A  L T +G+EYLH  
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH 131
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI- 241
               ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APEL+ 
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR---WYRAPELLF 185
Query: 242 -SRNFGTVSCKSDVYGFGMVLLEM 264
            +R +G      D++  G +L E+
Sbjct: 186 GARMYGV---GVDMWAVGCILAEL 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 10  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 122
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 180 RREFHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNV 122
               LG+G +G V   QL     T   +AVK+++  +     E    E+     ++H NV
Sbjct: 11  LVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+  G   EG+ + L  EY   G L   + P     +       H++  G      YLH 
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG 123
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
              + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R         DV+  G+VL  M  G
Sbjct: 181 RREFHAE-PVDVWSCGIVLTAMLAG 204

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       +   L+AVK L++   +A ++F  E   +  + H ++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVF-------------PKESRGQSLCWEKLHEVAL 171
             G C +G    +V+EYM +G L++ +              P++++G+    + LH +A 
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 140
Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA-TR 230
             A G+ YL        +H D+   N L+  N + K+ DFG+++      D+  +   T 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTM 196
Query: 231 GTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
             I ++ PE ++ R F T   +SDV+ FG++L E+
Sbjct: 197 LPIRWMPPESIMYRKFTT---ESDVWSFGVILWEI 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG G + +VYKG  +T G+ +A+K   L++ + +    I E+S +  + H N+V+L   
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 129 CSEGSKRALVYEYMPNG---SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
               +K  LV+E+M N     +D        RG  L   K  +  L   +G+ + H    
Sbjct: 72  IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFCHENK- 128
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI--S 242
             ILH D+KP N+L++     K+ DFGLA+ F    N F   S+   T+ Y AP+++  S
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF---SSEVVTLWYRAPDVLMGS 183
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
           R   T S   D++  G +L EM  G+
Sbjct: 184 R---TYSTSIDIWSCGCILAEMITGK 206

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       + L              +L  VA   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 202 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       + L              +L  VA   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 196 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 224

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 72  KLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +  TG  +AVK ++  K    E + NEV  +   HH NVV +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V E++  G+L   V         +  E++  V L   R + YLHN     ++
Sbjct: 112 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQ---GVI 163
Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISR-N 244
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR  
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV------GTPYWMAPEVISRLP 217
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNATRSSKAYFPSWVYD 289
           +GT   + D++  G++++EM  G         + A R  +   P  V D
Sbjct: 218 YGT---EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKD 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G   C+   H              
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 141 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 198 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 230

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH------------EV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G   C+   H              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 115/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+ +VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 25/212 (11%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+ +  SA ++F  E   +  + H ++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC-----------WEKLHEVALGT 173
             G C+EG    +V+EYM +G L+R +       + L              +L  VA   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL     +  +H D+   N L+    + K+ DFG+++     + +     T   I
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++ PE ++ R F T   +SDV+ FG+VL E+
Sbjct: 225 RWMPPESILYRKFTT---ESDVWSFGVVLWEI 253

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + + + +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 11/202 (5%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQL 125
               LG+G  G V       T   +AVK+++  +     E    E+     ++H NVV+ 
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G   EG+ + L  EY   G L   + P     +       H++  G      YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG--- 122
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
                  DV+  G+VL  M  G
Sbjct: 183 FHAE-PVDVWSCGIVLTAMLAG 203

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 70  THKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLG 127
           T  LG G FG V+K +    GL +A K+++       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVAL--GTARGIEYLHNGC 184
                +   LV EY+  G L DR +       +S    +L  +        GI ++H   
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII------DESYNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 185 DVCILHFDIKPHNILL---DHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPEL 240
            + ILH D+KP NIL    D   I K+ DFGLA ++ P+E     +    GT  ++APE+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPRE----KLKVNFGTPEFLAPEV 259
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ +F  VS  +D++  G++   +  G
Sbjct: 260 VNYDF--VSFPTDMWSVGVIAYMLLSG 284

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 73  LGQGGFGSVYKGQLQ----TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV +G L+    T   +AVK ++   +S+   EEF++E + +    H NV++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 126 LGFCSEGS-----KRALVYEYMPNGSLDRHVFPK--ESRGQSLCWEKLHEVALGTARGIE 178
           LG C E S     K  ++  +M  G L  ++     E+  + +  + L +  +  A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           YL N      LH D+   N +L  +    V+DFGL+K     + +      +  + +IA 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA 265
           E ++    T   KSDV+ FG+ + E+A
Sbjct: 219 ESLADRVYT--SKSDVWAFGVTMWEIA 243

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 26/210 (12%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-FC 129
           +G G +G VYKG+ ++TG L A+K+++ +    EE   E++ + +  HH N+    G F 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 130 SEG-----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +       +  LV E+   GS+   +  K ++G +L  E +  +     RG+ +LH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
              ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++APE+
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAPEV 200
Query: 241 ISRN---FGTVSCKSDVYGFGMVLLEMAGG 267
           I+ +     T   KSD++  G+  +EMA G
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +  +TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
               K  ++ E+ P G++D  +  +  RG  L   ++  V       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 139
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+D++  G+ L+EMA
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +  +TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
               K  ++ E+ P G++D  +  +  RG  L   ++  V       + +LH+     I+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDA-IMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RII 131
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  N+L+      +++DFG++    K   K + F+      GT  ++APE++   +
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 185
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+D++  G+ L+EMA
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMA 208

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYK----GQLQTGGLI--AVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V      G  +TG  I  AVKML+    S+E    ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQS------------------ 160
           H N+V LLG C+      L++EY   G L  ++  K  +                     
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 161 -LCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
            L +E L   A   A+G+E+L    C    +H D+   N+L+ H  + K+ DFGLA+   
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            ++++V     R  + ++APE +    G  + KSDV+ +G++L E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEI 267

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 209 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 266 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 298

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+++
Sbjct: 93  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 206 LESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +E  G            + L  + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+++
Sbjct: 152 VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 208 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 265 LESLQTQKFTT---KSDVWSFGVLLWEL 289

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+++
Sbjct: 91  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 147 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 204 LESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 89  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTI 233
           G+++L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  +
Sbjct: 145 GMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 202 KWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 22  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 75
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 134
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 135 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 190 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 45  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 98
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 157
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 158 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 213 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     +     +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 29  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 82
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 142 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 197 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPAFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 110/212 (51%), Gaps = 21/212 (9%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 30  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 90  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 145
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTI 233
           G+++L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  +
Sbjct: 146 GMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 203 KWMALESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 51  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 104
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 164 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 219 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 25  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 78
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 137
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 138 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 193 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 30  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 83
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 142
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 143 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 198 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 21/212 (9%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 28  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 88  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 143
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTI 233
           G++YL +      +H D+   N +LD  F  KV+DFGLA+  + KE   V + +  +  +
Sbjct: 144 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 201 KWMALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 36  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 89
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 148
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 149 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 204 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 18  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 71
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 130
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 131 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 186 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + +++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 48  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 108 SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 163
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 164 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 219
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 220 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 249

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 89  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 145 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 200
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 201 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 155 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 212 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 244

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 47  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 107 SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 162
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 163 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 218
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 219 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 248

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 120/291 (41%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I +++H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+++
Sbjct: 98  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 153
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+  + KE D V + +  +  + ++A
Sbjct: 154 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 211 LESLQTQKFTT---KSDVWSFGVLLWEL 235

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 21  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 81  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 136
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 137 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 192
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 193 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 222

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINE--VSTIGRIHHVNVVQLL---- 126
           +G+G +G+VYKG L     +AVK+   S  + + FINE  +  +  + H N+ + +    
Sbjct: 21  IGRGRYGAVYKGSLDERP-VAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 127 GFCSEGS-KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH---- 181
              ++G  +  LV EY PNGSL +++    S   S C      +A    RG+ YLH    
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-----RLAHSVTRGLAYLHTELP 132
Query: 182 --NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-------FHPKENDFVSISATRGT 232
             +     I H D+   N+L+ ++    +SDFGL+          P E D  +IS   GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-GT 191
Query: 233 IGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEM 264
           I Y+APE++      R+  +   + D+Y  G++  E+
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 150 TYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 207 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 239

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 29  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 89  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 144
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 145 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 200
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 201 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 230

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 53  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 106
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 165
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 166 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 221 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 222 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 261
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 262 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 55  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 108
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 167
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 168 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 223 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + + ++ L   
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 152 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 209 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 241

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 26  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 86  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 141
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 142 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 197
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 198 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 227

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 96  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 149
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 208
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 209 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 264 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 114/222 (51%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L++ +F   E    +  + ++
Sbjct: 21  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKL 74
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 133
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 134 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 189 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 242 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 281
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 282 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 24  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 84  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 139
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 140 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 196 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 225

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 28  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 88  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 143
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 144 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 199
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 200 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 229

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 74  GQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 133
            +G FG V+K QL     +AVK+       + +   EV ++  + H N++Q +G    G+
Sbjct: 33  ARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 134 ----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-------N 182
                  L+  +   GSL   +     +   + W +L  +A   ARG+ YLH       +
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIAP 238
           G    I H DIK  N+LL +N    ++DFGLA KF   +    S   T G +G   Y+AP
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAP 202
Query: 239 ELI--SRNFGTVS-CKSDVYGFGMVLLEMA 265
           E++  + NF   +  + D+Y  G+VL E+A
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 23/213 (10%)
Query: 64  AMTNHFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRI 117
           ++  HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +   
Sbjct: 27  SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 118 HHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
            H NV+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+
Sbjct: 87  SHPNVLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAK 142
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--- 232
           G++YL +      +H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    
Sbjct: 143 GMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 198
Query: 233 IGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++A E L ++ F T   KSDV+ FG++L E+
Sbjct: 199 VKWMALESLQTQKFTT---KSDVWSFGVLLWEL 228

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 232 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 271
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 272 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 33/211 (15%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL--HEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 139
Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMA 191
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 118/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L       +E  F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/257 (30%), Positives = 121/257 (47%), Gaps = 26/257 (10%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKML-ENSKFSA-EEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L EN+   A +E ++E   +  +    V +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + LV + MP G L  HV  +E+RG+ L  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHV--RENRGR-LGSQDLLNWCMQIAKGMSYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V ++H D+   N+L+      K++DFGLA+    +         +  I ++A E I R  
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 246 GTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
            T   +SDV+ +G+ + E M  G +  +    R         + D L KG  L    +  
Sbjct: 198 FT--HQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGERLPQPPICT 247
Query: 305 IES-MIARKLCMIGLWC 320
           I+  MI  K  MI   C
Sbjct: 248 IDVYMIMVKCWMIDSEC 264

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK------ESRGQSLCWEKLHEVALG 172
           H N+V LLG C+ G    ++ EY   G L   +  K      +  G+ L    L   +  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 169 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 255

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK------ESRGQSLCWEKLHEVALG 172
           H N+V LLG C+ G    ++ EY   G L   +  K      +  G+ L    L   +  
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++     R  
Sbjct: 161 VAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 218 VKWMAPESIFDCVYTV--QSDVWSYGILLWEI 247

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 230 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 269
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 270 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 207 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 246
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 247 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 216 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 255
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 256 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   + + +         + ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 215 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 254
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 255 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 118/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 256 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 295
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 296 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++  Y   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 38/299 (12%)
Query: 58  SYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVS 112
           S P  I   +   H   LG+G FG   K   +  G + V M E  +F  E    F+ EV 
Sbjct: 1   SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMV-MKELIRFDEETQRTFLKEVK 59
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
            +  + H NV++ +G   +  +   + EY+  G+L   +   +S      W +    A  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKD 116
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------HP------KE 220
            A G+ YLH+   + I+H D+  HN L+  N    V+DFGLA+        P      K+
Sbjct: 117 IASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 280
            D        G   ++APE+I  N  +   K DV+ FG+VL E+  GR N++ +      
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEII-GRVNADPD------ 224
Query: 281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            Y P  +   LN  G L+                 I + C  +    RPS  K+   LE
Sbjct: 225 -YLPRTMDFGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 118/291 (40%), Gaps = 42/291 (14%)
Query: 73  LGQGGFGSVYKGQLQ------TGGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQ 124
           LG G FG VY+GQ+       +   +AVK L    S+    +F+ E   I + +H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 125 LLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G +YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 182 NGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                  +H DI   N LL       + K+ DFG+A+   +   +         + ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E      G  + K+D + FG++L E+              S  Y P       +K     
Sbjct: 233 EAFME--GIFTSKTDTWSFGVLLWEIF-------------SLGYMP-----YPSKSNQEV 272
Query: 299 LQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           L+ VT    M   K C      I   C Q +  DRP+   +LE +E    D
Sbjct: 273 LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 33/211 (15%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G VY G+ L     IA+K +   +S++S +    E++    + H N+VQ LG  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-QPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL--HEVALG-----TARGIEYLHN 182
           SE     +  E +P GSL   +  K        W  L  +E  +G        G++YLH 
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSK--------WGPLKDNEQTIGFYTKQILEGLKYLH- 125
Query: 183 GCDVCILHFDIKPHNILLD-HNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIA 237
             D  I+H DIK  N+L++ ++ + K+SDFG    LA  +P    F       GT+ Y+A
Sbjct: 126 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT------GTLQYMA 177
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I +        +D++  G  ++EMA G+
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQL--QTGGLI--AVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L    G  I  AVK L       E  +F+ E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 122 VVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           V+ LLG C  SEGS   +V  YM +G L R+    E+   ++  + L    L  A+G+++
Sbjct: 94  VLSLLGICLRSEGSP-LVVLPYMKHGDL-RNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFV-SISATRGTIGYIA 237
           L +      +H D+   N +LD  F  KV+DFGLA+    KE D V + +  +  + ++A
Sbjct: 150 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 238 PE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            E L ++ F T   KSDV+ FG++L E+
Sbjct: 207 LESLQTQKFTT---KSDVWSFGVLLWEL 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 149 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 206 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 238

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 148 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 205 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 237

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 145 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 202 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 234

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYKGQ------LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHH 119
            +   +G+G FG V++ +       +   ++AVKML  E S     +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFP------------KESRGQSL--- 161
            N+V+LLG C+ G    L++EYM  G L+   R + P              +R  S    
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 162 ---CWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
              C E+L  +A   A G+ YL    +   +H D+   N L+  N + K++DFGL++   
Sbjct: 170 PLSCAEQLC-IARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             + + +       I ++ PE I  N  T   +SDV+ +G+VL E+
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTT--ESDVWAYGVVLWEI 269

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQ 124
           +LG+G FG V+  +       Q   L+AVK L+++  +A ++F  E   +  + H ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRH---------VFPKESRGQSLCWEKLHEVALGTAR 175
             G C EG    +V+EYM +G L++          +  + +    L   ++  +A   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+ YL        +H D+   N L+  N + K+ DFG+++     + +     T   I +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 236 IAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           + PE ++ R F T   +SDV+  G+VL E+
Sbjct: 197 MPPESIMYRKFTT---ESDVWSLGVVLWEI 223

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKG--QLQTGGL-IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  +++   + +A+K+L+    K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           G C +     LV E    G L + +  K E    S   E LH+V++G    ++YL    +
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG----MKYLE---E 128
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 186
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 187 FRKFSSRSDVWSYGVTMWE 205

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C +    +          
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 168 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 225 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K + +    +AVKML++     +  + ++E+  +  I  H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++  Y   G+L  ++  +   G            + + ++ L   
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
               ARG+EYL      CI H D+   N+L+  N + K++DFGLA+     + +   +  
Sbjct: 163 TYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG+++ E+
Sbjct: 220 RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 252

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 131
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 185
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 186 EIV--NYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     + +   +  
Sbjct: 197 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 254 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 286

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           KLG+G + +VYKG+ + T  L+A+K   LE+ + +    I EVS +  + H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV+EY+ +  L +++   +  G  +    +        RG+ Y H      +
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLAYCHRQK---V 121
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNFG 246
           LH D+KP N+L++     K++DFGLA+   K     +      T+ Y  P+++  S ++ 
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
           T   + D++G G +  EMA GR
Sbjct: 180 T---QIDMWGVGCIFYEMATGR 198

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 129
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI--N 187
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 37/223 (16%)
Query: 73  LGQGGFGSVYKGQL-----QTG-GLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K        + G   +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----------------------QSLC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +V  S  R  + ++A E +  +  T   +SDV+ FG++L E+ 
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEIV 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L+   F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S      E  ++E+  +  + +H
Sbjct: 43  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 102
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C +    +          
Sbjct: 103 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 161 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 218 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 256

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +L+   F   E    +  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S      E  ++E+  +  + +H
Sbjct: 45  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 104
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C +    +          
Sbjct: 105 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 163 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 220 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 258

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 73  LGQGGFGSVY--------KGQLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVN 121
           LG+G FG V         K +      +AVKML++     +  + I+E+  +  I  H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEKLHEV 169
           ++ LLG C++     ++ EY   G+L  ++  +   G            + L  + L   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG+EYL      CI H D+   N+L+  + + K++DFGLA+     +     +  
Sbjct: 156 AYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 230 RGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
           R  + ++APE L  R +   + +SDV+ FG++L E+
Sbjct: 213 RLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEI 245

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S      E  ++E+  +  + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C +    +          
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 145 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 202 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 240

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HH 119
           F   LG G FG V +       +      +AVKML+ S      E  ++E+  +  + +H
Sbjct: 50  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 109
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV---------- 169
           +N+V LLG C+ G    ++ EY   G L    F +  R   +C +    +          
Sbjct: 110 MNIVNLLGACTIGGPTLVITEYCCYGDLLN--FLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 170 ------ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF 223
                 +   A+G+ +L      CI H D+   NILL H  I K+ DFGLA+    ++++
Sbjct: 168 EDLLSFSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 224 VSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEM 264
           V     R  + ++APE I   F  V + +SDV+ +G+ L E+
Sbjct: 225 VVKGNARLPVKWMAPESI---FNCVYTFESDVWSYGIFLWEL 263

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 196
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGGL---IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           F  KLG G FG V+  + ++ GL   I     + S+   E+   E+  +  + H N++++
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                +     +V E    G L   +   ++RG++L    + E+       + Y H+   
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 186 VCILHFDIKPHNILLD----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
             ++H D+KP NIL      H+ I K+ DFGLA+    ++D  S +A  GT  Y+APE+ 
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELF--KSDEHSTNAA-GTALYMAPEVF 198
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            R+   V+ K D++  G+V+  +  G
Sbjct: 199 KRD---VTFKCDIWSAGVVMYFLLTG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/222 (33%), Positives = 112/222 (50%), Gaps = 31/222 (13%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFIN-EVSTIGRI 117
           PQ ++ T+  T  +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++
Sbjct: 17  PQEVSYTD--TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK----AFKNRELQIMRKL 70
Query: 118 HHVNVVQL-LGFCSEGSKRALVY-----EYMPNG--SLDRHVFPKESRGQSLCWEKLHEV 169
            H N+V+L   F S G K+  VY     +Y+P     + RH + +  +   + + KL+  
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
            L   R + Y+H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   
Sbjct: 130 QL--FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 229 TRGTIGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
           +R    Y APELI   FG     S  DV+  G VL E+  G+
Sbjct: 185 SR---YYRAPELI---FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +   +G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++    L  E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVTLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 123
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 181
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 182 YYKFSSKSDVWSFGVLMWE 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 145
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 203
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 204 YYKFSSKSDVWSFGVLMWE 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           H N+V LLG C+ G    ++ EY   G L   +     + + L  +    +A  TA   +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAFAIANSTASTRD 165
Query: 179 YLHNGCDV-----------CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            LH    V           CI H D+   N+LL +  + K+ DFGLA+    +++++   
Sbjct: 166 LLHFSSQVAQGMAFLASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI---------HHVN 121
           ++G G +G+VYK +   +G  +A+K +             +ST+  +          H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 122 VVQLLGFCSEGS-----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           VV+L+  C+        K  LV+E++     D   +  ++    L  E + ++     RG
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   ++++    T+ Y 
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  T +   D++  G +  EM
Sbjct: 187 APEVLLQS--TYATPVDMWSVGCIFAEM 212

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 193
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 194 YYKFSSKSDVWSFGVLMWE 212

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 142 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 196
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 197 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 125
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 183
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 184 YYKFSSKSDVWSFGVLMWE 202

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 70  THKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  +
Sbjct: 21  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 80
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTAR 175
           VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A 
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 233
           G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   +
Sbjct: 141 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 195
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 196 RWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 129
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 187
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 188 YYKFSSKSDVWSFGVLMWE 206

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 190
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 143
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 201
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 202 YYKFSSKSDVWSFGVLMWE 220

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 203
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 204 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 70  THKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTAR 175
           VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 233
           G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   +
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 198
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 199 RWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P  +    L      K+ ++A   A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 139 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 193
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 194 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 134 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P  +    L      K+ ++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 203
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 204 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 73  LGQGGFGSVYKGQL-----QTG-GLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K        + G   +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----------------------QSLC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+ 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEIV 246

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +   +G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++    L  E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +   +++     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVTLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K + ++ GL  A K ++  +        S E+   EVS +  I H NV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    E L ++      G+ YLH+
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI----LNGVYYLHS 132
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
              + I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT  ++AP
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAP 186
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 187 EIV--NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 26/217 (11%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESR-----------GQSLCWEKLH 167
           H N+V LLG C+ G    ++ EY   G L  +   ++SR             +L    L 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
             +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++   
Sbjct: 168 HFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 259

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++A
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE  S   G  +  SD++ FG+VL E+ 
Sbjct: 201 PE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 70  THKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVN 121
           + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  +
Sbjct: 52  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 111
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTAR 175
           VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A 
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--TI 233
           G+ YL+       +H D+   N ++  +F  K+ DFG+ +    E D+      +G   +
Sbjct: 172 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLPV 226
Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 227 RWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL+       +H D+   N ++ H+F  K+ DFG+ +   + + +         + ++A
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 PE--SLKDGVFTTSSDMWSFGVVLWEIT 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 80  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 197 APE--SLKDGVFTTSSDMWSFGVVLWEIT 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 26/218 (11%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWEKL 166
           H N+V LLG C+ G    ++ EY   G L            +    P  +  + L    L
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
              +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 LHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 226 GNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 261

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
            G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + +           + 
Sbjct: 143 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 200 WMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK Q  +T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              +   ++ E+   G++D  +   E   + L   ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  NIL   +   K++DFG++    +   + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI------GTPYWMAPEVVMCET 211
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++A
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE  S   G  +  SD++ FG+VL E+ 
Sbjct: 201 PE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 71  HKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNV 122
            +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARG 176
           V+LLG  S+G    +V E M +G L    R + P+           L E   +A   A G
Sbjct: 83  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           + YL+       +H D+   N ++ H+F  K+ DFG+ +   + +           + ++
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA 265
           APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 200 APE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 37/228 (16%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGR 116
           + IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 92
Query: 117 IHHVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           + H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++
Sbjct: 93  LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKL 144
Query: 170 ALGTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
           AL TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D +
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 225 SISATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
            I+     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 251

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 108/228 (47%), Gaps = 37/228 (16%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGR 116
           + IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     
Sbjct: 25  RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM---- 79
Query: 117 IHHVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           + H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++
Sbjct: 80  LRHENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKL 131
Query: 170 ALGTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
           AL TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D +
Sbjct: 132 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 191
Query: 225 SISATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
            I+     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 238

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK Q  +T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              +   ++ E+   G++D  +   E   + L   ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI---S 242
           H D+K  NIL   +   K++DFG++    +   + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAPEVVMCET 211
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLEN-SKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK Q  +T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              +   ++ E+   G++D  +   E   + L   ++  V   T   + YLH   D  I+
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHP----KENDFVSISATRGTIGYIAPELI---S 242
           H D+K  NIL   +   K++DFG++  +     + + F+      GT  ++APE++   +
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI------GTPYWMAPEVVMCET 211
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
                   K+DV+  G+ L+EMA
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMA 234

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 137
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 138 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 189
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 190 RLPYGP---EVDIWSLGIMVIEMVDG 212

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 74  GQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS 133
            +G FG V+K QL     +AVK+       + +   E+ +   + H N++Q +     GS
Sbjct: 24  ARGRFGCVWKAQLMND-FVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 134 ----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC-- 187
               +  L+  +   GSL  ++     +G  + W +L  VA   +RG+ YLH     C  
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 188 ------ILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIG---YIA 237
                 I H D K  N+LL  +    ++DFGLA +F P +        T G +G   Y+A
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPP----GDTHGQVGTRRYMA 193
Query: 238 PELI--SRNFGTVS-CKSDVYGFGMVLLEM 264
           PE++  + NF   +  + D+Y  G+VL E+
Sbjct: 194 PEVLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  +V   K++ G  L    L    +  A+G+ YL    
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 215
Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 267
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 268 TID------VYMVMVKCWMIDADSRPKFKEL 292

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 63  IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIH 118
           IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     + 
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 61
Query: 119 HVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
           H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++AL
Sbjct: 62  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 113
Query: 172 GTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 114 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 173
Query: 227 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 174 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 147 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 198
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 199 RLPYGP---EVDIWSLGIMVIEMVDG 221

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K+L  +       EF++E   +  + H ++V+L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           LG C   + + LV + MP+G L  +V   K++ G  L    L    +  A+G+ YL    
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQL----LLNWCVQIAKGMMYLE--- 134
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  ++H D+   N+L+      K++DFGLA+    +    +    +  I ++A E I  +
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--H 192
Query: 245 FGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
           +   + +SDV+ +G+ + E M  G +  +   TR         + D L KG  L    + 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
            I+      + M+ + C  + A  RP   ++
Sbjct: 245 TID------VYMVMVKCWMIDADSRPKFKEL 269

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH----HVNVVQLLG 127
           LG+G F  VY+ + + TG  +A+KM++         +  V    +IH    H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + +   LV E   NG ++R++   ++R +     +          G+ YLH+     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYLHSHG--- 132
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           ILH D+   N+LL  N   K++DFGLA     P E  +       GT  YI+PE+ +R+ 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRSA 188
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG--GDLELQNVT 303
             +  +SDV+  G +   +  GR   + +  +++           LNK    D E+ +  
Sbjct: 189 HGL--ESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------LNKVVLADYEMPSFL 235
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
            IE   A+ L       ++   ADR S++ VL+
Sbjct: 236 SIE---AKDLIH---QLLRRNPADRLSLSSVLD 262

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 103/207 (49%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVNV 122
           ++G G +G+VYK +   +G  +A+K +     + EE      + EV+ + R+    H NV
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVP--NGEEGLPISTVREVALLRRLEAFEHPNV 68
Query: 123 VQLLGFCSEGS-----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           V+L+  C+        K  LV+E++     D   +  ++    L  E + ++     RG+
Sbjct: 69  VRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 125
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           ++LH  C   I+H D+KP NIL+      K++DFGLA+ +  +     +     T+ Y A
Sbjct: 126 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV---TLWYRA 179
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PE++ ++  T +   D++  G +  EM
Sbjct: 180 PEVLLQS--TYATPVDMWSVGCIFAEM 204

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 148
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 149 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 200
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 201 RLPYGP---EVDIWSLGIMVIEMVDG 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 63  IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIH 118
           IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     + 
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 56
Query: 119 HVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
           H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++AL
Sbjct: 57  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 108
Query: 172 GTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 109 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 168
Query: 227 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 169 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 63  IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIH 118
           IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     + 
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 55
Query: 119 HVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
           H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++AL
Sbjct: 56  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 107
Query: 172 GTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 227 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 212

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 487
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 545
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 546 YYKFSSKSDVWSFGVLMWE 564

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIA------VKMLENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   ++       +K   N     +E + E + + ++ +  +V++
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++            E +H+V++G    ++YL    +
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG----MKYLE---E 488
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K     EN + + +  +  + + APE I  N
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI--N 546
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           +   S KSDV+ FG+++ E
Sbjct: 547 YYKFSSKSDVWSFGVLMWE 565

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 63  IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIH 118
           IA T      +G+G FG V++G+ + G  +AVK+     E S F   E    V     + 
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM----LR 58
Query: 119 HVNVVQLLGFCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
           H N+   LGF +  +K         LV +Y  +GSL    F   +R  ++  E + ++AL
Sbjct: 59  HENI---LGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNR-YTVTVEGMIKLAL 110
Query: 172 GTARGIEYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            TA G+ +LH           I H D+K  NIL+  N    ++D GLA  H    D + I
Sbjct: 111 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 170
Query: 227 SATR--GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMA 265
           +     GT  Y+APE++      ++F +   ++D+Y  G+V  E+A
Sbjct: 171 APNHRVGTKRYMAPEVLDDSINMKHFESFK-RADIYAMGLVFWEIA 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+   
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 138 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 192
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 193 AYGP---KVDIWSLGIMAIEMIEGE 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 141
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 142 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 193
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 194 RLPYGP---EVDIWSLGIMVIEMVDG 216

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 37/223 (16%)
Query: 73  LGQGGFGSVYKGQL-----QTG-GLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQ 124
           LG+G FG V K        + G   +AVKML+ +   +E  + ++E + + +++H +V++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----------------------QSLC 162
           L G CS+     L+ EY   GSL    F +ESR                       ++L 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSL--RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
              L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +E+ 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            V  S  R  + ++A E +  +  T   +SDV+ FG++L E+ 
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYT--TQSDVWSFGVLLWEIV 246

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  Q  TG   A K ++  + S+       EE   EV+ +  I H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L   +  KES  +    + L ++      G+ YLH+ 
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHSK 127
Query: 184 CDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    GT  ++APE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPE 181
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++  N+  +  ++D++  G++   +  G
Sbjct: 182 IV--NYEPLGLEADMWSIGVITYILLSG 207

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H DIK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRK 191
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 192 AYGP---KVDIWSLGIMAIEMIEGE 213

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHV 120
            + +LGQG FG VY+G      + +    +A+K +  +    E  EF+NE S +   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLC---WEKLHEVALGTA 174
           +VV+LLG  S+G    ++ E M  G L    R + P+      L      K+ ++A   A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG--T 232
            G+ YL+       +H D+   N  +  +F  K+ DFG+ +    E D+      +G   
Sbjct: 136 DGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR-DIYETDYYR-KGGKGLLP 190
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
           + +++PE  S   G  +  SDV+ FG+VL E+A
Sbjct: 191 VRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  Q  TG   A K ++  + S+       EE   EV+ +  I H N++
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L   +  KES  +    + L ++      G+ YLH+ 
Sbjct: 79  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHSK 134
Query: 184 CDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    GT  ++APE
Sbjct: 135 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG------ 231
            YL+       +H D+   N ++ H+F  K+ DFG+ +      D    +  R       
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETAYYRKGGKGLL 194
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA 265
            + ++APE  S   G  +  SD++ FG+VL E+ 
Sbjct: 195 PVRWMAPE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 268
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 269 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 320
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 321 RLPYGP---EVDIWSLGIMVIEMVDG 343

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 35/234 (14%)
Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+      +  +G L A+K+L+ +     + +    E   +  ++H  VV+L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+      E +       A G+++LH+  
Sbjct: 96  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLDHLHS-- 148
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 149 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC------GTVEYMAPEV 201
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 287
           ++R     S  +D + +G+++ EM        G  R   M     +K   P ++
Sbjct: 202 VNRQ--GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFL 253

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +A  GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 30/206 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +++ G L+AVK ++  K    E + NEV  +    H NVV++    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  +V E++  G+L     H    E +  ++C   L  +++  A+G+         
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGV--------- 191
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
             +H DIK  +ILL H+   K+SDFG    ++K  P+    V      GT  ++APELIS
Sbjct: 192 --IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV------GTPYWMAPELIS 243
Query: 243 R-NFGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G    + D++  G++++EM  G
Sbjct: 244 RLPYGP---EVDIWSLGIMVIEMVDG 266

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 72  KLGQGGFGSVYKG--QLQTGGL-IAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  +++   + +A+K+L+    K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           G C +     LV E    G L + +  K E    S   E LH+V++G    ++YL    +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG----MKYLE---E 454
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISRN 244
              +H ++   N+LL +    K+SDFGL+K     ++ + + SA +  + + APE I  N
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--N 512
Query: 245 FGTVSCKSDVYGFGMVLLE 263
           F   S +SDV+ +G+ + E
Sbjct: 513 FRKFSSRSDVWSYGVTMWE 531

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 56  RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVS 112
           R+   + I     F   LG G F  V   +  +T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHV---FPKESRGQSLCWEKLHE 168
            + +I H N+V L      G    L+ + +  G L DR V   F  E     L ++ L  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD- 127
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVS 225
                   ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    
Sbjct: 128 -------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
           +S   GT GY+APE++++     S   D +  G++
Sbjct: 175 LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 115/244 (47%), Gaps = 53/244 (21%)
Query: 56  RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIG 115
           +Y+  +   M       +G GGFG V+K + +  G   V  +   K++ E+   EV  + 
Sbjct: 3   KYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYV--IRRVKYNNEKAEREVKALA 60
Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMP---NGSLDRHVFPKE-----SRGQSLC----- 162
           ++ HVN+V   G C +G      ++Y P   + SL+   +  E     SR ++ C     
Sbjct: 61  KLDHVNIVHYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQM 113
Query: 163 ----------W------EKLHEV-AL----GTARGIEYLHNGCDVCILHFDIKPHNILLD 201
                     W      EKL +V AL       +G++Y+H+     ++H D+KP NI L 
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLV 170
Query: 202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMV 260
                K+ DFGL      +ND    + ++GT+ Y++PE I S+++G    + D+Y  G++
Sbjct: 171 DTKQVKIGDFGLVT--SLKNDGKR-TRSKGTLRYMSPEQISSQDYGK---EVDLYALGLI 224
Query: 261 LLEM 264
           L E+
Sbjct: 225 LAEL 228

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + ++   ++A+K +    + S    ++ I EV  + ++ H N +Q  
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   + L   ++  V  G  +G+ YLH+    
Sbjct: 121 GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 174
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 175 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 227
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNS-NMNA 275
           G    K DV+  G+  +E+A  +    NMNA
Sbjct: 228 GQYDGKVDVWSLGITCIELAERKPPLFNMNA 258

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + ++   ++A+K +    + S    ++ I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   + L   ++  V  G  +G+ YLH+    
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDL----LEVHKKPLQEVEIAAVTHGALQGLAYLHSHN-- 135
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVILAMDE 188
Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNS-NMNA 275
           G    K DV+  G+  +E+A  +    NMNA
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNA 219

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 56  RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVS 112
           R+   + I     F   LG G F  V   +  +T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHV---FPKESRGQSLCWEKLHE 168
            + +I H N+V L      G    L+ + +  G L DR V   F  E     L ++ L  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD- 127
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVS 225
                   ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    
Sbjct: 128 -------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
           +S   GT GY+APE++++     S   D +  G++
Sbjct: 175 LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 32/210 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           +G GGFG V+K + +  G   V  ++  K++ E+   EV  + ++ HVN+V   G C +G
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYV--IKRVKYNNEKAEREVKALAKLDHVNIVHYNG-CWDG 75
Query: 133 --------------SKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
                         SK   ++   E+   G+L++ +  ++ RG+ L      E+     +
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQITK 133
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G++Y+H+     +++ D+KP NI L      K+ DFGL      +ND      ++GT+ Y
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKR-XRSKGTLRY 187
Query: 236 IAPELI-SRNFGTVSCKSDVYGFGMVLLEM 264
           ++PE I S+++G    + D+Y  G++L E+
Sbjct: 188 MSPEQISSQDYGK---EVDLYALGLILAEL 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 69  FTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHV 120
           F  +LG+  FG VYKG L      +    +A+K L++       EEF +E     R+ H 
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK----------ESRGQSLCWEK---LH 167
           NVV LLG  ++    ++++ Y  +G L   +  +          + R      E    +H
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            VA   A G+EYL +     ++H D+   N+L+      K+SD GL +     + +  + 
Sbjct: 150 LVA-QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 206 NSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 68  HFTHKLGQGGFGSVYK------GQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-H 118
            F   LG G FG V +      G+      +AVKML+++  + E+   ++E+  +  +  
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 93
Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHVFPKESRG 158
           H N+V LLG C+ G    ++ EY   G L                    D     KE  G
Sbjct: 94  HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED-G 152
Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           + L    L   +   A+G+ +L      CI H D+   N+LL +  + K+ DFGLA+   
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +++++     R  + ++APE I     TV  +SDV+ +G++L E+
Sbjct: 210 NDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDVWSYGILLWEI 253

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 70  THKLGQGGFGSVYKGQLQTG-GLIAVKMLENSKFSA--------------EEFINEVSTI 114
             KLG G +G V   + + G    A+K+++ S+F                EE  NE+S +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 115 GRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
             + H N+++L     +     LV E+   G L   +  +    +      + ++     
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI----L 156
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRG 231
            GI YLH      I+H DIKP NILL++       K+ DFGL+ F  K+     +    G
Sbjct: 157 SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLG 210
Query: 232 TIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
           T  YIAPE++ + +     K DV+  G+++
Sbjct: 211 TAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +  K SR               TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQ----------RTATYITELANALSYC 128
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL  N   K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 184
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                  K D++  G++  E   G
Sbjct: 185 RMH--DEKVDLWSLGVLCYEFLVG 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEG 183
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 184 RMHDE--KVDLWSLGVLCYEFLVGK 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +  A       EE   EVS + ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           ++  N+  +  ++D++  G++   +  G      +  + + A   S  YD
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 56  RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVS 112
           R+   + I     F   LG G F  V   +  +T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHV---FPKESRGQSLCWEKLHE 168
            + +I H N+V L      G    L+ + +  G L DR V   F  E     L ++ L  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD- 127
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVS 225
                   ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    
Sbjct: 128 -------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
           +S   GT GY+APE++++     S   D +  G++
Sbjct: 175 LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           ++  N+  +  ++D++  G++   +  G      +  + + A   S  YD
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 106/230 (46%), Gaps = 24/230 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           ++  N+  +  ++D++  G++   +  G      +  + + A   S  YD
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 56  RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVS 112
           R+   + I     F   LG G F  V   +  +T  L+A+K +       +E    NE++
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 68
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHV---FPKESRGQSLCWEKLHE 168
            + +I H N+V L      G    L+ + +  G L DR V   F  E     L ++ L  
Sbjct: 69  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD- 127
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVS 225
                   ++YLH   D+ I+H D+KP N+L   LD +    +SDFGL+K    E+    
Sbjct: 128 -------AVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSV 174
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
           +S   GT GY+APE++++     S   D +  G++
Sbjct: 175 LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 71  HKLGQGGFGSVYK-GQLQTGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNV 122
            +LG G F  V K  Q  TG   A K ++  +        S EE   EV+ +  I H N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L       +   L+ E +  G L   +  KES  +    + L ++      G+ YLH+
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI----LDGVHYLHS 147
Query: 183 GCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    GT  ++AP
Sbjct: 148 K---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAP 201
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++  N+  +  ++D++  G++   +  G
Sbjct: 202 EIV--NYEPLGLEADMWSIGVITYILLSG 228

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++A
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE  S   G  +  SD++ FG+VL E+ 
Sbjct: 201 PE--SLKDGVFTTSSDMWSFGVVLWEIT 226

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSK-------FSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K + ++ GL  A K ++  +        S EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L    F   ++ +SL  E+          G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 184 CDVCILHFDIKPHNI-LLDHNF-IP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
               I HFD+KP NI LLD N  IP  K+ DFGLA  H  E D V      GT  ++APE
Sbjct: 135 ---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE-DGVEFKNIFGTPEFVAPE 188
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++  N+  +  ++D++  G++   +  G
Sbjct: 189 IV--NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQL 125
           K+G+G +G VYK +   G ++A+K +   +  AE+       I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +          LV+E+M      + V  +   G      K++   L   RG+ + H    
Sbjct: 85  IDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQHR- 139
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI-- 241
             ILH D+KP N+L++ +   K++DFGLA+    P      S +    T+ Y AP+++  
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDVLMG 193
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           S+ + T     D++  G +  EM  G+
Sbjct: 194 SKKYST---SVDIWSIGCIFAEMITGK 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 69  FTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHV 120
           F  +LG+  FG VYKG L      +    +A+K L++       EEF +E     R+ H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK----------ESRGQSLCWEK---LH 167
           NVV LLG  ++    ++++ Y  +G L   +  +          + R      E    +H
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 168 EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
            VA   A G+EYL +     ++H D+   N+L+      K+SD GL +     + +  + 
Sbjct: 133 LVA-QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
            +   I ++APE I   +G  S  SD++ +G+VL E+
Sbjct: 189 NSLLPIRWMAPEAIM--YGKFSIDSDIWSYGVVLWEV 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 72  KLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVV 123
           +LGQG FG VY+G        +    +AVK +  S    E  EF+NE S +      +VV
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHE---VALGTARGI 177
           +LLG  S+G    +V E M +G L    R + P+           L E   +A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL+       +H ++   N ++ H+F  K+ DFG+ +   + + +         + ++A
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA 265
           PE  S   G  +  SD++ FG+VL E+ 
Sbjct: 202 PE--SLKDGVFTTSSDMWSFGVVLWEIT 227

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQL 125
           K+G+G +G VYK +   G ++A+K +   +  AE+       I E+S +  +HH N+V L
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +          LV+E+M      + V  +   G      K++   L   RG+ + H    
Sbjct: 85  IDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQL--LRGVAHCHQHR- 139
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI-- 241
             ILH D+KP N+L++ +   K++DFGLA+    P      S +    T+ Y AP+++  
Sbjct: 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR----SYTHEVVTLWYRAPDVLMG 193
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           S+ + T     D++  G +  EM  G+
Sbjct: 194 SKKYST---SVDIWSIGCIFAEMITGK 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C +  +++L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH+ 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLHSQ 136
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 137 H---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
                    SDV+ FG+ L E+      ++ ++++S    F   +     +   L L  +
Sbjct: 194 EY--KFYYASDVWSFGVTLYELL-----THCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 246
Query: 303 TEIESMIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
            E    + R   C   ++     C + +A+ RP+   ++ +L+
Sbjct: 247 LERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILK 289

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 35/234 (14%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+      E +       A  +++LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 287
           ++R   T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 198 VNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 35/234 (14%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+      E +       A  +++LH+  
Sbjct: 93  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 146 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 198
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 287
           ++R   T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 199 VNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 250

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 111/234 (47%), Gaps = 35/234 (14%)
Query: 73  LGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQL 125
           LGQG FG V+  +  +G     L A+K+L+ +     + +    E   +  ++H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 126 -LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              F +EG K  L+ +++  G L    F + S+      E +       A  +++LH+  
Sbjct: 92  HYAFQTEG-KLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLHS-- 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK----FHPKENDFVSISATRGTIGYIAPEL 240
            + I++ D+KP NILLD     K++DFGL+K       K   F       GT+ Y+APE+
Sbjct: 145 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMAPEV 197
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM-------AGGRRNSNMNATRSSKAYFPSWV 287
           ++R   T S  +D + FG+++ EM        G  R   M     +K   P ++
Sbjct: 198 VNRRGHTQS--ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+ + TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  S   +V EY+  G L  ++  K  R       +L +  L    G++Y H      
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILS---GVDYCHRHM--- 136
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSC--GSPNYAAPEVISGRL-Y 192
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +   +   +E I NE+  +    + N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL   V      E +  ++C E L        + +E+LH+   
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSN-- 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGL-AKFHPKENDFVSISATRGTIGYIAPELISRN 244
             ++H +IK  NILL  +   K++DFG  A+  P+++     S   GT  ++APE+++R 
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRK 192
Query: 245 -FGTVSCKSDVYGFGMVLLEMAGGR 268
            +G    K D++  G++ +EM  G 
Sbjct: 193 AYGP---KVDIWSLGIMAIEMIEGE 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 134 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 191 KTRTF---SHASDTWMFGVTLWEM 211

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 30/207 (14%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 150
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMI 204
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                    K D++  G++  E   G+
Sbjct: 205 EGRMHDE--KVDLWSLGVLCYEFLVGK 229

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 129
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 187 KTRTF---SHASDTWMFGVTLWEM 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 125
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPEMIEG 181
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 182 RMH--DEKVDLWSLGVLCYEFLVGK 204

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +  K SR               TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQ----------RTATYITELANALSYC 128
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL  N   K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEG 184
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                  K D++  G++  E   G
Sbjct: 185 RMH--DEKVDLWSLGVLCYEFLVG 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V K Q +  GLI  + L   E       + I E+  +   +   +V   G 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ +  KE++   +  E L +V++   RG+ YL       I
Sbjct: 83  FYSDGEISICMEHMDGGSLDQVL--KEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--I 136
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y+APE   R  G
Sbjct: 137 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMAPE---RLQG 187
Query: 247 T-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           T  S +SD++  G+ L+E+A GR        +  +A F   V D
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVD 231

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+ Q TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  +   +V EY+  G L  ++  K  R + +   +L +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILS---AVDYCHRHM--- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSC--GSPNYAAPEVISGRL-Y 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 148
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 129
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 187 KTRTF---SHASDTWMFGVTLWEM 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
              + S  SD++  G ++ ++  G
Sbjct: 209 K--SASKSSDLWALGCIIYQLVAG 230

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 133
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 134 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 191 KTRTF---SHASDTWMFGVTLWEM 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 152
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++ 
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 30/218 (13%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  + +D        GT+ Y+ PE+I
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC------GTLDYLPPEMI 181
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
                    K D++  G++  E   G+     N  + +
Sbjct: 182 EGRMH--DEKVDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 197 KTRTF---SHASDTWMFGVTLWEM 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 75  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 129
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 187 KTRTF---SHASDTWMFGVTLWEM 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 125
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMI 179
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                    K D++  G++  E   G+
Sbjct: 180 EGRMHDE--KVDLWSLGVLCYEFLVGK 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 127
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 185 K---SACKSSDLWALGCIIYQLVAG 206

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C +  +++L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLHAQ 136
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
                +H ++   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 137 H---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
                    SDV+ FG+ L E+
Sbjct: 194 EY--KFYYASDVWSFGVTLYEL 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 183
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 184 RMHDE--KVDLWSLGVLCYEFLVGK 206

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 183
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVV 123
           KLG G FG V +G+          +AVK L+    S  E    FI EV+ +  + H N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +L G       + +V E  P GSL DR    ++ +G  L    L   A+  A G+ YL +
Sbjct: 85  RLYGVVLTPPMK-MVTELAPLGSLLDRL---RKHQGHFLL-GTLSRYAVQVAEGMGYLES 139
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPE-L 240
                 +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + APE L
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
            +R F   S  SD + FG+ L EM
Sbjct: 197 KTRTF---SHASDTWMFGVTLWEM 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 123
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 179
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 180 RMH--DEKVDLWSLGVLCYEFLVGK 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMI 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                    K D++  G++  E   G+
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFLVGK 203

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 11  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 71  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 126
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 127 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 184 K---SACKSSDLWALGCIIYQLVAG 205

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 141
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 197
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 198 RMHDE--KVDLWSLGVLCYEFLVGK 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 13  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 73  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 128
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 129 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 186 K---SACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 14  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 74  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 129
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 130 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 187 K---SACKSSDLWALGCIIYQLVAG 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKGQLQTGGLI-AVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  + +    I A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +A  GT+ Y+ PE+I  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLE-----NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           K+G+G F  VY+      G+ +A+K ++     ++K  A+  I E+  + +++H NV++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPNVIKY 97
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHV--FPKESR--GQSLCWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R +  F K+ R   +   W+    V L +A  +E++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQLCSA--LEHMH 153
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H DIKP N+ +    + K+ D GL +F   +    +  +  GT  Y++PE I
Sbjct: 154 SRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERI 208
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAG 266
             N    + KSD++  G +L EMA 
Sbjct: 209 HEN--GYNFKSDIWSLGCLLYEMAA 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 129
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 185
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 186 RMHDE--KVDLWSLGVLCYEFLVGK 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 126 LGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C +  +++  LV EY+P GSL R   P+   G +    +L   A     G+ YLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLA----QLLLFAQQICEGMAYLHAQ 130
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
                +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 131 H---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 243 RNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
                  CK    SDV+ FG+ L E+      +  ++ +S    F   +     +   L 
Sbjct: 188 ------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMTVLR 236
Query: 299 LQNVTEIESMIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSIDDLQ 346
           L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 237 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 290

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 33  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 93  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 148
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 149 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 206 K---SACKSSDLWALGCIIYQLVAG 227

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMI 178
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                    K D++  G++  E   G+
Sbjct: 179 EGRMHDE--KVDLWSLGVLCYEFLVGK 203

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 132/294 (44%), Gaps = 39/294 (13%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 126 LGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C +  +++  LV EY+P GSL R   P+   G +    +L   A     G+ YLH  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGLA----QLLLFAQQICEGMAYLHAQ 131
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
                +H  +   N+LLD++ + K+ DFGLAK  P+ +++  +     + + + APE + 
Sbjct: 132 H---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 243 RNFGTVSCK----SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
                  CK    SDV+ FG+ L E+      +  ++ +S    F   +     +   L 
Sbjct: 189 ------ECKFYYASDVWSFGVTLYELL-----TYCDSNQSPHTKFTELIGHTQGQMTVLR 237
Query: 299 LQNVTEIESMIAR-KLCMIGLW-----CIQVKAADRPSMTKVLEMLEGSIDDLQ 346
           L  + E    + R   C   ++     C + +A+ RP+   ++ +L+ + +  Q
Sbjct: 238 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 291

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 18  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 78  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 133
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 134 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 191 K---SACKSSDLWALGCIIYQLVAG 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 128
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 184
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 185 RMH--DEKVDLWSLGVLCYEFLVGK 207

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 72  KLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V    +  +G  +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  ++ E++  G+L   V   + R   L  E++  V     + + YLH      ++
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV--SQVR---LNEEQIATVCEAVLQALAYLHAQG---VI 163
Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+ISR+ 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV------GTPYWMAPEVISRSL 217
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
              + + D++  G++++EM  G
Sbjct: 218 --YATEVDIWSLGIMVIEMVDG 237

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 129
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELI 241
               ++H DIKP N+LL      K++DFG +   P  +  D        GT+ Y+ PE+I
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------GTLDYLPPEMI 183
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                    K D++  G++  E   G+
Sbjct: 184 EGRMHDE--KVDLWSLGVLCYEFLVGK 208

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMHDE--KVDLWSLGVLCYEFLVGK 203

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 150
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 206
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 207 RMHDE--KVDLWSLGVLCYEFLVGK 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGS-VYKGQLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F + V   +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 34  FGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 149
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 207 K---SACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 39  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 99  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 154
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 155 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 212 K---SACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 37  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 97  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 152
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 153 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 210 K---SACKSSDLWALGCIIYQLVAG 231

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+ Q TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             S  +   +V EY+  G L  ++  K  R + +   +L +  L     ++Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC-KHGRVEEMEARRLFQQILS---AVDYCHRHM--- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS     
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSC--GSPNYAAPEVISGRL-Y 187
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
              + D++  G++L  +  G
Sbjct: 188 AGPEVDIWSCGVILYALLCG 207

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMHDE--KVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 125
           LG+G FG V           TG ++AVK L+          +  E+  +  ++H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C +    +L  V EY+P GSL R   P+ S G +    +L   A     G+ YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSL-RDYLPRHSIGLA----QLLLFAQQICEGMAYLHAQ 153
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
                +H D+   N+LLD++ + K+ DFGLAK  P+ ++   +     + + + APE + 
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
                    SDV+ FG+ L E+
Sbjct: 211 EY--KFYYASDVWSFGVTLYEL 230

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSVYKGQLQ-----TGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V   +       TG  +AVK L  E+      +   E+  +  ++H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 126 LGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C+E  G+   L+ E++P+GSL +   PK     +L  ++  + A+   +G++YL + 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINL--KQQLKYAVQICKGMDYLGSR 145
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
             V   H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 146 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
           ++   ++  SDV+ FG+ L E+
Sbjct: 203 QSKFYIA--SDVWSFGVTLHEL 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSVYKGQLQ-----TGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG+G FG V   +       TG  +AVK L  E+      +   E+  +  ++H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 126 LGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            G C+E  G+   L+ E++P+GSL +   PK     +L  ++  + A+   +G++YL + 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSL-KEYLPKNKNKINL--KQQLKYAVQICKGMDYLGSR 133
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT-IGYIAPELIS 242
             V   H D+   N+L++     K+ DFGL K    + +  ++   R + + + APE + 
Sbjct: 134 QYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 243 RNFGTVSCKSDVYGFGMVLLEM 264
           ++   ++  SDV+ FG+ L E+
Sbjct: 191 QSKFYIA--SDVWSFGVTLHEL 210

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 41  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 101 KLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 156
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 157 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 214 K---SACKSSDLWALGCIIYQLVAG 235

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCK-SDVYGFGMVLLEMAGG 267
                +CK SD++  G ++ ++  G
Sbjct: 209 K---SACKSSDLWALGCIIYQLVAG 230

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 125
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEG 181
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 182 RMHDE--KVDLWSLGVLCYEFLVGK 204

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEG 183
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G + + +       Q L   K  E    TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-------QKLS--KFDEQR--TATYITELANALSYC 129
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEG 185
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 186 RMH--DEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 126
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEG 182
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 183 RMHDE--KVDLWSLGVLCYEFLVGK 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G + + +       Q L   K  E    TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-------QKLS--KFDEQR--TATYITELANALSYC 129
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 185
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 186 RMHDE--KVDLWSLGVLCYEFLVGK 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G V+K +   TG ++A+K     E+     +  + E+  + ++ H N+V LL 
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRG------QSLCWEKLHEVALGTARGIEYLH 181
                 +  LV+EY  +  L  H   +  RG      +S+ W+ L  V         + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFC------HKH 121
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           N    CI H D+KP NIL+  + + K+ DFG A+     +D+        T  Y +PEL+
Sbjct: 122 N----CI-HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV--ATRWYRSPELL 174
Query: 242 --SRNFGTVSCKSDVYGFGMVLLEMAGG 267
                +G      DV+  G V  E+  G
Sbjct: 175 VGDTQYGP---PVDVWAIGCVFAELLSG 199

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 124
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEG 180
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 181 RMH--DEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q   ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 121
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE+I  
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 177
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 178 RMH--DEKVDLWSLGVLCYEFLVGK 200

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           F  KLG+GGF  V   + L  G   A+K +L + +   EE   E       +H N+++L+
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 127 GFC--SEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
            +C    G+K    L+  +   G+L   +   + +G  L  +++  + LG  RG+E +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFG---LAKFHPKEN----DFVSISATRGTIGY 235
                  H D+KP NILL     P + D G    A  H + +         +A R TI Y
Sbjct: 153 KG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 236 IAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM 273
            APEL S ++   +  ++DV+  G VL  M  G    +M
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVV 123
           F   LG+G F +V    +L T    A+K+LE      E  +     E   + R+ H   V
Sbjct: 36  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +L     +  K      Y  NG L +++    S  ++       E+       +EYLH  
Sbjct: 96  KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK 151
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               I+H D+KP NILL+ +   +++DFG AK    E+     +   GT  Y++PEL++ 
Sbjct: 152 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
                S  SD++  G ++ ++  G
Sbjct: 209 KSAXKS--SDLWALGCIIYQLVAG 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 110/218 (50%), Gaps = 30/218 (13%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            ++G+G FG V+KG   +T  ++A+K+++   ++   E+   E++ + +     V +  G
Sbjct: 29  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 128 FCSEGSKRALVYEYMPNGS---LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              +GSK  ++ EY+  GS   L R     E +  ++  E L        +G++YLH+  
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL--------KGLDYLHSEK 140
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+
Sbjct: 141 KI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 191
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
           I ++      K+D++  G+  +E+A G   NS+M+  R
Sbjct: 192 IQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--QTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G      G  I V +    K       E+F++E   +  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    SL    L   +L   + + YL +   +
Sbjct: 76  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 185
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 186 RFTTASDVWMFAVCMWEI 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--QTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G      G  I V +    K       E+F++E   +  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    SL    L   +L   + + YL +   +
Sbjct: 92  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 144
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 201
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 202 RFTTASDVWMFAVCMWEI 219

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 30/218 (13%)
Query: 63  IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVK-MLENSKFSAEEFINEVSTIGRIHHVN 121
           IA TN     +G G FG V++ +L     +A+K +L++ +F   E    +  +  + H N
Sbjct: 40  IAYTN--CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPN 93
Query: 122 VVQLLGFC-SEGSKRA-----LVYEYMPNG--SLDRHVFPKESRGQSLCWEKLHEVALGT 173
           VV L  F  S G K+      LV EY+P       RH + K  +   +   KL+   L  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH-YAKLKQTMPMLLIKLYMYQL-- 150
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            R + Y+H+   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R  
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSR-- 205
Query: 233 IGYIAPELISRNFGTVSCKS--DVYGFGMVLLEMAGGR 268
             Y APELI   FG  +  +  D++  G V+ E+  G+
Sbjct: 206 -YYRAPELI---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQL--QTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG VY+G      G  I V +    K       E+F++E   +  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G   E     ++ E  P G L  ++   E    SL    L   +L   + + YL +   +
Sbjct: 80  GIIEE-EPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES---I 132
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   NIL+      K+ DFGL+++   E D+   S TR  I +++PE I  NF 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-DYYKASVTRLPIKWMSPESI--NFR 189
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ F + + E+
Sbjct: 190 RFTTASDVWMFAVCMWEI 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 126
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 182
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 183 RMHDE--KVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 127
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K+++FG +   P        +   GT+ Y+ PE+I  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEG 183
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 184 RMH--DEKVDLWSLGVLCYEFLVGK 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 26/205 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q+  ++A+K+L  ++        +   EV     + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           +  + ++  L+ EY P G++ R +       Q L   K  E    TA  I  L N    C
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-------QKLS--KFDEQR--TATYITELANALSYC 129
Query: 188 ----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               ++H DIKP N+LL      K++DFG +   P        +   GT+ Y+ PE I  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEG 185
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGR 268
                  K D++  G++  E   G+
Sbjct: 186 RXHDE--KVDLWSLGVLCYEFLVGK 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V K + + TG ++A+K     ++ K   +  + E+  + ++ H N+V LL  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 129 CSEGSKRALVYEYMPNGSLDR-HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           C +  +  LV+E++ +  LD   +FP       L ++ + +       GI + H+     
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRNF 245
           I+H DIKP NIL+  + + K+ DFG A+      +         T  Y APEL+     +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDVKY 202
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           G      DV+  G ++ EM  G
Sbjct: 203 GKA---VDVWAIGCLVTEMFMG 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 76  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 129
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++     E  N+FV      GT  Y++PE   R  G
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV------GTRSYMSPE---RLQG 180
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 109/269 (40%), Gaps = 86/269 (31%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+    ++E    + E+  +  I HH+NVV
Sbjct: 35  LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGSLDRHVFPKESR----- 157
            LLG              +C  G       SKR L   +  N     H+ PK+ +     
Sbjct: 95  NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDL---FFLNKDAALHMEPKKEKMEPGL 151
Query: 158 -----------------------------------------GQSLCWEKLHEVALGTARG 176
                                                     + +  E L   +   ARG
Sbjct: 152 EQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARG 211
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +E+L +    CI H D+   NILL  N + K+ DFGLA+   K  D+V    TR  + ++
Sbjct: 212 MEFLSS--RKCI-HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWM 268
Query: 237 APELISRNFGTV-SCKSDVYGFGMVLLEM 264
           APE I   F  + S KSDV+ +G++L E+
Sbjct: 269 APESI---FDKIYSTKSDVWSYGVLLWEI 294

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 199 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 247
Query: 304 EIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+  MI RK       C  + A  RP   +++
Sbjct: 248 TIDVYMIMRK-------CWMIDADSRPKFRELI 273

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 93  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 145
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 146 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 206 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 254
Query: 304 EIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+  MI RK       C  + A  RP   +++
Sbjct: 255 TIDVYMIMRK-------CWMIDADSRPKFRELI 280

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 91/201 (45%), Gaps = 31/201 (15%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI--NEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG V++   +  G + V    N+ +  +++   NE+S + ++HH  ++ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC----- 184
            +  +  L+ E++  G L   +  ++ +             +  A  I Y+   C     
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYK-------------MSEAEVINYMRQACEGLKH 164
Query: 185 --DVCILHFDIKPHNILLDHNFIP--KVSDFGLA-KFHPKENDFVSISATRGTIGYIAPE 239
             +  I+H DIKP NI+ +       K+ DFGLA K +P E     +  T  T  + APE
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPE 220
Query: 240 LISRNFGTVSCKSDVYGFGMV 260
           ++ R    V   +D++  G++
Sbjct: 221 IVDRE--PVGFYTDMWAIGVL 239

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q   G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S+  +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 241
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     +G G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EYMP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 97  LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LD--RHVFP 153
           LE  + S +E + E+  + + HH N+V          +  LV + +  GS LD  +H+  
Sbjct: 50  LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 109
Query: 154 K-ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
           K E +   L    +  +      G+EYLH    +   H D+K  NILL  +   +++DFG
Sbjct: 110 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG 166
Query: 213 LAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +E+A G
Sbjct: 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 92  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 145
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 196
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 105 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL---DRHVFPKESRGQSL 161
           ++F NE+  I  I +   +   G  +   +  ++YEYM N S+   D + F  +      
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 162 CWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
              ++ +  + +      Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++   +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
                I  +RGT  ++ PE  S        K D++  G+ L  M
Sbjct: 206 ----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM 245

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 139
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 200 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 248
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 249 TID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     +G G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EYMP G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q   G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S+  +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELI-- 241
           D  +LH D+KP N+L++     K++DFGLA+ F      +        T+ Y AP+++  
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV---TLWYRAPDVLMG 174
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           S+ + T     D++  G +  EM  G
Sbjct: 175 SKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG- 127
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F S+G + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       
Sbjct: 135 FYSDG-EISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK-- 187
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNF 245
           I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQ 238
Query: 246 GT-VSCKSDVYGFGMVLLEMAGGR 268
           GT  S +SD++  G+ L+EMA GR
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G L  G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y  +GSL   +     + Q+L       +A+  A G+ +LH
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFL-----QRQTLEPHLALRLAVSAACGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D K  N+L+  N    ++D GLA  H + +D++ I  +   GT  
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSCKS----DVYGFGMVLLEMA 265
           Y+APE++     T   +S    D++ FG+VL E+A
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 11/178 (6%)
Query: 97  LENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-LD--RHVFP 153
           LE  + S +E + E+  + + HH N+V          +  LV + +  GS LD  +H+  
Sbjct: 45  LEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVA 104
Query: 154 K-ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
           K E +   L    +  +      G+EYLH    +   H D+K  NILL  +   +++DFG
Sbjct: 105 KGEHKSGVLDESTIATILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFG 161
Query: 213 LAKFHPKENDFVSISATR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ F     D       +   GT  ++APE++ +  G    K+D++ FG+  +E+A G
Sbjct: 162 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRG-YDFKADIWSFGITAIELATG 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 119/273 (43%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+  MI RK       C  + A  RP   +++
Sbjct: 245 TIDVYMIMRK-------CWMIDADSRPKFRELI 270

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 197 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 245
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 246 TID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 55  KRYSYPQIIAMTNHFTHKLGQGGFGSV-----YKGQLQTG-GLIAVKMLENSKFSAEEFI 108
           KR+  P II  T      LG+G FG V     YK Q +     I+ ++L+ S        
Sbjct: 5   KRHIGPYIIRET------LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VE 57
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+S +  + H ++++L    +  +   +V EY   G L  ++  K+   +        +
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQ 116
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISA 228
           +       IEY H      I+H D+KP N+LLD N   K++DFGL+      N F+  S 
Sbjct: 117 IICA----IEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC 168
Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             G+  Y APE+I+        + DV+  G+VL  M  GR
Sbjct: 169 --GSPNYAAPEVINGKL-YAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 245 TID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 124
           H   K+G+G +G VYK Q   G   A+K +   K         I E+S +  + H N+V+
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L        +  LV+E++ +  L + +   E   +S+  +      L    GI Y H   
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF---LLQLLNGIAYCH--- 117
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELI- 241
           D  +LH D+KP N+L++     K++DFGLA+    P       I     T+ Y AP+++ 
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLM 173
Query: 242 -SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            S+ + T     D++  G +  EM  G
Sbjct: 174 GSKKYSTT---IDIWSVGCIFAEMVNG 197

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 198 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 246
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 247 TID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 199 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 247
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 248 TID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 84  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 136
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 137 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 197 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 245
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 246 TID------VYMIMVKCWMIDADSRPKFRELI 271

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 108 LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 160
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 161 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 221 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 269
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 270 TID------VYMIMVKCWMIDADSRPKFRELI 295

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 198 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 246
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 247 TID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +   +T GL  A K++   K SA +F     E     ++ H N+V+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   +  +E   +   S C +++ E        I Y H NG
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 125
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 179 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 212

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 199 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 247
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 248 TID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 153
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 204
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 245 TID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +   +T GL  A K++   K SA +F     E     ++ H N+V+L  
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   +  +E   +   S C +++ E        I Y H NG
Sbjct: 72  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 124
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 125 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 177
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 178 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGXLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 245 TID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +LG G  G V+K   +  GL+  + L   E       + I E+  +   +   +V   G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                + ++  E+M  GSLD+ V  K  R   +  + L +V++   +G+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQ-VLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRNFG 246
           +H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE   R  G
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPE---RLQG 177
Query: 247 T-VSCKSDVYGFGMVLLEMAGGR 268
           T  S +SD++  G+ L+EMA GR
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 77  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 129
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 190 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 238
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 239 TID------VYMIMVKCWMIDADSRPKFRELI 264

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +   +T GL  A K++   K SA +F     E     ++ H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKE---SRGQSLCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   +  +E       S C +++ E        I Y H NG
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 148
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 149 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 201
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 202 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 235

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 65  MTNHFTHKLGQGGFGSVYKG----QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIH 118
           +  H    +G+G FG VY G    Q Q     A+K L         E F+ E   +  ++
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 119 HVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           H NV+ L+G     EG    L+  YM +G L + +    S  ++   + L    L  ARG
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARG 136
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---I 233
           +EYL    +   +H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     +
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLAR-DILDREYYSVQQHRHARLPV 192
Query: 234 GYIAPE-LISRNFGTVSCKSDVYGFGMVLLEM 264
            + A E L +  F T   KSDV+ FG++L E+
Sbjct: 193 KWTALESLQTYRFTT---KSDVWSFGVLLWEL 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 86  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 138
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 139 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 199 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 247
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 248 TID------VYMIMVKCWMIDADSRPKFRELI 273

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++   S+D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++   S+D   F   S    +    +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 89  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 141
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 142 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 202 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 250
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 251 TID------VYMIMVKCWMIDADSRPKFRELI 276

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++   S+D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++   S+D   F   S    +    +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 67  NHFT--HKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHH 119
           +HF     +G+G FG V   Q   T  + A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTA 174
             +V L     +     +V + +  G L  H+     F +E+    +C     E+ +   
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC-----ELVMA-- 127
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
             ++YL N     I+H D+KP NILLD +    ++DF +A   P+E     I+   GT  
Sbjct: 128 --LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKP 179
Query: 235 YIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 280
           Y+APE+ S   G   S   D +  G+   E+  GRR  ++ ++ SSK
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 203 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 251
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 252 TID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 119/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG---LIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G    I V ++E     S  + +E ++E   +  + + +V +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 117 LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 169
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 170 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 229
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 230 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 278
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 279 TID------VYMIMVKCWMIDADSRPKFRELI 304

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +   +T GL  A K++   K SA +F     E     ++ H N+V+L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTARGIEYLH-NG 183
              E S   LV++ +  G L   +  +E   +   S C +++ E        I Y H NG
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------SIAYCHSNG 125
Query: 184 CDVCILHFDIKPHNILLDHN---FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               I+H ++KP N+LL         K++DFGLA    + ND  +     GT GY++PE+
Sbjct: 126 ----IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           + ++    S   D++  G++L  +  G              Y P W  DQ
Sbjct: 179 LKKD--PYSKPVDIWACGVILYILLVG--------------YPPFWDEDQ 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 73  LGQGGFGSVYKGQL-QTGG---LIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 125
           LG+G FGSV + QL Q  G    +AVKML+    ++   EEF+ E + +    H +V +L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 126 LGFCSEGSKRA------LVYEYMPNGSLDRHVFPKESR-GQS---LCWEKLHEVALGTAR 175
           +G       +       ++  +M +G  D H F   SR G++   L  + L    +  A 
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHG--DLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           G+EYL +      +H D+   N +L  +    V+DFGL++     + +    A++  + +
Sbjct: 149 GMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           +A E ++ N  TV   SDV+ FG+ + E+
Sbjct: 206 LALESLADNLYTV--HSDVWAFGVTMWEI 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 26/201 (12%)
Query: 69  FTHKLGQGGFGSVY-KGQLQTGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLL 126
           F   LG G F  V+   Q  TG L A+K ++ S  F      NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLH-N 182
                 +   LV + +  G L   +  +     +  SL  +++          ++YLH N
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV-------LSAVKYLHEN 125
Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           G    I+H D+KP N+L    + N    ++DFGL+K   ++N  +S +   GT GY+APE
Sbjct: 126 G----IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC--GTPGYVAPE 177
Query: 240 LISRNFGTVSCKSDVYGFGMV 260
           ++++     S   D +  G++
Sbjct: 178 VLAQK--PYSKAVDCWSIGVI 196

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQ 124
            F   LG G F  V   + + TG L AVK +       +E    NE++ + +I H N+V 
Sbjct: 25  EFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVA 84
Query: 125 LLGFCSEGSKRALVYEYMPNGSL-DRHV---FPKESRGQSLCWEKLHEVALGTARGIEYL 180
           L       +   LV + +  G L DR V   F  E    +L  + L          + YL
Sbjct: 85  LEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD--------AVYYL 136
Query: 181 HNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           H    + I+H D+KP N+L    D      +SDFGL+K   K  D +S +   GT GY+A
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK-GDVMSTAC--GTPGYVA 190
Query: 238 PELISRNFGTVSCKSDVYGFGMV 260
           PE++++     S   D +  G++
Sbjct: 191 PEVLAQK--PYSKAVDCWSIGVI 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 30/247 (12%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVN-VVQLLG 127
           ++G+G +GSV K     +G ++AVK + ++    E+   + ++  + R      +VQ  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 128 FCSEGSKRALVYEYMPNGSLDR-HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                    +  E M + S D+ + +        +  E L ++ L T + + +L    ++
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI--SRN 244
            I+H DIKP NILLD +   K+ DFG++    +  D ++ +   G   Y+APE I  S +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW--VYDQLN---KGGDLEL 299
                 +SDV+  G+ L E+A GR              +P W  V+DQL    KG   +L
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFP------------YPKWNSVFDQLTQVVKGDPPQL 250
Query: 300 QNVTEIE 306
            N  E E
Sbjct: 251 SNSEERE 257

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 108/235 (45%), Gaps = 24/235 (10%)
Query: 69  FTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNV 122
           F   LG+G FG V   ++ +TG L AVK+L+      ++ +    T  RI     +H  +
Sbjct: 27  FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
            QL        +   V E++  G L  H+  ++SR       + +   + +A  + +LH 
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISA--LMFLH- 141
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             D  I++ D+K  N+LLDH    K++DFG+ K      + V+ +   GT  YIAPE++ 
Sbjct: 142 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ 197
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWVYDQ 290
                 +   D +  G++L EM  G         +    A  + +  +P+W+++ 
Sbjct: 198 EMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLENS---KFSAEEFIN-EVSTIGRIHHVNVVQLLG 127
           LG G FG V+  + +  G   A+K+L+     +    E  N E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              +  +  ++ +Y+  G L    F    + Q          A      +EYLH+     
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I++ D+KP NILLD N   K++DFG AK+ P     +      GT  YIAPE++S     
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAPEVVSTKPYN 181
Query: 248 VSCKSDVYGFGMVLLEMAGG 267
            S   D + FG+++ EM  G
Sbjct: 182 KSI--DWWSFGILIYEMLAG 199

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 106 GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 159
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 160 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 215
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 216 RFTSASDVWMFGVCMWEI 233

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           ++G+G FG VYKG    T  ++A+K+++   ++   E+   E++ + +     + +  G 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             + +K  ++ EY+  GS    + P   +E+   ++  E L        +G++YLH+   
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL--------KGLDYLHSERK 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 241
           +   H DIK  N+LL      K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 138 I---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVI 188
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
            ++      K+D++  G+  +E+A G   NS+++  R
Sbjct: 189 KQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 75  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 128
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 184
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 185 RFTSASDVWMFGVCMWEI 202

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 80  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 133
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 134 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 189
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 190 RFTSASDVWMFGVCMWEI 207

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A G+ YL    D
Sbjct: 80  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAEGMNYLE---D 132
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 133 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 193 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 241
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 242 TID------VYMIMVKCWMIDADSRPKFRELI 267

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 83  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 136
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 137 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 192
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 193 RFTSASDVWMFGVCMWEI 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 81  GVITENPV-WIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESKR-- 134
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 135 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 190
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 191 RFTSASDVWMFGVCMWEI 208

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 103/200 (51%), Gaps = 12/200 (6%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK +  +  S E+    ++   ++  +     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ++  + L ++A+   + +E+LH+   + 
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 174
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR--NF 245
           ++H D+KP N+L++     K+ DFG++ +     D V+ +   G   Y+APE I+   N 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDSVAKTIDAGCKPYMAPERINPELNQ 231
Query: 246 GTVSCKSDVYGFGMVLLEMA 265
              S KSD++  G+ ++E+A
Sbjct: 232 KGYSVKSDIWSLGITMIELA 251

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L+ GG  +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +     +  E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     +G G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L+ GG  +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +     +  E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKMLENSKFSAEE-----FINEVSTIGRIH---HVN 121
           ++G+G +G V+K + L+ GG  +A+K +     + EE      I EV+ +  +    H N
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 122 VVQLLGFCS-----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           VV+L   C+       +K  LV+E++     D   +  +     +  E + ++     RG
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +++LH+     ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y 
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TLWYR 186
Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEM 264
           APE++ ++  + +   D++  G +  EM
Sbjct: 187 APEVLLQS--SYATPVDLWSVGCIFAEM 212

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK   K   +       GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAK-RVKGRTWTLC----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 198 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 246
Query: 304 EIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+  MI RK       C  + A  RP   +++
Sbjct: 247 TIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 72  KLGQGGFGSVY--KGQLQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 125
           KLG G +G V   K +L TG   A+K+++ S  +        ++EV+ + ++ H N+++L
Sbjct: 11  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             F  +     LV E    G L   +  ++   +      + +V  GT     YLH    
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT----YLHKHN- 124
Query: 186 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 125 --IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 179
Query: 243 RNFGTVSCKSDVYGFGMVL 261
           + +     K DV+  G++L
Sbjct: 180 KKYDE---KCDVWSCGVIL 195

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 28/275 (10%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAV-KMLENSKFSAEE---FINEVSTIGRIHHVNVVQLL 126
           + +G G +G   K + ++ G I V K L+    +  E    ++EV+ +  + H N+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
               + +   L  V EY   G L   +       Q L  E +  V       ++  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 185 D--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           D    +LH D+KP N+ LD     K+ DFGLA+    + DF       GT  Y++PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV--GTPYYMSPEQMN 189
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV-YDQLNKGGDLELQN 301
           R   + + KSD++  G +L E+                A  P +  + Q    G +    
Sbjct: 190 RM--SYNEKSDIWSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGK 232
Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              I    + +L  I    + +K   RPS+ ++LE
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           GLAK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 35/273 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 198 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 246
Query: 304 EIES-MIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+  MI RK       C  + A  RP   +++
Sbjct: 247 TIDVYMIMRK-------CWMIDADSRPKFRELI 272

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 65  MTNHFT-------HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE----EFINEVS 112
           +T HFT         LG+G FG+VY   + ++  ++A+K+L  S+   E    +   E+ 
Sbjct: 16  LTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIE 75
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
               +HH N+++L  +  +  +  L+ EY P G L + +     +  +   ++   +   
Sbjct: 76  IQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL----QKSCTFDEQRTATIMEE 131
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            A  + Y H      ++H DIKP N+LL      K++DFG +   P     +      GT
Sbjct: 132 LADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRKTMCGT 184
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           + Y+ PE+I         K D++  G++  E+  G
Sbjct: 185 LDYLPPEMIEGRMHNE--KVDLWCIGVLCYELLVG 217

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 20/200 (10%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT--IGYIAPELISRN 244
             +H DI   N+L+  N   K+ DFGL+++     D     A++G   I ++APE I  N
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPESI--N 185
Query: 245 FGTVSCKSDVYGFGMVLLEM 264
           F   +  SDV+ FG+ + E+
Sbjct: 186 FRRFTSASDVWMFGVCMWEI 205

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE  +    +     +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  H++             + +     AR + Y    C  C
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY------------HMGQAGFPEARAVFYAAEIC--C 297
Query: 188 ---------ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                    I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAP 354
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E++     T S   D +  G +L EM  G+
Sbjct: 355 EVVKNERYTFS--PDWWALGCLLYEMIAGQ 382

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 106/220 (48%), Gaps = 21/220 (9%)
Query: 61  QIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           + IA       ++G+G +G V+ G+ + G  +AVK+   ++ ++     E+     + H 
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHE 91
Query: 121 NVVQLLGFCSEGS----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           N++  +    +G+    +  L+ +Y  NGSL  ++     +  +L  + + ++A  +  G
Sbjct: 92  NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSG 146
Query: 177 IEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLA-KFHPKENDFVSISATR 230
           + +LH           I H D+K  NIL+  N    ++D GLA KF    N+      TR
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 231 -GTIGYIAPEL----ISRNFGTVSCKSDVYGFGMVLLEMA 265
            GT  Y+ PE+    ++RN       +D+Y FG++L E+A
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q++ TG + A K LE  +    +     +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    LV   M  G L  H++             + +     AR + Y    C  C
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIY------------HMGQAGFPEARAVFYAAEIC--C 297
Query: 188 ---------ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                    I++ D+KP NILLD +   ++SD GLA   P+     +I    GT+GY+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAP 354
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E++     T S   D +  G +L EM  G+
Sbjct: 355 EVVKNERYTFS--PDWWALGCLLYEMIAGQ 382

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG   +T  ++A+K+++   ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 124
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 175
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I ++      K+D++  G+  +E+A G 
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGE 201

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 567
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 568 RFTSASDVWMFGVCMWEI 585

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 72  KLGQGGFGSVY--KGQLQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQL 125
           KLG G +G V   K +L TG   A+K+++ S  +        ++EV+ + ++ H N+++L
Sbjct: 28  KLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             F  +     LV E    G L   +  ++   +      + +V  GT     YLH    
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT----YLHKHN- 141
Query: 186 VCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL+    + + K+ DFGL+           +    GT  YIAPE++ 
Sbjct: 142 --IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG---KMKERLGTAYYIAPEVLR 196
Query: 243 RNFGTVSCKSDVYGFGMVL 261
           + +     K DV+  G++L
Sbjct: 197 KKYDE---KCDVWSCGVIL 212

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG   +T  ++A+K+++   ++   E+   E++ + +     V +  G
Sbjct: 13  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+  
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 124
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 125 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEV 175
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I ++      K+D++  G+  +E+A G 
Sbjct: 176 IKQS--AYDSKADIWSLGITAIELARGE 201

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LGQG   +V++G+  +TG L A+K+  N  F    +  + E   + +++H N+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 130 SEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-HNGCDV 186
            E + R   L+ E+ P GSL   V  + S    L   +   V      G+ +L  NG   
Sbjct: 77  EETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 187 CILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
            I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  Y+ P++  
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHPDMYE 188
Query: 243 R 243
           R
Sbjct: 189 R 189

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 245 TID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 87  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 139
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 140 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 200 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 248
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 249 TID------VYMIMVKCWMIDADSRPKFRELI 274

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 203 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 251
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 252 TID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 29/208 (13%)
Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG   +T  ++A+K+++   ++   E+   E++ + +     V +  G
Sbjct: 33  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+  
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPEL 240
            +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+
Sbjct: 145 KI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 195
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I ++      K+D++  G+  +E+A G 
Sbjct: 196 IKQS--AYDSKADIWSLGITAIELARGE 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 85  LGICLTSTVQ-LIMQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 137
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 138 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 198 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 246
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 247 TID------VYMIMVKCWMIDADSRPKFRELI 272

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 29/207 (14%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G FG V+KG   +T  ++A+K+++   ++   E+   E++ + +     V +  G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFP---KESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+   
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEKK 140
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLA----KFHPKENDFVSISATRGTIGYIAPELI 241
           +   H DIK  N+LL  +   K++DFG+A        K N FV      GT  ++APE+I
Sbjct: 141 I---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV------GTPFWMAPEVI 191
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++      K+D++  G+  +E+A G 
Sbjct: 192 KQS--AYDSKADIWSLGITAIELARGE 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 135
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 196 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 244
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 245 TID------VYMIMVKCWMIDADSRPKFRELI 270

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 101/200 (50%), Gaps = 12/200 (6%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK +  +  S E+    ++   ++  +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ++  + L ++A+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LS 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+KP N+L++     K+ DFG++ +     D V+     G   Y+APE I+     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 248 --VSCKSDVYGFGMVLLEMA 265
              S KSD++  G+ ++E+A
Sbjct: 188 KGYSVKSDIWSLGITMIELA 207

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           L  G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 203 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 251
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 252 TID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 24/235 (10%)
Query: 42  IEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVKML 97
           +++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K+L
Sbjct: 1   VKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL 60
Query: 98  ENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFP 153
           +  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+  
Sbjct: 61  DKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-- 118
Query: 154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
              R            A       EYLH+   + +++ D+KP N+L+D     +V+DFG 
Sbjct: 119 --RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGF 173
Query: 214 AKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           AK   K   +       GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 174 AK-RVKGRTWTLC----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVK--MLENSKFSAEEFINEVSTIGRIHHVNVVQLL-GF 128
           LG+GGFG V++ + +      A+K   L N + + E+ + EV  + ++ H  +V+    +
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 129 CSEGSKRAL------VYEYMPNGSLDRHVFPK--------ESRGQSLCWEKLHEVALGTA 174
             + +   L      VY Y+      +             E R +S+C   LH + L  A
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC---LH-IFLQIA 128
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND----------FV 224
             +E+LH+     ++H D+KP NI    + + KV DFGL     ++ +          + 
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
             +   GT  Y++PE I  N  + S K D++  G++L E+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 33/272 (12%)
Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLE--NSKFSAEEFINEVSTIGRIHHVNVVQL 125
           LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           LG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL    D
Sbjct: 90  LGICLTSTVQ-LITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE---D 142
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             ++H D+   N+L+      K++DFG AK    E         +  I ++A E I    
Sbjct: 143 RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
            T   +SDV+ +G+ + E+   G +    + A+  S           L KG  L    + 
Sbjct: 203 YT--HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------LEKGERLPQPPIC 251
Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            I+      + MI + C  + A  RP   +++
Sbjct: 252 TID------VYMIMVKCWMIDADSRPKFRELI 277

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 28/275 (10%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAV-KMLENSKFSAEE---FINEVSTIGRIHHVNVVQLL 126
           + +G G +G   K + ++ G I V K L+    +  E    ++EV+ +  + H N+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
               + +   L  V EY   G L   +       Q L  E +  V       ++  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 185 D--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           D    +LH D+KP N+ LD     K+ DFGLA+    +  F    A  GT  Y++PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPEQMN 189
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV-YDQLNKGGDLELQN 301
           R   + + KSD++  G +L E+                A  P +  + Q    G +    
Sbjct: 190 RM--SYNEKSDIWSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGK 232
Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              I    + +L  I    + +K   RPS+ ++LE
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 180
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 71  HKLGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLL 126
            K+G+G FG ++     + G    +K +  S+ S+   EE   EV+ +  + H N+VQ  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
               E     +V +Y   G L + +     +G     +++ +  +     ++++H   D 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DR 144
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS-ATRGTIGYIAPELISRNF 245
            ILH DIK  NI L  +   ++ DFG+A+     N  V ++ A  GT  Y++PE+     
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENK- 200
Query: 246 GTVSCKSDVYGFGMVLLEM 264
              + KSD++  G VL E+
Sbjct: 201 -PYNNKSDIWALGCVLYEL 218

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKF 102
           N+ +W +PK Y  P         TH +G G +GSV      ++G  +A+K L     S+ 
Sbjct: 34  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 83
Query: 103 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY---MPNGSLDRHVFPKESRGQ 159
            A+    E+  +  + H NV+ LL   +  S     Y++   MP    D     ++  G 
Sbjct: 84  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGM 139
Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
               EK+  +     +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 196
Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E     ++    T  Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 197 E-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +   Q TG  +A+K    E S  + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHVFPKESRGQSLCWEK---LHEVALGTAR 175
                    K A      L  EY   G L +++    ++ ++ C  K   +  +    + 
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISS 132
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISAT 229
            + YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV     
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 184
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 286
            GT+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 185 -GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 227

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL-LGXKY 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S   D++  G +  EM   R
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRR 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 102/237 (43%), Gaps = 44/237 (18%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +   Q TG  +A+K    E S  + E +  E+  + +++H NVV 
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHVFPKESRGQSLCWEK---LHEVALGTAR 175
                    K A      L  EY   G L +++    ++ ++ C  K   +  +    + 
Sbjct: 78  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISS 133
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE---NDFVSISAT 229
            + YLH      I+H D+KP NI+L       I K+ D G AK   +     +FV     
Sbjct: 134 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 185
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 286
            GT+ Y+APEL+ +   TV+   D + FG +  E   G R            + P+W
Sbjct: 186 -GTLQYLAPELLEQKKYTVTV--DYWSFGTLAFECITGFR-----------PFLPNW 228

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 176
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 179
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 24/236 (10%)
Query: 41  NIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVKM 96
           ++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 97  LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R            A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 227

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 17  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 77  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 182
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 71  HKLGQGGFGSVYKGQLQTGGLIAV-KMLENSKFSAEE---FINEVSTIGRIHHVNVVQLL 126
           + +G G +G   K + ++ G I V K L+    +  E    ++EV+ +  + H N+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 127 GFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
               + +   L  V EY   G L   +       Q L  E +  V       ++  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 185 D--VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
           D    +LH D+KP N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMN 189
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV-YDQLNKGGDLELQN 301
           R   + + KSD++  G +L E+                A  P +  + Q    G +    
Sbjct: 190 RM--SYNEKSDIWSLGCLLYELC---------------ALMPPFTAFSQKELAGKIREGK 232
Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              I    + +L  I    + +K   RPS+ ++LE
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEHVHQ---DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 24/236 (10%)
Query: 41  NIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVKM 96
           ++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K+
Sbjct: 7   DVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKI 66
Query: 97  LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+ 
Sbjct: 67  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL- 125
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R            A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 126 ---RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG 179
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 180 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 227

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE----EFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q   ++A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 128 FCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +  +  +  L+ E+ P G L     +H    E R  +   E         A  + Y H  
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 131
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 186
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
              T   K D++  G++  E   G
Sbjct: 187 K--THDEKVDLWCAGVLCYEFLVG 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 78  GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 131
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 132 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 187
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 188 RFTSASDVWMFGVCMWEI 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI- 117
           P++      +   LG+G FG V    +  TG   A+K+L      A++ +    T  R+ 
Sbjct: 5   PKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 64
Query: 118 ---HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
               H  +  L        +   V EY   G L  H+    SR +    E+         
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIV 120
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
             +EYLH+     +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  
Sbjct: 121 SALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPE 175
Query: 235 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 176 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 174
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 175 --LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 31/229 (13%)
Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKF 102
           N+ +W +PK Y  P         TH +G G +GSV      ++G  +A+K L     S+ 
Sbjct: 16  NKTAWELPKTYVSP---------TH-VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 103 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY---MPNGSLDRHVFPKESRGQ 159
            A+    E+  +  + H NV+ LL   +  S     Y++   MP    D     ++  G 
Sbjct: 66  FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL----QKIMGL 121
Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
               EK+  +     +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E     ++    T  Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 179 E-----MTGYVVTRWYRAPEVI-LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMK 93
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+P G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL 153
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQDLKD---FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 175
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 176 --LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE----EFINEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY   + Q   ++A+K+L  S+   E    +   E+     + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 128 FCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
           +  +  +  L+ E+ P G L     +H    E R  +   E         A  + Y H  
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH-- 132
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  ++H DIKP N+L+ +    K++DFG +   P     +      GT+ Y+ PE+I  
Sbjct: 133 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 187
Query: 244 NFGTVSCKSDVYGFGMVLLEMAGG 267
              T   K D++  G++  E   G
Sbjct: 188 K--THDEKVDLWCAGVLCYEFLVG 209

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   + +L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     KV+DF
Sbjct: 134 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K + + T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L   +  ++   +      + +V      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 14  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 74  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 127
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 179
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 180 --LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G  Q G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++     +  +L       + L  A G+ +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 11  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 71  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 124
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 176
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 177 --LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLQTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   +  ++   +      + +V      GI Y+H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNK-- 146
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 200
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 201 H---GTYDEKCDVWSTGVILYILLSG 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 43/284 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGFC 129
           +G+G FG VY G+    G +A+++++  + + ++   F  EV    +  H NVV  +G C
Sbjct: 41  IGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE--KLHEVALGTARGIEYLHNGCDVC 187
                 A++       +L   V     R   +  +  K  ++A    +G+ YLH      
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVV-----RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP-----KENDFVSISATRGTIGYIAPELIS 242
           ILH D+K  N+  D+  +  ++DFGL          +  D + I    G + ++APE+I 
Sbjct: 151 ILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQ--NGWLCHLAPEIIR 207
Query: 243 R-------NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 295
           +       +    S  SDV+  G +  E+     ++     ++  A    W   Q+  G 
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYEL-----HAREWPFKTQPAEAIIW---QMGTGM 259
Query: 296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              L  +      + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 260 KPNLSQIG-----MGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 12  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 72  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 177
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 178 --LGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G  Q G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENI---LGF 96
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++     +  +L       + L  A G+ +LH
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 151
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 211
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 212 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 37/216 (17%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V++G  Q G  +AVK+     E S F   E  N V     + H N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENI---LGF 67
Query: 129 CSE-------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
            +         ++  L+  Y   GSL  ++     +  +L       + L  A G+ +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122
Query: 182 -----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI--SATRGTIG 234
                      I H D+K  NIL+  N    ++D GLA  H +  + + +  +   GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 235 YIAPELISRNFGTVSC-----KSDVYGFGMVLLEMA 265
           Y+APE++      V C     + D++ FG+VL E+A
Sbjct: 183 YMAPEVLDETI-QVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +    +TG   AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   +  +   G                  + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KP N+LL    N  P K+ DFG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 132 G----------SKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
                       K++ ++   EY  NG+L   +  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 226
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 281
           ++  GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 128
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 187 RA---VDWWGLGVVMYEMMCGR 205

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 63  IAMTNHFTHKL-GQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           + M +   H++ G+GGFG VY   +  TG + A+K L+  +   ++        G    +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLAL 237
Query: 121 NVVQLLGFCSEGS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
           N   +L   S G                K + + + M  G L  H+    S+        
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAD 293
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           +   A     G+E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           +    GT GY+APE++ +     S  +D +  G +L ++  G      + T+  
Sbjct: 351 V----GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 63  IAMTNHFTHKL-GQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           + M +   H++ G+GGFG VY   +  TG + A+K L+  +   ++        G    +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLAL 237
Query: 121 NVVQLLGFCSEGS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
           N   +L   S G                K + + + M  G L  H+    S+        
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAD 293
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           +   A     G+E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           +    GT GY+APE++ +     S  +D +  G +L ++  G      + T+  
Sbjct: 351 V----GTHGYMAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 73  LGQGGFG---SVYKGQLQTGGLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQL 125
           +G+G +G   S Y    +T   +A+K +  S F  + +    + E+  + R  H NV+ +
Sbjct: 51  IGEGAYGMVSSAYDHVRKTR--VAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGI 106
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                  +  A+   Y+    ++  ++ K  + Q L  + +        RG++Y+H+   
Sbjct: 107 RDILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRN 244
             +LH D+KP N+L++     K+ DFGLA+    E+D    ++    T  Y APE++  +
Sbjct: 165 --VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLN 292
            G      D++  G +L EM             S++  FP   Y DQLN
Sbjct: 223 KGYTK-SIDIWSVGCILAEML------------SNRPIFPGKHYLDQLN 258

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 63  IAMTNHFTHKL-GQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           + M +   H++ G+GGFG VY   +  TG + A+K L+  +   ++        G    +
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLAL 236
Query: 121 NVVQLLGFCSEGS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
           N   +L   S G                K + + + M  G L  H+    S+        
Sbjct: 237 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAD 292
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           +   A     G+E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S
Sbjct: 293 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 349
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           +    GT GY+APE++ +     S  +D +  G +L ++  G      + T+  
Sbjct: 350 V----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + +  G    L  +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 10  KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 70  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 123
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 175
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 72  KLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + +  G    L  +++   ++      I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 69  VIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 122
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         + +    T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL------ 174
Query: 248 VSCK-----SDVYGFGMVLLEMAGGR 268
           + CK      D++  G +  EM   R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHF--THKLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      +TG   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE      ++   +V+L     + S   +V EY P G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     KV+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 73  LGQGGFGSVYKGQLQT----GGLIAVKMLEN--SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G+G FG V++G   +       +A+K  +N  S    E+F+ E  T+ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G  +E     ++ E    G L   +   + R  SL    L   A   +  + YL +    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H DI   N+L+      K+ DFGL+++  +++ +   S  +  I ++APE I  NF 
Sbjct: 512 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI--NFR 567
Query: 247 TVSCKSDVYGFGMVLLEM 264
             +  SDV+ FG+ + E+
Sbjct: 568 RFTSASDVWMFGVCMWEI 585

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 72  KLGQGGFGSVYKGQLQ-TGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK + + TG ++A+K +     ++      I E+S +  ++H N+V+LL 
Sbjct: 13  KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++     D   F   S    +    +        +G+ + H+     
Sbjct: 73  VIHTENKLYLVFEHVDQ---DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--- 126
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRNF 245
           +LH D+KP N+L++     K++DFGLA+    P       +     T+ Y APE++    
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV----TLWYRAPEIL---- 178
Query: 246 GTVSCK-----SDVYGFGMVLLEMAGGR 268
             + CK      D++  G +  EM   R
Sbjct: 179 --LGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 63  IAMTNHFTHKL-GQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           + M +   H++ G+GGFG VY   +  TG + A+K L+  +   ++        G    +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ--------GETLAL 237
Query: 121 NVVQLLGFCSEGS---------------KRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
           N   +L   S G                K + + + M  G L  H+    S+        
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAD 293
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           +   A     G+E++HN     +++ D+KP NILLD +   ++SD GLA    K+    S
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 350
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           +    GT GY+APE++ +     S  +D +  G +L ++  G      + T+  
Sbjct: 351 V----GTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLQTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 40  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   +  ++   +      + +V      GI Y+H     
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNK-- 152
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 153 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 206
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 207 H---GTYDEKCDVWSTGVILYILLSG 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 104/264 (39%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 147 --------------------------LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                                     ++    P++     L  E L   +   A+G+E+L
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 210 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 266
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 267 IFDRVYTI--QSDVWSFGVLLWEI 288

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K + + T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L   +  ++   +      + +V      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLGF 128
           LG+G FG V K + + T    AVK++  +    ++    + EV  + ++ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
             + S   +V E    G L   +  ++   +      + +V      GI Y+H      I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF----SGITYMHKHN---I 142
Query: 189 LHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           +H D+KP NILL   + +   K+ DFGL+    +      +    GT  YIAPE++    
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLR--- 196
Query: 246 GTVSCKSDVYGFGMVLLEMAGG 267
           GT   K DV+  G++L  +  G
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 104/264 (39%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 154
Query: 147 --------------------------LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                                     ++    P++     L  E L   +   A+G+E+L
Sbjct: 155 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 214
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 215 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 271
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 272 IFDRVYTI--QSDVWSFGVLLWEI 293

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 104/264 (39%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 147
Query: 147 --------------------------LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                                     ++    P++     L  E L   +   A+G+E+L
Sbjct: 148 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 207
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 208 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 264
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 265 IFDRVYTI--QSDVWSFGVLLWEI 286

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L      A++ +    T  R+     H  +  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    E+           +EYLH+     
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
           +++ DIK  N++LD +   K++DFGL K     +D  ++    GT  Y+APE++  N +G
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 184 RA---VDWWGLGVVMYEMMCGR 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLQTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 57  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   +  ++   +      + +V      GI Y+H     
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNK-- 169
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 170 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 223
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 224 ---HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 104/264 (39%), Gaps = 77/264 (29%)
Query: 73  LGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAEE--FINEVSTIGRI-HHVNVV 123
           LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I HH+NVV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 QLLG--------------FCSEG-------SKRALVYEYMPNGS---------------- 146
            LLG              FC  G       SKR     Y   G+                
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 156
Query: 147 --------------------------LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                                     ++    P++     L  E L   +   A+G+E+L
Sbjct: 157 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 216
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                 CI H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE 
Sbjct: 217 --ASRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET 273
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEM 264
           I     T+  +SDV+ FG++L E+
Sbjct: 274 IFDRVYTI--QSDVWSFGVLLWEI 295

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           ++YLH+  +V 
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 270
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 271 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 328 RA---VDWWGLGVVMYEMMCGR 346

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 73  LGQGGFGSVY--KGQLQTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK++       K   E  + EV  + ++ H N+++L 
Sbjct: 58  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   +  ++   +      + +V      GI Y+H     
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYMHKNK-- 170
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            I+H D+KP N+LL     D N   ++ DFGL+           +    GT  YIAPE++
Sbjct: 171 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVL 224
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
               GT   K DV+  G++L  +  G
Sbjct: 225 ---HGTYDEKCDVWSTGVILYILLSG 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G FG V       TG  +A+K++ N K  A+  +      E+S +  + H ++++L 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D ++  ++   +        ++       +EY H     
Sbjct: 81  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 133
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS    
Sbjct: 134 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL- 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRR 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G FG V       TG  +A+K++ N K  A+  +      E+S +  + H ++++L 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D ++  ++   +        ++       +EY H     
Sbjct: 71  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 123
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS    
Sbjct: 124 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL- 178
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRR 200

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G FG V       TG  +A+K++ N K  A+  +      E+S +  + H ++++L 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D ++  ++   +        ++       +EY H     
Sbjct: 80  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 132
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+      N F+  S   G+  Y APE+IS    
Sbjct: 133 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLKTSC--GSPNYAAPEVISGKL- 187
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRR 209

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           ++YLH+  +V 
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 273
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 274 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPEVLEDNDYG 330
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 331 RA---VDWWGLGVVMYEMMCGR 349

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 22/157 (14%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIH-HVNV 122
              KLG+G +G V+K    +TG ++AVK +    +NS   A+    E+  +  +  H N+
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST-DAQRTFREIMILTELSGHENI 71
Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE--VALGTARGIE 178
           V LL      + R   LV++YM     D H   + +       E +H+  V     + I+
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRAN-----ILEPVHKQYVVYQLIKVIK 123
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
           YLH+G    +LH D+KP NILL+     KV+DFGL++
Sbjct: 124 YLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 17/215 (7%)
Query: 60  PQIIAMTNHFTHKLGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI- 117
           P++      +   LG+G FG V    +  TG   A+K+L+     A++ +    T  R+ 
Sbjct: 5   PRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL 64
Query: 118 ---HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
               H  +  L        +   V EY   G L  H+    SR +    ++         
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIV 120
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
             ++YLH+  +V  ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  
Sbjct: 121 SALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPE 176
Query: 235 YIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGR 268
           Y+APE++  N +G      D +G G+V+ EM  GR
Sbjct: 177 YLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGR 208

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 73  LGQGGFGSVYKGQ----LQTGGLIAVKMLE------NSKFSAEEFINEVSTIGRIHHVNV 122
           LG+GG+G V++ +      TG + A+K+L+      N+K +A     E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----QSLCWEKLHEVALGTARGIE 178
           V L+     G K  L+ EY+  G L   +   E  G     + C+  L E+++     + 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACF-YLAEISMA----LG 135
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           +LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+AP
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAP 190
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++ R+    +   D +  G ++ +M  G
Sbjct: 191 EILMRSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V     ++TG   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G FG V       TG  +A+K++ N K  A+  +      E+S +  + H ++++L 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKII-NKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +V EY  N   D ++  ++   +        ++       +EY H     
Sbjct: 75  DVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQII----SAVEYCHRHK-- 127
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y APE+IS    
Sbjct: 128 -IVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSC--GSPNYAAPEVISGKL- 182
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
               + DV+  G++L  M   R
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRR 204

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 72  KLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLG 127
           KLG G +G V   + +   +  A+K++  +  S     + + EV+ +  + H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA-----RGIEYLHN 182
           F  +     LV E    G L   +  +          K +EV           G+ YLH 
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHK 154
Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
                I+H D+KP N+LL   + + + K+ DFGL+     +     +    GT  YIAPE
Sbjct: 155 HN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE 208
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++ + +     K DV+  G++L  +  G
Sbjct: 209 VLRKKYDE---KCDVWSIGVILFILLAG 233

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 30/209 (14%)
Query: 73  LGQGGFGSVYKGQ----LQTGGLIAVKMLE------NSKFSAEEFINEVSTIGRIHHVNV 122
           LG+GG+G V++ +      TG + A+K+L+      N+K +A     E + +  + H  +
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG----QSLCWEKLHEVALGTARGIE 178
           V L+     G K  L+ EY+  G L   +   E  G     + C+  L E+++     + 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACF-YLAEISMA----LG 135
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           +LH      I++ D+KP NI+L+H    K++DFGL K     +D        GTI Y+AP
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAP 190
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++ R+    +   D +  G ++ +M  G
Sbjct: 191 EILMRSGHNRAV--DWWSLGALMYDMLTG 217

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHV 120
           H    +GQG +G V    + QT  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DR-HVFPKESRGQSL----------CWEKLHE 168
           N+ +L     +     LV E    G L D+ +VF  +S G+            C E   E
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 169 VALGTARG------------------------IEYLHNGCDVCILHFDIKPHNILLDHN- 203
              G+  G                        + YLHN     I H DIKP N L   N 
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNK 205
Query: 204 -FIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMV 260
            F  K+ DFGL+K   K N  ++  ++   GT  ++APE+++    +   K D +  G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 261 L 261
           L
Sbjct: 266 L 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 105/243 (43%), Gaps = 23/243 (9%)
Query: 31  SRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTG 89
           SR  + KT DN    L  +    P  Y Y + +    H   +LG+G FG V++ +  QTG
Sbjct: 43  SREPSPKTEDNEGVLLTEKLK--PVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTG 99
Query: 90  GLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
              AVK +    F AEE +        +    +V L G   EG    +  E +  GSL +
Sbjct: 100 FQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 150 HVFPKESRGQSLCWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PK 207
            V     + Q    E      LG A  G+EYLH+     ILH D+K  N+LL  +     
Sbjct: 156 LV-----KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAA 207
Query: 208 VSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFG A    P     D ++     GT  ++APE++     +   K DV+    ++L M
Sbjct: 208 LCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 265
Query: 265 AGG 267
             G
Sbjct: 266 LNG 268

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +  +TG  +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  +V  K          ++  V     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLL 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 25/208 (12%)
Query: 74  GQGGFGSVYKGQLQTGGL-IAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF--- 128
           GQG FG+V  G+ ++ G+ +A+K ++++ +F   E +  +  +  +HH N+VQL  +   
Sbjct: 32  GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFYT 90
Query: 129 CSEGSKRAL----VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NG 183
             E  +R +    V EY+P+ +L R       R  +     +        R I  LH   
Sbjct: 91  LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS 149
Query: 184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI 241
            +VC  H DIKPHN+L++  +   K+ DFG A K  P E +   I +      Y APELI
Sbjct: 150 VNVC--HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY----YRAPELI 203
Query: 242 SRNFGT--VSCKSDVYGFGMVLLEMAGG 267
              FG    +   D++  G +  EM  G
Sbjct: 204 ---FGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 93  AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           AVK+++ SK    E I  +   G+  H N++ L     +G    LV E M  G L   + 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KV 208
            ++   +      LH +     + +EYLH+     ++H D+KP NIL +D +  P   ++
Sbjct: 114 RQKFFSEREASFVLHTIG----KTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRI 166
Query: 209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 167 CDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           ++YLH+  +V 
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 130
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 131 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 187
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 188 RA---VDWWGLGVVMYEMMCGR 206

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 93  AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           AVK+++ SK    E I  +   G+  H N++ L     +G    LV E M  G L   + 
Sbjct: 56  AVKVIDKSKRDPSEEIEILLRYGQ--HPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL 113
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KV 208
            ++   +      LH +     + +EYLH+     ++H D+KP NIL +D +  P   ++
Sbjct: 114 RQKFFSEREASFVLHTIG----KTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRI 166
Query: 209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            DFG AK    EN  +       T  ++APE++ R      C  D++  G++L  M  G
Sbjct: 167 CDFGFAKQLRAENGLLMTPCY--TANFVAPEVLKRQGYDEGC--DIWSLGILLYTMLAG 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 73  LGQGGFGSV-YKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLLG 127
           LG+G FG V    +  TG   A+K+L+     A++ +    T  R+     H  +  L  
Sbjct: 17  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 76
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 +   V EY   G L  H+    SR +    ++           ++YLH+  +V 
Sbjct: 77  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSEKNV- 131
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN-FG 246
            ++ D+K  N++LD +   K++DFGL K   K  D  ++    GT  Y+APE++  N +G
Sbjct: 132 -VYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D +G G+V+ EM  GR
Sbjct: 189 RA---VDWWGLGVVMYEMMCGR 207

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +  +TG  +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 80
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  +V  K +  +      +  V     
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IKRVMQMLL 134
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 191
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +  +TG  +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  +V  K +  +      +  V     
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE------IKRVMQMLL 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 93  AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           AVK+++ SK    E I  +   G+  H N++ L     +G    +V E M  G L     
Sbjct: 51  AVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELMKGGEL----L 104
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KV 208
            K  R +     +   V     + +EYLH      ++H D+KP NIL +D +  P   ++
Sbjct: 105 DKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRI 161
Query: 209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            DFG AK    EN  +       T  ++APE++ R     +C  D++  G++L  M  G
Sbjct: 162 CDFGFAKQLRAENGLLMTPCY--TANFVAPEVLERQGYDAAC--DIWSLGVLLYTMLTG 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        ++     GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLA-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 36/214 (16%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
           K+GQG FG V+K +  +TG  +A+K  ++EN K   E F    + E+  +  + H NVV 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK---EGFPITALREIKILQLLKHENVVN 81
Query: 125 LLGFCSEGSKRA--------LVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
           L+  C   +           LV+++  +    L  +V  K +  +      +  V     
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IKRVMQMLL 135
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATR-GT 232
            G+ Y+H      ILH D+K  N+L+  + + K++DFGLA+ F   +N   +    R  T
Sbjct: 136 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 233 IGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
           + Y  PEL+   R++G      D++G G ++ EM
Sbjct: 193 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEM 223

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 73  LGQGGFGSVY--KGQLQTGGLIAVKMLEN----SKFSAEEFINEVSTIGRIHHVNVVQLL 126
           LG+G FG V   K ++ TG   AVK++       K   E  + EV  + ++ H N+ +L 
Sbjct: 34  LGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F  +     LV E    G L   +  ++   +      + +V      GI Y H     
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL----SGITYXHKNK-- 146
Query: 187 CILHFDIKPHNILL-----DHNFIPKVSDFGLA---KFHPKENDFVSISATRGTIGYIAP 238
            I+H D+KP N+LL     D N   ++ DFGL+   +   K  D +      GT  YIAP
Sbjct: 147 -IVHRDLKPENLLLESKSKDANI--RIIDFGLSTHFEASKKXKDKI------GTAYYIAP 197
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           E++    GT   K DV+  G++L  +  G
Sbjct: 198 EVL---HGTYDEKCDVWSTGVILYILLSG 223

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)
Query: 73  LGQGGFGSVY-----KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQL 125
           LG G +G V+      G   TG L A+K+L+ +    +    E +   R  + H+     
Sbjct: 62  LGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 126 L-----GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           L      F +E +K  L+ +Y+  G L  H+  +E   +      + E+ L     +E+L
Sbjct: 121 LVTLHYAFQTE-TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA----LEHL 175
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTIGY 235
           H    + I++ DIK  NILLD N    ++DFGL+K      +FV+    R     GTI Y
Sbjct: 176 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK------EFVADETERAYDFCGTIEY 226
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 281
           +AP+++           D +  G+++ E+  G     ++  ++S+A
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 272

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 262
           ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A+K++   KF+      A+  +N  
Sbjct: 3   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 62
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 122 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 262
           ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 174 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 262
           ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A+K++   KF+      A+  +N  
Sbjct: 4   YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 123 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 262
           ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 175 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 129 CSEGSKRALVYEYMPNGS----LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
                   LV EY   G     L  H + KE   ++    K  ++       ++Y H   
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARA----KFRQIV----SAVQYCHQKF 126
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELI 241
              I+H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL 
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELF 177
Query: 242 S-RNFGTVSCKSDVYGFGMVLLEMAGG 267
             + +     + DV+  G++L  +  G
Sbjct: 178 QGKKYD--GPEVDVWSLGVILYTLVSG 202

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMAGFVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G+V+K +  +T  ++A+K +   ++ +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  K  LV+E+  +  L ++    +S    L  E +        +G+ + H+    
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++ N   K++DFGLA+    P        SA   T+ Y  P+++   
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR----CYSAEVVTLWYRPPDVL--- 173
Query: 245 FGT--VSCKSDVYGFGMVLLEMAGGRR 269
           FG    S   D++  G +  E+A   R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 45/241 (18%)
Query: 71  HK-LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVV 123
           HK LG+G FG V+  + + T    A+K L+      ++ +       R+      H  + 
Sbjct: 23  HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 82
Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR---GIE 178
            +  FC+  +K  L  V EY+  G L  H+       QS     L       A    G++
Sbjct: 83  HM--FCTFQTKENLFFVMEYLNGGDLMYHI-------QSCHKFDLSRATFYAAEIILGLQ 133
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATRGTIG 234
           +LH+     I++ D+K  NILLD +   K++DFG+ K +     K N+F       GT  
Sbjct: 134 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC------GTPD 184
Query: 235 YIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSW 286
           YIAPE++    G     S D + FG++L EM  G+            ++ R    ++P W
Sbjct: 185 YIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 241
Query: 287 V 287
           +
Sbjct: 242 L 242

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKF 102
           N+  W +P+RY   Q +A        +G G +GSV      +TG  +AVK L     S  
Sbjct: 24  NKTIWEVPERY---QNLA-------PVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 103 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKE----SRG 158
            A+    E+  +  + H NV+ LL   +    R+L  E   +  L  H+   +     + 
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPA--RSL--EEFNDVYLVTHLMGADLNNIVKC 129
Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           Q L  + +  +     RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+   
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-- 184
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            +++     ATR    Y APE I  N+   +   D++  G ++ E+  GR
Sbjct: 185 TDDEMTGYVATR---WYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A+K++   KF+      A+  +N  
Sbjct: 10  YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 69
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 129 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLL 262
           ++    GT  Y+APE L+S      +   D +  G++L 
Sbjct: 181 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 104/243 (42%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 132 G----------SKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
                       K++ ++   EY  N +L   +  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 226
           Y+H+     I+H D+KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 281
           ++  GT  Y+A E++    G  + K D+Y  G++  EM      G  R + +   RS   
Sbjct: 188 TSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK               GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRT-----WXLXGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV     ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 55  KRYSYPQIIAMT-----NHFT--HKLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEE 106
           K+Y YPQ + +      +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 35  KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 93
Query: 107 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
            +  E+ T+  + H  +V L     + ++  ++YE+M  G L   V  + ++   +  ++
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDE 150
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKEND 222
             E      +G+ ++H       +H D+KP NI+     +   K+ DFGL A   PK+  
Sbjct: 151 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 205
Query: 223 FVSISATRGTIGYIAPEL 240
             S+  T GT  + APE+
Sbjct: 206 --SVKVTTGTAEFAAPEV 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 23/198 (11%)
Query: 55  KRYSYPQIIAMT-----NHFT--HKLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEE 106
           K+Y YPQ + +      +H+    +LG G FG V++  +  TG   A K +     S +E
Sbjct: 141 KQY-YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE 199
Query: 107 FI-NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK 165
            +  E+ T+  + H  +V L     + ++  ++YE+M  G L   V  + ++   +  ++
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDE 256
Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGL-AKFHPKEND 222
             E      +G+ ++H       +H D+KP NI+     +   K+ DFGL A   PK+  
Sbjct: 257 AVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311
Query: 223 FVSISATRGTIGYIAPEL 240
             S+  T GT  + APE+
Sbjct: 312 --SVKVTTGTAEFAAPEV 327

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   L+ EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---I 135
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     + A  G   Y APEL   + 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 190 YD--GPEVDVWSLGVILYTLVSG 210

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AV++++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +    F  K ++F       G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC------GSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 14  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 73
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 74  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 133
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 134 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 186
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 187 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK         +     GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKG-----ATWTLCGTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 89  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 144
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 145 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 195
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 196 WMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 207
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGXVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AV++++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKF---I 134
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDTFCGSPPYAAPELFQGKK 188
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 189 YD--GPEVDVWSLGVILYTLVSG 209

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 215
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 95  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 150
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 151 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 201
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 202 WMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 108/249 (43%), Gaps = 45/249 (18%)
Query: 63  IAMTNHFTHK-LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI--- 117
           + + +   HK LG+G FG V+  + + T    A+K L+      ++ +       R+   
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 118 --HHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT 173
              H  +  +  FC+  +K  L  V EY+  G L  H+       QS     L       
Sbjct: 74  AWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHI-------QSCHKFDLSRATFYA 124
Query: 174 AR---GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSI 226
           A    G+++LH+     I++ D+K  NILLD +   K++DFG+ K +     K N F   
Sbjct: 125 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-- 179
Query: 227 SATRGTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGR-------RNSNMNATRS 278
               GT  YIAPE++    G     S D + FG++L EM  G+            ++ R 
Sbjct: 180 ----GTPDYIAPEIL---LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
Query: 279 SKAYFPSWV 287
              ++P W+
Sbjct: 233 DNPFYPRWL 241

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +AVK+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   LV EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIV----SAVQYCHQKY---I 135
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 136 VHRDLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELFQGKK 189
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 190 YD--GPEVDVWSLGVILYTLVSG 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +G+V      +TG  +A+K L     S+  A+    E+  +  + H NV+ LL  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 129 ------CSEGSKRALVYEYMPN--GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                   + +   LV  +M    G L +H    E R Q L ++ L        +G+ Y+
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML--------KGLRYI 144
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H      I+H D+KP N+ ++ +   K+ DFGLA+    +++      TR    Y APE+
Sbjct: 145 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVVTR---WYRAPEV 196
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           I  N+   +   D++  G ++ EM  G+
Sbjct: 197 IL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 87  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 142
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 143 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 193
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 194 WMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 8   ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 67
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 68  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 127
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 128 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 180
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 181 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVSTIGR-IHHVNVVQLLG 127
           +LG+G +G V K + + +G + AVK +  +  S E+   + ++    R +     V   G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 128 -FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
               EG     +   + + SLD+       +GQ++  + L ++A+   + +E+LH+   +
Sbjct: 101 ALFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--L 156
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            ++H D+KP N+L++     K  DFG++ +     D V+     G   Y APE I+    
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYL---VDDVAKDIDAGCKPYXAPERINPELN 213
Query: 247 T--VSCKSDVYGFGMVLLEMA 265
               S KSD++  G+  +E+A
Sbjct: 214 QKGYSVKSDIWSLGITXIELA 234

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 88  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 143
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 144 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 194
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 219
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKF 102
           N+  W +P+RY   Q ++        +G G +GSV     +++G  IAVK L     S  
Sbjct: 43  NKTIWEVPERY---QTLS-------PVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSII 92
Query: 103 SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKE----SRG 158
            A+    E+  +  + H NV+ LL   +  +      E   +  L  H+   +     + 
Sbjct: 93  HAKRTYRELRLLKHMKHENVIGLLDVFTPATS----LEEFNDVYLVTHLMGADLNNIVKC 148
Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           Q L  + +  +     RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+   
Sbjct: 149 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-- 203
Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            +++     ATR    Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 204 TDDEMTGYVATR---WYRAPEIM-LNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 34  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 93
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 94  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 153
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 154 ----RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 206
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 207 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 255

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 101 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 156
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 157 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 207
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 208 WMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 102 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 157
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 158 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 208
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 209 WMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGXVATR---WYRAPE-IMLN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 92  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 147
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 148 ---IIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 198
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 199 WMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A++++   KF+      A+  +N  
Sbjct: 143 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 202
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 262 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++    GT  Y+APE L+S      +   D +  G++L     G
Sbjct: 314 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 96  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 151
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 152 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 202
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 59  YPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS------AEEFIN-- 109
           YP+ +      +  LG G  G V    + +T   +A++++   KF+      A+  +N  
Sbjct: 129 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVE 188
Query: 110 -EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E+  + +++H  ++++  F  +     +V E M  G L   V   +   ++ C    ++
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 169 VALGTARGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFV 224
           + L     ++YLH NG    I+H D+KP N+LL   + + + K++DFG +K   + +   
Sbjct: 248 MLLA----VQYLHENG----IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 225 SISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++    GT  Y+APE L+S      +   D +  G++L     G
Sbjct: 300 TLC---GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 25/244 (10%)
Query: 35  TLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSV----YKGQLQTGG 90
            L+   NI+ FL N+   + K+    Q+ A        +G+G FG V    +K   +   
Sbjct: 46  ALRKNKNIDNFL-NRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYA 104
Query: 91  LIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMPNGSL-- 147
           +  +   E  K S   F  E   I    +   VVQL     +     +V EYMP G L  
Sbjct: 105 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 164
Query: 148 --DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI 205
               +  P++       W K +   +  A  ++ +H+   + ++H D+KP N+LLD +  
Sbjct: 165 LMSNYDVPEK-------WAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGH 212
Query: 206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT--VSCKSDVYGFGMVLLE 263
            K++DFG       E   V      GT  YI+PE++    G      + D +  G+ L E
Sbjct: 213 LKLADFGTC-MKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 271
Query: 264 MAGG 267
           M  G
Sbjct: 272 MLVG 275

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q++ TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  H++  +         +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 24/236 (10%)
Query: 41  NIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVKM 96
           ++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K+
Sbjct: 1   SVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKI 60
Query: 97  LENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+ 
Sbjct: 61  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL- 119
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R            A       EYLH+   + +++ D+KP N+L+D     +V+DFG
Sbjct: 120 ---RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFG 173
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            AK        +      GT  Y+APE+I S+ +       D +  G+++ EMA G
Sbjct: 174 FAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYEMAAG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 109 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 164
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 165 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 215
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 216 WMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCS 130
           LG+G F    K    ++    AVK++  SK        E++ +     H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILH 190
           +     LV E +  G L    F +  + +     +   +       + ++H   DV ++H
Sbjct: 77  DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVH 129
Query: 191 FDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            D+KP N+L    + N   K+ DFG A+  P +N    +     T+ Y APEL+++N   
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYD 187
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            SC  D++  G++L  M  G+
Sbjct: 188 ESC--DLWSLGVILYTMLSGQ 206

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q++ TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  H++  +         +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 110 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 165
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 166 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 216
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q++ TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  H++  +         +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 113 FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 168
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 169 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMXGYVATR---WYRAPE-IMLN 219
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q++ TG L A K L   +       +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   LV   M  G +  H++  +         +          G+E+LH      
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RN 309
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-------GTIGYIAPEL 240
           I++ D+KP N+LLD +   ++SD GLA         V + A +       GT G++APEL
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLA---------VELKAGQTKTKGYAGTPGFMAPEL 360
Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +       S   D +  G+ L EM   R
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAAR 386

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+++D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE +IS+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 97  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 152
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE I  N
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPE-IMLN 203
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +    +TG   AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   +  +   G                  + Y H   D
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 206
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 207 REPYGK---PVDVWGCGVILFILLSG 229

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNR 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V +    +TG   AVK+++ +KF      S E+   E S    + H ++V+L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           L   S      +V+E+M    L   +  +   G                  + Y H   D
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 150
Query: 186 VCILHFDIKPHNILL--DHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             I+H D+KPH +LL    N  P K+  FG+A     E+  V+     GT  ++APE++ 
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVA-GGRVGTPHFMAPEVVK 208
Query: 243 RN-FGTVSCKSDVYGFGMVLLEMAGG 267
           R  +G      DV+G G++L  +  G
Sbjct: 209 REPYGK---PVDVWGCGVILFILLSG 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 104/243 (42%), Gaps = 23/243 (9%)
Query: 31  SRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTG 89
           SR  + KT DN    L   +   P  Y Y + +    H   +LG+G FG V++ +  QTG
Sbjct: 62  SREPSPKTEDNEGVLL--TEKLKPVDYEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTG 118
Query: 90  GLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDR 149
              AVK +    F AEE +        +    +V L G   EG    +  E +  GSL +
Sbjct: 119 FQCAVKKVRLEVFRAEELM----ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 174
Query: 150 HVFPKESRGQSLCWEKLHEVALGTA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PK 207
            V     + Q    E      LG A  G+EYLH+     ILH D+K  N+LL  +     
Sbjct: 175 LV-----KEQGCLPEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAA 226
Query: 208 VSDFGLAK-FHPK--ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
           + DFG A    P       ++     GT  ++APE++     +   K DV+    ++L M
Sbjct: 227 LCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR--SCDAKVDVWSSCCMMLHM 284
Query: 265 AGG 267
             G
Sbjct: 285 LNG 287

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+APE+I S+ +       D +  G+++ +MA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA---VDWWALGVLIYQMAAG 234

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 42/213 (19%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE------FINEVSTIGRIHHVNVVQ 124
           KLG+G +G VYK     T   +A+K +   +   EE       I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY-LHNG 183
           L        +  L++EY  N  L +++            +K  +V++   +   Y L NG
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYM------------DKNPDVSMRVIKSFLYQLING 144
Query: 184 CDVC----ILHFDIKPHNILL---DHNFIP--KVSDFGLAK-FHPKENDFVSISATRGTI 233
            + C     LH D+KP N+LL   D +  P  K+ DFGLA+ F      F   +    T+
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF---THEIITL 201
Query: 234 GYIAPELI--SRNFGTVSCKSDVYGFGMVLLEM 264
            Y  PE++  SR++ T     D++    +  EM
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEM 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 23/203 (11%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K+++ ++    S ++   EV  +  ++H N+V+L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                   L+ EY   G +  ++       +     K  ++       ++Y H      I
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR---I 132
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELIS-RN 244
           +H D+K  N+LLD +   K++DFG +      N+F     +    G+  Y APEL   + 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 245 FGTVSCKSDVYGFGMVLLEMAGG 267
           +     + DV+  G++L  +  G
Sbjct: 187 YD--GPEVDVWSLGVILYTLVSG 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D+GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 213 YTK-SIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 205 YTK-SIDIWSVGCILAEMLSNR 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGL +    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 129
           L +GGF  VY+ Q + +G   A+K +L N +      I EV  + ++  H N+VQ   FC
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ---FC 92
Query: 130 SE----------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           S           G    L+   +  G L   +   ESRG   C + + ++   T R +++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC-DTVLKIFYQTCRAVQH 151
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA---------KFHPKENDFVSISATR 230
           +H      I+H D+K  N+LL +    K+ DFG A          +  +    V    TR
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 231 GTIG-YIAPELIS--RNFGTVSCKSDVYGFGMVL 261
            T   Y  PE+I    NF  +  K D++  G +L
Sbjct: 211 NTTPMYRTPEIIDLYSNF-PIGEKQDIWALGCIL 243

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 164
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 225 YTK-SIDIWSVGCILAEMLSNR 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHV----FPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
                  RA   E M +  L  H+      K  + Q L  + +        RG++Y+H+ 
Sbjct: 109 II-----RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELIS 242
               +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++ 
Sbjct: 164 N---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR 268
            + G      D++  G +L EM   R
Sbjct: 221 NSKGYTK-SIDIWSVGCILAEMLSNR 245

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               +   D++  G ++ E+  GR
Sbjct: 197 AMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 44/241 (18%)
Query: 64  AMTNHFT--HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRI 117
           +MT+ +    +LG+G F  V +  ++ TG   A K++   K SA   ++   E      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTA 174
            H N+V+L    SE     LV++ +  G L   +  +E   +   S C +++ E      
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE------ 114
Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
             + + H NG    I+H D+KP N+LL         K++DFGLA     + D  +     
Sbjct: 115 -SVNHCHLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFA 167
Query: 231 GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           GT GY++PE++ ++ +G      D++  G++L  +  G              Y P W  D
Sbjct: 168 GTPGYLSPEVLRKDPYGK---PVDMWACGVILYILLVG--------------YPPFWDED 210
Query: 290 Q 290
           Q
Sbjct: 211 Q 211

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 142
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 203 YTK-SIDIWSVGCILAEMLSNR 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L+    +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+L  E +  +     RG++Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 150
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 211 YTK-SIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 141
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 202 YTK-SIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIH-HVNVVQLLGFC 129
           LG+G +  V     LQ G   AVK++E  +  S      EV T+ +   + N+++L+ F 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + ++  LV+E +  GS+  H+     + +     +   V    A  +++LH      I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI----QKQKHFNEREASRVVRDVAAALDFLHTK---GIA 133
Query: 190 HFDIKPHNILLD--HNFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 241
           H D+KP NIL +      P K+ DF L       N    I+        G+  Y+APE++
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 242 -----SRNFGTVSCKSDVYGFGMVLLEMAGG 267
                   F    C  D++  G+VL  M  G
Sbjct: 194 EVFTDQATFYDKRC--DLWSLGVVLYIMLSG 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NIL+      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 108/241 (44%), Gaps = 44/241 (18%)
Query: 64  AMTNHFT--HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRI 117
           +MT+ +    +LG+G F  V +  ++ TG   A K++   K SA   ++   E      +
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTA 174
            H N+V+L    SE     LV++ +  G L   +  +E   +   S C +++ E      
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE------ 114
Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR 230
             + + H NG    I+H D+KP N+LL         K++DFGLA     + D  +     
Sbjct: 115 -SVNHCHLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAI--EVQGDQQAWFGFA 167
Query: 231 GTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           GT GY++PE++ ++ +G      D++  G++L  +  G              Y P W  D
Sbjct: 168 GTPGYLSPEVLRKDPYGK---PVDMWACGVILYILLVG--------------YPPFWDED 210
Query: 290 Q 290
           Q
Sbjct: 211 Q 211

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     +   L  + +  +     RG++Y+H+  
Sbjct: 86  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DFGLA+    +++     ATR    Y APE I  N
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 192
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
            K+G+G +G+V+K +  +T  ++A+K +   ++ +      + E+  +  + H N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  K  LV+E+  +  L ++    +S    L  E +        +G+ + H+    
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIAPELISRN 244
            +LH D+KP N+L++ N   K+++FGLA+    P        SA   T+ Y  P+++   
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR----CYSAEVVTLWYRPPDVL--- 173
Query: 245 FGT--VSCKSDVYGFGMVLLEMAGGRR 269
           FG    S   D++  G +  E+A   R
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT  Y+AP +I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 148
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 209 YTK-SIDIWSVGCILAEMLSNR 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 117 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 177 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 215

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  + R  H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 149
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    +     T  Y APE++  + G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 210 YTK-SIDIWSVGCILAEMLSNR 230

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLGF 128
           +G+G +G V          + V + + S F  + +    + E+  + R  H N++ +   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
               +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     +
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN---V 149
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFGT 247
           LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
                D++  G +L EM   R
Sbjct: 210 TK-SIDIWSVGCILAEMLSNR 229

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 175 RGIEYLHNGCDVC-------ILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSI 226
           R IE + + C          I+H D+KP NI++      KV DFG+A+      N     
Sbjct: 134 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +A  GT  Y++PE    +  +V  +SDVY  G VL E+  G
Sbjct: 194 AAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTG 232

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L+    +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+L  E +  +     RG++Y+H+    
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 143
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 144 -IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 196
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 197 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 232

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ DF LA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 30/228 (13%)
Query: 73  LGQGGFGSV---YKGQLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +G G +GSV   Y  +L+    +AVK L     S   A     E+  +  + H NV+ LL
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              +  +      E     +L         + Q+L  E +  +     RG++Y+H+    
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I+H D+KP N+ ++ +   ++ DFGLA+    + +     ATR    Y APE++  N+ 
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATR---WYRAPEIM-LNWM 204
Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY-DQLNK 293
             +   D++  G ++ E+  G            KA FP   Y DQL +
Sbjct: 205 HYNQTVDIWSVGCIMAELLQG------------KALFPGSDYIDQLKR 240

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQ-TGGLIAVKMLE--NSKFSAEEF 107
           MPKR  Y     +++ F  K  LG+G +G V     + TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGF----CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCW 163
           + E+  +    H N++ +         E      + + +    L R +       Q L  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH G +V  +H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++  V   ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMVEFVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLI-AVKMLENS----KFSAEEFINEVSTIGR-IHHVN 121
           HF   +G+G FG V   + +   +  AVK+L+      K   +  ++E + + + + H  
Sbjct: 41  HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +V L        K   V +Y+  G L  H+     R +     +    A   A  + YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARFYAAEIASALGYLH 156
Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   + I++ D+KP NILLD      ++DFGL K + + N   + S   GT  Y+APE++
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVL 211
Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
            +         D +  G VL EM  G
Sbjct: 212 HKQ--PYDRTVDWWCLGAVLYEMLYG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGG--------LIAVKMLENS-KFSAEEFINEVSTIGRIHH 119
           F   LGQG F  ++KG  +  G         + +K+L+ + +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            ++V   G C  G +  LV E++  GSLD ++  K     ++ W+   EVA   A  + +
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKL--EVAKQLAAAMHF 128
Query: 180 LHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISAT 229
           L       ++H ++   NILL         +  FI K+SD G++    PK+         
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------IL 177
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 178 QERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 33/170 (19%)
Query: 105 EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWE 164
           E+   E++ + ++ H NVV+L+    + ++  L   YM        VF   ++G  +   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL---YM--------VFELVNQGPVMEVP 129
Query: 165 KLHEVALGTAR--------GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
            L  ++   AR        GIEYLH      I+H DIKP N+L+  +   K++DFG++  
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS-- 184
Query: 217 HPKENDF----VSISATRGTIGYIAPELISRNFGTVSCKS-DVYGFGMVL 261
               N+F      +S T GT  ++APE +S      S K+ DV+  G+ L
Sbjct: 185 ----NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 24/237 (10%)
Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFTH--KLGQGGFGSV-YKGQLQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V      ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 96  MLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH+   + +++ D+KP N+L+D     +V+DF
Sbjct: 133 ----RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           G AK        +      GT   +APE+I S+ +       D +  G+++ EMA G
Sbjct: 186 GFAKRVKGRTWXLC-----GTPEALAPEIILSKGYNKA---VDWWALGVLIYEMAAG 234

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 88  TGGLIAVKMLE--NSKFSAEEFINEVSTIGRIH---------HVNVVQLLGFCSEGSKRA 136
           TG   AVK++E    + S E+ + EV    R           H +++ L+      S   
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQ-LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMF 176
Query: 137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH 196
           LV++ M  G L    F   +   +L  ++   +       + +LH      I+H D+KP 
Sbjct: 177 LVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPE 229
Query: 197 NILLDHNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC----K 251
           NILLD N   ++SDFG +    P E     +    GT GY+APE++  +          +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 252 SDVYGFGMVLLEMAGG 267
            D++  G++L  +  G
Sbjct: 286 VDLWACGVILFTLLAG 301

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 93  AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF 152
           AVK+++ SK    E I  +   G+  H N++ L     +G    +V E    G L     
Sbjct: 51  AVKIIDKSKRDPTEEIEILLRYGQ--HPNIITLKDVYDDGKYVYVVTELXKGGEL----L 104
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-LDHNFIP---KV 208
            K  R +     +   V     + +EYLH      ++H D+KP NIL +D +  P   ++
Sbjct: 105 DKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRI 161
Query: 209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            DFG AK    EN  +       T  ++APE++ R     +C  D++  G++L     G
Sbjct: 162 CDFGFAKQLRAENGLLXTPCY--TANFVAPEVLERQGYDAAC--DIWSLGVLLYTXLTG 216

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 69  FTHKLGQGGFGSVYKGQLQTGG--------LIAVKMLENS-KFSAEEFINEVSTIGRIHH 119
           F   LGQG F  ++KG  +  G         + +K+L+ + +  +E F    S + ++ H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            ++V   G C  G +  LV E++  GSLD ++  K     ++ W+   EVA   A  + +
Sbjct: 72  KHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKL--EVAKQLAWAMHF 128
Query: 180 LHNGCDVCILHFDIKPHNILL---------DHNFIPKVSDFGLA-KFHPKENDFVSISAT 229
           L       ++H ++   NILL         +  FI K+SD G++    PK+         
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI-KLSDPGISITVLPKD-------IL 177
Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +  I ++ PE I  N   ++  +D + FG  L E+  G
Sbjct: 178 QERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K   +  G I    ++ SK      ++E + +  ++       H 
Sbjct: 10  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 67
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   +             +L ++ L   RG+ Y+
Sbjct: 68  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS------ 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D   ++      
Sbjct: 128 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 184
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              G   ++A E++  N+ T   K+D++   + ++  AG 
Sbjct: 185 VEEGDSRFLANEVLQENY-THLPKADIFALALTVVXAAGA 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+  FGLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 38/243 (15%)
Query: 73  LGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      E
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 132 G----------SKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
                       K++ ++   EY  N +L   +  +    Q   + +L    L     + 
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---EALS 130
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV------------SI 226
           Y+H+     I+H ++KP NI +D +   K+ DFGLAK   +  D +            ++
Sbjct: 131 YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM-----AGGRRNSNMNATRSSKA 281
           ++  GT  Y+A E++    G  + K D Y  G++  E       G  R + +   RS   
Sbjct: 188 TSAIGTAXYVATEVLD-GTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNILKKLRSVSI 246
Query: 282 YFP 284
            FP
Sbjct: 247 EFP 249

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+ T  + A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R + L  E     +   +  + YLH   + 
Sbjct: 88  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 140
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 198
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 199 G---FSVDWWALGVLMFEMMAGR 218

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 42/240 (17%)
Query: 64  AMTNHFT--HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRI 117
           +MT+ +     +G+G F  V +  +L TG   A K++   K SA   ++   E      +
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTA 174
            H N+V+L    SE     LV++ +  G L   +  +E   +   S C +++ E  L   
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL--- 117
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRG 231
               + H    + ++H D+KP N+LL         K++DFGLA     + D  +     G
Sbjct: 118 ----HCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAI--EVQGDQQAWFGFAG 168
Query: 232 TIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
           T GY++PE++ +  +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 169 TPGYLSPEVLRKEAYGK---PVDIWACGVILYILLVG--------------YPPFWDEDQ 211

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 42/247 (17%)
Query: 59  YPQIIAMTNHFT------HKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSA---EEFI 108
           Y Q +A    FT       +LG+G F  V +   +T     A K++   K SA   ++  
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 109 NEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
            E      + H N+V+L    SE     LV++ +  G L   +  +E   ++     +H+
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQ 138
Query: 169 VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLA-KFHPKENDFV 224
           +       + ++H      I+H D+KP N+LL         K++DFGLA +   ++  + 
Sbjct: 139 I----LESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 225 SISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF 283
             +   GT GY++PE++ ++ +G      D++  G++L  +  G              Y 
Sbjct: 192 GFA---GTPGYLSPEVLRKDPYGK---PVDIWACGVILYILLVG--------------YP 231
Query: 284 PSWVYDQ 290
           P W  DQ
Sbjct: 232 PFWDEDQ 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+ T  + A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R + L  E     +   +  + YLH   + 
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 125
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 183
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 184 G---FSVDWWALGVLMFEMMAGR 203

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R +++   +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKTLCGTPNYIAPEVLCKK--G 218
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + D++  G +L  +  G+
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 27/191 (14%)
Query: 93  AVKMLENS---KFSAEEF-------INEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY 141
           AVK+++ +    FSAEE        + EV  + ++  H N++QL       +   LV++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD 201
           M  G L    F   +   +L  ++  ++       I  LH    + I+H D+KP NILLD
Sbjct: 106 MKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD 158
Query: 202 HNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI----SRNFGTVSCKSDVYG 256
            +   K++DFG + +  P E     + +  GT  Y+APE+I    + N      + D++ 
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEK----LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 257 FGMVLLEMAGG 267
            G+++  +  G
Sbjct: 215 TGVIMYTLLAG 225

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE---NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKE----SRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +    R+L  E   +  L  H+   +     + Q L  + +  +     RG++Y+H+  
Sbjct: 90  FTPA--RSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 145
Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H D+KP N+ ++ +   K+ D GLA+    +++     ATR    Y APE I  N
Sbjct: 146 ---IIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEMTGYVATR---WYRAPE-IMLN 196
Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +   D++  G ++ E+  GR
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+ T  + A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R + L  E     +   +  + YLH   + 
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 129
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSXFCGTPNYIAPEILRGEDY 187
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 188 G---FSVDWWALGVLMFEMMAGR 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R +++   +       T +G++YLHN     
Sbjct: 94  FFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKK--G 202
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + D++  G +L  +  G+
Sbjct: 203 HSFEVDIWSLGCILYTLLVGK 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R +++   +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKXLCGTPNYIAPEVLCKK--G 218
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + D++  G +L  +  G+
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 69  FTHKLGQGGFG--SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           F   +G G FG   + + +L T  L+AVK +E      E    E+     + H N+V+  
Sbjct: 24  FVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFK 82
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 +  A++ EY   G L    + +         ++          G+ Y H+   +
Sbjct: 83  EVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCHS---M 135
Query: 187 CILHFDIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELI 241
            I H D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE++
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVL 189
Query: 242 SRN--FGTVSCKSDVYGFGMVLLEMAGG 267
            R    G +   +DV+  G+ L  M  G
Sbjct: 190 LRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 93  AVKMLENS---KFSAEEF-------INEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY 141
           AVK+++ +    FSAEE        + EV  + ++  H N++QL       +   LV++ 
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 92
Query: 142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD 201
           M  G L    F   +   +L  ++  ++       I  LH    + I+H D+KP NILLD
Sbjct: 93  MKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD 145
Query: 202 HNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI----SRNFGTVSCKSDVYG 256
            +   K++DFG + +  P E     +    GT  Y+APE+I    + N      + D++ 
Sbjct: 146 DDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 201
Query: 257 FGMVLLEMAGG 267
            G+++  +  G
Sbjct: 202 TGVIMYTLLAG 212

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K   +  G I    ++ SK      ++E + +  ++       H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   +             +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS------ 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D   ++      
Sbjct: 130 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              G   ++A E++  N+  +  K+D++   + ++  AG 
Sbjct: 187 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 225

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   Y+   + T  + A K++  S        E+   E++    + + +VV   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R +++   +       T +G++YLHN     
Sbjct: 110 FFEDDDFVYVVLEICRRRSL----LELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR--- 162
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++ +    
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLAT--KIEFDGERKKDLCGTPNYIAPEVLCKK--G 218
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + D++  G +L  +  G+
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K   +  G I    ++ SK      ++E + +  ++       H 
Sbjct: 12  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 69
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   +             +L ++ L   RG+ Y+
Sbjct: 70  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS------ 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D   ++      
Sbjct: 130 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 186
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              G   ++A E++  N+  +  K+D++   + ++  AG 
Sbjct: 187 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLG 127
           +G+G +G V         + +A+K +  S F  + +    + E+  +    H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +   Y+    ++  ++ K  + Q L  + +        RG++Y+H+     
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-ISATRGTIGYIAPELISRNFG 246
           +LH D+KP N+LL+     K+ DFGLA+    ++D    ++    T  Y APE++  + G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 247 TVSCKSDVYGFGMVLLEMAGGR 268
                 D++  G +L EM   R
Sbjct: 207 YTK-SIDIWSVGCILAEMLSNR 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNV 122
           +G+G FG V   QL     T  + A+K+L  SKF       +  F  E   +   +   V
Sbjct: 77  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           VQL     +     +V EYMP G L      +  P++       W + +   +  A  ++
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTAEVVLA--LD 182
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
            +H+   +  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+P
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISP 238
Query: 239 ELISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           E++    G      + D +  G+ L EM  G
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-------HV 120
           H   K+G G FGSV+K   +  G I    ++ SK      ++E + +  ++       H 
Sbjct: 14  HELEKIGSGEFGSVFKCVKRLDGCIYA--IKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +VV+     +E     +  EY   GSL   +             +L ++ L   RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVS-------DFGLAKFHPKENDFVSIS------ 227
           H+   + ++H DIKP NI +    IP  +       D+   K   K  D   ++      
Sbjct: 132 HS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              G   ++A E++  N+  +  K+D++   + ++  AG 
Sbjct: 189 VEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGA 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 27/191 (14%)
Query: 93  AVKMLENS---KFSAEEF-------INEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY 141
           AVK+++ +    FSAEE        + EV  + ++  H N++QL       +   LV++ 
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDL 105
Query: 142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD 201
           M  G L    F   +   +L  ++  ++       I  LH    + I+H D+KP NILLD
Sbjct: 106 MKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLD 158
Query: 202 HNFIPKVSDFGLA-KFHPKENDFVSISATRGTIGYIAPELI----SRNFGTVSCKSDVYG 256
            +   K++DFG + +  P E     +    GT  Y+APE+I    + N      + D++ 
Sbjct: 159 DDMNIKLTDFGFSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 257 FGMVLLEMAGG 267
            G+++  +  G
Sbjct: 215 TGVIMYTLLAG 225

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNV 122
           +G+G FG V   QL     T  + A+K+L  SKF       +  F  E   +   +   V
Sbjct: 82  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 136
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           VQL     +     +V EYMP G L      +  P++       W + +   +  A  ++
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTAEVVLA--LD 187
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
            +H+   +  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+P
Sbjct: 188 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISP 243
Query: 239 ELISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           E++    G      + D +  G+ L EM  G
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L+ T  + A+++++    + +E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                 S+   V EY+  G L  H+     R + L  E     +   +  + YLH   + 
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLH---ER 172
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I++ D+K  N+LLD     K++D+G+ K   +  D  + S   GT  YIAPE++   ++
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDY 230
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G      D +  G+++ EM  GR
Sbjct: 231 G---FSVDWWALGVLMFEMMAGR 250

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 72  KLGQGGFGSVYKGQL-QTGGLIAVKMLENS--KFSAEEFINEVSTIGRIHHVN-VVQLLG 127
           ++G G  G V+K +  +TG +IAVK +  S  K   +  + ++  + + H    +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK-LHEVALGTARGIEYLHNGCDV 186
                +   +  E M  G+    +   + R Q    E+ L ++ +   + + YL     V
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKL---KKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+KP NILLD     K+ DFG++    +  D  +   + G   Y+APE I     
Sbjct: 147 --IHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 247 T---VSCKSDVYGFGMVLLEMAGGR 268
           T      ++DV+  G+ L+E+A G+
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 73  LGQGGFGSVYKGQL----QTGGLIAVKMLENSKF------SAEEFINEVSTIGRIHHVNV 122
           +G+G FG V   QL     T  + A+K+L  SKF       +  F  E   +   +   V
Sbjct: 82  IGRGAFGEV---QLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWV 136
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           VQL     +     +V EYMP G L      +  P++       W + +   +  A  ++
Sbjct: 137 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFYTAEVVLA--LD 187
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
            +H+   +  +H D+KP N+LLD +   K++DFG      KE   V      GT  YI+P
Sbjct: 188 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISP 243
Query: 239 ELISRNFGT--VSCKSDVYGFGMVLLEMAGG 267
           E++    G      + D +  G+ L EM  G
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   + + T  L AVK+L+      ++ +       R+  +      
Sbjct: 23  NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 82
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L  H+       Q   +++ H V  A   A G+ +
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           L +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIA 189
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 190 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQ-TGGLIAVKMLE--NSKFSAEEF 107
           MPKR  Y     +++ F  K  LG+G +G V     + TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGF----CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCW 163
           + E+  +    H N++ +         E      + + +    L R +       Q L  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH G +V  +H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMTEXVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 36/232 (15%)
Query: 53  MPKRYSYPQIIAMTNHFTHK--LGQGGFGSVYKGQLQ-TGGLIAVKMLE--NSKFSAEEF 107
           MPKR  Y     +++ F  K  LG+G +G V     + TG ++A+K +E  +    A   
Sbjct: 1   MPKRIVY----NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT 56
Query: 108 INEVSTIGRIHHVNVVQLLGF----CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCW 163
           + E+  +    H N++ +         E      + + +    L R +       Q L  
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSD 111
Query: 164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF------- 216
           + +      T R ++ LH G +V  +H D+KP N+L++ N   KV DFGLA+        
Sbjct: 112 DHIQYFIYQTLRAVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 217 --HP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              P  +++      ATR    Y APE++  +    S   DV+  G +L E+
Sbjct: 169 NSEPTGQQSGMTEYVATR---WYRAPEVMLTS-AKYSRAMDVWSCGCILAEL 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNV 122
           +F   LG+G FG V     + T  L A+K+L+      ++ +     E   +  +     
Sbjct: 22  NFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPF 81
Query: 123 VQLLGFCSEGSKRA-LVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEY 179
           +  L  C +   R   V EY+  G L  H+    K    Q++ +      A   + G+ +
Sbjct: 82  LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISIGLFF 135
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH      I++ D+K  N++LD     K++DFG+ K H    D V+     GT  YIAPE
Sbjct: 136 LHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH--MMDGVTTREFCGTPDYIAPE 190
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +I+  +       D + +G++L EM  G+
Sbjct: 191 IIA--YQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 72  KLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSAEEFINEVSTIGRI----HHVNVVQLL 126
           +LG G +G V+K + +  G L AVK   +     ++   +++ +G       H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSL----CWEKLHEVALGTARGIEYLHN 182
               EG    L  E +   SL +H    E+ G SL     W  L +  L  A    +LH+
Sbjct: 124 QAWEEGGILYLQTE-LCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALA----HLHS 175
Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                ++H D+KP NI L      K+ DFGL     +     +     G   Y+APEL+ 
Sbjct: 176 ---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 243 RNFGTVSCKSDVYGFGMVLLEMA 265
            ++GT    +DV+  G+ +LE+A
Sbjct: 230 GSYGTA---ADVFSLGLTILEVA 249

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 68  HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 121
           +F   LG+G FG V   + + T  L AVK+L+      ++ +       R+  +      
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEY 179
           + QL        +   V EY+  G L  H+       Q   +++ H V  A   A G+ +
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI------QQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIA 237
           L +     I++ D+K  N++LD     K++DFG+     KEN  D V+     GT  YIA
Sbjct: 458 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENIWDGVTTKXFCGTPDYIA 510
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           PE+I+  +       D + FG++L EM  G+
Sbjct: 511 PEIIA--YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 40/230 (17%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +  ++  G   A K++   K SA   ++   E      + H N+V+L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTARGIEYLHNGC 184
             SE     L+++ +  G L   +  +E   +   S C +++ E  L       + H   
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ-- 139
Query: 185 DVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            + ++H D+KP N+LL         K++DFGLA     E +  +     GT GY++PE++
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVL 196
Query: 242 SRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
            ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 197 RKDPYGK---PVDLWACGVILYILLVG--------------YPPFWDEDQ 229

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVV---QL 125
           +G G +G V   + + TG  +A+K + N+     +A+  + E+  +    H N++    +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           L       +   VY  +     D H     S  Q L  E +        RG++Y+H+   
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ- 178
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS 242
             ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APEL+ 
Sbjct: 179 --VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPELML 235
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            +    +   D++  G +  EM   R+
Sbjct: 236 -SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +      Q+  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +         ++          G+ Y H    VC  H 
Sbjct: 86  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 138
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIAPEVLLKKEY 192
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 193 DGKV---ADVWSCGVTLYVMLVG 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 17/207 (8%)
Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVV---QL 125
           +G G +G V   + + TG  +A+K + N+     +A+  + E+  +    H N++    +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           L       +   VY  +     D H     S  Q L  E +        RG++Y+H+   
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ- 179
Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAK---FHPKENDFVSISATRGTIGYIAPELIS 242
             ++H D+KP N+L++ N   K+ DFG+A+     P E+ +  ++    T  Y APEL+ 
Sbjct: 180 --VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-MTEYVATRWYRAPELM- 235
Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
            +    +   D++  G +  EM   R+
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +      Q+  L+AVK +E  +  A     E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +         ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+ DFG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 124
           +F  KL +   G ++KG+ Q G  I VK+L+   +S   + +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 125 LLGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEYL 180
           +LG C         L+  +MP GSL    +     G +   ++   V  AL  ARG+ +L
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSL----YNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H   +  I    +   ++++D +   ++S     KF      F S         ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARIS-MADVKF-----SFQSPGRMYAP-AWVAPEA 179
Query: 241 ISRNFGTVSCKS-DVYGFGMVLLEM 264
           + +     + +S D++ F ++L E+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWEL 204

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 88/185 (47%), Gaps = 19/185 (10%)
Query: 64  AMTNHFT--HKLGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV 120
           A+++ F    +LG+G    VY+  Q  T    A+K+L+ +    +    E+  + R+ H 
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-VDKKIVRTEIGVLLRLSHP 108
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           N+++L       ++ +LV E +  G L   +  K    +    + + ++       + YL
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL----EAVAYL 164
Query: 181 H-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           H NG    I+H D+KP N+L      +   K++DFGL+K    +   V +    GT GY 
Sbjct: 165 HENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYC 217
Query: 237 APELI 241
           APE++
Sbjct: 218 APEIL 222

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 54  PKRYSYPQIIAMTNHFTHK------LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE 106
           PK      + A    ++ K      LG G FG V+     +    + VK ++  K   + 
Sbjct: 7   PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 107 FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS-----LDRHVF 152
           +I          E++ + R+ H N++++L          LV E   +G      +DRH  
Sbjct: 67  WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR 126
Query: 153 PKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
             E     +  +      L +A G   L +     I+H DIK  NI++  +F  K+ DFG
Sbjct: 127 LDEPLASYIFRQ------LVSAVGYLRLKD-----IIHRDIKDENIVIAEDFTIKLIDFG 175
Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRN 244
            A +  +   F +     GTI Y APE++  N
Sbjct: 176 SAAYLERGKLFYTFC---GTIEYCAPEVLMGN 204

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVS 112
           PK+Y+      ++      LG G  G V +    +TG   A+K+L +S  + +E  +   
Sbjct: 2   PKKYAVTDDYQLSKQV---LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQ 58
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
             G  H V ++ +      G KR L  + E M  G L   +  +E   Q+    +  E+ 
Sbjct: 59  ASGGPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIM 115
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 227
                 I++LH+     I H D+KP N+L    + + + K++DFG A    KE    ++ 
Sbjct: 116 RDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQ 168
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
               T  Y+APE++       SC  D++  G+++  +  G
Sbjct: 169 TPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYILLCG 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVS 112
           PK+Y+      ++      LG G  G V +    +TG   A+K+L +S  + +E  +   
Sbjct: 21  PKKYAVTDDYQLSKQV---LGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQ 77
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA 170
             G  H V ++ +      G KR L  + E M  G L   +  +E   Q+    +  E+ 
Sbjct: 78  ASGGPHIVCILDVYENMHHG-KRCLLIIMECMEGGELFSRI--QERGDQAFTEREAAEIM 134
Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSIS 227
                 I++LH+     I H D+KP N+L    + + + K++DFG A    KE    ++ 
Sbjct: 135 RDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQ 187
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
               T  Y+APE++       SC  D++  G+++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIM 219

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +      Q+  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +         ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+  FG +K    H +  D      T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKD------TVGTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +      Q   L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +         ++          G+ Y H    + + H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYAHA---MQVAHR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K++DFG +K    H +    V      GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV------GTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 70  THKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHV-NVVQ 124
           + +LG+G F  V +     TG   A K L+  +   +   E ++E++ +        V+ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L       S+  L+ EY   G +     P+    + +    +  +      G+ YLH   
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 185 DVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
              I+H D+KP NILL  +  P    K+ DFG+++   K      +    GT  Y+APE+
Sbjct: 152 ---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAPEI 204
Query: 241 ISRNFGTVSCKSDVYGFGMV 260
           +  N+  ++  +D++  G++
Sbjct: 205 L--NYDPITTATDMWNIGII 222

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 130 GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 183
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 240
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 241 DKSC--DMWSLGVIMYILLCG 259

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 89
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 90  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 143
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 200
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 201 DKSC--DMWSLGVIMYILLCG 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 86  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 139
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 196
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 197 DKSC--DMWSLGVIMYILLCG 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 90
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 91  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 144
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 201
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 202 DKSC--DMWSLGVIMYILLCG 220

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 85
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 86  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 139
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 196
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 197 DKSC--DMWSLGVIMYILLCG 215

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 84
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 85  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 138
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 195
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 196 DKSC--DMWSLGVIMYILLCG 214

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 83
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 84  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 137
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 194
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 195 DKSC--DMWSLGVIMYILLCG 213

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 91
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 92  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 145
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 202
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 203 DKSC--DMWSLGVIMYILLCG 221

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 16/180 (8%)
Query: 93  AVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHV 151
           A+KML++   +  E           H V +V +      G K  L V E +  G L   +
Sbjct: 61  ALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 120
Query: 152 FPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK 207
              + RG Q+    +  E+       I+YLH+   + I H D+KP N+L      N I K
Sbjct: 121 ---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILK 174
Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
           ++DFG AK     N   S++    T  Y+APE++       SC  D++  G+++  +  G
Sbjct: 175 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC--DMWSLGVIMYILLCG 229

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 24/169 (14%)
Query: 109 NEVSTIGRIHHVNVVQLLG--FCSEGSKRALVYEYMPNG------SLDRHVFPKESRGQS 160
            E+  + R+ H NV+QL+   +  E  K  +V EY   G      S+    FP       
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP------- 107
Query: 161 LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPK 219
           +C  + H        G+EYLH+     I+H DIKP N+LL      K+S  G+A+  HP 
Sbjct: 108 VC--QAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGG 267
             D  +   ++G+  +  PE I+    T S  K D++  G+ L  +  G
Sbjct: 163 AAD-DTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 135
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 136 GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 189
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 246
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 247 DKSC--DMWSLGVIMYILLCG 265

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           LG G  G V +    +T    A+KML++   +  E           H V +V +      
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYA 83
Query: 132 GSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           G K  L V E +  G L   +   + RG Q+    +  E+       I+YLH+   + I 
Sbjct: 84  GRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLHS---INIA 137
Query: 190 HFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           H D+KP N+L      N I K++DFG AK     N   S++    T  Y+APE++     
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTEPCYTPYYVAPEVLGPEKY 194
Query: 247 TVSCKSDVYGFGMVLLEMAGG 267
             SC  D++  G+++  +  G
Sbjct: 195 DKSC--DMWSLGVIMYILLCG 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK--G 191
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK--G 193
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 137
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK--G 193
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGK 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 107 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 159
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKKGH- 216
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 217 -SFEVDVWSIGCIMYTLLVGK 236

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQ 124
           F  ++G+G F +VYKG   +T   +A   L++ K +  E   F  E   +  + H N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVR 89
Query: 125 LLGFCSEGSKR----ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                    K      LV E   +G+L  ++     R +    + L        +G+++L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYL----KRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 181 HNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H      I+H D+K  NI +       K+ D GLA    K   F    A  GT  + APE
Sbjct: 146 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL--KRASFA--KAVIGTPEFXAPE 200
Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA 265
                +       DVY FG   LE A
Sbjct: 201 XYEEKYDE---SVDVYAFGXCXLEXA 223

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 89  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 141
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKTLCGTPNYIAPEVLSKK--G 197
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGK 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 73  LGQGGFGSVYK-GQLQTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
           F  +     +V E     SL         R ++L   +          G +YLH      
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--- 161
Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ++H D+K  N+ L+ +   K+ DFGLA     E D        GT  YIAPE++S+    
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLAT--KVEYDGERKKVLCGTPNYIAPEVLSKK--G 217
Query: 248 VSCKSDVYGFGMVLLEMAGGR 268
            S + DV+  G ++  +  G+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 57/120 (47%), Gaps = 19/120 (15%)
Query: 155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           E R   +C   LH + +  A  +E+LH+     ++H D+KP NI    + + KV DFGL 
Sbjct: 159 EDREHGVC---LH-IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 215 KFHPKEND----------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
               ++ +          + +     GT  Y++PE I  N    S K D++  G++L E+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGN--NYSHKVDIFSLGLILFEL 269

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 41/209 (19%)
Query: 73  LGQGGFGS-VYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 130
           LG G  G+ VY+G       +AVK +    FS  +   EV  +     H NV++   FC+
Sbjct: 32  LGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFAD--REVQLLRESDEHPNVIRY--FCT 86
Query: 131 EGSKRALVYEYMP----NGSLDRHVFPKESRGQSLCWEKLHEVAL--GTARGIEYLHNGC 184
           E  ++   ++Y+       +L  +V  K+          L  + L   T  G+ +LH+  
Sbjct: 87  EKDRQ---FQYIAIELCAATLQEYVEQKD-----FAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 185 DVCILHFDIKPHNILLD----HNFIPK-VSDFGLA-KFHPKENDFVSISATRGTIGYIAP 238
            + I+H D+KPHNIL+     H  I   +SDFGL  K     + F   S   GT G+IAP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 239 ELISRNFGTVSCKS------DVYGFGMVL 261
           E++S +     CK       D++  G V 
Sbjct: 196 EMLSED-----CKENPTYTVDIFSAGCVF 219

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 73  LGQGGFG-SVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG +      Q+  L+AVK +E  +   E    E+     + H N+V+       
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +  A+V EY   G L    F +         ++          G+ Y H    VC  H 
Sbjct: 87  PTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVC--HR 139
Query: 192 DIKPHNILLDHNFIP--KVSDFGLAK---FHPKENDFVSISATRGTIGYIAPE-LISRNF 245
           D+K  N LLD +  P  K+  FG +K    H +        +T GT  YIAPE L+ + +
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK------STVGTPAYIAPEVLLKKEY 193
Query: 246 -GTVSCKSDVYGFGMVLLEMAGG 267
            G V   +DV+  G+ L  M  G
Sbjct: 194 DGKV---ADVWSCGVTLYVMLVG 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVS 112
           P  Y Y + +    H   +LG+G FG V++ +  QTG   AVK +    F  EE +    
Sbjct: 62  PVDYEYREEVHWMTH-QPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 116
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
               +    +V L G   EG    +  E +  GSL + +     +      E      LG
Sbjct: 117 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLG 171
Query: 173 TA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLA-KFHPK--ENDFVSIS 227
            A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++  
Sbjct: 172 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              GT  ++APE++         K D++    ++L M  G
Sbjct: 229 YIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 266

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 68  HFTHKLGQGGFGSVY-KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 121
           H   KLG G F +V+    +Q    +A+K++++++   E  ++E+  +  + + +     
Sbjct: 24  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 83
Query: 122 ---VVQLLGFCS----EGSKRALVYEYMPNGSLDRHVFPKESRGQSL-CWEKLHEVALGT 173
              VVQLL         G+   +V+E + +  L + +     +G  L C +K+ +  L  
Sbjct: 84  REMVVQLLDDFKISGVNGTHICMVFEVLGHHLL-KWIIKSNYQGLPLPCVKKIIQQVL-- 140
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHN 203
            +G++YLH  C   I+H DIKP NILL  N
Sbjct: 141 -QGLDYLHTKCR--IIHTDIKPENILLSVN 167

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +  ++  G   A  ++   K SA   ++   E      + H N+V+L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGTARGIEYLHNGC 184
             SE     L+++ +  G L   +  +E   +   S C +++ E  L       + H   
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL-------HCHQ-- 128
Query: 185 DVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            + ++H ++KP N+LL         K++DFGLA     E +  +     GT GY++PE++
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI--EVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 242 SRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ 290
            ++ +G      D++  G++L  +  G              Y P W  DQ
Sbjct: 186 RKDPYGK---PVDLWACGVILYILLVG--------------YPPFWDEDQ 218

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 20/150 (13%)
Query: 68  HFTHKLGQGGFGSVY-KGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN----- 121
           H   KLG G F +V+    +Q    +A+K++++++   E  ++E+  +  + + +     
Sbjct: 40  HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPN 99
Query: 122 ---VVQLLGFCS----EGSKRALVYEYMPNGSLDRHVFPKESRGQSL-CWEKLHEVALGT 173
              VVQLL         G+   +V+E + +  L + +     +G  L C +K+ +  L  
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLL-KWIIKSNYQGLPLPCVKKIIQQVL-- 156
Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHN 203
            +G++YLH  C   I+H DIKP NILL  N
Sbjct: 157 -QGLDYLHTKCR--IIHTDIKPENILLSVN 183

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFC 129
           KLG+G +  V++   +     + VK+L+  K    +   E+  +  +    N++ L    
Sbjct: 44  KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KNKIKREIKILENLRGGPNIITLADIV 101
Query: 130 SEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
            +   R  ALV+E++ N          +   Q+L    +        + ++Y H+   + 
Sbjct: 102 KDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALDYCHS---MG 151
Query: 188 ILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   PEL+  ++ 
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLV-DYQ 207
Query: 247 TVSCKSDVYGFGMVLLEM 264
                 D++  G +L  M
Sbjct: 208 MYDYSLDMWSLGCMLASM 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVS 112
           P  Y Y + +    H   ++G+G FG V++ +  QTG   AVK +    F  EE +    
Sbjct: 48  PVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 102
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
               +    +V L G   EG    +  E +  GSL + +     +      E      LG
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLG 157
Query: 173 TA-RGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLA-KFHPK--ENDFVSIS 227
            A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++  
Sbjct: 158 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              GT  ++APE++         K D++    ++L M  G
Sbjct: 215 YIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVS 112
           P  Y Y + +    H   ++G+G FG V++ +  QTG   AVK +    F  EE +    
Sbjct: 64  PVDYEYREEVHWMTH-QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV---- 118
Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
               +    +V L G   EG    +  E +  GSL + +     +      E      LG
Sbjct: 119 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLG 173
Query: 173 TA-RGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLA-KFHPK--ENDFVSIS 227
            A  G+EYLH      ILH D+K  N+LL  +     + DFG A    P       ++  
Sbjct: 174 QALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
              GT  ++APE++         K D++    ++L M  G
Sbjct: 231 YIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNG 268

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIH-HVNVVQLLGFC 129
           LG+G    V     L T    AVK++E         +  EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            E  +  LV+E M  GS+  H+  +    +     +   V    A  +++LHN     I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNEL----EASVVVQDVASALDFLHNK---GIA 133
Query: 190 HFDIKPHNILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 241
           H D+KP NIL +H     P K+ DFGL        D   IS        G+  Y+APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 242 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 267
              S        + D++  G++L  +  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 16/148 (10%)
Query: 118 HHVNVVQLLGFCSEGSKRAL-VYEYMPNGSLDRHVFPKESRG-QSLCWEKLHEVALGTAR 175
           H V +V +      G K  L V E +  G L   +   + RG Q+    +  E+      
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRI---QDRGDQAFTEREASEIXKSIGE 172
Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            I+YLH+   + I H D+KP N+L      N I K++DFG AK     N   S++    T
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYT 226
Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMV 260
             Y+APE++       SC  D +  G++
Sbjct: 227 PYYVAPEVLGPEKYDKSC--DXWSLGVI 252

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 115/281 (40%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VQLLGFCSEGSKRALVYEYM-PNGSLDRHVFPK----ESRGQSLCWEKLHEVALGTARGI 177
           ++LL +        L+ E M P   L   +  +    E   +S  W+ L          +
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVL--------EAV 127
Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYI 236
            + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y 
Sbjct: 128 RHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VYS 180
Query: 237 APELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG 294
            PE I   R  G  +    V+  G++L +M  G                P    +++ +G
Sbjct: 181 PPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIRG 223
Query: 295 GDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
                Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 224 QVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 256

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 56/254 (22%)
Query: 47  RNQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG--QLQTGGLIAVKMLE--NSK 101
           R    W +P RY             H +G G +G V +   +L+   +   K+L      
Sbjct: 44  RPHSDWQIPDRYE----------IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL 93
Query: 102 FSAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRALVYEYMPNGSLDRHVFPKESRGQ 159
              +  + E++ + R++H +VV++L      +  K   +Y  +     D   F K  R  
Sbjct: 94  IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD---FKKLFRTP 150
Query: 160 SLCWEKLHEVAL--GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-- 215
               E LH   L      G++Y+H+     ILH D+KP N L++ +   KV DFGLA+  
Sbjct: 151 VYLTE-LHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
Query: 216 -----------FHPKEND--FVSISATRG----------TIGYIAPELI--SRNFGTVSC 250
                        P+E+D   V+   T+           T  Y APELI    N+     
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-- 264
Query: 251 KSDVYGFGMVLLEM 264
             DV+  G +  E+
Sbjct: 265 -IDVWSIGCIFAEL 277

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 95  DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 147 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 95  DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 146
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 147 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 79  DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 130
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 131 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 223
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 224 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 250
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 74/313 (23%), Positives = 119/313 (38%), Gaps = 50/313 (15%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENS------------KFSAEEFINEVSTIGRIHHV 120
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH--EVALGTARGIE 178
           N++ L        + A+   Y+    L R    +    Q +     H          G+ 
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVT-ELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
            LH   +  ++H D+ P NILL  N    + DF LA+    + +       R    Y AP
Sbjct: 149 VLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR---WYRAP 202
Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK---- 293
           EL+ + F   +   D++  G V+ EM             + KA F  S  Y+QLNK    
Sbjct: 203 ELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQLNKIVEV 249
Query: 294 GGDLELQNVTEIESMIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLEGS----I 342
            G  ++++V    S  AR      L       W   V  AD  ++  + +MLE +    I
Sbjct: 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
Query: 343 DDLQMPPRPFFSS 355
              Q    P+F S
Sbjct: 310 STEQALRHPYFES 322

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 123 DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 174
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 21/205 (10%)
Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQ 124
           +F  KL +   G ++KG+ Q G  I VK+L+   +S   + +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 125 LLGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV--ALGTARGIEYL 180
           +LG C         L+  + P GSL    +     G +   ++   V  AL  ARG  +L
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSL----YNVLHEGTNFVVDQSQAVKFALDXARGXAFL 127
Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H   +  I    +   ++ +D +   ++S   + KF      F S         ++APE 
Sbjct: 128 HT-LEPLIPRHALNSRSVXIDEDXTARISXADV-KF-----SFQSPGRXYAP-AWVAPEA 179
Query: 241 ISRNFGTVSCKS-DVYGFGMVLLEM 264
           + +     + +S D + F ++L E+
Sbjct: 180 LQKKPEDTNRRSADXWSFAVLLWEL 204

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 75/317 (23%), Positives = 120/317 (37%), Gaps = 58/317 (18%)
Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENS------------KFSAEEFINEVSTIGRIHHV 120
           +  G +G+V  G    G  +A+K + N+             F  +  + E+  +   HH 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH------EVALGTA 174
           N++ L        + A+   Y+    L R    +    Q +     H       + LG  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVT-ELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG-- 146
Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
                LH   +  ++H D+ P NILL  N    + DF LA+    + +       R    
Sbjct: 147 -----LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR---W 198
Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           Y APEL+ + F   +   D++  G V+ EM             + KA F  S  Y+QLNK
Sbjct: 199 YRAPELVMQ-FKGFTKLVDMWSAGCVMAEMF------------NRKALFRGSTFYNQLNK 245
Query: 294 ----GGDLELQNVTEIESMIARKLCMIGL-------WCIQVKAADRPSMTKVLEMLEGS- 341
                G  ++++V    S  AR      L       W   V  AD  ++  + +MLE + 
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305
Query: 342 ---IDDLQMPPRPFFSS 355
              I   Q    P+F S
Sbjct: 306 QRRISTEQALRHPYFES 322

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 50/244 (20%)
Query: 51  SWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYK--GQLQTGGLIAVKMLENSKFSAEEFI 108
            W+ +RY   +I++        LG+G FG V +     + G  +A+K+++N +   E   
Sbjct: 29  DWLQERY---EIVST-------LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAAR 78
Query: 109 NEVSTIGRIHHVN------VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLC 162
            E++ + +I+  +       VQ+  +        + +E +   + D   F K++      
Sbjct: 79  LEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFD---FLKDNNYLPYP 135
Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL-------LDHNFIPK-------- 207
             ++  +A    + +++LH   D  + H D+KP NIL       L +N   K        
Sbjct: 136 IHQVRHMAFQLCQAVKFLH---DNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKS 192
Query: 208 ----VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
               V DFG A F     D    S    T  Y APE+I     +  C  DV+  G ++ E
Sbjct: 193 TAVRVVDFGSATF-----DHEHHSTIVSTRHYRAPEVILELGWSQPC--DVWSIGCIIFE 245
Query: 264 MAGG 267
              G
Sbjct: 246 YYVG 249

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 76  DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 127
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 237
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 238 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 271

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 223
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 224 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 75  DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 126
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 127 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 126
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 127 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 179
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 180 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 222
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 223 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 256

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 127
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 128 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 180
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 181 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 223
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 224 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 257

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+KP NIL+  +    + DFG+A     E     +  T GT+ Y APE  S +  T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYXAPERFSESHATY- 214
Query: 250 CKSDVYGFGMVLLEMAGG 267
            ++D+Y    VL E   G
Sbjct: 215 -RADIYALTCVLYECLTG 231

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 169
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 170 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 222
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 223 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 265
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 266 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 299

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 113/280 (40%), Gaps = 57/280 (20%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIH--HVNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 295
             PE I R        + V+  G++L +M  G                P    +++ +G 
Sbjct: 176 SPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGD--------------IPFEHDEEIIRGQ 220
Query: 296 DLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
               Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 221 VFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIH--HVNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 125
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 126 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 178
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 179 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 221
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 222 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 255

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 239 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 272

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 141
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 142 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 194
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 195 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 237
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 238 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 239 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 272

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---ENSKFSAEEFINEVSTIGRI--HHVNVVQLL 126
           ++G GG   V++   +   + A+K +   E    + + + NE++ + ++  H   +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            +         +Y  M  G++D + + K+ +     WE+           +E +H     
Sbjct: 123 DY---EITDQYIYMVMECGNIDLNSWLKKKKSID-PWER----KSYWKNMLEAVHTIHQH 174
Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI----- 241
            I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+ PE I     
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 233
Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
           SR  G     +S KSDV+  G +L  M  G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 161
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 162 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 214
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 215 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 257
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 258 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 291

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 174
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 175 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 227
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 228 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 270
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 271 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 304

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 169
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 170 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 222
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 223 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 265
Query: 294 GGDLELQNV-TEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V +E + +I         WC+ ++ +DRP+  ++
Sbjct: 266 GQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 299

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIH--HVNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN     +LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 218
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 219 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------ 121
              KLG G F +V+  + +     +A+K++   K   E   +E+  + R++  +      
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 122 -----VVQLLGFCSE----GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
                +++LL   +     G    +V+E +    L   +   E RG  L + K  +++  
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYVK--QISKQ 139
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLD-----HNFIP-KVSDFGLAKFHPKENDFVSI 226
              G++Y+H  C   I+H DIKP N+L++      N I  K++D G A ++  +  + + 
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNS 195
Query: 227 SATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
             TR    Y +PE L+   +G   C +D++    ++ E+  G
Sbjct: 196 IQTR---EYRSPEVLLGAPWG---CGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------ 121
              KLG G F +V+  + +     +A+K++   K   E   +E+  + R++  +      
Sbjct: 23  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 122 -----VVQLLGFCSE----GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG 172
                +++LL   +     G    +V+E +    L   +   E RG  L + K  +++  
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL-IKKYEHRGIPLIYVK--QISKQ 139
Query: 173 TARGIEYLHNGCDVCILHFDIKPHNILLD-----HNFIP-KVSDFGLAKFHPKENDFVSI 226
              G++Y+H  C   I+H DIKP N+L++      N I  K++D G A ++  +  + + 
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY--DEHYTNS 195
Query: 227 SATRGTIGYIAPE-LISRNFGTVSCKSDVYGFGMVLLEMAGG 267
             TR    Y +PE L+   +G   C +D++    ++ E+  G
Sbjct: 196 IQTR---EYRSPEVLLGAPWG---CGADIWSTACLIFELITG 231

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 114/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 149
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 150 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 202
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 203 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 245
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++ +DRP+  ++
Sbjct: 246 GQVFFRQRVSXECQHLIR--------WCLALRPSDRPTFEEI 279

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N         K+ R Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF------KQLR-QTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 21/209 (10%)
Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIH-HVNVVQLLGFC 129
           LG+G    V     L T    AVK++E         +  EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            E  +  LV+E M  GS+  H+  +    +     +   V    A  +++LHN     I 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNEL----EASVVVQDVASALDFLHNK---GIA 133
Query: 190 HFDIKPHNILLDH--NFIP-KVSDFGLAKFHPKENDFVSISATR-----GTIGYIAPELI 241
           H D+KP NIL +H     P K+ DF L        D   IS        G+  Y+APE++
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 242 ---SRNFGTVSCKSDVYGFGMVLLEMAGG 267
              S        + D++  G++L  +  G
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 285

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 73  LGQGGFGSVYKGQLQTGG--LIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQ 124
           LG+G FG V +      G   +AVK+++N     E   +E+  +  ++  +       VQ
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           +L +        +V+E +   + D   F KE+       + + ++A    + + +LH+  
Sbjct: 82  MLEWFEHHGHICIVFELLGLSTYD---FIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138
Query: 185 DVCILHFDIKPHNILLDHN-----FIPKVS--------------DFGLAKFHPKENDFVS 225
              + H D+KP NIL   +     + PK+               DFG A +  + +    
Sbjct: 139 ---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH---- 191
Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGG 267
            S    T  Y APE+I     +  C  DV+  G +L+E   G
Sbjct: 192 -STLVSTRHYRAPEVILALGWSQPC--DVWSIGCILIEYYLG 230

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +     E     +      WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+L+DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 284

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 155
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 156 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 208
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 209 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 250
Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +     E     +      WC+ ++ +DRP+  ++
Sbjct: 251 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 285

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 113/282 (40%), Gaps = 61/282 (21%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 142
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 143 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 195
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                P    +++ +
Sbjct: 196 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGD--------------IPFEHDEEIIR 238
Query: 294 GGDLELQNVT-EIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           G     Q V+ E + +I         WC+ ++  DRP+  ++
Sbjct: 239 GQVFFRQRVSXECQHLIR--------WCLALRPXDRPTFEEI 272

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 111/281 (39%), Gaps = 59/281 (20%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIHH--VNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 154
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 155 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 207
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 208 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 249
Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +     E     +      WC+ ++ +DRP+  ++
Sbjct: 250 GGQVFFRQRVSXECQHLIR------WCLALRPSDRPTFEEI 284

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 114/283 (40%), Gaps = 63/283 (22%)
Query: 73  LGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAE-EFIN------EVSTIGRIH--HVNV 122
           LG GGFGSVY G   +  L +A+K +E  + S   E  N      EV  + ++      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFP------KESRGQSLCWEKLHEVALGTARG 176
           ++LL +        L+ E  P    D   F       +E   +S  W+ L          
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVL--------EA 122
Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGY 235
           + + HN C V  LH DIK  NIL+D N    K+ DFG      K+  +     TR    Y
Sbjct: 123 VRHCHN-CGV--LHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTR---VY 175
Query: 236 IAPELIS--RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
             PE I   R  G  +    V+  G++L +M  G                  + +D+   
Sbjct: 176 SPPEWIRYHRYHGRSAA---VWSLGILLYDMVCGDI---------------PFEHDEEII 217
Query: 294 GGDLELQN--VTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
           GG +  +    +E + +I         WC+ ++ +DRP+  ++
Sbjct: 218 GGQVFFRQRVSSECQHLIR--------WCLALRPSDRPTFEEI 252

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G    + D +  G+ + EM  G 
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNF 245
           +H DIKP N+LLD N   +++DFG +     ++  V  S   GT  YI+PE++       
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 246 GTVSCKSDVYGFGMVLLEMAGGR 268
           G    + D +  G+ + EM  G 
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 17/147 (11%)
Query: 121 NVVQLLGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N++ L     +   R  ALV+E++ N          +   Q+L    +        + ++
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDF-------KQLYQTLTDYDIRFYMYEILKALD 145
Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           Y H+   + I+H D+KPHN+++DH     ++ D+GLA+F+    ++    A+R   G   
Sbjct: 146 YCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG--- 199
Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEM 264
           PEL+  ++       D++  G +L  M
Sbjct: 200 PELLV-DYQMYDYSLDMWSLGCMLASM 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	373
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-101
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-101
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-66
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-60
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-48
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-42
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-40
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-33
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-23
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	8e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-21
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-20
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-04
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-05

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  337 bits (867), Expect = e-115
 Identities = 112/302 (37%), Positives = 161/302 (53%), Gaps = 25/302 (8%)

Query: 54  PKRYSYPQIIAMTNHF--THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE--EFIN 109
            KR+S  ++   +++F   + LG+GGFG VYKG+L  G L+AVK L+  +      +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 110 EVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEV 169
           EV  I    H N+++L GFC   ++R LVY YM NGS+   +  +      L W K   +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           ALG+ARG+ YLH+ CD  I+H D+K  NILLD  F   V DFGLAK    ++  V+   T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---T 193

Query: 230 R--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN-ATRSSKAYFPSW 286
              GTIG+IAPE +S   G  S K+DV+G+G++LLE+  G+R  ++             W
Sbjct: 194 AVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 287 VYDQLNKGGDLEL--------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           V   L +     L            E+E +I      + L C Q    +RP M++V+ ML
Sbjct: 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ-----VALLCTQSSPMERPKMSEVVRML 306

Query: 339 EG 340
           EG
Sbjct: 307 EG 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  301 bits (772), Expect = e-101
 Identities = 93/309 (30%), Positives = 145/309 (46%), Gaps = 39/309 (12%)

Query: 54  PKRYSYPQIIAMTNHF--------THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA- 104
              +S+ ++  +TN+F         +K+G+GGFG VYKG +     +AVK L        
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITT 70

Query: 105 ----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQS 160
               ++F  E+  + +  H N+V+LLGF S+G    LVY YMPNGSL   +   +     
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT-PP 129

Query: 161 LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
           L W    ++A G A GI +LH       +H DIK  NILLD  F  K+SDFGLA+   K 
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 221 ND-FVSISATR--GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR 277
               ++   +R  GT  Y+APE +    G ++ KSD+Y FG+VLLE+  G    + +   
Sbjct: 187 AQTVMT---SRIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDEH--- 237

Query: 278 SSKAYFPSWVYDQLNKGGDLE------LQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
                      +  ++   +E      + +           +  +   C+  K   RP +
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDI 294

Query: 332 TKVLEMLEG 340
            KV ++L+ 
Sbjct: 295 KKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  301 bits (773), Expect = e-101
 Identities = 107/300 (35%), Positives = 155/300 (51%), Gaps = 22/300 (7%)

Query: 55  KRYSYPQIIAMTNHF--THKLGQGGFGSVYKGQLQTGGLIAVKML-ENSKFSAEEFINEV 111
            R     +   TN+F     +G G FG VYKG L+ G  +A+K     S    EEF  E+
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 112 STIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
            T+    H ++V L+GFC E ++  L+Y+YM NG+L RH++  +    S+ WE+  E+ +
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATR 230
           G ARG+ YLH      I+H D+K  NILLD NF+PK++DFG++K   + +   +S   T 
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS---TV 200

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY 288
             GT+GYI PE   +   T   KSDVY FG+VL E+   R     +  R        W  
Sbjct: 201 VKGTLGYIDPEYFIKGRLTE--KSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAV 257

Query: 289 DQLNKGG-----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 343
           +  N G      D  L +    ES+  RK     + C+ + + DRPSM  VL  LE ++ 
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESL--RKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  222 bits (568), Expect = 2e-70
 Identities = 69/308 (22%), Positives = 115/308 (37%), Gaps = 34/308 (11%)

Query: 58  SYPQIIAMTNHFT--HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIG 115
               +   +          +G FG V+K QL     +AVK+       + +   EV ++ 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLP 73

Query: 116 RIHHVNVVQLLGFCSEGSKRA----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL 171
            + H N++Q +G    G+       L+  +   GSL   +     +   + W +L  +A 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAE 128

Query: 172 GTARGIEYLH-------NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
             ARG+ YLH       +G    I H DIK  N+LL +N    ++DFGLA          
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188

Query: 225 SISATRGTIGYIAPELISRNFGT---VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 281
                 GT  Y+APE++            + D+Y  G+VL E+A     ++         
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV-DEYML 247

Query: 282 YFPSWVYDQ----------LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
            F   +             ++K     L++  +  + +   LC     C    A  R S 
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGM-AMLCETIEECWDHDAEARLSA 306

Query: 332 TKVLEMLE 339
             V E + 
Sbjct: 307 GCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 6e-66
 Identities = 81/288 (28%), Positives = 142/288 (49%), Gaps = 30/288 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
           +   K+G G FG+V++ +   G  +AVK+L    F A    EF+ EV+ + R+ H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +G  ++    ++V EY+  GSL   +  K    + L   +   +A   A+G+ YLHN  
Sbjct: 99  FMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           +  I+H ++K  N+L+D  +  KV DFGL++   K + F+S  +  GT  ++APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
               + KSDVY FG++L E+A  ++   N+N  +         V     K   LE+    
Sbjct: 215 --PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLEIPRNL 264

Query: 304 --EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 349
             ++ ++I          C   +   RPS   ++++L   +    +PP
Sbjct: 265 NPQVAAIIEG--------CWTNEPWKRPSFATIMDLLR-PLIKSAVPP 303

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (498), Expect = 6e-60
 Identities = 70/328 (21%), Positives = 124/328 (37%), Gaps = 47/328 (14%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINE--VSTIGRIHHVNVVQL 125
                +G+G +G+VYKG L     +AVK+   S  + + FINE  +  +  + H N+ + 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD-ERPVAVKVF--SFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 126 LGFCSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           +      +        LV EY PNGSL +++        +  W     +A    RG+ YL
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 181 HN------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH----PKENDFVSISATR 230
           H            I H D+   N+L+ ++    +SDFGL+                +A  
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187

Query: 231 --GTIGYIAPELIS-----RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY- 282
             GTI Y+APE++      R+  +   + D+Y  G++  E+    R +++    S   Y 
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCTDLFPGESVPEYQ 245

Query: 283 --FPSWVYDQ----------LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
             F + V +             +    +     +  S+  R L      C    A  R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 331 MTKVLEMLEGSIDDLQMPPRPFFSSSRH 358
                E +   +   +       ++  H
Sbjct: 306 AQXAEERMAELMMIWERNKSVSPTAHHH 333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  193 bits (493), Expect = 2e-59
 Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 31/302 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V K + +    +A+K +E+     + FI E+  + R++H N+V+L G
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER-KAFIVELRQLSRVNHPNIVKLYG 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
            C       LV EY   GSL  +V                   L  ++G+ YLH+     
Sbjct: 69  ACLN--PVCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125

Query: 188 ILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
           ++H D+KP N+LL     + K+ DFG A           ++  +G+  ++APE+   +  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGS-- 178

Query: 247 TVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNV-T 303
             S K DV+ +G++L E+   R+    +             +   ++ G    L +N+  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGP-------AFRIMWAVHNGTRPPLIKNLPK 231

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISGTG 363
            IES++ R        C     + RPSM ++++++   +        P     +H    G
Sbjct: 232 PIESLMTR--------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283

Query: 364 RE 365
            +
Sbjct: 284 ED 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (487), Expect = 9e-59
 Identities = 79/275 (28%), Positives = 142/275 (51%), Gaps = 26/275 (9%)

Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAE---EFINEVSTIGRIHHVNVVQLLG 127
            ++G G FG+VYKG+    G +AVKML  +  + +    F NEV  + +  HVN++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDV 186
           + +   + A+V ++    SL  H+    +       +KL ++A  TARG++YLH      
Sbjct: 88  YSTAP-QLAIVTQWCEGSSLYHHL---HASETKFEMKKLIDIARQTARGMDYLHAKS--- 140

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  ++ 
Sbjct: 141 -IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
              S +SDVY FG+VL E+  G+   SN+N            + + + +G      ++++
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIEMVGRGS--LSPDLSK 249

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + S   +++  +   C++ K  +RPS  ++L  +E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  189 bits (483), Expect = 3e-58
 Identities = 66/288 (22%), Positives = 117/288 (40%), Gaps = 42/288 (14%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-LIAVKMLENSKFSA--------EEFINEVSTIGRIHH 119
           +  ++G+GGFG V+KG+L     ++A+K L               +EF  EV  +  ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+V+L G         +V E++P G L   +     +   + W     + L  A GIEY
Sbjct: 83  PNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 180 LHNGCDVCILHFDIKPHNILLD-----HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + N  +  I+H D++  NI L           KV+DFGL++         S+S   G   
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNK 293
           ++APE I     + + K+D Y F M+L  +  G       +  +        ++     +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------IKFINMIREE 245

Query: 294 GGDLELQNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G    +       + ++I          C       RP  + +++ L 
Sbjct: 246 GLRPTIPEDCPPRLRNVIEL--------CWSGDPKKRPHFSYIVKELS 285

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  188 bits (479), Expect = 8e-58
 Identities = 72/288 (25%), Positives = 116/288 (40%), Gaps = 44/288 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKML-----ENSKFSAEEFINEVSTIGRIHHVNV 122
                +G GGFG VY+     G  +AVK       E+   + E    E      + H N+
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           + L G C +     LV E+   G L+R +      G+ +  + L   A+  ARG+ YLH+
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHD 123

Query: 183 GCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
              V I+H D+K  NIL+          N I K++DFGLA+   +     +  +  G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYA 179

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNK 293
           ++APE+I  +    S  SDV+ +G++L E+  G      ++             Y     
Sbjct: 180 WMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMN 229

Query: 294 GGDLELQNVT--EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              L + +        ++          C       RPS T +L+ L 
Sbjct: 230 KLALPIPSTCPEPFAKLMED--------CWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  185 bits (471), Expect = 4e-56
 Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 37/286 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
                +G+G FG VY G+    G +A+++++  + +    + F  EV    +  H NVV 
Sbjct: 36  EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +G C      A++       +L   V         L   K  ++A    +G+ YLH   
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV---SISATRGTIGYIAPELI 241
              ILH D+K  N+  D+  +  ++DFGL               +    G + ++APE+I
Sbjct: 149 -KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206

Query: 242 SRNFGTVSC-------KSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNK 293
            +               SDV+  G +  E+                       +  Q+  
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---------AEAIIWQMGT 257

Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G    L      +  + +++  I L+C   +  +RP+ TK+++MLE
Sbjct: 258 GMKPNL-----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  182 bits (465), Expect = 1e-55
 Identities = 53/281 (18%), Positives = 106/281 (37%), Gaps = 36/281 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
           +F  KL +   G ++KG+ Q G  I VK+L+   +S     +F  E   +    H NV+ 
Sbjct: 13  NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 125 LLGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           +LG C         L+  +MP GSL   +   E     +   +  + AL  ARG+ +LH 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI- 241
             +  I    +   ++++D +   ++S   +                     ++APE + 
Sbjct: 130 -LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQ 181

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLEL- 299
            +   T    +D++ F ++L E+       ++++                  +G    + 
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALEGLRPTIP 233

Query: 300 -QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +  ++          C+    A RP    ++ +LE
Sbjct: 234 PGISPHVSKLMKI--------CMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  172 bits (439), Expect = 2e-51
 Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 36/300 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSA-EEFINEVSTIGRIHHVNVVQL 125
                LG+G FG   K    +TG ++ +K L          F+ EV  +  + H NV++ 
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G   +  +   + EY+  G+L   +   +S      W +    A   A G+ YLH    
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLH---S 126

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKF------------HPKENDFVSISATRGTI 233
           + I+H D+  HN L+  N    V+DFGLA+               K+ D        G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
            ++APE+I  N  +   K DV+ FG+VL E+ G                 P ++   ++ 
Sbjct: 187 YWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDF 232

Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL--QMPPRP 351
           G ++                  I + C  +    RPS  K+   LE     L   +P  P
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  173 bits (440), Expect = 2e-51
 Identities = 61/305 (20%), Positives = 124/305 (40%), Gaps = 38/305 (12%)

Query: 62  IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN 121
            IA       ++G+G +G V+ G+ + G  +AVK+   ++ ++     E+     + H N
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHEN 92

Query: 122 VVQLLGFCSEGSKR----ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           ++  +    +G+       L+ +Y  NGSL  ++     +  +L  + + ++A  +  G+
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGL 147

Query: 178 EYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT--R 230
            +LH           I H D+K  NIL+  N    ++D GLA     + + V I      
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207

Query: 231 GTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 286
           GT  Y+ PE++  +           +D+Y FG++L E+A  RR  +       +  +   
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYHDL 265

Query: 287 VYDQLNKGGDLELQNVT-------EIESMIARKLCMIGLW-----CIQVKAADRPSMTKV 334
           V    +     +++ +           +  +   C+  +      C     A R +  +V
Sbjct: 266 VPSDPSYE---DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322

Query: 335 LEMLE 339
            + L 
Sbjct: 323 KKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (427), Expect = 1e-49
 Identities = 60/296 (20%), Positives = 112/296 (37%), Gaps = 32/296 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G +G V++G  Q G  +AVK+  +    +     E+     + H N++  + 
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 128 FCSEGSKRA----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-- 181
                   +    L+  Y   GSL  ++     +  +L       + L  A G+ +LH  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 182 ---NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT--RGTIGYI 236
                    I H D+K  NIL+  N    ++D GLA  H +  + + +      GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 237 APELI----SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN 292
           APE++      +      + D++ FG+VL E+A  RR  +       K  F   V +  +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 293 KGGDLEL---QNVT-EIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                ++         I +       +  L      C     + R +  ++ + L 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  164 bits (418), Expect = 5e-48
 Identities = 68/305 (22%), Positives = 125/305 (40%), Gaps = 38/305 (12%)

Query: 62  IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN 121
            IA T      +G+G FG V++G+ + G  +AVK+  + +  +     E+     + H N
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 97

Query: 122 VVQLLGFCSEGSKRA----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           ++  +   ++ +       LV +Y  +GSL  ++        ++  E + ++AL TA G+
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGL 152

Query: 178 EYLH-----NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT--R 230
            +LH           I H D+K  NIL+  N    ++D GLA  H    D + I+     
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 231 GTIGYIAPELISRNFGTVSC----KSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW 286
           GT  Y+APE++  +          ++D+Y  G+V  E+A  RR S        +  +   
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYYDL 270

Query: 287 VYDQLNKGGDLELQNVT-------EIESMIARKLCMIGLW-----CIQVKAADRPSMTKV 334
           V    +     E++ V         I +       +  +      C     A R +  ++
Sbjct: 271 VPSDPSVE---EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327

Query: 335 LEMLE 339
            + L 
Sbjct: 328 KKTLS 332

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  153 bits (387), Expect = 4e-42
 Identities = 77/275 (28%), Positives = 130/275 (47%), Gaps = 28/275 (10%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
             HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
            C+      ++ E+M  G+L    + +E   Q +    L  +A   +  +EYL       
Sbjct: 284 VCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H ++   N L+  N + KV+DFGL++     + + + +  +  I + APE +   +  
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--AYNK 395

Query: 248 VSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTE 304
            S KSDV+ FG++L E+A  G      ++ ++         VY+ L K   +E  +   E
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYELLEKDYRMERPEGCPE 446

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  K+  +   C Q   +DRPS  ++ +  E
Sbjct: 447 -------KVYELMRACWQWNPSDRPSFAEIHQAFE 474

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (383), Expect = 8e-42
 Identities = 77/330 (23%), Positives = 143/330 (43%), Gaps = 43/330 (13%)

Query: 28  FLVSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNH---------------FTHK 72
           F +S R+T  T+  +    +     + ++ S P + +                      K
Sbjct: 136 FYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKK 195

Query: 73  LGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG 132
           LG G FG V+         +AVK ++    S E F+ E + +  + H  +V+L    ++ 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 254

Query: 133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
               ++ E+M  GSL    F K   G      KL + +   A G+ ++        +H D
Sbjct: 255 EPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309

Query: 193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKS 252
           ++  NIL+  + + K++DFGLA+   ++N++ +    +  I + APE I  NFG+ + KS
Sbjct: 310 LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI--NFGSFTIKS 366

Query: 253 DVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTEIESMI 309
           DV+ FG++L+E+   G      M+            V   L +G  +   +N  E     
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPE---------VIRALERGYRMPRPENCPE----- 412

Query: 310 ARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +L  I + C + +  +RP+   +  +L+
Sbjct: 413 --ELYNIMMRCWKNRPEERPTFEYIQSVLD 440

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  146 bits (371), Expect = 1e-41
 Identities = 82/280 (29%), Positives = 129/280 (46%), Gaps = 36/280 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL-IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
              HKLG G +G VY+G  +   L +AVK L+      EEF+ E + +  I H N+VQLL
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGC 184
           G C+      ++ E+M  G+L    + +E   Q +    L  +A   +  +EYL   N  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I H D+   N L+  N + KV+DFGL++     + + + +  +  I + APE +   
Sbjct: 132 --FI-HRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESL--A 185

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL- 299
           +   S KSDV+ FG++L E+          AT     Y P      VY+ L K   +E  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEI----------ATYGMSPY-PGIDLSQVYELLEKDYRMERP 234

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +   E       K+  +   C Q   +DRPS  ++ +  E
Sbjct: 235 EGCPE-------KVYELMRACWQWNPSDRPSFAEIHQAFE 267

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (379), Expect = 2e-41
 Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 28/274 (10%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
              KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
            SE     +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 358

Query: 249 SCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTEI 305
           + KSDV+ FG++L E+   G      M             V DQ+ +G  +       E 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECPE- 408

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  L  +   C + +  +RP+   +   LE
Sbjct: 409 ------SLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (381), Expect = 4e-41
 Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 28/274 (10%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
              KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
            SE     +V EYM  GSL    F K   G+ L   +L ++A   A G+ Y+     +  
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D++  NIL+  N + KV+DFGLA+   ++N++ +    +  I + APE     +G  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAA--LYGRF 441

Query: 249 SCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTEI 305
           + KSDV+ FG++L E+   G      M             V DQ+ +G  +       E 
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECPE- 491

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  L  +   C + +  +RP+   +   LE
Sbjct: 492 ------SLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (366), Expect = 5e-41
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 36/279 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V+ G       +AVK L+    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGCD 185
             ++     ++ EYM NGSL    F K   G  L   KL ++A   A G+ ++   N   
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I H D++  NIL+      K++DFGLA+   ++N++ +    +  I + APE I  N+
Sbjct: 130 -YI-HRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAI--NY 184

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL-Q 300
           GT + KSDV+ FG++L E+           T     Y P      V   L +G  +    
Sbjct: 185 GTFTIKSDVWSFGILLTEI----------VTHGRIPY-PGMTNPEVIQNLERGYRMVRPD 233

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           N  E       +L  +   C + +  DRP+   +  +LE
Sbjct: 234 NCPE-------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (362), Expect = 1e-40
 Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V  G+ +    +AVKM++    S +EF  E  T+ ++ H  +V+  G
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-HNGCDV 186
            CS+     +V EY+ NG L  ++    S G+ L   +L E+      G+ +L  +    
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N L+D +   KVSDFG+ ++   ++ +VS   T+  + + APE+   ++ 
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF--HYF 180

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLEL- 299
             S KSDV+ FG+++ E+              S    P        V  ++++G  L   
Sbjct: 181 KYSSKSDVWAFGILMWEVF-------------SLGKMPYDLYTNSEVVLKVSQGHRLYRP 227

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
              ++        +  I   C       RP+  ++L  +E
Sbjct: 228 HLASD-------TIYQIMYSCWHELPEKRPTFQQLLSSIE 260

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (369), Expect = 2e-40
 Identities = 64/282 (22%), Positives = 116/282 (41%), Gaps = 38/282 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL-IAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
               ++G+G FG V+ G+L+     +AVK            +F+ E   + +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           L+G C++     +V E +  G     +    + G  L  + L ++    A G+EYL    
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE--- 230

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
             C +H D+   N L+    + K+SDFG+++         S    +  + + APE +  N
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL--N 288

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLE 298
           +G  S +SDV+ FG++L E               S    P          + + KGG L 
Sbjct: 289 YGRYSSESDVWSFGILLWETF-------------SLGASPYPNLSNQQTREFVEKGGRLP 335

Query: 299 L-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +   +        +  +   C   +   RPS + + + L+
Sbjct: 336 CPELCPD-------AVFRLMEQCWAYEPGQRPSFSTIYQELQ 370

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  143 bits (364), Expect = 3e-40
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 35/281 (12%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGL-----IAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
               LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           V +LLG C   S   L+ + MP G L  +V  +E +   +  + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 300 -QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               T         + MI   C  + A  RP   +++    
Sbjct: 241 PPICTI-------DVYMIMRKCWMIDADSRPKFRELIIEFS 274

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  141 bits (358), Expect = 6e-40
 Identities = 72/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGCD 185
            C E +   LV E+M +G L    + +  RG     E L  + L    G+ YL       
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSD--YLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC--- 124

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             I H D+   N L+  N + KVSDFG+ +F   ++ + S + T+  + + +PE+   +F
Sbjct: 125 -VI-HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF--SF 179

Query: 246 GTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL- 299
              S KSDV+ FG+++ E  + G+              + +     V + ++ G  L   
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEVVEDISTGFRLYKP 227

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +  +         +  I   C + +  DRP+ +++L  L 
Sbjct: 228 RLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLA 260

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (354), Expect = 3e-39
 Identities = 70/286 (24%), Positives = 128/286 (44%), Gaps = 40/286 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGCD 185
            C++     ++ EYM NG L    + +E R +    ++L E+       +EYL       
Sbjct: 87  VCTKQRPIFIITEYMANGCLLN--YLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ--- 140

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
             + H D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++   +
Sbjct: 141 -FL-HRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVL--MY 195

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKGGDLEL 299
              S KSD++ FG+++ E+              S    P          + + +G  L  
Sbjct: 196 SKFSSKSDIWAFGVLMWEIY-------------SLGKMPYERFTNSETAEHIAQGLRLYR 242

Query: 300 -QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
               +E       K+  I   C   KA +RP+   +L  +   +D+
Sbjct: 243 PHLASE-------KVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (351), Expect = 1e-38
 Identities = 61/291 (20%), Positives = 116/291 (39%), Gaps = 35/291 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL-----QTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHV 120
                LG+G FG V   +       TG  +AVK L  E+      +   E+  +  ++H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 121 NVVQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           N+V+  G C+E       L+ E++P+GSL  ++         +  ++  + A+   +G++
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMD 140

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
           YL        +H D+   N+L++     K+ DFGL K    + ++   +        + +
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY--YTVKDDRDSPVFW 195

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLE-MAGGRRNSNMNATRSSKAYFPSW------VY 288
            APE +          SDV+ FG+ L E +     +S+  A                 + 
Sbjct: 196 YAPECL--MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253

Query: 289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + L +G  L        E      +  +   C + + ++R S   ++E  E
Sbjct: 254 NTLKEGKRLPCPPNCPDE------VYQLMRKCWEFQPSNRTSFQNLIEGFE 298

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  139 bits (351), Expect = 2e-38
 Identities = 75/324 (23%), Positives = 128/324 (39%), Gaps = 44/324 (13%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
               LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           V +LLG C   S   L+ + MP G L  +V  +E +   +  + L    +  A+G+ YL 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYV--REHKDN-IGSQYLLNWCVQIAKGMNYLE 134

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              D  ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I
Sbjct: 135 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
                  + +SDV+ +G+ + E+   G +    + A+          +   L KG  L  
Sbjct: 192 --LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGERLPQ 240

Query: 300 -QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE------GSIDDLQMPPR-- 350
               T         + MI + C  + A  RP   +++               +Q   R  
Sbjct: 241 PPICTI-------DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 293

Query: 351 -PFFSSSRHISGTGREIESDSSAE 373
            P  + S        E + D   +
Sbjct: 294 LPSPTDSNFYRALMDEEDMDDVVD 317

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (350), Expect = 3e-38
 Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 35/282 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL-----IAVKML--ENSKFSAEEFINEVSTIGRIHHV 120
                LG G FG+V+KG     G      + +K++  ++ + S +   + +  IG + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           ++V+LLG C   S   LV +Y+P GSL  HV  ++ RG  L  + L    +  A+G+ YL
Sbjct: 76  HIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGA-LGPQLLLNWGVQIAKGMYYL 131

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
               +  ++H ++   N+LL      +V+DFG+A   P ++  +  S  +  I ++A E 
Sbjct: 132 E---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           I  +FG  + +SDV+ +G+ + E+   G    + +             V D L KG  L 
Sbjct: 189 I--HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---------VPDLLEKGERLA 237

Query: 299 L-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             Q  T         + M+ + C  +    RP+  ++     
Sbjct: 238 QPQICTI-------DVYMVMVKCWMIDENIRPTFKELANEFT 272

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (348), Expect = 4e-38
 Identities = 72/302 (23%), Positives = 120/302 (39%), Gaps = 45/302 (14%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   +   + +   KL +      +G+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 237
                   +H D+   NIL+++    K+ DFGL K  P++ +F            I + A
Sbjct: 131 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF--FKVKEPGESPIFWYA 185

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSW------VYD 289
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 186 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243

Query: 290 QLNKGGDLEL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
            L   G L         +  I         M   W        RPS   +   ++   D+
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVDQIRDN 292

Query: 345 LQ 346
           + 
Sbjct: 293 MA 294

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (343), Expect = 3e-37
 Identities = 67/293 (22%), Positives = 119/293 (40%), Gaps = 43/293 (14%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
               LG+G FG V           TG ++AVK L  +        +  E+  +  ++H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 122 VVQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
           +++  G C +    +  LV EY+P GSL  ++        S+   +L   A     G+ Y
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-VSISATRGTIGYIAP 238
           LH       +H D+   N+LLD++ + K+ DFGLAK  P+ +++          + + AP
Sbjct: 150 LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSW------VYDQL 291
           E +          SDV+ FG+ L E+      + +                    + + L
Sbjct: 207 ECL--KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 292 NKGGDLEL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L         V  +  M   K C    W  + +A+ RP+   ++ +L+
Sbjct: 265 ERGERLPRPDKCPAEVYHL--M---KNC----W--ETEASFRPTFENLIPILK 306

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 9e-37
 Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 46/289 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
           H    +G+G FG VY G+           A+K L         E F+ E   +  ++H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 122 VVQLLGFCSEGSKRAL-VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+ L+G           +  YM +G L + +    S  ++   + L    L  ARG+EYL
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD +F  KV+DFGLA+    + ++ S+   R     + +
Sbjct: 141 AEQK----FV-HRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHRHARLPVKW 194

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQL 291
            A E  S      + KSDV+ FG++L E+           TR +  Y        +   L
Sbjct: 195 TALE--SLQTYRFTTKSDVWSFGVLLWEL----------LTRGAPPY-RHIDPFDLTHFL 241

Query: 292 NKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +G  L   +   +        L  +   C +   A RP+   ++  +E
Sbjct: 242 AQGRRLPQPEYCPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE 283

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  133 bits (336), Expect = 1e-36
 Identities = 63/291 (21%), Positives = 115/291 (39%), Gaps = 47/291 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 122
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-- 180
           V+L+G  +E +   ++ E    G L    F +  +   L    L   A   +  + YL  
Sbjct: 79  VKLIGVITE-NPVWIIMELCTLGELRS--FLQVRKYS-LDLASLILYAYQLSTALAYLES 134

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 135 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 188

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNKG 294
           I  NF   +  SDV+ FG+ + E+                   P        V  ++  G
Sbjct: 189 I--NFRRFTSASDVWMFGVCMWEIL-------------MHGVKPFQGVKNNDVIGRIENG 233

Query: 295 GDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
             L +  N           L  +   C     + RP  T++   L   +++
Sbjct: 234 ERLPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (337), Expect = 1e-36
 Identities = 77/295 (26%), Positives = 117/295 (39%), Gaps = 46/295 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 122 VVQLLGFCSEGSKRAL-VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+ LLG C       L V  YM +G L    F +         + L    L  A+G++YL
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN-PTVKDLIGFGLQVAKGMKYL 144

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD  F  KV+DFGLA+    + ++ S+    G    + +
Sbjct: 145 ASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDKEYYSVHNKTGAKLPVKW 198

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQL 291
           +A E  S      + KSDV+ FG++L E+           TR +  Y P      +   L
Sbjct: 199 MALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTRGAPPY-PDVNTFDITVYL 245

Query: 292 NKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
            +G  L   +   +        L  + L C   KA  RPS ++++  +       
Sbjct: 246 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  134 bits (338), Expect = 2e-36
 Identities = 70/295 (23%), Positives = 117/295 (39%), Gaps = 45/295 (15%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 122
           F  +LG+G FGSV   +       TG ++AVK L  +++    +F  E+  +  + H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G C    +R   L+ EY+P GSL  ++   +   + +   KL +      +G+EYL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 161

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIA 237
                   +H D+   NIL+++    K+ DFGL K  P++ ++            I + A
Sbjct: 162 G---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY--YKVKEPGESPIFWYA 216

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSW------VYD 289
           PE +       S  SDV+ FG+VL E+     +  S                     + +
Sbjct: 217 PESL--TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274

Query: 290 QLNKGGDLEL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            L   G L         +  I         M   W        RPS   +   ++
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMI---------MTECW--NNNVNQRPSFRDLALRVD 318

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  132 bits (335), Expect = 2e-36
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 44/281 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
                +G+G FG V  G  + G  +AVK +  ++  +A+ F+ E S + ++ H N+VQLL
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLL 80

Query: 127 GFCSEGSKRA-LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNG 183
           G   E      +V EYM  GSL    + +      L  + L + +L     +EYL  +N 
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               + H D+   N+L+  + + KVSDFGL K         +    +  + + APE +  
Sbjct: 138 ---FV-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL-- 186

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQLNKGGDLEL 299
                S KSDV+ FG++L E+           +     Y P      V  ++ KG  ++ 
Sbjct: 187 REKKFSTKSDVWSFGILLWEI----------YSFGRVPY-PRIPLKDVVPRVEKGYKMDA 235

Query: 300 -QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                         +  +   C  + AA RPS  ++ E LE
Sbjct: 236 PDGCPP-------AVYEVMKNCWHLDAAMRPSFLQLREQLE 269

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (338), Expect = 2e-36
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 47/288 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG-----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
               +G G FG VYKG L+T        +A+K L    ++    +F+ E   +G+  H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +++L G  S+     ++ EYM NG+LD+  F +E  G+     +L  +  G A G++YL 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGE-FSVLQLVGMLRGIAAGMKYLA 164

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 238
              ++  +H D+   NIL++ N + KVSDFGL++    E+D  +   T G    I + AP
Sbjct: 165 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP 219

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLN 292
           E I  ++   +  SDV+ FG+V+ E+              +    P W      V   +N
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM-------------TYGERPYWELSNHEVMKAIN 264

Query: 293 KGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            G  L    +           +  + + C Q + A RP    ++ +L+
Sbjct: 265 DGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILD 305

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  133 bits (336), Expect = 3e-36
 Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 40/309 (12%)

Query: 69  FTHKLGQGGFGSVYKGQL-----QTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNV 122
           +  +LG+G FGSV   +       TG L+AVK L  +      +F  E+  +  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 123 VQLLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+  G      +++  LV EY+P+G L    F +  R + L   +L   +    +G+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRAR-LDASRLLLYSSQICKGMEYL 143

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPE 239
                   +H D+   NIL++     K++DFGLAK  P + D +V     +  I + APE
Sbjct: 144 G---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
            +  +    S +SDV+ FG+VL E+           T   K+  PS  + ++  G + ++
Sbjct: 201 SL--SDNIFSRQSDVWSFGVVLYEL----------FTYCDKSCSPSAEFLRM-MGCERDV 247

Query: 300 QNVTEIESMIAR-------KLC-----MIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM 347
             ++ +  ++           C      +   C      DRPS + +   L+      + 
Sbjct: 248 PALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307

Query: 348 PPRPFFSSS 356
                F++ 
Sbjct: 308 CETHAFTAH 316

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (336), Expect = 3e-36
 Identities = 80/320 (25%), Positives = 124/320 (38%), Gaps = 58/320 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML--ENSKFSAEEFINEVSTIGRIHH 119
                LG G FG VY+GQ+           +AVK L    S+    +F+ E   I + +H
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARG 176
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 177 IEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR- 230
            +YL  ++     I H DI   N LL       + K+ DFG+A+      D    S  R 
Sbjct: 153 CQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRK 201

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
           G    +      PE  +   G  + K+D + FG++L E+           +     Y PS
Sbjct: 202 GGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEI----------FSLGYMPY-PS 248

Query: 286 W----VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E 
Sbjct: 249 KSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEY 301

Query: 341 SIDDLQMPPRPFFSSSRHIS 360
              D  +           + 
Sbjct: 302 CTQDPDVINTALPIEYGPLV 321

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (338), Expect = 4e-36
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 46/287 (16%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 122
               +G G FG V  G+L+        +A+K L    ++    +F+ E S +G+  H N+
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           ++L G  ++     +V EYM NGSLD   F ++   Q     +L  +  G A G++YL  
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQ-FTVIQLVGMLRGIASGMKYLS- 164

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPE 239
             D+  +H D+   NIL++ N + KVSDFGL +    + +      TRG    I + +PE
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRGGKIPIRWTSPE 220

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL 297
            I   +   +  SDV+ +G+VL E+   G R    M+            V   +++G  L
Sbjct: 221 AI--AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEGYRL 269

Query: 298 ELQNVTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                           C   L+     C Q    +RP   +++ +L+
Sbjct: 270 P-----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  132 bits (335), Expect = 5e-36
 Identities = 83/284 (29%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
           H    +G G  G V  G+L+  G     +A+K L    ++    +F++E S +G+  H N
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +++L G  + G    +V EYM NGSLD   F +   GQ     +L  +  G   G+ YL 
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQ-FTIMQLVGMLRGVGAGMRYLS 168

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAP 238
              D+  +H D+   N+L+D N + KVSDFGL++    + D      T G    I + AP
Sbjct: 169 ---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA--YTTTGGKIPIRWTAP 223

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGD 296
           E I   F T S  SDV+ FG+V+ E+   G R   NM             V   + +G  
Sbjct: 224 EAI--AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---------VISSVEEGYR 272

Query: 297 LEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           L                L  + L C     A RP  ++++ +L+
Sbjct: 273 LPAPMGCPH-------ALHQLMLDCWHKDRAQRPRFSQIVSVLD 309

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (337), Expect = 5e-36
 Identities = 76/295 (25%), Positives = 117/295 (39%), Gaps = 46/295 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 122 VVQLLGFCSEG-SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+ LLG C        +V  YM +G L    F +         + L    L  A+G+++L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN-PTVKDLIGFGLQVAKGMKFL 208

Query: 181 --HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGY 235
                    + H D+   N +LD  F  KV+DFGLA+    + +F S+    G    + +
Sbjct: 209 ASKK----FV-HRDLAARNCMLDEKFTVKVADFGLARD-MYDKEFDSVHNKTGAKLPVKW 262

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW----VYDQL 291
           +A E  S      + KSDV+ FG++L E+           TR +  Y P      +   L
Sbjct: 263 MALE--SLQTQKFTTKSDVWSFGVLLWEL----------MTRGAPPY-PDVNTFDITVYL 309

Query: 292 NKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
            +G  L   +   +        L  + L C   KA  RPS ++++  +       
Sbjct: 310 LQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  131 bits (331), Expect = 1e-35
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
           LG+G +G VY G  L     IA+K +       ++    E++    + H N+VQ LG  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA---RGIEYLHNGCDVC 187
           E     +  E +P GSL      +   G     E+   +   T     G++YLH   D  
Sbjct: 90  ENGFIKIFMEQVPGGSL--SALLRSKWGPLKDNEQT--IGFYTKQILEGLKYLH---DNQ 142

Query: 188 ILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRNF 245
           I+H DIK  N+L++ ++ + K+SDFG +K   +       + T  GT+ Y+APE+I +  
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSK---RLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR 269
                 +D++  G  ++EMA G+ 
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 1e-35
 Identities = 66/283 (23%), Positives = 115/283 (40%), Gaps = 46/283 (16%)

Query: 72  KLGQGGFGSVYKGQLQTGG---LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  +       +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G C       LV E    G L + +     + + +    + E+    + G++YL    + 
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---EEK 129

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPELISR 243
             +H D+   N+LL +    K+SDFGL+K    ++ +   +A       + + APE I  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY--YTARSAGKWPLKWYAPECI-- 185

Query: 244 NFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
           NF   S +SDV+ +G+ + E    G +    M             V   + +G  +E   
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRME--- 233

Query: 302 VTEIESMIARKLCMIGLW-----CIQVKAADRPSMTKVLEMLE 339
                       C   L+     C   K  DRP    V + + 
Sbjct: 234 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (330), Expect = 1e-35
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 29/210 (13%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           ++G+G F +VYKG   +T   +A   L++ K +  E   F  E   +  + H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 128 FCSEGSKRA----LVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
                 K      LV E M +G+L     R    K    +S C + L         G+++
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK--------GLQF 144

Query: 180 LHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           LH      I+H D+K  NI +       K+ D GLA             A  GT  ++AP
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAP 199

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E+    +       DVY FGM +LEMA   
Sbjct: 200 EMYEEKYDE---SVDVYAFGMCMLEMATSE 226

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (338), Expect = 1e-35
 Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 40/278 (14%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKML-ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               +G+G FG V  G  + G  +AVK +  ++  +A+ F+ E S + ++ H N+VQLLG
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 128 FCSEGSKRA-LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNGC 184
              E      +V EYM  GSL    + +      L  + L + +L     +EYL  +N  
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 309

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              + H D+   N+L+  + + KVSDFGL K         +    +  + + APE +   
Sbjct: 310 --FV-HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL--R 359

Query: 245 FGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL-QN 301
               S KSDV+ FG++L E+   G      +             V  ++ KG  ++    
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAPDG 410

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                      +  +   C  + AA RP+  ++ E LE
Sbjct: 411 CPP-------AVYDVMKNCWHLDAATRPTFLQLREQLE 441

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  130 bits (329), Expect = 2e-35
 Identities = 76/301 (25%), Positives = 128/301 (42%), Gaps = 48/301 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFSAEE---FINEVSTIGRIHHV 120
                LG+G FGSV +G L+        +AVK ++    S  E   F++E + +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 121 NVVQLLGFCSEGSKRA-----LVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALG 172
           NV++LLG C E S +      ++  +M  G L     +    E+  + +  + L +  + 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVD 155

Query: 173 TARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
            A G+EYL   N     + H D+   N +L  +    V+DFGL+K     + +      +
Sbjct: 156 IALGMEYLSNRN----FL-HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW---- 286
             + +IA E  S      + KSDV+ FG+ + E+          ATR    Y P      
Sbjct: 211 MPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEI----------ATRGMTPY-PGVQNHE 257

Query: 287 VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
           +YD L  G  L+  ++  +       +L  I   C +    DRP+ + +   LE  ++ L
Sbjct: 258 MYDYLLHGHRLKQPEDCLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

Query: 346 Q 346
            
Sbjct: 311 P 311

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  131 bits (331), Expect = 3e-35
 Identities = 80/304 (26%), Positives = 121/304 (39%), Gaps = 58/304 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSAE-EFINEVSTIGRIHH 119
                LG G FG VY+GQ+           +AVK L E      E +F+ E   I + +H
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARG 176
            N+V+ +G   +   R ++ E M  G L    R   P+ S+  SL    L  VA   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 177 IEYL--HNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSISATR- 230
            +YL  ++     I H DI   N LL       + K+ DFG+A+      D       R 
Sbjct: 194 CQYLEENH----FI-HRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRK 242

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
           G    +      PE  +   G  + K+D + FG++L E+           +     Y PS
Sbjct: 243 GGCAMLPVKWMPPE--AFMEGIFTSKTDTWSFGVLLWEI----------FSLGYMPY-PS 289

Query: 286 W----VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                V + +  GG ++  +N           +  I   C Q +  DRP+   +LE +E 
Sbjct: 290 KSNQEVLEFVTSGGRMDPPKNCPG-------PVYRIMTQCWQHQPEDRPNFAIILERIEY 342

Query: 341 SIDD 344
              D
Sbjct: 343 CTQD 346

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  130 bits (328), Expect = 5e-35
 Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 49/309 (15%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL---IAVKML-ENSKFSA-EEFI 108
           P    YP +      F   +G+G FG V K +++  GL    A+K + E +      +F 
Sbjct: 14  PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 73

Query: 109 NEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKE 155
            E+  + ++ HH N++ LLG C       L  EY P+G+L            D       
Sbjct: 74  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 156 SRGQSLCWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
           S   +L  ++L   A   ARG++YL         I H D+   NIL+  N++ K++DFGL
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQ----FI-HRDLAARNILVGENYVAKIADFGL 188

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNS 271
           ++    +  +V  +  R  + ++A E  S N+   +  SDV+ +G++L E+   GG    
Sbjct: 189 SR---GQEVYVKKTMGRLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 272 NMNATRSSKAYFPSWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
            M             +Y++L +G  LE   N  +       ++  +   C + K  +RPS
Sbjct: 244 GMTCAE---------LYEKLPQGYRLEKPLNCDD-------EVYDLMRQCWREKPYERPS 287

Query: 331 MTKVLEMLE 339
             ++L  L 
Sbjct: 288 FAQILVSLN 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  129 bits (327), Expect = 7e-35
 Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 58/304 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKML-ENSKFSA-EEFINEVSTIGRIHH 119
             + +LGQG FG VY+G        +    +A+K + E +      EF+NE S +   + 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD------RHVFPKESRGQSLCWEKLHEVALGT 173
            +VV+LLG  S+G    ++ E M  G L       R               K+ ++A   
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 174 ARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR- 230
           A G+ YL  +      + H D+   N ++  +F  K+ DFG+ +      D       R 
Sbjct: 148 ADGMAYLNANK----FV-HRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRK 196

Query: 231 GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
           G  G +     +PE  S   G  +  SDV+ FG+VL E+          AT + + Y   
Sbjct: 197 GGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEI----------ATLAEQPY-QG 243

Query: 286 W----VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                V   + +GG L+   N  +        L  +   C Q     RPS  +++  ++ 
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKE 296

Query: 341 SIDD 344
            ++ 
Sbjct: 297 EMEP 300

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (324), Expect = 7e-35
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 47/287 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL----IAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
                LG+G FG VY+G           +AVK    + +  + E+F++E   +  + H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL- 180
           +V+L+G   E     ++ E  P G L  ++   E    SL    L   +L   + + YL 
Sbjct: 75  IVKLIGIIEEEPTW-IIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 181 -HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             N    C+ H DI   NIL+      K+ DFGL+++  ++ D+   S TR  I +++PE
Sbjct: 131 SIN----CV-HRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPE 184

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW------VYDQLNK 293
            I  NF   +  SDV+ F + + E+              S    P +      V   L K
Sbjct: 185 SI--NFRRFTTASDVWMFAVCMWEIL-------------SFGKQPFFWLENKDVIGVLEK 229

Query: 294 GGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           G  L                L  +   C     +DRP  T+++  L 
Sbjct: 230 GDRLPKPDLCPP-------VLYTLMTRCWDYDPSDRPRFTELVCSLS 269

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  128 bits (325), Expect = 1e-34
 Identities = 70/301 (23%), Positives = 119/301 (39%), Gaps = 47/301 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG----LIAVKMLENSKFS---AEEFINEVSTIGRIHHV 120
                LG+G FGSV + QL+        +AVKML+    +    EEF+ E + +    H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 121 NVVQLLGFCSEGSKRA------LVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVAL 171
           +V +L+G       +       ++  +M +G L          E+   +L  + L    +
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN-PFNLPLQTLVRFMV 144

Query: 172 GTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
             A G+EYL   N     I H D+   N +L  +    V+DFGL++     + +    A+
Sbjct: 145 DIACGMEYLSSRN----FI-HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---PSW 286
           +  + ++A E  S      +  SDV+ FG+ + E+           TR    Y     + 
Sbjct: 200 KLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEI----------MTRGQTPYAGIENAE 247

Query: 287 VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL 345
           +Y+ L  G  L+      E       ++  +   C       RPS T +   LE  +  L
Sbjct: 248 IYNYLIGGNRLKQPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

Query: 346 Q 346
            
Sbjct: 301 S 301

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  127 bits (321), Expect = 2e-34
 Identities = 67/281 (23%), Positives = 117/281 (41%), Gaps = 42/281 (14%)

Query: 72  KLGQGGFGSVYKGQLQTGGL---IAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q   +   +AVK+L    N     +E + E + + ++ +  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL--HNG 183
           +G C       LV E    G L++++     + + +  + + E+    + G++YL   N 
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEESN- 137

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYIAPEL 240
               + H D+   N+LL      K+SDFGL+K    + ++    A       + + APE 
Sbjct: 138 ---FV-HRDLAARNVLLVTQHYAKISDFGLSKALRADENY--YKAQTHGKWPVKWYAPEC 191

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           I  N+   S KSDV+ FG+++ E    G +    M  +          V   L KG  + 
Sbjct: 192 I--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---------VTAMLEKGERMG 240

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  E      +  +   C      +RP    V   L 
Sbjct: 241 CPAGCPRE------MYDLMNLCWTYDVENRPGFAAVELRLR 275

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  127 bits (322), Expect = 3e-34
 Identities = 70/305 (22%), Positives = 119/305 (39%), Gaps = 66/305 (21%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSAEEFINEVSTIGRIHHV 120
               +LG+G FG V+  +           L+AVK L E S+ + ++F  E   +  + H 
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-----------DRHVFPKESRGQSLCWEKLHEV 169
           ++V+  G C+EG    +V+EYM +G L                 ++     L   +L  V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 170 ALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSIS 227
           A   A G+ YL   +     + H D+   N L+    + K+ DFG+++      D  S  
Sbjct: 164 ASQVAAGMVYLAGLH----FV-HRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTD 212

Query: 228 ATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA 281
             R G    +      PE I   +   + +SDV+ FG+VL E+              +  
Sbjct: 213 YYRVGGRTMLPIRWMPPESI--LYRKFTTESDVWSFGVVLWEIF-------------TYG 257

Query: 282 YFPSW------VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             P +        D + +G +LE  +           ++  I   C Q +   R S+  V
Sbjct: 258 KQPWYQLSNTEAIDCITQGRELERPRACPP-------EVYAIMRGCWQREPQQRHSIKDV 310

Query: 335 LEMLE 339
              L+
Sbjct: 311 HARLQ 315

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  132 bits (333), Expect = 4e-34
 Identities = 64/290 (22%), Positives = 116/290 (40%), Gaps = 40/290 (13%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGG----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNV 122
               +G+G FG V++G   +       +A+K      S    E+F+ E  T+ +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL-- 180
           V+L+G  +E +   ++ E    G L   +   + R  SL    L   A   +  + YL  
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  + H DI   N+L+  N   K+ DFGL+++  +++ +   S  +  I ++APE 
Sbjct: 510 KR----FV-HRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPES 563

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           I  NF   +  SDV+ FG+ + E+   G +    +             V  ++  G  L 
Sbjct: 564 I--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---------VIGRIENGERLP 612

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP 348
           +             L  +   C     + RP  T++   L      L+  
Sbjct: 613 MPPNCPPT------LYSLMTKCWAYDPSRRPRFTELKAQLS---TILEEE 653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 4e-34
 Identities = 66/279 (23%), Positives = 110/279 (39%), Gaps = 40/279 (14%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCS 130
            LG G  G++    +     +AVK +    FS  +   EV  +     H NV++      
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFCTEK 88

Query: 131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDVCIL 189
           +   + +  E     +L  +V   E +  +    +   +   T  G+ +LH       I+
Sbjct: 89  DRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN----IV 140

Query: 190 HFDIKPHNILL-----DHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPELISR 243
           H D+KPHNIL+            +SDFGL K      + F   S   GT G+IAPE++S 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 244 NFGT-VSCKSDVYGFGMVLLEM-AGGR----RNSNMNATRSSKAYFPSWVYDQLNKGGDL 297
           +     +   D++  G V   + + G     ++    A             + L     L
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------------NILLGACSL 247

Query: 298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +  +  + E +IAR+L  I    I +    RPS   VL+
Sbjct: 248 DCLHPEKHEDVIAREL--I-EKMIAMDPQKRPSAKHVLK 283

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  126 bits (319), Expect = 6e-34
 Identities = 63/306 (20%), Positives = 120/306 (39%), Gaps = 67/306 (21%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSAEEFINEVSTIGRIHHV 120
               +LG+G FG V+  +           L+AVK L + +  + ++F  E   +  + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWEKLHE 168
           ++V+  G C +G    +V+EYM +G L                         L   ++  
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 169 VALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
           +A   A G+ YL   +     + H D+   N L+  N + K+ DFG+++      D  S 
Sbjct: 138 IASQIASGMVYLASQH----FV-HRDLATRNCLVGANLLVKIGDFGMSR------DVYST 186

Query: 227 SATR-GTIGYI-----APELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 280
              R G    +      PE I   +   + +SDV+ FG++L E+              + 
Sbjct: 187 DYYRVGGHTMLPIRWMPPESI--MYRKFTTESDVWSFGVILWEIF-------------TY 231

Query: 281 AYFPSW------VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK 333
              P +      V + + +G  LE  +   +       ++  + L C Q +   R ++ +
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPK-------EVYDVMLGCWQREPQQRLNIKE 284

Query: 334 VLEMLE 339
           + ++L 
Sbjct: 285 IYKILH 290

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 6e-34
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 29/218 (13%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
            ++G+G FG V++ +  QTG   AVK +    F  EE    +     +    +V L G  
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYGAV 119

Query: 130 SEGSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            EG    +  E +  GSL + +      P E R      + L         G+EYLH   
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLGQALE--------GLEYLH--- 167

Query: 185 DVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKENDFVSISAT---RGTIGYIAPEL 240
              ILH D+K  N+LL  +     + DFG A     +    S+       GT  ++APE+
Sbjct: 168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
           +         K D++    ++L M  G    +      
Sbjct: 228 VMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (317), Expect = 7e-34
 Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 51/285 (17%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF-- 128
            +G GGFG V+K +    G    +K +   K++ E+   EV  + ++ HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 129 -----------CSEGSKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA 174
                       S  SK   ++   E+   G+L++ +  ++ RG+ L      E+     
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDKVLALELFEQIT 132

Query: 175 RGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           +G++Y+H      +++ D+KP NI L      K+ DFGL      +        ++GT+ 
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGTLR 186

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMA-GGRRNSNMNATRSSKAYFPSWVYDQLNK 293
           Y++PE IS        + D+Y  G++L E+          +             +  L  
Sbjct: 187 YMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFETSK-----------FFTDLRD 233

Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
           G          I  +  +K   +    +  K  DRP+ +++L  L
Sbjct: 234 G---------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (318), Expect = 7e-34
 Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 48/290 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL----IAVKMLENSKFS----AEEFINEVSTIGRIHH 119
               KLG G FG V +G+          +AVK L+    S     ++FI EV+ +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+++L G         +V E  P GSL   +  ++ +G       L   A+  A G+ Y
Sbjct: 81  RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGT---IGYI 236
           L        +H D+   N+LL    + K+ DFGL +  P+ +D               + 
Sbjct: 137 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWC 191

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKG 294
           APE +     T S  SD + FG+ L EM   G      +N ++         +  +++K 
Sbjct: 192 APESL--KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------ILHKIDKE 240

Query: 295 GDLELQNVTEIESMIARKLC-----MIGLWCIQVKAADRPSMTKVLEMLE 339
           G          E +   + C      + + C   K  DRP+   + + L 
Sbjct: 241 G----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  125 bits (317), Expect = 1e-33
 Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 68/302 (22%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
            LGQG FG V K +        A+K + +++      ++EV  +  ++H  VV+      
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 131 EGSKRA-------------LVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALG 172
           E                  +  EY  NG+L       ++  +        W    ++   
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE----YWRLFRQILEA 128

Query: 173 TARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR- 230
               + Y+H  G    I+H D+KP NI +D +   K+ DFGLAK   +  D + + +   
Sbjct: 129 ----LSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 231 -----------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA-----GGRRNSNMN 274
                      GT  Y+A E++    G  + K D+Y  G++  EM      G  R + + 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILK 239

Query: 275 ATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV 334
             RS    FP    D                +  + +K+       I      RP    +
Sbjct: 240 KLRSVSIEFPPDFDDN---------------KMKVEKKII---RLLIDHDPNKRPGARTL 281

Query: 335 LE 336
           L 
Sbjct: 282 LN 283

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (327), Expect = 2e-33
 Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 32/283 (11%)

Query: 72  KLGQGGFGSVYKGQLQTGG---LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  +       +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G C       LV E    G L +  F    R + +    + E+    + G++YL    + 
Sbjct: 403 GVCQA-EALMLVMEMAGGGPLHK--FLVGKREE-IPVSNVAELLHQVSMGMKYL---EEK 455

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND-FVSISATRGTIGYIAPELISRNF 245
             +H ++   N+LL +    K+SDFGL+K    ++  + + SA +  + + APE I  NF
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 513

Query: 246 GTVSCKSDVYGFGMVLLEMA--GGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
              S +SDV+ +G+ + E    G +    M             V   + +G  +E     
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VMAFIEQGKRMECPPEC 564

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 346
             E      L  +   C   K  DRP    V + +      L 
Sbjct: 565 PPE------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (314), Expect = 2e-33
 Identities = 65/316 (20%), Positives = 113/316 (35%), Gaps = 62/316 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL--------IAVKML-ENSKFSAEEFINEVSTIGRIH 118
            F   LGQG F  ++KG  +  G         + +K+L +  +  +E F    S + ++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           H ++V   G C  G +  LV E++  GSLD   + K+++   +      EVA   A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNC-INILWKLEVAKQLAAAMH 127

Query: 179 YL--HNGCDVCILHFDIKPHNILLD--------HNFIPKVSDFGLAKFHPKENDFVSISA 228
           +L  +      I H ++   NILL         +    K+SD G++         +    
Sbjct: 128 FLEENT----LI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------TVLPKDI 176

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW-- 286
            +  I ++ PE I  N   ++  +D + FG  L E+              S    P    
Sbjct: 177 LQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC-------------SGGDKPLSAL 222

Query: 287 ----VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI 342
                         L      E+ ++I          C+  +   RPS   ++  L    
Sbjct: 223 DSQRKLQFYEDRHQLPAPKAAELANLI--------NNCMDYEPDHRPSFRAIIRDLNSLF 274

Query: 343 DDLQMPPRPFFSSSRH 358
               + PR       H
Sbjct: 275 TP-DLVPRGSHHHHHH 289

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  124 bits (314), Expect = 3e-33
 Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 56/301 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 119
            F  +LG+  FG VYKG L           +A+K L + ++    EEF +E     R+ H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLD------------RHVFPKESRGQSLCWEKLH 167
            NVV LLG  ++    ++++ Y  +G L                    +   +L      
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 168 EVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
            +    A G+EYL  H+     + H D+   N+L+      K+SD GL +     + +  
Sbjct: 132 HLVAQIAAGMEYLSSHH----VV-HKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKL 186

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
           +  +   I ++APE I   +G  S  SD++ +G+VL E+              S    P 
Sbjct: 187 LGNSLLPIRWMAPEAI--MYGKFSIDSDIWSYGVVLWEVF-------------SYGLQPY 231

Query: 286 W------VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                  V + +     L    +           +  + + C     + RP    +   L
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPA-------WVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 339 E 339
            
Sbjct: 285 R 285

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  123 bits (311), Expect = 8e-33
 Identities = 58/312 (18%), Positives = 114/312 (36%), Gaps = 55/312 (17%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            LG+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 129 CSEG---------SKRALVY---EYMPNGSLDRHVFPKESRGQ---SLCWEKLHEVALGT 173
             E          S +  +Y   +     +L   +  + +  +   S+C     ++A   
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA- 130

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--- 230
              +E+LH      ++H D+KP NI    + + KV DFGL     ++ +  ++       
Sbjct: 131 ---VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 231 -------GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF 283
                  GT  Y++PE I  N  + S K D++  G++L E+              S    
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL----------LYPFSTQME 232

Query: 284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID 343
                  +      +   +   +      +       +     +RP    ++E      +
Sbjct: 233 RVRTLTDVRNL---KFPPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINIIEN--AVFE 284

Query: 344 DLQMPPRPFFSS 355
           DL  P +     
Sbjct: 285 DLDFPGKTVLRQ 296

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (313), Expect = 9e-33
 Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 58/307 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSA-EEFINEVSTIGRI-H 118
            F   LG G FG V +      G       +AVKML   +     E  ++E+  +  +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL----------DRHVFPKESRGQSLCWEKLHE 168
           H N+V LLG C+ G    ++ EY   G L                      +     L  
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 169 VALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI 226
            +   A+G+ +L   N    CI H D+   N+LL +  + K+ DFGLA+    +++++  
Sbjct: 169 FSSQVAQGMAFLASKN----CI-HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 223

Query: 227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMA--------GGRRNSNMNATRS 278
              R  + ++APE  S      + +SDV+ +G++L E+         G   NS       
Sbjct: 224 GNARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------ 275

Query: 279 SKAYFPSWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                    Y  +  G  +       +        +  I   C  ++   RP+  ++   
Sbjct: 276 --------FYKLVKDGYQMAQPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSF 320

Query: 338 LEGSIDD 344
           L+    +
Sbjct: 321 LQEQAQE 327

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (312), Expect = 1e-32
 Identities = 58/273 (21%), Positives = 110/273 (40%), Gaps = 33/273 (12%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           K+G+G FG     +  + G    +K +  S+ S++E      EV+ +  + H N+VQ   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
              E     +V +Y   G L + +     +G     +++ +  +     ++++H   D  
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVH---DRK 145

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           ILH DIK  NI L  +   ++ DFG+A+      +        GT  Y++PE+       
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPYYLSPEICENK--P 201

Query: 248 VSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
            + KSD++  G VL E+   +      +M             +  ++  G      +   
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----------LVLKIISG------SFPP 244

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
           +    +  L  +     +    DRPS+  +LE 
Sbjct: 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  120 bits (304), Expect = 9e-32
 Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 47/291 (16%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           KLG+GGF  V   + L  G   A+K +L + +   EE   E       +H N+++L+ +C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 130 SEGSKRA----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                      L+  +   G+L   +   + +G  L  +++  + LG  RG+E +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS-------ISATRGTIGYIAP 238
               H D+KP NILL     P + D G         +           +A R TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 239 ELIS-RNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATR---SSKAYFPSW-VY 288
           EL S ++   +  ++DV+  G VL  M  G           ++      ++   P    +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                           +  ++           + V    RP +  +L  LE
Sbjct: 273 SS-------------ALWQLLN--------SMMTVDPHQRPHIPLLLSQLE 302

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (303), Expect = 4e-31
 Identities = 66/301 (21%), Positives = 125/301 (41%), Gaps = 53/301 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQL--------QTGGLIAVKML-ENSKFSA-EEFINEVSTIGRI 117
                LG+G FG V   +         +    +AVKML +++      + ++E+  +  I
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWE 164
             H N++ LLG C++     ++ EY   G+L            +          + + ++
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203

Query: 165 KLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
            L       ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     + 
Sbjct: 204 DLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY 258

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
           +   +  R  + ++APE  +      + +SDV+ FG+++ E+           T     Y
Sbjct: 259 YKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPY 306

Query: 283 F---PSWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                  ++  L +G  ++   N T        +L M+   C     + RP+  +++E L
Sbjct: 307 PGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDL 359

Query: 339 E 339
           +
Sbjct: 360 D 360

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  119 bits (301), Expect = 4e-31
 Identities = 66/301 (21%), Positives = 125/301 (41%), Gaps = 53/301 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQL--------QTGGLIAVKML-ENSKFSA-EEFINEVSTIGRI 117
                LG+G FG V   +         +    +AVKML +++      + ++E+  +  I
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWE 164
             H N++ LLG C++     ++ EY   G+L            +          + + ++
Sbjct: 98  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 165 KLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
            L       ARG+EYL        CI H D+   N+L+  N + K++DFGLA+     + 
Sbjct: 158 DLVSCTYQLARGMEYLASQK----CI-HRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
           +   +  R  + ++APE  +      + +SDV+ FG+++ E+           T     Y
Sbjct: 213 YKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPY 260

Query: 283 F---PSWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML 338
                  ++  L +G  ++   N T        +L M+   C     + RP+  +++E L
Sbjct: 261 PGIPVEELFKLLKEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDL 313

Query: 339 E 339
           +
Sbjct: 314 D 314

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (297), Expect = 4e-31
 Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 32/277 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
            +G G +G   K +    G ++  K L+    +  E    ++EV+ +  + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 128 FCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH--NG 183
              + +   L  V EY   G L   +       Q L  E +  V       ++  H  + 
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
               +LH D+KP N+ LD     K+ DFGLA+    +  F       GT  Y++PE ++R
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYYMSPEQMNR 190

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRR---NSNMNATRSSKAYFPSWVYDQLNKGGDLELQ 300
              + + KSD++  G +L E+          +              +  ++ +G      
Sbjct: 191 M--SYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----------LAGKIREG------ 231

Query: 301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
               I    + +L  I    + +K   RPS+ ++LE 
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  119 bits (300), Expect = 6e-31
 Identities = 67/316 (21%), Positives = 118/316 (37%), Gaps = 64/316 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 119
            +   +G+G FG V++ +           ++AVKML E +      +F  E + +    +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHVFPKESRGQ 159
            N+V+LLG C+ G    L++EYM  G L                                
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 160 SLCWEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 217
            L   +   +A   A G+ YL         + H D+   N L+  N + K++DFGL++  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK----FV-HRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR 277
              + + +       I ++ PE  S  +   + +SDV+ +G+VL E+             
Sbjct: 225 YSADYYKADGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIF------------ 270

Query: 278 SSKAYFPSW------VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPS 330
            S    P +      V   +  G  L   +N          +L  +   C     ADRPS
Sbjct: 271 -SYGLQPYYGMAHEEVIYYVRDGNILACPENCPL-------ELYNLMRLCWSKLPADRPS 322

Query: 331 MTKVLEMLEGSIDDLQ 346
              +  +L+   +  +
Sbjct: 323 FCSIHRILQRMCERAE 338

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (302), Expect = 6e-31
 Identities = 70/325 (21%), Positives = 129/325 (39%), Gaps = 59/325 (18%)

Query: 68  HFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKML-ENSKFSA-EEFINEVSTIGRI 117
                LG+G FG V   +              +AVKML  ++      + I+E+  +  I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWE 164
             H N++ LLG C++     ++ EY   G+L            +    P  +  + L  +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 165 KLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
            L   A   ARG+EYL        CI H D+   N+L+  + + K++DFGLA+     + 
Sbjct: 192 DLVSCAYQVARGMEYLASKK----CI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY 282
           +   +  R  + ++APE  +      + +SDV+ FG++L E+              +   
Sbjct: 247 YKKTTNGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIF-------------TLGG 291

Query: 283 FP------SWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL 335
            P        ++  L +G  ++   N T        +L M+   C     + RP+  +++
Sbjct: 292 SPYPGVPVEELFKLLKEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLV 344

Query: 336 EMLEGSIDDLQMPPRPFFSSSRHIS 360
           E L+  +         ++    H  
Sbjct: 345 EDLDRIVALTSNQEMGYYHHHHHHD 369

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (298), Expect = 7e-31
 Identities = 62/283 (21%), Positives = 115/283 (40%), Gaps = 45/283 (15%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVK--MLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
            K+G+G F  VY+   L  G  +A+K   + +   +    + I E+  + +++H NV++ 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ----SLCWEKLHEVALGTARGIEYLH 181
                E ++  +V E    G L R +   + + +       W+   ++       +E++H
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----LEHMH 153

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 ++H DIKP N+ +    + K+ D GL +F   +          GT  Y++PE I
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV--GTPYYMSPERI 208

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR-----NSNMNA--TRSSKAYFPSWVYDQLNKG 294
             N    + KSD++  G +L EMA  +        N+ +   +  +  +P    D     
Sbjct: 209 HEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY--- 263

Query: 295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                       S   R+L      CI      RP +T V ++
Sbjct: 264 ------------SEELRQLVN---MCINPDPEKRPDVTYVYDV 291

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (299), Expect = 9e-31
 Identities = 76/313 (24%), Positives = 125/313 (39%), Gaps = 61/313 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSA-EEFINEVSTIGRI-H 118
            F   LG G FG V                +AVKML E +  S  E  ++E+  + ++  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL-------------------DRHVFPKESRGQ 159
           H N+V LLG C+      L++EY   G L                   ++    +E    
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            L +E L   A   A+G+E+L      C+ H D+   N+L+ H  + K+ DFGLA+    
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS--CV-HRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           ++++V     R  + ++APE  S   G  + KSDV+ +G++L E+              S
Sbjct: 225 DSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIF-------------S 269

Query: 280 KAYFP-------SWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSM 331
               P       +  Y  +  G  ++     TE       ++ +I   C    +  RPS 
Sbjct: 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATE-------EIYIIMQSCWAFDSRKRPSF 322

Query: 332 TKVLEMLEGSIDD 344
             +   L   + D
Sbjct: 323 PNLTSFLGCQLAD 335

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  118 bits (297), Expect = 9e-31
 Identities = 71/314 (22%), Positives = 129/314 (41%), Gaps = 60/314 (19%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGG------LIAVKML-ENSKFSA-EEFINEVSTIGRIHH 119
                LG+G FG V K              +AVKML EN+  S   + ++E + + +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL--------------------DRHVFPKESRGQ 159
            +V++L G CS+     L+ EY   GSL                               +
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
           +L    L   A   ++G++YL    ++ ++H D+   NIL+      K+SDFGL++   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
           E+ +V  S  R  + ++A E  S      + +SDV+ FG++L E+              +
Sbjct: 203 EDSYVKRSQGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV-------------T 247

Query: 280 KAYFPSW------VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 332
               P        +++ L  G  +E   N +E       ++  + L C + +   RP   
Sbjct: 248 LGGNPYPGIPPERLFNLLKTGHRMERPDNCSE-------EMYRLMLQCWKQEPDKRPVFA 300

Query: 333 KVLEMLEGSIDDLQ 346
            + + LE  +   +
Sbjct: 301 DISKDLEKMMVKRR 314

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  118 bits (297), Expect = 1e-30
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 34/222 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQ 124
             +  LGQG   +V++G+  +TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 125 LLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE-VALGTAR----GI 177
           L     E + R   L+ E+ P GSL   +    +         L E   L   R    G+
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGM 125

Query: 178 EYLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
            +L  NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT
Sbjct: 126 NHLRENG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL---YGT 178

Query: 233 IGYIAPELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 268
             Y+ P++  R               D++  G+     A G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  118 bits (297), Expect = 1e-30
 Identities = 76/312 (24%), Positives = 127/312 (40%), Gaps = 64/312 (20%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLI--------AVKML-ENSKFSA-EEFINEVSTIGRI 117
            F   LG G FG V +      GLI        AVKML  ++  +  E  ++E+  +  +
Sbjct: 26  SFGKTLGAGAFGKVVEATAY--GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSL--------------DRHVFPKESRGQSLC 162
            +H+N+V LLG C+ G    ++ EY   G L                     E    +L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 163 WEKLHEVALGTARGIEYL--HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
            E L   +   A+G+ +L   N    CI H D+   NILL H  I K+ DFGLA+    +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN----CI-HRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 280
           +++V     R  + ++APE  S      + +SDV+ +G+ L E+              S 
Sbjct: 199 SNYVVKGNARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELF-------------SL 243

Query: 281 AYFP-------SWVYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 332
              P       S  Y  + +G  +   ++          ++  I   C       RP+  
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPA-------EMYDIMKTCWDADPLKRPTFK 296

Query: 333 KVLEMLEGSIDD 344
           ++++++E  I +
Sbjct: 297 QIVQLIEKQISE 308

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  117 bits (296), Expect = 2e-30
 Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 51/300 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKML-ENSKFSA-EEFINEVSTIGRI-H 118
                LG+G FG V +          T   +AVKML E +  S     ++E+  +  I H
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89

Query: 119 HVNVVQLLGFCS-EGSKRALVYEYMPNGSL------------DRHVFPKESRGQSLCWEK 165
           H+NVV LLG C+  G    ++ E+   G+L               V P++     L  E 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 166 LHEVALGTARGIEYL-HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
           L   +   A+G+E+L    C    +H D+   NILL    + K+ DFGLA+   K+ D+V
Sbjct: 150 LICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-- 282
                R  + ++APE  +      + +SDV+ FG++L E+           +  +  Y  
Sbjct: 206 RKGDARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEI----------FSLGASPYPG 253

Query: 283 FPSW--VYDQLNKGGDLEL-QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                    +L +G  +      T        ++    L C   + + RP+ ++++E L 
Sbjct: 254 VKIDEEFCRRLKEGTRMRAPDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLG 306

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (294), Expect = 2e-30
 Identities = 54/292 (18%), Positives = 105/292 (35%), Gaps = 57/292 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRI-HHVNVVQLL 126
           K+G G FGSV+K      G + A+K  +     + +    + EV     +  H +VV+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              +E     +  EY   GSL   +             +L ++ L   RG+ Y+H    +
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134

Query: 187 CILHFDIKPHNILLDHN-------------------FIPKVSDFGLAKFHPKENDFVSIS 227
            ++H DIKP NI +                       + K+ D G               
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191

Query: 228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFP 284
              G   ++A E++  N+     K+D++   + ++  AG     RN +            
Sbjct: 192 ---GDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ----------- 236

Query: 285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              + ++ +G       +  I  +++++   +    I      RPS   +++
Sbjct: 237 ---WHEIRQG------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (292), Expect = 5e-30
 Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 52/280 (18%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRI-HHVNVVQLL 126
           +LG G +G V+K +  + G L AVK   +     ++    + EV +  ++  H   V+L 
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
               EG    L  E     SL +H    E+ G SL   ++      T   + +LH     
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKF---HPKENDFVSISATRGTIGYIAPELISR 243
            ++H D+KP NI L      K+ DFGL                    G   Y+APEL+  
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE------GDPRYMAPELLQG 230

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNATRSSKAY--FPSWVYDQLNKGGDL 297
           ++G     +DV+  G+ +LE+A               R       F + +          
Sbjct: 231 SYG---TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL---------- 277

Query: 298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                    S   R + +     ++     R +   +L +
Sbjct: 278 ---------SSELRSVLV---MMLEPDPKLRATAEALLAL 305

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (291), Expect = 1e-29
 Identities = 59/323 (18%), Positives = 115/323 (35%), Gaps = 47/323 (14%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFI------------------NEVST 113
            L QG F  +   + +     A+K  E S    +                     NE+  
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 114 IGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEV 169
           I  I +   +   G  +   +  ++YEYM N S+    +      ++    +  + +  +
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
                    Y+HN  ++C  H D+KP NIL+D N   K+SDFG +++   +     I  +
Sbjct: 157 IKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKK----IKGS 210

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR----RNSNMNAT----RSSKA 281
           RGT  ++ PE  S        K D++  G+ L  M           ++       R+   
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNI 270

Query: 282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKL--CMIGLWCIQVKAADRPSMTKVLE--- 336
            +P      L    + +        S               ++   A+R +    L+   
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLF-----LRKNPAERITSEDALKHEW 325

Query: 337 MLEGSIDDLQMPPRPFFSSSRHI 359
           + + +I+DL+   +  +   + +
Sbjct: 326 LADTNIEDLREFSKELYKKRKKL 348

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  116 bits (292), Expect = 2e-29
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQ 124
             +  LGQG   +V++G+  +TG L A+K+  N  F    +  + E   + +++H N+V+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 125 LLGFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH- 181
           L     E + R   L+ E+ P GSL   V  + S    L   +   V      G+ +L  
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 182 NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           NG    I+H +IKP NI+     D   + K++DFG A+    +  FVS+    GT  Y+ 
Sbjct: 131 NG----IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLH 183

Query: 238 PELISRNFGTV------SCKSDVYGFGMVLLEMAGGR 268
           P++  R               D++  G+     A G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (282), Expect = 1e-28
 Identities = 57/205 (27%), Positives = 83/205 (40%), Gaps = 19/205 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 125
           KLG GG  +VY  +       +A+K +       +E     F  EV    ++ H N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGC 184
           +    E     LV EY+   +L             L  +           GI++ H    
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTL-SEYIESHGP---LSVDTAINFTNQILDGIKHAHDMR- 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              I+H DIKP NIL+D N   K+ DFG+AK    E      +   GT+ Y +PE     
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKG- 186

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR 269
                  +D+Y  G+VL EM  G  
Sbjct: 187 -EATDECTDIYSIGIVLYEMLVGEP 210

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (284), Expect = 1e-28
 Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 35/221 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRI--HHVNV 122
               ++G GG   V++   +   + A+K +   +   +    + NE++ + ++  H   +
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT-----ARGI 177
           ++L  +        +V E   N  L+  +   + +        +      +        +
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKK------SIDPWERKSYWKNMLEAV 121

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             +H +G    I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+
Sbjct: 122 HTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 237 APELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            PE I     +         +S KSDV+  G +L  M  G+
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  111 bits (280), Expect = 1e-28
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 35/234 (14%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQL 125
             LG+G FG+VY  +  Q+  ++A+K+L  ++        +   EV     + H N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGC 184
            G+  + ++  L+ EY P G++ R +       +      + E+A      + Y H    
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA----LSYCHSKR- 129

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIAPEL 240
              ++H DIKP N+LL      K++DFG +   P        S+ R    GT+ Y+ PE+
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--------SSRRTDLCGTLDYLPPEM 178

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           I         K D++  G++  E   G+     +    T       +  FP +V
Sbjct: 179 IEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (281), Expect = 2e-28
 Identities = 44/221 (19%), Positives = 89/221 (40%), Gaps = 35/221 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRI--HHVNV 122
               ++G GG   V++   +   + A+K +   +   +    + NE++ + ++  H   +
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT-----ARGI 177
           ++L  +        +V E   N  L+  +   + +        +      +        +
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKK------SIDPWERKSYWKNMLEAV 140

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             +H +G    I+H D+KP N L+    + K+ DFG+A     +   V   +  GT+ Y+
Sbjct: 141 HTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 237 APELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            PE I     +         +S KSDV+  G +L  M  G+
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  112 bits (281), Expect = 3e-28
 Identities = 72/323 (22%), Positives = 119/323 (36%), Gaps = 74/323 (22%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
           F  +     +V E     SL + H      R        L E     AR        G +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHK----RRK------ALTE---PEARYYLRQIVLGCQ 155

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIA 237
           YLH      ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIA
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIA 209

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWVYDQ 290
           PE++S+     S + DV+  G ++  +  G+     S +  T    + ++   P  +   
Sbjct: 210 PEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--- 264

Query: 291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSIDD--- 344
                           + +A  L  I    +Q     RP++ ++L       G I     
Sbjct: 265 ----------------NPVAASL--IQ-KMLQTDPTARPTINELLNDEFFTSGYIPARLP 305

Query: 345 ---LQMPPRPFFSSSRHISGTGR 364
              L +PPR   + S       +
Sbjct: 306 ITCLTIPPRFSIAPSSLDPSNRK 328

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  111 bits (279), Expect = 3e-28
 Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 74/309 (23%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGF   ++     T  + A K++  S        E+   E+S    + H +VV   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
           F  +     +V E     SL + H      R        L E     AR        G +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHK----RRK------ALTE---PEARYYLRQIVLGCQ 129

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIA 237
           YLH      ++H D+K  N+ L+ +   K+ DFGLA     + +         GT  YIA
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIA 183

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWVYDQ 290
           PE++S+     S + DV+  G ++  +  G+     S +  T    + ++   P  +   
Sbjct: 184 PEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--- 238

Query: 291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---MLEGSIDD--- 344
                           S+I + L        Q     RP++ ++L       G I     
Sbjct: 239 -----------NPVAASLIQKML--------QTDPTARPTINELLNDEFFTSGYIPARLP 279

Query: 345 ---LQMPPR 350
              L +PPR
Sbjct: 280 ITCLTIPPR 288

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  111 bits (280), Expect = 3e-28
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 28/205 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLLGFC 129
           K+G+G  G V   +   +G  +AVKM++  K    E + NEV  +    H NVV++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111

Query: 130 SEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
             G +  ++ E++  G+L      V   E +  ++C   L        + + YLH     
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL--------QALAYLHAQG-- 161

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELIS 242
            ++H DIK  +ILL  +   K+SDFG    ++K  PK    V      GT  ++APE+IS
Sbjct: 162 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVIS 214

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGG 267
           R+    + + D++  G++++EM  G
Sbjct: 215 RS--LYATEVDIWSLGIMVIEMVDG 237

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  112 bits (281), Expect = 5e-28
 Identities = 42/221 (19%), Positives = 87/221 (39%), Gaps = 35/221 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHH--VNV 122
               ++G GG   V++   +   + A+K +   +   +    + NE++ + ++      +
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT-----ARGI 177
           ++L  +        +V E   N  L+  +   + +        +      +        +
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKK------SIDPWERKSYWKNMLEAV 168

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             +H +G    I+H D+KP N L+    + K+ DFG+A     +   V   +  G + Y+
Sbjct: 169 HTIHQHG----IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223

Query: 237 APELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            PE I     +         +S KSDV+  G +L  M  G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  109 bits (275), Expect = 9e-28
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            K+GQG  G+VY    + TG  +A++ +    +   E  INE+  +    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 129 CSEGSKRALVYEYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
              G +  +V EY+  GSL          E +  ++C E L        + +E+LH+   
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL--------QALEFLHSNQ- 136

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELI 241
             ++H DIK  NILL  +   K++DFG    +     K +  V      GT  ++APE++
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV------GTPYWMAPEVV 188

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGG 267
           +R       K D++  G++ +EM  G
Sbjct: 189 TRK--AYGPKVDIWSLGIMAIEMIEG 212

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  109 bits (275), Expect = 1e-27
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 30/215 (13%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
            +G G    V           +A+K   LE  + S +E + E+  + + HH N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALG-----TARGIEYLH-N 182
                +  LV + +  GS+   +              L E  +         G+EYLH N
Sbjct: 82  FVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATRGTI 233
           G     +H D+K  NILL  +   +++DFG++ F         +     FV      GT 
Sbjct: 141 G----QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV------GTP 190

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            ++APE++ +  G    K+D++ FG+  +E+A G 
Sbjct: 191 CWMAPEVMEQVRG-YDFKADIWSFGITAIELATGA 224

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (274), Expect = 1e-27
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK +  +TG L A K++E  S+   E++I E+  +    H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
               K  ++ E+ P G++D  +       + L   ++  V       + +LH+     I+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKR---II 139

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           H D+K  N+L+      +++DFG      K   K + F+      GT  ++APE++    
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEVVMCET 193

Query: 246 GTVS---CKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
              +    K+D++  G+ L+EMA     +  +N  R
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  113 bits (283), Expect = 2e-27
 Identities = 48/213 (22%), Positives = 82/213 (38%), Gaps = 40/213 (18%)

Query: 72  KLGQGGFGSVYKG---QLQTGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQL 125
            +  GG G +Y      +  G  + +K L +S          + E   +  + H ++VQ+
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEA-QAMAMAERQFLAEVVHPSIVQI 144

Query: 126 LGFCSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
             F     +       +V EY+   SL      K S+GQ L   +     L     + YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYL 198

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYI 236
           H  G    +++ D+KP NI+L    + K+ D G             I++     GT G+ 
Sbjct: 199 HSIG----LVYNDLKPENIMLTEEQL-KLIDLGAVS---------RINSFGYLYGTPGFQ 244

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           APE++       +  +D+Y  G  L  +     
Sbjct: 245 APEIVR---TGPTVATDIYTVGRTLAALTLDLP 274

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (268), Expect = 1e-26
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 30/218 (13%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            K+G+G FG V+KG   +T  ++A+K+  LE ++   E+   E++ + +     V +  G
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
              + +K  ++ EY+  GS    + P    E++  ++  E L        +G++YLH+  
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL--------KGLDYLHSEK 139

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPEL 240
               +H DIK  N+LL  +   K++DFG    L     K N FV      GT  ++APE+
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV------GTPFWMAPEV 190

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
           I +       K+D++  G+  +E+A G   +S ++  +
Sbjct: 191 IKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMK 226

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  107 bits (269), Expect = 1e-26
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 127
           ++G+G +GSV K     +G ++AVK       +   ++ + ++  + R      +VQ  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 128 FCSEGSKRALVYEYMPNGSLDRHV-FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                    +  E M + S D+   +        +  E L ++ L T + + +L    ++
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NL 145

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG---YIAPELI-- 241
            I+H DIKP NILLD +   K+ DFG++         V   A     G   Y+APE I  
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           S +      +SDV+  G+ L E+A GR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  107 bits (268), Expect = 1e-26
 Identities = 73/325 (22%), Positives = 117/325 (36%), Gaps = 47/325 (14%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVK-MLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG 127
             L +GGF  VY+ Q + +G   A+K +L N +      I EV  + ++  H N+VQ   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 128 FCSEGSKRA-------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
             S G + +       L+   +  G L   +   ESRG   C   L  +   T R ++++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK-IFYQTCRAVQHM 152

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF---------HPKENDFVSISATR- 230
           H      I+H D+K  N+LL +    K+ DFG A             +    V    TR 
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 231 GTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR---RNSNMNATRSSKAYFPSW 286
            T  Y  PE+I       +  K D++  G +L  +   +    +       + K   P  
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH 271

Query: 287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ 346
                           T   S+I           +QV   +R S+ +V+  L+       
Sbjct: 272 ------------DTQYTVFHSLIR--------AMLQVNPEERLSIAEVVHQLQEIAAARN 311

Query: 347 M-PPRPFFSSSRHISGTGREIESDS 370
           + P  P         G G    S  
Sbjct: 312 VNPKSPITELLEQNGGYGSATLSRG 336

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (265), Expect = 2e-26
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 28/211 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 127
           +LG+G +G V K + + +G ++AVK      +    +  + ++    R +     V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                    +  E M + SLD+       +GQ++  + L ++A+   + +E+LH+   + 
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLS 130

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFG--------LAKFHPKENDFVSISATRGTIGYIAPE 239
           ++H D+KP N+L++     K+ DFG        +AK     +         G   Y+APE
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK-----DIDA------GCKPYMAPE 179

Query: 240 LI--SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            I    N    S KSD++  G+ ++E+A  R
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  107 bits (268), Expect = 2e-26
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 71  HKLGQGGFGSVYKGQL-QTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            +LG G  G V+K     +G ++A K+  LE       + I E+  +   +   +V   G
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 128 -FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
            F S+G + ++  E+M  GSLD+ +     +   +  + L +V++   +G+ YL      
Sbjct: 99  AFYSDG-EISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KH 151

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAK--FHPKENDFVSISATRGTIGYIAPELISRN 244
            I+H D+KP NIL++     K+ DFG++        N FV      GT  Y++PE +   
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV------GTRSYMSPERLQGT 205

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
               S +SD++  G+ L+EMA GR
Sbjct: 206 --HYSVQSDIWSMGLSLVEMAVGR 227

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  107 bits (268), Expect = 2e-26
 Identities = 38/216 (17%), Positives = 74/216 (34%), Gaps = 24/216 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQ------LQTGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHV 120
           +  H LG+G F  VY+         +      +K+ + +  +        +  +      
Sbjct: 68  YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQH 127

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
             ++        +   LV E    G+L +     K +  + +    +   A+     IE 
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIP-----------KVSDFGLAKFHPKENDFVSISA 228
           +H   D  I+H DIKP N +L + F+             + D G +            +A
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM 264
              T G+   E++S      + + D +G    +  M
Sbjct: 245 KCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCM 278

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (263), Expect = 3e-26
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 40/236 (16%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLG 127
           LG+G F  VY+ + + TG  +A+KM++          +   NEV    ++ H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--------GIEY 179
           +  + +   LV E   NG ++R++  +             E     AR        G+ Y
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSEN---EARHFMHQIITGMLY 127

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
           LH+     ILH D+   N+LL  N   K++DFGLA      ++      T  GT  YI+P
Sbjct: 128 LHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISP 181

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           E+ +R+      +SDV+  G +   +  GR       +  T      +    PS++
Sbjct: 182 EIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL 235

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  105 bits (265), Expect = 3e-26
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 29/213 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 125
            LG GG   V+  + L+    +AVK+L  +  + +      F  E      ++H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 126 L--GFCSEGSKRALVY---EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
              G  +E     L Y   EY+   +L R +   E     +  ++  EV     + + + 
Sbjct: 78  YDTG-EAETPAGPLPYIVMEYVDGVTL-RDIVHTEGP---MTPKRAIEVIADACQALNFS 132

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIGYI 236
           H NG    I+H D+KP NI++      KV DFG+A+     +   S++ T    GT  Y+
Sbjct: 133 HQNG----IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYL 186

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           +PE       +V  +SDVY  G VL E+  G  
Sbjct: 187 SPEQARG--DSVDARSDVYSLGCVLYEVLTGEP 217

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 4e-26
 Identities = 56/237 (23%), Positives = 101/237 (42%), Gaps = 45/237 (18%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G FG+VY  +  Q   ++A+K+L  S+   E        E+     + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 128 FCSEGSKRALVYEYMPNGSLDRHV-----FP-KESRGQSLCWEKLHEVALGTARGIEYLH 181
           +  +  +  L+ E+ P G L + +     F  + S         + E+A      + Y H
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA------TFMEELADA----LHYCH 131

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----GTIGYIA 237
                 ++H DIKP N+L+ +    K++DFG +   P        S  R    GT+ Y+ 
Sbjct: 132 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--------SLRRRTMCGTLDYLP 180

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           PE+I     T   K D++  G++  E   G     + +   T     +    FP ++
Sbjct: 181 PEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  109 bits (272), Expect = 4e-26
 Identities = 58/223 (26%), Positives = 87/223 (39%), Gaps = 39/223 (17%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQ 124
               +LG GGFG V +     TG  +A+K         + E +  E+  + +++H NVV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 125 LLGFCSEGSKRA------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--- 175
                    K A      L  EY   G L +++   E+         L E      R   
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC------GLKEG---PIRTLL 127

Query: 176 -----GIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKENDFVSIS 227
                 + YLH   +  I+H D+KP NI+L       I K+ D G AK   +        
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184

Query: 228 ATRGTIGYIAPELIS-RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
              GT+ Y+APEL+  + +       D + FG +  E   G R
Sbjct: 185 ---GTLQYLAPELLEQKKYT---VTVDYWSFGTLAFECITGFR 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 7e-26
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 21/213 (9%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG+G +GSVYK    +TG ++A+K +       +E I E+S + +    +VV+  G  
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSY 93

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
            + +   +V EY   GS+   +     R ++L  +++  +   T +G+EYLH       +
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFMR---KI 147

Query: 190 HFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           H DIK  NILL+     K++DFG    L     K N  +      GT  ++APE+I    
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI------GTPFWMAPEVIQE-- 199

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
              +C +D++  G+  +EMA G+   ++++  R
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 1e-25
 Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 27/223 (12%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG- 127
             +G G +G VYKG+ ++TG L A+K+++ +    EE   E++ + +  HH N+    G 
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 128 -----FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
                      +  LV E+   GS+   +  K ++G +L  E +  +     RG+ +LH 
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQ 147

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFG----LAKFHPKENDFVSISATRGTIGYIAP 238
                ++H DIK  N+LL  N   K+ DFG    L +   + N F+      GT  ++AP
Sbjct: 148 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------GTPYWMAP 198

Query: 239 ELISRNFGTVS---CKSDVYGFGMVLLEMAGGR-RNSNMNATR 277
           E+I+ +    +    KSD++  G+  +EMA G     +M+  R
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (265), Expect = 1e-25
 Identities = 51/231 (22%), Positives = 87/231 (37%), Gaps = 30/231 (12%)

Query: 58  SYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI 117
           ++ Q +         LG G  G+V       G  +AVK +       +  + E+  +   
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALMEIKLLTES 65

Query: 118 -HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVA---LGT 173
             H NV++     +      +  E   N +L   V  K    ++L  +K +         
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDH-------------NFIPKVSDFGLAK-FHPK 219
           A G+ +LH    + I+H D+KP NIL+               N    +SDFGL K     
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 220 ENDFVSISATR-GTIGYIAPELISRNFGTV-----SCKSDVYGFGMVLLEM 264
           ++ F +      GT G+ APEL+  +         +   D++  G V   +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (262), Expect = 2e-25
 Identities = 43/230 (18%), Positives = 86/230 (37%), Gaps = 41/230 (17%)

Query: 72  KLGQG--GFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFI-NEVSTIGRIHHVNVVQL 125
            +G+G     +V   +   TG  + V+   LE        F+  E+      +H N+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE-----VALGTARGIEYL 180
                  ++  +V  +M  GS  + +        +   + ++E     +  G  + ++Y+
Sbjct: 92  RATFIADNELWVVTSFMAYGSA-KDLI------CTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA-----------KFHPKENDFVSISA 228
           H  G     +H  +K  +IL+  +    +S                  H      V    
Sbjct: 145 HHMGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV---- 196

Query: 229 TRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
               + +++PE++ +N      KSD+Y  G+   E+A G     +M AT+
Sbjct: 197 --KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  104 bits (261), Expect = 2e-25
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 28/218 (12%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQL 125
            ++G G FG+VY  + ++   ++A+K +    + S    ++ I EV  + ++ H N +Q 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 126 LGFCSEGSKRALVYEYMPNGSLD-RHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLH 181
            G         LV EY    + D   V  K   E    ++    L        +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--------QGLAYLH 171

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVI 222

Query: 242 SRNF-GTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATR 277
                G    K DV+  G+  +E+A  +    NMNA  
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  106 bits (266), Expect = 2e-25
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 32/207 (15%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVV 123
               KLG G +G V       T    A+K++  +  S       + EV+ +  + H N++
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           +L  F  +     LV E    G L      R  F  E     +  + L         G+ 
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN-EVDAAVIIKQVL--------SGVT 150

Query: 179 YLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           YLH +     I+H D+KP N+LL   + + + K+ DFGL+     +          GT  
Sbjct: 151 YLHKHN----IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAY 203

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVL 261
           YIAPE++ + +     K DV+  G++L
Sbjct: 204 YIAPEVLRKKYDE---KCDVWSIGVIL 227

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  105 bits (263), Expect = 4e-25
 Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 33/208 (15%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 122
                LG+G FG V       TG   AVK++   +   +      + EV  + ++ H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSL-----DRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           ++L  F  +     LV E    G L      R  F  E     +  + L         GI
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVL--------SGI 139

Query: 178 EYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
            Y+H N     I+H D+KP N+LL     +   ++ DFGL+                GT 
Sbjct: 140 TYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI---GTA 192

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVL 261
            YIAPE++   +     K DV+  G++L
Sbjct: 193 YYIAPEVLHGTYDE---KCDVWSTGVIL 217

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 4e-25
 Identities = 48/192 (25%), Positives = 82/192 (42%), Gaps = 27/192 (14%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI------NEVSTIGRIHHVN 121
               +G+G F  V +    +TG   AVK+++ +KF++   +       E S    + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR----G 176
           +V+LL   S      +V+E+M    L    +  +   G     E    VA    R     
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFE-IVKRADAGFVYS-EA---VASHYMRQILEA 142

Query: 177 IEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGT 232
           + Y H N     I+H D+KPH +LL   +++   K+  FG+A    +           GT
Sbjct: 143 LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV--GT 196

Query: 233 IGYIAPELISRN 244
             ++APE++ R 
Sbjct: 197 PHFMAPEVVKRE 208

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  104 bits (262), Expect = 6e-25
 Identities = 54/206 (26%), Positives = 88/206 (42%), Gaps = 30/206 (14%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVV 123
           +    LG+G FG V K     T    AVK++  +    ++    + EV  + ++ H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPK---ESRGQSLCWEKLHEVALGTARGIEY 179
           +L     + S   +V E    G L D  +  K   E     +  +           GI Y
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF--------SGITY 136

Query: 180 LH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           +H +     I+H D+KP NILL   + +   K+ DFGL+    +           GT  Y
Sbjct: 137 MHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAYY 189

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVL 261
           IAPE++   +     K DV+  G++L
Sbjct: 190 IAPEVLRGTYDE---KCDVWSAGVIL 212

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (255), Expect = 7e-25
 Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 19/205 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 125
            +G+GG G VY+ +      ++A+K++ +   S++         E  T GR+   +VV +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGC 184
             F     +  +    +    L   +     R   L   +   +       ++  H  G 
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAAG- 154

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
                H D+KP NIL+  +    + DFG+A     +     +  T GT+ Y+APE  S  
Sbjct: 155 ---ATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE- 209

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRR 269
               + ++D+Y    VL E   G  
Sbjct: 210 -SHATYRADIYALTCVLYECLTGSP 233

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (253), Expect = 8e-25
 Identities = 67/236 (28%), Positives = 96/236 (40%), Gaps = 37/236 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 130 SEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIEYL 180
            EG+ + L  EY   G L DR                + E     A+        G+ YL
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE----PDI------GMPE---PDAQRFFHQLMAGVVYL 121

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATR---SSKAYFPSWVY 288
           + R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  101 bits (253), Expect = 8e-25
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 29/207 (14%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQ 124
            F  KLG G FG V+   +  +G    +K +   +     E+   E+  +  + H N+++
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84

Query: 125 LLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GIE 178
           +     +     +V E    G L +R V  +           L E       +     + 
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK------ALSEGYVAELMKQMMNALA 138

Query: 179 YLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           Y H       ++H D+KP NIL      +   K+ DFGLA+    +    + +   GT  
Sbjct: 139 YFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTAL 191

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVL 261
           Y+APE+  R+      K D++  G+V+
Sbjct: 192 YMAPEVFKRDVTF---KCDIWSAGVVM 215

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (252), Expect = 3e-24
 Identities = 52/242 (21%), Positives = 88/242 (36%), Gaps = 52/242 (21%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA------EEFINEVSTIGRIHHV 120
           H    +GQG +G V    + QT  + A+K++  +K         E    EV  + ++HH 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR---- 175
           N+ +L     +     LV E    G L D+     +        + +             
Sbjct: 89  NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148

Query: 176 -------------------------------GIEYLH-NGCDVCILHFDIKPHNILL--D 201
                                           + YLH  G    I H DIKP N L   +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTN 204

Query: 202 HNFIPKVSDFGLAKFHP--KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGM 259
            +F  K+ DFGL+K        ++  ++   GT  ++APE+++    +   K D +  G+
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

Query: 260 VL 261
           +L
Sbjct: 265 LL 266

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  100 bits (252), Expect = 3e-24
 Identities = 40/193 (20%), Positives = 77/193 (39%), Gaps = 28/193 (14%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS 130
            LG+G FG V++  +  +      K ++           E+S +    H N++ L     
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 131 EGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR----GIEYLH-NGC 184
              +  +++E++    + +R      +    L  E+     +         +++LH +  
Sbjct: 72  SMEELVMIFEFISGLDIFERIN----TSAFELN-ER---EIVSYVHQVCEALQFLHSHN- 122

Query: 185 DVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
              I HFDI+P NI+      + I K+ +FG A+   K  D   +        Y APE+ 
Sbjct: 123 ---IGHFDIRPENIIYQTRRSSTI-KIIEFGQARQL-KPGDNFRLLF--TAPEYYAPEVH 175

Query: 242 SRNFGTVSCKSDV 254
             +   VS  +D+
Sbjct: 176 QHDV--VSTATDM 186

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (251), Expect = 3e-24
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGR-IHHVNVVQLLG 127
           ++G G  G V+K +  +TG +IAVK      +K   +  + ++  + +      +VQ  G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +   +  E M   +       K+     +    L ++ +   + + YL       
Sbjct: 92  TFITNTDVFIAMELMGTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLKE--KHG 145

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPELISRNF 245
           ++H D+KP NILLD     K+ DFG++            +  R  G   Y+APE I    
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISG-----RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 246 ---GTVSCKSDVYGFGMVLLEMAGGR 268
                   ++DV+  G+ L+E+A G+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 99.6 bits (249), Expect = 4e-24
 Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 31/188 (16%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLL 126
            +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHE-VALGTAR----GIEYL 180
               E S   LV++ +  G L +  V    +R          E  A    +     I Y 
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIV----ARE------FYSEADASHCIQQILESIAYC 121

Query: 181 H-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           H NG    I+H ++KP N+LL         K++DFGLA        +   +   GT GY+
Sbjct: 122 HSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYL 174

Query: 237 APELISRN 244
           +PE++ ++
Sbjct: 175 SPEVLKKD 182

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 43/204 (21%), Positives = 78/204 (38%), Gaps = 28/204 (13%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE-FINEVSTIGRIHHVNVVQL 125
              + +G+G +G V    Q  T    A K +        + F  E+  +  + H N+++L
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DR---HVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                + +   LV E    G L +R       +ES    +  + L          + Y H
Sbjct: 72  YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVL--------SAVAYCH 123

Query: 182 -NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
                  + H D+KP N L      +   K+ DFGLA          +     GT  Y++
Sbjct: 124 KLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVS 176

Query: 238 PELISRNFGTVSCKSDVYGFGMVL 261
           P+++   +G    + D +  G+++
Sbjct: 177 PQVLEGLYGP---ECDEWSAGVMM 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 4e-24
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 34/207 (16%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQ 124
               LG+G FG V K     T    AVK++  +    ++    + EV  + ++ H N+++
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 125 LLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHE-VALGTAR----GIE 178
           L     + S   +V E    G L D  +     R       +  E  A    +    GI 
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEII----KRK------RFSEHDAARIIKQVFSGIT 135

Query: 179 YLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           Y+H +     I+H D+KP NILL   + +   K+ DFGL+    +           GT  
Sbjct: 136 YMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---GTAY 188

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVL 261
           YIAPE++   +     K DV+  G++L
Sbjct: 189 YIAPEVLRGTYDE---KCDVWSAGVIL 212

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  102 bits (255), Expect = 5e-24
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 45/219 (20%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA--------------EEFINEVS 112
               KLG G +G V    +       A+K+++ S+F                EE  NE+S
Sbjct: 39  FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98

Query: 113 TIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-A 170
            +  + H N+++L     +     LV E+   G L ++ +    +R       K  E  A
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRH------KFDECDA 148

Query: 171 LGTAR----GIEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKEND 222
               +    GI YLH +     I+H DIKP NILL   +     K+ DFGL+ F  K+  
Sbjct: 149 ANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVL 261
                   GT  YIAPE++ + +     K DV+  G+++
Sbjct: 205 LRDRL---GTAYYIAPEVLKKKYNE---KCDVWSCGVIM 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (252), Expect = 5e-24
 Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 29/196 (14%)

Query: 70  THKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLG 127
           T  LG G FG V+K  +  TG  +A K+++       EE  NE+S + ++ H N++QL  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR----GIEYLH- 181
                +   LV EY+  G L DR +        +L  E      +   +    GI ++H 
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRII----DESYNLT-EL---DTILFMKQICEGIRHMHQ 205

Query: 182 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                 ILH D+KP NIL    D   I K+ DFGLA+ +             GT  ++AP
Sbjct: 206 MY----ILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---GTPEFLAP 257

Query: 239 ELISRNFGTVSCKSDV 254
           E+++ +F  VS  +D+
Sbjct: 258 EVVNYDF--VSFPTDM 271

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.7 bits (249), Expect = 5e-24
 Identities = 67/236 (28%), Positives = 96/236 (40%), Gaps = 37/236 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC 129
           LG+G +G V       T   +AVK+++  +     E    E+     ++H NVV+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 130 SEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIEYL 180
            EG+ + L  EY   G L DR                + E     A+        G+ YL
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIE----PDI------GMPE---PDAQRFFHQLMAGVVYL 121

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H    + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL
Sbjct: 122 HG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATR---SSKAYFPSWVY 288
           + R     +   DV+  G+VL  M  G       + +          K Y   W  
Sbjct: 179 LKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (250), Expect = 6e-24
 Identities = 26/229 (11%), Positives = 55/229 (24%), Gaps = 41/229 (17%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKML----ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           L  G    V+    ++     A+K+     ENS+   E          R+   +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 128 FCSEGSKRA--------------------------LVYEYMP--NGSLDRHVFPKESRGQ 159
                                              L+          L   +        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
                 LH +     R    L       ++H    P N+ +  +    + D        K
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---K 243

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                  S+    + Y   E ++ +  T +   + +  G+ +  +    
Sbjct: 244 VGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =   99 bits (250), Expect = 7e-24
 Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 46/238 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
            LG+G F +VYK +   T  ++A+K   L +   + +      + E+  +  + H N++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYL 180
           LL      S  +LV+++M       +  +      S  ++     L        +G+EYL
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL--------QGLEYL 128

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      ILH D+KP+N+LLD N + K++DFGLAK F      +     TR    Y APE
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR---WYRAPE 182

Query: 240 LI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           L+  +R +G  V    D++  G +L E+                 + P     DQL +
Sbjct: 183 LLFGARMYGVGV----DMWAVGCILAELLLR------------VPFLPGDSDLDQLTR 224

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (251), Expect = 8e-24
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 30/210 (14%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-FC 129
            +G G FG V++ +L     +A+K +   K     F N E+  +  + H NVV L   F 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 130 SEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT---ARGIEYLH 181
           S G K+      LV EY+P  ++ R         Q++    +  + L      R + Y+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTM---PMLLIKLYMYQLLRSLAYIH 158

Query: 182 NGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           +   + I H DIKP N+LLD  + + K+ DFG AK        VS   +R    Y APEL
Sbjct: 159 S---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR---YYRAPEL 212

Query: 241 ISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
           I   FG    +   D++  G V+ E+  G+
Sbjct: 213 I---FGATNYTTNIDIWSTGCVMAELMQGQ 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 51/187 (27%), Positives = 81/187 (43%), Gaps = 31/187 (16%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVVQLLG 127
           +LG+G F  V +     TG   A K++   K SA +      E     ++ H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHE-VALGTAR----GIEYLH 181
              E S   LV++ +  G L +  V    +R          E  A    +     I Y H
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIV----ARE------FYSEADASHCIQQILESIAYCH 145

Query: 182 -NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            NG    I+H ++KP N+LL         K++DFGLA        +   +   GT GY++
Sbjct: 146 SNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPGYLS 198

Query: 238 PELISRN 244
           PE++ ++
Sbjct: 199 PEVLKKD 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 1e-23
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 31/211 (14%)

Query: 72  KLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFIN-EVSTIGRIHHVNVVQLLG-F 128
            +G G FG VY+ +L  +G L+A+K +   K     F N E+  + ++ H N+V+L   F
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFF 116

Query: 129 CSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT---ARGIEYL 180
            S G K+      LV +Y+P  ++ R         Q+L    +  V L      R + Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYI 172

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H+     I H DIKP N+LLD +  + K+ DFG AK   +    VS   +R    Y APE
Sbjct: 173 HS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---YYRAPE 226

Query: 240 LISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
           LI   FG    +   DV+  G VL E+  G+
Sbjct: 227 LI---FGATDYTSSIDVWSAGCVLAELLLGQ 254

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K ++  +  A       EE   EVS + ++ H NV+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D        +        L E  A    +    G+
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLA----QKE------SLSEEEATSFIKQILDGV 128

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    IP    K+ DFGLA    ++          GT
Sbjct: 129 NYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF--GT 181

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 182 PEFVAPEIVNYEP--LGLEADM 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K ++  +  A       EE   EVS + ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D        +        L E  A    +    G+
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLA----QKE------SLSEEEATSFIKQILDGV 128

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    IP    K+ DFGLA       +F +I    GT
Sbjct: 129 NYLHTKK----IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF---GT 181

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 182 PEFVAPEIVNYEP--LGLEADM 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 30/212 (14%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQLL 126
           LG+G +G V +    +T    AVK+L+  K             E+  + R+ H NV+QL+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 127 GFCSEGSKRA--LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR--------G 176
                  K+   +V EY   G  +  +             +        A         G
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------RFPV---CQAHGYFCQLIDG 121

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +EYLH+     I+H DIKP N+LL      K+S  G+A+         +   ++G+  + 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            PE+ +        K D++  G+ L  +  G 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 56/202 (27%), Positives = 87/202 (43%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  Q  TG   A K ++  + S+       EE   EV+ +  I H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D        +        L E  A    +    G+
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLA----EKE------SLTEDEATQFLKQILDGV 121

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    +P    K+ DFG+A      N+F +I    GT
Sbjct: 122 HYLHSKR----IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GT 174

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 175 PEFVAPEIVNYEP--LGLEADM 194

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 50/236 (21%), Positives = 97/236 (41%), Gaps = 38/236 (16%)

Query: 32  RRTTLKTIDNI------EKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKG- 84
           +R  L     I       K        +  +  YP+ +      +  LG G  G V    
Sbjct: 96  KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF 155

Query: 85  QLQTGGLIAVKMLENSKFSAEE---------FINEVSTIGRIHHVNVVQLLGFCSEGSKR 135
           + +T   +A++++   KF+               E+  + +++H  ++++  F  +    
Sbjct: 156 ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDY 214

Query: 136 ALVYEYMPNGSL-DR---HVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF 191
            +V E M  G L D+   +   KE+  +   ++ L          ++YLH   +  I+H 
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL--------AVQYLH---ENGIIHR 263

Query: 192 DIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
           D+KP N+LL   + + + K++DFG +K    E   +      GT  Y+APE++   
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC--GTPTYLAPEVLVSV 316

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.0 bits (240), Expect = 7e-23
 Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 46/236 (19%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQL 125
           K+G+G +G VYK Q   G   A+K   LE        +    I E+S +  + H N+V+L
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT---IREISILKELKHSNIVKL 65

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLH 181
                   +  LV+E++       LD      +    +S   + L         GI Y H
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLL--------NGIAYCH 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
              D  +LH D+KP N+L++     K++DFGLA+ F      +     T     Y AP++
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL---WYRAPDV 171

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           +  S+ + T     D++  G +  EM  G               FP     DQL +
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT------------PLFPGVSEADQLMR 212

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.5 bits (243), Expect = 8e-23
 Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 27/197 (13%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQL 125
               +LG G FG V++  +  TG +   K +            NE+S + ++HH  ++ L
Sbjct: 54  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR----GIEYL 180
                +  +  L+ E++  G L DR      +    +  E      +   R    G++++
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRIA----AEDYKMS-EA---EVINYMRQACEGLKHM 165

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
           H +     I+H DIKP NI+ +       K+ DFGLA     +      +    T  + A
Sbjct: 166 HEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAA 218

Query: 238 PELISRNFGTVSCKSDV 254
           PE++ R    V   +D+
Sbjct: 219 PEIVDREP--VGFYTDM 233

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 9e-23
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 46/237 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQ 124
           K+G+G +G+V+K +  +T  ++A+K   L++       SA   + E+  +  + H N+V+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELKHKNIVR 65

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYL 180
           L        K  LV+E+         D           +S  ++ L        +G+ + 
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLL--------KGLGFC 117

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPE 239
           H      +LH D+KP N+L++ N   K+++FGLA+ F      + +   T     Y  P+
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL---WYRPPD 171

Query: 240 LISRNFGTV--SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           ++   FG    S   D++  G +  E+A              +  FP + V DQL +
Sbjct: 172 VL---FGAKLYSTSIDMWSAGCIFAELANAG-----------RPLFPGNDVDDQLKR 214

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 67/264 (25%), Positives = 112/264 (42%), Gaps = 49/264 (18%)

Query: 46  LRNQQSWMPKRYSYPQIIAMTN-HFTHKLGQGGFGSVYKGQLQTGGLIAVKM--LENSK- 101
           + +       R +      M       K+G+G +G VYK +   G ++A+K   L+    
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 102 ---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN---GSLDRHVFP-K 154
               +A   I E+S +  +HH N+V L+          LV+E+M       LD +    +
Sbjct: 61  GIPSTA---IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ 117

Query: 155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA 214
           +S+ +   ++ L        RG+ + H      ILH D+KP N+L++ +   K++DFGLA
Sbjct: 118 DSQIKIYLYQLL--------RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA 166

Query: 215 K-FHPKENDFVSISATRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRN 270
           + F      +     T     Y AP+++  S+ + T V    D++  G +  EM  G   
Sbjct: 167 RAFGIPVRSYTHEVVTL---WYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITG--- 216

Query: 271 SNMNATRSSKAYFP-SWVYDQLNK 293
                    K  FP     DQL K
Sbjct: 217 ---------KPLFPGVTDDDQLPK 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 32/189 (16%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQLL 126
           F   LG G F  V+   Q  TG L A+K ++ S    +  + NE++ + +I H N+V L 
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQ------SLCWEKLHEVALGTARGIEY 179
                 +   LV + +  G L DR +     RG       SL  +++          ++Y
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQV-------LSAVKY 121

Query: 180 LH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           LH NG    I+H D+KP N+L    + N    ++DFGL+K   +     +     GT GY
Sbjct: 122 LHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTAC---GTPGY 173

Query: 236 IAPELISRN 244
           +APE++++ 
Sbjct: 174 VAPEVLAQK 182

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 70/246 (28%), Positives = 107/246 (43%), Gaps = 61/246 (24%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN-----EVSTIGRIHHVNVVQL 125
           KLG G + +VYKG    TG  +A+K +   K  +EE        E+S +  + H N+V+L
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHVFPKESRG------QSLCWEKLHEVALGTARG 176
                  +K  LV+E+M N     +D        RG      +   W+ L        +G
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL--------QG 120

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDF----VSISATRG 231
           + + H      ILH D+KP N+L++     K+ DFGLA+ F    N F    V       
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV------- 170

Query: 232 TIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWV 287
           T+ Y AP+++  SR + T +    D++  G +L EM  G            K  FP +  
Sbjct: 171 TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAEMITG------------KPLFPGTND 214

Query: 288 YDQLNK 293
            +QL  
Sbjct: 215 EEQLKL 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 59/236 (25%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN---------------------- 109
           +G+G +G V            A+K+L   K   +                          
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 110 -----EVSTIGRIHHVNVVQLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLC 162
                E++ + ++ H NVV+L+    + ++  L  V+E +  G +        +      
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK---- 132

Query: 163 WEKLHEVALGTAR--------GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGL 213
              L E     AR        GIEYLH       I+H DIKP N+L+  +   K++DFG+
Sbjct: 133 --PLSED---QARFYFQDLIKGIEYLHYQK----IIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGR 268
           +      +  +S +   GT  ++APE +S      S    DV+  G+ L     G+
Sbjct: 184 SNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 30/190 (15%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
              +LG+G F  V +  ++  G   A  ++   K SA   ++   E      + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 125 LLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHE-VALGTAR----GIE 178
           L    SE     L+++ +  G L +  V    +R          E  A    +     + 
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIV----ARE------YYSEADASHCIQQILEAVL 124

Query: 179 YLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           + H  G    ++H ++KP N+LL         K++DFGLA     E       A  GT G
Sbjct: 125 HCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPG 178

Query: 235 YIAPELISRN 244
           Y++PE++ ++
Sbjct: 179 YLSPEVLRKD 188

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 48/191 (25%), Positives = 76/191 (39%), Gaps = 32/191 (16%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA----------EEFINEVSTIGRI-H 118
             LG+G    V +     T    AVK+++ +   +          E  + EV  + ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSL-DR---HVFPKESRGQSLCWEKLHEVALGTA 174
           H N++QL       +   LV++ M  G L D     V   E   + +    L        
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL-------- 134

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
             I  LH       I+H D+KP NILLD +   K++DFG +           +    GT 
Sbjct: 135 EVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTP 187

Query: 234 GYIAPELISRN 244
            Y+APE+I  +
Sbjct: 188 SYLAPEIIECS 198

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 97.2 bits (242), Expect = 3e-22
 Identities = 48/199 (24%), Positives = 83/199 (41%), Gaps = 31/199 (15%)

Query: 68  HFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI-NEVSTIGRIHHVNVVQL 125
               +LG G FG V++  +  TG   A K +     S +E +  E+ T+  + H  +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219

Query: 126 LGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GIEY 179
                + ++  ++YE+M  G L ++                + E  A+   R    G+ +
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---------MSEDEAVEYMRQVCKGLCH 270

Query: 180 LH-NGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGY 235
           +H N      +H D+KP NI+      N + K+ DFGL          V ++   GT  +
Sbjct: 271 MHENN----YVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHL-DPKQSVKVTT--GTAEF 322

Query: 236 IAPELISRNFGTVSCKSDV 254
            APE+       V   +D+
Sbjct: 323 AAPEVA--EGKPVGYYTDM 339

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 47/192 (24%), Positives = 75/192 (39%), Gaps = 38/192 (19%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGR-IHHVNVVQLL 126
               +G G +    +     T    AVK+++ SK    E   E+  + R   H N++ L 
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLK 82

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLH-------EVALGTARGIE 178
               +G    +V E M  G L D+ +             +          V     + +E
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKIL------------RQKFFSEREASAVLFTITKTVE 130

Query: 179 YLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAKFHPKENDFVSISATR-GT 232
           YLH  G    ++H D+KP NIL      +    ++ DFG AK    EN  +    T   T
Sbjct: 131 YLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYT 183

Query: 233 IGYIAPELISRN 244
             ++APE++ R 
Sbjct: 184 ANFVAPEVLERQ 195

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 56/202 (27%), Positives = 86/202 (42%), Gaps = 38/202 (18%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA-------EEFINEVSTIGRIHHVNVV 123
           +LG G F  V K  +  TG   A K ++  +  +       E+   EVS +  I H NV+
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 124 QLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GI 177
            L       +   L+ E +  G L D        +        L E  A    +    G+
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLA----EKE------SLTEEEATEFLKQILNGV 127

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGT 232
            YLH       I HFD+KP NI+L    +P    K+ DFGLA      N+F +I    GT
Sbjct: 128 YYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180

Query: 233 IGYIAPELISRNFGTVSCKSDV 254
             ++APE+++     +  ++D+
Sbjct: 181 PEFVAPEIVNYEP--LGLEADM 200

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 55/241 (22%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEF--------INEVSTIGRIHHVNV 122
           K+G+G +G V+K +   TG ++A+K     KF   E         + E+  + ++ H N+
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 123 VQLLGFCSEGSKRALVYEYMPN---GSLDRH-VFPKESRGQSLCWEKLHEVALGTARGIE 178
           V LL       +  LV+EY  +     LDR+     E   +S+ W+ L        + + 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QAVN 116

Query: 179 YLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYI 236
           + H +      +H D+KP NIL+  + + K+ DFG A+      + +    ATR    Y 
Sbjct: 117 FCHKHN----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR---WYR 169

Query: 237 APELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLN 292
           +PEL+     +G  V    DV+  G V  E+  G               +P     DQL 
Sbjct: 170 SPELLVGDTQYGPPV----DVWAIGCVFAELLSGV------------PLWPGKSDVDQLY 213

Query: 293 K 293
            
Sbjct: 214 L 214

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 70  THKLGQGGFGSVYKGQL-QTGGLIAVK-MLENSKFSAEEFINEVSTIGRIHHVNVVQLL- 126
               GQG FG+V  G+   TG  +A+K ++++ +F   E +  +  +  +HH N+VQL  
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQS 86

Query: 127 GFCSEGSKR------ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT---ARGI 177
            F + G +        +V EY+P+ +L R       R  +        + +      R I
Sbjct: 87  YFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAP---PPILIKVFLFQLIRSI 142

Query: 178 EYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
             LH    V + H DIKPHN+L++  +   K+ DFG AK        V+   +R    Y 
Sbjct: 143 GCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR---YYR 198

Query: 237 APELISRNFGTV--SCKSDVYGFGMVLLEMAGGR 268
           APELI   FG    +   D++  G +  EM  G 
Sbjct: 199 APELI---FGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 6e-22
 Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 30/197 (15%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRI-HHVNVVQLL 126
           +LG+G F  V +     TG   A K L+  +       E ++E++ +        V+ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 127 GFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR----GIEYLH 181
                 S+  L+ EY   G +    +       + +  E      +   +    G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCL---PELAEMVS-EN---DVIRLIKQILEGVYYLH 148

Query: 182 -NGCDVCILHFDIKPHNILLDHNFIP---KVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            N     I+H D+KP NILL   +     K+ DFG+++        +      GT  Y+A
Sbjct: 149 QNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIM--GTPEYLA 201

Query: 238 PELISRNFGTVSCKSDV 254
           PE+++ +   ++  +D+
Sbjct: 202 PEILNYDP--ITTATDM 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 29/187 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN---------EVSTIGRIHHVNV 122
           LG G FG V+     +    + VK ++  K   + +I          E++ + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 123 VQLLGFCSEGSKRALVYEYMPNGS-----LDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           +++L          LV E   +G      +DRH    E     +  +            +
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ--------LVSAV 143

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            YL       I+H DIK  NI++  +F  K+ DFG A +  +           GTI Y A
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYTFC--GTIEYCA 197

Query: 238 PELISRN 244
           PE++  N
Sbjct: 198 PEVLMGN 204

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 50/183 (27%), Positives = 75/183 (40%), Gaps = 31/183 (16%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
           +G G FG     +   T  L+AVK +E      E    E+     + H N+V+       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87

Query: 132 GSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIEYLHN 182
            +  A++ EY   G L +R      + G      +  E     AR        G+ Y H+
Sbjct: 88  PTHLAIIMEYASGGELYERIC----NAG------RFSE---DEARFFFQQLLSGVSYCHS 134

Query: 183 GCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
              + I H D+K  N LLD +  P  K+ DFG +K     +     +   GT  YIAPE+
Sbjct: 135 ---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV--GTPAYIAPEV 188

Query: 241 ISR 243
           + R
Sbjct: 189 LLR 191

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 50/190 (26%), Positives = 74/190 (38%), Gaps = 34/190 (17%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE-FINEVSTIGRI-HHVNVVQLLGFC 129
           LG+G    V     L T    AVK++E            EV  + +   H NV++L+ F 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 130 SEGSKRALVYEYMPNGSL-DRHVFPKESRGQ------SLCWEKLHEVALGTARGIEYLH- 181
            E  +  LV+E M  GS+          R        S+  + +       A  +++LH 
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDV-------ASALDFLHN 129

Query: 182 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATR-----GTI 233
            G    I H D+KP NIL    +     K+ DF L        D   IS        G+ 
Sbjct: 130 KG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 234 GYIAPELISR 243
            Y+APE++  
Sbjct: 186 EYMAPEVVEA 195

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 59/245 (24%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSK----FSAEEFINEVSTIGRIHHVNVVQ 124
           KLG+G +G VYK     T   +A+K   LE+ +     +A   I EVS +  + H N+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA---IREVSLLKELQHRNIIE 97

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           L        +  L++EY  N     +D++        +S  ++ +         G+ + H
Sbjct: 98  LKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI--------NGVNFCH 149

Query: 182 NGCDVCILHFDIKPHNILLDHNFIP-----KVSDFGLAK-FHPKENDF----VSISATRG 231
                  LH D+KP N+LL  +        K+ DFGLA+ F      F    +       
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------- 199

Query: 232 TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVY 288
           T+ Y  PE++  SR++ T     D++    +  EM                  FP     
Sbjct: 200 TLWYRPPEILLGSRHYST---SVDIWSIACIWAEMLMK------------TPLFPGDSEI 244

Query: 289 DQLNK 293
           DQL K
Sbjct: 245 DQLFK 249

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 9e-22
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 46/236 (19%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE-----FINEVSTIGRIHHVNVVQL 125
           KLG+G + +VYKG    T  L+A+K +   +   EE      I EVS +  + H N+V L
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVTL 65

Query: 126 LGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYLH 181
                      LV+EY+       LD           +   ++ L        RG+ Y H
Sbjct: 66  HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL--------RGLAYCH 117

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAPEL 240
                 +LH D+KP N+L++     K++DFGLA+        + +   T     Y  P++
Sbjct: 118 ---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL---WYRPPDI 171

Query: 241 I--SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           +  S ++ T   + D++G G +  EMA GR              FP S V +QL+ 
Sbjct: 172 LLGSTDYST---QIDMWGVGCIFYEMATGR------------PLFPGSTVEEQLHF 212

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 42/207 (20%)

Query: 58  SYPQIIAMTNHFTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEE---------F 107
            YP+ +      +  LG G  G V    + +T   +A+K++   KF+             
Sbjct: 3   VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV 62

Query: 108 INEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKL 166
             E+  + +++H  ++++  F  +     +V E M  G L D+ V             +L
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVV----GNK------RL 111

Query: 167 HEVALGTAR--------GIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 215
            E      +         ++YLH   +  I+H D+KP N+LL   + + + K++DFG +K
Sbjct: 112 KEAT---CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

Query: 216 FHPKENDFVSISATRGTIGYIAPELIS 242
               E   +      GT  Y+APE++ 
Sbjct: 166 IL-GETSLMRTLC--GTPTYLAPEVLV 189

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 42/308 (13%), Positives = 90/308 (29%), Gaps = 73/308 (23%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRI---------- 117
           LGQ    +  +    +TG    V +   ++      I     EV  +  +          
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 118 ---------------HHVNVVQLLGFCSEGSKRALVYEYM----PNGSLDRHVFPKESRG 158
                              ++++     +    +  + Y        +    +    S  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 159 QSLCWEKLHEVALGTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH 217
           +SL      ++ L   R +  LH  G    ++H  ++P +I+LD      ++ F      
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 218 PKENDFVSISATRGTIGYIAPELISRNFGT---------VSCKSDVYGFGMVLLEMAGGR 268
            ++   V    +  + G+  PEL +R             ++   D +  G+V+  +    
Sbjct: 255 -RDGARVV---SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA- 309

Query: 269 RNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADR 328
                          P    D    G +   ++   I     R L       ++    DR
Sbjct: 310 -------------DLP-ITKDAALGGSEWIFRSCKNI-PQPVRALLE---GFLRYPKEDR 351

Query: 329 PSMTKVLE 336
               + +E
Sbjct: 352 LLPLQAME 359

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 44/243 (18%)

Query: 53  MPKRYSYPQIIAMT--NHFT--HKLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSK---- 101
           M K+Y   +       + +    K+GQG FG V+K +  +TG  +A+K   +EN K    
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP 60

Query: 102 FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--------LVYEYMPN---GSLDRH 150
            +A   + E+  +  + H NVV L+  C   +           LV+++  +   G L   
Sbjct: 61  ITA---LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 117

Query: 151 VFP-KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS 209
           +     S  + +    L         G+ Y+H      ILH D+K  N+L+  + + K++
Sbjct: 118 LVKFTLSEIKRVMQMLL--------NGLYYIH---RNKILHRDMKAANVLITRDGVLKLA 166

Query: 210 DFGLAKFHPKENDFVSISATRG--TIGYIAPELI--SRNFGTVSCKSDVYGFGMVLLEMA 265
           DFGLA+      +      T    T+ Y  PEL+   R++G      D++G G ++ EM 
Sbjct: 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGP---PIDLWGAGCIMAEMW 223

Query: 266 GGR 268
              
Sbjct: 224 TRS 226

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 51/239 (21%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEF----INEVSTIGRIHHVNVVQ 124
            +G+G +G V K +   TG ++A+K     +     +      + E+  + ++ H N+V 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQLRHENLVN 88

Query: 125 LLGFCSEGSKRALVYEYMPN---GSLDRHVFP-KESRGQSLCWEKLHEVALGTARGIEYL 180
           LL  C +  +  LV+E++ +     L+           Q   ++ +         GI + 
Sbjct: 89  LLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII--------NGIGFC 140

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKENDFVSISATRGTIGYIAP 238
           H +     I+H DIKP NIL+  + + K+ DFG A+        +    ATR    Y AP
Sbjct: 141 HSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---WYRAP 193

Query: 239 ELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
           EL+     +G  V    DV+  G ++ EM  G               FP     DQL  
Sbjct: 194 ELLVGDVKYGKAV----DVWAIGCLVTEMFMGE------------PLFPGDSDIDQLYH 236

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 46/185 (24%), Positives = 78/185 (42%), Gaps = 30/185 (16%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC 129
            LG+G F    K    ++    AVK++     +  +   E++ +     H N+V+L    
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75

Query: 130 SEGSKRALVYEYMPNGSL-DRHVFPKESRGQ------SLCWEKLHEVALGTARGIEYLHN 182
            +     LV E +  G L +R       +        S    KL          + ++H 
Sbjct: 76  HDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSA-------VSHMH- 123

Query: 183 GCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             DV ++H D+KP N+L    + N   K+ DFG A+  P +N  +       T+ Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAAPE 179

Query: 240 LISRN 244
           L+++N
Sbjct: 180 LLNQN 184

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 48/195 (24%), Positives = 76/195 (38%), Gaps = 41/195 (21%)

Query: 71  HKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSA---------EEFINEVSTIGRIH-H 119
             +G+G    V +     TG   AVK++E +             E    E   + ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--- 175
            +++ L+      S   LV++ M  G L D        +        L E      R   
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKV------ALSEKE---TRSIM 206

Query: 176 -----GIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
                 + +LH N     I+H D+KP NILLD N   ++SDFG +           +   
Sbjct: 207 RSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC-- 260

Query: 230 RGTIGYIAPELISRN 244
            GT GY+APE++  +
Sbjct: 261 -GTPGYLAPEILKCS 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 26/233 (11%), Positives = 64/233 (27%), Gaps = 41/233 (17%)

Query: 73  LGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFI----NEVSTIGRI---------- 117
           LGQ    +  +    +TG    V +   ++      I     EV  +  +          
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 118 ---------------HHVNVVQLLGFCSEGSKRALV----YEYMPNGSLDRHVFPKESRG 158
                              ++++     +    +             +    +    S  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 159 QSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP 218
           +SL      ++ L   R +  LH      ++H  ++P +I+LD      ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RD 261

Query: 219 KENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGR 268
             +    I          A  ++     +   ++   D +  G+ +  +    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 29/186 (15%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
              +LG+G    VY+  Q  T    A+K+L+ +    +    E+  + R+ H N+++L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEV-ALGTAR----GIEYLH 181
                ++ +LV E +  G L DR V     +G         E  A    +     + YLH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIV----EKG------YYSERDAADAVKQILEAVAYLH 165

Query: 182 -NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIA 237
            NG    I+H D+KP N+L      +   K++DFGL+K    +    ++    GT GY A
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYCA 218

Query: 238 PELISR 243
           PE++  
Sbjct: 219 PEILRG 224

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 89.6 bits (223), Expect = 1e-20
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
             S  +   +V EY+  G L D         G      ++ E+    AR         ++
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYIC----KHG------RVEEM---EARRLFQQILSAVD 125

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           Y H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y AP
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAP 179

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E+IS        + D++  G++L  +  G 
Sbjct: 180 EVISGR-LYAGPEVDIWSCGVILYALLCGT 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 33/209 (15%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN---EVSTIGRIHHVNVVQLLGF 128
           +G+G F  V   + + TG  +A+K+++ ++ +         EV  +  ++H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 129 CSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIEY 179
                   L+ EY   G + D  V    + G      ++ E     AR         ++Y
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLV----AHG------RMKE---KEARSKFRQIVSAVQY 129

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
            H      I+H D+K  N+LLD +   K++DFG +         +      G   Y APE
Sbjct: 130 CHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFC--GAPPYAAPE 183

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           L          + DV+  G++L  +  G 
Sbjct: 184 LFQGK-KYDGPEVDVWSLGVILYTLVSGS 211

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 69/317 (21%), Positives = 115/317 (36%), Gaps = 86/317 (27%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGR-----------IHHV 120
           LG+GGFG+V+ G  L     +A+K++  ++      +++  T                H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTAR---- 175
            V++LL +        LV E        + +F     +G       L E   G +R    
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKG------PLGE---GPSRCFFG 146

Query: 176 ----GIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKEN--DFVSIS 227
                I++ H      ++H DIK  NIL+D       K+ DFG       E   DF    
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFGSGALLHDEPYTDFD--- 199

Query: 228 ATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGR-----RNSNMNATRSSK 280
              GT  Y  PE ISR+         + V+  G++L +M  G          + A    +
Sbjct: 200 ---GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEA----E 249

Query: 281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE---M 337
            +FP+ V                +  ++I          C+  K + RPS+ ++L    M
Sbjct: 250 LHFPAHV--------------SPDCCALIR--------RCLAPKPSSRPSLEEILLDPWM 287

Query: 338 LEGSIDDLQMPPRPFFS 354
              + D    P +   +
Sbjct: 288 QTPAEDVPLNPSKGGPA 304

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.2 bits (221), Expect = 3e-20
 Identities = 51/335 (15%), Positives = 106/335 (31%), Gaps = 56/335 (16%)

Query: 28  FLVSRRTT-----LKTIDNIEKFLRNQQSW----MPKRYSYPQIIAMTNHFTHKLGQGGF 78
           F    +       +K I    + L  ++         +  +P I+   N +     +   
Sbjct: 23  FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82

Query: 79  GSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV 138
             + +  L+           +   +    I  +      + V            S +  +
Sbjct: 83  EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG------QLQPSSPKVYL 136

Query: 139 Y---EYMPNGSLD---RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFD 192
           Y   +     +L          E R   +C     ++A      +E+LH      ++H D
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH---SKGLMHRD 189

Query: 193 IKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR----------GTIGYIAPELIS 242
           +KP NI    + + KV DFGL     ++ +  ++              GT  Y++PE I 
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
            N    S K D++  G++L E+           T+  +      +   +           
Sbjct: 250 GN--NYSHKVDIFSLGLILFELLYSFS------TQMERVR----IITDVRNL------KF 291

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
             + +    +  M+    +     +RP  T ++E 
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
             +G+GGFG V++ +        A+K   L N + + E+ + EV  + ++ H  +V+   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCW 163
              E        E       D       S    +  
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA 107

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 43/223 (19%)

Query: 72  KLGQGGFGSVYKGQ---LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G +G VYK +    +     A+K +E +  S      E++ +  + H NV+ L   
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-CREIALLRELKHPNVISLQKV 86

Query: 129 CSEGSKRA--LVYEYMPN---GSLDRHVFPKESRG---------QSLCWEKLHEVALGTA 174
               + R   L+++Y  +     +  H   K ++          +SL ++ L        
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-------- 138

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLA-KFHPKENDFVSISA 228
            GI YLH N     +LH D+KP NIL+          K++D G A  F+        +  
Sbjct: 139 DGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 229 TRGTIGYIAPELI--SRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
              T  Y APEL+  +R++   +    D++  G +  E+    
Sbjct: 195 VVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 37/235 (15%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFI----NEVSTIGRIHHVNVVQLLG 127
           LG+G F +V   +   T    A+K+LE      E  +     E   + R+ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 128 FCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLH--EVALGTARGIEYL 180
              +  K      Y  NG L ++      F  E+        + +  E+       +EYL
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFD-ETCT------RFYTAEIVSA----LEYL 146

Query: 181 H-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H  G    I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PE
Sbjct: 147 HGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGR---RNSNMNAT----RSSKAYFPSWV 287
           L++      S  SD++  G ++ ++  G    R  N           +  FP   
Sbjct: 203 LLTEKSACKS--SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 255

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 54/185 (29%), Positives = 85/185 (45%), Gaps = 33/185 (17%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG G FG V  G+   TG  +AVK+L   K  + + +     E+  +    H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
             S  S   +V EY+  G L D         G      +L E     +R        G++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYIC----KNG------RLDEK---ESRRLFQQILSGVD 130

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           Y H      ++H D+KP N+LLD +   K++DFGL+     + +F+  S   G+  Y AP
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC--GSPNYAAP 184

Query: 239 ELISR 243
           E+IS 
Sbjct: 185 EVISG 189

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V+  Q+  TG L A K L       +   +  + E   + ++H   +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 128 FCSE-GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK----LHEVALGTARGIEYLHN 182
           +  E  +   LV   M  G +  H++  +         +      ++  G    +E+LH 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEHLHQ 307

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELI 241
                I++ D+KP N+LLD +   ++SD GLA                 GT G++APEL+
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK---GYAGTPGFMAPELL 361

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                  S   D +  G+ L EM   R
Sbjct: 362 LGEEYDFSV--DYFALGVTLYEMIAAR 386

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 62/244 (25%), Positives = 102/244 (41%), Gaps = 51/244 (20%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSKFSAEEF----INEVSTIGRIH---HVN 121
           ++G G +G+VYK +   +G  +A+K   + N            + EV+ + R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 122 VVQLLGFCSEGSKRA-----LVYEYMPN---GSLDRHVFPKESRGQ--SLCWEKLHEVAL 171
           VV+L+  C+           LV+E++       LD+   P         L  + L     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL----- 130

Query: 172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG 231
              RG+++LH     CI+H D+KP NIL+      K++DFGLA+ +  +     +  T  
Sbjct: 131 ---RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL- 183

Query: 232 TIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYD 289
              Y APE++      T +   D++  G +  EM               K  F  +   D
Sbjct: 184 --WYRAPEVL---LQSTYATPVDMWSVGCIFAEMFRR------------KPLFCGNSEAD 226

Query: 290 QLNK 293
           QL K
Sbjct: 227 QLGK 230

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 60/220 (27%), Positives = 85/220 (38%), Gaps = 48/220 (21%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN-------EVSTIGRIHHV--NV 122
           LG GGFGSVY G  +     +A+K +E  + S    +        EV  + ++      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTAR------ 175
           ++LL +        L+ E  P    D  +F     RG       L E     AR      
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERG------ALQE---ELARSFFWQV 158

Query: 176 --GIEYLHNGCDVCILHFDIKPHNILLDHNFIP-KVSDFGLAKFHPKE--NDFVSISATR 230
              + + HN     +LH DIK  NIL+D N    K+ DFG           DF       
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD------ 209

Query: 231 GTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGR 268
           GT  Y  PE I  +   G     + V+  G++L +M  G 
Sbjct: 210 GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)

Query: 67  NHFT-HK-LGQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHH 119
           +HF   + +G+G FG V   Q   T  + A+K +   K            E+  +  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 120 VNVVQLLG-FCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLH--EVAL 171
             +V L   F  E     +V + +  G L  H      F  E         KL   E+ +
Sbjct: 75  PFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHLQQNVHFK-EETV------KLFICELVM 126

Query: 172 GTARGIEYLH-NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
                ++YL        I+H D+KP NILLD +    ++DF +A   P+E    +++   
Sbjct: 127 A----LDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--- 175

Query: 231 GTIGYIAPELISRNFGTVSCKS-DVYGFGMVLLEMAGGRR 269
           GT  Y+APE+ S   G     + D +  G+   E+  GRR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 48/189 (25%), Positives = 73/189 (38%), Gaps = 31/189 (16%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLL 126
            +  LG G  G V +    +T    A+KML++      +   EV    R     ++V+++
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121

Query: 127 GFCSEGSKRA----LVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGT---ARGIE 178
                         +V E +  G L  R       RG     E+  E +         I+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTER--EASEIMKSIGEAIQ 175

Query: 179 YLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIG 234
           YLH       I H D+KP N+L      N I K++DFG AK     N   +      T  
Sbjct: 176 YLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC---YTPY 228

Query: 235 YIAPELISR 243
           Y+APE++  
Sbjct: 229 YVAPEVLGP 237

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 47/185 (25%), Positives = 74/185 (40%), Gaps = 30/185 (16%)

Query: 72  KLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC 129
            LG G  G V +    +TG   A+K+L +S     +   EV    +     ++V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVY 91

Query: 130 SEGSKRA----LVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGT---ARGIEYLH 181
                      ++ E M  G L  R       RG     E+  E A         I++LH
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTER--EAAEIMRDIGTAIQFLH 145

Query: 182 NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
                 I H D+KP N+L    + + + K++DFG AK    +N   +      T  Y+AP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPC---YTPYYVAP 198

Query: 239 ELISR 243
           E++  
Sbjct: 199 EVLGP 203

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 42/219 (19%)

Query: 72  KLGQGGFGSVYKGQ--LQTGGLIAVKM--LENSK----FSAEEFINEVST---IGRIHHV 120
           ++G+G +G V+K +     G  +A+K   ++  +     S    I EV+    +    H 
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---IREVAVLRHLETFEHP 74

Query: 121 NVVQLL-----GFCSEGSKRALVYEYMPN---GSLDRH--VFPKESRGQSLCWEKLHEVA 170
           NVV+L            +K  LV+E++       LD+           + + ++ L    
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL---- 130

Query: 171 LGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR 230
               RG+++LH      ++H D+KP NIL+  +   K++DFGLA+ +  +    S+  T 
Sbjct: 131 ----RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 183

Query: 231 GTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 268
               Y APE++      + +   D++  G +  EM   +
Sbjct: 184 ---WYRAPEVL---LQSSYATPVDLWSVGCIFAEMFRRK 216

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 35/210 (16%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN----EVSTIGRIHHVNVVQLLG 127
           LG+G FG V      +T   +A+K +        +       E+S +  + H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 128 FCSEGSKRALVYEYMPNGSL-DRHVFPKESRGQSLCWEKLHEVALGTAR--------GIE 178
             +  +   +V EY   G L D  V     +       ++ E      R         IE
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIV----EKK------RMTED---EGRRFFQQIICAIE 122

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAP 238
           Y H      I+H D+KP N+LLD N   K++DFGL+     + +F+  S   G+  Y AP
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTSC--GSPNYAAP 176

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           E+I+        + DV+  G+VL  M  GR
Sbjct: 177 EVINGK-LYAGPEVDVWSCGIVLYVMLVGR 205

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 73  LGQGGFGSVYKGQLQ-TGGLIAVKMLE----NSKFSAEEFINE---VSTIGRIHHVNVVQ 124
           +G+GGFG VY  +   TG + A+K L+      K      +NE   +S +       +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTARGIEY 179
           +        K + + + M  G L  H     VF  E+  +        E+ LG    +E+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADMRFYA----AEIILG----LEH 307

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE--NDFVSISATRGTIGYIA 237
           +HN     +++ D+KP NILLD +   ++SD GLA    K+  +  V      GT GY+A
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 358

Query: 238 PELISRNFG-TVSCKSDVYGFGMVLLEMAGGR 268
           PE++ +      S   D +  G +L ++  G 
Sbjct: 359 PEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 53/233 (22%), Positives = 104/233 (44%), Gaps = 43/233 (18%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLG-F 128
           KLG+G +  V++   +     + VK+L+      ++   E+  +  +    N++ L    
Sbjct: 43  KLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 129 CSEGSKR-ALVYEYMPNGSLDRHVFPKESRG--QSLCWEKLHEVALGTARGIEYLHNGCD 185
               S+  ALV+E++ N    + ++   +    +   +E L        + ++Y H+   
Sbjct: 101 KDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRFYMYEIL--------KALDYCHSMG- 150

Query: 186 VCILHFDIKPHNILLDH-NFIPKVSDFGLAKF-HPKE--NDFVSISATRGTIGYIAPELI 241
             I+H D+KPHN+++DH +   ++ D+GLA+F HP +  N  V   A+R    +  PEL+
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASR---YFKGPELL 202

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-SWVYDQLNK 293
             ++       D++  G +L  M   +             +F     YDQL +
Sbjct: 203 V-DYQMYDYSLDMWSLGCMLASMIFRKE-----------PFFHGHDNYDQLVR 243

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 54/261 (20%), Positives = 103/261 (39%), Gaps = 73/261 (27%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFIN-EV 111
            K+YS  + +          G G FG V +   +++G   A+K +         + N E+
Sbjct: 6   SKKYSLGKTL----------GTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNREL 51

Query: 112 STIGRIHHVNVVQLL-GFCSEGSKRA---------------------------------- 136
             +  + HVN+++L+  F + G +                                    
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 137 ---LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT---ARGIEYLHNGCDVCILH 190
              ++ EY+P+ +L + +      G+S+       +++      R + ++H+   + I H
Sbjct: 112 YLNVIMEYVPD-TLHKVLKSFIRSGRSI--PMNL-ISIYIYQLFRAVGFIHS---LGICH 164

Query: 191 FDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV- 248
            DIKP N+L++  +   K+ DFG AK        V+   +R    Y APEL+    G   
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR---FYRAPELM---LGATE 218

Query: 249 -SCKSDVYGFGMVLLEMAGGR 268
            +   D++  G V  E+  G+
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           LG+GGFG V   Q+  TG + A K LE      +      +NE   + +++   VV L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLH--EVALGTARGIEYLHNGCD 185
                    LV   M  G L  H++     G        +  E+  G    +E LH    
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----LEDLH---R 304

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAPELISRN 244
             I++ D+KP NILLD +   ++SD GLA  H  E   +     R GT+GY+APE++   
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIK---GRVGTVGYMAPEVVKNE 360

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR 268
             T S   D +  G +L EM  G+
Sbjct: 361 RYTFSP--DWWALGCLLYEMIAGQ 382

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 33/213 (15%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 125
           +G+G FG V   +L     + A+K+L  +K+          F  E   +       +  L
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKIL--NKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEK-----LHEVALGTARGIEYL 180
                + +   LV +Y   G L   +    S+ +    E+     L E+ +     I+ +
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLL----SKFEDRLPEEMARFYLAEMVIA----IDSV 191

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
           H    +  +H DIKP NIL+D N   +++DFG      ++    S  A  GT  YI+PE+
Sbjct: 192 HQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247

Query: 241 ISRNFG-----TVSCKSDVYGFGMVLLEMAGGR 268
           +    G        C  D +  G+ + EM  G 
Sbjct: 248 LQAMEGGKGRYGPEC--DWWSLGVCMYEMLYGE 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 125
           +G+G FG V   +   T  + A+K+L  SKF       +  F  E   +   +   VVQL
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLL--SKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 126 LGFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
                +     +V EYMP G L      +  P E   +        EV L     ++ +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARFY----TAEVVLA----LDAIH 185

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   +  +H D+KP N+LLD +   K++DFG      KE      +A  GT  YI+PE++
Sbjct: 186 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVL 241

Query: 242 SRNFG----TVSCKSDVYGFGMVLLEMAGGR 268
               G       C  D +  G+ L EM  G 
Sbjct: 242 KSQGGDGYYGREC--DWWSVGVFLYEMLVGD 270

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 23/208 (11%), Positives = 52/208 (25%), Gaps = 55/208 (26%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE----NSKFSAEEFINEVSTIGRIHHVNVVQLL 126
             G       ++         +A+  ++          +E ++    + RI    V ++L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 127 GFCSEGSKRALVYEYMPNGSL----DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH- 181
                 +   +V E++  GSL    D    P  +                 A   +  H 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAI----------RAMQSLAAAADAAHR 147

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
            G    +      P  + +  +    ++                          +     
Sbjct: 148 AG----VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD--- 178

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                  + + D+ G G  L  +   R 
Sbjct: 179 ------ANPQDDIRGIGASLYALLVNRW 200

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 27/220 (12%)

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           S+ S  +   E      ++    P++     L  E L   +   A+G+E+L      CI 
Sbjct: 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCI- 215

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H D+   NILL    + K+ DFGLA+   K+ D+V     R  + ++APE I     T+ 
Sbjct: 216 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI- 274

Query: 250 CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY----FPSWVYDQLNKGGDLEL-QNVTE 304
            +SDV+ FG++L E+           +  +  Y           +L +G  +      T 
Sbjct: 275 -QSDVWSFGVLLWEI----------FSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
                  ++    L C   + + RP+ ++++E L   +  
Sbjct: 324 -------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 37/158 (23%), Positives = 61/158 (38%), Gaps = 21/158 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-H 118
                LG+G FG V +          T   +AVKML+     +E    ++E+  +  I H
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84

Query: 119 HVNVVQLLGFCSEGSKRALV-YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGI 177
           H+NVV LLG C++     +V  E+   G+L  ++             K +E      +G 
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----------RSKRNEFVPYKTKGA 133

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK 215
            +      V  +  D+K     +  +     S F   K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 29/212 (13%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQL 125
           +G+G F  V   ++ QTG + A+K++  +K+          F  E   +       + QL
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIM--NKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 126 LGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEK--LHEVALGTARGIEYLH 181
               +   +  L  V EY   G L   +  K          +  L E+ +     I+ +H
Sbjct: 127 --HFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMA----IDSVH 179

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
               +  +H DIKP NILLD     +++DFG       +    S+ A  GT  Y++PE++
Sbjct: 180 R---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235

Query: 242 SRNFGTVSCKS-----DVYGFGMVLLEMAGGR 268
               G     S     D +  G+   EM  G+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 48/240 (20%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEV-STIG------RIHHVNVVQ 124
           LG+G FG V   +   TG   A+K+L+     A+   +EV  T+          H  +  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK---DEVAHTLTENRVLQNSRHPFLTA 212

Query: 125 LLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTARGI 177
           L    S     +   V EY   G L  H     VF  E R +        E+       +
Sbjct: 213 L--KYSFQTHDRLCFVMEYANGGELFFHLSRERVFS-EDRARFYG----AEIVSA----L 261

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR---GTIG 234
           +YLH+  +  +++ D+K  N++LD +   K++DFGL K   K+         +   GT  
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-----TMKTFCGTPE 314

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 287
           Y+APE++  N    +   D +G G+V+ EM  GR                  +  FP  +
Sbjct: 315 YLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.7 bits (182), Expect = 8e-15
 Identities = 65/249 (26%), Positives = 103/249 (41%), Gaps = 65/249 (26%)

Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFI---NEVSTIG------RIHH 119
           LGQG FG V+            L A+K+L   K      +   + V T         ++H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVL--KK----ATLKVRDRVRTKMERDILVEVNH 85

Query: 120 VNVVQLLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLH--EVA 170
             +V+L    +     K  L+ +++  G L        +F  E         K +  E+A
Sbjct: 86  PFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-EEDV------KFYLAELA 136

Query: 171 LGTARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISA 228
           L     +++LH  G    I++ D+KP NILLD    I K++DFGL+K             
Sbjct: 137 LA----LDHLHSLG----IIYRDLKPENILLDEEGHI-KLTDFGLSKESIDHEKK----- 182

Query: 229 TR---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRS 278
                GT+ Y+APE+++R   T S   D + FG+++ EM  G        R   M     
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240

Query: 279 SKAYFPSWV 287
           +K   P ++
Sbjct: 241 AKLGMPQFL 249

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 45/271 (16%)

Query: 40  DNIEKFLRNQQSWMPKRYSYPQIIAMT-NHFTHK--LGQGGFGSVYKGQL-QTGGLIAVK 95
           +++++FL   +    K++  P       + F     LG G FG V   +  ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 96  MLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL---- 147
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +    
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 148 -DRHVFPKESRGQSLCWEKLH--EVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 204
                F  E         + +  ++ L      EYLH    + +++ D+KP N+L+D   
Sbjct: 133 RRIGRFS-EPHA------RFYAAQIVLT----FEYLH---SLDLIYRDLKPENLLIDQQG 178

Query: 205 IPKVSDFGLAKFHP-KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLE 263
             +V+DFG AK    +           GT   +APE+I       +   D +  G+++ E
Sbjct: 179 YIQVTDFGFAKRVKGRTWTLC------GTPEALAPEIILSKGYNKAV--DWWALGVLIYE 230

Query: 264 MAGGR---RNSNMNAT----RSSKAYFPSWV 287
           MA G                 S K  FPS  
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.4 bits (176), Expect = 4e-14
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 45/214 (21%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLG 127
           LG G FG V+  +    G   A+K+L+          E   +E   +  + H  ++++ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 128 FCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLH--EVALGTARGIEYL 180
              +  +  ++ +Y+  G L         FP           K +  EV L     +EYL
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVA------KFYAAEVCLA----LEYL 122

Query: 181 HNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGYI 236
           H+  D  I++ D+KP NILLD N  I K++DFG AK      D      T    GT  YI
Sbjct: 123 HS-KD--IIYRDLKPENILLDKNGHI-KITDFGFAK---YVPD-----VTYTLCGTPDYI 170

Query: 237 APELISRN-FGTVSCKS-DVYGFGMVLLEMAGGR 268
           APE++S   +     KS D + FG+++ EM  G 
Sbjct: 171 APEVVSTKPYN----KSIDWWSFGILIYEMLAGY 200

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 46/230 (20%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN---SKFSAEEFIN 109
           PK Y  P  +          G G +GSV      ++G  +A+K L     S+  A+    
Sbjct: 23  PKTYVSPTHV----------GSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR 72

Query: 110 EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHVFPK----ESRGQ 159
           E+  +  + H NV+ LL  F    S R      LV  +M     D          E + Q
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT---DLQKIMGLKFSEEKIQ 129

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHP 218
            L ++ L        +G++Y+H+     ++H D+KP N+ ++ +   K+ DFGLA+    
Sbjct: 130 YLVYQML--------KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA 178

Query: 219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +   +V    TR    Y APE+I  ++   +   D++  G ++ EM  G+
Sbjct: 179 EMTGYV---VTR---WYRAPEVIL-SWMHYNQTVDIWSVGCIMAEMLTGK 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 62/242 (25%), Positives = 94/242 (38%), Gaps = 53/242 (21%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEV-STIG------RIHHVNVVQ 124
           LG+G FG V   +   TG   A+K+L      A+   +EV  T+          H  +  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK---DEVAHTVTESRVLQNTRHPFLTA 69

Query: 125 LLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTARGI 177
           L    +     +   V EY   G L  H     VF  E R +        E+       +
Sbjct: 70  L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARFYG----AEIVSA----L 118

Query: 178 EYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GT 232
           EYLH       +++ DIK  N++LD +  I K++DFGL K    +         +   GT
Sbjct: 119 EYLHSRD----VVYRDIKLENLMLDKDGHI-KITDFGLCKEGISDGA-----TMKTFCGT 168

Query: 233 IGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPS 285
             Y+APE++  N    +   D +G G+V+ EM  GR                  +  FP 
Sbjct: 169 PEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226

Query: 286 WV 287
            +
Sbjct: 227 TL 228

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 55/245 (22%)

Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFINEV-STIG------RIHHVN 121
           LG+GG+G V+         TG + A+K+L   K        +   T         + H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVL--KKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 122 VVQLLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTA 174
           +V L    +   G K  L+ EY+  G L        +F  E          L E+++   
Sbjct: 83  IVDL--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFM-EDTACFY----LAEISM--- 132

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             + +LH  G    I++ D+KP NI+L+H   + K++DFGL K    +        T   
Sbjct: 133 -ALGHLHQKG----IIYRDLKPENIMLNHQGHV-KLTDFGLCKESIHDGT-----VTHTF 181

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAY 282
            GTI Y+APE++ R+    +   D +  G ++ +M  G        R   ++     K  
Sbjct: 182 CGTIEYMAPEILMRSGHNRAV--DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239

Query: 283 FPSWV 287
            P ++
Sbjct: 240 LPPYL 244

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 58/245 (23%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V+  +  +T    A+K L   K    + +   ++V  T+   R+      H 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KK----DVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 121 NVVQLLG-FCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTA 174
            +  +   F ++      V EY+  G L  H      F   SR          E+ LG  
Sbjct: 79  FLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYA----AEIILG-- 130

Query: 175 RGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR-- 230
             +++LH  G    I++ D+K  NILLD +  I K++DFG+ K +   +       T   
Sbjct: 131 --LQFLHSKG----IVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAK-----TNTF 178

Query: 231 -GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAY 282
            GT  YIAPE++       S   D + FG++L EM  G+            ++ R    +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSV--DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF 236

Query: 283 FPSWV 287
           +P W+
Sbjct: 237 YPRWL 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 51/253 (20%), Positives = 83/253 (32%), Gaps = 67/253 (26%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEE 106
             +   M   Y               +  G +G+V  G    G  +A+K + N+      
Sbjct: 14  IAELHAMQSPY----------TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRT 63

Query: 107 ---FIN---------EVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYM------- 142
                +         E+  +   HH N++ L        + A     LV E M       
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123

Query: 143 ---PNGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI 198
                  +  +H+       Q   +  L         G+  LH      ++H D+ P NI
Sbjct: 124 IHDQRIVISPQHI-------QYFMYHIL--------LGLHVLHEAG---VVHRDLHPGNI 165

Query: 199 LLDHNFIPKVSDFGLAKFHPKEN---DFVSISATRGTIGYIAPELISRNFGTVSCKSDVY 255
           LL  N    + DF LA+    +     +V     R    Y APEL+   F   +   D++
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYV---THR---WYRAPELVM-QFKGFTKLVDMW 218

Query: 256 GFGMVLLEMAGGR 268
             G V+ EM   +
Sbjct: 219 SAGCVMAEMFNRK 231

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 46/239 (19%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           LG+G FG V   +   T  L AVK+L+      ++ +       R+         + QL 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 127 GFCSEGSKRA-LVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTARGIEYL 180
             C +   R   V EY+  G L  H      F  E            E+A+G    + +L
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFYA----AEIAIG----LFFL 458

Query: 181 H-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGY 235
              G    I++ D+K  N++LD    I K++DFG+ K +  +        T+   GT  Y
Sbjct: 459 QSKG----IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKTFCGTPDY 508

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYFPSWV 287
           IAPE+I+      S   D + FG++L EM  G+        +    +       +P  +
Sbjct: 509 IAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 60/246 (24%), Positives = 89/246 (36%), Gaps = 60/246 (24%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFI---NEV-STIG-------RIHHV 120
           +G+G FG V   +        AVK+L   K    + I    E    +         + H 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVL--QK----KAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGT 173
            +V L    S     K   V +Y+  G L  H      F  E R +        E+A   
Sbjct: 100 FLVGL--HFSFQTADKLYFVLDYINGGELFYHLQRERCFL-EPRARFYA----AEIASA- 151

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR- 230
              + YLH       I++ D+KP NILLD    I  ++DFGL K + + N       T  
Sbjct: 152 ---LGYLHSLN----IVYRDLKPENILLDSQGHI-VLTDFGLCKENIEHNST-----TST 198

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKA 281
             GT  Y+APE++ +     +   D +  G VL EM  G             +   +   
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTV--DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 256

Query: 282 YFPSWV 287
                +
Sbjct: 257 QLKPNI 262

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 41/163 (25%), Positives = 63/163 (38%), Gaps = 32/163 (19%)

Query: 69  FTHKLGQGGFGSVYKG-QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLL 126
            +  LG G  G V +    +T    A+KML++      +   EV    R     ++V+++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77

Query: 127 GFCSEGSKRA----LVYEYMPNGSL-DRHVFPKESRGQSLCWEK-----LHEVALGTARG 176
                         +V E +  G L  R       RG     E+     +  +       
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIG----EA 129

Query: 177 IEYLH-NGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAK 215
           I+YLH       I H D+KP N+L      N I K++DFG AK
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 39/213 (18%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L +T  + A+K+++    + +E I+ V T   +     +H  +V L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 127 GFCSE-GSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEYL 180
             C +  S+   V EY+  G L  H+      P E   +        E++L     + YL
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYS----AEISLA----LNYL 126

Query: 181 H-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGY 235
           H  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T    GT  Y
Sbjct: 127 HERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGDT-----TSTFCGTPNY 176

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           IAPE++       S   D +  G+++ EM  GR
Sbjct: 177 IAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 207

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 60/256 (23%), Positives = 95/256 (37%), Gaps = 58/256 (22%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN---SKFSAEEFIN 109
            KRY   + I          G G  G V           +A+K L     ++  A+    
Sbjct: 24  LKRYQNLKPI----------GSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR 73

Query: 110 EVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHVFPK----ESRGQ 159
           E+  +  ++H N++ LL  F  + S        +V E M     +     +      R  
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---NLCQVIQMELDHERMS 130

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            L ++ L         GI++LH+     I+H D+KP NI++  +   K+ DFGLA+    
Sbjct: 131 YLLYQML--------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179

Query: 220 ENDFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS 278
                    TR    Y APE+I    +       D++  G ++ EM  G           
Sbjct: 180 SFMMTPYVVTR---YYRAPEVILGMGYKE---NVDIWSVGCIMGEMIKG----------- 222

Query: 279 SKAYFPSWVY-DQLNK 293
               FP   + DQ NK
Sbjct: 223 -GVLFPGTDHIDQWNK 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 54/240 (22%), Positives = 93/240 (38%), Gaps = 52/240 (21%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN---SKF 102
              ++ + KRY   + I          G G  G V           +A+K L     ++ 
Sbjct: 54  GDSTFTVLKRYQNLKPI----------GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 103

Query: 103 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHVFPK-- 154
            A+    E+  +  ++H N++ LL  F  + +        LV E M     +     +  
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQME 160

Query: 155 --ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG 212
               R   L ++ L         GI++LH+     I+H D+KP NI++  +   K+ DFG
Sbjct: 161 LDHERMSYLLYQML--------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209

Query: 213 LAKFHPKEN---DFVSISATRGTIGYIAPELI-SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           LA+          +V    TR    Y APE+I    +       D++  G ++ EM   +
Sbjct: 210 LARTAGTSFMMTPYV---VTR---YYRAPEVILGMGYKE---NVDIWSVGCIMGEMVRHK 260

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 37/227 (16%)

Query: 53  MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN---SKFSAEEFI 108
           +   Y   Q +          G G +G+V      +TG  +A+K L     S+  A+   
Sbjct: 23  VRAVYRDLQPV----------GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 72

Query: 109 NEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHVFPKESRGQSLC 162
            E+  +  + H NV+ LL  F  + +        LV  +M     D     K  + + L 
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLG---KLMKHEKLG 126

Query: 163 WEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK-FHPKEN 221
            +++  +     +G+ Y+H      I+H D+KP N+ ++ +   K+ DFGLA+    +  
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 183

Query: 222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
            +V    TR    Y APE+I  N+   +   D++  G ++ EM  G+
Sbjct: 184 GYV---VTR---WYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 64/244 (26%), Positives = 102/244 (41%), Gaps = 56/244 (22%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V   ++ +TG L AVK+L   K    + I   ++V  T+   RI     +H 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVL--KK----DVILQDDDVECTMTEKRILSLARNHP 84

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGTAR 175
            + QL        +   V E++  G L  H      F  E+R +        E+      
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-EARARFYA----AEIISA--- 136

Query: 176 GIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR--- 230
            + +LH  G    I++ D+K  N+LLDH     K++DFG+ K             T    
Sbjct: 137 -LMFLHDKG----IIYRDLKLDNVLLDHEGHC-KLADFGMCKEGICNGVT-----TATFC 185

Query: 231 GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKAYF 283
           GT  YIAPE++       +   D +  G++L EM  G         +    A  + +  +
Sbjct: 186 GTPDYIAPEILQEMLYGPAV--DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 243

Query: 284 PSWV 287
           P+W+
Sbjct: 244 PTWL 247

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 61/246 (24%), Positives = 98/246 (39%), Gaps = 60/246 (24%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFI---NEV-STIG--RI-----HHV 120
           LG+G FG V   +   T  L AVK+L   K    + +   ++V  T+   R+        
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKIL--KK----DVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLHEVALGT 173
            + QL          +   V EY+  G L  H      F  E            E+A+G 
Sbjct: 82  FLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHAVFY----AAEIAIG- 133

Query: 174 ARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR- 230
              + +L   G    I++ D+K  N++LD    I K++DFG+ K +  +        T+ 
Sbjct: 134 ---LFFLQSKG----IIYRDLKLDNVMLDSEGHI-KIADFGMCKENIWDGV-----TTKT 180

Query: 231 --GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-------RNSNMNATRSSKA 281
             GT  YIAPE+I+      S   D + FG++L EM  G+        +    +      
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSV--DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 238

Query: 282 YFPSWV 287
            +P  +
Sbjct: 239 AYPKSM 244

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.0 bits (164), Expect = 1e-12
 Identities = 47/242 (19%), Positives = 102/242 (42%), Gaps = 46/242 (19%)

Query: 50  QSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFI 108
           + +   RY    ++        KLG G F +V+  + +     +A+K++   K   E   
Sbjct: 14  EPYKDARY---ILVR-------KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE 63

Query: 109 NEVSTIGRIHHV-----------NVVQLLG-FCSEGSKRA---LVYEYMPNGSLDRHVFP 153
           +E+  + R++             ++++LL  F  +G       +V+E +     +     
Sbjct: 64  DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL---GENLLALI 120

Query: 154 KESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH------NFIPK 207
           K+   + +    + +++     G++Y+H  C   I+H DIKP N+L++           K
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIK 178

Query: 208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAG 266
           ++D G A +   +  + +   TR    Y +PE++    G    C +D++    ++ E+  
Sbjct: 179 IADLGNACW--YDEHYTNSIQTR---EYRSPEVL---LGAPWGCGADIWSTACLIFELIT 230

Query: 267 GR 268
           G 
Sbjct: 231 GD 232

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 39/213 (18%)

Query: 73  LGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQLL 126
           +G+G +  V   +L +T  + A+++++    + +E I+ V T   +     +H  +V L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 127 GFCSE-GSKRALVYEYMPNGSLDRHV-----FPKESRGQSLCWEKLHEVALGTARGIEYL 180
             C +  S+   V EY+  G L  H+      P E   +        E++L     + YL
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHARFYS----AEISLA----LNYL 169

Query: 181 H-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATR---GTIGY 235
           H  G    I++ D+K  N+LLD    I K++D+G+ K   +  D      T    GT  Y
Sbjct: 170 HERG----IIYRDLKLDNVLLDSEGHI-KLTDYGMCKEGLRPGD-----TTSTFCGTPNY 219

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           IAPE++       S   D +  G+++ EM  GR
Sbjct: 220 IAPEILRGEDYGFSV--DWWALGVLMFEMMAGR 250

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 45/232 (19%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN--SKFSAEEFINE 110
             RY+    I          G+G +G V           +A+K +     +   +  + E
Sbjct: 26  GPRYTNLSYI----------GEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75

Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMPNGSLDRHVFPK-----ESRGQS 160
           +  + R  H N++ +       +        +V + M     D +   K           
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHICY 132

Query: 161 LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
             ++ L        RG++Y+H+     +LH D+KP N+LL+     K+ DFGLA+    +
Sbjct: 133 FLYQIL--------RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181

Query: 221 NDFVSIS----ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
           +D         ATR    Y APE++  N    +   D++  G +L EM   R
Sbjct: 182 HDHTGFLTEYVATR---WYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 36/232 (15%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN---SKF 102
           N+  W +P+RY     +          G G +GSV      +TG  +AVK L     S  
Sbjct: 21  NKTIWEVPERYQNLSPV----------GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70

Query: 103 SAEEFINEVSTIGRIHHVNVVQLLG-FCSEGSKRA-----LVYEYMPNGSLDRHVFPKES 156
            A+    E+  +  + H NV+ LL  F    S        LV   M     D +      
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLN---NIV 124

Query: 157 RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
           + Q L  + +  +     RG++Y+H+     I+H D+KP N+ ++ +   K+ DFGLA+ 
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR- 180

Query: 217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
               ++     ATR    Y APE++  N+   +   D++  G ++ E+  GR
Sbjct: 181 -HTADEMTGYVATR---WYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 50/222 (22%)

Query: 73  LGQGGFGSVY----KGQLQTGGLIAVKMLENSKFSAEEFINEV-STIG--RI-----HHV 120
           LG G +G V+         TG L A+K+L   K +  +       T    ++        
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVL--KKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 121 NVVQLLGFCS--EGSKRALVYEYMPNGSLDRH-----VFPKESRGQSLCWEKLH--EVAL 171
            +V L    +    +K  L+ +Y+  G L  H      F  E         +++  E+ L
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFT-EHEV------QIYVGEIVL 170

Query: 172 GTARGIEYLH-NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISAT 229
                +E+LH  G    I++ DIK  NILLD N  +  ++DFGL+    KE         
Sbjct: 171 A----LEHLHKLG----IIYRDIKLENILLDSNGHV-VLTDFGLS----KEFVADETERA 217

Query: 230 R---GTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
               GTI Y+AP+++           D +  G+++ E+  G 
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 50/205 (24%)

Query: 31  SRRTTLKTIDNIEKFLRNQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQT 88
            +R    +        R    W +P RY   +I        H +G G +G V +      
Sbjct: 28  QQRKQHHSSKPTASMPRPHSDWQIPDRY---EIR-------HLIGTGSYGHVCEAYDKLE 77

Query: 89  GGLIAVKMLENSKFSAEEF----INEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVY 139
             ++A+K +    F         + E++ + R++H +VV++L               +V 
Sbjct: 78  KRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 140 EYMP---------NGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           E               L + H+       ++L +  L         G++Y+H+     IL
Sbjct: 137 EIADSDFKKLFRTPVYLTELHI-------KTLLYNLL--------VGVKYVHSAG---IL 178

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLA 214
           H D+KP N L++ +   KV DFGLA
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLA 203

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 42/215 (19%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV------NVVQL 125
           +G+G FG V K    +    +A+KM+ N K    +   E+  +  +         NV+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164

Query: 126 LGF-------CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
           L         C       + +E +   S++ +   K+++ Q      + + A    + ++
Sbjct: 165 LENFTFRNHIC-------MTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFVS--ISATRGTIG 234
            LH      I+H D+KP NILL        KV DFG + +   E+  V   I  +R    
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQ-SR---F 264

Query: 235 YIAPELISRNFGT-VSCKSDVYGFGMVLLEMAGGR 268
           Y APE+I    G       D++  G +L E+  G 
Sbjct: 265 YRAPEVI---LGARYGMPIDMWSLGCILAELLTGY 296

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 51/240 (21%), Positives = 90/240 (37%), Gaps = 54/240 (22%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLE--NSKFSAEEFINE 110
              +   Q+          LG+G +G V       TG ++A+K +E  +    A   + E
Sbjct: 10  SSDF---QLK-------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE 59

Query: 111 VSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMP--------NGSL-DRHVFPKES 156
           +  +    H N++ +       S        ++ E M            L D H+     
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI----- 114

Query: 157 RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF 216
             Q   ++ L        R ++ LH      ++H D+KP N+L++ N   KV DFGLA+ 
Sbjct: 115 --QYFIYQTL--------RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 217 HPKENDFVSISATRGTI--GYI------APELISRNFGTVSCKSDVYGFGMVLLEMAGGR 268
             +     S    + +    ++      APE++       S   DV+  G +L E+   R
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVML-TSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 52/280 (18%), Positives = 97/280 (34%), Gaps = 70/280 (25%)

Query: 45  FLRNQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLEN--- 99
           + +  ++  +P  Y    I        H +G+G +G VY      T   +A+K +     
Sbjct: 15  YFQGIKNVHVPDNY---IIK-------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE 64

Query: 100 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA-----LVYEYMP---------NG 145
                +  + E++ + R+    +++L                +V E              
Sbjct: 65  DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI 124

Query: 146 SL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 204
            L + H+       +++ +  L         G  ++H      I+H D+KP N LL+ + 
Sbjct: 125 FLTEEHI-------KTILYNLL--------LGENFIHESG---IIHRDLKPANCLLNQDC 166

Query: 205 IPKVSDFGLAKFHPKENDFVSISATRGTIG--------------------YIAPELISRN 244
             KV DFGLA+    E D   ++                           Y APELI   
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL-L 225

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 284
               +   D++  G +  E+    + S++N   +    FP
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQ-SHINDPTNRFPLFP 264

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 49/253 (19%), Positives = 94/253 (37%), Gaps = 65/253 (25%)

Query: 48  NQQSW-MPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFS 103
           N   + +  RY   + +          G GG G V+          +A+K +   + +  
Sbjct: 3   NIHGFDLGSRYMDLKPL----------GCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS- 51

Query: 104 AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA--------------LVYEYMP------ 143
            +  + E+  I R+ H N+V++         +               +V EYM       
Sbjct: 52  VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111

Query: 144 --NGSL-DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL 200
              G L + H        +   ++ L        RG++Y+H+     +LH D+KP N+ +
Sbjct: 112 LEQGPLLEEHA-------RLFMYQLL--------RGLKYIHSAN---VLHRDLKPANLFI 153

Query: 201 D-HNFIPKVSDFGLAKFHPKENDFVSIS----ATRGTIGYIAPELISRNFGTVSCKSDVY 255
           +  + + K+ DFGLA+                 T+    Y +P L+  +    +   D++
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK---WYRSPRLLL-SPNNYTKAIDMW 209

Query: 256 GFGMVLLEMAGGR 268
             G +  EM  G+
Sbjct: 210 AAGCIFAEMLTGK 222

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 29/164 (17%)

Query: 67  NHF--THKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNV 122
            +F    K+G G FG +  G+ L T   +A+K LE  K  A +   E     ++     +
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGI 67

Query: 123 VQLLGFCSEGSKRALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTA----RGI 177
            Q+  F   G   A+V E +  G SL+  +F    R  SL      +  L  A      +
Sbjct: 68  PQVYYFGPCGKYNAMVLELL--GPSLE-DLFDLCDRTFSL------KTVLMIAIQLISRM 118

Query: 178 EYLHNGCDVCILHFDIKPHNILL------DHNFIPKVSDFGLAK 215
           EY+H+     +++ D+KP N L+          I  + DF LAK
Sbjct: 119 EYVHS---KNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 25/159 (15%)

Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLL 126
              ++G+G FG +++G  L     +A+K  E  +  A +  +E  T   +     +  + 
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 72

Query: 127 GFCSEGSKRALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTA----RGIEYLH 181
            F  EG    LV + +  G SL+  +     R  S+      +     A      ++ +H
Sbjct: 73  YFGQEGLHNVLVIDLL--GPSLE-DLLDLCGRKFSV------KTVAMAAKQMLARVQSIH 123

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPK-----VSDFGLAK 215
                 +++ DIKP N L+            V DFG+ K
Sbjct: 124 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 25/161 (15%)

Query: 67  NHF--THKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNV 122
           N +    K+G G FG +Y G  +  G  +A+K+ E  K    +   E      +   V +
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 123 VQLLGFCSEGSKRALVYEYMPNG-SLDRHVFPKESRGQSL---CWEKLHEVALGTARGIE 178
             +    +EG    +V E +  G SL+  +F   SR  SL          +A      IE
Sbjct: 68  PTIRWCGAEGDYNVMVMELL--GPSLE-DLFNFCSRKFSLKTVLL-----LADQMISRIE 119

Query: 179 YLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 215
           Y+H+      +H D+KP N L+      N +  + DFGLAK
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAK 156

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 42/217 (19%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI--------HHVNV 122
            +G+G FG V K         +A+K+++N K    +   EV  +  +        +++  
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI-- 118

Query: 123 VQLLGF-------CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
           V L          C       LV+E +   S + +   + +  + +      + A     
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFGLAKFHPKENDFV-SISATRGT 232
            + +L    ++ I+H D+KP NILL +      K+ DFG +         +     +R  
Sbjct: 169 ALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQYIQSR-- 222

Query: 233 IGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGGR 268
             Y +PE++    G       D++  G +L+EM  G 
Sbjct: 223 -FYRSPEVL---LGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 52/263 (19%), Positives = 97/263 (36%), Gaps = 78/263 (29%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-------- 121
            KLG G F +V+    +Q    +A+K++++++   E  ++E+  +  + + +        
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 122 VVQLLG-FCSEGSK---RALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           VVQLL  F   G       +V+E +  G  L +  +  +S  Q L    + ++     +G
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL--GHHLLK--WIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 177 IEYLHNGCDVCILHFDIKPHNILL------------------------------------ 200
           ++YLH  C +   H DIKP NILL                                    
Sbjct: 159 LDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 201 -------------DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
                              K++D G A     ++    I     T  Y + E++    G+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNA-CWVHKHFTEDIQ----TRQYRSLEVL---IGS 268

Query: 248 -VSCKSDVYGFGMVLLEMAGGRR 269
             +  +D++    +  E+A G  
Sbjct: 269 GYNTPADIWSTACMAFELATGDY 291

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 33/182 (18%), Positives = 61/182 (33%), Gaps = 57/182 (31%)

Query: 71  HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF------------------SAEEFINEVS 112
             +GQGGFG +Y   + +   +        K                   +  E I +  
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 113 TIGRIHHVNVVQLLGFCSEGSK----RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE 168
              ++ ++ V +  G           R ++ +                 G  L  +K++E
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF---------------GSDL--QKIYE 143

Query: 169 -------------VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGL 213
                        ++L     +EY+H       +H DIK  N+LL++    +V   D+GL
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200

Query: 214 AK 215
           A 
Sbjct: 201 AY 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.9 bits (131), Expect = 1e-08
 Identities = 44/310 (14%), Positives = 81/310 (26%), Gaps = 90/310 (29%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKML---------ENSKFSAEEFINEV---------ST 113
           K+G+G FG V++        +A+K++          + + + EE + E+         S 
Sbjct: 27  KIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 114 IGRIHHVNVVQLLGF--CSEGSKRALVYEY---------------------------MPN 144
                    + L             L+  +                              
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF 204
           G +D      +    +     LH++    A     L         H D+   N+LL    
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR------FEHRDLHWGNVLLKKTS 199

Query: 205 IPKVSDFGLAK--------FHPKENDFVSISATRGTIGYIA-----PELISRNFGTVSCK 251
           + K+      K              D+      R  I          +L +   G    +
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT---GDGDYQ 256

Query: 252 SDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS----WVY---DQLNKGGDLELQNVTE 304
            D+Y             R            Y P     W++   D++ K    + +  T 
Sbjct: 257 FDIY-------------RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303

Query: 305 IESMIARKLC 314
               I RK+ 
Sbjct: 304 AMKQIKRKIQ 313

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 37/237 (15%), Positives = 74/237 (31%), Gaps = 60/237 (25%)

Query: 72  KLGQGGFGSVYKGQLQTGGLI---------AVKM-LENSKFSAE----------EFINEV 111
              +   G +Y+    +             ++K+  ++ +   E            +N+ 
Sbjct: 49  FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 112 STIGRIHHVNVVQLLGF-CSEGSKRALVYEYM-PN-----GSLDRHVFPKESRGQSLCWE 164
             +     + +   +GF   +   R LV   +  +         +HV  + S    L   
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS---VLQ-- 163

Query: 165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAKF------ 216
               VA      +E+LH       +H ++   NI +D     +V  + +G A        
Sbjct: 164 ----VACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

Query: 217 --HPKENDFVSISATRGTIGYIAPELISRN--FG-TVSCKSDVYGFGMVLLEMAGGR 268
                E          G + +     IS +   G   S +SD+   G  +L+   G 
Sbjct: 217 HVAYVEGSRSPH---EGDLEF-----ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 27/162 (16%)

Query: 67  NHF--THKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNV 122
           N F    K+G G FG +Y G  +QT   +A+K+ EN K    + + E      +     +
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 123 VQLLGFCSEGSKRALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTA----RGI 177
             +  F  EG    LV + +  G SL+  +F   SR  SL      +  L  A      +
Sbjct: 66  PNVRWFGVEGDYNVLVMDLL--GPSLE-DLFNFCSRKLSL------KTVLMLADQMINRV 116

Query: 178 EYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK 215
           E++H+      LH DIKP N L+      N +  + DFGLAK
Sbjct: 117 EFVHS---KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 32/178 (17%), Positives = 61/178 (34%), Gaps = 54/178 (30%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKM--LENSK-------------FSAEEFINEVSTIG 115
           K+G GGFG +Y           A  +  +E  +              + ++ I +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 116 RIHHVNVVQLLGF----CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHE--- 168
           ++ ++ +    G         S R +V E +               G  L  +K+     
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL---------------GIDL--QKISGQNG 146

Query: 169 ---------VALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV--SDFGLAK 215
                    + +     +EY+H       +H DIK  N+LL +    +V  +D+GL+ 
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 57/257 (22%), Positives = 96/257 (37%), Gaps = 78/257 (30%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVS 112
            ++Y              KLG+G +G V+K    +TG ++AVK + ++      F N   
Sbjct: 8   LRKY----------ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTD 51

Query: 113 TIGRI-----------HHVNVVQLLG-FCSEGSKRA-LVYEYMP--------NGSL-DRH 150
              R             H N+V LL    ++  +   LV++YM            L   H
Sbjct: 52  AQ-RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH 110

Query: 151 VFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD 210
                   Q + ++ +        + I+YLH+G    +LH D+KP NILL+     KV+D
Sbjct: 111 K-------QYVVYQLI--------KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVAD 152

Query: 211 FGLAKFHPKENDFVSISATRGTIG-------------------YIAPELISRNFGTVSCK 251
           FGL++         +                            Y APE++       +  
Sbjct: 153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL-GSTKYTKG 211

Query: 252 SDVYGFGMVLLEMAGGR 268
            D++  G +L E+  G+
Sbjct: 212 IDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 2e-07
 Identities = 41/266 (15%), Positives = 76/266 (28%), Gaps = 84/266 (31%)

Query: 15  LVISN--SATYLESNFLVSRRTTLKTID-NIEKFLRNQQSWMPKRYSYPQIIAMTNHFTH 71
           LV+ N  +A    + F +S +  L T    +  FL           ++  +   +   T 
Sbjct: 248 LVLLNVQNAKAWNA-FNLSCKILLTTRFKQVTDFL------SAATTTHISLDHHSMTLTP 300

Query: 72  KLGQGGFGSVYKG-------QLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ 124
              +                ++ T     + ++      AE   + ++T     HVN  +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII------AESIRDGLATWDNWKHVNCDK 354

Query: 125 L-------LGFCSEGSKRALVYEYMPNGSLDRHVFPKESR--GQSLC--W---------- 163
           L       L        R + ++ +        VFP  +      L   W          
Sbjct: 355 LTTIIESSLNVLEPAEYRKM-FDRLS-------VFPPSAHIPTILLSLIWFDVIKSDVMV 406

Query: 164 --EKLHEVAL---GTARGIEYLHNGCDVCILHFDIKP--------HNILLDHNFIPKVSD 210
              KLH+ +L           + +      ++ ++K         H  ++DH  IPK  D
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPS------IYLELKVKLENEYALHRSIVDHYNIPKTFD 460

Query: 211 FGLAKFHPKENDFVSISATRGTIGYI 236
                  P   D            Y 
Sbjct: 461 SD--DLIPPYLD-----------QYF 473

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 7e-05
 Identities = 47/355 (13%), Positives = 95/355 (26%), Gaps = 89/355 (25%)

Query: 30  VSRRTTLKTIDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFTHKLGQGGFG-SVYKGQLQT 88
           VSR   L+    + + L   +   P +      + +        G  G G +        
Sbjct: 131 VSR---LQPYLKLRQALLELR---PAKN-----VLI-----D--GVLGSGKTW------- 165

Query: 89  GGLIAVKMLENSKFSAEEFINEVS--TIGRIHHVNVV--QLLGFCSEGSKRALVY-EYMP 143
              +A+ +  + K    +   ++    +   +    V   L     +         ++  
Sbjct: 166 ---VALDVCLSYKVQ-CKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221

Query: 144 NGSLDRHVFPKESRGQSLCWEKLHEVAL------GTARGIEYLHNGCDVCILHFDIKPHN 197
           N  L  H    E R   L   K +E  L        A+     +  C + +     +  +
Sbjct: 222 NIKLRIHSIQAELR--RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGF 257
            L          D       P E   + +         +  E+++ N   +S        
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-------- 331

Query: 258 GMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK--GGDLELQNVTEIESM------- 308
            ++           +  AT      +     D+L       L +    E   M       
Sbjct: 332 -II------AESIRDGLATWD---NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF 381

Query: 309 -----IARK-LCMIGLWCIQVKAADRPSMTKVLE---MLEG-------SIDDLQM 347
                I    L +  +W   V  +D   +   L    ++E        SI  + +
Sbjct: 382 PPSAHIPTILLSL--IWF-DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 64/237 (27%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-----HHVNVVQL 125
           K+G G FG V   Q +      AVK++ N K        E   + +I     ++ N+V+ 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101

Query: 126 LGF-------CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE 178
            G        C       L++E +       +     +       E +    +   + + 
Sbjct: 102 HGKFMYYDHMC-------LIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 179 YLHNGCDVCILHFDIKPHNILLDHNFIP-------------------------KVSDFGL 213
           YL     + + H D+KP NILLD  +                           K+ DFG 
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 214 AKFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
           A F   ++D+    I+ TR    Y APE+I           SD++ FG VL E+  G
Sbjct: 209 ATF---KSDYHGSIIN-TR---QYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 47/236 (19%), Positives = 84/236 (35%), Gaps = 66/236 (27%)

Query: 72  KLGQGGFGSVYKG--QLQTGGLIAVKMLENSKFSAE---------EFINEVSTIGRIHHV 120
            LG+G FG V +     +    +A+K++ N     E         + I E     +    
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL-- 83

Query: 121 NVVQLLGF-------CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGT 173
             V +  +       C       + +E +     +   F KE+  Q      +  +A   
Sbjct: 84  -CVLMSDWFNFHGHMC-------IAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQL 132

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KVSDFGLA 214
              + +LH   +  + H D+KP NIL  ++                      +V+DFG A
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 215 KFHPKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
            F   +++  +  ++ TR    Y  PE+I        +   DV+  G +L E   G
Sbjct: 190 TF---DHEHHTTIVA-TR---HYRPPEVI---LELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 56/233 (24%), Positives = 93/233 (39%), Gaps = 60/233 (25%)

Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKMLENSKFSAEEFINEVSTIGRI------HHVNVV 123
            LG+G FG V +    + GG  +AVK+++N     E   +E+  +  +           V
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCV 80

Query: 124 QLLGF-------CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARG 176
           Q+L +       C       +V+E +    L  + F KE+       + + ++A    + 
Sbjct: 81  QMLEWFEHHGHIC-------IVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 177 IEYLHNGCDVCILHFDIKPHNILLDHNFIP-------------------KVSDFGLAKFH 217
           + +LH      + H D+KP NIL   +                      KV DFG A + 
Sbjct: 131 VNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY- 186

Query: 218 PKENDFVS--ISATRGTIGYIAPELISRNFGTV-SCKSDVYGFGMVLLEMAGG 267
             +++  S  +S TR    Y APE+I        S   DV+  G +L+E   G
Sbjct: 187 --DDEHHSTLVS-TR---HYRAPEVI---LALGWSQPCDVWSIGCILIEYYLG 230

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	373
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.25
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.16
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.06
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.84
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.79
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.77
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.76
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.74
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.72
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.69
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.39
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.34
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.25
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.8
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.49
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.07
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.08
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.65
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.99

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-59  Score=425.02  Aligned_cols=263  Identities=24%  Similarity=0.350  Sum_probs=217.4

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      ++...++++.++||+|+||+||+|.+.      +++.||||+++....  ..++|.+|+.++++++||||++++|+|.++
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            444456788899999999999999863      467899999976433  347899999999999999999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      ...++|||||++|+|.+++.....            ....+++..+..++.||+.||+|||++   +|+||||||+|||+
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            999999999999999999854321            235699999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~  279 (373)
                      ++++++||+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |..||.....   
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---  253 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---  253 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999865443333334456799999999999774  89999999999999999998 8899975442   


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                           ..+...+..+...+.+      ..++..+.+|+.+||+.||++|||++||++.|+...
T Consensus       254 -----~~~~~~i~~~~~~~~p------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          254 -----QDVVEMIRNRQVLPCP------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             -----HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----HHHHHHHHcCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                 2244445555443332      344567899999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-59  Score=421.22  Aligned_cols=262  Identities=27%  Similarity=0.473  Sum_probs=206.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .+.+.++||+|+||+||+|+++  ..||||+++....+   .++|.+|+.++++++||||+++++++.+ +..++|||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            4567799999999999999875  36999999765443   3678999999999999999999999865 5689999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++|+|.+++...   ..++++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+.......
T Consensus       114 ~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          114 EGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             SSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999998432   35699999999999999999999998   999999999999999999999999999987654433


Q ss_pred             ceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .......+||+.|+|||++.+. .+.++.++|||||||++|||+||+.||......       ......+..+...  +.
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~~--p~  258 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYAS--PD  258 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCCC--CC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCC--CC
Confidence            3344566899999999998653 346899999999999999999999999754432       1223333333221  11


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ....+..++..+.+|+.+||+.||++|||+.||++.|+.+...+
T Consensus       259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            12333456678999999999999999999999999998765443

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.4e-59  Score=422.31  Aligned_cols=260  Identities=23%  Similarity=0.399  Sum_probs=213.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..+.+.++||+|+||+||+|++.      ++..||||+++..... .++|.+|+++|++++||||++++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            34567799999999999999864      4678999999765433 3679999999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          138 VYEYMPNGSLDRHVFPKE---------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      |||||++|+|.+++....         .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999985432         2345799999999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ..+
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~  239 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV  239 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            999999865444333333345699999999999875  89999999999999999998 8999976542        224


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ...+..+..+..+      ..++..+.+|+.+||+.||++|||++++++.|+++.+
T Consensus       240 ~~~i~~~~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          240 IECITQGRVLQRP------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCC------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            4445555443332      3346689999999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-58  Score=422.11  Aligned_cols=259  Identities=26%  Similarity=0.413  Sum_probs=207.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .+.+.++||+|+||+||+|+++      ++..||||+++..... .++|.+|+.+|++++|||||+++++|.++...++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4456789999999999999864      4678999999765433 36799999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          139 YEYMPNGSLDRHVFPKES-----------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                      ||||++|+|.+++.....           ...++++..+..++.|++.||+|||++   +|+||||||+|||++.++++|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEE
Confidence            999999999999865322           235699999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||+++...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||.....        ..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~  268 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TE  268 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            9999999866544433334456799999999999775  78999999999999999999 8999975442        22


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +...+..+..+..+      ..++..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       269 ~~~~i~~g~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          269 AIDCITQGRELERP------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHTCCCCCC------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCc------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            33444455444332      2345689999999999999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.6e-57  Score=414.40  Aligned_cols=255  Identities=21%  Similarity=0.241  Sum_probs=207.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .|.+.++||+|+||.||+|+++ +|+.||||+++.....    .+|+.+++.++|||||++++++.++...|+|||||++
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            3556688999999999999976 7899999999865433    4799999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCCCCCc
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  223 (373)
                      |+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+|+........
T Consensus       135 g~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          135 GSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999983    345699999999999999999999998   999999999999999887 6999999999876543221


Q ss_pred             e---eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          224 V---SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       224 ~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .   .....+||+.|+|||++.+.  .++.++|||||||++|||++|+.||........       .. .+.....    
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~-~i~~~~~----  273 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CL-KIASEPP----  273 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HH-HHHHSCC----
T ss_pred             cceecCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HH-HHHcCCC----
Confidence            1   22345799999999999875  789999999999999999999999976543221       11 1122111    


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ...+++..++..+.+|+.+||+.||.+|||+.|+++.|...+.+.
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            112334456788999999999999999999999999888765443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-57  Score=416.04  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=202.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.+.||+|+||+||+|+++ +|+.||||++.......   +.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            5788899999999999999975 78999999998655433   6788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |++|+|.+++...  .+..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus       105 ~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          105 CEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999998432  345689999999999999999999998   99999999999999999999999999998654321


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                        ......+||+.|+|||++.+.  .|+.++|||||||++|+|++|+.||......        .+...+..+....   
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~---  244 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSMK--------NLVLKIISGSFPP---  244 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCC---
T ss_pred             --ccccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCC---
Confidence              112345799999999999875  7899999999999999999999999765421        1222233332221   


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .+..++.++.+|+.+||+.||++|||++|+++
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               12345678999999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-57  Score=410.60  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=209.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||+||+|+++ +|+.||||++.+.    ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35889999999999999999975 7899999999753    234577899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||++|+|.+++.    +...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       112 Ey~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999983    345799999999999999999999998   999999999999999999999999999997755


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..........+||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .+...+..+. ..+
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~-~~~  253 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNEG--------LIFAKIIKLE-YDF  253 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC-CCC
T ss_pred             CCCcccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-CCC
Confidence            4443445567899999999999875  7899999999999999999999999754321        1223333322 111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                            +..++.++.+|+.+||+.||++|||++|++
T Consensus       254 ------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 ------PEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                  234567899999999999999999999863

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.9e-57  Score=411.95  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=207.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|++.++||+|+||+||+|.++ +|+.||||++..... ..+.+.+|+.+|+.++||||+++++++.+++..|+|||||+
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  154 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  154 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            3677789999999999999976 789999999975433 33668899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       155 gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          155 GGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            999999883     24599999999999999999999998   999999999999999999999999999987654322 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       .....+||+.|+|||++.+.  .|+.++||||+||++|||++|..||......        .....+.......+..  
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~~--  292 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLKN--  292 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSSCCCCSC--
T ss_pred             -cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCCc--
Confidence             23456799999999999765  7899999999999999999999999754321        1223333332222222  


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ...++..+.+|+.+||+.||++|||++|+++
T Consensus       293 --~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              2345678999999999999999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-56  Score=397.40  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=199.3

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee----CCeeEEEE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  139 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~  139 (373)
                      ++.++||+|+||+||+|.+. ++..||+|.+......   .+.+.+|+.+++.++||||+++++++.+    +...|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56788999999999999876 6889999999765443   3678999999999999999999999865    35689999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeee-CCCceEEeeccCccc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLAKF  216 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~  216 (373)
                      |||++|+|.+++.    +...+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+|+.
T Consensus       109 Ey~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          109 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            9999999999984    346799999999999999999999987   6  99999999999997 479999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .....    ....+||+.|+|||++.+   .++.++|||||||++|||++|+.||......       ..+...+..+..
T Consensus       182 ~~~~~----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~  247 (290)
T 3fpq_A          182 KRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  247 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             CCCCc----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCC
Confidence            43322    345679999999999864   5889999999999999999999999754321       123333333322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.     ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 PA-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CG-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC-----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11     222334567899999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-56  Score=397.00  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||+||+|..+ +|+.||||++.....    ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            36888899999999999999865 789999999976432    2367899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||| +|+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 679988883    346799999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..   .....+||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.....        ......+..+.. . 
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~-~-  230 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVY-T-  230 (275)
T ss_dssp             -------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC-C-
T ss_pred             CC---ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC-C-
Confidence            32   23346799999999999875 2346799999999999999999999975432        122333333321 1 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           .+..++..+.+|+.+||+.||++|||++|+++
T Consensus       231 -----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 -----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 12335678999999999999999999999987

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-55  Score=413.18  Aligned_cols=247  Identities=26%  Similarity=0.332  Sum_probs=207.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|++.++||+|+||.||+|.++ +|+.||||++..... ..+.+.+|+.+|+.++||||+++++++.+++..|+|||||+
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~  231 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  231 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence            3677789999999999999976 789999999976443 34678899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|........ 
T Consensus       232 gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-  302 (423)
T 4fie_A          232 GGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  302 (423)
T ss_dssp             TEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred             CCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence            999999883     24599999999999999999999998   999999999999999999999999999987654322 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       .....+||+.|+|||++.+.  .|+.++|||||||++|||++|..||......        .....+.......+..  
T Consensus       303 -~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~~~~~~~--  369 (423)
T 4fie_A          303 -RRKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNLPPRLKN--  369 (423)
T ss_dssp             -CBCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCSC--
T ss_pred             -cccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCCCCCCcc--
Confidence             23456799999999999775  7899999999999999999999999754321        1223333333222222  


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ...++..+.+|+.+||+.||++|||++|+++
T Consensus       370 --~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              1234678999999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-55  Score=406.94  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=216.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC------CceeEEEEeccCccC--HHHHHHHHHHhcccCC-CceeeEeeEeee-CC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT------GGLIAVKMLENSKFS--AEEFINEVSTIGRIHH-VNVVQLLGFCSE-GS  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h-~ni~~~~~~~~~-~~  133 (373)
                      ...|++.+.||+|+||+||+|.+..      ++.||||.+......  .+++.+|+.+|.+++| |||++++++|.+ +.
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            4567888999999999999998652      347999999765443  3678999999999965 899999999866 45


Q ss_pred             eeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ..++|||||++|+|.+++.....            ....+++..+..++.||+.||+|||++   +|+||||||+|||++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~  219 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  219 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeC
Confidence            78999999999999999854321            235589999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccc
Q 048542          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  280 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~  280 (373)
                      .++++||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||+| |+.||......   
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~---  294 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---  294 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---
Confidence            9999999999999877655555555566799999999999875  88999999999999999998 89999765432   


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          ..+...+..+..+..+.      .++.++.+|+.+||+.||++|||++|+++.|+.+++
T Consensus       295 ----~~~~~~i~~g~~~~~p~------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          295 ----EEFCRRLKEGTRMRAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             ----HHHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHcCCCCCCCc------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence                23445555555444332      345678999999999999999999999999987643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-55  Score=397.76  Aligned_cols=270  Identities=23%  Similarity=0.276  Sum_probs=203.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC----eeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e~  141 (373)
                      ++.+.++||+|+||+||+|+++ |+.||||++.........+..|+..+..++||||+++++++.++.    ..++||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey   82 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY   82 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence            4567789999999999999985 899999999765433333445666777889999999999997643    57999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      |++|+|.+++.     ...+++..+..++.|++.||+|||++.     ..+|+||||||+|||++.++++||+|||+++.
T Consensus        83 ~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           83 HEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            99999999983     245899999999999999999999752     34899999999999999999999999999986


Q ss_pred             CCCCCCce--eeecccCCCCccccccccccc----CCcCcccchHHHHHHHHHHHcCCCCCCCCcCcc--c------ccc
Q 048542          217 HPKENDFV--SISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--S------KAY  282 (373)
Q Consensus       217 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~--~------~~~  282 (373)
                      ........  ......||+.|+|||++.+..    +.++.++|||||||++|||+||..|+.......  .      ...
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            64433222  123457999999999986531    246789999999999999999988775432211  0      011


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ...........+..+.++... ...+.+..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            111112222233333333221 12345678899999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.1e-56  Score=398.91  Aligned_cols=246  Identities=22%  Similarity=0.283  Sum_probs=196.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..|++.+.||+|+||+||+|+..    +++.||||+++....   ...++.+|+.+++.++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            36888999999999999999863    467899999975432   22467889999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||+||+|.+++.    +...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999983    345799999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .....  .....+||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .....+..+.. 
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~-  243 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--------ETMTMILKAKL-  243 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-
T ss_pred             cCCCc--cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCHH--------HHHHHHHcCCC-
Confidence            33221  23456799999999999775  7889999999999999999999999765422        12222322221 


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ell~  336 (373)
                      .      .+..++.++.+|+.+||+.||++|||+     +|+++
T Consensus       244 ~------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 G------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1      123456789999999999999999984     67764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-53  Score=384.85  Aligned_cols=249  Identities=20%  Similarity=0.288  Sum_probs=187.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCC---------
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGS---------  133 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---------  133 (373)
                      .|++.+.||+|+||.||+|+++ +|+.||||+++.....  .+++.+|+.+++.++||||+++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            4778899999999999999976 7899999999764433  367899999999999999999999986543         


Q ss_pred             ---eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEee
Q 048542          134 ---KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSD  210 (373)
Q Consensus       134 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~D  210 (373)
                         ..|+|||||++|+|.+++.... ......+..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence               3689999999999999985332 122355677889999999999999998   999999999999999999999999


Q ss_pred             ccCcccCCCCCCc----------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc
Q 048542          211 FGLAKFHPKENDF----------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  280 (373)
Q Consensus       211 fg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~  280 (373)
                      ||+|+........          ......+||+.|+|||++.+.  .++.++|||||||++|||++   ||.....    
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            9999876443221          112345799999999999875  78999999999999999996   6642211    


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ............   .   .......++.+.+|+.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~~~~~~~---~---p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 ---RVRTLTDVRNLK---F---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ---HHHHHHHHHTTC---C---CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHHhcCC---C---CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               001111222211   1   1233445567789999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.2e-52  Score=387.07  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=200.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeee------CCee
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~  135 (373)
                      .|++.+.||+|+||+||+|.++ +|+.||||+++......   +.+.+|+.+|+.++||||+++++++..      ....
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            5788899999999999999975 79999999997654433   567899999999999999999998753      3678


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+|||||+ |+|.+++.    +...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       135 ~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence            99999995 67888883    356799999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCC--CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH--------
Q 048542          216 FHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS--------  285 (373)
Q Consensus       216 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~--------  285 (373)
                      ......  ........+||+.|+|||++.+. ..++.++||||+||++|||++|+.||........-..+..        
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            654321  11223456899999999998764 4578899999999999999999999976542210000000        


Q ss_pred             --------HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 --------WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                              .......................++..+.+|+.+||+.||.+|||++|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    000000000000000011122234678899999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-50  Score=373.06  Aligned_cols=199  Identities=23%  Similarity=0.331  Sum_probs=169.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.++||+|+||+||+|+.+    +++.||+|.+.... ...++.+|+.+++.+ +||||+++++++.+.+..|+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            45788899999999999999854    46789999987543 456788999999988 6999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCcccCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHP  218 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~  218 (373)
                      |||++|+|.+++       ..+++..+..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||+|+...
T Consensus       100 E~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          100 PYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             ECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             eCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            999999999988       3489999999999999999999998   99999999999999976 799999999997543


Q ss_pred             CCCC--------------------------ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          219 KEND--------------------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       219 ~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      ....                          .......+||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            3211                          0112345799999999998764 357889999999999999999999996


Q ss_pred             CCc
Q 048542          273 MNA  275 (373)
Q Consensus       273 ~~~  275 (373)
                      ...
T Consensus       249 ~~~  251 (361)
T 4f9c_A          249 KAS  251 (361)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.5e-50  Score=391.91  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=208.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|++...... .+.+.+|+.+|+.++||||+++++++.++...|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            36788899999999999999976 7899999998765433 467889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC--CceEEeeccCcccCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--FIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~--~~~kl~Dfg~~~~~~~~  220 (373)
                      +||+|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.....
T Consensus       237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999998843   345699999999999999999999998   99999999999999854  89999999999977544


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .   .....+||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+..... .+ 
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~--------~~~~~i~~~~~-~~-  375 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDW-NM-  375 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC-CC-
T ss_pred             C---ceeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHhCCC-CC-
Confidence            3   23455799999999999875  7899999999999999999999999765432        12223322211 11 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       376 -~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          376 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             12223445778999999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-49  Score=387.78  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHH---HHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFIN---EVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~---e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      .|++.+.||+|+||.||+|+.+ +|+.||||++.+..    .......+   ++.+++.++||||+++++++.+....|+
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            4677799999999999999976 78999999997532    22233333   4667778899999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||+||+|.+++.    +...+++..+..++.||+.||.|||++   +|+||||||+|||++.+|++||+|||+|...
T Consensus       270 VmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999983    346799999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ....    ....+||+.|+|||++.+. ..|+.++|+||+||++|+|++|..||........     ..+........ .
T Consensus       343 ~~~~----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~~~-~  411 (689)
T 3v5w_A          343 SKKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLTMA-V  411 (689)
T ss_dssp             SSCC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHHCC-C
T ss_pred             CCCC----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcCCC-C
Confidence            5433    2346799999999998642 3688999999999999999999999975443211     11222222211 1


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                            ..+..++..+.+|+.+||+.||.+|++     ++|+++
T Consensus       412 ------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                  122345678999999999999999998     677754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-47  Score=350.04  Aligned_cols=272  Identities=35%  Similarity=0.616  Sum_probs=220.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      .|++.+.||+|+||.||+|.+++++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus        40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  119 (321)
T 2qkw_B           40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN  119 (321)
T ss_dssp             CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred             ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence            56677899999999999999888999999998765443 47789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.........+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..........
T Consensus       120 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  196 (321)
T 2qkw_B          120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH  196 (321)
T ss_dssp             CBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred             CcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            999999866554455799999999999999999999998   99999999999999999999999999998654333222


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc---cCc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE---LQN  301 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  301 (373)
                      ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......... ...|.......+....   ...
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          197 LSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSSC
T ss_pred             cccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChhh
Confidence            23344589999999998764  78899999999999999999999998655433221 2222222222221111   111


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+...+..+.+++.+||+.||++|||++|+++.|+..++
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            223456778899999999999999999999999999997643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-47  Score=348.02  Aligned_cols=263  Identities=30%  Similarity=0.488  Sum_probs=202.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|++.+.||+|+||.||+|... |+.||+|++.......   +++.+|+.++++++||||+++++++.+....++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            446778899999999999999874 8899999997655443   568899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |+++++|.+++.... ....+++..+..++.|++.||+|||+.   +  ++||||||+||+++.++.+||+|||++....
T Consensus       115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            999999999884321 112389999999999999999999998   8  9999999999999999999999999997543


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH-hcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL-NKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~  297 (373)
                      ...  .......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ..... ......
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~~~~  258 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRL  258 (309)
T ss_dssp             -------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHHSCCCC
T ss_pred             ccc--cccccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCC
Confidence            321  122345699999999999765  67889999999999999999999997543211        11122 122222


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP  349 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~  349 (373)
                      ..      +..++..+.+|+.+||+.||.+|||++++++.|+.+.+...+|+
T Consensus       259 ~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          259 EI------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             CC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             CC------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            22      23345678999999999999999999999999999877654443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-47  Score=350.29  Aligned_cols=285  Identities=38%  Similarity=0.632  Sum_probs=224.8

Q ss_pred             CCccChhHHHHH--HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           54 PKRYSYPQIIAM--TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        54 ~~~~~~~~i~~~--~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      ...++..++...  .|.+.+.||+|+||.||+|..++++.||+|++......  ...+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            345677766654  45666899999999999999888999999998764432  24688999999999999999999999


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      ......++||||+++|+|.+++.........+++..+..++.|++.||+|||+....+++||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999997666666779999999999999999999998655589999999999999999999999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcc-ccccchHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-SKAYFPSWVY  288 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~  288 (373)
                      |||++......... ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||....... .......|..
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             cCccccccCccccc-ccccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999876543322 23445699999999998764  68899999999999999999999996332111 1111222222


Q ss_pred             HHHhcCCCccc---CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          289 DQLNKGGDLEL---QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       289 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...........   ......+...+..+.+++.+||+.||.+|||++++++.|++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            22222111111   112234566788999999999999999999999999999974

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-47  Score=348.65  Aligned_cols=270  Identities=25%  Similarity=0.328  Sum_probs=209.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC----eeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e  140 (373)
                      ..|++.+.||+|+||.||+|++. ++.||||++............|+.+++.++||||+++++++....    ..++|||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            46778899999999999999876 789999999876655566777999999999999999999997744    4699999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-------DVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      |+++|+|.+++..     ..+++..+..++.|++.||+|||+..       ..+++||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999832     45899999999999999999999741       22899999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------  282 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------  282 (373)
                      +................||+.|+|||.+.+.   ...++.++|||||||++|+|++|+.||...........        
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            9866544333333445799999999998752   12456788999999999999999999976543221111        


Q ss_pred             -chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          283 -FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       283 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                       ...+............... .......+..+.+|+.+||+.||++|||++|+++.|+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          258 SLEDMQEVVVHKKKRPVLRD-YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CHHHHHHHHTTSCCCCCCCG-GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhhhhhcccCCCCccc-cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             1111111111222222221 111234466799999999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.8e-47  Score=353.29  Aligned_cols=260  Identities=23%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  132 (373)
                      ...|++.+.||+|+||.||+|.+.        ++..||+|+++.....  .+++.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            346778899999999999999853        3457999999765432  36789999999999 899999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      ...++||||+++|+|.+++.....            ....+++..+..++.|++.||.|||++   +++||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999998854321            124589999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~  279 (373)
                      +.++.+||+|||++................+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||....... 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            99999999999999866544333333344578899999998764  78899999999999999999 999987543221 


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                             ....+..+.....+      ..++..+.+++.+||+.||.+|||++|+++.|+.++
T Consensus       314 -------~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 -------LFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             -------HHHHHHTTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                   23334444332222      234567999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-46  Score=345.79  Aligned_cols=245  Identities=19%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.+.||+|+||.||+|.+. +|+.||||++......   .+++.+|+.+++.++||||+++++++......++||||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            5778899999999999999974 8899999999765443   35688999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.......
T Consensus        96 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           96 ASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999998832    35699999999999999999999998   99999999999999999999999999998654333


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .   ....+||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||......        .....+..+.. .   
T Consensus       169 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~~-~---  232 (328)
T 3fe3_A          169 K---LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--------ELRERVLRGKY-R---  232 (328)
T ss_dssp             G---GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC-C---
T ss_pred             c---cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC-C---
Confidence            2   2456799999999999765 23357899999999999999999999765422        12222222221 1   


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       233 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          233 ---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               11224567899999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.4e-46  Score=334.25  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=215.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...|++.+.||+|+||.||+|.++++..||+|+++......+++.+|+.+++.++||||+++++++.+....++||||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            34678889999999999999999888899999999888788889999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++...   +..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  159 (268)
T 3sxs_A           87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-  159 (268)
T ss_dssp             TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred             CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence            99999988432   34589999999999999999999998   999999999999999999999999999986654332 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......+|+.|+|||.+.+.  .++.++||||+|+++|+|++ |..||......        ........+.....+  
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  227 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLYRP--  227 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCC--
T ss_pred             hcccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCCCC--
Confidence            223345577789999998764  67889999999999999999 99998654422        122223333222222  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          ...+..+.+++.+||+.||.+|||++++++.|+.+.+
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                1234578999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=345.09  Aligned_cols=250  Identities=16%  Similarity=0.220  Sum_probs=207.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..|.+.+.||+|+||.||+|... ++..+|+|.+.........+.+|+.+++.++||||+++++++.+....++||||++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   84 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS   84 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence            35778899999999999999976 68899999998766566778899999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC--CCceEEeeccCcccCCCCC
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+|||++.  ++.+||+|||++.......
T Consensus        85 g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           85 GLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999998842   235699999999999999999999998   9999999999999986  7899999999998765433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .   .....||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+..+...   .
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~---~  222 (321)
T 1tki_A          159 N---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEYT---F  222 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCC---C
T ss_pred             c---cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHcCCCC---C
Confidence            2   3345699999999999764  6788999999999999999999999764421        122222222111   1


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11222345678999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-46  Score=347.80  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=206.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|+++....       ..+.+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            45788899999999999999976 688999999976432       3477899999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC----ceEEeecc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFG  212 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~----~~kl~Dfg  212 (373)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        92 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           92 LILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999983    345799999999999999999999998   999999999999998776    79999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++........   .....||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+.
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~--------~~~~~i~  231 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANIT  231 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHH
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH
Confidence            9987654322   2345699999999998764  7889999999999999999999999764321        1222222


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+..   .........++..+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          232 AVSY---DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TTCC---CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcCC---CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2211   1112233445678999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-47  Score=364.71  Aligned_cols=260  Identities=25%  Similarity=0.417  Sum_probs=215.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +....+++.+.||+|+||.||+|.++++..||||.++......+++.+|+.+++.++||||+++++++. ....++||||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            445567788999999999999999988889999999987778899999999999999999999999986 5678999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+++....  +..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||+++......
T Consensus       264 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            99999999984321  23588899999999999999999998   99999999999999999999999999998654321


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                       ........++..|+|||.+...  .++.++|||||||++|||++ |..||......        .+...+..+.....+
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~  407 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPRP  407 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCCCCC
T ss_pred             -eeccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence             1112234467889999999764  78999999999999999999 99999754321        233334444333222


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                            ..++..+.+|+.+||+.||++|||++++++.|+.+...
T Consensus       408 ------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          408 ------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             ------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                  23456789999999999999999999999999998654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-47  Score=364.49  Aligned_cols=265  Identities=28%  Similarity=0.419  Sum_probs=213.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +....|++.+.||+|+||.||+|.++.+..||||+++......+++.+|+.+++.++||||+++++++.+ ...++||||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3455677889999999999999999877889999999877778899999999999999999999999876 678999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++|+|.+++...  .+..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......
T Consensus       260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            9999999998432  234589999999999999999999998   99999999999999999999999999998654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                       ........++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ......+..+.....+
T Consensus       335 -~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~  403 (452)
T 1fmk_A          335 -YTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP  403 (452)
T ss_dssp             ---------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC
T ss_pred             -eecccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence             1222334577899999998764  78999999999999999999 8999875432        1233344444333222


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP  349 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~  349 (373)
                            ..++..+.+|+.+||+.||++|||++++++.|+..........
T Consensus       404 ------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          404 ------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             ------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence                  2345678999999999999999999999999999876654433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-46  Score=340.01  Aligned_cols=248  Identities=26%  Similarity=0.363  Sum_probs=204.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            35778899999999999999864 78899999986543 34577899999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..     ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A          100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            99999998832     3589999999999999999999998   999999999999999999999999999986644332


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                        ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......       ........ ....... 
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~~~~-~~~~~~~-  238 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATN-GTPELQN-  238 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHH-CSCCCSC-
T ss_pred             --ccCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhC-CCCCCCC-
Confidence              22345699999999999765  78899999999999999999999997543211       11111111 1111111 


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         +..++..+.+|+.+||+.||++|||++|+++
T Consensus       239 ---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 ---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               2334667899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=340.14  Aligned_cols=260  Identities=26%  Similarity=0.369  Sum_probs=208.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            45678899999999999999976 68899999886533 33477899999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           90 KGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             TTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             CCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999843   245699999999999999999999998   999999999999999999999999999986543322


Q ss_pred             ce------------eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          223 FV------------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       223 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ..            ......||+.|+|||.+.+.  .++.++||||||+++|+|++|..|+.............  ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~--~~~~  239 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--VRGF  239 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--HHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--hhcc
Confidence            11            01145699999999999764  78899999999999999999999987654332211111  1111


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      ....          .+..++..+.+++.+||+.||++|||++++++.|+.+...
T Consensus       240 ~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          240 LDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1111          1122345789999999999999999999999999976543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=346.23  Aligned_cols=261  Identities=30%  Similarity=0.455  Sum_probs=210.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      +...+|++.+.||+|+||.||+|.+.    .+..||||+++....  ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34557788899999999999999975    334599999986433  236789999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999998843   235699999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhc
Q 048542          216 FHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       216 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ........ .......+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+..
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~  269 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEE  269 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHT
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHc
Confidence            76543222 222334567889999999764  78889999999999999999 99998654432        23333333


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      +.....+      ..++..+.+|+.+||+.||.+|||++++++.|+.+.+.
T Consensus       270 ~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          270 GYRLPAP------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCC------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            3322222      23456799999999999999999999999999987654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=334.95  Aligned_cols=255  Identities=27%  Similarity=0.491  Sum_probs=213.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|++.+.||+|+||.||+|.+.+++.||+|++.......+++.+|+.++++++||||+++++++.+....++||||+++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   89 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence            46778899999999999999998889999999998887888999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        90 ~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  162 (269)
T 4hcu_A           90 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  162 (269)
T ss_dssp             CBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence            999998843   345689999999999999999999998   99999999999999999999999999998654321 11


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......+|+.|+|||.+.+.  .++.++||||+|+++|+|++ |..||......        .....+..+.....+   
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  229 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKP---  229 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCC---
T ss_pred             cccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCccCCCC---
Confidence            22334567789999999764  78899999999999999999 89998754321        223333333222221   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                         ..++..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       230 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          230 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence               223567899999999999999999999999998753

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-46  Score=339.34  Aligned_cols=262  Identities=24%  Similarity=0.327  Sum_probs=207.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++++.++...++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            456788899999999999999865 788999999865332    236788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        90 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999883    235699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .... .......||+.|+|||.+.+.  .++.++||||+|+++|+|++|+.||......       .......... ...
T Consensus       163 ~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~  231 (294)
T 4eqm_A          163 ETSL-TQTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VPN  231 (294)
T ss_dssp             -------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CCC
T ss_pred             cccc-cccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CCC
Confidence            3221 122345699999999998775  6788999999999999999999999754421       1111112111 111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSIDDL  345 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~~  345 (373)
                        .....+..++..+.+++.+||+.||.+|| +++++.+.|+..+...
T Consensus       232 --~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          232 --VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             --HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             --cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence              11122234567899999999999999998 9999999999876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=340.49  Aligned_cols=251  Identities=24%  Similarity=0.286  Sum_probs=206.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....|++.+.||+|+||.||+|... +|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3457888999999999999999976 688999999875432       35788999999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC----ceEEee
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  210 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~----~~kl~D  210 (373)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|
T Consensus        89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            999999999999999883    345699999999999999999999998   999999999999998877    899999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ||++........   .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....
T Consensus       162 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~  228 (326)
T 2y0a_A          162 FGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN  228 (326)
T ss_dssp             CTTCEECCTTSC---CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred             CCCCeECCCCCc---cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHH
Confidence            999987643322   2345699999999998764  7889999999999999999999999754321        11122


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.....   .........++..+.+|+.+||+.||.+|||++|+++
T Consensus       229 ~~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          229 VSAVNY---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHTCC---CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhcCC---CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222111   1112223345678899999999999999999999987

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.4e-46  Score=337.59  Aligned_cols=277  Identities=34%  Similarity=0.565  Sum_probs=220.8

Q ss_pred             CCccChhHHHHHHhhhh--------cccCCCCcEEEEEEEEcCCceeEEEEeccCc-----cCHHHHHHHHHHhcccCCC
Q 048542           54 PKRYSYPQIIAMTNHFT--------HKLGQGGFGSVYKGQLQTGGLIAVKMLENSK-----FSAEEFINEVSTIGRIHHV  120 (373)
Q Consensus        54 ~~~~~~~~i~~~~~~~~--------~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~  120 (373)
                      ...|++.++...+..+.        +.||+|+||.||+|.. +++.||+|++....     ...+.+.+|+.+++.++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45678888888877665        5699999999999987 48899999986532     2246788999999999999


Q ss_pred             ceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       121 ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      ||+++++++.+....++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.   +++||||||+||++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili  166 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL  166 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence            99999999999999999999999999998885432 245699999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  280 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~  280 (373)
                      +.++.+||+|||++................||+.|+|||.+.+   .++.++||||||+++|+|++|..||.........
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            9999999999999987654433333344569999999998864   5788999999999999999999999865543211


Q ss_pred             ccchHHHHHHHhcCCC-cc---cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          281 AYFPSWVYDQLNKGGD-LE---LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                         ..+. ........ ..   .......+...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       244 ---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          244 ---LDIK-EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             ---THHH-HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             ---HHHH-HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence               1111 11111110 00   00112234566788999999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-46  Score=346.67  Aligned_cols=255  Identities=22%  Similarity=0.295  Sum_probs=207.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC------ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ....|++.+.||+|+||.||+|..+ +++.||+|++...      ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4567889999999999999999875 7899999998642      22467889999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc---eEEeecc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFG  212 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~---~kl~Dfg  212 (373)
                      ++|||||++++|.+.+......+..+++..+..++.|++.||.|||++   +++||||||+|||++.++.   +||+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence            999999999999887755444456789999999999999999999998   9999999999999986554   9999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++........  ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....         .....+.
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~  245 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGII  245 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHH
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHH
Confidence            9987654322  12345699999999999764  688999999999999999999999975321         1222222


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+...   ........++..+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          246 KGKYK---MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HTCCC---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCC---CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22111   111122345678999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-46  Score=342.10  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||+|+||.||+|.+. +++.||+|++......  .+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   87 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   87 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence            5778899999999999999976 7889999998654332  366889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++........
T Consensus        88 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           88 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            9999999883    345699999999999999999999998   999999999999999999999999999986543332


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      ........||+.|+|||.+.+. ...+.++|||||||++|+|++|..||........       ........... ... 
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~-~~~-  230 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTY-LNP-  230 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-------HHHHHHTTCTT-STT-
T ss_pred             ccccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHHhccccc-CCc-
Confidence            2233456799999999998764 2347789999999999999999999976543211       11111111111 111 


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                         ...++..+.+|+.+||+.||.+|||++|+++.
T Consensus       231 ---~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 ---WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               12345678899999999999999999999863

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.5e-47  Score=353.34  Aligned_cols=256  Identities=24%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|.+.+.||+|+||.||+|.++ +++.||||.++.....  .+++.+|+.+++.++||||+++++++......++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            456777899999999999999986 7889999998754322  2467899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++..   .+..+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++......
T Consensus       193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            9999999998843   234589999999999999999999998   9999999999999999999999999999764332


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..........++..|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ......+..+.....
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~  336 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGRLPC  336 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCCCCC
T ss_pred             ceeecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence            111111112356789999998764  78899999999999999998 9999875542        223334444443332


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      +      ..++..+.+|+.+||+.||++|||++++++.|+.+
T Consensus       337 ~------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          337 P------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            2      22356789999999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.4e-46  Score=337.38  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=202.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcc--cCCCceeeEeeEeee----CCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGFCSE----GSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~~~~----~~~~~l  137 (373)
                      ...|++.+.||+|+||.||+|.. +++.||||++...  ....+..|.+++..  ++||||+++++++..    ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            45678889999999999999988 5889999998754  33455566666665  799999999998644    345889


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      ||||+++|+|.+++.     ...+++..+..++.|++.||+|||        +.   +++||||||+|||++.++.+||+
T Consensus        84 v~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred             ehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence            999999999999982     346999999999999999999999        77   99999999999999999999999


Q ss_pred             eccCcccCCCCCCcee--eecccCCCCcccccccccccC----CcCcccchHHHHHHHHHHHcC----------CCCCCC
Q 048542          210 DFGLAKFHPKENDFVS--ISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG----------RRNSNM  273 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwslG~~l~~ll~g----------~~p~~~  273 (373)
                      |||++...........  .....||+.|+|||.+.+...    .++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999976544332221  223469999999999876411    345689999999999999999          777765


Q ss_pred             CcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          274 NATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .......  . ......... ...... .....+...+..+.+|+.+||+.||.+|||++++++.|+.+
T Consensus       236 ~~~~~~~--~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          236 VVPNDPS--F-EDMRKVVCVDQQRPNI-PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TSCSSCC--H-HHHHHHHTTSCCCCCC-CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCcc--h-hhhhHHHhccCCCCCC-ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4322211  1 111222222 222222 22233455678899999999999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.5e-45  Score=335.39  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +...+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            344578999999999999976 789999999876443 457789999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus       127 ~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--  196 (321)
T 2c30_A          127 GALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  196 (321)
T ss_dssp             CBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--
T ss_pred             CCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--
Confidence            99999873     34689999999999999999999998   999999999999999999999999999986543321  


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||.+.+.  .++.++||||||+++|+|++|..||......        .....+..........   
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~---  263 (321)
T 2c30_A          197 KRKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDSPPPKLKN---  263 (321)
T ss_dssp             CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSSCCCCTT---
T ss_pred             ccccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCcCc---
Confidence            12345699999999998764  7888999999999999999999999754321        1222233322222221   


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ...++..+.+++.+||+.||++|||++++++
T Consensus       264 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          264 -SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1234567899999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=349.29  Aligned_cols=272  Identities=24%  Similarity=0.382  Sum_probs=218.2

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEe
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFC  129 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~  129 (373)
                      ++...+|.+.+.||+|+||.||+|...        .+..||+|+++.....  ..++.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            344567888899999999999999853        2347999999765433  26788999999999 899999999999


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCC
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~N  197 (373)
                      ..+...++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999998854321            134699999999999999999999998   99999999999


Q ss_pred             eeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcC
Q 048542          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNAT  276 (373)
Q Consensus       198 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~  276 (373)
                      ||++.++.+||+|||++................+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||.....
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999876544433333445678899999998764  78899999999999999999 9999875432


Q ss_pred             ccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 048542          277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRP  351 (373)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~p  351 (373)
                              ......+..+.....+      ..++..+.+|+.+||+.||++|||++|+++.|+.+.........+
T Consensus       300 --------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  360 (382)
T 3tt0_A          300 --------EELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG  360 (382)
T ss_dssp             --------HHHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred             --------HHHHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence                    2233444444333322      223567899999999999999999999999999876544433333

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=366.47  Aligned_cols=297  Identities=26%  Similarity=0.413  Sum_probs=234.2

Q ss_pred             EEEEEeecchhhhhHHHHHhhhcCCCCCcc----------------ChhHHHHHHhhhhcccCCCCcEEEEEEEEcCCce
Q 048542           28 FLVSRRTTLKTIDNIEKFLRNQQSWMPKRY----------------SYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGL   91 (373)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~   91 (373)
                      |++..+..+.++.++..+..........++                ..-++....+++.+.||+|+||.||+|.++.+..
T Consensus       214 ~~i~~~~~F~SL~eLv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~  293 (535)
T 2h8h_A          214 FYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR  293 (535)
T ss_dssp             EEEETTEEESSHHHHHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEE
T ss_pred             EEeeccccccChHHhheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEECCCce
Confidence            555556677788887766655433322111                1112345567788999999999999999988888


Q ss_pred             eEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHH
Q 048542           92 IAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVAL  171 (373)
Q Consensus        92 vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~  171 (373)
                      ||||+++......+++.+|+.+++.++||||+++++++.+ ...++||||+++|+|.+++...  .+..+++..+..++.
T Consensus       294 vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~  370 (535)
T 2h8h_A          294 VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAA  370 (535)
T ss_dssp             EEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHH
T ss_pred             EEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHH
Confidence            9999999877778899999999999999999999999876 6789999999999999998432  234589999999999


Q ss_pred             HHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcc
Q 048542          172 GTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCK  251 (373)
Q Consensus       172 ~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~  251 (373)
                      |++.||+|||++   +|+||||||+|||++.++.+||+|||++....... ........++..|+|||.+.+.  .++.+
T Consensus       371 qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~  444 (535)
T 2h8h_A          371 QIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG--RFTIK  444 (535)
T ss_dssp             HHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC--CCCHH
T ss_pred             HHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccC--CCCch
Confidence            999999999998   99999999999999999999999999998654321 1112234467889999998764  78999


Q ss_pred             cchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          252 SDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       252 ~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                      +|||||||++|+|++ |..||.....        ..+...+..+......      ..++..+.+|+.+||+.||++|||
T Consensus       445 sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt  510 (535)
T 2h8h_A          445 SDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCP------PECPESLHDLMCQCWRKEPEERPT  510 (535)
T ss_dssp             HHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC------CCCCHHHHHHHHHHcCCChhHCcC
Confidence            999999999999999 8999875432        2233444444333222      234567899999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCC
Q 048542          331 MTKVLEMLEGSIDDLQM  347 (373)
Q Consensus       331 ~~ell~~L~~~~~~~~~  347 (373)
                      +++|++.|+.+......
T Consensus       511 ~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          511 FEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHHHHTSSCCCSC
T ss_pred             HHHHHHHHHHHhhccCc
Confidence            99999999998765443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.2e-46  Score=341.63  Aligned_cols=246  Identities=23%  Similarity=0.314  Sum_probs=203.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+.+ +|+.||+|+++..    ......+.+|..+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            35778899999999999999976 7889999999753    334567889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        85 E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999988883    235689999999999999999999998   999999999999999999999999999985432


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+.... .. 
T Consensus       158 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~-~~-  223 (337)
T 1o6l_A          158 DGA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEE-IR-  223 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC-
T ss_pred             CCC--cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-CC-
Confidence            221  23445799999999999764  7889999999999999999999999754321        1222222221 11 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                           .+..++..+.+|+.+||+.||.+||     +++|+++
T Consensus       224 -----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          224 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 1223467899999999999999999     8999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.8e-46  Score=359.66  Aligned_cols=262  Identities=29%  Similarity=0.448  Sum_probs=218.4

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ++....|++.+.||+|+||.||+|.++ ++..||||.++......+++.+|+.+++.++||||+++++++.+....++||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            344556778899999999999999977 4789999999987777889999999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            999999999998532  235689999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .. ........++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        +...+..+....
T Consensus       371 ~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~  439 (495)
T 1opk_A          371 DT-YTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRME  439 (495)
T ss_dssp             CC-EECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCC
T ss_pred             Cc-eeecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC
Confidence            22 2222344567889999998764  78899999999999999999 888987654321        333344443332


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .+      ..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       440 ~~------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          440 RP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CC------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            22      23456789999999999999999999999999987653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-45  Score=332.61  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=211.5

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ....|++.+.||+|+||.||+|.++++..||+|++.......+++.+|+.+++.++||||+++++++.+....++||||+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            34567888999999999999999998889999999988878889999999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus       102 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A          102 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             TTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             CCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            999999988432   34699999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      ........+|+.|+|||.+.+.  .++.++||||+|+++|+|++ |+.||......        .....+..+.....+ 
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-  243 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRP-  243 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCC-
T ss_pred             cccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCC-
Confidence            1112234467889999998765  68899999999999999998 99998754422        122333333222222 


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                           ...+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       244 -----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          244 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                 122467899999999999999999999999998754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-46  Score=345.49  Aligned_cols=263  Identities=25%  Similarity=0.403  Sum_probs=211.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...|++.+.||+|+||.||+|.+.      +++.||+|+++.....  .+.+.+|+.+++.++||||+++++++.++...
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            346778899999999999999875      3478999999765432  36789999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCC
Q 048542          136 ALVYEYMPNGSLDRHVFPKESR--------------------GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp  195 (373)
                      ++||||+++++|.+++......                    ...+++..++.++.|++.||.|||+.   +++||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence            9999999999999988543211                    25799999999999999999999998   999999999


Q ss_pred             CCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCC
Q 048542          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMN  274 (373)
Q Consensus       196 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~  274 (373)
                      +||+++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||...
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999765433322223345688999999998764  78899999999999999999 99998754


Q ss_pred             cCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          275 ATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ..        ......+..+.....+      ..++..+.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus       281 ~~--------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          281 AH--------EEVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             CH--------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             Ch--------HHHHHHHhCCCcCCCC------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            32        1222333333322222      234567999999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-45  Score=343.62  Aligned_cols=252  Identities=22%  Similarity=0.305  Sum_probs=206.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      .....|++.+.||+|+||.||+|..+ ++..||+|++.......   +.+.+|+.+++.++||||+++++++.+....++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            34567889999999999999999876 68899999997655433   567899999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEeeccCc
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLA  214 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~  214 (373)
                      ||||+++|+|.+.+.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||++
T Consensus       106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999988883    345689999999999999999999998   99999999999999864   45999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ........   .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+..+
T Consensus       179 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~  245 (362)
T 2bdw_A          179 IEVNDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAG  245 (362)
T ss_dssp             BCCTTCCS---CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             eEecCCcc---cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhC
Confidence            86654322   2345799999999998764  7889999999999999999999999754321        122333332


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .... +  ......++..+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~-~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 AYDY-P--SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCC-C--TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCC-C--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2111 1  1111334668899999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=351.89  Aligned_cols=251  Identities=19%  Similarity=0.278  Sum_probs=205.1

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ....|++.+.||+|+||.||+|... +|+.+|+|++......   .+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            3457888999999999999999865 7889999999865543   35688999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee---CCCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~  215 (373)
                      |||+++|+|.+.+..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||++.
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999888842    45699999999999999999999998   999999999999998   46789999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .......  ......||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+..+.
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~  229 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQH--------RLYQQIKAGA  229 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTC
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhCC
Confidence            6654322  22346799999999999764  7889999999999999999999999754421        1223333322


Q ss_pred             C-cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 D-LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      . ...+    ....++..+.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          230 YDFPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1 1111    11234668899999999999999999999987

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.4e-45  Score=333.96  Aligned_cols=259  Identities=22%  Similarity=0.292  Sum_probs=201.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..+|++.+.||+|+||.||+|.+.+|+.||+|++......   ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            3467788999999999999999988999999999754332   3678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++ +|.+.+..   ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus       100 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A          100 FMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             CCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             CCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9975 77776632   345699999999999999999999998   9999999999999999999999999999866433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc---
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL---  297 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---  297 (373)
                      ..  ......||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||.........    .............   
T Consensus       173 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          173 VR--SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL----PKIFSILGTPNPREWP  245 (311)
T ss_dssp             CC-----CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH----HHHHHHHCCCCTTTSG
T ss_pred             cc--cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHHHCCCChHHhh
Confidence            22  22345689999999998653 46788999999999999999999999765433211    1111111110000   


Q ss_pred             ----------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ----------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                      ...........++..+.+|+.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                            000111222334568899999999999999999999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.9e-46  Score=338.30  Aligned_cols=260  Identities=25%  Similarity=0.398  Sum_probs=211.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...|.+.+.||+|+||.||+|...      ++..||+|++.....  ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            346778899999999999999862      347899999976433  236788999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCC
Q 048542          136 ALVYEYMPNGSLDRHVFPKES--------------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp  195 (373)
                      ++||||+++++|.+++.....                    ....+++..++.++.|++.||.|||++   +++||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999998854332                    123488999999999999999999998   999999999


Q ss_pred             CCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCC
Q 048542          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMN  274 (373)
Q Consensus       196 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~  274 (373)
                      +||+++.++.+||+|||++................+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||...
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876554433333445578899999998764  68889999999999999999 99998755


Q ss_pred             cCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          275 ATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ....        ....+..+......      ..++..+.+++.+||+.||.+|||++++++.|+.++
T Consensus       257 ~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          257 PPER--------LFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             CGGG--------HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CHHH--------HHHHhhcCCcCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            4321        23333333322222      234568999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.8e-47  Score=341.51  Aligned_cols=269  Identities=27%  Similarity=0.420  Sum_probs=206.1

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeee--CCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~  134 (373)
                      ....|++.+.||+|+||.||+|++     .+++.||+|++...... .+.+.+|+.+++.++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            345778889999999999999984     26789999999765433 3678899999999999999999999854  456


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            89999999999999998432   34589999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc--------cccccchH
Q 048542          215 KFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPS  285 (373)
Q Consensus       215 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~  285 (373)
                      .......... ......++..|+|||.+.+.  .++.++||||||+++|+|++|..|+......        ........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            8764433221 12234477789999999765  7889999999999999999999988643211        00011111


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .....+........      +..++..+.+|+.+||+.||++|||++|+++.|+.+.+.+
T Consensus       240 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          240 HLIELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccCcCCC------CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            22233333332222      2234568999999999999999999999999999875543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8.1e-46  Score=340.51  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=201.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCce----eEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGL----IAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...|++.+.||+|+||.||+|.+. +++.    ||+|.+....  ...+++.+|+.+++.++||||+++++++.++. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            346778899999999999999865 4444    5788775432  34478899999999999999999999998754 78


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +++||+++|+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999998843   245699999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ..............+|..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ....+..+.
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGE  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTC
T ss_pred             ccCCcccccccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCC
Confidence            6554443333445678899999999764  78899999999999999999 999997544321        233333333


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+      ..++..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       237 ~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          237 RLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCC------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCC------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22222      2234578999999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=333.98  Aligned_cols=267  Identities=19%  Similarity=0.288  Sum_probs=212.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC--eeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~  139 (373)
                      ..|.+.+.||+|+||.||+|... +++.||||++....  ...+.+.+|+.+++.++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            35778899999999999999976 68899999987543  34577889999999999999999999987655  789999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee----eCCCceEEeeccCcc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  215 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~~~  215 (373)
                      ||+++++|.+++..... ...+++..+..++.|++.||+|||+.   +++||||||+||++    +.++.+||+|||++.
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999998854432 33499999999999999999999998   99999999999999    778889999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccc------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      .......   .....||+.|+|||.+...      ...++.++|||||||++|+|++|..||.........   ......
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~  238 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYK  238 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHHH
Confidence            7654432   2345699999999988531      247888999999999999999999999754432221   111222


Q ss_pred             HHhcCCC-----------------cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          290 QLNKGGD-----------------LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       290 ~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .......                 ...+........++..+.+++.+||+.||++|||++|+++.....
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            2211110                 011222345567888999999999999999999999999988753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.4e-46  Score=342.30  Aligned_cols=273  Identities=24%  Similarity=0.400  Sum_probs=194.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC-Cc---eeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCee-
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT-GG---LIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~---~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-  135 (373)
                      ...|++.+.||+|+||.||+|.+.. ++   .||+|+++...   ...+++.+|+.+++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4467888999999999999998653 32   79999997642   2346789999999999999999999999876655 


Q ss_pred             -----EEEEeccCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          136 -----ALVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       136 -----~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                           ++||||+++++|.+++....  .....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence                 99999999999998885432  2233689999999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||++................+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        .
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~  248 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------I  248 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------H
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------H
Confidence            999999866544333333344578899999998765  78899999999999999999 899987554321        2


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCcccc
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL---QMPPRPFFSS  355 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~---~~~~~p~~~~  355 (373)
                      ......+......      ..++..+.+|+.+||+.||.+|||+.++++.|+.++...   ...+.|.+..
T Consensus       249 ~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~  313 (323)
T 3qup_A          249 YNYLIGGNRLKQP------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN  313 (323)
T ss_dssp             HHHHHTTCCCCCC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------------
T ss_pred             HHHHhcCCCCCCC------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence            2233333222221      234567899999999999999999999999999865533   3344444443

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-47  Score=352.73  Aligned_cols=264  Identities=26%  Similarity=0.390  Sum_probs=210.3

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCC
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  133 (373)
                      +....|++.+.||+|+||.||+|.+.      ++..||||+++.....  ..++.+|+.+++.++||||+++++++.+..
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34456788899999999999999843      4668999999754332  356889999999999999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---ceE
Q 048542          134 KRALVYEYMPNGSLDRHVFPKE---SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPK  207 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~~k  207 (373)
                      ..++||||+++|+|.+++....   .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999885432   2235689999999999999999999998   999999999999998554   599


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++................||+.|+|||.+.+.  .++.++|||||||++|+|++ |..||.....        ..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~  294 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QE  294 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            9999999744222211122334578999999998764  78899999999999999998 9999875432        22


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      ....+..+......      ..++..+.+|+.+||+.||.+|||++++++.|+.+.+.
T Consensus       295 ~~~~i~~~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          295 VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHcCCCCCCC------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            33334443332222      23356789999999999999999999999999876543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.8e-46  Score=334.04  Aligned_cols=270  Identities=29%  Similarity=0.473  Sum_probs=200.7

Q ss_pred             ccChhHHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           56 RYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        56 ~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      .+...++...+|++.++||+|+||.||+|...  ..+|+|+++......   +.+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             ---CCBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCCccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            34444566677888999999999999999865  359999997654433   6688999999999999999999965 45


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg  165 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG  165 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred             CccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence            668999999999999988843   345699999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      ++................||+.|+|||.+... ...++.++||||||+++|+|++|+.||......       .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~  238 (289)
T 3og7_A          166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMV  238 (289)
T ss_dssp             ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHH
T ss_pred             eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHh
Confidence            99765433323333455699999999998522 246788999999999999999999999754432       1222333


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ..+.....  .......++..+.+|+.+||+.||.+|||++++++.|+.+.+
T Consensus       239 ~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          239 GRGSLSPD--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHTSCCCC--TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccccCcc--hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            33222111  111223446789999999999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-45  Score=345.36  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH----HHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|+.+ +++.||+|+++......    +.+.+|..++..+ +||||+++++++.+....++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            46778899999999999999976 67899999998643322    4577899999887 899999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|..++.    ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       132 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999988883    235699999999999999999999998   99999999999999999999999999998533


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-ccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-AYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  297 (373)
                      ....  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......... ..........+..... 
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred             cCCC--ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence            2221  23456799999999999875  7889999999999999999999999754322211 1112223333333221 


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                      .      .+..++..+.+|+.+||+.||.+||++
T Consensus       280 ~------~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 R------IPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             C------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             C------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            1      123356789999999999999999996

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=339.36  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=210.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ...|++.+.||+|+||.||+|.+.      ++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            456788899999999999999862      455799999975432  236789999999999 89999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCC
Q 048542          135 RALVYEYMPNGSLDRHVFPKESR-------------------GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp  195 (373)
                      .++||||+++|+|.+++......                   ...+++..++.++.|++.||.|||+.   +++||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence            99999999999999988543221                   13489999999999999999999998   999999999


Q ss_pred             CCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCC
Q 048542          196 HNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMN  274 (373)
Q Consensus       196 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~  274 (373)
                      +||+++.++.+||+|||++................||+.|+|||.+.+.  .++.++|||||||++|+|++ |..||...
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            9999999999999999999866544443334445678899999998764  78899999999999999998 99999765


Q ss_pred             cCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          275 ATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ...       ......+..+.....+      ..++..+.+|+.+||+.||.+|||++++++.|+..+...
T Consensus       279 ~~~-------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          279 PVD-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCS-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CcH-------HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            432       1223333333322222      223567899999999999999999999999999876643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-45  Score=343.41  Aligned_cols=261  Identities=27%  Similarity=0.419  Sum_probs=210.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC-
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~-  133 (373)
                      ...|++.+.||+|+||.||+|.+.      +++.||||+++.....  .+.+.+|+.++..+ +||||+++++++.+.. 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            456778899999999999999742      4578999999765432  25689999999999 7899999999987754 


Q ss_pred             eeEEEEeccCcCCccccccCCCCC--------------------------------------------------------
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESR--------------------------------------------------------  157 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  157 (373)
                      ..++||||+++|+|.+++......                                                        
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            489999999999999988554321                                                        


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccC
Q 048542          158 ------GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRG  231 (373)
Q Consensus       158 ------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g  231 (373)
                            ...+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++................|
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence                  12288999999999999999999998   999999999999999999999999999987655444444455668


Q ss_pred             CCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHH
Q 048542          232 TIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIA  310 (373)
Q Consensus       232 t~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (373)
                      |+.|+|||.+.+.  .++.++|||||||++|+|++ |..||......       ......+..+.....+      ..++
T Consensus       258 t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~------~~~~  322 (359)
T 3vhe_A          258 PLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAP------DYTT  322 (359)
T ss_dssp             CGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTCCCCCC------TTCC
T ss_pred             CceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCCCCCCC------CCCC
Confidence            9999999998764  78899999999999999998 99999755432       1233333433333222      2235


Q ss_pred             HHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          311 RKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       311 ~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ..+.+++.+||+.||.+|||++|+++.|+.++
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            67899999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=328.77  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---------------------------CHHHHHHHHHHhcc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---------------------------SAEEFINEVSTIGR  116 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~~  116 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|++.....                           ..+.+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            35778899999999999999865 688999999875432                           12467899999999


Q ss_pred             cCCCceeeEeeEeee--CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcC
Q 048542          117 IHHVNVVQLLGFCSE--GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIK  194 (373)
Q Consensus       117 l~h~ni~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dik  194 (373)
                      ++||||+++++++.+  ....++||||+++++|.+++     ....+++..+..++.|++.||+|||+.   +++|||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  164 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK  164 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            999999999999976  56889999999999998765     235699999999999999999999998   99999999


Q ss_pred             CCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccC-CcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          195 PHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG-TVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       195 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                      |+||+++.++.+||+|||++........  ......||+.|+|||.+.+... .++.++|||||||++|+|++|..||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999986644322  2344579999999999876421 146789999999999999999999975


Q ss_pred             CcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          274 NATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....        .....+.... ...+..    ..++..+.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~--------~~~~~~~~~~-~~~~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIM--------CLHSKIKSQA-LEFPDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHH--------HHHHHHHHCC-CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHH--------HHHHHHhccc-CCCCCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            4321        1222222221 111111    123567899999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.4e-45  Score=327.79  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=203.9

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--H------HHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--A------EEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~------~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++......  .      +.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            346778899999999999999975 7889999998653322  1      57889999999999999999999987655 


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeeeCCCc-----eE
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFI-----PK  207 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~~~~~-----~k  207 (373)
                       ++||||+++++|.+.+..   ....+++..+..++.|++.||+|||+.   +  ++||||||+||+++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             699999999999887743   345799999999999999999999998   8  999999999999987776     99


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      |+|||++.....     ......||+.|+|||.+.+....++.++|||||||++|+|++|..||........     ...
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~  239 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-----KFI  239 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-----HHH
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-----HHH
Confidence            999999974432     1234569999999999854445678899999999999999999999975543211     111


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ............      +..++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus       240 ~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIREEGLRPTI------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHHSCCCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhccCCCCCC------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            112222222222      223456899999999999999999999999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-46  Score=342.04  Aligned_cols=244  Identities=23%  Similarity=0.300  Sum_probs=200.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|.+.+.||+|+||.||+|.+. +++.||+|++....    .....+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            5778899999999999999974 78899999986532    223578899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+ +|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++......
T Consensus        90 ~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           90 YA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             CC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99 6788887732    35699999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..   ....+||+.|+|||.+.+. ...+.++|||||||++|+|++|..||...........+        ..+      
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------~~~------  223 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------NSC------  223 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------CSS------
T ss_pred             cc---cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------HcC------
Confidence            22   2345699999999999764 23367999999999999999999999765432211110        000      


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             01122334667899999999999999999999976

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-45  Score=345.40  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=197.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ...|.+.+.||+|+||.||+|+.+    ++..||||.++....  ..+++.+|+.+++.++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            446778899999999999999865    567899999976533  23678999999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++++|.+++..   .+..+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus       124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999843   345699999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       218 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ...... .......++..|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+..+.
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~  267 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGY  267 (373)
T ss_dssp             ----------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTE
T ss_pred             ccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC
Confidence            433221 112223457789999998764  78899999999999999998 99998754321        1223333332


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .....      ..++..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       268 ~~~~~------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          268 RLPPP------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ECCCC------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            22111      2345678999999999999999999999999987643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-45  Score=338.86  Aligned_cols=255  Identities=27%  Similarity=0.423  Sum_probs=203.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCce----eEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGL----IAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .|++.+.||+|+||.||+|.+. +++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. +...++|
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   92 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV   92 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence            5677899999999999999865 4554    7777765432  22255678999999999999999999986 4568999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           93 TQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999988432   34688899999999999999999998   99999999999999999999999999998775


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ............+|..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ....+..+...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~  236 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGERL  236 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCBC
T ss_pred             cccccccccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCC
Confidence            54443334455688899999999764  78899999999999999999 999997654321        22333333322


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ..+.      .++..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       237 ~~~~------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          237 AQPQ------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             CCCT------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             CCCC------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2221      234468899999999999999999999999998654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-44  Score=345.63  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=208.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++....    ...+.+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            35778899999999999999976 78999999997532    23467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++.    .+..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        96 E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999883    345699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..   .....+||+.|+|||++.+. ...+.++||||+||++|+|++|..||......        .....+..+... .
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~-~  235 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--------TLFKKICDGIFY-T  235 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--------HHHHHHHTTCCC-C
T ss_pred             cc---cccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCcC-C
Confidence            32   12345799999999998764 23467899999999999999999999755432        122233332211 1


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcCCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSID  343 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~  343 (373)
                            +..++..+.+|+.+||+.||.+|||++++++  .+.....
T Consensus       236 ------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          236 ------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             ------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence                  1224567899999999999999999999997  4555443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=333.74  Aligned_cols=265  Identities=24%  Similarity=0.387  Sum_probs=204.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+  ..++||||+++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~   83 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG   83 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence            45678899999999999999876 788999998753 345778999999999999999999998874  47899999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc-eEEeeccCcccCCCCCCc
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-PKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~  223 (373)
                      ++|.+++.... ....+++..+..++.|+++||+|||+....+++||||||+||+++.++. +||+|||++......   
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           84 GSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             CBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            99999985432 1234788999999999999999999932238999999999999998886 799999999754322   


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        .....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||........      ........+......   
T Consensus       160 --~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~---  226 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIMWAVHNGTRPPLI---  226 (307)
T ss_dssp             -------CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH------HHHHHHHTTCCCCCB---
T ss_pred             --cccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH------HHHHHHhcCCCCCcc---
Confidence              1234599999999998764  788999999999999999999999975433211      111122222222211   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCcc
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFF  353 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~p~~  353 (373)
                         ..++..+.+++.+||+.||.+|||++++++.|+.+...++.+..|..
T Consensus       227 ---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          227 ---KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             ---cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence               23456789999999999999999999999999988776665555543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-45  Score=331.03  Aligned_cols=257  Identities=22%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +|++.+.||+|+||.||+|...+++.||+|++......   ...+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            46788999999999999999988999999998754332   367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++ +|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           83 DQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             SE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             CC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            75 88877743   235689999999999999999999998   999999999999999999999999999976543221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc-----
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL-----  297 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  297 (373)
                        ......||+.|+|||.+.+. ..++.++||||+||++|+|++|..||........    ..............     
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ----LMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHHCCCChhhchhh
Confidence              12344689999999998653 3578899999999999999999999975432110    00011111100000     


Q ss_pred             --------cc-----CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 --------EL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 --------~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                              ..     .........++..+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    00     0001112235678899999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=340.61  Aligned_cols=251  Identities=23%  Similarity=0.324  Sum_probs=205.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...|++.+.||+|+||.||+|..+ +++.||+|++...    ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            346788899999999999999876 6789999998653    23446788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+.+|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999998883    345699999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ...   .....+||+.|+|||++.+. ...++.++|||||||++|+|++|..||........     ............ 
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-----~~~~~~~~~~~~-  237 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-----KEIVHTFETTVV-  237 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-----HHHHHHHHHCCC-
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-----HHHHHHHhhccc-
Confidence            433   23456799999999998643 23578899999999999999999999975543221     112222222211 


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPS-MTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~ell~  336 (373)
                            ..+..++..+.+|+.+||+.||.+||+ ++++++
T Consensus       238 ------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 ------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                  112234678999999999999999998 777764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-45  Score=332.75  Aligned_cols=260  Identities=29%  Similarity=0.439  Sum_probs=216.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +....|++.+.||+|+||.||+|.++ ++..||+|.+.......+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            44567788899999999999999976 57889999998877777889999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999988432  245689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      .. .......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+........
T Consensus       165 ~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  233 (288)
T 3kfa_A          165 TY-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRMER  233 (288)
T ss_dssp             SS-EEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCCC
T ss_pred             cc-ccccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccCCCCC
Confidence            32 233445578899999998765  78899999999999999999 888887554321        2233333322222


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +      ..++..+.+|+.+||+.||.+|||++++++.|+.+..
T Consensus       234 ~------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          234 P------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             C------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            1      2345678999999999999999999999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.7e-45  Score=329.01  Aligned_cols=258  Identities=20%  Similarity=0.286  Sum_probs=199.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.+.||+|+||+||+|..+ +++.||+|++......   ...+.+|+.+++.++||||+++++++.++...++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            4678899999999999999976 6889999999754332   36788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++ ++.+.+.   ..+..+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~-~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           83 CDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSE-EHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             CCC-CHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            976 5544442   2346799999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc---
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE---  298 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  298 (373)
                      .  ......||+.|+|||.+.+. ..++.++||||+||++|+|++|..||........   ................   
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~---~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTCTT
T ss_pred             c--cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhhhh
Confidence            2  22345689999999998764 3478999999999999999999988654332110   0000111111000000   


Q ss_pred             ---------------cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 ---------------LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ---------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                     ..........++..+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                           00011122345678899999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.5e-45  Score=326.33  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=212.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|++.+.||+|+||.||+|.+.+++.||+|++.......+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH   87 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence            46778899999999999999998888999999998877788999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      ++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....... ..
T Consensus        88 ~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~  160 (267)
T 3t9t_A           88 GCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  160 (267)
T ss_dssp             CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred             CcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence            999998843   235689999999999999999999998   99999999999999999999999999998654321 11


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      ......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .....+..+.....+   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~---  227 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKP---  227 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCC---
T ss_pred             ccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCcCCCC---
Confidence            12234577889999998764  67889999999999999999 88888754321        122333333222211   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                         ..++..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus       228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          228 ---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               223567899999999999999999999999998753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-45  Score=336.27  Aligned_cols=254  Identities=20%  Similarity=0.298  Sum_probs=185.1

Q ss_pred             Hhhhh---cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFT---HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~---~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.   +.||+|+||.||+|.++ +++.||+|++...  ....+.+|+.+++.+. ||||+++++++.+....++|||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            45554   78999999999999976 6889999998653  3467789999999997 9999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---ceEEeeccCcccC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---IPKVSDFGLAKFH  217 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~~kl~Dfg~~~~~  217 (373)
                      |+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++   .+||+|||++...
T Consensus        87 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           87 LLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             CCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999999999883    345799999999999999999999998   999999999999998665   8999999999865


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .....  ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||........... .......+..+.  
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~-~~~~~~~i~~~~--  232 (325)
T 3kn6_A          160 PPDNQ--PLKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS-AVEIMKKIKKGD--  232 (325)
T ss_dssp             CC------------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC-HHHHHHHHTTTC--
T ss_pred             CCCCC--cccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc-HHHHHHHHHcCC--
Confidence            43322  22345689999999999765  788999999999999999999999976543221111 112222333222  


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .....+....++..+.+|+.+||+.||.+|||++++++
T Consensus       233 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          233 -FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence             12222333456788999999999999999999999874

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=334.32  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=202.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+.+ +|+.||+|+++...    ...+.+.+|..+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            35778899999999999999976 78899999987532    34567889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus        86 e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999883    345689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      .     ....+||+.|+|||++.+.  .++.++|+|||||++|+|++|..||......        .....+.... .. 
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~i~~~~-~~-  221 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAE-LR-  221 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCC-CC-
T ss_pred             c-----cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-CC-
Confidence            2     2345699999999998765  7889999999999999999999999754321        1222222221 11 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                           .+..++..+.+++.+||+.||.+||     +++++++
T Consensus       222 -----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 -----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 1123456889999999999999999     8999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.8e-45  Score=348.82  Aligned_cols=250  Identities=29%  Similarity=0.455  Sum_probs=206.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC-eeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-KRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-~~~lv~e~~~  143 (373)
                      ..|++.+.||+|+||.||+|.++ ++.||||+++... ..+.+.+|+.+++.++||||+++++++.... ..++||||++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~  270 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA  270 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence            45667799999999999999886 7899999998654 4578999999999999999999999987655 7899999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++.......  
T Consensus       271 ~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          271 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             TCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            99999998533  223478999999999999999999998   99999999999999999999999999998543221  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                         ....++..|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        +...+..+.....+  
T Consensus       344 ---~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~~~p--  408 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP--  408 (450)
T ss_dssp             ------CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTTCCCCCC--
T ss_pred             ---cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCCC--
Confidence               223578899999999764  78999999999999999998 999997654322        23344444333322  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                          ..++..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       409 ----~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          409 ----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                234568899999999999999999999999998753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.7e-45  Score=333.75  Aligned_cols=262  Identities=27%  Similarity=0.437  Sum_probs=212.9

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ..+|++.+.||+|+||.||+|.+      .++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35678889999999999999985      2467899999986543  236788999999999 89999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          135 RALVYEYMPNGSLDRHVFPKES--------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      .++||||+++|+|.+++.....              ....+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence            9999999999999998854321              123589999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~  279 (373)
                      +.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  254 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--  254 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence            99999999999999876655444333445578899999998764  78899999999999999998 99998755432  


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                           ................      ..++..+.+++.+||+.||.+|||++++++.|+..+.
T Consensus       255 -----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          255 -----SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             -----HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----hHHHHHhccCCCCCCc------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                 1122333333222211      2335678999999999999999999999999997643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.7e-45  Score=327.77  Aligned_cols=260  Identities=27%  Similarity=0.438  Sum_probs=212.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ..+|++.+.||+|+||.||+|..+++..||+|.+.......+.+.+|+.+++.++||||+++++++.+ +..++||||++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            35678889999999999999998888899999998877778899999999999999999999999864 56899999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++....  +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....... .
T Consensus        91 ~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           91 NGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             TCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            999999984321  23689999999999999999999998   99999999999999999999999999998664332 1


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......++..|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .....+..+.....+  
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  232 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMVRP--  232 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC--
T ss_pred             ccccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCCCc--
Confidence            222344577899999998764  77889999999999999999 88888654321        122333333222221  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                          ..++..+.+++.+||+.||++|||++++++.|+.......
T Consensus       233 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          233 ----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence                2345688999999999999999999999999998765443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.2e-45  Score=343.74  Aligned_cols=268  Identities=16%  Similarity=0.171  Sum_probs=203.2

Q ss_pred             HHhhhhcccCCC--CcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQG--GFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .+|++.+.||+|  +||.||+|..+ +++.||||++.......   +.+.+|+.+++.++||||+++++++.++...++|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            468888999999  99999999976 78999999997654333   5678899999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||||++|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+....
T Consensus       105 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999885432  35589999999999999999999998   99999999999999999999999999886432


Q ss_pred             CCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH-HHh
Q 048542          219 KENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD-QLN  292 (373)
Q Consensus       219 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~  292 (373)
                      .....     .......||+.|+|||++.+....++.++|||||||++|+|++|+.||.................. ...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            21110     111234688999999999764347889999999999999999999999764432210000000000 000


Q ss_pred             c-------------------C----C-------CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          293 K-------------------G----G-------DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       293 ~-------------------~----~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .                   +    .       ..........+..++..+.+|+.+||+.||++|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0                   0    0       000000112334566789999999999999999999999853

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-45  Score=342.50  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=204.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|..+ +++.+|+|++..... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            46788899999999999999876 788999999876532 3357889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC--CCceEEeeccCcccCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~  220 (373)
                      ++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+|||++.  ++.+||+|||++......
T Consensus       131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999988842   235689999999999999999999998   9999999999999974  578999999999876543


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..   .....||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+...... . 
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~i~~~~~~-~-  269 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWE-F-  269 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCC-C-
T ss_pred             cc---eeeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-C-
Confidence            32   2334699999999999764  6888999999999999999999999754321        112222222111 1 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence             11112234668999999999999999999999987

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=339.99  Aligned_cols=248  Identities=23%  Similarity=0.287  Sum_probs=199.5

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~  136 (373)
                      ....|++.+.||+|+||.||+|+.+ +++.||+|+++..    ....+.+.+|..++..+ +||||+++++++.+....|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3446788899999999999999976 6889999999753    23446678899999988 7999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       101 lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999998883    235699999999999999999999998   999999999999999999999999999975


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .....  ......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+..+..
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~  241 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEV  241 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCC
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            43222  123455799999999999775  6888999999999999999999999765432        12223322221


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM------TKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~------~ell~  336 (373)
                       .      .+..++..+.+|+.+||+.||.+||++      +++++
T Consensus       242 -~------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 -V------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -C------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -C------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             1      112345678999999999999999998      77764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-45  Score=337.41  Aligned_cols=260  Identities=17%  Similarity=0.201  Sum_probs=205.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|... +++.||||++..... .+.+.+|+.+++.+ +||||+++++++......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            35778899999999999999964 788999999875432 34678999999999 9999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc-----eEEeeccCcccC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKFH  217 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~-----~kl~Dfg~~~~~  217 (373)
                       +++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.     +||+|||++...
T Consensus        88 -~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           88 -GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             -CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence             99999988432   45799999999999999999999998   9999999999999998887     999999999865


Q ss_pred             CCCCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          218 PKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       218 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      .......     ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||..........     ....+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~-----~~~~i~  233 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE-----RYQKIG  233 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH-----HHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccHHH-----HHHHHH
Confidence            4332211     12345799999999999774  78899999999999999999999998654322111     111111


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ......  ........++ .+.+++.+||+.||.+||+++++++.|+...
T Consensus       234 ~~~~~~--~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          234 DTKRAT--PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHHS--CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhhccC--CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            100000  0001111134 8999999999999999999999999998643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-44  Score=331.53  Aligned_cols=251  Identities=23%  Similarity=0.290  Sum_probs=207.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....|++.+.||+|+||.||+|... +|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3457889999999999999999976 688999999875432       35778999999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC----ceEEee
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  210 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~----~~kl~D  210 (373)
                      .++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999883    345689999999999999999999998   999999999999999887    799999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ||++........   .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......        .....
T Consensus       163 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~  229 (321)
T 2a2a_A          163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLAN  229 (321)
T ss_dssp             CTTCEECCTTCC---CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHH
T ss_pred             CccceecCcccc---ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHH
Confidence            999986654322   2345699999999998764  7888999999999999999999999754321        11222


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.....   .........++..+.+|+.+||+.||++|||++|+++
T Consensus       230 i~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          230 ITSVSY---DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHhccc---ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            222211   1112223345678999999999999999999999987

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.4e-45  Score=332.64  Aligned_cols=261  Identities=24%  Similarity=0.350  Sum_probs=189.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|+++....  ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            35778899999999999999865 688999999875432  336788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          142 MPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       142 ~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ++ ++|.+++....  .....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            97 58888774322  2234589999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC---
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD---  296 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  296 (373)
                      ...  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........    ...+.........   
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          161 PVN--TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ----LKLIFDIMGTPNESLW  233 (317)
T ss_dssp             CCC--CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCTTTC
T ss_pred             Ccc--cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCChhHh
Confidence            221  12345689999999998653 3578899999999999999999999976543211    0001111100000   


Q ss_pred             ----------cccC-----cc-----chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 ----------LELQ-----NV-----TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ----------~~~~-----~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                ....     ..     ......++..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                      0000     00     0011134568999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.8e-45  Score=335.78  Aligned_cols=262  Identities=23%  Similarity=0.414  Sum_probs=211.6

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc--------CCceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSE  131 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~  131 (373)
                      ....|.+.+.||+|+||.||+|.+.        ++..||+|+++....  ....+.+|+.+++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3457888899999999999999863        466899999976543  236788999999999 89999999999999


Q ss_pred             CCeeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCee
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil  199 (373)
                      ....++||||+++++|.+++.....            ....+++..++.++.|++.||.|||+.   +++||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence            9999999999999999999854332            123489999999999999999999998   9999999999999


Q ss_pred             eeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcc
Q 048542          200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRS  278 (373)
Q Consensus       200 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~  278 (373)
                      ++.++.+||+|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||.....  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            999999999999999876554433333445578899999998764  68889999999999999999 9999865432  


Q ss_pred             ccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          279 SKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                            ......+..+......      ..++..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       266 ------~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 ------EELFKLLKEGHRMDKP------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ------HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCCCCCC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                  1223333333322221      2345678999999999999999999999999998654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-45  Score=334.30  Aligned_cols=270  Identities=21%  Similarity=0.353  Sum_probs=209.8

Q ss_pred             hhHHHHHHhhhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeee
Q 048542           59 YPQIIAMTNHFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSE  131 (373)
Q Consensus        59 ~~~i~~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~  131 (373)
                      ...+....|++.+.||+|+||.||+|.+     .+++.||+|++....  ...+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3334455678889999999999999983     368899999987543  344788999999999999999999999977


Q ss_pred             C--CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          132 G--SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       132 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      .  ...++||||+++++|.+++..   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEEC
Confidence            6  668999999999999998843   235689999999999999999999998   99999999999999999999999


Q ss_pred             eccCcccCCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc-------cccc
Q 048542          210 DFGLAKFHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR-------SSKA  281 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~-------~~~~  281 (373)
                      |||++.......... ......||..|+|||.+.+.  .++.++||||+|+++|+|++|..|+......       ....
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  246 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ  246 (302)
T ss_dssp             CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG
T ss_pred             cccccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc
Confidence            999998765544322 22345688889999998765  6788999999999999999999886432110       0001


Q ss_pred             cchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ............+.....      +..++..+.+|+.+||+.||.+|||++++++.|+.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          247 MTVTRLVNTLKEGKRLPC------PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GHHHHHHHHHHTTCCCCC------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHhccCCCCC------CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111122223333322222      1234568999999999999999999999999998753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.6e-45  Score=337.64  Aligned_cols=251  Identities=23%  Similarity=0.286  Sum_probs=194.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .+|++.+.||+|+||.||++... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            46788899999999999999976 78899999998776666788999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc--eEEeeccCcccCCCCC
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLAKFHPKEN  221 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  221 (373)
                      +|+|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.  +||+|||++.......
T Consensus       100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A          100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            9999988832    34699999999999999999999998   9999999999999987665  9999999987432222


Q ss_pred             CceeeecccCCCCcccccccccccCCcC-cccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVS-CKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                         ......||+.|+|||++.+.  .++ .++||||+||++|+|++|+.||........   .............  ..+
T Consensus       173 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~--~~~  242 (361)
T 3uc3_A          173 ---QPKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKY--SIP  242 (361)
T ss_dssp             -----------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCC--CCC
T ss_pred             ---CCCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCC--CCC
Confidence               12345699999999998764  444 448999999999999999999976543221   1111111221111  111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..    ..++..+.+|+.+||+.||.+|||++|+++
T Consensus       243 ~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          243 DD----IRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             TT----SCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             Cc----CCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            11    123567899999999999999999999987

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.7e-45  Score=336.47  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=198.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|++.+.||+|+||.||+|+.+ +++.||+|++......    .+.+.+|..++..+ +||||+++++++.+....|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            5778899999999999999976 6889999999764332    35578899999887 8999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        90 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           90 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999988832    35699999999999999999999998   999999999999999999999999999985432


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc-cchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-YFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  298 (373)
                      ...  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......... .........+.... ..
T Consensus       163 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~~  237 (345)
T 3a8x_A          163 PGD--TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IR  237 (345)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-CC
T ss_pred             CCC--cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-CC
Confidence            221  23456799999999999775  78899999999999999999999997543221110 11122333333222 11


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSM  331 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~  331 (373)
                            .+..++..+.+|+.+||+.||.+||++
T Consensus       238 ------~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 ------IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  122346689999999999999999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.3e-45  Score=325.44  Aligned_cols=249  Identities=29%  Similarity=0.436  Sum_probs=193.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc-----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF-----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|.+. ++.||+|++.....     ..+.+.+|+.+++.++||||+++++++.++...++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            35677899999999999999976 88999999875432     2367889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC---eEecCcCCCCeeeeC--------CCceEE
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC---ILHFDIKPHNILLDH--------NFIPKV  208 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~---ivH~dikp~Nil~~~--------~~~~kl  208 (373)
                      ||+++++|.+++.     +..+++..++.++.|++.||.|||++   +   ++||||||+||+++.        ++.+||
T Consensus        86 e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           86 EFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             ECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence            9999999998882     35689999999999999999999998   6   999999999999985        678999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      +|||++........    ....||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.......       ...
T Consensus       158 ~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~  224 (271)
T 3dtc_A          158 TDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-------VAY  224 (271)
T ss_dssp             CCCCC-----------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-------HHH
T ss_pred             ccCCcccccccccc----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence            99999976543321    234689999999998764  68899999999999999999999997543211       111


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ...........      +..++..+.+++.+||+.||.+|||++|+++.|+.+
T Consensus       225 ~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 GVAMNKLALPI------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHTSCCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hhhcCCCCCCC------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11222211111      123456799999999999999999999999999863

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-44  Score=332.85  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=197.3

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCC-------
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS-------  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-------  133 (373)
                      ...|++.+.||+|+||.||+|+++ +|+.||||+++....  ..+.+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356788899999999999999987 789999999875432  3477899999999999999999999885543       


Q ss_pred             --------------------------------------------------eeEEEEeccCcCCccccccCCCCCCCCCCH
Q 048542          134 --------------------------------------------------KRALVYEYMPNGSLDRHVFPKESRGQSLCW  163 (373)
Q Consensus       134 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  163 (373)
                                                                        ..++|||||++++|.+++..... .....+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                              37999999999999998854332 334567


Q ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc----------eeeecccCCC
Q 048542          164 EKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF----------VSISATRGTI  233 (373)
Q Consensus       164 ~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~  233 (373)
                      ..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            77899999999999999998   9999999999999999999999999999876543211          1123456999


Q ss_pred             CcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHH
Q 048542          234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKL  313 (373)
Q Consensus       234 ~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
                      .|+|||.+.+.  .++.++|||||||++|+|++|..|+...          ...........      ........+..+
T Consensus       241 ~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~----------~~~~~~~~~~~------~~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER----------VRIITDVRNLK------FPLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH----------HHHHHHHHTTC------CCHHHHHHCHHH
T ss_pred             CccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH----------HHHHHHhhccC------CCcccccCChhH
Confidence            99999998764  7889999999999999999987653210          11111111111      122334556778


Q ss_pred             HHHHHhhcCCCCCCCCCHHHHHH
Q 048542          314 CMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       314 ~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+|+.+||+.||++|||++|+++
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999999987

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.8e-45  Score=338.62  Aligned_cols=243  Identities=24%  Similarity=0.290  Sum_probs=203.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+.+ +|+.||+|++....    ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            46788899999999999999976 78999999986532    34567889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999998842    35689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..     ...+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+..+. ..+
T Consensus       194 ~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~-~~~  257 (350)
T 1rdq_E          194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQPI--------QIYEKIVSGK-VRF  257 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CCC
T ss_pred             Cc-----ccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCHH--------HHHHHHHcCC-CCC
Confidence            21     245699999999999765  7889999999999999999999999754321        1223333322 111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                            +..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       258 ------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 ------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                  1234668999999999999999998     888865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.4e-45  Score=331.61  Aligned_cols=266  Identities=17%  Similarity=0.247  Sum_probs=210.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEec
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ...|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+..++.+ +|+|++.+++++.+....++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            34677889999999999999996 478899999986543 334578899999999 799999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc-----eEEeeccCccc
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI-----PKVSDFGLAKF  216 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~-----~kl~Dfg~~~~  216 (373)
                      + +++|.+++...   +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.     +||+|||++..
T Consensus        88 ~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           88 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             c-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9 99999998432   35699999999999999999999998   9999999999999987765     99999999986


Q ss_pred             CCCCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          217 HPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       217 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      .......     .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........     .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~  233 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERI  233 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHHH
Confidence            6543221     112345699999999998764  6889999999999999999999999865432211     111111


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      .....  ..........++..+.+++.+||+.||++|||++++++.|+.+.+.+.
T Consensus       234 ~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          234 GEKKQ--STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHH--HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             Hhhcc--CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            11000  000112222456789999999999999999999999999998766544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=338.68  Aligned_cols=250  Identities=19%  Similarity=0.276  Sum_probs=189.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ...|++.+.||+|+||.||+|... +++.||+|+++... ..+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            345778899999999999999976 67889999997643 3466788999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcccCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~~~~~  219 (373)
                      ++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.   ++.+||+|||++.....
T Consensus       131 ~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          131 TGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            9999999883    345689999999999999999999998   9999999999999975   88999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..   ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......       ......+........
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~~  271 (349)
T 2w4o_A          204 QV---LMKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYFI  271 (349)
T ss_dssp             ------------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCCC
T ss_pred             cc---ccccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCccC
Confidence            22   12345699999999999764  7889999999999999999999999754432       112222222221111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ......++..+.+|+.+||+.||++|||+.++++
T Consensus       272 ---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 ---SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1112334668899999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=335.04  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=199.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCcee----EEEEeccC--ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLI----AVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..|++.+.||+|+||.||+|.+. +++.+    |+|.+...  ......+.+|+.+++.++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            45778899999999999999865 55544    66666543  334578999999999999999999999998754 789


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +++|+.+|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        94 v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            99999999999988432   45689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .............+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        ....+..+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             cCccccccccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            544333333445578899999999775  78899999999999999999 999997654322        2333333332


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      ...+      ..++..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus       238 ~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 LPQP------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            2222      22355789999999999999999999999999987543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.5e-45  Score=326.94  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ....|.+.+.||+|+||.||+|... ++..+|+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3457889999999999999999875 68899999987643  34578899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCccc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKF  216 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~  216 (373)
                      ||+++++|.+.+......+..+++..+..++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999988855444457799999999999999999999998   99999999999999   4567899999999976


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ......   .....||+.|+|||.+.+   .++.++||||||+++|+|++|..||.......        ..........
T Consensus       177 ~~~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~--------~~~~~~~~~~  242 (285)
T 3is5_A          177 FKSDEH---STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE--------VQQKATYKEP  242 (285)
T ss_dssp             -------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC
T ss_pred             cCCccc---CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH--------HHhhhccCCc
Confidence            543321   234569999999999853   67889999999999999999999997543211        1111211111


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......    ..++..+.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAVEC----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccccc----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111    113467889999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=330.51  Aligned_cols=282  Identities=21%  Similarity=0.278  Sum_probs=208.6

Q ss_pred             hcCCCCCccChhHHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc--CCCceeeEe
Q 048542           49 QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI--HHVNVVQLL  126 (373)
Q Consensus        49 ~~~~~~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l--~h~ni~~~~  126 (373)
                      ..+...............|++.+.||+|+||.||+|+.. ++.||||++....  ...+..|.+++..+  +||||++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           21 SGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             HCSCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             CCCCCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEE
Confidence            334444445556667789999999999999999999886 8999999986543  34445555555554  899999999


Q ss_pred             eEeeeC----CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCcCCCC
Q 048542          127 GFCSEG----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-----DVCILHFDIKPHN  197 (373)
Q Consensus       127 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivH~dikp~N  197 (373)
                      +++...    ...++||||+++|+|.+++.     ...+++..+..++.|++.||+|||+..     ..+++||||||+|
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence            999877    78899999999999999983     235899999999999999999999741     2389999999999


Q ss_pred             eeeeCCCceEEeeccCcccCCCCCCce--eeecccCCCCcccccccccccCCcCc------ccchHHHHHHHHHHHcC--
Q 048542          198 ILLDHNFIPKVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFGTVSC------KSDVYGFGMVLLEMAGG--  267 (373)
Q Consensus       198 il~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~------~~DvwslG~~l~~ll~g--  267 (373)
                      ||++.++.+||+|||++..........  ......||+.|+|||.+.+.  ..+.      ++|||||||++|+|++|  
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccC
Confidence            999999999999999997654333221  12245699999999998764  3333      48999999999999999  


Q ss_pred             --------CCCCCCCcCccccccchHHHHHHHhc-CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 048542          268 --------RRNSNMNATRSSKAYFPSWVYDQLNK-GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEML  338 (373)
Q Consensus       268 --------~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L  338 (373)
                              ..||........  .. ......... ......+ .......++..+.+|+.+||+.||.+|||++++++.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDP--SY-EDMREIVCIKKLRPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSC--CH-HHHHHHHTTSCCCCCCC-GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cccccccccccHhhhcCCCC--ch-hhhHHHHhhhccCcccc-ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                    555543322111  11 111122211 1122221 1122346778899999999999999999999999999


Q ss_pred             hcCCCC
Q 048542          339 EGSIDD  344 (373)
Q Consensus       339 ~~~~~~  344 (373)
                      +.+.++
T Consensus       327 ~~l~~~  332 (337)
T 3mdy_A          327 AKMSES  332 (337)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            986543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-45  Score=340.10  Aligned_cols=245  Identities=21%  Similarity=0.286  Sum_probs=202.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|.+.+.||+|+||.||+|+.+ +|+.||+|+++..    ....+.+..|..++..+ +||||+++++++.+....|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            46778899999999999999976 6889999999764    23456778899999877 899999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        97 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            999999999988832    35689999999999999999999998   99999999999999999999999999997543


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+.... ..
T Consensus       170 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~-~~  236 (345)
T 1xjd_A          170 LGDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN-PF  236 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC
T ss_pred             cCCC--cccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCC-CC
Confidence            2221  23456799999999999775  6889999999999999999999999754421        1222232222 11


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVL  335 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell  335 (373)
                            .+..++..+.+|+.+||+.||.+||++. +++
T Consensus       237 ------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          237 ------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                  1223467899999999999999999997 664

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-45  Score=336.95  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ....|++.+.||+|+||.||+|..+ +++.||+|++......   ..+|++++.++ +||||+++++++.++...|+|||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            3457888899999999999999976 6889999999765433   34688888887 79999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC----CceEEeeccCccc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN----FIPKVSDFGLAKF  216 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~----~~~kl~Dfg~~~~  216 (373)
                      |+++|+|.+.+.    ....+++..+..++.|++.||.|||++   +++||||||+|||+..+    +.+||+|||++..
T Consensus        97 ~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           97 LMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999998883    345699999999999999999999998   99999999999998432    3599999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ......  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.......     .......+..+..
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~  240 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT-----PEEILARIGSGKF  240 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC-----HHHHHHHHHHCCC
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC-----HHHHHHHHccCCc
Confidence            543322  22345789999999999764  67889999999999999999999997543211     1223333333322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..   .......++..+.+|+.+||+.||++|||+.++++
T Consensus       241 ~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 SL---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CC---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cc---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11   11222345678999999999999999999999875

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-45  Score=336.09  Aligned_cols=258  Identities=22%  Similarity=0.283  Sum_probs=195.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCe----
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK----  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~----  134 (373)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++......    ...+.+|+.+++.++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            356788899999999999999964 7889999999764332    2567899999999999999999999866543    


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4999999999999998842    35689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          215 KFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       215 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......... .......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||......       .........
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~  234 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRE  234 (311)
T ss_dssp             ------------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcC
Confidence            865433221 122345689999999999765  7888999999999999999999999754421       112222222


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHH-HHHHHhcC
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK-VLEMLEGS  341 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e-ll~~L~~~  341 (373)
                      ....    .......++..+.+++.+||+.||.+||+..+ +...|...
T Consensus       235 ~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          235 DPIP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            2111    11112235678999999999999999996554 55556554

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=332.45  Aligned_cols=252  Identities=20%  Similarity=0.300  Sum_probs=195.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCH---HHHHHHHHHhcccCC--CceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||++...+++.||||++.......   +.+.+|+.+++.++|  |||+++++++.++...++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            3577889999999999999998889999999997654433   668899999999976  99999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |+ .+++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||++.....
T Consensus        89 e~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           89 EC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             CC-CSEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             eC-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            95 5889999884    345689999999999999999999998   999999999999997 57899999999987654


Q ss_pred             CCCceeeecccCCCCcccccccccc---------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          220 ENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ...........||+.|+|||.+.+.         ...++.++|||||||++|+|++|+.||......      .......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~  233 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAI  233 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHHH
Confidence            4333233456799999999998641         146788999999999999999999999643321      1111222


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      .........+.      ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          234 IDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HCTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcCCcccCCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            22222222221      123578999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-45  Score=334.03  Aligned_cols=265  Identities=29%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCC-
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGS-  133 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-  133 (373)
                      +....|.+.+.||+|+||.||+|...    ++..||+|.+.......   +.+.+|+.+++.++||||+++++++.+.. 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34456788899999999999999764    34479999997654433   56889999999999999999999987654 


Q ss_pred             ----eeEEEEeccCcCCccccccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          134 ----KRALVYEYMPNGSLDRHVFPKE--SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       134 ----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                          ..++||||+++++|.+++....  .....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence                3599999999999998874322  3346799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++................+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------  257 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE--------  257 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------
Confidence            9999999866443322223344578899999998764  78889999999999999999 888886544321        


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .......+.....+      ..++..+.+++.+||+.||.+|||++++++.|+.+.+.+
T Consensus       258 ~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          258 MYDYLLHGHRLKQP------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHHHHTTCCCCCB------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHcCCCCCCC------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            22233333222221      234567999999999999999999999999999875543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-44  Score=320.87  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|++.+.||+|+||.||+|... +++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            357888899999999999999976 788999999875432  34778899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999883    345689999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..........|++.|+|||.+.+. ...+.++||||||+++|+|++|..||........       .......... ...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-~~~  229 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKT-YLN  229 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-------HHHHHHTTCT-TST
T ss_pred             cchhcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-------HHHHhhhccc-ccC
Confidence            222223445689999999998764 2346789999999999999999999976543211       1111221111 111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ....++..+.+|+.+||+.||.+|||++|+++
T Consensus       230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                11234567899999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=337.53  Aligned_cols=275  Identities=21%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEee-----eCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS-----EGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+. +++.||||++............|+..+..++||||+++++.+.     .....++||
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            3567889999999999999977 5899999999754432222233444455689999999997553     233578999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeEecCcCCCCeeeeCCCceEEeeccC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC------DVCILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      ||+++|+|.+++..     ...++..+..++.|++.||+|||+..      ..+++||||||+|||++.++.+||+|||+
T Consensus        92 e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           92 EYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             CCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            99999999999832     33588899999999999999999752      22899999999999999999999999999


Q ss_pred             cccCCCCCC------ceeeecccCCCCccccccccccc-----CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc-cc
Q 048542          214 AKFHPKEND------FVSISATRGTIGYIAPELISRNF-----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KA  281 (373)
Q Consensus       214 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-~~  281 (373)
                      +........      ........||+.|+|||++.+..     ..++.++|||||||++|+|++|..||........ ..
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            986543221      11123446999999999986521     2456789999999999999999877654432211 11


Q ss_pred             c----------chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          282 Y----------FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       282 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .          ................++........++..+.+|+.+||+.||++|||++|+++.|+.++...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            1          111111111122223333222223446778999999999999999999999999999876544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=327.39  Aligned_cols=251  Identities=24%  Similarity=0.292  Sum_probs=199.9

Q ss_pred             cChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhccc-CCCceeeEeeEeee
Q 048542           57 YSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRI-HHVNVVQLLGFCSE  131 (373)
Q Consensus        57 ~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l-~h~ni~~~~~~~~~  131 (373)
                      ....++....|++.++||+|+||+||+|.+. +|+.||||++.......   .....|+..+..+ +||||+++++++.+
T Consensus        49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3445667788999999999999999999977 78999999987654433   3445566555555 89999999999999


Q ss_pred             CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      +...++||||+ +++|.+++...   +..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DF  201 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDF  201 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccc
Confidence            99999999999 66888877432   45699999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |++.......   ......||+.|+|||++.+   .++.++|||||||++|+|++|..|+....           ....+
T Consensus       202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~~  264 (311)
T 3p1a_A          202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQL  264 (311)
T ss_dssp             TTCEECC---------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHHH
T ss_pred             eeeeecccCC---CCcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHHH
Confidence            9988654332   2234569999999999864   67889999999999999999987764321           11222


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+..     ....+..++..+.+++.+||+.||++|||++|+++
T Consensus       265 ~~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          265 RQGYL-----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTTCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hccCC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            22211     12333445678999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.1e-45  Score=326.32  Aligned_cols=256  Identities=23%  Similarity=0.352  Sum_probs=195.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...+|++.+.||+|+||.||+|.+..    +..||+|.+......  .+.+.+|+.+++.++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34577888999999999999998652    446999998764332  367889999999999999999999985 46789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999998842   234689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....... ......+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+..+.
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~~  234 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGE  234 (281)
T ss_dssp             --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTC
T ss_pred             cCccccc-ccccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcCC
Confidence            5433221 12234477899999998764  78889999999999999996 888987544321        222333332


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ....      +..++..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       235 ~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          235 RLPM------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            2222      1234567899999999999999999999999998753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7e-45  Score=336.55  Aligned_cols=260  Identities=22%  Similarity=0.260  Sum_probs=202.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC------ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS------KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...+|++.+.||+|+||.||+|..+ ++..||+|++...      ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  103 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI  103 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence            3457888999999999999999875 6788999998653      23347789999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC------------------------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 048542          136 ALVYEYMPNGSLDRHVFPKES------------------------------------RGQSLCWEKLHEVALGTARGIEY  179 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i~~al~~  179 (373)
                      ++||||+++|+|.+++.....                                    ....+++..++.++.|++.||+|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            999999999999888742100                                    02234677888999999999999


Q ss_pred             HHcCCCCCeEecCcCCCCeeeeCCC--ceEEeeccCcccCCCCC--CceeeecccCCCCcccccccccccCCcCcccchH
Q 048542          180 LHNGCDVCILHFDIKPHNILLDHNF--IPKVSDFGLAKFHPKEN--DFVSISATRGTIGYIAPELISRNFGTVSCKSDVY  255 (373)
Q Consensus       180 LH~~~~~~ivH~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~Dvw  255 (373)
                      ||+.   +++||||||+||+++.++  .+||+|||++.......  .........||+.|+|||.+.+....++.++|||
T Consensus       184 LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw  260 (345)
T 3hko_A          184 LHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW  260 (345)
T ss_dssp             HHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred             HHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence            9998   999999999999998766  89999999998543221  1112345569999999999876445788999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          256 GFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       256 slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      ||||++|+|++|+.||......       ...............+    ....++..+.+|+.+||+.||.+|||+.+++
T Consensus       261 slG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          261 SAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENP----NYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSG----GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            9999999999999999755432       1122222222222211    1123466899999999999999999999998


Q ss_pred             H
Q 048542          336 E  336 (373)
Q Consensus       336 ~  336 (373)
                      +
T Consensus       330 ~  330 (345)
T 3hko_A          330 Q  330 (345)
T ss_dssp             H
T ss_pred             c
Confidence            7

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=326.46  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             Hhhhhc-ccCCCCcEEEEEEEEc---CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTH-KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~-~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|.+.+ .||+|+||.||+|.+.   ++..||+|+++....  ..+.+.+|+.+++.++||||+++++++ .....++||
T Consensus        10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   88 (287)
T 1u59_A           10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM   88 (287)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence            445555 8999999999999854   577899999987533  346788999999999999999999999 456789999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           89 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             ECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            99999999998842   345699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          220 ENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ..... ......+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .....+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~~  232 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRM  232 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCC
T ss_pred             CcceeeccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCcC
Confidence            33222 12234468899999998764  68889999999999999998 99999754432        122333333322


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      ..+      ..++..+.+++.+||+.||.+|||+.++++.|+.+..+..
T Consensus       233 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          233 ECP------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CCC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            222      2345689999999999999999999999999998765443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.3e-44  Score=341.95  Aligned_cols=268  Identities=20%  Similarity=0.262  Sum_probs=197.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC-----Cee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~  135 (373)
                      ..|++.+.||+|+||.||+|.+. +++.||||++......   .+++.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            46788899999999999999876 6789999999764333   36788999999999999999999999765     578


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+||||+. ++|.+++.    ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            99999985 59988883    346699999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc--------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          216 FHPKENDF--------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       216 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      ........                    .......||+.|+|||++... ..++.++||||+||++|+|++|..||....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccccc
Confidence            76433211                    123456799999999986443 468899999999999999998665554321


Q ss_pred             Ccc-----ccccc----------------hHHH-----------------------HHHHhcCCCcccCccchhhHHHHH
Q 048542          276 TRS-----SKAYF----------------PSWV-----------------------YDQLNKGGDLELQNVTEIESMIAR  311 (373)
Q Consensus       276 ~~~-----~~~~~----------------~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~  311 (373)
                      ...     +...+                ....                       ...+.................++.
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  336 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISD  336 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCH
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCH
Confidence            100     00000                0000                       000000000000011111123567


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHH--HHhcC
Q 048542          312 KLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  341 (373)
Q Consensus       312 ~l~~li~~cl~~dp~~Rps~~ell~--~L~~~  341 (373)
                      .+.+|+.+||+.||.+|||++|+++  .+++.
T Consensus       337 ~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  368 (432)
T 3n9x_A          337 DGINLLESMLKFNPNKRITIDQALDHPYLKDV  368 (432)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence            8999999999999999999999987  34443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-44  Score=321.36  Aligned_cols=252  Identities=21%  Similarity=0.321  Sum_probs=204.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC--CeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG--SKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|.++ ++.||+|++......   .+.+.+|+.+++.++||||+++++++.+.  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46778899999999999999986 889999999875543   35688999999999999999999999876  7889999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||+++|+|.+++...  .+..+++..+..++.|++.||+|||+.   +  ++||||||+||+++.++.++|+|||++...
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999998542  234689999999999999999999997   7  999999999999999999999999887543


Q ss_pred             CCCCCceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ..       ....||+.|+|||.+.+. ...++.++|||||||++|+|++|..||......       .........+..
T Consensus       164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~  229 (271)
T 3kmu_A          164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLR  229 (271)
T ss_dssp             SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCC
T ss_pred             cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCC
Confidence            22       234589999999998754 123344799999999999999999999754422       112222333322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ...+      ..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       230 ~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          230 PTIP------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2222      234567999999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-45  Score=342.43  Aligned_cols=271  Identities=16%  Similarity=0.180  Sum_probs=202.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC------CceeEEEEeccCccCH------------HHHHHHHHHhcccCCCceeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT------GGLIAVKMLENSKFSA------------EEFINEVSTIGRIHHVNVVQL  125 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~------------~~~~~e~~~l~~l~h~ni~~~  125 (373)
                      ...|++.+.||+|+||.||+|.++.      ++.||||++.......            ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3478889999999999999998764      4689999987654211            234456667788899999999


Q ss_pred             eeEeeeC----CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          126 LGFCSEG----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       126 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ++++...    ...++||||+ +++|.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998664    4589999999 9999998843   246799999999999999999999998   999999999999999


Q ss_pred             --CCCceEEeeccCcccCCCCCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCC
Q 048542          202 --HNFIPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMN  274 (373)
Q Consensus       202 --~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~  274 (373)
                        .++.+||+|||++..........     ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||...
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence              88999999999997654322111     11234599999999999765  6899999999999999999999999753


Q ss_pred             cCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 048542          275 ATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQM  347 (373)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~  347 (373)
                      .....   ............. .......-....++..+.+++..||+.||.+||+++++++.|+.+++....
T Consensus       265 ~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          265 LKDPK---YVRDSKIRYRENI-ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             TTCHH---HHHHHHHHHHHCH-HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ccCHH---HHHHHHHHhhhhH-HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            32211   0000111100000 000000000012356789999999999999999999999999987665443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.9e-45  Score=330.77  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CC-------ceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TG-------GLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~-------~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  133 (373)
                      ....|.+.+.||+|+||.||+|... ++       ..||+|++.... ...+.+.+|+.+++.++||||+++++++.++.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3456788899999999999999865 33       469999987544 34478899999999999999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc--------
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--------  205 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~--------  205 (373)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            999999999999999998432   33489999999999999999999998   9999999999999998876        


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~  285 (373)
                      +||+|||++......      ....||+.|+|||.+.+. ..++.++|||||||++|+|++|..|+.......       
T Consensus       160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-------  225 (289)
T 4fvq_A          160 IKLSDPGISITVLPK------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-------  225 (289)
T ss_dssp             EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------
T ss_pred             eeeccCcccccccCc------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------
Confidence            999999998754322      233488999999998763 368889999999999999999765554332211       


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .............        ...+..+.+|+.+||+.||.+|||++++++.|+.++.+
T Consensus       226 ~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          226 RKLQFYEDRHQLP--------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHHHHTTCCCC--------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHHHHhhccCCCC--------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            1111122211111        11234688999999999999999999999999998763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=336.95  Aligned_cols=245  Identities=27%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      .+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            357999999999999865 788999999986543 346789999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee--eCCCceEEeeccCcccCCCCCCcee
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      .+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+|||++........   
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            888743   234689999999999999999999998   99999999999999  5678899999999987654332   


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||......       ..............    ...
T Consensus       245 ~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~----~~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWDLE----DEE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCSC----SGG
T ss_pred             cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCC----hhh
Confidence            2344699999999998754  7888999999999999999999999755421       11122222221111    111


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...++..+.+|+.+||+.||.+|||++|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2345678999999999999999999999987

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-44  Score=346.44  Aligned_cols=246  Identities=22%  Similarity=0.311  Sum_probs=193.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|... +|+.||+|++...    ......+.+|+.+++.++||||+++++++.+....++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            35777899999999999999865 7889999998753    223356788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||+++|+|.+++.    ....+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||++....
T Consensus       228 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999988883    23568999999999999999999997 7   99999999999999999999999999997543


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ...  .......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......        ....+.... ..
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~-~~  367 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEE-IR  367 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCC-CC
T ss_pred             CCC--cccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCC-CC
Confidence            222  123456799999999998764  78999999999999999999999997554321        222222211 11


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                            .+..++..+.+|+.+||+.||.+||     |++|+++
T Consensus       368 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 ------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                  1223456889999999999999999     9999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.4e-44  Score=336.51  Aligned_cols=250  Identities=20%  Similarity=0.296  Sum_probs=195.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccC--CCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|...+++.||||++......   .+.+.+|+.+++.++  ||||+++++++..+...++|||
T Consensus        57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            47888999999999999999888999999999765443   367889999999996  5999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                       +.+++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++......
T Consensus       137 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          137 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             -cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence             568899988842    34688999999999999999999998   999999999999995 589999999999876543


Q ss_pred             CCceeeecccCCCCcccccccccc---------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          221 NDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      ..........||+.|+|||++.+.         ...++.++|||||||++|+|++|..||......      ........
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~~~  281 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHAII  281 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHH
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHHHh
Confidence            332223455799999999998641         135788999999999999999999999653321      01122222


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ........+.      ..+..+.+|+.+||+.||.+|||++|+++
T Consensus       282 ~~~~~~~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCc------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            2222222221      12457899999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.6e-45  Score=332.07  Aligned_cols=264  Identities=25%  Similarity=0.389  Sum_probs=207.3

Q ss_pred             Hh-hhhcccCCCCcEEEEEEEEc-----CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeee--CCee
Q 048542           66 TN-HFTHKLGQGGFGSVYKGQLQ-----TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSE--GSKR  135 (373)
Q Consensus        66 ~~-~~~~~ig~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~  135 (373)
                      +| ++.+.||+|+||.||++.+.     +++.||+|++......  .+.+.+|+.+++.++||||+++++++.+  ....
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            44 78899999999999998643     6788999999865432  3678999999999999999999999987  4678


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++++|.+++..     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            999999999999998832     3489999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc-------cccchHHH
Q 048542          216 FHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-------KAYFPSWV  287 (373)
Q Consensus       216 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-------~~~~~~~~  287 (373)
                      .......... .....+|..|+|||.+.+.  .++.++||||||+++|+|++|..||........       ........
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            7655433222 2344578889999999764  678899999999999999999999864321100       00000112


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ...+..+.....      +..++..+.+|+.+||+.||.+|||++|+++.|+.+.+.+
T Consensus       261 ~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGERLPR------PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCC------CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            222222222222      1234568999999999999999999999999999865543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-44  Score=322.25  Aligned_cols=249  Identities=18%  Similarity=0.207  Sum_probs=204.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC-ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS-KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ...|++.+.||+|+||.||+|..+ ++..+|+|.+... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            457888899999999999999976 5678999998764 34457899999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCcccCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  218 (373)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           88 CTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999888732    35689999999999999999999998   99999999999999   788999999999998665


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....   .....||+.|+|||.+.+   .++.++||||||+++|+|++|..||......        .....+..+....
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~  226 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGTFTF  226 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCC
T ss_pred             Cccc---hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCC
Confidence            4332   234569999999999864   5788999999999999999999999754321        1222222222111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         .......++..+.+|+.+||+.||.+|||+.++++
T Consensus       227 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 ---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               11111234678999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3e-44  Score=345.02  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=183.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee-----CCee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE-----GSKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~~  135 (373)
                      .+|++.+.||+|+||.||+|.++ +++.||||++......   .+++.+|+.+++.++||||+++++++..     ....
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            46788899999999999999866 7889999998764333   3678899999999999999999999843     3568


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+||||+ +++|.+++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence            9999998 568888873    345699999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc-------------------------eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc----
Q 048542          216 FHPKENDF-------------------------VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG----  266 (373)
Q Consensus       216 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~----  266 (373)
                      ........                         ......+||+.|+|||++... ..++.++|||||||++|||++    
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccc
Confidence            65422110                         123445689999999986433 468899999999999999999    


Q ss_pred             -------CCCCCCCCcCcccccc------c-------hHH---HHHHH--------------------hcCCCcccCccc
Q 048542          267 -------GRRNSNMNATRSSKAY------F-------PSW---VYDQL--------------------NKGGDLELQNVT  303 (373)
Q Consensus       267 -------g~~p~~~~~~~~~~~~------~-------~~~---~~~~~--------------------~~~~~~~~~~~~  303 (373)
                             |+++|...........      .       ...   +...+                    ............
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   4555543321100000      0       000   00000                    000000000111


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.....+..+.+|+.+||+.||.+|||++|+++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            112234678899999999999999999999998

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.5e-45  Score=334.33  Aligned_cols=243  Identities=21%  Similarity=0.272  Sum_probs=200.5

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---------CHHHHHHHHHHhcccCCCceeeEeeEeeeC
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCSEG  132 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~  132 (373)
                      ....|++.+.||+|+||.||+|... +++.||||++.....         ....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            3457888899999999999999865 788999999976532         223567899999999999999999999999


Q ss_pred             CeeEEEEeccCcC-CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          133 SKRALVYEYMPNG-SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       133 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      ...++||||+.+| +|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999776 8888873    345699999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |++........   .....||+.|+|||.+.+. ...+.++|||||||++|+|++|..||........            
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------------  238 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------------  238 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh------------
Confidence            99987654432   2235699999999998764 2337889999999999999999999965322110            


Q ss_pred             hcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                       ..  ..      .+..++..+.+|+.+||+.||++|||++++++.
T Consensus       239 -~~--~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 -AA--IH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -TC--CC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -hc--cC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             00  00      011235678999999999999999999999983

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-44  Score=322.75  Aligned_cols=251  Identities=23%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....|++.+.||+|+||.||+|... +++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            4467889999999999999999976 788999999875432       35788999999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC----ceEEee
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSD  210 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~----~~kl~D  210 (373)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++    .+||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEe
Confidence            9999999999999998832    35689999999999999999999998   999999999999998776    899999


Q ss_pred             ccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          211 FGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       211 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ||++........   .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..||......        .....
T Consensus       156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~  222 (283)
T 3bhy_A          156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTN  222 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHH
T ss_pred             cccceeccCCCc---ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHH
Confidence            999986644322   2344689999999998764  7888999999999999999999999754321        11222


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.....   .........++..+.+++.+||+.||.+|||+.++++
T Consensus       223 ~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          223 ISAVNY---DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHTTCC---CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hHhccc---CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            222111   1112223345678999999999999999999999987

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-44  Score=335.40  Aligned_cols=246  Identities=23%  Similarity=0.271  Sum_probs=201.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|+.+ +++.||+|+++..    ....+.+..|..++..+ +||||+++++++.+....|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            45778899999999999999976 5789999999753    23456788999999988 799999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus       100 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999988842    34689999999999999999999998   99999999999999999999999999998543


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||......        .....+.... ..
T Consensus       173 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~-~~  239 (353)
T 2i0e_A          173 WDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN-VA  239 (353)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC
T ss_pred             cCCc--ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCC-CC
Confidence            2221  23456799999999999765  7889999999999999999999999754321        1222222221 11


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                            .+..++..+.+|+.+||+.||.+||+     ++++++
T Consensus       240 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 ------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                  12245678999999999999999995     467654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=338.91  Aligned_cols=269  Identities=19%  Similarity=0.289  Sum_probs=212.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCC--eeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~lv~  139 (373)
                      ..|.+.+.||+|+||.||+|.+. +|+.||||++....  ...+.+.+|+.+++.++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            35778899999999999999976 68899999997543  34577889999999999999999999987655  779999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee----eCCCceEEeeccCcc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSDFGLAK  215 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~----~~~~~~kl~Dfg~~~  215 (373)
                      ||+++|+|.+++..... ...+++..++.++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++.
T Consensus        89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            99999999999854332 33499999999999999999999998   99999999999999    777889999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccc------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRN------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      .......   .....||+.|+|||.+.+.      ...++.++|||||||++|+|++|+.||.........   ......
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~  238 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYK  238 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHH
Confidence            6644322   2345699999999998641      135678999999999999999999999754432211   111222


Q ss_pred             HHhcCCCc-----------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          290 QLNKGGDL-----------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       290 ~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ........                 ..+........++..+.+++.+||+.||++|||++++++.++.++.
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            22211100                 1112223446788899999999999999999999999999988654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=330.96  Aligned_cols=264  Identities=23%  Similarity=0.337  Sum_probs=196.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH--HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +|.+.+.||+|+||.||+|... +++.||+|++.......  ..+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   82 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence            4678899999999999999976 78899999987543322  23457999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      + ++|.+++..   .+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        83 ~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           83 D-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             S-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             c-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            6 588777743   245689999999999999999999998   999999999999999999999999999975543221


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc---
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL---  299 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  299 (373)
                        ......||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||........    ...+............   
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ----LHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ---------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCCCTTTSTTG
T ss_pred             --ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChHhchhh
Confidence              22345689999999998653 4678899999999999999999999976543211    0111111110000000   


Q ss_pred             ----------------CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcCCC
Q 048542          300 ----------------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGSID  343 (373)
Q Consensus       300 ----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~~~  343 (373)
                                      .........++..+.+|+.+||+.||.+|||++|+++  .+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                            0011112234678899999999999999999999987  4555443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.3e-45  Score=333.76  Aligned_cols=267  Identities=27%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEee--eCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|.+     .++..||+|++...... .+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            4678889999999999999984     36789999999765433 366899999999999999999999886  456789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999988432   24589999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcc-------ccccchHHHH
Q 048542          217 HPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS-------SKAYFPSWVY  288 (373)
Q Consensus       217 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~-------~~~~~~~~~~  288 (373)
                      ......... .....||..|+|||.+.+.  .++.++||||||+++|+|++|..||.......       ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence            654433222 2334578889999998764  67889999999999999999999986443210       0000111122


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .....+.....      +..++..+.+|+.+||+.||.+|||++++++.|+.+....
T Consensus       255 ~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQRLPA------PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHTTCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHhhcccCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            22333322222      2334568999999999999999999999999999876544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.1e-44  Score=341.53  Aligned_cols=252  Identities=22%  Similarity=0.274  Sum_probs=202.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+.+ +++.||+|++....    ...+.+.+|..+++.++||||+++++++.+....|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            35677799999999999999976 68899999986522    22245788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       149 E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~  220 (410)
T 3v8s_A          149 EYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  220 (410)
T ss_dssp             CCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             eCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence            9999999999883     23589999999999999999999998   999999999999999999999999999986654


Q ss_pred             CCCceeeecccCCCCccccccccccc--CCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC-CC
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNF--GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GD  296 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~  296 (373)
                      .. .......+||+.|+|||++.+..  +.++.++|||||||++|+|++|+.||.......        ....+... ..
T Consensus       221 ~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~  291 (410)
T 3v8s_A          221 EG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNS  291 (410)
T ss_dssp             TS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTHHHH
T ss_pred             CC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--------HHHHHHhcccc
Confidence            32 22334567999999999987642  127889999999999999999999997554321        11111111 11


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLEM  337 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~~  337 (373)
                      ...+..    ..++..+.+|+.+||+.+|.+  ||+++|+++.
T Consensus       292 ~~~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          292 LTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CCCCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccCCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            111111    124568899999999999988  9999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4e-44  Score=329.23  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=207.0

Q ss_pred             ccChhHHHHHHhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccC-CCceeeEeeEe
Q 048542           56 RYSYPQIIAMTNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIH-HVNVVQLLGFC  129 (373)
Q Consensus        56 ~~~~~~i~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~ni~~~~~~~  129 (373)
                      .|...+.....|.+. +.||+|+||.||+|... +++.||+|++....   .....+.+|+.+++.+. ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            456667777788887 88999999999999876 68999999987533   23578899999999994 69999999999


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCce
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIP  206 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~  206 (373)
                      .+....++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.   ++.+
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999988432  246699999999999999999999998   9999999999999987   7899


Q ss_pred             EEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH
Q 048542          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  286 (373)
                      ||+|||++........   .....||+.|+|||.+.+.  .++.++||||||+++|+|++|..||.......        
T Consensus       174 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------  240 (327)
T 3lm5_A          174 KIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------  240 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------
T ss_pred             EEeeCccccccCCccc---cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------
Confidence            9999999986643322   2345699999999998764  78889999999999999999999997644321        


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ....+.......   .......++..+.+|+.+||+.||.+|||++++++.
T Consensus       241 ~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          241 TYLNISQVNVDY---SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHHTCCCC---CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHhccccc---CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            111122111110   111122345678999999999999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.6e-44  Score=330.99  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=210.2

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ....|++.+.||+|+||.||+|.+.      ++..||+|.+......  ...+.+|+.+++.++||||+++++++.+...
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            3456788899999999999999754      4678999999765432  3568899999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          135 RALVYEYMPNGSLDRHVFPKE------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .++||||+++++|.+++....      .....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence            999999999999999885321      1124578999999999999999999998   9999999999999999999999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWV  287 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~  287 (373)
                      +|||++................+|+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......        ..
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~  249 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QV  249 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--------HH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCHH--------HH
Confidence            999999765433222222234568899999998764  68889999999999999999 78888654321        12


Q ss_pred             HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          288 YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ...+..+......      ..++..+.+++.+||+.||.+|||+.++++.|+..+.
T Consensus       250 ~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRFVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHcCCcCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2333333222211      2345678999999999999999999999999998755

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=329.48  Aligned_cols=261  Identities=20%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.+.||+|+||.||+|.+. +|+.||+|++......   .+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            5778899999999999999976 6889999998765443   25678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.    ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           84 CDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            99999988763    345689999999999999999999998   99999999999999999999999999998665332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-------HHHHHHHhc-
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQLNK-  293 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~-  293 (373)
                      .  ......||+.|+|||.+.+. ..++.++||||+|+++|+|++|..||.............       ......... 
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             c--ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            2  12345689999999998753 467889999999999999999999997654321110000       000000000 


Q ss_pred             ----CCC-cccCcc---chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 ----GGD-LELQNV---TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ----~~~-~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          +.. ......   ......++..+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                000 000000   1111235667899999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-44  Score=335.34  Aligned_cols=266  Identities=24%  Similarity=0.302  Sum_probs=189.6

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccC-CCceeeEeeEeeeCC--e
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIH-HVNVVQLLGFCSEGS--K  134 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~--~  134 (373)
                      ....+|++.+.||+|+||.||+|.+. +|+.||||++......   ...+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34567888999999999999999865 7889999998654332   356789999999997 999999999996543  7


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|+|||||+ ++|.+.+.     ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999996 58888773     24689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCC-------------------CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          215 KFHPKEN-------------------DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       215 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      +......                   .........||+.|+|||++.+. ..++.++||||+||++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8653211                   11123345799999999998763 468899999999999999999999997654


Q ss_pred             Cccccccc-------------------hHHHHHHHhcCC---CcccCccch-h---------hHHHHHHHHHHHHhhcCC
Q 048542          276 TRSSKAYF-------------------PSWVYDQLNKGG---DLELQNVTE-I---------ESMIARKLCMIGLWCIQV  323 (373)
Q Consensus       276 ~~~~~~~~-------------------~~~~~~~~~~~~---~~~~~~~~~-~---------~~~~~~~l~~li~~cl~~  323 (373)
                      .......+                   .......+....   ......... .         ...++..+.+|+.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            22110000                   000000000000   000000000 0         002356789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 048542          324 KAADRPSMTKVLEM  337 (373)
Q Consensus       324 dp~~Rps~~ell~~  337 (373)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.2e-44  Score=324.65  Aligned_cols=259  Identities=27%  Similarity=0.399  Sum_probs=201.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEe-eeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv  138 (373)
                      +|++.+.||+|+||.||+|....    ...+|+|.+.....  ..+.+.+|+.+++.++||||+++++++ ..+...++|
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  105 (298)
T 3f66_A           26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  105 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence            46777999999999999998642    22589998876433  236788999999999999999999986 456678999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       106 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          106 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999843   345689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcCccccccchHHHHHHHhcCC
Q 048542          219 KENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       219 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .....  .......+|+.|+|||.+.+.  .++.++||||+|+++|+|++|.. ||.......        .......+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--------~~~~~~~~~  249 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGR  249 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--------HHHHHHTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--------HHHHHhcCC
Confidence            32211  122344578899999999765  78889999999999999999554 444333221        122222222


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      ....+      ..++..+.+++.+||+.||.+|||++++++.|+.+...+.
T Consensus       250 ~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 RLLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            22211      1234578999999999999999999999999998766543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-44  Score=330.31  Aligned_cols=266  Identities=26%  Similarity=0.442  Sum_probs=209.5

Q ss_pred             hhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCce--eEEEEeccCc--cCHHHHHHHHHHhccc-CCCceeeEeeEeeeC
Q 048542           59 YPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGL--IAVKMLENSK--FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (373)
Q Consensus        59 ~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~--vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  132 (373)
                      ++.+....|++.+.||+|+||.||+|... ++..  +|+|.+....  ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        19 ~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           19 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            33344467888999999999999999865 5554  4999887532  2336788999999999 899999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKE------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                      ...++||||+++++|.+++....            .....+++..++.++.|++.||.|||+.   +++||||||+||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  175 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEE
Confidence            99999999999999999985432            2345799999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~  279 (373)
                      +.++.+||+|||++.......   ......+++.|+|||.+.+.  .++.++|||||||++|+|++ |..||......  
T Consensus       176 ~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--  248 (327)
T 1fvr_A          176 GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--  248 (327)
T ss_dssp             CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred             cCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcHH--
Confidence            999999999999987432211   11233478899999998764  67889999999999999998 99999754321  


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                            .....+..+.....+      ..++..+.+|+.+||+.||.+|||++++++.|+.++....
T Consensus       249 ------~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          249 ------ELYEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ------HHHHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ------HHHHHhhcCCCCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  123333333222221      2345678999999999999999999999999998765443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-43  Score=328.27  Aligned_cols=279  Identities=23%  Similarity=0.295  Sum_probs=214.6

Q ss_pred             CCCCCccChhHHHHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcc--cCCCceeeEeeE
Q 048542           51 SWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGR--IHHVNVVQLLGF  128 (373)
Q Consensus        51 ~~~~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~ni~~~~~~  128 (373)
                      +.....+...+.....|.+.+.||+|+||.||+|... ++.||||++...  ....+.+|.+++..  ++||||++++++
T Consensus        28 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           28 SGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             CCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             CCCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            3334455566777889999999999999999999885 899999998654  34667788888877  789999999999


Q ss_pred             eeeCC----eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEecCcCCC
Q 048542          129 CSEGS----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH--------NGCDVCILHFDIKPH  196 (373)
Q Consensus       129 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--------~~~~~~ivH~dikp~  196 (373)
                      +....    ..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||        +.   +++||||||+
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~  176 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSK  176 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGG
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHH
Confidence            98765    78999999999999999832     35899999999999999999999        76   9999999999


Q ss_pred             CeeeeCCCceEEeeccCcccCCCCCCce--eeecccCCCCcccccccccccC----CcCcccchHHHHHHHHHHHcC---
Q 048542          197 NILLDHNFIPKVSDFGLAKFHPKENDFV--SISATRGTIGYIAPELISRNFG----TVSCKSDVYGFGMVLLEMAGG---  267 (373)
Q Consensus       197 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~----~~s~~~DvwslG~~l~~ll~g---  267 (373)
                      ||+++.++.+||+|||++..........  ......||+.|+|||.+.+...    .++.++|||||||++|+|++|   
T Consensus       177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            9999999999999999997654433221  1234569999999999865311    233689999999999999999   


Q ss_pred             -------CCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          268 -------RRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       268 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                             ..||........  ....+.............+. .......+..+.+|+.+||+.||++|||++++++.|+.
T Consensus       257 ~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCG-GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcccccccCccccCcCcc--cHHHHHHHHHHHHhCCCCcc-cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence                   667654432211  11122221222222222221 11223567789999999999999999999999999997


Q ss_pred             CCC
Q 048542          341 SID  343 (373)
Q Consensus       341 ~~~  343 (373)
                      +.+
T Consensus       334 i~~  336 (342)
T 1b6c_B          334 LSQ  336 (342)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.2e-44  Score=328.44  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE----cCCceeEEEEeccCcc-----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL----QTGGLIAVKMLENSKF-----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~  134 (373)
                      ...|++.+.||+|+||.||+|+.    .+++.||+|+++....     ....+.+|+.+++.++||||+++++++.....
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            34678889999999999999986    4788999999976432     23567889999999999999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999988832    35688999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ........  ......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.......        ....+...
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~  236 (327)
T 3a62_A          169 KESIHDGT--VTHTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--------TIDKILKC  236 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHT
T ss_pred             cccccCCc--cccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhC
Confidence            75432221  22345699999999998764  67889999999999999999999997544211        12222222


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                      . ..      .+..++..+.+|+.+||+.||.+||     +++|+++
T Consensus       237 ~-~~------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 K-LN------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             C-CC------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             C-CC------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1 11      1123456889999999999999999     7778865

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-44  Score=323.52  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=202.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..|++.+.||+|+||.||+|..+ +++.||+|++.......   +.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45778899999999999999876 68899999997654433   567899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc---eEEeeccCcccC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFH  217 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~  217 (373)
                      |+++++|.+.+..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.   +||+|||++...
T Consensus        86 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           86 LVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999887732    35689999999999999999999998   9999999999999986655   999999999766


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC-
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD-  296 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  296 (373)
                      .....   .....||+.|+|||.+.+.  .++.++||||+|+++|+|++|..||......        ........+.. 
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~  225 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAYD  225 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCC
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhcccc
Confidence            54332   2345699999999998764  7888999999999999999999999754422        12222222221 


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....    ....++..+.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 YPSP----EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCch----hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111    11234567899999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=326.21  Aligned_cols=262  Identities=23%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc------cCHHHHHHHHHHhcccC---CCceeeEeeEe
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK------FSAEEFINEVSTIGRIH---HVNVVQLLGFC  129 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~---h~ni~~~~~~~  129 (373)
                      +++...+|++.+.||+|+||.||+|.+. +++.||+|++....      .....+.+|+.+++.++   ||||+++++++
T Consensus         4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~   83 (308)
T 3g33_A            4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC   83 (308)
T ss_dssp             ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence            4456678899999999999999999964 78899999987432      12246677887777764   99999999999


Q ss_pred             eeCC-----eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          130 SEGS-----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       130 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      ....     ..+++|||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  157 (308)
T ss_dssp             EECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred             eccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence            7755     5789999996 59988884332  34499999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch
Q 048542          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP  284 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~  284 (373)
                      .+||+|||++........   .....||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||........    .
T Consensus       158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~  228 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----L  228 (308)
T ss_dssp             CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH----H
T ss_pred             CEEEeeCccccccCCCcc---cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----H
Confidence            999999999986543322   2345689999999998764  788999999999999999999999976543211    0


Q ss_pred             HHHHHHHhcCCCccc----------------CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 SWVYDQLNKGGDLEL----------------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...............                .........++..+.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            011111110000000                0011122345678899999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.1e-44  Score=327.23  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=211.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC-
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS-  133 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~-  133 (373)
                      ...|++.+.||+|+||.||+|.+      .+++.||+|++......  .+.+.+|+.++..+ +||||+++++++.... 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            45778889999999999999974      24678999999765432  25788999999999 7999999999987654 


Q ss_pred             eeEEEEeccCcCCccccccCCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESR------------GQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ..++||||+++++|.+++......            ...+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEEC
Confidence            589999999999999998544321            22388999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccc
Q 048542          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  280 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~  280 (373)
                      .++.+||+|||++................||+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......   
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---  257 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---  257 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred             CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchh---
Confidence            9999999999999876554444444455688999999998764  78899999999999999998 99998754432   


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                          ......+..+.....+      ..++..+.+++.+||+.||.+|||++++++.|+.+++
T Consensus       258 ----~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          258 ----EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             ----HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhccCccCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                1233333333322222      2235678999999999999999999999999987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=334.18  Aligned_cols=270  Identities=16%  Similarity=0.152  Sum_probs=199.7

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCccC------------HHHHHHHHHHhcccCCCcee
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSKFS------------AEEFINEVSTIGRIHHVNVV  123 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~h~ni~  123 (373)
                      .++....|++.+.||+|+||.||+|...    ++..+|+|++......            ...+.+|+..++.++||||+
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            3445567888999999999999999975    5678999998765321            13466788899999999999


Q ss_pred             eEeeEeee----CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCee
Q 048542          124 QLLGFCSE----GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (373)
Q Consensus       124 ~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil  199 (373)
                      ++++++..    ....++||||+ +++|.+++..    ...+++..++.++.|++.||+|||+.   +++||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  183 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLL  183 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEE
Confidence            99999977    77899999999 9999998843    23799999999999999999999998   9999999999999


Q ss_pred             eeCCC--ceEEeeccCcccCCCCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          200 LDHNF--IPKVSDFGLAKFHPKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       200 ~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      ++.++  .+||+|||++.........     .......||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99877  9999999999765432211     111345699999999998764  78899999999999999999999996


Q ss_pred             CCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          273 MNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ........  . ................. ......++..+.+++.+||+.||++|||++++++.|+....
T Consensus       262 ~~~~~~~~--~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          262 QNLKDPVA--V-QTAKTNLLDELPQSVLK-WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             GGTTCHHH--H-HHHHHHHHHTTTHHHHH-HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccccccHH--H-HHHHHhhcccccHHHHh-hccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            43221100  0 01111111110000000 00000345689999999999999999999999999998643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-44  Score=329.25  Aligned_cols=262  Identities=21%  Similarity=0.334  Sum_probs=200.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|... +|..||+|++.....    ...++.+|+.+++.++||||+++++++......++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            46888899999999999999865 788999999875322    2367889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999998854444456799999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|..||.......      ......+........
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~  258 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPL  258 (310)
T ss_dssp             ------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CCH------HHHHHHHHTTCSCCC
T ss_pred             CCc--cccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchhH------HHHHHHhhcccCCCC
Confidence            221  12334689999999998764  78889999999999999999999997543211      112222333222221


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .     ...++..+.+|+.+||+.||.+|||++++++.|+.+...
T Consensus       259 ~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          259 P-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             C-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1     123456789999999999999999999999999986543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-44  Score=329.24  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=201.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|++......    .+.+.+|+.+++.++||||+++++++..+...+++|
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            46788899999999999999976 7889999998764322    267889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus       114 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          114 RLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             ECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999998842    35689999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ... .......|++.|+|||.+.+.  .++.++||||||+++|+|++|..||......        ...........   
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~---  252 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIP---  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCC---
T ss_pred             ccc-ccccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCC---
Confidence            221 122345689999999998764  7788999999999999999999999754321        12222222211   


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcCCCCCC
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~~~~~~  346 (373)
                       .....+..++..+.+++.+||+.||++|| |++++++.|+..+....
T Consensus       253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence             11122334566899999999999999999 99999999998876543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3e-44  Score=340.75  Aligned_cols=256  Identities=22%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---------HHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---------AEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      +......|.+.+.||+|+||.||+|... +++.||+|++......         ...+.+|+.+++.++||||+++++++
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3455678889999999999999999866 6889999998753211         12478999999999999999999997


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---Cce
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIP  206 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~  206 (373)
                      .. ...++||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.+   +.+
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred             ec-CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence            54 56899999999999998883    346799999999999999999999998   99999999999999754   459


Q ss_pred             EEeeccCcccCCCCCCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH
Q 048542          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~  285 (373)
                      ||+|||++.......   ......||+.|+|||.+.+ ....++.++|||||||++|+|++|..||........      
T Consensus       282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------  352 (419)
T 3i6u_A          282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------  352 (419)
T ss_dssp             EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------
T ss_pred             EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------
Confidence            999999998764332   2234569999999999854 224678899999999999999999999975443211      


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....+..+....   ..+....++..+.+|+.+||+.||++|||++|+++
T Consensus       353 -~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 -LKDQITSGKYNF---IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             -HHHHHHTTCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHhcCCCCC---CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence             122222222111   12222345678999999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4e-44  Score=323.76  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             HHhhhhc-ccCCCCcEEEEEEEEc---CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTH-KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..|++.+ .||+|+||.||+|.+.   +++.||+|+++.....   .+++.+|+.+++.++||||+++++++ .....++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            3556666 8999999999999643   4678999999764322   46789999999999999999999999 5677899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999998842    45689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          218 PKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       218 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ........ .....+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .....+..+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~  237 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGE  237 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC
Confidence            54433221 2233467889999998764  67889999999999999999 99998754321        2333333333


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      ....+      ..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       238 ~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          238 RMGCP------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CCCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            22222      23456899999999999999999999999999986543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.7e-44  Score=346.05  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC---ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS---KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ...+|++.+.||+|+||.||+|... +++.||+|++...   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4568999999999999999999976 7889999998642   33457889999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee---CCCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~  215 (373)
                      ||||.+++|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999888743    35689999999999999999999998   999999999999995   45679999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ......   ......||+.|+|||++.+   .++.++||||+||++|+|++|..||......        .....+..+.
T Consensus       173 ~~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  238 (486)
T 3mwu_A          173 CFQQNT---KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGK  238 (486)
T ss_dssp             TBCCC-------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             ECCCCC---ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            654432   2334569999999999864   5888999999999999999999999754321        1222333322


Q ss_pred             -CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 -DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....    +....++..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          239 YAFDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             CCSCS----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCC----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             1111    122345678999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-44  Score=332.35  Aligned_cols=260  Identities=24%  Similarity=0.430  Sum_probs=208.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC-C-----ceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT-G-----GLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ...|++.+.||+|+||.||+|.... +     ..||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++.+...
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4567788999999999999998652 2     3699999976543  236788999999999 89999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC
Q 048542          135 RALVYEYMPNGSLDRHVFPKES----------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF  204 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~  204 (373)
                      .++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence            9999999999999998853211          134689999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccc
Q 048542          205 IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYF  283 (373)
Q Consensus       205 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~  283 (373)
                      .+||+|||++................+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||......      
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------  273 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------  273 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchh------
Confidence            9999999999865444333333445578899999998764  78899999999999999998 88898754432      


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                       .........+.....+      ...+..+.+|+.+||+.||.+|||++++++.|+..
T Consensus       274 -~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          274 -SKFYKLVKDGYQMAQP------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCCCCCC------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             1122333333222211      12246789999999999999999999999999864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=335.53  Aligned_cols=258  Identities=27%  Similarity=0.401  Sum_probs=194.5

Q ss_pred             hhhhcccCCCCcEEEEEEEEc--CC--ceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEee-eCCeeEEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ--TG--GLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCS-EGSKRALVY  139 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~--~~--~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~  139 (373)
                      |++.+.||+|+||.||+|.+.  ++  ..||+|.++....  ..+++.+|+.+++.++||||+++++++. .+...++||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            456689999999999999864  22  3689999875433  3367899999999999999999999875 456789999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++..   ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++.....
T Consensus       171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999842   345688999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          220 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       220 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ....  .......+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||.......        .......+..
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~~  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGRR  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCCC
Confidence            2211  112334577899999998764  78899999999999999999 566665443321        1122233322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      ...+      ..++..+.+++.+||+.||++|||++++++.|+.+...+.
T Consensus       315 ~~~p------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          315 LLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             CCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             CCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            2211      2235678999999999999999999999999998765543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=325.58  Aligned_cols=259  Identities=25%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCc---eeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee-EEEE
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGG---LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-ALVY  139 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~---~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-~lv~  139 (373)
                      |+..+.||+|+||.||+|.+. ++.   .+|+|.+......  .+.+.+|+.+++.++||||+++++++.+.+.. +++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            345589999999999999854 222   6999998764432  36788999999999999999999999766554 9999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+.+++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.....
T Consensus       103 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          103 PYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             CCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             ecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999998843   346689999999999999999999998   999999999999999999999999999975543


Q ss_pred             CCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          220 ENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       220 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ....  .......+++.|+|||.+.+.  .++.++||||||+++|+|++|..|+.......       ............
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~~~  247 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQGRRL  247 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHHHHTTCCC
T ss_pred             CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHHhhcCCCC
Confidence            2211  122344578899999999764  78889999999999999999766654333221       122333333322


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      ..+      ..++..+.+++.+||+.||.+|||++++++.|+.+.+.+.
T Consensus       248 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          248 PQP------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCC------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            221      2235678999999999999999999999999998766543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.6e-44  Score=334.79  Aligned_cols=270  Identities=23%  Similarity=0.281  Sum_probs=207.5

Q ss_pred             CCccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-----CCceeeEee
Q 048542           54 PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-----HVNVVQLLG  127 (373)
Q Consensus        54 ~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h~ni~~~~~  127 (373)
                      ...+...++....|++.++||+|+||.||+|... +++.||||+++........+..|+.+++.++     ||||+++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            3345555666778899999999999999999975 7889999999866555577788999999986     999999999


Q ss_pred             EeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-----
Q 048542          128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----  202 (373)
Q Consensus       128 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-----  202 (373)
                      ++......++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.     
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence            999999999999999 889999885332  34589999999999999999999998   9999999999999975     


Q ss_pred             --------------------CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHH
Q 048542          203 --------------------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLL  262 (373)
Q Consensus       203 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~  262 (373)
                                          ++.+||+|||++.......     ....||+.|+|||++.+.  .++.++|||||||++|
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~  250 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCC--CCCCccchHHHHHHHH
Confidence                                7899999999998654322     245689999999999765  7889999999999999


Q ss_pred             HHHcCCCCCCCCcCcccccc-------chHHHHHHHhcCC----------CcccCcc--------------chhhHHHHH
Q 048542          263 EMAGGRRNSNMNATRSSKAY-------FPSWVYDQLNKGG----------DLELQNV--------------TEIESMIAR  311 (373)
Q Consensus       263 ~ll~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~----------~~~~~~~--------------~~~~~~~~~  311 (373)
                      +|++|+.||...........       .+...........          ....+..              .......+.
T Consensus       251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (360)
T 3llt_A          251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE  330 (360)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred             HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence            99999999976442210000       0000100000000          0000000              001111225


Q ss_pred             HHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          312 KLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       312 ~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+.+|+.+||+.||.+|||++|+++
T Consensus       331 ~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          331 LFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHhc
Confidence            6889999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-44  Score=327.03  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=198.0

Q ss_pred             Hhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++. +.||+|+||.||+|... +++.||||++..... ....+.+|+.++.++ +||||+++++++.++...++||||
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~   92 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK   92 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence            45664 78999999999999865 788999999976533 457889999999885 799999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc---eEEeeccCcccCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDFGLAKFHP  218 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~~  218 (373)
                      +++++|.+++..    ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.   +||+|||++....
T Consensus        93 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           93 MRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             CCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            999999998843    35689999999999999999999998   9999999999999987765   9999999987553


Q ss_pred             CCCCc-----eeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc----cc---
Q 048542          219 KENDF-----VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA----YF---  283 (373)
Q Consensus       219 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~----~~---  283 (373)
                      .....     .......||+.|+|||.+.+.   ...++.++|||||||++|+|++|..||..........    ..   
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            22111     112234599999999998641   1257889999999999999999999997654321100    00   


Q ss_pred             hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......+..+.. ..+  ......++..+.+|+.+||+.||.+|||++|+++
T Consensus       246 ~~~~~~~i~~~~~-~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKY-EFP--DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCC-CCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCc-ccC--chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            1112222222221 111  1111235678999999999999999999999988

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.8e-44  Score=346.61  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=201.0

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ....|++.+.||+|+||.||+|..+ ++..||+|++....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567889999999999999999976 78899999987643   2346789999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~~~  215 (373)
                      ||||++|+|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++..   +.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            999999999887732    35689999999999999999999998   99999999999999754   459999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ......   ......||+.|+|||++.+   .++.++||||+||++|+|++|..||......        .....+..+.
T Consensus       188 ~~~~~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~  253 (494)
T 3lij_A          188 VFENQK---KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGK  253 (494)
T ss_dssp             ECBTTB---CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC
T ss_pred             ECCCCc---cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            664432   2234569999999999853   6888999999999999999999999765431        1223333322


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....   ......++..+.+|+.+||+.||.+|||++++++
T Consensus       254 ~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          254 YTFD---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             CCCC---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCC---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1111   1112345678999999999999999999999875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7e-44  Score=330.09  Aligned_cols=246  Identities=26%  Similarity=0.347  Sum_probs=199.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|...+.||+|+||.||+|... +++.||||++......    .+++.+|+.+++.++||||+++++++..+...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45777799999999999999964 7889999999764332    256889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+. |+|.+.+..   ....+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.....
T Consensus       134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9996 577776632   245689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .      ....||+.|+|||.+.+ ..+.++.++|||||||++|+|++|..||......       ....... ......
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~-~~~~~~  272 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIA-QNESPA  272 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHH-HSCCCC
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHH-hcCCCC
Confidence            2      23469999999999853 1246888999999999999999999998754321       1122222 222111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..     +..++..+.+|+.+||+.||++|||++++++
T Consensus       273 ~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          273 LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            11     1223567899999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-44  Score=332.20  Aligned_cols=258  Identities=29%  Similarity=0.453  Sum_probs=201.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC-C----ceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT-G----GLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~-~----~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ...|.+.+.||+|+||.||+|..+. +    ..||+|.++.....  ...+.+|+.+++.++||||+++++++.+....+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3456667899999999999998652 2    35999999764332  356889999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999998843   245689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          217 HPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       217 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ....... .......+|..|+|||.+.+.  .++.++||||||+++|+|++ |..||.....        ......+..+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~  266 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDG  266 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT
T ss_pred             hccccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCC
Confidence            5433211 112233467889999998764  78889999999999999998 9999865432        1233333333


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ......      ..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       267 ~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          267 FRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             CCCCCC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CcCCCc------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            222221      2345678999999999999999999999999987654

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.2e-44  Score=321.02  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             ChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee-----
Q 048542           58 SYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----  131 (373)
Q Consensus        58 ~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----  131 (373)
                      +.+......|++.+.||+|+||.||+|.+. +++.||+|.+....   +.+.+|+.+++.++||||+++++++..     
T Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             CCCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             cccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            345566778899999999999999999976 78999999997654   356789999999999999999998854     


Q ss_pred             -----------CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee
Q 048542          132 -----------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL  200 (373)
Q Consensus       132 -----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~  200 (373)
                                 ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  155 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFL  155 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEE
Confidence                       44579999999999999988533  235689999999999999999999998   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  280 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~  280 (373)
                      +.++.+||+|||++........   .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..|+...      
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~------  224 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET------  224 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred             cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence            9999999999999987654332   2334699999999998764  6788999999999999999999876321      


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP  348 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~  348 (373)
                          ............         +..++..+.+++.+||+.||.+|||+.|+++.|+...+.....
T Consensus       225 ----~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~  279 (284)
T 2a19_B          225 ----SKFFTDLRDGII---------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN  279 (284)
T ss_dssp             ----HHHHHHHHTTCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred             ----HHHHHHhhcccc---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence                111222222211         1223457899999999999999999999999999876654433

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=321.96  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=182.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|... +++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            5778899999999999999974 78899999986532    224678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           92 MCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             CCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             cCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999988843   235689999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|+.||.........           .......  
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------~~~~~~~--  228 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----------NKVVLAD--  228 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------CCSSC--
T ss_pred             CC--cceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----------HHHhhcc--
Confidence            21  12234689999999998764  6788999999999999999999999765432110           0000001  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ...+..++..+.+++.+||+.||++|||++++++
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              1112234567899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.3e-44  Score=346.62  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--------------cCHHHHHHHHHHhcccCCCceeeEeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--------------FSAEEFINEVSTIGRIHHVNVVQLLGF  128 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni~~~~~~  128 (373)
                      ...|.+.++||+|+||.||+|..+ ++..||+|++....              ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456888899999999999999976 67899999987643              224678899999999999999999999


Q ss_pred             eeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC---c
Q 048542          129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF---I  205 (373)
Q Consensus       129 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~---~  205 (373)
                      +.+....++|||||++|+|.+.+..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999888842    35699999999999999999999998   999999999999998765   6


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~  285 (373)
                      +||+|||++........   .....||+.|+|||++.+   .++.++||||+||++|+|++|..||......        
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------  253 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------  253 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence            99999999987654332   234569999999999864   6788999999999999999999999765432        


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....+..+....   .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       254 ~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          254 DIIKKVEKGKYYF---DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcCCCCC---CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1223333322111   11222345678999999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-44  Score=347.36  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=207.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      +....|++.+.||+|+||.||+|... +++.||||++...    ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45668899999999999999999976 7899999998654    334578999999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccC
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGL  213 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~  213 (373)
                      +||||+.+++|.+.+.    ....+++..+..++.|++.||.|||++   +++||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            9999999999988884    345699999999999999999999998   99999999999999   4678999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      +........   .....||+.|+|||++.+   .++.++||||+||++|+|++|..||......        .....+..
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~  241 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEK  241 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             eEEcccccc---cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHc
Confidence            986654332   234569999999999864   6788999999999999999999999765421        12233333


Q ss_pred             CC-CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GG-DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +. ....    +....++..+.+|+.+||+.||.+|||++|+++
T Consensus       242 ~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          242 GKYTFEL----PQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CCCCCCS----GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCC----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            32 1111    122345678999999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.2e-44  Score=347.53  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=205.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|+.+ +|+.||+|++....    .....+.+|..+++.++||||+++++++.+....|+|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            4556688999999999999976 78999999997532    334678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++|+|.+++.........+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            9999999988865544456799999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||........    .......+.....    
T Consensus       343 ~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~----~~~~~~~i~~~~~----  410 (543)
T 3c4z_A          343 QT--KTKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----NKELKQRVLEQAV----  410 (543)
T ss_dssp             CC--CBCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC----HHHHHHHHHHCCC----
T ss_pred             Cc--ccccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchh----HHHHHHHHhhccc----
Confidence            32  12345799999999999774  788999999999999999999999976543211    1112222222211    


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ell~  336 (373)
                         ..+..++..+.+|+.+||+.||.+||++     +++++
T Consensus       411 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          411 ---TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               1123456788999999999999999975     66653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-43  Score=319.12  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=198.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|... ++..||+|++....    .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            35778899999999999999876 56789999986532    23467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+.+..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        89 e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           89 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999888832    35689999999999999999999998   999999999999999999999999998865433


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..    .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..||......        .....+..... . 
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~-~-  225 (279)
T 3fdn_A          162 SR----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEF-T-  225 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC-C-
T ss_pred             cc----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCCC-C-
Confidence            22    2344689999999998764  6788999999999999999999999754321        12222222211 1 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           .+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       226 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          226 -----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             -----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 11224567899999999999999999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.3e-44  Score=333.37  Aligned_cols=246  Identities=26%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHH-hcccCCCceeeEeeEeeeCCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVST-IGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ...|++.+.||+|+||.||+|+.+ ++..||+|+++....    ....+..|..+ ++.++||||+++++++.+....|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            346788899999999999999976 678899999976543    22455667776 567899999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++|+|.+++.    +...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++...
T Consensus       117 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999998883    235688999999999999999999998   9999999999999999999999999999853


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .....  .....+||+.|+|||++.+.  .++.++|+|||||++|+|++|..||......        .....+.... .
T Consensus       190 ~~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~-~  256 (373)
T 2r5t_A          190 IEHNS--TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKP-L  256 (373)
T ss_dssp             BCCCC--CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--------HHHHHHHHSC-C
T ss_pred             ccCCC--ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcc-c
Confidence            32221  23456799999999999765  7889999999999999999999999754421        1222222221 1


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      .+      +..++..+.+|+.+||+.||.+||++.+.+
T Consensus       257 ~~------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 QL------KPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             CC------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             CC------CCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            11      123456789999999999999999985433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-43  Score=333.97  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=190.1

Q ss_pred             Hhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcc-cCCCceeeEeeEeee----CCeeEEE
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGR-IHHVNVVQLLGFCSE----GSKRALV  138 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~h~ni~~~~~~~~~----~~~~~lv  138 (373)
                      .|++. +.||+|+||+||+|.++ +++.||||+++..    ..+.+|+.++.+ .+||||+++++++..    ....|+|
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            34444 68999999999999876 7889999998643    456778888744 589999999998865    5678999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~  215 (373)
                      ||||++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++.
T Consensus       138 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          138 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999998532  234699999999999999999999998   9999999999999987   7899999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ......   .....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||...........    ....+..+.
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~i~~~~  283 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQ  283 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS----HHHHHHHTC
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH----HHHHHHcCc
Confidence            654322   22345689999999999764  788999999999999999999999976543321111    112222221


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      . ....  .....++..+.+|+.+||+.||.+|||++|+++
T Consensus       284 ~-~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          284 Y-EFPN--PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             C-CCCT--TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c-cCCC--cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1 1110  111234668999999999999999999999987

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.9e-44  Score=341.37  Aligned_cols=257  Identities=21%  Similarity=0.214  Sum_probs=192.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeC------Ce
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~  134 (373)
                      .+|++.+.||+|+||.||+|.+. +++.||||++.....   ...++.+|+.+++.++||||+++++++...      ..
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            45778899999999999999865 788999999976432   236788999999999999999999998654      45


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|+||||+++ +|.+.+      ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       142 ~~lv~E~~~~-~l~~~~------~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEECCSE-EHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEEEeCCCC-CHHHHH------hhcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            7999999976 455555      13488999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc------------
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------------  282 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~------------  282 (373)
                      .......   ......||+.|+|||++.+.  .++.++||||+||++|+|++|+.||........-..            
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            8654332   22345799999999999875  788999999999999999999999976542110000            


Q ss_pred             ---chHHHHHHHhcCCCc------------ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 ---FPSWVYDQLNKGGDL------------ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 ---~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ...............            ......+.....+..+.+|+.+||+.||++|||++|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               000000111110000            001112233344778999999999999999999999987

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.2e-44  Score=341.01  Aligned_cols=255  Identities=20%  Similarity=0.206  Sum_probs=202.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||+||+|+.+ +++.||+|++.....    ....+.+|..++..++||||+++++++.+....|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            35677799999999999999977 578899999875321    2234788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||++|+|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       154 Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          154 DYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             CCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            99999999999843   245699999999999999999999998   999999999999999999999999999976644


Q ss_pred             CCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          220 ENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ... ......+||+.|+|||++...   .+.++.++|||||||++|||++|+.||.......       .....+.....
T Consensus       228 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~  299 (437)
T 4aw2_A          228 DGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHKER  299 (437)
T ss_dssp             TSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTHHHH
T ss_pred             CCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------HHHhhhhcccc
Confidence            332 223346799999999998631   2468889999999999999999999997654321       11111111111


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAAD--RPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rps~~ell~  336 (373)
                      ..++..   ...++..+.+|+.+||..+|++  ||+++|+++
T Consensus       300 ~~~p~~---~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          300 FQFPTQ---VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             CCCCSS---CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccCCcc---cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            111110   0124567899999999988888  999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.2e-44  Score=324.93  Aligned_cols=255  Identities=23%  Similarity=0.313  Sum_probs=205.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEee--eCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|.+......   .+.+.+|+.+++.++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            36778899999999999999976 7889999999765433   356889999999999999999999874  36788999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEecCcCCCCeeeeCCCceEEeeccC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC-----ILHFDIKPHNILLDHNFIPKVSDFGL  213 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~-----ivH~dikp~Nil~~~~~~~kl~Dfg~  213 (373)
                      |||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++||||||+||+++.++.+||+|||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999865544456699999999999999999999998   7     99999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      +.........  .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..||......        .....+..
T Consensus       163 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~  230 (279)
T 2w5a_A          163 ARILNHDTSF--AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIRE  230 (279)
T ss_dssp             HHHC---CHH--HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             heeecccccc--ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------HHHHHHhh
Confidence            9865433211  1234589999999998764  6788999999999999999999998755321        12233333


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      +.....+      ..++..+.+++.+||+.||.+|||++|+++.+..
T Consensus       231 ~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          231 GKFRRIP------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             TCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccccCC------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            3322221      2345689999999999999999999999986643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.6e-43  Score=316.60  Aligned_cols=245  Identities=26%  Similarity=0.374  Sum_probs=198.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee----CCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~l  137 (373)
                      .|++.+.||+|+||.||+|.+. ++..||+|.+......   .+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3567789999999999999875 6778999998765443   3568899999999999999999998865    456899


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeee-CCCceEEeeccCc
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLA  214 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~  214 (373)
                      ||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +  ++||||||+||+++ .++.+||+|||++
T Consensus       107 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          107 VTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            999999999999883    235689999999999999999999998   7  99999999999997 7899999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      .......    .....||+.|+|||.+.+   .++.++||||+|+++|+|++|+.||......       .........+
T Consensus       180 ~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~  245 (290)
T 1t4h_A          180 TLKRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG  245 (290)
T ss_dssp             GGCCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT
T ss_pred             ccccccc----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhcc
Confidence            7554332    234569999999998864   5788999999999999999999999754332       1122222222


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....     ..+...+..+.+++.+||+.||.+|||++++++
T Consensus       246 ~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 VKPA-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CCCG-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCcc-----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            2111     122233457899999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=350.90  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             ccCCCCcEEEEEEEEc---CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           72 KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      .||+|+||.||+|.++   ++..||||+++...  ...+++.+|+.+++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999864   45679999998643  345789999999999999999999999976 56899999999999


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce-e
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-S  225 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~  225 (373)
                      |.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......... .
T Consensus       422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9998843   345699999999999999999999998   99999999999999999999999999998664332211 1


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      .....+++.|+|||++.+.  .++.++|||||||++|||++ |..||......        .+...+..+.....+    
T Consensus       496 ~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p----  561 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECP----  561 (613)
T ss_dssp             ------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCCCCCC----
T ss_pred             ccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCC----
Confidence            2233467899999999764  78999999999999999998 99999765432        233444444433322    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        ..++..+.+|+.+||+.||++|||++++++.|+....
T Consensus       562 --~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          562 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             --TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence              2345689999999999999999999999999997543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-43  Score=329.38  Aligned_cols=252  Identities=21%  Similarity=0.272  Sum_probs=203.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---------HHHHHHHHHHhccc-CCCceeeEeeEeeeC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---------AEEFINEVSTIGRI-HHVNVVQLLGFCSEG  132 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~  132 (373)
                      ...|++.+.||+|+||.||+|.+. +|+.||||++......         .+.+.+|+.+++.+ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            456777799999999999999986 7899999998764321         24578899999999 799999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++||||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence            99999999999999999884    235689999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccc----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ++........   .....||+.|+|||++.+.    ...++.++|||||||++|+|++|..||......        ...
T Consensus       246 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--------~~~  314 (365)
T 2y7j_A          246 FSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--------LML  314 (365)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred             cccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--------HHH
Confidence            9987654332   2345799999999998643    135788999999999999999999999754321        122


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+..+....   .......++..+.+|+.+||+.||++|||++++++
T Consensus       315 ~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 RMIMEGQYQF---SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHTCCCC---CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCCC---CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2222221110   01111234567899999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-43  Score=318.31  Aligned_cols=247  Identities=21%  Similarity=0.352  Sum_probs=201.1

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ....|++.+.||+|+||.||+|... +++.||+|++.....   ...++.+|+..+..+ +||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3457888899999999999999976 789999999876422   346788999999999 89999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC--------------
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN--------------  203 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~--------------  203 (373)
                      ||||+++++|.+++.........+++..+..++.|++.||.|||++   +++||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999855433346789999999999999999999998   99999999999999844              


Q ss_pred             -----CceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcc
Q 048542          204 -----FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS  278 (373)
Q Consensus       204 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~  278 (373)
                           ..+||+|||.+.......      ...||+.|+|||.+.+. ..++.++|||||||++|+|++|.+++....   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~---  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD---  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh---
Confidence                 479999999998765432      23489999999998754 356679999999999999999987764321   


Q ss_pred             ccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          279 SKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                              ....+..+.....+      ..++..+.+++.+||+.||.+|||+.++++
T Consensus       236 --------~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 --------QWHEIRQGRLPRIP------QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             --------HHHHHHTTCCCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------HHHHHHcCCCCCCC------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                    12223333222222      234567899999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.8e-44  Score=321.71  Aligned_cols=264  Identities=18%  Similarity=0.251  Sum_probs=205.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEe-eeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|.. .+++.||+|++..... .+++.+|+.+++.++|++++..+..+ ......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            3577889999999999999996 4788999999875433 34688999999999988766655554 6677889999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCcccCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  219 (373)
                       +++|.+++..   ....+++..+..++.|++.||+|||++   +++||||||+||++   +.++.+||+|||++.....
T Consensus        88 -~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           88 -GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence             8999998842   235699999999999999999999998   99999999999999   4788999999999986554


Q ss_pred             CCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          220 ENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       220 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      .....     ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||.......................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            33211     12345699999999998765  688999999999999999999999986543322221111111111100


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                             .......++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       239 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          239 -------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             -------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence                   01112334678999999999999999999999999999875543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.7e-44  Score=321.65  Aligned_cols=265  Identities=18%  Similarity=0.250  Sum_probs=203.4

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEe-eeCCeeEEEEec
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC-SEGSKRALVYEY  141 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~e~  141 (373)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            45788889999999999999996 4788999998655332 23577899999999888766665554 677888999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCcccCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~  218 (373)
                      + +++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++....
T Consensus        87 ~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           87 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             C-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             c-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9 9999998842   235699999999999999999999998   99999999999999   788999999999998664


Q ss_pred             CCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          219 KENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       219 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      .....     .......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||......................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            43221     112345699999999999775  68899999999999999999999998654432222211111111111


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      .       .......++..+.+++.+||+.||++|||++++++.|+.+....
T Consensus       238 ~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          238 P-------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             C-------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             h-------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            0       01111234568999999999999999999999999999875543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.6e-44  Score=323.96  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...+|.+.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3467888999999999999999976 788999999976543 33568899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCcccC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~  217 (373)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999888732    34689999999999999999999998   99999999999999   78899999999998754


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ....    .....||+.|+|||.+.+.  .++.++||||||+++|+|++|..||......        .....+..+...
T Consensus       160 ~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~  225 (304)
T 2jam_A          160 QNGI----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYE  225 (304)
T ss_dssp             CCBT----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCC
T ss_pred             CCCc----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            3321    1234589999999998764  7889999999999999999999999754321        122233332211


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .   .......++..+.+++.+||+.||.+|||++++++
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          226 F---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             C---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             C---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1   11122334668999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=328.45  Aligned_cols=265  Identities=25%  Similarity=0.318  Sum_probs=204.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEee----eCCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCS----EGSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~~~~~l  137 (373)
                      ..+|++.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            34678889999999999999997 4789999998865432 3467889999999999999999999986    2347889


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++++|.+++......+..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999998865444567799999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCCCc-------eeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          218 PKENDF-------VSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       218 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      ......       .......||+.|+|||.+.+. ...++.++||||||+++|+|++|..||........  .    ...
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~----~~~  258 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S----VAL  258 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C----HHH
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--h----hhH
Confidence            321100       001123479999999998653 12368899999999999999999999853221110  0    111


Q ss_pred             HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .......  .+.    ...++..+.+++.+||+.||.+|||++++++.|+.+..
T Consensus       259 ~~~~~~~--~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 AVQNQLS--IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             HHHCC----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             HhhccCC--CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            1122111  111    12335679999999999999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.4e-44  Score=347.16  Aligned_cols=251  Identities=27%  Similarity=0.332  Sum_probs=205.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|..+ +|+.||+|++...    ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            34667789999999999999976 7899999998653    234467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       264 Ey~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             CCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999998885432  34589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...   ....+||+.|+|||++.+.  .++.++|||||||++|+|++|..||........    ...+...+.... .  
T Consensus       339 ~~~---~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~~-~--  406 (576)
T 2acx_A          339 GQT---IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEVP-E--  406 (576)
T ss_dssp             TCC---EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHCC-C--
T ss_pred             Ccc---ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhccc-c--
Confidence            332   2345799999999999764  688999999999999999999999976543221    112222222221 1  


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                          ..+..++..+.+|+.+||+.||.+||     +++|+++
T Consensus       407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                11233567899999999999999999     7888874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=331.15  Aligned_cols=262  Identities=22%  Similarity=0.285  Sum_probs=195.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------e
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~  134 (373)
                      ..|++.+.||+|+||.||+|.+. +|+.||||++......   .+++.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            35778899999999999999975 7899999999654333   356889999999999999999999997653      4


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|+||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            59999999 7899888732     4689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHH-
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSW-  286 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~-  286 (373)
                      ......     .....+|..|+|||++.+. ..++.++||||+||++|+|++|+.||........-..+       +.. 
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            865432     2345689999999998763 46889999999999999999999999765422100000       000 


Q ss_pred             --------HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcC
Q 048542          287 --------VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  341 (373)
Q Consensus       287 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~  341 (373)
                              ....+..................+..+.+|+.+||+.||.+|||++|+++  .+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                    00000000000011111222344678999999999999999999999988  45544

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.2e-44  Score=328.74  Aligned_cols=255  Identities=20%  Similarity=0.290  Sum_probs=193.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..+|++.+.||+|+||.||+|... +++.||+|+++.....   .+.+.+|+.+++.++||||+++++++.++...++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            446888899999999999999865 7889999999765433   256779999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-----CCCceEEeeccCc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-----HNFIPKVSDFGLA  214 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-----~~~~~kl~Dfg~~  214 (373)
                      ||++ ++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++     .++.+||+|||++
T Consensus       113 e~~~-~~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          113 EYAE-NDLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             ECCS-EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             ecCC-CCHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9997 48888873    345689999999999999999999998   999999999999994     4556999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ........  ......||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.......       .........
T Consensus       185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~~~~~  254 (329)
T 3gbz_A          185 RAFGIPIR--QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-------QLFKIFEVL  254 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHHH
T ss_pred             cccCCccc--ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-------HHHHHHHHh
Confidence            86543221  22345689999999998764 357899999999999999999999997654221       111111110


Q ss_pred             C---Ccc-------------cC------ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 G---DLE-------------LQ------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~---~~~-------------~~------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .   ...             ..      .....+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0   000             00      001112225678899999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=326.88  Aligned_cols=265  Identities=26%  Similarity=0.418  Sum_probs=206.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEE-----cCCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCC--ee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQL-----QTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGS--KR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~  135 (373)
                      ...|++.+.||+|+||.||+|..     .+++.||+|++...... .+.+.+|+.+++.++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            44577889999999999999984     36889999999765433 367899999999999999999999886543  78


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999988432   34689999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc--------cccccchHH
Q 048542          216 FHPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR--------SSKAYFPSW  286 (373)
Q Consensus       216 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~~  286 (373)
                      .......... .....++..|+|||.+.+.  .++.++||||||+++|+|++|..|+......        .........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            7655443222 1233467789999998764  6788999999999999999999887643110        000001111


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ....+..+.....      +..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       272 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          272 LIELLKNNGRLPR------PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHHTTCCCCC------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCC------CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2223333322221      1234568999999999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.3e-43  Score=317.17  Aligned_cols=253  Identities=26%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|.+.+.||+|+||.||+|.+..    +..||+|.+.....  ..+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            467788999999999999998652    23599999876532  34678899999999999999999999865 456899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        91 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           91 MELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999998843   235689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ..... ......+++.|+|||.+.+.  .++.++||||||+++|+|++ |+.||.......        ....+..+...
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~  233 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL  233 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             ccccc-ccccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence            43221 22344578899999998764  78889999999999999998 999997544321        22233333222


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ..+      ..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       234 ~~~------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 PKP------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            221      22356789999999999999999999999999865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-44  Score=331.00  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=205.1

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEE------cCCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCC
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  133 (373)
                      +....|++.+.||+|+||.||+|.+      .++..||+|.+.....  ...++.+|+.+++.++||||+++++++.+..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3456778889999999999999983      2567899999975432  3367889999999999999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceE
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES---RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPK  207 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~k  207 (373)
                      ..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999998854322   224589999999999999999999998   9999999999999984   44699


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++................||+.|+|||.+.+.  .++.++||||||+++|+|++ |..||......        .
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~  253 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------E  253 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------H
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------H
Confidence            9999998754333222223345578899999998764  78899999999999999998 88888654321        1


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ....+..+......      ..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       254 ~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          254 VLEFVTSGGRMDPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCC------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            22333333322222      2345678999999999999999999999999997644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=338.80  Aligned_cols=253  Identities=21%  Similarity=0.226  Sum_probs=201.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|+.+ +|+.||+|++.+...    ..+.+.+|..++..++||||+++++++.+....|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            45677799999999999999976 789999999975322    2234788999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++|+|.+++...   +..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||++.....
T Consensus       141 E~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             cCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            999999999998432   34699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCceeeecccCCCCcccccccccc-----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc-
Q 048542          220 ENDFVSISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK-  293 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-  293 (373)
                      ... ......+||+.|+|||++.+.     .+.++.++|||||||++|||++|+.||.......        ....+.. 
T Consensus       215 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~  285 (412)
T 2vd5_A          215 DGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--------TYGKIVHY  285 (412)
T ss_dssp             TSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTH
T ss_pred             CCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhc
Confidence            332 222345799999999998642     2367889999999999999999999997654321        1111111 


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADR---PSMTKVLE  336 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---ps~~ell~  336 (373)
                      ......+   ..+..++..+.+|+.+||+ +|.+|   |+++|+++
T Consensus       286 ~~~~~~p---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          286 KEHLSLP---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ccCcCCC---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            0001111   1123456789999999999 99998   58999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.7e-43  Score=322.94  Aligned_cols=255  Identities=22%  Similarity=0.314  Sum_probs=200.1

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---------CHHHHHHHHHHhcccCCCceeeEeeEee
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---------SAEEFINEVSTIGRIHHVNVVQLLGFCS  130 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~ni~~~~~~~~  130 (373)
                      ......|.+.+.||+|+||.||+|... +++.||||++.....         ....+.+|+.+++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            445678899999999999999999876 678999999875432         1235789999999999999999999987


Q ss_pred             eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc---eE
Q 048542          131 EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PK  207 (373)
Q Consensus       131 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~---~k  207 (373)
                      .+. .++||||+++++|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.   +|
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             CCc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence            654 899999999999998883    346799999999999999999999998   9999999999999986654   99


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW  286 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~  286 (373)
                      |+|||++.......   ......||+.|+|||.+.+ ....++.++|||||||++|+|++|..||........       
T Consensus       158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------  227 (322)
T 2ycf_A          158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------  227 (322)
T ss_dssp             ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------
T ss_pred             EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------
Confidence            99999998664322   1223458999999999743 124678899999999999999999999975443211       


Q ss_pred             HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          287 VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....+..+...   ........++..+.+|+.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 LKDQITSGKYN---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHHHTCCC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCccc---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11222222111   112222345678999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.6e-44  Score=319.76  Aligned_cols=249  Identities=30%  Similarity=0.459  Sum_probs=196.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEEeccC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEYMP  143 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~  143 (373)
                      ..|++.+.||+|+||.||+|..+ |+.||+|+++... ..+.+.+|+.+++.++||||+++++++.+ ....++||||++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            46788899999999999999876 8899999997643 55788999999999999999999998754 457899999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.......  
T Consensus        99 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  171 (278)
T 1byg_A           99 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  171 (278)
T ss_dssp             TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence            999999884321  22378899999999999999999998   99999999999999999999999999987543322  


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                         ....+++.|+|||.+.+.  .++.++||||||+++|+|++ |..||.......        ....+..+......  
T Consensus       172 ---~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~--  236 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMDAP--  236 (278)
T ss_dssp             -------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCCCC--
T ss_pred             ---cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCCCCc--
Confidence               233578899999998764  78889999999999999998 999987543221        22333333222221  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          ..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       237 ----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          237 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                23456789999999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-43  Score=326.47  Aligned_cols=262  Identities=23%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+|++.+.||+|+||.||+|... +|+.||+|++.......   +.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            36778899999999999999976 68899999987654433   557899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.++..    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          105 FVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             CCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999998887752    245699999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------hHHHHHHHhc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------PSWVYDQLNK  293 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~  293 (373)
                      ..  ......||+.|+|||.+.+. ..++.++|||||||++|+|++|..||............       ..........
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             cc--ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            22  22345689999999998653 36788999999999999999999999765432110000       0000000000


Q ss_pred             -----CC-CcccC---ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 -----GG-DLELQ---NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 -----~~-~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           +. .....   ........++..+.+|+.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00 01111   111122245678999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9.8e-44  Score=352.94  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=199.9

Q ss_pred             cccCCCCcEEEEEEEEc---CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +.||+|+||.||+|.+.   ++..||||+++....   ..+++.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   457899999986433   34789999999999999999999999965 558899999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc-
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF-  223 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  223 (373)
                      |+|.+++.    .+..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......... 
T Consensus       454 g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            99999983    345689999999999999999999998   9999999999999999999999999999876543322 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......+|+.|+|||++.+.  .++.++|||||||++|+|++ |..||......        .+...+..+.....+  
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p--  594 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGCP--  594 (635)
T ss_dssp             --------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC--
T ss_pred             ccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            122334577899999999764  78999999999999999998 99999765432        244445554433332  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          ..++..+.+|+.+||+.||++|||++++++.|+..
T Consensus       595 ----~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          595 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                23456899999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8e-43  Score=314.07  Aligned_cols=244  Identities=20%  Similarity=0.318  Sum_probs=201.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|... ++..||+|++....    .....+.+|+.+++.++||||+++++++.+....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35778899999999999999976 67789999986532    23467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999988843    34689999999999999999999998   999999999999999999999999999875543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..    .....|++.|+|||.+.+.  .++.++||||||+++|+|++|..||.......        ....+.... .. 
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~-~~-  230 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--------THRRIVNVD-LK-  230 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-CC-
T ss_pred             cc----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--------HHHHHhccc-cC-
Confidence            22    2345689999999998764  67889999999999999999999997543211        112222211 11 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           .+..++..+.+++.+||+.||.+|||++++++
T Consensus       231 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 -----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                 11234567899999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.6e-43  Score=322.63  Aligned_cols=251  Identities=23%  Similarity=0.324  Sum_probs=204.6

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..+|.+.+.||+|+||.||++.+. +++.+|+|++.....    ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            346778899999999999999976 578899999875432    236788999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++++|.+++.    ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++....
T Consensus       120 ~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999988873    235689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  ......||..|+|||.+.+.  .++.++||||||+++|+|++|..||.......        ....+..... .
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~-~  259 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNEY-S  259 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHTCC-C
T ss_pred             cCcc--cccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHhcCCC-C
Confidence            3322  12345699999999998764  67889999999999999999999997543211        1122222211 1


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhc
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEG  340 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~  340 (373)
                      .      +..++..+.+|+.+||+.||++|||++|+++  .+.+
T Consensus       260 ~------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          260 I------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             C------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             C------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            1      1233567899999999999999999999987  4444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=314.94  Aligned_cols=256  Identities=22%  Similarity=0.264  Sum_probs=202.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-----cCHHHHHHHHHHhcccCCCceeeEeeEe--eeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-----FSAEEFINEVSTIGRIHHVNVVQLLGFC--SEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~ni~~~~~~~--~~~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|... ++..||+|++....     ...+.+.+|+.+++.++||||+++++++  .+....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            35778899999999999999975 68899999987542     2346789999999999999999999998  4456789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||++++ |.+++...  ....+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        85 lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            999999876 65555332  245689999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ..............||+.|+|||.+.+.....+.++||||||+++|+|++|..||......        .....+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKGSY  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcCCC
Confidence            6543333334456799999999998764334577999999999999999999999754321        12233333221


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  341 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~  341 (373)
                      . .      +..++..+.+++.+||+.||.+|||++++++  .+...
T Consensus       231 ~-~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          231 A-I------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             C-C------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             C-C------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            1 1      1223567899999999999999999999996  45543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=334.75  Aligned_cols=255  Identities=22%  Similarity=0.259  Sum_probs=202.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEE----cCCceeEEEEeccCc-----cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQL----QTGGLIAVKMLENSK-----FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~  134 (373)
                      ..|++.+.||+|+||.||+|+.    .+++.||||+++...     ...+.+.+|+.+++.+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4678889999999999999987    368899999987532     2335667899999999 69999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999998843    34689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ......... ......||+.|+|||.+.+....++.++|||||||++|+|++|..||.........    ..........
T Consensus       207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~~~~  281 (355)
T 1vzo_A          207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ----AEISRRILKS  281 (355)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH----HHHHHHHHHC
T ss_pred             eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH----HHHHHHHhcc
Confidence            765332211 12345699999999999764345788999999999999999999999755432211    1111222211


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLEML  338 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~~L  338 (373)
                      ..       ..+..++..+.+|+.+||+.||.+||     |++|+++..
T Consensus       282 ~~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 EP-------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CC-------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11       11233456789999999999999999     999998743

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-43  Score=327.26  Aligned_cols=260  Identities=26%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++......      ...+.+|+.+++.++||||+++++++.+....+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            346788899999999999999976 6889999998754322      146789999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++ +|.+.+..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        89 lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999976 78777732   335688889999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ......  ......||+.|+|||.+.+. ..++.++|||||||++|+|++|..||........   + ............
T Consensus       162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~-~~i~~~~~~~~~  234 (346)
T 1ua2_A          162 FGSPNR--AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---L-TRIFETLGTPTE  234 (346)
T ss_dssp             TTSCCC--CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCCT
T ss_pred             ccCCcc--cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---H-HHHHHHcCCCCh
Confidence            543322  22345689999999998653 3578899999999999999999999875542110   0 001111100000


Q ss_pred             cccC-----------------ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          297 LELQ-----------------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       297 ~~~~-----------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                      ...+                 ........++..+.+|+.+||+.||.+|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000                 0011223445789999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2e-43  Score=329.40  Aligned_cols=253  Identities=18%  Similarity=0.168  Sum_probs=202.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEE------EcCCceeEEEEeccCccCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQ------LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~  134 (373)
                      ...|.+.+.||+|+||.||+|.      ..+++.||+|++...  ...++..|..+++.++   |+||+.+++++...+.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            3457778899999999999994      447889999999754  4566778888888776   8999999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-----------
Q 048542          135 RALVYEYMPNGSLDRHVFPKES-RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----------  202 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-----------  202 (373)
                      .++|||||++|+|.+++..... ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.           
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccc
Confidence            9999999999999999854322 346799999999999999999999998   9999999999999988           


Q ss_pred             CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc
Q 048542          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY  282 (373)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~  282 (373)
                      ++.+||+|||++................||+.|+|||++.+.  .++.++|||||||++|+|++|+.||.......... 
T Consensus       219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-  295 (365)
T 3e7e_A          219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP-  295 (365)
T ss_dssp             CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEE-
T ss_pred             cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCceee-
Confidence            899999999999755433333445567799999999999875  68999999999999999999999986443221100 


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHHhcCC
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADR-PSMTKVLEMLEGSI  342 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-ps~~ell~~L~~~~  342 (373)
                                 ..  .+...     ..+..+.+++..|++.+|.+| |+++++.+.|+..+
T Consensus       296 -----------~~--~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          296 -----------EG--LFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             -----------CS--CCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             -----------ch--hcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                       00  00000     113467789999999999999 68888888888754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=334.14  Aligned_cols=267  Identities=16%  Similarity=0.143  Sum_probs=204.5

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcC---------CceeEEEEeccCccCHHHHHHHHHHhcccCCCceee----------
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQT---------GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQ----------  124 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~----------  124 (373)
                      ...|++.+.||+|+||.||+|....         ++.||+|++...    +.+.+|+.+++.++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            4578888999999999999998763         789999998755    35779999999999999887          


Q ss_pred             -----EeeEeee-CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCe
Q 048542          125 -----LLGFCSE-GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNI  198 (373)
Q Consensus       125 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Ni  198 (373)
                           +++++.. +...++||||+ +++|.+++....  +..+++..+..++.|++.||.|||++   +++||||||+||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI  190 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI  190 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence                 5667665 77899999999 999999985331  35799999999999999999999998   999999999999


Q ss_pred             eeeCCC--ceEEeeccCcccCCCCCCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCC
Q 048542          199 LLDHNF--IPKVSDFGLAKFHPKENDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  271 (373)
Q Consensus       199 l~~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~  271 (373)
                      |++.++  .+||+|||++..........     ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999998  99999999997654322111     11334699999999998764  7889999999999999999999999


Q ss_pred             CCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 048542          272 NMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ  346 (373)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~  346 (373)
                      ........  .+...... ..... ..+.........++..+.+|+.+||+.||.+|||++++++.|+.+.+...
T Consensus       269 ~~~~~~~~--~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          269 TNCLPNTE--DIMKQKQK-FVDKP-GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGGTTCHH--HHHHHHHH-HHHSC-CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCCcCHH--HHHHHHHh-ccCCh-hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            75542211  01111111 11111 11111000011235679999999999999999999999999998765443

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.6e-43  Score=325.53  Aligned_cols=257  Identities=21%  Similarity=0.218  Sum_probs=190.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------e
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~  134 (373)
                      ..|++.+.||+|+||.||+|... +++.||||++......   ...+.+|+.+++.++||||+++++++....      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            35778899999999999999865 6889999999764333   356789999999999999999999987654      7


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++||||+++ +|.+.+.      ..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             eEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            8999999965 7777662      3488999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccc-------------
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKA-------------  281 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~-------------  281 (373)
                      .......   ......||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..........             
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  249 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  249 (371)
T ss_dssp             ------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            8654322   12345689999999999764  78899999999999999999999997654211000             


Q ss_pred             --cchHHHHHHHhcCCC------------cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          282 --YFPSWVYDQLNKGGD------------LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       282 --~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .+.............            ...+...+.....+..+.+|+.+||+.||.+|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence              000000011111000            0011122333455788999999999999999999999987

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.7e-43  Score=316.46  Aligned_cols=246  Identities=23%  Similarity=0.334  Sum_probs=203.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|++....  ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            34677899999999999999865 78899999987643  3457889999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +++++|.+++.     ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            99999999883     34689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      .  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|..||......        ............... 
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-  240 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLE-  240 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCC-
T ss_pred             c--ccCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCHH--------HHHHHhhcCCCCCCc-
Confidence            1  12345689999999998764  7788999999999999999999998754321        112222222222211 


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ..++..+.+|+.+||+.||.+|||++++++
T Consensus       241 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          241 -----GNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             -----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 233567899999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4e-43  Score=325.71  Aligned_cols=260  Identities=20%  Similarity=0.251  Sum_probs=197.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee--------C
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~  132 (373)
                      .+|++.+.||+|+||.||+|... +|+.||+|++......   ...+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            46888899999999999999975 7899999998654332   3577899999999999999999999876        3


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||+.   +++||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999975 66666532   235699999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCC--ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          213 LAKFHPKEND--FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       213 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ++........  ........||+.|+|||.+.+. ..++.++|||||||++|+|++|..||.........    ......
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~  244 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL----ALISQL  244 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH----HHHHHH
Confidence            9986543221  1223445689999999998654 35788999999999999999999999765422110    001110


Q ss_pred             HhcCCCccc----------------CccchhhHH-----HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKGGDLEL----------------QNVTEIESM-----IARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~~~~~~----------------~~~~~~~~~-----~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .........                .........     .+..+.+|+.+||+.||.+|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000000000                000011111     2456899999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.4e-43  Score=333.77  Aligned_cols=276  Identities=20%  Similarity=0.241  Sum_probs=208.4

Q ss_pred             hcCCCCCccChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC--------C
Q 048542           49 QQSWMPKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH--------H  119 (373)
Q Consensus        49 ~~~~~~~~~~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~--------h  119 (373)
                      +.......+..+++...+|++.+.||+|+||.||+|... +++.||||++.......+.+.+|+.+++.++        |
T Consensus        21 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~  100 (397)
T 1wak_A           21 YCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR  100 (397)
T ss_dssp             -CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred             CCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence            333444456666777788999999999999999999865 6889999999876555678889999999985        7


Q ss_pred             CceeeEeeEee----eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCC
Q 048542          120 VNVVQLLGFCS----EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKP  195 (373)
Q Consensus       120 ~ni~~~~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp  195 (373)
                      +||+++++++.    .....++||||+ +++|.+.+...  ....+++..+..++.|++.||+|||++  .+|+||||||
T Consensus       101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp  175 (397)
T 1wak_A          101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKP  175 (397)
T ss_dssp             GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSG
T ss_pred             ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCH
Confidence            88999999987    556889999999 55665555322  235699999999999999999999984  1899999999


Q ss_pred             CCeeeeCCC-------------------------------------------------ceEEeeccCcccCCCCCCceee
Q 048542          196 HNILLDHNF-------------------------------------------------IPKVSDFGLAKFHPKENDFVSI  226 (373)
Q Consensus       196 ~Nil~~~~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~  226 (373)
                      +|||++.++                                                 .+||+|||++......     .
T Consensus       176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~  250 (397)
T 1wak_A          176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----F  250 (397)
T ss_dssp             GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----S
T ss_pred             HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----C
Confidence            999998775                                                 7999999999865432     2


Q ss_pred             ecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHH--HHHHHh--------cCCC
Q 048542          227 SATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSW--VYDQLN--------KGGD  296 (373)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~--------~~~~  296 (373)
                      ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...............  ......        .+..
T Consensus       251 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  328 (397)
T 1wak_A          251 TEDIQTRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY  328 (397)
T ss_dssp             CSCCSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred             ccCCCCCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence            344689999999999775  6889999999999999999999999765543221110000  000000        0000


Q ss_pred             c-----------ccC------------ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 L-----------ELQ------------NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~-----------~~~------------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .           ...            .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0           000            001224566788999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3e-43  Score=328.12  Aligned_cols=257  Identities=22%  Similarity=0.260  Sum_probs=182.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeC------Ce
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEG------SK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~  134 (373)
                      .+|++.+.||+|+||.||+|... +|+.||||++......   ...+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            46778899999999999999865 7889999999764333   36778999999999999999999998654      56


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .++++|++ +++|.+++.     ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++
T Consensus       109 ~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             EEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            79999999 789988873     25699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch----------
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP----------  284 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~----------  284 (373)
                      ......     .....||..|+|||.+.+. ..++.++||||+||++|+|++|+.||...........+.          
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            764332     2345689999999998763 468889999999999999999999997654321000000          


Q ss_pred             ------HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 ------SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            .........................+..+.+|+.+||+.||.+|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence                  0000000000000000111111233567899999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-43  Score=332.24  Aligned_cols=261  Identities=19%  Similarity=0.200  Sum_probs=195.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee------------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------------  131 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------------  131 (373)
                      .+|++.+.||+|+||.||+|... +|+.||||++......   ..+|+.+++.++||||+++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            46788899999999999999864 7899999998754332   2479999999999999999999843            


Q ss_pred             --------------------------CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 048542          132 --------------------------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD  185 (373)
Q Consensus       132 --------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~  185 (373)
                                                ....++||||++ ++|.+.+......+..+++..+..++.|++.||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      334889999997 587777654334567799999999999999999999998  


Q ss_pred             CCeEecCcCCCCeeee-CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHH
Q 048542          186 VCILHFDIKPHNILLD-HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEM  264 (373)
Q Consensus       186 ~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~l  264 (373)
                       +|+||||||+||+++ .++.+||+|||++........   .....||..|+|||.+.+. ..++.++||||+||++|+|
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHH
Confidence             999999999999998 688999999999986644332   2344689999999998764 3588999999999999999


Q ss_pred             HcCCCCCCCCcCccccccch-------HHHHHHHhcC-CCcccCc------cchhhHHHHHHHHHHHHhhcCCCCCCCCC
Q 048542          265 AGGRRNSNMNATRSSKAYFP-------SWVYDQLNKG-GDLELQN------VTEIESMIARKLCMIGLWCIQVKAADRPS  330 (373)
Q Consensus       265 l~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps  330 (373)
                      ++|+.||...........+.       .......... ....++.      ....+..++..+.+|+.+||+.||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999997654321100000       0000000000 0000000      01122335667999999999999999999


Q ss_pred             HHHHHH
Q 048542          331 MTKVLE  336 (373)
Q Consensus       331 ~~ell~  336 (373)
                      +.|+++
T Consensus       316 ~~e~l~  321 (383)
T 3eb0_A          316 PYEAMA  321 (383)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6e-43  Score=323.99  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=204.1

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC------------------HHHHHHHHHHhcccCCCceeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS------------------AEEFINEVSTIGRIHHVNVVQL  125 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~e~~~l~~l~h~ni~~~  125 (373)
                      ...|++.+.||+|+||.||+|.. +++.||+|.+......                  .+.+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            34678889999999999999999 8999999998753221                  1788999999999999999999


Q ss_pred             eeEeeeCCeeEEEEeccCcCCcccccc----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeee
Q 048542          126 LGFCSEGSKRALVYEYMPNGSLDRHVF----PKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILL  200 (373)
Q Consensus       126 ~~~~~~~~~~~lv~e~~~~gsL~~~l~----~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~  200 (373)
                      ++++.+.+..++||||+++++|.+++.    ........+++..++.++.|++.||.|||+ .   +++||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            999999999999999999999999832    112225679999999999999999999998 7   99999999999999


Q ss_pred             eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCc-ccchHHHHHHHHHHHcCCCCCCCCcCccc
Q 048542          201 DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSC-KSDVYGFGMVLLEMAGGRRNSNMNATRSS  279 (373)
Q Consensus       201 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~~DvwslG~~l~~ll~g~~p~~~~~~~~~  279 (373)
                      +.++.+||+|||++......    ......|+..|+|||.+.+. ..++. ++|||||||++|+|++|..||......  
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            99999999999999865432    23456699999999998764 24445 899999999999999999999765431  


Q ss_pred             cccchHHHHHHHhcCCCcccCc-------------cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          280 KAYFPSWVYDQLNKGGDLELQN-------------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ......+..+.. ..+.             .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       259 -----~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -----VELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -----HHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 112222222211 1110             00111345678999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.9e-43  Score=317.93  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .....|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            34556788899999999999999876 68899999987643 34678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999988832   246789999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  ......|++.|+|||.+.+.  .++.++||||||+++|+|++|..||.......        ..............
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  246 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPMR--------AIFMIPTNPPPTFR  246 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCS
T ss_pred             cc--ccCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCCCcccC
Confidence            21  12345689999999998764  68889999999999999999999997543211        11112222211111


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .+..++..+.+|+.+||+.||.+|||++++++
T Consensus       247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                12234567899999999999999999999976

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-43  Score=329.62  Aligned_cols=258  Identities=22%  Similarity=0.317  Sum_probs=201.6

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ++....|++.+.||+|+||.||+|.+. ++..||+|++......  .+.+.+|+.+++.++||||+++++++.++...++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            344557788899999999999999976 7889999998765332  3678899999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+ +   +++||||||+||+++.++.+||+|||++..
T Consensus       109 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999998832    3468999999999999999999997 4   799999999999999999999999999864


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------------
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------------  283 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------------  283 (373)
                      ....    ......||+.|+|||.+.+.  .++.++|||||||++|+|++|+.||............             
T Consensus       182 ~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          182 LIDS----MANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             HHHH----C----CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             cccc----cccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            4221    12334699999999999764  7889999999999999999999999754422110000             


Q ss_pred             ---------------------hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 ---------------------PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                           .................     ...++..+.+|+.+||+.||.+|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP-----SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCC-----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC-----cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                                 00000011111111110     1124567999999999999999999999976

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.8e-43  Score=316.10  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .+|.+.+.||+|+||.||+|... +++.+|+|++.....    ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            45777899999999999999976 678899999875432    2367889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++.    ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           95 ELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             ECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999988773    235689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...  ......||+.|+|||.+.+.  .++.++||||||+++|+|++|..||.......        ......... ...
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~-~~~  234 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--------TYLRIKKNE-YSI  234 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTC-CCC
T ss_pred             Ccc--ccccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhhcc-CCC
Confidence            222  12345689999999998764  67889999999999999999999997543211        112222221 111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            +..++..+.+++.+||+.||++|||++++++
T Consensus       235 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          235 ------PKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ------ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                  1234567899999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=326.15  Aligned_cols=260  Identities=22%  Similarity=0.261  Sum_probs=185.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccC-CCceeeEeeEee--------eC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIH-HVNVVQLLGFCS--------EG  132 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-h~ni~~~~~~~~--------~~  132 (373)
                      ..+|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            346788899999999999999975 788999998865433 3367889999999996 999999999983        34


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeeeCCCceEEee
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLDHNFIPKVSD  210 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~~~~~~kl~D  210 (373)
                      ...+++|||+. |+|.+++.... ....+++..++.++.|++.||.|||+.   +  ++||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            45789999995 68888774322 245699999999999999999999998   7  99999999999999999999999


Q ss_pred             ccCcccCCCCCCce----------eeecccCCCCccccccccc-ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc
Q 048542          211 FGLAKFHPKENDFV----------SISATRGTIGYIAPELISR-NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  279 (373)
Q Consensus       211 fg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~  279 (373)
                      ||++..........          ......||+.|+|||.+.. ....++.++|||||||++|+|++|..||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            99998665432211          1113458999999999832 12467889999999999999999999996543211 


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                                ...........      ...+..+.+|+.+||+.||.+|||++|+++.|+.+....
T Consensus       261 ----------~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 ----------IVNGKYSIPPH------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ---------------CCCCTT------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ----------hhcCcccCCcc------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                      01111111111      112345789999999999999999999999999875543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.8e-43  Score=326.76  Aligned_cols=262  Identities=19%  Similarity=0.219  Sum_probs=199.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~  136 (373)
                      .+|++.+.||+|+||.||+|... ++..||+|++......  ...+.+|+.+++.++||||+++++++...     ...+
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            36788899999999999999866 6788999999754332  26788999999999999999999998654     4689


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+. ++|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||+++.++.+||+|||++..
T Consensus       107 iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            9999996 58888773     24589999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH-------H--
Q 048542          217 HPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS-------W--  286 (373)
Q Consensus       217 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------~--  286 (373)
                      ........ ......||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||...........+..       .  
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            54332211 12344699999999987654 3578899999999999999999999976543221100000       0  


Q ss_pred             -------HHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          287 -------VYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       287 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                             ......................++..+.+|+.+||+.||++|||++|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   00000000000001111222334678999999999999999999999987

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.2e-43  Score=312.54  Aligned_cols=246  Identities=23%  Similarity=0.366  Sum_probs=194.8

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|.+.+.||+|+||.||+|.++ +|+.||+|++....    ...+.+.+|+..++.++||||+++++++......++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            35778899999999999999976 78999999986532    23467889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999998843    34689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...   .....|++.|+|||.+.+. ...+.++||||||+++|+|++|..||......        .....+..+... .
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~-~  230 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVFY-I  230 (276)
T ss_dssp             ----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC-C
T ss_pred             Ccc---eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCccc-C
Confidence            321   2334689999999998764 23367899999999999999999999754321        122223322211 1


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            +..++..+.+++.+||+.||.+|||++++++
T Consensus       231 ------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          231 ------PEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                  1223567899999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=9.7e-43  Score=325.49  Aligned_cols=256  Identities=21%  Similarity=0.292  Sum_probs=195.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCee-----
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR-----  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~-----  135 (373)
                      .+|.+.+.||+|+||.||+|.+. +|+.||+|++......   ...+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            35677899999999999999866 7889999999765433   36788999999999999999999999876654     


Q ss_pred             -EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          136 -ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       136 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                       ++||||+. ++|.+.+      +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus       122 ~~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CEEEEECCC-EEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             EEEEEcccc-ccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence             99999996 5887766      34489999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-----------
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-----------  283 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-----------  283 (373)
                      ......     .....||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||............           
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cccccC-----cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            755332     2345689999999998763 46888999999999999999999999765421100000           


Q ss_pred             -----hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 -----PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           .........................++..+.+|+.+||+.||++|||++|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                 00000000000011111111222344678999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.7e-42  Score=318.54  Aligned_cols=256  Identities=18%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeee--CCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e  140 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|+++..  ..+.+.+|+.+++.++ ||||+++++++.+  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            46788899999999999999864 7889999998743  4577899999999997 9999999999987  667899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  219 (373)
                      |+.+++|.+++       ..+++..+..++.|++.||+|||+.   +++||||||+|||++.++ .+||+|||++.....
T Consensus       114 ~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          114 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999998887       2388999999999999999999998   999999999999999766 899999999986654


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc------chHHHHHHHhc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------FPSWVYDQLNK  293 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~------~~~~~~~~~~~  293 (373)
                      ...   .....|+..|+|||.+.+. ..++.++|||||||++|+|++|..||...........      -.......+..
T Consensus       184 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            332   2345689999999998653 4688899999999999999999999965432211000      00000111111


Q ss_pred             CCC---------------cccC--ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGD---------------LELQ--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~---------------~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...               ....  .....+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100               0000  001112235678999999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=7.3e-43  Score=332.18  Aligned_cols=199  Identities=23%  Similarity=0.308  Sum_probs=171.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc------CCCceeeEeeEeeeCCeeE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI------HHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..+|++.+.||+|+||.||+|... +++.||||+++........+.+|+.+++.+      +|+||+++++++......+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            346788899999999999999866 688999999987655556778888888877      5779999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc--eEEeeccCc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI--PKVSDFGLA  214 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~  214 (373)
                      +||||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||++
T Consensus       176 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            9999995 68888874332  34589999999999999999999998   9999999999999998887  999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      .......     ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||....
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCcc-----cccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            7654322     245689999999999775  78999999999999999999999997654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.2e-43  Score=319.03  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=193.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee-----------
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-----------  131 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----------  131 (373)
                      ...|++.+.||+|+||.||+|... +++.||+|++.......+.+.+|+.+++.++||||+++++++.+           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            457888899999999999999975 78899999997655555788999999999999999999998754           


Q ss_pred             --CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          132 --GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       132 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                        ....++||||+++++|.+++..   .+..+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence              3567899999999999999843   234578899999999999999999998   99999999999999999999999


Q ss_pred             eccCcccCCCCCC------------ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCc
Q 048542          210 DFGLAKFHPKEND------------FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATR  277 (373)
Q Consensus       210 Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~  277 (373)
                      |||++........            ........||+.|+|||.+.+. +.++.++|||||||++|+|++   ||..... 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            9999986543211            1112345689999999998753 467889999999999999998   4432111 


Q ss_pred             cccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          278 SSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            .......+.... ...+  ...+...+..+.+++.+||+.||.+|||++++++
T Consensus       234 ------~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 ------RVNILKKLRSVS-IEFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ------HHHHHHHHHSTT-CCCC--TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHHhccccc-cccC--ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                  011122222211 1111  1222334567899999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.2e-43  Score=323.34  Aligned_cols=262  Identities=21%  Similarity=0.270  Sum_probs=197.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~  136 (373)
                      ..|++.+.||+|+||.||+|.+. +|+.||||.+......  ..++.+|+.+++.++||||+++++++...     ...+
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            45778899999999999999976 7889999999754332  35678999999999999999999988654     6789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+. ++|.+++.     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus        91 lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEECCCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEeccC-ccHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            9999996 58888773     24689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCce--------eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc------
Q 048542          217 HPKENDFV--------SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY------  282 (373)
Q Consensus       217 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~------  282 (373)
                      ........        ......||+.|+|||.+.+. ..++.++|||||||++|+|++|..||...........      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            54322111        12234689999999987543 4688899999999999999999999976542110000      


Q ss_pred             ----------c-hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 ----------F-PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 ----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                . .........................++..+.+|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                      0 00000000000000001111222345678999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=312.47  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=196.8

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      ..||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            48999999999999965 678999999876543 3477899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeeccCcccCCCCCCceeee
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSIS  227 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~  227 (373)
                      +++.... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++. ++.+||+|||++........  ...
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~  181 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTE  181 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------C
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--ccc
Confidence            9885432 234567889999999999999999998   9999999999999997 89999999999986543221  123


Q ss_pred             cccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhH
Q 048542          228 ATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES  307 (373)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (373)
                      ...|++.|+|||.+.+....++.++||||||+++|+|++|+.||.......      ..............      .+.
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~------~~~  249 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKVGMFKVHPE------IPE  249 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHHHHHCCCCC------CCT
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhhcccccccc------ccc
Confidence            456899999999987643347889999999999999999999986433211      11111111111111      123


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          308 MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       308 ~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .++..+.+++.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            34568899999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=323.00  Aligned_cols=266  Identities=24%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|++.+.||+|+||.||+|..+  ..+|+|++.....   ..+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            345678899999999999999876  3599999875432   22456789999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..   .+..+++..+..++.|++.||+|||+.   +++||||||+||+++ ++.+||+|||++......
T Consensus       110 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          110 LCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             cccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            9999999999843   235689999999999999999999998   999999999999998 679999999998754321


Q ss_pred             CC---ceeeecccCCCCcccccccccc-------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          221 ND---FVSISATRGTIGYIAPELISRN-------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       221 ~~---~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ..   ........|++.|+|||.+.+.       ...++.++||||||+++|+|++|..||......        .....
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~  254 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--------AIIWQ  254 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--------HHHHH
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHH
Confidence            11   1112334589999999998642       135788999999999999999999999754321        12223


Q ss_pred             HhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 048542          291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRP  351 (373)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~~~p  351 (373)
                      ...+.......     ..++..+.+++.+||+.||.+|||++++++.|+.+.+.......|
T Consensus       255 ~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~  310 (319)
T 2y4i_B          255 MGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP  310 (319)
T ss_dssp             HHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------
T ss_pred             hccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCC
Confidence            33333222221     123456899999999999999999999999999987765444444

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-43  Score=316.92  Aligned_cols=251  Identities=21%  Similarity=0.225  Sum_probs=202.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----------CHHHHHHHHHHhcccC-CCceeeEeeEeeeC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----------SAEEFINEVSTIGRIH-HVNVVQLLGFCSEG  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  132 (373)
                      ..|++.+.||+|+||.||+|..+ +++.||+|++.....          ..+.+.+|+.+++++. ||||+++++++...
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (298)
T 1phk_A           17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   96 (298)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence            46778899999999999999976 688999999875431          1256788999999995 99999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           97 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999998842    35689999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccc----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ++........   .....|++.|+|||.+.+.    ...++.++||||||+++|+|++|..||......        ...
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~  238 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LML  238 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHH
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HHH
Confidence            9986644332   2345689999999988531    235788999999999999999999999754321        122


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+..+.....   ......++..+.+|+.+||+.||.+|||++++++
T Consensus       239 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 RMIMSGNYQFG---SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHTCCCCC---TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHhcCCcccC---cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            22222221111   1111235668999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-44  Score=335.82  Aligned_cols=242  Identities=17%  Similarity=0.146  Sum_probs=184.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEE-cCCceeEEEEeccC----ccCHHHHHHHHH---HhcccCCCceeeEe-------eEee
Q 048542           66 TNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENS----KFSAEEFINEVS---TIGRIHHVNVVQLL-------GFCS  130 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~~~~~~~~e~~---~l~~l~h~ni~~~~-------~~~~  130 (373)
                      .|++.+.||+|+||.||+|.+ .+|+.||||++...    ....+.+.+|+.   .++.++||||++++       +++.
T Consensus        74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            456678999999999999996 47899999998743    223477889994   55555799999998       6655


Q ss_pred             eCC-----------------eeEEEEeccCcCCccccccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 048542          131 EGS-----------------KRALVYEYMPNGSLDRHVFPKES---RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILH  190 (373)
Q Consensus       131 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH  190 (373)
                      +.+                 ..+++|||+ +|+|.+++.....   ....+++..+..++.|++.||+|||++   +|+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            543                 278999999 6799998853211   112344588889999999999999998   9999


Q ss_pred             cCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccc---------cCCcCcccchHHHHHHH
Q 048542          191 FDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVL  261 (373)
Q Consensus       191 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslG~~l  261 (373)
                      |||||+|||++.++.+||+|||++.....     ......| +.|+|||.+.+.         ...++.++|||||||++
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            99999999999999999999999985332     2344567 999999998753         11578899999999999


Q ss_pred             HHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          262 LEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       262 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      |+|++|+.||............        ..           ....++..+.+|+.+||+.||.+|||+.++++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~--------~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWI--------FR-----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CCSGGG--------GS-----------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccchhhh--------hh-----------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999754432211100        00           00123567899999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.7e-43  Score=335.75  Aligned_cols=260  Identities=19%  Similarity=0.250  Sum_probs=204.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.++||+|+||.||+|.+. +++.||||++..... ..++.+|+.+++.++| +++..+..++......++||||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            45778899999999999999964 788999998765432 2457889999999976 56666677778888999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---eCCCceEEeeccCcccCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---DHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~  219 (373)
                       +++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        86 -g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           86 -GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             -CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence             9999998842   245699999999999999999999998   99999999999999   5889999999999986654


Q ss_pred             CCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          220 ENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       220 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ....     .......||..|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+.........  
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--  234 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA--  234 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH--
T ss_pred             CccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc--
Confidence            3321     112255699999999999775  7889999999999999999999999865443211111111111111  


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                           .........++..+.+|+.+||+.||++||++++|++.|+.+
T Consensus       235 -----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          235 -----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             -----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             -----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                 011122234467899999999999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.1e-43  Score=349.02  Aligned_cols=247  Identities=23%  Similarity=0.270  Sum_probs=203.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ...|++.+.||+|+||.||+|..+ +++.||||+++..    ....+.+..|..++..+ +||||+.+++++.+....|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            345777899999999999999976 6788999998753    22346778899999988 79999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       420 V~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999988842    35699999999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      .....  .....+||+.|+|||++.+.  .++.++|||||||++|||++|..||......        .....+.... .
T Consensus       493 ~~~~~--~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~-~  559 (674)
T 3pfq_A          493 IWDGV--TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN-V  559 (674)
T ss_dssp             CCTTC--CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHSSC-C
T ss_pred             ccCCc--ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhCC-C
Confidence            32221  23456799999999999765  7899999999999999999999999765431        1223333222 1


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSM-----TKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~-----~ell~  336 (373)
                            .++..++..+.+|+.+||+.||.+||++     +|+++
T Consensus       560 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          560 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                  1223456789999999999999999997     67754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-43  Score=329.29  Aligned_cols=265  Identities=20%  Similarity=0.275  Sum_probs=182.4

Q ss_pred             Hhhh-hcccCCCCcEEEEEEEEc---CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEee--eCCeeEEEE
Q 048542           66 TNHF-THKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCS--EGSKRALVY  139 (373)
Q Consensus        66 ~~~~-~~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~lv~  139 (373)
                      .|++ .++||+|+||.||+|.++   ++..||+|++...... ..+.+|+.+++.++||||+++++++.  .....++||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4455 468999999999999965   5789999999765433 56789999999999999999999995  467899999


Q ss_pred             eccCcCCccccccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee----eCCCceEEee
Q 048542          140 EYMPNGSLDRHVFPKE-----SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL----DHNFIPKVSD  210 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~----~~~~~~kl~D  210 (373)
                      ||+.+ +|.+++....     .....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99964 7766663211     1233599999999999999999999998   99999999999999    6778999999


Q ss_pred             ccCcccCCCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc--cccchHHH
Q 048542          211 FGLAKFHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS--KAYFPSWV  287 (373)
Q Consensus       211 fg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~  287 (373)
                      ||++........ ........||+.|+|||++.+. ..++.++|||||||++|+|++|..||........  ........
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999986643221 1223445799999999998764 3588999999999999999999999975543210  00111111


Q ss_pred             HHHHhcCCCcc---cCcc--------------------chhhH-------HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 YDQLNKGGDLE---LQNV--------------------TEIES-------MIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ~~~~~~~~~~~---~~~~--------------------~~~~~-------~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .........+.   ....                    .....       ..+..+.+|+.+||+.||.+|||++|+++
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111100000   0000                    00000       01457889999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.5e-43  Score=325.26  Aligned_cols=266  Identities=24%  Similarity=0.249  Sum_probs=188.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCe-------
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSK-------  134 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-------  134 (373)
                      ....|++.+.||+|+||.||+|.+. +|..||||++...........+++..+..++||||+++++++.....       
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            3456788899999999999999975 78899999987665555667788888999999999999999865332       


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEecCcCCCCeeeeC-CCceEEeec
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH--NGCDVCILHFDIKPHNILLDH-NFIPKVSDF  211 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH--~~~~~~ivH~dikp~Nil~~~-~~~~kl~Df  211 (373)
                      .++||||+++ +|...+.........+++..+..++.|++.||.|||  +.   +++||||||+|||++. ++.+||+||
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeC
Confidence            7899999976 544444322234567899999999999999999999  77   9999999999999996 899999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------h
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------P  284 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------~  284 (373)
                      |++........   .....||+.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+       +
T Consensus       177 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          177 GSAKKLSPSEP---NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             TTCBCCCTTSC---CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCceecCCCCC---cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99986654332   2345689999999998654 35789999999999999999999999765432110000       0


Q ss_pred             HHHHHHHhcC-CCcccCcc---------chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          285 SWVYDQLNKG-GDLELQNV---------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       285 ~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......... ........         .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000111000 00000000         0011124678999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-42  Score=314.05  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=187.8

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ...|++.+.||+|+||.||+|... +|+.||+|++.......   +.+.++...++.++||||+++++++.++...++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            346788899999999999999975 78899999997653332   23445555688889999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||++ |+|.+++......+..+++..+..++.|++.||+|||++  .+++||||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9996 488777644334467799999999999999999999973  2899999999999999999999999999976543


Q ss_pred             CCCceeeecccCCCCccccccccc--ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          220 ENDFVSISATRGTIGYIAPELISR--NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ...   .....||+.|+|||.+..  ....++.++||||+||++|+|++|..||.......      .......... ..
T Consensus       163 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~~  232 (290)
T 3fme_A          163 DVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEP-SP  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSC-CC
T ss_pred             ccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccC-CC
Confidence            321   233469999999999632  12467889999999999999999999997543211      1122222222 11


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....     ..++..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 QLPA-----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCT-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             Cccc-----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111     234567899999999999999999999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=318.36  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeee------CCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE------GSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~------~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.+ +||||+++++++..      ....+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            35678899999999999999975 788999999987766678899999999999 79999999999976      46789


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++..
T Consensus       104 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  178 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  178 (326)
T ss_dssp             EEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred             EEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence            999999999999988543  235689999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCCCceeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......  ......|++.|+|||.+.+.   ...++.++|||||||++|+|++|..||.......        .......
T Consensus       179 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~  248 (326)
T 2x7f_A          179 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPR  248 (326)
T ss_dssp             --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHH
T ss_pred             cCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhc
Confidence            543221  12334689999999998631   2467889999999999999999999996543211        1111112


Q ss_pred             CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......     ...++..+.+|+.+||+.||.+|||++++++
T Consensus       249 ~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCCCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CccccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111     1223567899999999999999999999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-43  Score=320.73  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=185.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc--cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||.||+|... +++.||+|.+....  ...+++.+|+.+++.++||||+++++++......++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            45778899999999999999854 78899999887543  2346788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          142 MPNGSLDRHVFPK----ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       142 ~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +++++|.+++...    ......+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            9999999888431    12345689999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCc---eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          218 PKENDF---VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       218 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ......   .......||+.|+|||.+.+. ..++.++||||||+++|+|++|..||.......       ........ 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~-  242 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQN-  242 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTS-
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhcc-
Confidence            433211   112344689999999998653 357889999999999999999999997654321       11111111 


Q ss_pred             CCcccCc---cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          295 GDLELQN---VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       295 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .......   .......++..+.+|+.+||+.||.+|||++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1111100   01111234567899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6e-44  Score=333.73  Aligned_cols=252  Identities=10%  Similarity=0.015  Sum_probs=178.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhccc--CCCceeeEe-------eEeeeC
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRI--HHVNVVQLL-------GFCSEG  132 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l--~h~ni~~~~-------~~~~~~  132 (373)
                      |++.+.||+|+||.||+|.+. +|+.||+|++......    .+.+.+|+.+++.+  +||||++++       +++...
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            667799999999999999976 7889999999875542    35567775544444  699988754       444332


Q ss_pred             -----------------CeeEEEEeccCcCCccccccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCeE
Q 048542          133 -----------------SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKL------HEVALGTARGIEYLHNGCDVCIL  189 (373)
Q Consensus       133 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~al~~LH~~~~~~iv  189 (373)
                                       ...++||||++ |+|.+++...   +..+.+..+      ..++.|++.||+|||++   +|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence                             33799999998 8999998543   123344445      67789999999999998   999


Q ss_pred             ecCcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC
Q 048542          190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR  269 (373)
Q Consensus       190 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~  269 (373)
                      ||||||+|||++.++.+||+|||++......     .....+|+.|+|||.+.+....++.++|||||||++|+|++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865421     12445779999999997632478899999999999999999999


Q ss_pred             CCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          270 NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       270 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ||.............. .. ..........+    ....++..+.+|+.+||+.||++|||+.++++
T Consensus       292 Pf~~~~~~~~~~~~~~-~~-~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRP-SL-RVPGTDSLAFG----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBC-CT-TSCCCCSCCCT----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhh-hh-hhccccccchh----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9986643221110000 00 00000011111    11234678999999999999999999999864

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.9e-43  Score=315.84  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=195.9

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc--CCc--eeEEEEeccCc----cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ--TGG--LIAVKMLENSK----FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...|++.+.||+|+||.||+|.+.  +++  .||+|+++...    ...+.+.+|+.+++.++||||+++++++..+. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            346788899999999999999854  233  58999887542    22367889999999999999999999997754 8


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            8999999999999988432   34588999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhc
Q 048542          216 FHPKENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       216 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      ......... ......+|..|+|||.+.+.  .++.++||||||+++|+|++ |..||......       . .......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~  239 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------Q-ILHKIDK  239 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHT
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-------H-HHHHHHc
Confidence            765443322 12334577889999998764  67889999999999999999 99998754321       1 2222222


Q ss_pred             -CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          294 -GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       294 -~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                       ......      +..++..+.+++.+||+.||.+|||+.++++.|+...+
T Consensus       240 ~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          240 EGERLPR------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             SCCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCCCCC------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence             211111      12345689999999999999999999999999997643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-42  Score=313.04  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=204.3

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc---cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK---FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      .....+|++.+.||+|+||.||+|... +++.||+|++....   ...+.+.+|+.+++.++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            445678899999999999999999976 78899999986533   34578899999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC---CceEEeeccC
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN---FIPKVSDFGL  213 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~---~~~kl~Dfg~  213 (373)
                      +||||+++++|.+.+..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999888742    34689999999999999999999998   99999999999999754   4799999999


Q ss_pred             cccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc
Q 048542          214 AKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK  293 (373)
Q Consensus       214 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
                      +........   .....|++.|+|||.+.+   .++.++||||||+++|+|++|..||......        .....+..
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~  236 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVET  236 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc
Confidence            986544322   123358889999999864   5788999999999999999999999764321        12222333


Q ss_pred             CCC-cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 GGD-LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +.. ...+    ....++..+.+++.+||+.||++|||++++++
T Consensus       237 ~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 GKYAFDLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCCCCCSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            221 1111    11234667899999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-43  Score=329.54  Aligned_cols=261  Identities=21%  Similarity=0.222  Sum_probs=193.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC------eeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS------KRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~lv  138 (373)
                      .+|.+.+.||+|+||.||+|.+..++.+|+|++......   ..+|+.+++.++||||+++++++....      ..++|
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            467888999999999999999887777999987654322   236999999999999999999985433      37899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceEEeeccCcccC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVSDFGLAKFH  217 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~  217 (373)
                      |||++++.+ ..+.........+++..+..++.|++.||+|||+.   +|+||||||+|||++ .++.+||+|||++...
T Consensus       117 ~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          117 LEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999976443 33322222356799999999999999999999998   999999999999999 7999999999999866


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-------HHHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQ  290 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~  290 (373)
                      .....   .....||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||...........+.       ......
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP---NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTCC---CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCCC---CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            43332   2345689999999998654 458899999999999999999999998654321100000       000000


Q ss_pred             Hhc-CCCcccCc------cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNK-GGDLELQN------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~-~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ... .....++.      ....+..++..+.+|+.+||+.||.+|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            000 00000000      01112235678999999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=5.3e-43  Score=332.36  Aligned_cols=260  Identities=23%  Similarity=0.270  Sum_probs=192.4

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeC------CeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEG------SKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~------~~~~lv  138 (373)
                      .|++.+.||+|+||.||+|.+. +|+.||||++.....   ...+|+.+++.++||||+++++++...      ...++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            5777899999999999999976 689999999875432   234799999999999999999988431      236799


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-CceEEeeccCcccC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFH  217 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~  217 (373)
                      |||+++ ++.+.+.........+++..+..++.|++.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999975 56555533223456799999999999999999999998   99999999999999955 67899999999865


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccch-------HHHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP-------SWVYDQ  290 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~~~~~~  290 (373)
                      .....   .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||........-..+.       ......
T Consensus       208 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          208 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CTTCC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCCC---ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            43322   2235689999999998653 368889999999999999999999997654221000000       000000


Q ss_pred             HhcC-CCcccCcc--c----hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNKG-GDLELQNV--T----EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~~-~~~~~~~~--~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .... ....++..  .    ..+..++..+.+|+.+||+.||.+|||+.|+++
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            1000 00111110  0    111234578999999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.8e-43  Score=325.94  Aligned_cols=261  Identities=19%  Similarity=0.211  Sum_probs=191.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC------------HHHHHHHHHHhcccCCCceeeEeeEeee-
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS------------AEEFINEVSTIGRIHHVNVVQLLGFCSE-  131 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~h~ni~~~~~~~~~-  131 (373)
                      ..|.+.+.||+|+||.||+|...+|..||||++......            .+.+.+|+.+++.++||||+++++++.. 
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            456778999999999999999888999999998653221            2678999999999999999999999843 


Q ss_pred             ----CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceE
Q 048542          132 ----GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPK  207 (373)
Q Consensus       132 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~k  207 (373)
                          ....++||||++ |+|.+.+.   ..+..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIH---DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEE
Confidence                346899999997 57777774   2345799999999999999999999998   999999999999999999999


Q ss_pred             EeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc----
Q 048542          208 VSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF----  283 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~----  283 (373)
                      |+|||++.......   ......||+.|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+    
T Consensus       175 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  250 (362)
T 3pg1_A          175 ICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV  250 (362)
T ss_dssp             ECCTTC------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEecCccccccccc---ccceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence            99999997543322   12345689999999998763 36888999999999999999999999765421100000    


Q ss_pred             -----hH-------HHHHHHhcCC-CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 -----PS-------WVYDQLNKGG-DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 -----~~-------~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ..       .......... ..............+..+.+|+.+||+.||.+|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                 00       0000000000 00011111222344667999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.8e-42  Score=313.39  Aligned_cols=253  Identities=20%  Similarity=0.289  Sum_probs=194.9

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccC--CCceeeEeeEeeeCCeeEE
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIH--HVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~~~l  137 (373)
                      ....|++.+.||+|+||.||++...+++.||+|++......   .+.+.+|+.+++.++  ||||+++++++......++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34467888999999999999999888999999999765433   367889999999997  5999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      +|| +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||++++ +.+||+|||++...
T Consensus       106 v~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence            999 558899988842    35689999999999999999999998   9999999999999975 89999999999866


Q ss_pred             CCCCCceeeecccCCCCcccccccccc---------cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRN---------FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      .............|++.|+|||.+.+.         ...++.++||||||+++|+|++|..||.......      ....
T Consensus       177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~  250 (313)
T 3cek_A          177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLH  250 (313)
T ss_dssp             -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHH
T ss_pred             cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHH
Confidence            543332223345689999999998641         1367889999999999999999999996543211      1112


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...........+.      ..+..+.+++.+||+.||.+|||++|+++
T Consensus       251 ~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          251 AIIDPNHEIEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHCTTSCCCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhcccccCCcc------cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            2222222222221      12457899999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.5e-42  Score=318.89  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=193.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCe------e
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSK------R  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~------~  135 (373)
                      +|.+.+.||+|+||.||+|.+. +|+.||||++......   ...+.+|+.+++.++||||+++++++.....      .
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  104 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  104 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence            5677899999999999999975 7889999999764433   3578899999999999999999999977654      4


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+. ++|.+.+      ...+++..+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       105 ~lv~e~~~-~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          105 YLVMPFMQ-TDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             EEEEECCS-EEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEecccc-CCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            99999996 5887776      23589999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc------------
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF------------  283 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~------------  283 (373)
                      .....     .....||+.|+|||.+.+. ..++.++|||||||++|+|++|..||...........+            
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            64322     2345689999999998653 46788999999999999999999999754421100000            


Q ss_pred             ----hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 ----PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .........................++..+.+|+.+||+.||++|||++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                00000000000000001111222345678999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3e-42  Score=322.22  Aligned_cols=266  Identities=18%  Similarity=0.286  Sum_probs=200.7

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-----------CCceeeEeeEee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCS  130 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~  130 (373)
                      ...+|++.+.||+|+||.||+|... +++.||||++.......+.+.+|+.+++.++           ||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3457888999999999999999965 7889999999876656677889999999886           889999999987


Q ss_pred             eCC----eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-----
Q 048542          131 EGS----KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-----  201 (373)
Q Consensus       131 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-----  201 (373)
                      ...    ..+++||++ +++|.+++....  ...+++..+..++.|++.||+|||++  .+++||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence            644    789999999 889998885432  34589999999999999999999983  2899999999999995     


Q ss_pred             -CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc
Q 048542          202 -HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK  280 (373)
Q Consensus       202 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~  280 (373)
                       ..+.+||+|||++......     .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||.........
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence             3447999999999865432     2334689999999999765  6889999999999999999999999865432211


Q ss_pred             ccchHHHHHHHhc-CC--------------------------Cccc-------CccchhhHHHHHHHHHHHHhhcCCCCC
Q 048542          281 AYFPSWVYDQLNK-GG--------------------------DLEL-------QNVTEIESMIARKLCMIGLWCIQVKAA  326 (373)
Q Consensus       281 ~~~~~~~~~~~~~-~~--------------------------~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dp~  326 (373)
                      ... ......... +.                          ....       ......+..++..+.+|+.+||+.||.
T Consensus       245 ~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          245 KDD-DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             CHH-HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             ChH-HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            100 000000000 00                          0000       000123356788999999999999999


Q ss_pred             CCCCHHHHHH--HHhcC
Q 048542          327 DRPSMTKVLE--MLEGS  341 (373)
Q Consensus       327 ~Rps~~ell~--~L~~~  341 (373)
                      +|||++|+++  .+.+.
T Consensus       324 ~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          324 KRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             TCBCHHHHHTCGGGTTC
T ss_pred             ccCCHHHHhhChhhhcc
Confidence            9999999987  45544

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.1e-43  Score=321.84  Aligned_cols=263  Identities=22%  Similarity=0.324  Sum_probs=202.2

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEE-c-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCc------eeeEeeEeeeC
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQL-Q-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLGFCSEG  132 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~-~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~~~~  132 (373)
                      ++...+|++.+.||+|+||.||+|.. . +++.||+|+++......+.+.+|+.+++.++|++      ++++++++...
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            34455788899999999999999986 3 6789999999876555577889999999987654      99999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC----------
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH----------  202 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~----------  202 (373)
                      ...++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +++||||||+||+++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            9999999999 88998888432  234688999999999999999999998   9999999999999987          


Q ss_pred             ---------CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCC
Q 048542          203 ---------NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNM  273 (373)
Q Consensus       203 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~  273 (373)
                               ++.+||+|||++.......     ....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||..
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                     6689999999998654322     345689999999999764  788999999999999999999999976


Q ss_pred             CcCcccccc-------chHHHHHHHhcC-----CCccc-----------------CccchhhHHHHHHHHHHHHhhcCCC
Q 048542          274 NATRSSKAY-------FPSWVYDQLNKG-----GDLEL-----------------QNVTEIESMIARKLCMIGLWCIQVK  324 (373)
Q Consensus       274 ~~~~~~~~~-------~~~~~~~~~~~~-----~~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~d  324 (373)
                      .........       .+..........     .....                 ..........+..+.+|+.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            543211000       000000000000     00000                 0000112245678999999999999


Q ss_pred             CCCCCCHHHHHH
Q 048542          325 AADRPSMTKVLE  336 (373)
Q Consensus       325 p~~Rps~~ell~  336 (373)
                      |.+|||++|+++
T Consensus       317 P~~Rpt~~ell~  328 (339)
T 1z57_A          317 PAKRITLREALK  328 (339)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             cccccCHHHHhc
Confidence            999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=8.9e-43  Score=316.41  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=197.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            46788899999999999999976 68899999987543 34578899999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++++|.+++..   ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        99 ~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           99 PGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999888743   235689999999999999999999998   99999999999999999999999999875321110 


Q ss_pred             ceeeecccCCCCccccccccc---ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          223 FVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                       .......||+.|+|||.+..   ....++.++||||||+++|+|++|..||......       . .............
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~  242 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------R-VLLKIAKSDPPTL  242 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSCCCCC
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------H-HHHHHhccCCccc
Confidence             01123458999999998842   1246788999999999999999999998754321       1 1112222221111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .    .+..++..+.+++.+||+.||.+|||++++++
T Consensus       243 ~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 L----TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             S----SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C----CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1    12334567899999999999999999999876

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=317.18  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=191.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEee------------
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCS------------  130 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~------------  130 (373)
                      .+|++.+.||+|+||.||+|... +++.||+|.+..... ..+++.+|+.+++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            45778899999999999999976 588999999875443 3367889999999999999999999873            


Q ss_pred             --eCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceE
Q 048542          131 --EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPK  207 (373)
Q Consensus       131 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~k  207 (373)
                        +....++||||++ |+|.+++.     ...+++..+..++.|++.||+|||++   +++||||||+||+++ .++.+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence              4467899999997 69988873     35689999999999999999999998   999999999999998 567999


Q ss_pred             EeeccCcccCCCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc---
Q 048542          208 VSDFGLAKFHPKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF---  283 (373)
Q Consensus       208 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~---  283 (373)
                      |+|||++......... .......+|..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+   
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999865432111 112344578999999988653 46788999999999999999999999765421100000   


Q ss_pred             ----hHHHHHHHhc--------CCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          284 ----PSWVYDQLNK--------GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       284 ----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ..........        ...............++..+.+|+.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                0000000000        0000001111222345678999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.5e-42  Score=342.25  Aligned_cols=257  Identities=24%  Similarity=0.354  Sum_probs=203.4

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      +....|++.+.||+|+||.||+|.+..    +..||+|.++.....  .+.+.+|+.+++.++||||+++++++.+ +..
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~  465 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV  465 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence            334567788999999999999998652    346999998764332  3678999999999999999999999854 568


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ++||||+++|+|.+++..   .+..+++..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999998842   235689999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ........ ......+|+.|+|||.+.+.  .++.++|||||||++|+|++ |..||......        .....+..+
T Consensus       540 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~  608 (656)
T 2j0j_A          540 YMEDSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENG  608 (656)
T ss_dssp             SCCC-----------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHT
T ss_pred             ecCCCcce-eccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcC
Confidence            66443221 22334577899999999764  78899999999999999997 88898754321        122333333


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      .....+      ..++..+.+|+.+||+.||.+|||+.++++.|+.++
T Consensus       609 ~~~~~~------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ERLPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCC------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            322222      234568899999999999999999999999998753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-41  Score=324.62  Aligned_cols=253  Identities=21%  Similarity=0.218  Sum_probs=185.9

Q ss_pred             hhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           68 HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      ...+.||+|+||+||.+...+|+.||||++....  .+.+.+|+.+++.+ +||||+++++++.++...++|||||. |+
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            3457899999999988777789999999986542  35678899999876 89999999999999999999999995 69


Q ss_pred             ccccccCCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC-------------CceEEee
Q 048542          147 LDRHVFPKESRGQS---LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-------------FIPKVSD  210 (373)
Q Consensus       147 L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~-------------~~~kl~D  210 (373)
                      |.+++.........   ..+..+..++.|++.||+|||+.   +|+||||||+|||++.+             +.+||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            99988543221111   12334578999999999999998   99999999999999754             4899999


Q ss_pred             ccCcccCCCCCCce--eeecccCCCCcccccccccc-----cCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccccc
Q 048542          211 FGLAKFHPKENDFV--SISATRGTIGYIAPELISRN-----FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAY  282 (373)
Q Consensus       211 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~  282 (373)
                      ||++..........  ......||+.|+|||++.+.     ...++.++|||||||++|+|++ |..||.......    
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----  247 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----  247 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----
Confidence            99998765433211  12345699999999998652     2467889999999999999999 899986543211    


Q ss_pred             chHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 FPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                           ............. .......++..+.+|+.+||+.||.+|||+.++++
T Consensus       248 -----~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 -----SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -----HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                 1111111111111 11113456788999999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.4e-42  Score=318.63  Aligned_cols=266  Identities=20%  Similarity=0.275  Sum_probs=201.1

Q ss_pred             ChhHHHHHHhhhhcccCCCCcEEEEEEEEc-CC-ceeEEEEeccCccCHHHHHHHHHHhcccCCCc------eeeEeeEe
Q 048542           58 SYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TG-GLIAVKMLENSKFSAEEFINEVSTIGRIHHVN------VVQLLGFC  129 (373)
Q Consensus        58 ~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n------i~~~~~~~  129 (373)
                      ..++.....|++.+.||+|+||.||+|... ++ ..||+|+++......+.+.+|+.+++.++|++      ++.+++++
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            344445667889999999999999999875 44 68999999876555677889999999997665      89999999


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeee---------
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILL---------  200 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~---------  200 (373)
                      ......++||||+ ++++.+.+...  ....+++..+..++.|++.||+|||++   +|+||||||+|||+         
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccc
Confidence            9999999999999 55666666332  235689999999999999999999998   99999999999999         


Q ss_pred             ----------eCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCC
Q 048542          201 ----------DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN  270 (373)
Q Consensus       201 ----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p  270 (373)
                                +.++.+||+|||++.......     ....||+.|+|||++.+.  .++.++|||||||++|+|++|..|
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCC
Confidence                      678899999999998654322     345699999999999764  788999999999999999999999


Q ss_pred             CCCCcCcccccc-------chHHHHHHHhcCC-----CcccCc-----------------cchhhHHHHHHHHHHHHhhc
Q 048542          271 SNMNATRSSKAY-------FPSWVYDQLNKGG-----DLELQN-----------------VTEIESMIARKLCMIGLWCI  321 (373)
Q Consensus       271 ~~~~~~~~~~~~-------~~~~~~~~~~~~~-----~~~~~~-----------------~~~~~~~~~~~l~~li~~cl  321 (373)
                      |...........       .+...........     ......                 ........+..+.+|+.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            976543211000       0000000000000     000000                 00011234568999999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 048542          322 QVKAADRPSMTKVLE  336 (373)
Q Consensus       322 ~~dp~~Rps~~ell~  336 (373)
                      +.||.+|||++|+++
T Consensus       319 ~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          319 EFDPAQRITLAEALL  333 (355)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=317.64  Aligned_cols=244  Identities=24%  Similarity=0.333  Sum_probs=190.4

Q ss_pred             hHHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-------HHHHHHHHHHhccc----CCCceeeEee
Q 048542           60 PQIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-------AEEFINEVSTIGRI----HHVNVVQLLG  127 (373)
Q Consensus        60 ~~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l----~h~ni~~~~~  127 (373)
                      .+.....|++.+.||+|+||.||+|... +++.||+|++......       ...+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            4555678899999999999999999865 7889999999765432       23355789999888    8999999999


Q ss_pred             EeeeCCeeEEEEec-cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCc
Q 048542          128 FCSEGSKRALVYEY-MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFI  205 (373)
Q Consensus       128 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~  205 (373)
                      ++...+..++|||+ +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++ .++.
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence            99999999999999 789999998843    34689999999999999999999998   999999999999999 8899


Q ss_pred             eEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchH
Q 048542          206 PKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS  285 (373)
Q Consensus       206 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~  285 (373)
                      +||+|||++.......    .....|+..|+|||.+.+. ...+.++||||||+++|+|++|+.||.....         
T Consensus       179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------  244 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQE---------  244 (312)
T ss_dssp             EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             EEEEEcchhhhcccCc----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence            9999999998665432    2345689999999998764 2334589999999999999999999864211         


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          ......  .      .+..++..+.+++.+||+.||++|||++|+++
T Consensus       245 ----~~~~~~--~------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ----ILEAEL--H------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHTCC--C------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----Hhhhcc--C------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                111111  1      11234567899999999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-41  Score=312.44  Aligned_cols=251  Identities=19%  Similarity=0.248  Sum_probs=171.2

Q ss_pred             HHhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee----CCeeEEE
Q 048542           65 MTNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALV  138 (373)
Q Consensus        65 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv  138 (373)
                      ..|++. +.||+|+||.||+|.++ +++.||+|++.....   ...+....++.++||||+++++++..    ....++|
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  104 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII  104 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence            466775 46999999999999977 789999999876432   22233334566789999999999866    4558999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~  215 (373)
                      |||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.   ++.+||+|||++.
T Consensus       105 ~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          105 MECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999998533  235699999999999999999999998   9999999999999975   4559999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ......    .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||...........    .........
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~  249 (336)
T 3fhr_A          180 ETTQNA----LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRLGQ  249 (336)
T ss_dssp             EC--------------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             eccccc----cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhccc
Confidence            654322    2345689999999998654  778899999999999999999999975543221100    001111100


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ...  .......++..+.+|+.+||+.||.+|||++|+++
T Consensus       250 -~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 -YGF--PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CC--CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -ccc--CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             000  01111234668899999999999999999999998

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-41  Score=317.97  Aligned_cols=204  Identities=21%  Similarity=0.251  Sum_probs=170.5

Q ss_pred             HHHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CC-----ceeeEeeEeeeCC
Q 048542           61 QIIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HV-----NVVQLLGFCSEGS  133 (373)
Q Consensus        61 ~i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni~~~~~~~~~~~  133 (373)
                      +.....|++.+.||+|+||.||+|... +++.||||+++.......++..|+.+++.++ |+     +|+.+++++....
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            334457888899999999999999876 6789999999866555567778888888874 44     5999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCCceEEeec
Q 048542          134 KRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDF  211 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~~~kl~Df  211 (373)
                      ..++||||++ ++|.+++....  ...+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             ceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999995 59988885432  24589999999999999999999952 23899999999999995  5778999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCc
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNA  275 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~  275 (373)
                      |++.......     ....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||....
T Consensus       206 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          206 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             TTCEETTCCC-----CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCceeccccc-----ccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9998764322     345689999999999775  68899999999999999999999998654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.9e-42  Score=312.31  Aligned_cols=242  Identities=23%  Similarity=0.343  Sum_probs=197.0

Q ss_pred             HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-------HHHHHHHHHHhcccC--CCceeeEeeEeee
Q 048542           62 IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-------AEEFINEVSTIGRIH--HVNVVQLLGFCSE  131 (373)
Q Consensus        62 i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~--h~ni~~~~~~~~~  131 (373)
                      .....|++.+.||+|+||.||+|... +++.||||++......       ...+.+|+.+++.++  |+||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34456788899999999999999865 7889999998764322       245668999999996  5999999999999


Q ss_pred             CCeeEEEEeccCc-CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee-CCCceEEe
Q 048542          132 GSKRALVYEYMPN-GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD-HNFIPKVS  209 (373)
Q Consensus       132 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~-~~~~~kl~  209 (373)
                      ....++|||++.+ ++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++ .++.+||+
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999975 899888832    35689999999999999999999998   999999999999999 78999999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      |||++.......    .....||+.|+|||.+.+. ...+.++||||||+++|+|++|..||.....             
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------  254 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------  254 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------
Confidence            999998665332    2345699999999998764 2346789999999999999999999864321             


Q ss_pred             HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       ....... .      +..++..+.+|+.+||+.||++|||++++++
T Consensus       255 -~~~~~~~-~------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 -IIRGQVF-F------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -HHHCCCC-C------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hhccccc-c------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1111111 1      1123567899999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.2e-42  Score=314.22  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=196.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc--CCceeEEEEeccCccC---HHHHHHHHHHhccc---CCCceeeEeeEee-----e
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSKFS---AEEFINEVSTIGRI---HHVNVVQLLGFCS-----E  131 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l---~h~ni~~~~~~~~-----~  131 (373)
                      ..|++.+.||+|+||.||+|...  +++.||+|++......   ...+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            35778899999999999999973  6788999998653321   23556777777766   8999999999986     5


Q ss_pred             CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      ....++||||+. |+|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence            567899999997 69988874332  34589999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |++.......   ......||..|+|||.+.+.  .++.++||||||+++|+|++|+.||........    ........
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~  235 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILDVI  235 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHc
Confidence            9997654322   12345689999999998764  688899999999999999999999976542210    00011111


Q ss_pred             hcCCC----------------cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKGGD----------------LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .....                ............++..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000                0000111222345678899999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=304.83  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=179.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ..|++.+.||+|+||.||+|.+. +|+.||||++.......   +.+.++..+++.++||||+++++++.++...++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            35677899999999999999976 78899999997654332   233445556788899999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |+ ++.+..+..   .....+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.+||+|||++.....
T Consensus       105 ~~-~~~~~~l~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          105 LM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CC-SEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cc-CCcHHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            99 444444432   124568999999999999999999997 5   899999999999999999999999999976543


Q ss_pred             CCCceeeecccCCCCccccccccc---ccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          220 ENDFVSISATRGTIGYIAPELISR---NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ...   .....||+.|+|||.+.+   ....++.++||||||+++|+|++|..||......       ............
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~  247 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCC
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCC
Confidence            221   233468999999999853   1236788999999999999999999999754321       112222222222


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...+..    ..++..+.+++.+||+.||.+|||++++++
T Consensus       248 ~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PLLPGH----MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCCSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCcc----CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            222211    123567899999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-41  Score=310.78  Aligned_cols=256  Identities=24%  Similarity=0.326  Sum_probs=175.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHH-HhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVS-TIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.+.||+|+||.||+|..+ +|+.||||++......  ..++..|+. +++.++||||+++++++.+.+..++||||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~  102 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL  102 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence            5667799999999999999976 7889999999765332  244555665 77788999999999999999999999999


Q ss_pred             cCcCCccccccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          142 MPNGSLDRHVFPK-ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       142 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      +++ +|.+++... ......+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus       103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  179 (327)
T 3aln_A          103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS  179 (327)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred             cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence            975 776665321 11246789999999999999999999973  28999999999999999999999999999765432


Q ss_pred             CCceeeecccCCCCcccccccccc--cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          221 NDFVSISATRGTIGYIAPELISRN--FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ..   .....||+.|+|||.+...  ...++.++|||||||++|+|++|..||.........       ......+....
T Consensus       180 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~  249 (327)
T 3aln_A          180 IA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDPPQ  249 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred             cc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCCCC
Confidence            21   2234689999999998421  236788999999999999999999999754321100       00001111111


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      +..  .....++..+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          250 LSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111  111234567999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-40  Score=300.64  Aligned_cols=239  Identities=13%  Similarity=0.079  Sum_probs=190.0

Q ss_pred             ccChhH-HHHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           56 RYSYPQ-IIAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        56 ~~~~~~-i~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      .+..++ +...+|++.+.||+|+||.||+|.+. +++.||||++......    .+.+.+|+..+..++||||+++++++
T Consensus        21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            344454 55667899999999999999999976 5889999999875443    26789999999999999999999999


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      .+++..|+||||+++++|.+++..     . .....+..++.|++.||+|||++   +++||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEEC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEE
Confidence            999999999999999999999821     2 35567888999999999999998   99999999999999999999998


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD  289 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~  289 (373)
                      +++.                      ++         .++.++|||||||++|+|++|+.||............      
T Consensus       172 ~~~~----------------------~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------  214 (286)
T 3uqc_A          172 YPAT----------------------MP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------  214 (286)
T ss_dssp             SCCC----------------------CT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------
T ss_pred             eccc----------------------cC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------
Confidence            5432                      22         3567899999999999999999999865542211000      


Q ss_pred             HHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                        .................++..+.+++.+||+.||++| |++|+++.|+....
T Consensus       215 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          215 --ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             --CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             --HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence              0000111111122334456789999999999999999 99999999998544

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=319.45  Aligned_cols=250  Identities=24%  Similarity=0.262  Sum_probs=184.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +|.+.+.||+|+||+|+.....+++.||||++.....  ..+.+|+.+++.+ +||||+++++++.+....++|||||. 
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            4566789999999997766566799999999865432  2346799999999 79999999999999999999999995 


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-----CCceEEeeccCcccCCC
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-----~~~~kl~Dfg~~~~~~~  219 (373)
                      |+|.+++....   ....+..+..++.|++.||.|||+.   +|+||||||+|||++.     ...+||+|||++.....
T Consensus       102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            59988885432   3344445678999999999999998   9999999999999953     23588999999986643


Q ss_pred             CCC-ceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          220 END-FVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       220 ~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ... ........||+.|+|||++.+. ...++.++|||||||++|+|++ |..||.......        . ........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~-~~~~~~~~  246 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------A-NILLGACS  246 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------H-HHHTTCCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------H-HHHhccCC
Confidence            321 1223446799999999998642 2466779999999999999999 888885432211        1 11111111


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ....   ......+..+.+|+.+||+.||.+|||++++++
T Consensus       247 ~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LDCL---HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CTTS---CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccc---CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            1111   111234566899999999999999999999983

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-40  Score=331.44  Aligned_cols=244  Identities=21%  Similarity=0.245  Sum_probs=195.6

Q ss_pred             ChhHHHHHHhhhhcccCCCCcEEEEEEEEc--CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCC
Q 048542           58 SYPQIIAMTNHFTHKLGQGGFGSVYKGQLQ--TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGS  133 (373)
Q Consensus        58 ~~~~i~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~  133 (373)
                      ..+++...+|++.+.||+|+||.||+|.+.  +++.||||++.....  ....+.+|+.+++.++||||+++++++....
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            344555678899999999999999999975  588999999875432  2356889999999999999999999997755


Q ss_pred             e-----eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          134 K-----RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       134 ~-----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      .     .|+||||+++++|.+++.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.+ .+||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence            4     699999999999988762      2699999999999999999999998   99999999999999875 8999


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      +|||++......      ....||+.|+|||++.+.   .+.++|||||||++|+|++|..|+........         
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------  284 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------  284 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence            999999866443      234699999999998653   47899999999999999999888764321110         


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcC
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGS  341 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~  341 (373)
                                 .. .......+..+.+|+.+||+.||.+|| +++++...|.+.
T Consensus       285 -----------~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 -----------PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -----------CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                       00 011123456789999999999999999 566777766654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-41  Score=330.79  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeee------CCe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSK  134 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~  134 (373)
                      ...|++.+.||+|+||.||+|.+. +|+.||||++.....  ..+.+.+|+.+++.++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            357889999999999999999875 688999999876432  23678899999999999999999998755      677


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCc---eEEeec
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFI---PKVSDF  211 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~---~kl~Df  211 (373)
                      .++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999885433 234688899999999999999999998   9999999999999997664   899999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc-cccchHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS-KAYFPSWVYDQ  290 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~  290 (373)
                      |++........   .....||+.|+|||.+.+.  .++.++|||||||++|+|++|..||........ ...........
T Consensus       169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH  243 (676)
T ss_dssp             CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred             ccccccccccc---cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence            99987654332   2345699999999999764  788999999999999999999999975421100 00000000000


Q ss_pred             Hh--c--CCC----cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 048542          291 LN--K--GGD----LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTK  333 (373)
Q Consensus       291 ~~--~--~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  333 (373)
                      ..  .  ...    ...+........++..+.+++.+||+.||++|||+++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            00  0  000    0111122334456788999999999999999999977

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-40  Score=314.49  Aligned_cols=239  Identities=16%  Similarity=0.132  Sum_probs=175.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHHHHHHHhcccCC-Cceee----------------
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFINEVSTIGRIHH-VNVVQ----------------  124 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h-~ni~~----------------  124 (373)
                      +...+.||+|+||.||+|.+. +|+.||||++.....    ..+.+.+|+.+++.++| +|...                
T Consensus        80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  159 (413)
T 3dzo_A           80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  159 (413)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred             EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence            345578999999999999955 789999999884322    23678899999999976 22111                


Q ss_pred             -----EeeEeee-----CCeeEEEEeccCcCCccccccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec
Q 048542          125 -----LLGFCSE-----GSKRALVYEYMPNGSLDRHVFPK---ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHF  191 (373)
Q Consensus       125 -----~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~  191 (373)
                           +..++..     ....+++|+++ +++|.+++...   ...+..+++..+..++.|++.||+|||++   +|+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr  235 (413)
T 3dzo_A          160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT  235 (413)
T ss_dssp             CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence                 1111111     12356777776 67888877311   22345678889999999999999999998   99999


Q ss_pred             CcCCCCeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccc--------cCCcCcccchHHHHHHHHH
Q 048542          192 DIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN--------FGTVSCKSDVYGFGMVLLE  263 (373)
Q Consensus       192 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~~~DvwslG~~l~~  263 (373)
                      ||||+|||++.++.+||+|||++......     .....| +.|+|||.+.+.        ...++.++|||||||++|+
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            99999999999999999999998764322     344567 999999998321        1357889999999999999


Q ss_pred             HHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 048542          264 MAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKV  334 (373)
Q Consensus       264 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~el  334 (373)
                      |++|+.||............               +....    .++..+.+|+.+||+.||++|||+.++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~---------------~~~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWI---------------FRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGG---------------GSSCC----CCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHCCCCCCCcchhhhHHHH---------------Hhhcc----cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99999999765432211100               00001    234679999999999999999996555

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.7e-39  Score=292.35  Aligned_cols=229  Identities=21%  Similarity=0.233  Sum_probs=177.4

Q ss_pred             Hhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHh-cccCCCceeeEeeEeee----CCeeEEE
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTI-GRIHHVNVVQLLGFCSE----GSKRALV  138 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~h~ni~~~~~~~~~----~~~~~lv  138 (373)
                      .|.+. +.||+|+||.||+|... +++.||+|+++..    ..+.+|+.++ +..+||||+++++++..    ....++|
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            45555 77999999999999875 7889999998643    4567888887 55689999999999876    6778999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~  215 (373)
                      |||+++++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.   ++.+||+|||++.
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           94 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             ECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999988542  234699999999999999999999998   9999999999999997   7889999999886


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ....                          ..++.++|||||||++|+|++|..||............       .....
T Consensus       169 ~~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~  215 (299)
T 3m2w_A          169 ETTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIR  215 (299)
T ss_dssp             ECTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSC
T ss_pred             cccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHh
Confidence            4321                          25677899999999999999999999754422110000       00000


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .............++..+.+|+.+||+.||.+|||++|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00111111122345678999999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.7e-40  Score=301.09  Aligned_cols=242  Identities=14%  Similarity=0.119  Sum_probs=186.3

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc---------CHHHHHHHHHHhcccC---------CCceee
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---------SAEEFINEVSTIGRIH---------HVNVVQ  124 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~ni~~  124 (373)
                      ....|++.+.||+|+||.||+|++ +|+.||||++.....         ..+.+.+|+.+++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            356788999999999999999998 589999999976432         2377889999988886         666666


Q ss_pred             EeeE-----------------eee-------------CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHH
Q 048542          125 LLGF-----------------CSE-------------GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTA  174 (373)
Q Consensus       125 ~~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~  174 (373)
                      +.++                 +.+             ....++||||+++|++.+.+.     ...+++..+..++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            5554                 332             678999999999998766662     25689999999999999


Q ss_pred             HHHHHHH-cCCCCCeEecCcCCCCeeeeCCC--------------------ceEEeeccCcccCCCCCCceeeecccCCC
Q 048542          175 RGIEYLH-NGCDVCILHFDIKPHNILLDHNF--------------------IPKVSDFGLAKFHPKENDFVSISATRGTI  233 (373)
Q Consensus       175 ~al~~LH-~~~~~~ivH~dikp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~  233 (373)
                      .||+||| +.   +|+||||||+|||++.++                    .+||+|||+++.....       ...||+
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence            9999999 88   999999999999999876                    8999999999865432       236999


Q ss_pred             CcccccccccccCCcCcccchHHHHHH-HHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchhhHHHHHH
Q 048542          234 GYIAPELISRNFGTVSCKSDVYGFGMV-LLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARK  312 (373)
Q Consensus       234 ~y~aPE~~~~~~~~~s~~~DvwslG~~-l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (373)
                      .|+|||++.+.   .+.++||||+|++ .+++++|..||....       ........+.................++..
T Consensus       242 ~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          242 VSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNVL-------WLHYLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             CTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHHH-------HHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             cccChhhhcCC---CccceehhhhhCCCCcccccccCCCcchh-------hhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence            99999999865   2789999998777 777888888873210       001112222222222222334556778999


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHH
Q 048542          313 LCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       313 l~~li~~cl~~dp~~Rps~~ell  335 (373)
                      +.+|+.+||+.|     |++|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.6e-33  Score=272.60  Aligned_cols=185  Identities=16%  Similarity=0.140  Sum_probs=130.1

Q ss_pred             cccCCCCcEEEEEEE-EcCCceeEEEEeccCc-----------cCHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEE
Q 048542           71 HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSK-----------FSAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~-~~~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ...+.|++|.+..++ .-.|+.+++|.+....           .+.+++.+|+++|+++ +|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345667777666654 3368899999987532           1235689999999999 79999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ||||++|++|.+.+.    .+.+++..   +|+.||+.||+|+|++   ||+||||||+|||++.+|++||+|||+++..
T Consensus       320 VMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~  389 (569)
T 4azs_A          320 VMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTT  389 (569)
T ss_dssp             EEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred             EEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeC
Confidence            999999999999993    34566654   4789999999999999   9999999999999999999999999999866


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCC
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRN  270 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p  270 (373)
                      .....  .....+||+.|+|||++.+   .+..++|+||+|++++++.++..+
T Consensus       390 ~~~~~--~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          390 PQDCS--WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             C---C--CSHHHHHHHHHHHHHHC--------------------CCCCTTHHH
T ss_pred             CCCCc--cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccch
Confidence            44322  2345679999999999975   456689999999998887666543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.1e-28  Score=240.41  Aligned_cols=184  Identities=15%  Similarity=0.160  Sum_probs=143.3

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---------HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---------AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .+.||+|+||.||+|.. .+..+++|........         .+++.+|++++++++||||+.+..++......++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            46899999999999954 4788899876543221         2457899999999999999966666667778899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      |+++++|.+++..            +..++.|+++||.|||++   +|+||||||+|||++.  ++||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999832            457999999999999998   9999999999999998  9999999999876543


Q ss_pred             CCce-----eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCC
Q 048542          221 NDFV-----SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNS  271 (373)
Q Consensus       221 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~  271 (373)
                      ....     ......||+.|+|||++.+....|+..+|+||..+-..+-+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2111     11345699999999999774346788899999998888888777655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.1e-25  Score=199.79  Aligned_cols=141  Identities=18%  Similarity=0.137  Sum_probs=114.4

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc-------------------CHHHHHHHHHHhcccCCCceeeEeeEe
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF-------------------SAEEFINEVSTIGRIHHVNVVQLLGFC  129 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~ni~~~~~~~  129 (373)
                      +.+.||+|+||.||+|.+.+|+.||+|+++....                   ....+.+|+.+++.++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            4489999999999999997799999999975322                   2356889999999998  4 5666655


Q ss_pred             eeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       130 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      .. +..++||||+++++|.+ +..          .....++.|++.||.|||+.   +++||||||+|||++ ++.+||+
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~  234 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII  234 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred             ec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence            44 55699999999999988 411          12346999999999999998   999999999999999 9999999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCccccccccc
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISR  243 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  243 (373)
                      |||++.               .+..+.|||.+.+
T Consensus       235 DFG~a~---------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          235 DFPQSV---------------EVGEEGWREILER  253 (282)
T ss_dssp             CCTTCE---------------ETTSTTHHHHHHH
T ss_pred             ECCCCe---------------ECCCCCHHHHHHH
Confidence            999986               3345689998743

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=1.8e-21  Score=172.00  Aligned_cols=135  Identities=17%  Similarity=0.126  Sum_probs=103.1

Q ss_pred             hhhhcccCCCCcEEEEEEEE-cCCce--eEEEEeccCccC-------------------------HHHHHHHHHHhcccC
Q 048542           67 NHFTHKLGQGGFGSVYKGQL-QTGGL--IAVKMLENSKFS-------------------------AEEFINEVSTIGRIH  118 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~  118 (373)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..+..++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            34568899999999999997 67888  999987653211                         135788999999998


Q ss_pred             CCce--eeEeeEeeeCCeeEEEEeccCc-C----CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEe
Q 048542          119 HVNV--VQLLGFCSEGSKRALVYEYMPN-G----SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH-NGCDVCILH  190 (373)
Q Consensus       119 h~ni--~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH-~~~~~~ivH  190 (373)
                      |+++  +.++++    ...++||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.   +++|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH  194 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH  194 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence            8754  344432    356899999942 4    44443311       123456789999999999999 87   9999


Q ss_pred             cCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          191 FDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       191 ~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=8.2e-19  Score=161.43  Aligned_cols=136  Identities=13%  Similarity=0.114  Sum_probs=98.4

Q ss_pred             hhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc---------------CHHHH--------HHHHHHhcccCCCcee
Q 048542           67 NHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---------------SAEEF--------INEVSTIGRIHHVNVV  123 (373)
Q Consensus        67 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------------~~~~~--------~~e~~~l~~l~h~ni~  123 (373)
                      |.+...||.|++|.||+|...+|+.||||+++....               ....+        ..|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            667789999999999999998999999999764211               11111        3456666666444332


Q ss_pred             eEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCC
Q 048542          124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN  203 (373)
Q Consensus       124 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~  203 (373)
                      -..-+..  ...++||||++|++|..+..        .  .....++.|++.+|.+||+.   |++||||||.|||++++
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence            1111111  22379999999988866541        1  12356789999999999998   99999999999999877


Q ss_pred             C----------ceEEeeccCcccC
Q 048542          204 F----------IPKVSDFGLAKFH  217 (373)
Q Consensus       204 ~----------~~kl~Dfg~~~~~  217 (373)
                      +          .+.|+||+.+...
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEET
T ss_pred             CCcccccccccceEEEEeCCcccC
Confidence            6          3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=4.9e-13  Score=117.98  Aligned_cols=140  Identities=14%  Similarity=0.066  Sum_probs=109.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCc-cCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSK-FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|.+...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+. +..++++++++.+.+..|+||||++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   93 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             cceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence            4566778888899999999755 6899999987522 22346788999999884 6778899999988889999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC---------------------------------------  184 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~---------------------------------------  184 (373)
                      |.+|.+.+..         ......++.+++++++.||+..                                       
T Consensus        94 G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           94 GVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             CeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9988765311         1123467889999999999810                                       


Q ss_pred             -----------------CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 -----------------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 -----------------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                                       ...++|+|++|.||+++++..+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             1358999999999999876667799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.32  E-value=5.7e-12  Score=110.77  Aligned_cols=128  Identities=18%  Similarity=0.164  Sum_probs=97.1

Q ss_pred             CCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEeeEeeeCCeeEEEEeccCcCCccccc
Q 048542           74 GQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGFCSEGSKRALVYEYMPNGSLDRHV  151 (373)
Q Consensus        74 g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~~~~~~~~~lv~e~~~~gsL~~~l  151 (373)
                      +.|..+.||++...+|..+++|+....  ....+.+|+.+++.+.+.+  +++++++...++..++||||++|.++.  .
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~  104 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S  104 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence            456669999998777888999987654  2245678999998885444  566888888777889999999998884  2


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------------------
Q 048542          152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-----------------------------------------------  184 (373)
Q Consensus       152 ~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----------------------------------------------  184 (373)
                       ..      ..   ...++.++++.++.||+..                                               
T Consensus       105 -~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          105 -SH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             -SC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             -Cc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence             11      11   1256778888888888742                                               


Q ss_pred             --------CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 --------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 --------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                              ...++|+|++|.||+++.++.+.|+||+.+.
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                    0129999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.25  E-value=2.8e-11  Score=111.74  Aligned_cols=139  Identities=17%  Similarity=0.194  Sum_probs=105.7

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEec--cCc--cCHHHHHHHHHHhcccC--CCceeeEeeEeeeC---CeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLE--NSK--FSAEEFINEVSTIGRIH--HVNVVQLLGFCSEG---SKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~---~~~~lv~e~  141 (373)
                      +.++.|.++.||+.... ++.+++|+..  ...  .....+.+|..+++.+.  +..+++++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            67899999999998876 4678898776  432  22356788999999986  45678888888766   458999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-------------------------------------  184 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-------------------------------------  184 (373)
                      ++|..+.+..      -..++......++.++++.|+.||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9998875432      134678888899999999999999721                                     


Q ss_pred             ------------------CCCeEecCcCCCCeeeeCCCc--eEEeeccCccc
Q 048542          185 ------------------DVCILHFDIKPHNILLDHNFI--PKVSDFGLAKF  216 (373)
Q Consensus       185 ------------------~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~  216 (373)
                                        ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              247999999999999987653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=4.6e-11  Score=107.68  Aligned_cols=187  Identities=21%  Similarity=0.265  Sum_probs=121.3

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC-CCc--eeeEeeEeeeCC---eeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVN--VVQLLGFCSEGS---KRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~n--i~~~~~~~~~~~---~~~lv~e~~~~  144 (373)
                      +.++.|.+..||+..    +.+++|+.... .....+.+|..+++.+. +..  ++.++.......   ..|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458899999999863    57899986533 23467889999998873 322  445555443333   35889999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC----------------------------------------  184 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~----------------------------------------  184 (373)
                      .++.+...      ..++......++.+++..++.||+..                                        
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            88865331      33667777888888999888888611                                        


Q ss_pred             ---------------CCCeEecCcCCCCeeeeC--CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccc---cc
Q 048542          185 ---------------DVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS---RN  244 (373)
Q Consensus       185 ---------------~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~  244 (373)
                                     ...++|+|++|.||+++.  +..+.++||+.+.......+.......  ... ..|+...   ..
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~~~-~~~~~~~~~l~~  251 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--DEE-YGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--TTS-CCHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--ccc-cCHHHHHHHHHH
Confidence                           135899999999999998  566889999988754322111100000  000 1222211   11


Q ss_pred             cCC---------cCcccchHHHHHHHHHHHcCCCCC
Q 048542          245 FGT---------VSCKSDVYGFGMVLLEMAGGRRNS  271 (373)
Q Consensus       245 ~~~---------~s~~~DvwslG~~l~~ll~g~~p~  271 (373)
                      ++.         .....+.|+++.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111         111258999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=1.9e-07  Score=83.92  Aligned_cols=136  Identities=18%  Similarity=0.154  Sum_probs=95.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCC---ceeeEeeEee-eCCeeEEEEeccCcCC
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHV---NVVQLLGFCS-EGSKRALVYEYMPNGS  146 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---ni~~~~~~~~-~~~~~~lv~e~~~~gs  146 (373)
                      +.++.|....||+.    |+.+++|+... ......+..|..+++.+.+.   .+++.+.+.. ..+..+++||+++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            45788888899988    67899998532 22346788999999999642   3566666664 4556789999999988


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC------------------------------------------  184 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~------------------------------------------  184 (373)
                      +.+...      ..++......++.++++.|+.||+..                                          
T Consensus       100 l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          100 LGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             Cchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            765321      12344555556666666666666431                                          


Q ss_pred             ---------------CCCeEecCcCCCCeeeeC---CCc-eEEeeccCcccC
Q 048542          185 ---------------DVCILHFDIKPHNILLDH---NFI-PKVSDFGLAKFH  217 (373)
Q Consensus       185 ---------------~~~ivH~dikp~Nil~~~---~~~-~kl~Dfg~~~~~  217 (373)
                                     ...++|+|++|.||+++.   ++. ..|+||+.+...
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           225699999999999987   355 479999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=3.3e-07  Score=80.71  Aligned_cols=134  Identities=15%  Similarity=0.137  Sum_probs=96.1

Q ss_pred             ccCCCCcE-EEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           72 KLGQGGFG-SVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        72 ~ig~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      .+..|..| .||+.... .+..+++|+-...  ...++.+|...++.+. +--+.+++.++.+++..++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445554 68988765 4567899976543  3466788999998884 334778888898899999999999987776


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC--------------------------------------------  184 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--------------------------------------------  184 (373)
                      +....        .......+..+++..++.||+..                                            
T Consensus       109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            54311        11123346667777777787531                                            


Q ss_pred             -----------CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 -----------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 -----------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                                 ...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       0137999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.47  E-value=5.2e-07  Score=82.86  Aligned_cols=79  Identities=8%  Similarity=0.059  Sum_probs=56.6

Q ss_pred             ccc-CCCCcEEEEEEEEc-------CCceeEEEEeccCc---c-CHHHHHHHHHHhcccCC---CceeeEeeEeeeC---
Q 048542           71 HKL-GQGGFGSVYKGQLQ-------TGGLIAVKMLENSK---F-SAEEFINEVSTIGRIHH---VNVVQLLGFCSEG---  132 (373)
Q Consensus        71 ~~i-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~---  132 (373)
                      +.| +.|....+|+....       +++.+++|+.....   . ....+.+|..+++.+..   -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 88889999998754       26689999876533   1 22456788888888842   3567788777654   


Q ss_pred             CeeEEEEeccCcCCccc
Q 048542          133 SKRALVYEYMPNGSLDR  149 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~  149 (373)
                      ...++||||++|.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=2.2e-05  Score=71.23  Aligned_cols=141  Identities=16%  Similarity=0.210  Sum_probs=80.0

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC--CceeeEee------EeeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH--VNVVQLLG------FCSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~------~~~~~~~~~lv~e~~  142 (373)
                      +.|+.|..+.||+....+ +.+++|+....   .+++..|..+++.+..  -.+++++.      +....+..+++|+|+
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            456667788999998764 45999988753   3444456666665531  12333332      123456789999999


Q ss_pred             CcCCccc--------------cccCC-C----CCC-----CCCCHHH-------------------------------HH
Q 048542          143 PNGSLDR--------------HVFPK-E----SRG-----QSLCWEK-------------------------------LH  167 (373)
Q Consensus       143 ~~gsL~~--------------~l~~~-~----~~~-----~~l~~~~-------------------------------~~  167 (373)
                      +|.++..              .++.. .    ...     ..-.|..                               ..
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            8866531              00000 0    000     0012211                               01


Q ss_pred             HHHHHHHHHHHHHHc----------CCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          168 EVALGTARGIEYLHN----------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       168 ~i~~~i~~al~~LH~----------~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      .+...+..++.+|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111223345666652          013489999999999999878899999999775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.16  E-value=6.9e-06  Score=76.52  Aligned_cols=73  Identities=15%  Similarity=0.103  Sum_probs=49.3

Q ss_pred             cccCCCCcEEEEEEEEc-CCceeEEEEeccCc--------cCHHHHHHHHHHhcccCC--C-ceeeEeeEeeeCCeeEEE
Q 048542           71 HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK--------FSAEEFINEVSTIGRIHH--V-NVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~h--~-ni~~~~~~~~~~~~~~lv  138 (373)
                      +.+|.|..+.||++... +++.+++|......        ...+++..|.++++.+..  + .+++++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            67999999999999754 46789999765321        123456788888887742  3 34455543  34556899


Q ss_pred             EeccCcC
Q 048542          139 YEYMPNG  145 (373)
Q Consensus       139 ~e~~~~g  145 (373)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.06  E-value=4.2e-05  Score=68.59  Aligned_cols=138  Identities=16%  Similarity=0.162  Sum_probs=91.1

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccC---CCceeeEeeEeeeCCeeEEEEeccCcCCc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIH---HVNVVQLLGFCSEGSKRALVYEYMPNGSL  147 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~ni~~~~~~~~~~~~~~lv~e~~~~gsL  147 (373)
                      +.|+.|....+|+.... ++.+++|+....  ....+..|...|+.+.   ...+++++.++...+..++||||+++..+
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            56899999999998764 678899987643  3567888999998884   35688888888878889999999988765


Q ss_pred             ccc-----------ccCCCC------------------CCCCCCHHHHHH---HH----------------HHHHHHH-H
Q 048542          148 DRH-----------VFPKES------------------RGQSLCWEKLHE---VA----------------LGTARGI-E  178 (373)
Q Consensus       148 ~~~-----------l~~~~~------------------~~~~l~~~~~~~---i~----------------~~i~~al-~  178 (373)
                      ...           ++....                  +...-+|.....   +.                ..+.+.+ .
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            311           010000                  001124443220   11                1122222 2


Q ss_pred             HHHc-CCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          179 YLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       179 ~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      .|.. .....++|+|+.+.|++++.++ +.++|+.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3321 1245899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.84  E-value=5.3e-05  Score=67.17  Aligned_cols=73  Identities=21%  Similarity=0.240  Sum_probs=53.0

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCcc-CHHHHHHHHHHhcccCC---CceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF-SAEEFINEVSTIGRIHH---VNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h---~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      +.+|.|..+.||+.+..+|+.+++|+...... ....+..|...|+.+..   -.+++++.+.    ..+++|||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            66899999999999999999999998764432 23567789999888842   2344555432    2478999987654


Q ss_pred             c
Q 048542          147 L  147 (373)
Q Consensus       147 L  147 (373)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.79  E-value=4.7e-05  Score=67.96  Aligned_cols=129  Identities=14%  Similarity=0.147  Sum_probs=76.4

Q ss_pred             hcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEecc-CcCCc
Q 048542           70 THKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYM-PNGSL  147 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~-~~gsL  147 (373)
                      .+.|+.|....+|+.     +.+++|+.........+..+|..+++.+...++ .+++.+  +....++++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            367888999999998     678999876532111223467877777742222 455544  334457899999 66555


Q ss_pred             cccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 048542          148 DRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG--------------------------------------------  183 (373)
Q Consensus       148 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~--------------------------------------------  183 (373)
                      .......           ...+..++++.|+-||+.                                            
T Consensus        96 ~~~~~~~-----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  164 (301)
T 3dxq_A           96 SPEKFKT-----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS  164 (301)
T ss_dssp             CHHHHHH-----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred             CHhhHhh-----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence            3210000           001222222333333321                                            


Q ss_pred             ------CCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          184 ------CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       184 ------~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                            ....++|+|+.+.||+ ..++.+.++||..+...
T Consensus       165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence                  1235899999999999 56677899999988643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.78  E-value=9e-05  Score=66.68  Aligned_cols=143  Identities=13%  Similarity=0.165  Sum_probs=78.8

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEeeE------eeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGF------CSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~------~~~~~~~~lv~e~~  142 (373)
                      +.|+.|....+|+....+| .+++|+.... ...+++..|..++..+...+  +++++..      ....+..+++++|+
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            4577888899999987644 7889988753 12234566777777764212  2333321      12345678999999


Q ss_pred             CcCCcccc--------------cc----CCCCCC-CCC---CHHHHHH------------HHHHHHHHHHHHHcC----C
Q 048542          143 PNGSLDRH--------------VF----PKESRG-QSL---CWEKLHE------------VALGTARGIEYLHNG----C  184 (373)
Q Consensus       143 ~~gsL~~~--------------l~----~~~~~~-~~l---~~~~~~~------------i~~~i~~al~~LH~~----~  184 (373)
                      +|..+...              ++    ...... ...   .|.....            +...+.+.+..++..    .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            88664321              00    000000 001   1111000            001133445555421    1


Q ss_pred             CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ..+++|+|+++.||+++.+..+.++||+.+.
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3479999999999999987666899999765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.77  E-value=0.00014  Score=65.57  Aligned_cols=142  Identities=15%  Similarity=0.119  Sum_probs=83.1

Q ss_pred             ccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEeeE-----eeeCCeeEEEEeccCc
Q 048542           72 KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLGF-----CSEGSKRALVYEYMPN  144 (373)
Q Consensus        72 ~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~~-----~~~~~~~~lv~e~~~~  144 (373)
                      .++ |....||+....+|+.+++|.......+.+.+..|..++..+....  +++++..     ...++..+++|+|++|
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            456 7788999987766778999998755456677778888888774222  3444432     1224566789999987


Q ss_pred             CCcccc--------------c----cCCC-CCCCCCCHHHH----------------------HHHHHHHHHHHHHHHc-
Q 048542          145 GSLDRH--------------V----FPKE-SRGQSLCWEKL----------------------HEVALGTARGIEYLHN-  182 (373)
Q Consensus       145 gsL~~~--------------l----~~~~-~~~~~l~~~~~----------------------~~i~~~i~~al~~LH~-  182 (373)
                      .++...              +    .... .......+...                      ...+..++..+.-+-. 
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            654310              0    0000 00111121110                      1111222222222211 


Q ss_pred             CCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       183 ~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1234689999999999998 4 899999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.76  E-value=6.7e-05  Score=62.58  Aligned_cols=145  Identities=11%  Similarity=-0.001  Sum_probs=92.5

Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      -||.+.+.   ..+.+++++++|.++.|.+.+|.-+-.+.  .-..+=+.|..|++..+|.+.+.+ +.+.         
T Consensus        33 vSL~eIL~---~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILR---LYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHH---HcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            36666663   34689999999999999999987763210  111233457899999999887764 1110         


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                           .....+.|||...   ...+.+.=|||+|+++|.-+--..|-                                .
T Consensus        98 -----~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDygL~e--------------------------------~  137 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYGLKE--------------------------------N  137 (229)
T ss_dssp             --------------CCSS---SSSCHHHHHHHHHHHHHHHHTTTCCT--------------------------------T
T ss_pred             -----ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcCCCc--------------------------------c
Confidence                 1223466888763   24456788999999999988433221                                1


Q ss_pred             hhHHHHHHHHHHHHhhcCC-------------------------CCCCCCCHHHHHHHHhcCCCC
Q 048542          305 IESMIARKLCMIGLWCIQV-------------------------KAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~-------------------------dp~~Rps~~ell~~L~~~~~~  344 (373)
                      -+..++.+|-.|+..|...                         .+..|+++++|++.-...+..
T Consensus       138 eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~  202 (229)
T 2yle_A          138 EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPT  202 (229)
T ss_dssp             EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSS
T ss_pred             cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccC
Confidence            1123456777777777655                         356899999999999887653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.74  E-value=0.00013  Score=67.26  Aligned_cols=142  Identities=15%  Similarity=0.165  Sum_probs=83.7

Q ss_pred             cccCCCCcEEEEEEEEc--------CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQ--------TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.+..|-...+|++...        +++.+++|+............+|..+++.+. +.-.+++++.+.+    .+||||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            56777888889999864        2468999986543334567779999998884 2223566666543    299999


Q ss_pred             cCcCCccccc-c----------------CCC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHH---
Q 048542          142 MPNGSLDRHV-F----------------PKE-SRGQSL--CWEKLHEVALGTAR-------------------GIEY---  179 (373)
Q Consensus       142 ~~~gsL~~~l-~----------------~~~-~~~~~l--~~~~~~~i~~~i~~-------------------al~~---  179 (373)
                      ++|.+|...- .                ... .-+...  .+..+.++..++..                   .+..   
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            9986664211 0                000 001112  23444444443321                   1222   


Q ss_pred             -HHcC-CCCCeEecCcCCCCeeeeCC----CceEEeeccCccc
Q 048542          180 -LHNG-CDVCILHFDIKPHNILLDHN----FIPKVSDFGLAKF  216 (373)
Q Consensus       180 -LH~~-~~~~ivH~dikp~Nil~~~~----~~~kl~Dfg~~~~  216 (373)
                       |... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             2221 23479999999999999876    6899999998763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.72  E-value=9.2e-05  Score=69.43  Aligned_cols=31  Identities=13%  Similarity=0.305  Sum_probs=27.2

Q ss_pred             CCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       186 ~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      ..++|+|++|.||+++.++ ++++||+.+...
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            4899999999999998776 999999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.69  E-value=0.00012  Score=68.89  Aligned_cols=73  Identities=15%  Similarity=0.263  Sum_probs=50.6

Q ss_pred             cccCCCCcEEEEEEEEcC--------CceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQT--------GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.|+.|....+|++...+        ++.+++|+.... ...+.+.+|..+++.+...++ +++++.+.+    .+|+||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~  153 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  153 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence            467888889999998653        478999988432 222566689999888853333 566665542    389999


Q ss_pred             cCcCCcc
Q 048542          142 MPNGSLD  148 (373)
Q Consensus       142 ~~~gsL~  148 (373)
                      ++|.++.
T Consensus       154 l~G~~l~  160 (429)
T 1nw1_A          154 IPSRPLS  160 (429)
T ss_dssp             CCEEECC
T ss_pred             eCCcccC
Confidence            9875553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.39  E-value=0.00062  Score=64.33  Aligned_cols=74  Identities=11%  Similarity=0.056  Sum_probs=47.7

Q ss_pred             cccCCCCcEEEEEEEEcC-CceeEEEEeccCccCHHHHHHHHHHhcccCCCce-eeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           71 HKLGQGGFGSVYKGQLQT-GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNV-VQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni-~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      +.|+.|-...+|++...+ +..+++|+........-+..+|..++..+...++ +++++.+.  +  ..||||++|.+|.
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l~  189 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYALS  189 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccCC
Confidence            467788889999998764 4789999875432111122578888888864444 56666653  2  2599999876653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.34  E-value=0.00031  Score=64.49  Aligned_cols=73  Identities=12%  Similarity=0.131  Sum_probs=44.3

Q ss_pred             cccCCCCcEEEEEEEEcC---------CceeEEEEeccCccCHHHHHHHHHHhcccCCCc-eeeEeeEeeeCCeeEEEEe
Q 048542           71 HKLGQGGFGSVYKGQLQT---------GGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e  140 (373)
                      +.++.|....+|+....+         ++.+++|+.........+...|..+++.+...+ .+++++..  .  .++|||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            567888888999998653         268899987653221112357888888774333 34565443  2  368999


Q ss_pred             ccCcCCc
Q 048542          141 YMPNGSL  147 (373)
Q Consensus       141 ~~~~gsL  147 (373)
                      |++|.++
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.00094  Score=60.29  Aligned_cols=34  Identities=29%  Similarity=0.307  Sum_probs=28.5

Q ss_pred             CCCeEecCcCCCCeeeeCC----CceEEeeccCcccCC
Q 048542          185 DVCILHFDIKPHNILLDHN----FIPKVSDFGLAKFHP  218 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~----~~~kl~Dfg~~~~~~  218 (373)
                      ...++|+|+.+.||+++.+    +.+.++||+.+....
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            3489999999999999874    678999999887543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.25  E-value=0.0014  Score=59.47  Aligned_cols=68  Identities=10%  Similarity=0.084  Sum_probs=43.7

Q ss_pred             CCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC---CceeeEeeE------eeeCCeeEEEEeccCc
Q 048542           74 GQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH---VNVVQLLGF------CSEGSKRALVYEYMPN  144 (373)
Q Consensus        74 g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---~ni~~~~~~------~~~~~~~~lv~e~~~~  144 (373)
                      |.|....||+....+| .+++|+......     ..|...++.|..   |++++.+..      ....+..+++|+|++|
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            4444678999987766 899998776542     345555555521   224444432      2335678899999988


Q ss_pred             CCc
Q 048542          145 GSL  147 (373)
Q Consensus       145 gsL  147 (373)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.49  E-value=0.013  Score=54.64  Aligned_cols=141  Identities=9%  Similarity=0.114  Sum_probs=83.6

Q ss_pred             cccCCCCcEEEEEEEEcC--------CceeEEEEeccCccCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQT--------GGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.+..|-...+|+....+        ++.+++|+........-+..+|..+++.+.. .-.+++++.+.    .++|++|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef  151 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF  151 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence            567778888999998653        5789999865432222233578888888742 22345554332    3789999


Q ss_pred             cCcCCcccc-ccC------------------C-----CC--CCCCCCHHHHHHHHHHH-------------------HHH
Q 048542          142 MPNGSLDRH-VFP------------------K-----ES--RGQSLCWEKLHEVALGT-------------------ARG  176 (373)
Q Consensus       142 ~~~gsL~~~-l~~------------------~-----~~--~~~~l~~~~~~~i~~~i-------------------~~a  176 (373)
                      ++|.+|... +..                  .     ..  ...+..+..+..+..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            998665321 100                  0     00  11222244443333322                   112


Q ss_pred             HHHHHc---------------------CCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          177 IEYLHN---------------------GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       177 l~~LH~---------------------~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +..|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            222221                     11246899999999999 8888999999998863

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.07  E-value=0.19  Score=46.41  Aligned_cols=30  Identities=27%  Similarity=0.306  Sum_probs=25.1

Q ss_pred             CeEecCcCCCCeeee------CCCceEEeeccCccc
Q 048542          187 CILHFDIKPHNILLD------HNFIPKVSDFGLAKF  216 (373)
Q Consensus       187 ~ivH~dikp~Nil~~------~~~~~kl~Dfg~~~~  216 (373)
                      .++|+|+.+.||++.      ++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            367999999999993      456799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.08  E-value=0.79  Score=38.00  Aligned_cols=116  Identities=10%  Similarity=0.108  Sum_probs=75.3

Q ss_pred             CCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCC
Q 048542          118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (373)
Q Consensus       118 ~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~N  197 (373)
                      .||+.++. .+-.+++...+.++.-+  +...+-     .-...+....++++.+|+....++++     -+|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~-----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD-----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG-----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH-----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            47777765 45555565555555433  222222     12447788899999999998766654     4788999999


Q ss_pred             eeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       198 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      ++++.++.+++.--|+-..                   ++|..+       +...=.-.+=|++..+++++..|.
T Consensus       110 L~f~~~~~p~i~~RGik~~-------------------l~P~~~-------~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNV-------------------VDPLPV-------SEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTT-------------------BSCCCC-------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccC-------------------CCCCCC-------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999997775322                   122211       111123356688999999987764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.65  E-value=0.91  Score=37.76  Aligned_cols=115  Identities=10%  Similarity=0.064  Sum_probs=72.7

Q ss_pred             CCCceeeEeeEeeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEecCcCCC
Q 048542          118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIE-YLHNGCDVCILHFDIKPH  196 (373)
Q Consensus       118 ~h~ni~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~-~LH~~~~~~ivH~dikp~  196 (373)
                      .||+.  -..+-.+++...+.++.-+++.-...+       ...+....++++.+++.... +++     .-+|--+.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            46776  333445566666666654332222222       44677888999998888666 455     4578899999


Q ss_pred             CeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCC
Q 048542          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN  272 (373)
Q Consensus       197 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~  272 (373)
                      |++++.++.+++.-.|+-..                   ++|.-+.       ..-=.-++=|++..++.++..|.
T Consensus       114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~~-------ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKES-------------------LPPDEWD-------DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTT-------------------BSSCSCC-------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCccc-------------------CCCCCCC-------HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999998775432                   2332211       11112356678888888876653

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.99  E-value=0.1  Score=49.19  Aligned_cols=61  Identities=5%  Similarity=0.040  Sum_probs=19.0

Q ss_pred             hhhcccCCCCcEEEEEEEEcC-CceeEE------EEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeee
Q 048542           68 HFTHKLGQGGFGSVYKGQLQT-GGLIAV------KMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSE  131 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~-~~~vai------K~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~  131 (373)
                      .+.+.+|   ||.||+|.+.. ..+||+      |..+......   ..+.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3456777   99999998763 467888      7665433322   457888999999999999999887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	373
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-64
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-60
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-57
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-54
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-38
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-69
 Identities = 77/277 (27%), Positives = 139/277 (50%), Gaps = 24/277 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
               ++G G FG+VYKG+      +AVKML  +  +    + F NEV  + +  HVN++ 
Sbjct: 11  TVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
            +G+ +   + A+V ++    SL  H+   E++       KL ++A  TA+G++YLH   
Sbjct: 69  FMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SR 243
              I+H D+K +NI L  +   K+ DFGLA    + +         G+I ++APE+I  +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRN-SNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
           +    S +SDVY FG+VL E+  G+   SN+N            +   + +G      ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRG--YLSPDL 231

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +++ S   + +  +   C++ K  +RP   ++L  +E
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-65
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 33/289 (11%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               +LG G FG V+ G       +AVK L+    S + F+ E + + ++ H  +V+L  
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             ++     ++ EYM NGSL   +  K   G  L   KL ++A   A G+ ++       
Sbjct: 76  VVTQE-PIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---N 129

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  NIL+      K++DFGLA+    +N++ +    +  I + APE I  N+GT
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAI--NYGT 186

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES 307
            + KSDV+ FG++L E+    R      T          V   L +G  +          
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRM------VRPD 233

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSS 356
               +L  +   C + +  DRP+   +  +LE            FF+++
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE-----------DFFTAT 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-65
 Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 22/284 (7%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
               KLGQG FG V+ G       +A+K L+    S E F+ E   + ++ H  +VQL  
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             SE     +V EYM  GSL      K   G+ L   +L ++A   A G+ Y+     + 
Sbjct: 80  VVSEE-PIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            +H D++  NIL+  N + KV+DFGLA+    +N++ +    +  I + APE      G 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY--GR 190

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES 307
            + KSDV+ FG++L E+    R                 V DQ+ +G  +          
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRM------PCPP 237

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRP 351
                L  +   C + +  +RP+   +   LE      +   +P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 4e-64
 Identities = 67/272 (24%), Positives = 125/272 (45%), Gaps = 22/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            F  +LG G FG V  G+ +    +A+KM++    S +EFI E   +  + H  +VQL G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
            C++     ++ EYM NG L  ++     R      ++L E+       +EYL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESK---Q 120

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
            LH D+   N L++   + KVSDFGL+++   ++++ S   ++  + +  PE++      
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMY--SK 177

Query: 248 VSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIES 307
            S KSD++ FG+++ E+    +          + +  S   + + +G  L          
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-------MPYERFTNSETAEHIAQGLRL------YRPH 224

Query: 308 MIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           + + K+  I   C   KA +RP+   +L  + 
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-63
 Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 69  FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGF 128
           F  ++G G FG V+ G       +A+K +     S E+FI E   + ++ H  +VQL G 
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
           C E +   LV+E+M +G L  ++  +         E L  + L    G   +    + C+
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFA---AETLLGMCLDVCEG---MAYLEEACV 122

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           +H D+   N L+  N + KVSDFG+ +F   +    S   T+  + + +PE+   +F   
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVF--SFSRY 179

Query: 249 SCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESM 308
           S KSDV+ FG+++ E+    +    N +        S V + ++ G  L          +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRL------YKPRL 226

Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            +  +  I   C + +  DRP+ +++L  L 
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 2e-60
 Identities = 62/291 (21%), Positives = 118/291 (40%), Gaps = 30/291 (10%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE 131
            +G+G FG V++G+   G  +AVK+  + +  +     E+     + H N++  +   ++
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 132 G----SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                ++  LV +Y  +GSL  ++        ++  E + ++AL TA G+ +LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 188 -----ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR--GTIGYIAPEL 240
                I H D+K  NIL+  N    ++D GLA  H    D + I+     GT  Y+APE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 241 ISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRS--------SKAYFPSWVY 288
           +  +          ++D+Y  G+V  E+A       ++            S         
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +     + N  +    + R +  I   C     A R +  ++ + L 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEAL-RVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 6e-59
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 22/273 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
              HKLG G +G VY+G   +    +AVK L+      EEF+ E + +  I H N+VQLL
Sbjct: 20  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G C+      ++ E+M  G+L  ++   E   Q +    L  +A   +  +EYL      
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KK 134

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N L+  N + KV+DFGL++    +      +  +  I + APE ++    
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAY--N 191

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE 306
             S KSDV+ FG++L E+A    +              S VY+ L K   +      E  
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRM------ERP 238

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                K+  +   C Q   +DRPS  ++ +  E
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (479), Expect = 5e-58
 Identities = 69/303 (22%), Positives = 127/303 (41%), Gaps = 41/303 (13%)

Query: 57  YSYPQIIAMTNHFT-----------HKLGQGGFGSVYKGQLQTGG----LIAVKML--EN 99
           +++         F              +G G FG V  G L+  G     +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 100 SKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQ 159
           ++    +F++E S +G+  H NV+ L G  ++ +   ++ E+M NGSLD  +   + +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
                +L  +  G A G++YL +   +  +H D+   NIL++ N + KVSDFGL++F   
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 220 ENDFVSISAT---RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNAT 276
           +    + ++    +  I + APE I   +   +  SDV+ +G+V+ E+            
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGE------- 231

Query: 277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           R         V + + +   L               L  + L C Q     RP   +++ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRL------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285

Query: 337 MLE 339
            L+
Sbjct: 286 TLD 288

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 8e-58
 Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 28/273 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
                +G+G FG V  G    G  +AVK ++N   +A+ F+ E S + ++ H N+VQLLG
Sbjct: 10  KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLG 67

Query: 128 FCSEGSKR-ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              E      +V EYM  GSL  ++  +      L  + L + +L     +EYL      
Sbjct: 68  VIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GN 122

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
             +H D+   N+L+  + + KVSDFGL K      D       +  + + APE +     
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALRE--K 175

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE 306
             S KSDV+ FG++L E+    R                 V  ++ KG  +      +  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKM------DAP 222

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                 +  +   C  + AA RPS  ++ E LE
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  186 bits (474), Expect = 4e-57
 Identities = 66/271 (24%), Positives = 110/271 (40%), Gaps = 32/271 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNVVQLL 126
           ++G G FG+VY  + ++   ++A+K +  S   + E     I EV  + ++ H N +Q  
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G         LV EY    + D      E   + L   ++  V  G  +G+ YLH     
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI-SRNF 245
            ++H D+K  NILL    + K+ DFG A      N FV      GT  ++APE+I + + 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMDE 188

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
           G    K DV+  G+  +E+A  +              F       L      + ++    
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKP-----------PLFNMNAMSALYH--IAQNESPALQ 235

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               +         C+Q    DRP+   +L+
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 46/300 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHH 119
            +   +G+G FG V++ +       +   ++AVKML  E S     +F  E + +    +
Sbjct: 16  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 75

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVF--------------------PKESRGQ 159
            N+V+LLG C+ G    L++EYM  G L+  +                            
Sbjct: 76  PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135

Query: 160 SLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK 219
            L   +   +A   A G+ YL        +H D+   N L+  N + K++DFGL++    
Sbjct: 136 PLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192

Query: 220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS 279
            + + +       I ++ PE I  N    + +SDV+ +G+VL E+               
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNR--YTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247

Query: 280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                  V   +  G      N+         +L  +   C     ADRPS   +  +L+
Sbjct: 248 ----HEEVIYYVRDG------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 1e-56
 Identities = 70/300 (23%), Positives = 122/300 (40%), Gaps = 40/300 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSA--EEFINEVSTIGRI-H 118
            F   LG G FG V +              +AVKML+ S      E  ++E+  +  + +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 119 HVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK--------------ESRGQSLCWE 164
           H+N+V LLG C+ G    ++ EY   G L   +  K              E    +L  E
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 165 KLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV 224
            L   +   A+G+ +L +      +H D+   NILL H  I K+ DFGLA+    ++++V
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFP 284
                R  + ++APE I       + +SDV+ +G+ L E+     +              
Sbjct: 203 VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------D 254

Query: 285 SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
           S  Y  + +G  +              ++  I   C       RP+  ++++++E  I +
Sbjct: 255 SKFYKMIKEGFRM------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 6e-56
 Identities = 67/296 (22%), Positives = 123/296 (41%), Gaps = 38/296 (12%)

Query: 72  KLGQGGFGSVYKGQLQ---TGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
           +LG G FGSV +G  +       +A+K+L     K   EE + E   + ++ +  +V+L+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G C +     LV E    G L + +     + + +    + E+    + G++YL      
Sbjct: 76  GVC-QAEALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEE---K 128

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSI-SATRGTIGYIAPELISRNF 245
             +H D+   N+LL +    K+SDFGL+K    ++ + +  SA +  + + APE I  NF
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI--NF 186

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
              S +SDV+ +G+ + E     +       +  K      V   + +G  +      E 
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQ-------KPYKKMKGPEVMAFIEQGKRM------EC 233

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSSRHISG 361
                 +L  +   C   K  DRP    V + +             ++S +  + G
Sbjct: 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR----------ACYYSLASKVEG 279

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 6e-55
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 26/277 (9%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE---FINEVSTIGRIHHVNVV 123
              + +G G +G   K +    G ++  K L+    +  E    ++EV+ +  + H N+V
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 124 QLLGFCSEGSKRAL--VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +      + +   L  V EY   G L   +       Q L  E +  V       ++  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 182 --NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             +     +LH D+KP N+ LD     K+ DFGLA+    +  F    A  GT  Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTPYYMSPE 184

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
            ++R   + + KSD++  G +L E+                A+    +  ++ +G     
Sbjct: 185 QMNR--MSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREG----- 229

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                I    + +L  I    + +K   RPS+ ++LE
Sbjct: 230 -KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 8e-55
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 33/277 (11%)

Query: 69  FTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQ 124
           F  ++G+G F +VYKG   +T   +A   L++ K +    + F  E   +  + H N+V+
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 125 LLGFCSEGSKR----ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
                    K      LV E M +G+L  ++     R + +  + L        +G+++L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 181 HNGCDVCILHFDIKPHNILL-DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           H      I+H D+K  NI +       K+ D GLA             A  GT  ++APE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPE 183

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
           +    +       DVY FGM +LEMA             S+    + +Y ++  G     
Sbjct: 184 MYEEKYDE---SVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPA- 232

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                 + +   ++  I   CI+    +R S+  +L 
Sbjct: 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 64/275 (23%), Positives = 116/275 (42%), Gaps = 30/275 (10%)

Query: 72  KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQL 125
           +LG G FG+V KG  Q       +AVK+L+N        +E + E + + ++ +  +V++
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
           +G C E     LV E    G L++++     + + +  + + E+    + G++YL     
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN- 127

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT-RGTIGYIAPELISRN 244
              +H D+   N+LL      K+SDFGL+K    + ++       +  + + APE I+  
Sbjct: 128 --FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY- 184

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
               S KSDV+ FG+++ E     +               S V   L KG  +       
Sbjct: 185 -YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERM------G 230

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
             +   R++  +   C      +RP    V   L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 4e-54
 Identities = 77/324 (23%), Positives = 138/324 (42%), Gaps = 45/324 (13%)

Query: 68  HFTHKLGQGGFGSVYKGQLQTGGL---IAVKML--ENSKFSAEEFINEVSTIGRI-HHVN 121
            F   +G+G FG V K +++  GL    A+K +    SK    +F  E+  + ++ HH N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVF------------PKESRGQSLCWEKLHEV 169
           ++ LLG C       L  EY P+G+L   +                S   +L  ++L   
Sbjct: 73  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132

Query: 170 ALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISAT 229
           A   ARG++YL        +H D+   NIL+  N++ K++DFGL++       +V  +  
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTMG 186

Query: 230 RGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYD 289
           R  + ++A E +  N+   +  SDV+ +G++L E+           T        + +Y+
Sbjct: 187 RLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYE 237

Query: 290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 349
           +L +G  L      E       ++  +   C + K  +RPS  ++L  L   +++ +   
Sbjct: 238 KLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291

Query: 350 RPFFSSSRHISGTGREIESDSSAE 373
                     +G       D SAE
Sbjct: 292 NTTLYEKFTYAGI------DCSAE 309

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 6e-54
 Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 17/209 (8%)

Query: 66  TNHFT--HKLGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHV 120
            + F    +LG G  G V+K     +G ++A K++  E       + I E+  +   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
            +V   G      + ++  E+M  GSLD+ +     +   +  + L +V++   +G+ YL
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
                  I+H D+KP NIL++     K+ DFG++            ++  GT  Y++PE 
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPER 174

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           +       S +SD++  G+ L+EMA GR 
Sbjct: 175 LQG--THYSVQSDIWSMGLSLVEMAVGRY 201

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 6e-54
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 30/281 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQL----QTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHH 119
               KLG G FG V +G+          +AVK L+    S     ++FI EV+ +  + H
Sbjct: 11  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 70

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N+++L G       + +V E  P GSL   +   +          L   A+  A G+ Y
Sbjct: 71  RNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGY 126

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
           L +      +H D+   N+LL    + K+ DFGL +  P+ +D   +   R     + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E +     T S  SD + FG+ L EM    +   +           S +  +++K G+  
Sbjct: 184 ESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKEGE-- 232

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                       + +  + + C   K  DRP+   + + L 
Sbjct: 233 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 1e-53
 Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 30/281 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQL----QTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVN 121
           HF   +G+G FG VY G L          AVK L          +F+ E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 122 VVQLLGFCSEGSKRA-LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
           V+ LLG C        +V  YM +G L   +        +   + L    L  A+G   +
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKG---M 143

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF--HPKENDFVSISATRGTIGYIAP 238
                   +H D+   N +LD  F  KV+DFGLA+     + +   + +  +  + ++A 
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E +       + KSDV+ FG++L E+         +            +   L +G  L 
Sbjct: 204 ESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRL- 253

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
                         L  + L C   KA  RPS ++++  + 
Sbjct: 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 1e-53
 Identities = 63/270 (23%), Positives = 117/270 (43%), Gaps = 25/270 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLE-NSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
           +LG G FG VYK Q  +T  L A K+++  S+   E+++ E+  +    H N+V+LL   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
              +   ++ E+   G++D  +       + L   ++  V   T   + YLH   D  I+
Sbjct: 79  YYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI---SRNFG 246
           H D+K  NIL   +   K++DFG++  + +        +  GT  ++APE++   +    
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 247 TVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIE 306
               K+DV+  G+ L+EMA                  P  V  ++ K     L   +   
Sbjct: 191 PYDYKADVWSLGITLIEMAEIE--------PPHHELNPMRVLLKIAKSEPPTLAQPSRW- 241

Query: 307 SMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           S   +        C++     R + +++L+
Sbjct: 242 SSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-53
 Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 29/276 (10%)

Query: 73  LGQGGFGSVYKGQLQTGG-----LIAVKMLENSKFSAE--EFINEVSTIGRIHHVNVVQL 125
           +G G FG VYKG L+T        +A+K L+      +  +F+ E   +G+  H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
            G  S+     ++ EYM NG+LD+ +     +       +L  +  G A G++YL N   
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN--- 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV-SISATRGTIGYIAPELISRN 244
           +  +H D+   NIL++ N + KVSDFGL++    + +   + S  +  I + APE IS  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY- 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
               +  SDV+ FG+V+ E+           +          V   +N G  L       
Sbjct: 188 -RKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDGFRL------P 233

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG 340
                   +  + + C Q + A RP    ++ +L+ 
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-53
 Identities = 57/294 (19%), Positives = 115/294 (39%), Gaps = 46/294 (15%)

Query: 68  HFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNV 122
                LG+G FG+VY  +  Q+  ++A+K+L  ++        +   EV     + H N+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           ++L G+  + ++  L+ EY P G++ R +     +      ++        A  + Y H+
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHS 124

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                ++H DIKP N+LL      K++DFG +   P            GT+ Y+ PE+I 
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIE 177

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV 302
                   K D++  G++  E   G+             +  +   +   +   +E    
Sbjct: 178 G--RMHDEKVDLWSLGVLCYEFLVGKP-----------PFEANTYQETYKRISRVEF--- 221

Query: 303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSSS 356
                 +      +    ++   + RP + +VLE              P+ +++
Sbjct: 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH-------------PWITAN 261

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-52
 Identities = 70/299 (23%), Positives = 120/299 (40%), Gaps = 45/299 (15%)

Query: 69  FTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-HH 119
           F   LG G FG V         +      +AVKML+    S+E    ++E+  + ++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK-------------------ESRGQS 160
            N+V LLG C+      L++EY   G L  ++  K                   E     
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 161 LCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE 220
           L +E L   A   A+G+E+L        +H D+   N+L+ H  + K+ DFGLA+    +
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK 280
           +++V     R  + ++APE +    G  + KSDV+ +G++L E+     N          
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV--- 272

Query: 281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +  Y  +  G  +      +       ++ +I   C    +  RPS   +   L 
Sbjct: 273 ---DANFYKLIQNGFKM------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 1e-51
 Identities = 67/272 (24%), Positives = 102/272 (37%), Gaps = 23/272 (8%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
                LG+G +G V       T   +AVK++  + +    E    E+     ++H NVV+
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
             G   EG+ + L  EY   G L   + P       +              G+ YLH   
Sbjct: 68  FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
            + I H DIKP N+LLD     K+SDFGLA      N    ++   GT+ Y+APEL+ R 
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
               +   DV+  G+VL  M  G    +            S       K     L    +
Sbjct: 181 -EFHAEPVDVWSCGIVLTAMLAGELPWDQP--------SDSCQEYSDWKEKKTYLNPWKK 231

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           I       L       +    + R ++  + +
Sbjct: 232 I-DSAPLALLH---KILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 66/301 (21%), Positives = 122/301 (40%), Gaps = 39/301 (12%)

Query: 68  HFTHKLGQGGFGSVYKGQL------QTGGLIAVKMLENSKFSAE--EFINEVSTIGRIHH 119
             + +LGQG FG VY+G        +    +A+K +  +    E  EF+NE S +   + 
Sbjct: 23  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK------ESRGQSLCWEKLHEVALGT 173
            +VV+LLG  S+G    ++ E M  G L  ++                   K+ ++A   
Sbjct: 83  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 174 ARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTI 233
           A G+ YL+       +H D+   N ++  +F  K+ DFG+ +   + + +         +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 234 GYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK 293
            +++PE +    G  +  SDV+ FG+VL E+A           +  +      V   + +
Sbjct: 200 RWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAE-------QPYQGLSNEQVLRFVME 250

Query: 294 GGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFF 353
           GG L      +        L  +   C Q     RPS  +++  ++  ++       P F
Sbjct: 251 GGLL------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME-------PGF 297

Query: 354 S 354
            
Sbjct: 298 R 298

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-51
 Identities = 69/314 (21%), Positives = 122/314 (38%), Gaps = 34/314 (10%)

Query: 72  KLGQGGFGSVYKGQLQTGG-----LIAVKML--ENSKFSAEEFINEVSTIGRIHHVNVVQ 124
            LG G FG+VYKG     G      +A+K L    S  + +E ++E   +  + + +V +
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           LLG C   + + L+ + MP G L  +V        ++  + L    +  A+G+ YL +  
Sbjct: 76  LLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              ++H D+   N+L+      K++DFGLAK    E         +  I ++A E I   
Sbjct: 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH- 187

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
               + +SDV+ +G+ + E+            +       S +   L KG  L       
Sbjct: 188 -RIYTHQSDVWSYGVTVWELMTFGS-------KPYDGIPASEISSILEKGERL------P 233

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQ-----MPPRPFFSSSRHI 359
              +    + MI + C  + A  RP   +++        D Q              S   
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTD 293

Query: 360 SGTGREIESDSSAE 373
           S   R +  +   +
Sbjct: 294 SNFYRALMDEEDMD 307

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 29/283 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQL----QTGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVN 121
                +G+G FG V++G           +A+K  +N    +  E+F+ E  T+ +  H +
Sbjct: 10  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +V+L+G  +E     ++ E    G L   +     R  SL    L   A   +  + YL 
Sbjct: 70  IVKLIGVITEN-PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE 125

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                  +H DI   N+L+  N   K+ DFGL+++      + + S  +  I ++APE I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESI 181

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
             NF   +  SDV+ FG+ + E+                    + V  ++  G  L    
Sbjct: 182 --NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL---- 228

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD 344
              +       L  +   C     + RP  T++   L   +++
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-49
 Identities = 72/294 (24%), Positives = 126/294 (42%), Gaps = 39/294 (13%)

Query: 68  HFTHKLGQGGFGSVYKG------QLQTGGLIAVKMLENSKFSAE--EFINEVSTIGRI-H 118
                LG+G FG V +       +  T   +AVKML+     +E    ++E+  +  I H
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 119 HVNVVQLLGFCSE-GSKRALVYEYMPNGSLDRH------------VFPKESRGQSLCWEK 165
           H+NVV LLG C++ G    ++ E+   G+L  +            V P++     L  E 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           L   +   A+G+E+L +      +H D+   NILL    + K+ DFGLA+   K+ D+V 
Sbjct: 136 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
               R  + ++APE I       + +SDV+ FG++L E+     +               
Sbjct: 193 KGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDE 244

Query: 286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
               +L +G  +              ++    L C   + + RP+ ++++E L 
Sbjct: 245 EFCRRLKEGTRM------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 7e-49
 Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 28/268 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-FINEVSTIGRIHHVNVVQLLGFC 129
           K+GQG  G+VY    + TG  +A++ +   +   +E  INE+  +    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
             G +  +V EY+  GSL   V             ++  V     + +E+LH      ++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH---SNQVI 138

Query: 190 HFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVS 249
           H DIK  NILL  +   K++DFG       E      S   GT  ++APE+++R      
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTR--KAYG 194

Query: 250 CKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESM 308
            K D++  G++ +EM  G     N N         P      +   G  ELQN  ++ S 
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNEN---------PLRALYLIATNGTPELQNPEKL-SA 244

Query: 309 IARKLCMIGLWCIQVKAADRPSMTKVLE 336
           I R        C+ +    R S  ++L+
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-48
 Identities = 65/294 (22%), Positives = 124/294 (42%), Gaps = 41/294 (13%)

Query: 69  FTHKLGQGGFGSVYKGQL--------QTGGLIAVKML--ENSKFSAEEFINEVSTIGRI- 117
               LG+G FG V   +              +AVKML  + ++    + I+E+  +  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 118 HHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRG------------QSLCWEK 165
            H N++ LLG C++     ++ EY   G+L  ++  +   G            + L  + 
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 166 LHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS 225
           L   A   ARG+EYL        +H D+   N+L+  + + K++DFGLA+     + +  
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPS 285
            +  R  + ++APE +       + +SDV+ FG++L E+     +               
Sbjct: 194 TTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 244

Query: 286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
            ++  L +G  +      +  S    +L M+   C     + RP+  +++E L+
Sbjct: 245 ELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-46
 Identities = 61/300 (20%), Positives = 106/300 (35%), Gaps = 50/300 (16%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 122
            F   LG+G F +V   + L T    A+K+LE      E        E   + R+ H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
           V+L     +  K      Y  NG L +++     +  S            TA  +  L  
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDET---CTRFYTAEIVSALEY 123

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I+H D+KP NILL+ +   +++DFG AK    E+     ++  GT  Y++PEL++
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGG 295
               +    SD++  G ++ ++  G                   +  FP   +       
Sbjct: 184 E--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP------ 235

Query: 296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSS 355
                   +   ++ +         + + A  R    ++     G          PFF S
Sbjct: 236 --------KARDLVEK--------LLVLDATKRLGCEEME----GYGPLKAH---PFFES 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 9e-46
 Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 26/273 (9%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQL 125
               +LG G FG V++     TG   A K +     S  E    E+ T+  + H  +V L
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                + ++  ++YE+M  G L   V         +  ++  E      +G+ ++H   +
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 186 VCILHFDIKPHNILL--DHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
              +H D+KP NI+     +   K+ DFGL      +        T GT  + APE+   
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 199

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
               V   +D++  G++   +  G              +      + L      +     
Sbjct: 200 --KPVGYYTDMWSVGVLSYILLSGLS-----------PFGGENDDETLRNVKSCDWNMDD 246

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              S I+          +      R ++ + LE
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (390), Expect = 2e-44
 Identities = 54/304 (17%), Positives = 117/304 (38%), Gaps = 28/304 (9%)

Query: 39  IDNIEKFLRNQQSWMPKRYSYPQIIAMTNHFT--HKLGQGGFGSVYKGQ-LQTGGLIAVK 95
           I++ +KF  +       +    +  ++ +++    +LG G FG V++     TG +   K
Sbjct: 1   INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 60

Query: 96  MLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPK 154
            +            NE+S + ++HH  ++ L     +  +  L+ E++  G L   +   
Sbjct: 61  FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--- 117

Query: 155 ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP--KVSDFG 212
            +    +   ++         G++++H   +  I+H DIKP NI+ +       K+ DFG
Sbjct: 118 AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG 174

Query: 213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSN 272
           LA     +        T  T  + APE++ R    V   +D++  G++   +  G     
Sbjct: 175 LATKLNPDEIVKV---TTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLS--- 226

Query: 273 MNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMT 332
                    +      + L      + +   +  S ++ +        +Q +   R ++ 
Sbjct: 227 --------PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 278

Query: 333 KVLE 336
             LE
Sbjct: 279 DALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-43
 Identities = 43/272 (15%), Positives = 93/272 (34%), Gaps = 25/272 (9%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLL 126
                LG+G FG V++     +      K ++           E+S +    H N++ L 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
                  +  +++E++    +   +    +    L   ++          +++LH     
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SH 121

Query: 187 CILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
            I HFDI+P NI+     +   K+ +FG A+     ++F           Y APE+    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQH- 177

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE 304
              VS  +D++  G ++  +  G              +        +    + E     E
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGIN-----------PFLAETNQQIIENIMNAEYTFDEE 225

Query: 305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               I+ +        +  +   R + ++ L+
Sbjct: 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (370), Expect = 7e-42
 Identities = 49/271 (18%), Positives = 93/271 (34%), Gaps = 23/271 (8%)

Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE--FINEVSTIGRIHHVNVVQL 125
           F   LG G F  V   +  +T  L+A+K +       +E    NE++ + +I H N+V L
Sbjct: 13  FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
                 G    L+ + +  G L   +                 +       ++YLH+   
Sbjct: 73  DDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 186 VCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNF 245
           V             LD +    +SDFGL+K     +   +     GT GY+APE++++  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---CGTPGYVAPEVLAQ-- 183

Query: 246 GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI 305
              S   D +  G++   +  G              ++         +    E +  +  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYP-----------PFYDENDAKLFEQILKAEYEFDSPY 232

Query: 306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              I+          ++     R +  + L+
Sbjct: 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 54/281 (19%), Positives = 105/281 (37%), Gaps = 37/281 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA----------EEFINEVSTIGRIH-H 119
            LG+G    V +     T    AVK+++ +   +          E  + EV  + ++  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 120 VNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            N++QL       +   LV++ M  G L  ++    +   +L  ++  ++       I  
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICA 125

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
           LH    + I+H D+KP NILLD +   K++DFG +           +    GT  Y+APE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPE 179

Query: 240 LIS----RNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 295
           +I      N      + D++  G+++  +  G              ++       L    
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-----------PFWHRKQMLMLRMIM 228

Query: 296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               Q  +      +  +  +    + V+   R +  + L 
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (372), Expect = 1e-41
 Identities = 60/292 (20%), Positives = 112/292 (38%), Gaps = 40/292 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE-------FINEVSTIGRIHHVNVV 123
            +G+GGFG VY  +   TG + A+K L+  +   ++           +S +       +V
Sbjct: 11  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            +        K + + + M  G L  H+    S+        +   A     G+E++H  
Sbjct: 71  CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHMH-- 124

Query: 184 CDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            +  +++ D+KP NILLD +   ++SD GLA    K+        + GT GY+APE++ +
Sbjct: 125 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEVLQK 179

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
                   +D +  G +L ++  G               F        ++   + L    
Sbjct: 180 GVA-YDSSADWFSLGCMLFKLLRGHS------------PFRQHKTKDKHEIDRMTLTMAV 226

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPPRPFFSS 355
           E+    + +L  +    +Q     R         L     +++    PFF S
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLG------CLGRGAQEVKE--SPFFRS 270

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-40
 Identities = 66/286 (23%), Positives = 109/286 (38%), Gaps = 30/286 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSA------EEFINEVSTIGRIHHVNVVQ 124
            LG+G F +VYK +   T  ++A+K ++    S          + E+  +  + H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 125 LLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC 184
           LL      S  +LV+++M            +     L    +    L T +G+EYLH   
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRN 244
              ILH D+KP+N+LLD N + K++DFGLAK     N   + +    T  Y APEL+   
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGA 175

Query: 245 FGTVSCKSDVYGFGMVLLEMAGGR-------------RNSNMNATRSSKAYFPSWVYDQL 291
                   D++  G +L E+                 R      T + + +         
Sbjct: 176 RM-YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 292 NKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM 337
                     +  I S     L  +           R + T+ L+M
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 55/298 (18%), Positives = 111/298 (37%), Gaps = 27/298 (9%)

Query: 61  QIIAMTNHFT--HKLGQGGFGSVYKGQ-LQTGGLIAVKML--ENSKFSAEEFINEVSTIG 115
           Q+  +   +T    +G+G +G V           +A+K +     +   +  + E+  + 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 116 RIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTAR 175
           R  H N++ +       +   +   Y+    +   ++ K  + Q L  + +        R
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILR 120

Query: 176 GIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF-HPKENDFVSISATRGTIG 234
           G++Y+H      +LH D+KP N+LL+     K+ DFGLA+   P  +    ++    T  
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 235 YIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMNATRSSKAYFPSWVYDQ 290
           Y APE++  + G  +   D++  G +L EM   R        ++          S   + 
Sbjct: 178 YRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 291 LNKGGDLELQNV------------TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           LN   +L+ +N               +      K   +    +      R  + + L 
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 5e-40
 Identities = 48/278 (17%), Positives = 93/278 (33%), Gaps = 27/278 (9%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC- 129
           K+G G FG +Y G  +  G  +A+K+    K    +   E      +     +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 130 SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCIL 189
           +EG    +V E +     D          +    + +  +A      IEY+H       +
Sbjct: 73  AEGDYNVMVMELLGPSLEDLF----NFCSRKFSLKTVLLLADQMISRIEYIH---SKNFI 125

Query: 190 HFDIKPHNIL---LDHNFIPKVSDFGLAKFHPKENDFVSI-----SATRGTIGYIAPELI 241
           H D+KP N L        +  + DFGLAK +        I         GT  Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN 301
                  S + D+   G VL+    G          + +  +      +++         
Sbjct: 186 LG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-------TP 236

Query: 302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE 339
           +  +      +      +C  ++  D+P  + + ++  
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  140 bits (354), Expect = 8e-40
 Identities = 56/282 (19%), Positives = 100/282 (35%), Gaps = 31/282 (10%)

Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVV 123
               LG GG   V+  + L+    +AVK+L             F  E      ++H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 124 QLLGFC----SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            +          G    +V EY+   +L   V         +  ++  EV     + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATR-GTIGYIAP 238
                   I+H D+KP NI++      KV DFG+A+      + V+ +A   GT  Y++P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 239 ELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE 298
           E       +V  +SDVY  G VL E+  G              +          +    +
Sbjct: 184 EQARG--DSVDARSDVYSLGCVLYEVLTGEP-----------PFTGDSPVSVAYQHVRED 230

Query: 299 LQNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLE 339
               +     ++  L  + L  +     +R  +  ++   L 
Sbjct: 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 1e-38
 Identities = 61/277 (22%), Positives = 103/277 (37%), Gaps = 35/277 (12%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML-------ENSKFSAEEFINEVSTIGRIHHVNVV 123
           +LG G F  V K +   TG   A K +            S E+   EVS +  I H NV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
            L       +   L+ E +  G L   +       +SL  E+  E       G   ++  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNG---VYYL 129

Query: 184 CDVCILHFDIKPHNILLDHNFIP----KVSDFGLAKFHPKENDFVSISATRGTIGYIAPE 239
             + I HFD+KP NI+L    +P    K+ DFGLA      N+F       GT  ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186

Query: 240 LISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
           ++  N+  +  ++D++  G++   +  G              +      + L     +  
Sbjct: 187 IV--NYEPLGLEADMWSIGVITYILLSGASP-----------FLGDTKQETLANVSAVNY 233

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
           +   E  S  +          +      R ++   L+
Sbjct: 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  137 bits (346), Expect = 1e-38
 Identities = 44/295 (14%), Positives = 95/295 (32%), Gaps = 31/295 (10%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQL 125
               ++G+G FG +++G  L     +A+K     +  A +  +E  T   +     +  +
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 126 LGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD 185
             F  EG    LV + +     D      +  G+    + +   A      ++ +H   +
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLL----DLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 186 VCILHFDIKPHNILLDHNFIP-----KVSDFGLAKFHPKEND-----FVSISATRGTIGY 235
             +++ DIKP N L+            V DFG+ KF+          +       GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 236 IAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG 295
           ++           S + D+   G V +    G                 +    +  + G
Sbjct: 180 MSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQ--------GLKAATNKQKYERIG 229

Query: 296 DLELQN-VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMPP 349
           + +    + E+ +    +      +   +     P    +  +    ++ L    
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 5e-38
 Identities = 58/287 (20%), Positives = 118/287 (41%), Gaps = 30/287 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGG-LIAVKML------ENSKFSAEEFINEVSTIGRIHHVNVV 123
           ++G+G +G V+K + L+ GG  +A+K +      E    S    +  +  +    H NVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 124 QLLGFCSEGSKRALVYEYMPNGSLDRHV--FPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +L   C+           +    +D+ +  +  +     +  E + ++     RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
                 ++H D+KP NIL+  +   K++DFGLA+ +  +    S+     T+ Y APE++
Sbjct: 134 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEVL 187

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR----NSNMN--------ATRSSKAYFPSWVYD 289
            +   + +   D++  G +  EM   +     +S+++             +  +P  V  
Sbjct: 188 LQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 290 QLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                     Q + +  + I      + L C+    A R S    L 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  136 bits (343), Expect = 6e-38
 Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 26/232 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLL 126
            LG G FG V+  +    G   A+K+L+          E   +E   +  + H  ++++ 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 127 GFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
           G   +  +  ++ +Y+  G L   +   +     +      EV L        L      
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHSK 123

Query: 187 CILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFG 246
            I++ D+KP NILLD N   K++DFG AK+ P            GT  YIAPE++S    
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST--K 176

Query: 247 TVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQL 291
             +   D + FG+++ EM  G                 +++  FP +  + +
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 9e-38
 Identities = 52/236 (22%), Positives = 91/236 (38%), Gaps = 24/236 (10%)

Query: 69  FTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS----AEEFINEVSTIGR-IHHVNV 122
               LG+G FG V+  +  +T    A+K L+          E  + E   +     H  +
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
             +            V EY+  G L  H+             +    A     G+++L  
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFL-- 119

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                I++ D+K  NILLD +   K++DFG+ K +   +     +   GT  YIAPE++ 
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILL 176

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQL 291
                 +   D + FG++L EM  G+            ++ R    ++P W+  + 
Sbjct: 177 G--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 33/286 (11%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G VYK +   TG ++A+K +     +       I E+S +  ++H N+V+LL 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                +K  LV+E++         F   S    +    +        +G+ +        
Sbjct: 69  VIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++     K++DFGLA+         +      T+ Y APE++      
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VTLWYRAPEILLGC-KY 179

Query: 248 VSCKSDVYGFGMVLLEMAGGRR----NSNMNA--------TRSSKAYFPSWVYD-----Q 290
            S   D++  G +  EM   R     +S ++             +  +P           
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 291 LNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             K    +   V        R L       +      R S    L 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-37
 Identities = 57/273 (20%), Positives = 107/273 (39%), Gaps = 30/273 (10%)

Query: 73  LGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFC- 129
           LG G  G V +    +T    A+KML++      +   EV    R     ++V+++    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYE 75

Query: 130 ---SEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDV 186
              +      +V E +  G L   +  ++   Q+    +  E+       I+YLH    +
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 187 CILHFDIKPHNILLDH---NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISR 243
            I H D+KP N+L      N I K++DFG AK     N   +   T     Y+APE++  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP---YYVAPEVLGP 187

Query: 244 NFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT 303
                    D++  G+++  +  G        +    A  P        + G  E  N  
Sbjct: 188 --EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMK--TRIRMGQYEFPN-- 238

Query: 304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              S ++ ++ M+    ++ +   R ++T+ + 
Sbjct: 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 8e-37
 Identities = 58/277 (20%), Positives = 95/277 (34%), Gaps = 45/277 (16%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS-------AEEFINEVSTIGRIH--HVN 121
            LG GGFGSVY G  +     +A+K +E  + S             EV  + ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           V++LL +        L+ E               +   +L  E            + +  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC- 126

Query: 182 NGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPEL 240
              +  +LH DIK  NIL+D N    K+ DFG              +   GT  Y  PE 
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEW 180

Query: 241 ISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
           I R        + V+  G++L +M  G     +       + +F   V            
Sbjct: 181 I-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV------------ 227

Query: 300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
                  S   + L     WC+ ++ +DRP+  ++  
Sbjct: 228 -------SSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  132 bits (333), Expect = 9e-37
 Identities = 57/282 (20%), Positives = 99/282 (35%), Gaps = 27/282 (9%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGF 128
           K+G+G +G VYK Q   G   A+K +   K         I E+S +  + H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCI 188
                +  LV+E++           +      L         L    GI Y H   D  +
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRV 121

Query: 189 LHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTV 248
           LH D+KP N+L++     K++DFGLA+           +    T+ Y AP+++       
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVL-MGSKKY 178

Query: 249 SCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGGDL---- 297
           S   D++  G +  EM  G            +           S  +  + +        
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 298 ---ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
              E          +      +    +++    R +  + LE
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-35
 Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 27/224 (12%)

Query: 54  PKRYSYPQIIAMTNHFTHKLGQGGFGSVYKGQL-QTGGLIAVKMLENSKFSAEEFINEVS 112
           P+  SY          T  +G G FG VY+ +L  +G L+A+K +   K        E+ 
Sbjct: 17  PQEVSY--------TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQ 65

Query: 113 TIGRIHHVNVVQLLGFCSEGSKR------ALVYEYMPNGSLDRHVFPKESRGQSLCWEKL 166
            + ++ H N+V+L  F     ++       LV +Y+P     R         Q+L    +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYV 124

Query: 167 HEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVS 225
                   R + Y+H      I H DIKP N+LLD +  + K+ DFG AK   +    VS
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
              +R    Y APELI       +   DV+  G VL E+  G+ 
Sbjct: 182 YICSR---YYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQP 221

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-35
 Identities = 52/296 (17%), Positives = 100/296 (33%), Gaps = 39/296 (13%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 127
           K+GQG FG V+K +  +TG  +A+K +             + E+  +  + H NVV L+ 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 128 FCSEGSKRA--------LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEY 179
            C   +           LV+++  +               S     +  +       +  
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-------LNG 129

Query: 180 LHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH--PKENDFVSISATRGTIGYIA 237
           L+      ILH D+K  N+L+  + + K++DFGLA+     K +     +    T+ Y  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 238 PELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQ 290
           PEL+           D++G G ++ EM               +             V+  
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 291 LNKGGDLELQNVTEIESMIARKLCMIGLW----------CIQVKAADRPSMTKVLE 336
           ++     E   + + +    +      +            + +  A R      L 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 4e-34
 Identities = 49/207 (23%), Positives = 79/207 (38%), Gaps = 16/207 (7%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEE----FINEVSTIGRIHHVNV 122
            +   LG+G FG V   +   TG   A+K+L      A++     + E   +    H  +
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 123 VQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN 182
             L        +   V EY   G L  H+  +                   A  +  L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEY 120

Query: 183 GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
                +++ DIK  N++LD +   K++DFGL K    +   +      GT  Y+APE++ 
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLE 178

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                     D +G G+V+ EM  GR 
Sbjct: 179 D--NDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-34
 Identities = 48/284 (16%), Positives = 104/284 (36%), Gaps = 29/284 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
           K+G+G +G+V+K +  +T  ++A+K +   ++ +      + E+  +  + H N+V+L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
                 K  LV+E+                           V     + ++ L       
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           +LH D+KP N+L++ N   K+++FGLA+         S      T+ Y  P+++      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA-KL 178

Query: 248 VSCKSDVYGFGMVLLEMAGGRR--------NSNMNATRSSKAYFPSWVYDQLNKGGDLEL 299
            S   D++  G +  E+A   R        +  +              +  + K  D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 300 QNVTEIESMIARKLCMIG-------LWCIQVKAADRPSMTKVLE 336
             +    + +   +  +           ++     R S  + L+
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 6e-34
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 22/238 (9%)

Query: 40  DNIEKFLRNQQSWMPKRYSYP-QIIAMTNHFT--HKLGQGGFGSVYKGQ-LQTGGLIAVK 95
           +++++FL   +    K++  P Q  A  + F     LG G FG V   +  ++G   A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 96  MLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNGSLDRHV 151
           +L+  K       E  +NE   +  ++   +V+L     + S   +V EY+  G +  H+
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132

Query: 152 FPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF 211
                R            A       EYLH    + +++ D+KP N+L+D     +V+DF
Sbjct: 133 R----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDF 185

Query: 212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
           G AK        +      GT   +APE+I       +   D +  G+++ EMA G  
Sbjct: 186 GFAKRVKGRTWTL-----CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYP 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  119 bits (300), Expect = 1e-31
 Identities = 53/297 (17%), Positives = 116/297 (39%), Gaps = 44/297 (14%)

Query: 68  HFTHKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQL 125
               KLG+G +  V++   +     + VK+L+  K   ++   E+  +  +    N++ L
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITL 95

Query: 126 LGFCSEGSKR--ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNG 183
                +   R  ALV+E++ N    +         Q+L    +        + ++Y H  
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH-- 146

Query: 184 CDVCILHFDIKPHNILLDH-NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELIS 242
             + I+H D+KPHN+++DH +   ++ D+GLA+F+    ++   +    +  +  PEL+ 
Sbjct: 147 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELL- 201

Query: 243 RNFGTVSCKSDVYGFGMVLLEMAGGR------RNSNMNATRSSKAYFPSWVYDQLNKGGD 296
            ++       D++  G +L  M   +       ++     R +K      +YD ++K   
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 297 LELQNVTEIESMIARKLCMIGL-----------------WCIQVKAADRPSMTKVLE 336
                  +I    +RK     +                   ++     R +  + +E
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-31
 Identities = 55/285 (19%), Positives = 110/285 (38%), Gaps = 29/285 (10%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKML---ENSKFSAEEFINEVSTIGRIHHVNVVQLLG 127
            +G G +G+V      +TG  +A+K L     S+  A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             +         ++            K  + + L  +++  +     +G+ Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP N+ ++ +   K+ DFGLA+    E     ++    T  Y APE+I  N+  
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVI-LNWMR 195

Query: 248 VSCKSDVYGFGMVLLEMAGGRR-------NSNMNATRSSKAYFPSWVYDQLNKGG----- 295
            +   D++  G ++ EM  G+           +          P+    +L         
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 296 ----DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
               +LE ++   I +  +     +    + + A  R +  + L 
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 7e-30
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 18/208 (8%)

Query: 72  KLGQGGFGSVYKGQL----QTGGLIAVKMLENSKFS-----AEEFINEVSTIGRI-HHVN 121
            LG G +G V+  +      TG L A+K+L+ +         E    E   +  I     
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90

Query: 122 VVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
           +V L       +K  L+ +Y+  G L  H+  +E   +      + E+ L        L 
Sbjct: 91  LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA-------LE 143

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +   + I++ DIK  NILLD N    ++DFGL+K    +    +     GTI Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIV 202

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGRR 269
                      D +  G+++ E+  G  
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 51/347 (14%), Positives = 118/347 (34%), Gaps = 55/347 (15%)

Query: 71  HKLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFC 129
            KLG G F +V+  + +     +A+K++   K   E   +E+  + R++  +  +     
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 130 SEGSKRALVY--EYMPNGSLDRHV----------FPKESRGQSLCWEKLHEVALGTARGI 177
           +    + L +     PNG     V            K+   + +    + +++     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 178 EYLHNGCDVCILHFDIKPHNILLDHN-FIPKVSDFGLAKFHPKENDFVSISATRGTIGYI 236
           +Y+H  C   I+H DIKP N+L++       +    +A            + +  T  Y 
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 237 APELISRNFGTVSCKSDVYGFGMVLLEMAGGRR--------------------------- 269
           +PE++        C +D++    ++ E+  G                             
Sbjct: 197 SPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 270 --NSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGL----WCIQV 323
                 N   +   +    +   ++K     L++V   +   ++             +Q+
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 324 KAADRPSMTKVLEM----LEGSIDDLQMPPRPFFSSSRHISGTGREI 366
               R     ++          ++++++P R  + S   I G   E+
Sbjct: 315 DPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEV 361

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 1e-26
 Identities = 57/288 (19%), Positives = 107/288 (37%), Gaps = 35/288 (12%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 127
            +G G +GSV      +TG  +AVK L     S   A+    E+  +  + H NV+ LL 
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84

Query: 128 FCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC 187
             +         +      L         + Q L  + +  +     RG++Y+H      
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141

Query: 188 ILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGT 247
           I+H D+KP N+ ++ +   K+ DFGLA+    E      +    T  Y APE++  N+  
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIM-LNWMH 195

Query: 248 VSCKSDVYGFGMVLLEMAGGRR----NSNMNA---------------TRSSKAYFPSWVY 288
            +   D++  G ++ E+  GR       +++                 +   +       
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255

Query: 289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE 336
             L +   +   NV    + +A  L       + + +  R +  + L 
Sbjct: 256 QSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 6e-26
 Identities = 46/207 (22%), Positives = 79/207 (38%), Gaps = 25/207 (12%)

Query: 72  KLGQGGFGSVYKGQ-LQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLG 127
            +G G  G V           +A+K L     +   A+    E+  +  ++H N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 128 FCS------EGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLH 181
             +      E     LV E M            +        E++  +      GI++LH
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136

Query: 182 NGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELI 241
           +     I+H D+KP NI++  +   K+ DFGLA+           +    T  Y APE+I
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVI 190

Query: 242 SRNFGTVSCKSDVYGFGMVLLEMAGGR 268
                      D++  G ++ EM   +
Sbjct: 191 LGM--GYKENVDIWSVGCIMGEMVRHK 215

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.4 bits (200), Expect = 7e-19
 Identities = 27/162 (16%), Positives = 49/162 (30%), Gaps = 22/162 (13%)

Query: 72  KLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSA-----------EEFINEVSTIGRIHHV 120
            +G+G   +V+    +  G   VK  +    S              F        R    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 121 NVVQLLGFCSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYL 180
            + +L G          VY +  N  L   +  KE     +      EV       +   
Sbjct: 67  ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAKF 119

Query: 181 HNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND 222
           ++     I+H D+  +N+L+       + DF  +    +E  
Sbjct: 120 YH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	373
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.58
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.84
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.0

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-56  Score=395.93  Aligned_cols=251  Identities=25%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .|++.+.||+|+||+||+|.++ +|+.||||++.....  ..+++.+|+.++++++||||+++++++.+++..|+|||||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~   85 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC   85 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence            4778899999999999999976 789999999876433  2356889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      ++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|........
T Consensus        86 ~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          86 SGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             TTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999983    345799999999999999999999998   999999999999999999999999999987654443


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      .......+||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.......       ............. .  
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~~~~~~~~~~-~--  227 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYL-N--  227 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-------HHHHHHHTTCTTS-T--
T ss_pred             cccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-------HHHHHHhcCCCCC-C--
Confidence            3334556799999999998764 234678999999999999999999997544321       1111122211111 1  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ....++..+.+|+.+||+.||++|||++|+++
T Consensus       228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 --PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11234667899999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=399.40  Aligned_cols=262  Identities=29%  Similarity=0.469  Sum_probs=206.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||+||+|+++  +.||||+++....   ..+.+.+|+.++++++||||+++++++.+ ...++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            34667899999999999999865  4699999875432   34778999999999999999999998765 568999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |++|+|.+++..   .+..+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          85 CEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             CCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999998843   235699999999999999999999998   99999999999999999999999999998765444


Q ss_pred             CceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          222 DFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .........||+.|+|||++.+. .+.++.++|||||||++|||++|+.||......       .........+....  
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p--  229 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSP--  229 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCC--
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCC--
Confidence            43344566799999999998653 245789999999999999999999999754432       12223333332211  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .....+..++..+.+|+.+||+.||++|||++|+++.|+.+.++
T Consensus       230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            12233345567899999999999999999999999999876543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=390.61  Aligned_cols=254  Identities=28%  Similarity=0.478  Sum_probs=204.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      .|++.+.||+|+||+||+|.+++++.||||+++......+++.+|+.++++++||||+++++++..++..++|||||++|
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g   85 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   85 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence            45678999999999999999988889999999988878899999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|.+++..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++........ .
T Consensus        86 ~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~  158 (263)
T d1sm2a_          86 CLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-S  158 (263)
T ss_dssp             BHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             cHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-e
Confidence            99998743   346689999999999999999999998   9999999999999999999999999999866443322 2


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccchh
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTEI  305 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (373)
                      .....||+.|+|||++.+.  .++.++|||||||++|||+++..|+.....       .......+..+.....+     
T Consensus       159 ~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~~~p-----  224 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRLYKP-----  224 (263)
T ss_dssp             ------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCCCCCC-----
T ss_pred             ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCCCCCc-----
Confidence            2345689999999999765  789999999999999999996555543322       12233444444433322     


Q ss_pred             hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          306 ESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       306 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                       ..++..+.+|+.+||+.||++|||++|+++.|+.+
T Consensus       225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence             22356789999999999999999999999999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.1e-56  Score=396.69  Aligned_cols=261  Identities=29%  Similarity=0.431  Sum_probs=219.8

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ....|++.+.||+|+||+||+|.++ +++.||||+++.+....+++.+|+.+++.++||||+++++++.+++..++||||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            3456778899999999999999976 688999999998888888999999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      |++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++......
T Consensus        95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999999888432  346799999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCc
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQN  301 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (373)
                      . .......|++.|+|||++.+.  .++.++|||||||++|||++|..|+......       ....+.+..+..+..+ 
T Consensus       170 ~-~~~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~~~~~~~~-  238 (287)
T d1opja_         170 Y-TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKDYRMERP-  238 (287)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTTCCCCCC-
T ss_pred             c-eeeccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhcCCCCCCC-
Confidence            2 233445689999999998775  7899999999999999999988776543321       2233444444433332 


Q ss_pred             cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          302 VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       302 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                           ..++..+.+|+.+||+.||++|||++|+++.|+.+.++
T Consensus       239 -----~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         239 -----EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 23456899999999999999999999999999987654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=392.53  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=212.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ..|++.+.||+|+||.||+|.+++++.||||+++......+++.+|+.++++++||||+++++++.+ +..++|||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            4678889999999999999999888899999999887788899999999999999999999998865 567999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++...  .+..+++..+..++.||++||.|||++   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        92 g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            9999877433  234689999999999999999999998   99999999999999999999999999998765432 22


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      ......||+.|+|||++.+.  .++.++|||||||++|||+||..|+.....       .......+..+.....+    
T Consensus       166 ~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p----  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRP----  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCC----
T ss_pred             cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCc----
Confidence            23455689999999998764  789999999999999999997766543332       12234444444433332    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        ..++..+.+|+.+||+.||++|||++++++.|+.
T Consensus       233 --~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 --DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence              2345678999999999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-56  Score=393.03  Aligned_cols=254  Identities=23%  Similarity=0.316  Sum_probs=197.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeee--CCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSE--GSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv  138 (373)
                      ..|++.+.||+|+||+||+|+.+ +|+.||+|.+.....+.   +.+.+|+.++++++||||+++++++.+  +...|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            35788899999999999999875 78899999998765443   568899999999999999999999864  4568999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC--DVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ||||++|+|.+++......+..+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||++..
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988654445677999999999999999999999851  12499999999999999999999999999987


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ......  ......||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....        ......+..+..
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~  231 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKF  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCC
Confidence            654332  22346799999999999764  789999999999999999999999975432        123333333332


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...      +..++..+.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 RRI------PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            222      2345678999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=388.81  Aligned_cols=243  Identities=23%  Similarity=0.399  Sum_probs=205.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||+||+|+++ +++.||+|++...    ....+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            5788899999999999999976 7889999998643    2345678899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|.+++.    +...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        87 y~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          87 YAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             ecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999883    345699999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .    .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||......        .....+.... ..  
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~-~~--  222 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVE-FT--  222 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTC-CC--
T ss_pred             c----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC-CC--
Confidence            2    2345799999999999875  6889999999999999999999999754321        1223333222 11  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .+..++..+.+|+.+||+.||++|||++|+++
T Consensus       223 ----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                12335678999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=381.97  Aligned_cols=252  Identities=26%  Similarity=0.428  Sum_probs=214.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCcC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPNG  145 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~g  145 (373)
                      .+++.++||+|+||+||+|++++++.||||+++......+++.+|+.++++++||||+++++++.++...++||||+++|
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g   84 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG   84 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence            35678999999999999999988889999999988888899999999999999999999999999999999999999999


Q ss_pred             CccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCcee
Q 048542          146 SLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFVS  225 (373)
Q Consensus       146 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  225 (373)
                      +|.+++..   ....+++..+..++.|+++||+|||++   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        85 ~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  157 (258)
T d1k2pa_          85 CLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS  157 (258)
T ss_dssp             EHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred             cHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence            99888643   245688999999999999999999998   999999999999999999999999999986544322 22


Q ss_pred             eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccch
Q 048542          226 ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVTE  304 (373)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (373)
                      .....||+.|+|||.+.+.  .++.++|||||||++|||++ |+.||......        .+...+..+.....+    
T Consensus       158 ~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p----  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRP----  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCCCCC----
T ss_pred             ecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCCc----
Confidence            3445689999999999875  78999999999999999998 78888755432        233444444443333    


Q ss_pred             hhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          305 IESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       305 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                        ...+..+.+|+.+||+.||++|||++++++.|..
T Consensus       224 --~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 --HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             --ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence              2334679999999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-55  Score=389.80  Aligned_cols=247  Identities=26%  Similarity=0.356  Sum_probs=205.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCc-cCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSK-FSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +|++.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+++..|+|||||+
T Consensus        21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~  100 (293)
T d1yhwa1          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (293)
T ss_dssp             TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence            4778899999999999999865 78999999987543 345778999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+++.     ...+++..+..++.|++.||+|||++   ||+||||||+|||++.++++||+|||++........ 
T Consensus       101 gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         101 GGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            999998763     24599999999999999999999998   999999999999999999999999999987644332 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                       ......||+.|+|||++.+.  .++.++||||+||++|+|++|..||......       .......... .....   
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~-~~~~~---  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG-TPELQ---  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHC-SCCCS---
T ss_pred             -cccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCC-CCCCC---
Confidence             23455799999999999774  7889999999999999999999999754321       1122222222 22221   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                       .+..++..+.+|+.+||+.||.+|||++|+++
T Consensus       238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             22345678999999999999999999999975

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-55  Score=392.86  Aligned_cols=257  Identities=28%  Similarity=0.447  Sum_probs=198.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCc---eeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGG---LIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~---~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||+||+|.++ +++   .||||.+......  .+++.+|+.++++++||||+++++++.++...++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            34566789999999999999875 333   5889988754333  36789999999999999999999999999999999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ||||++|+|.+++..   ....+++..+..++.|+++||+|||++   +++||||||+|||++.++++||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999987742   345699999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCce---eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          219 KENDFV---SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       219 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ......   ......||+.|+|||.+.+.  .++.++|||||||++|||+| |..||......        .+...+..+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~  249 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQD  249 (299)
T ss_dssp             ----------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTT
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC
Confidence            433221   12234578999999998764  78999999999999999998 89998754321        233444444


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      .....+      ..++..+.+|+.+||+.||++|||++|+++.|+.+++
T Consensus       250 ~~~~~~------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         250 YRLPPP------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCC------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            333322      2345678999999999999999999999999987654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=386.18  Aligned_cols=263  Identities=27%  Similarity=0.411  Sum_probs=212.2

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      ...|++.+.||+|+||.||+|.+++++.||||+++......+.+.+|+.++++++||||+++++++.+ +..++|||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            35688899999999999999999888899999998888788899999999999999999999999855 56799999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|..++....  ...+++..+..++.||+.||+|||++   +++||||||+|||++.++++||+|||+++....... 
T Consensus        95 ~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          95 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999988875432  34699999999999999999999998   999999999999999999999999999986543322 


Q ss_pred             eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          224 VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                      .......||+.|+|||.+.+.  .++.++|||||||++|||++|..|+......       ......+..+...+.+   
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-------~~~~~~i~~~~~~~~~---  236 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYRMPCP---  236 (285)
T ss_dssp             -------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCCCCCC---
T ss_pred             eeeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhcCCCCCC---
Confidence            223445699999999999764  7899999999999999999987776544332       2233344444333322   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDLQMP  348 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~~~~  348 (373)
                         ..++..+.+|+.+||+.||++|||+++|+++|+.......++
T Consensus       237 ---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         237 ---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             ---cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence               334568999999999999999999999999999977654433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=378.86  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=198.7

Q ss_pred             hhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeee----CCeeEEEE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSE----GSKRALVY  139 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~~lv~  139 (373)
                      ++.++||+|+||+||+|.+. ++..||+|.+......   .+.+.+|++++++++||||+++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56778999999999999976 6889999998765433   3568899999999999999999999864    45679999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCC--eEecCcCCCCeeee-CCCceEEeeccCccc
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVC--ILHFDIKPHNILLD-HNFIPKVSDFGLAKF  216 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~  216 (373)
                      |||++|+|.+++.    +...+++..+..++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+++.
T Consensus        92 E~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          92 ELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             ECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999999999883    345699999999999999999999987   6  99999999999996 578999999999986


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      .....    .....||+.|+|||++.+   .++.++|||||||++|+|++|+.||......       ......+..+..
T Consensus       165 ~~~~~----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~~  230 (270)
T d1t4ha_         165 KRASF----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVK  230 (270)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCC
T ss_pred             ccCCc----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCCC
Confidence            44322    234679999999999864   5889999999999999999999999754321       123333333322


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..     ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~-----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PA-----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CG-----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc-----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11     222334567899999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-55  Score=391.32  Aligned_cols=247  Identities=22%  Similarity=0.303  Sum_probs=203.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||+||+|.++ +|+.||||++...    ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            35788999999999999999975 7899999998753    234467899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        88 Ey~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999998873    345799999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...........||+.|+|||++.+.  .++.++||||+||++|+|++|..||.....        ......+..+. ..+
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~-~~~  229 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLE-YDF  229 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC-CCC
T ss_pred             CCcccccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCC-CCC
Confidence            4433344456799999999999875  788999999999999999999999975432        12223333222 111


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVL  335 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell  335 (373)
                            +..++.++.+|+.+||+.||++|||++|++
T Consensus       230 ------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         230 ------PEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ------CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence                  233567899999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=382.87  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=206.7

Q ss_pred             hhhhc-ccCCCCcEEEEEEEEc---CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           67 NHFTH-KLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        67 ~~~~~-~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      +.+.+ +||+|+||.||+|.++   ++..||||+++.....  .+++.+|+.++++++||||+++++++.+ +..++|||
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE   88 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME   88 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence            34445 4999999999999764   3457999999765432  3678999999999999999999999865 46899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|.+++..   .+..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          89 MAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             CCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             eCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999998732   345799999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          221 NDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       221 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .... ......||+.|+|||++.+.  .++.++|||||||++|||++ |..||......        .+...+..+..++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~~~  232 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRME  232 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCCCC
T ss_pred             ccccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            3322 22345689999999999764  78999999999999999998 89999754432        2344455555444


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      .+      ..++..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       233 ~p------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         233 CP------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            33      34457889999999999999999999999999854

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=387.06  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=205.1

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      .|++.+.||+|+||+||+|.++ +|..||+|+++.... ..+.+.+|+++++.++||||+++++++.+++..++|||||+
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~   92 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   92 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence            4678899999999999999976 788999999976433 34678999999999999999999999999999999999999


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCc
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDF  223 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  223 (373)
                      +|+|.+++..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||++.......  
T Consensus        93 ~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          93 GGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            9999988742   245699999999999999999999998   99999999999999999999999999997543211  


Q ss_pred             eeeecccCCCCcccccccccc---cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          224 VSISATRGTIGYIAPELISRN---FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~---~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .......||+.|+|||++...   ...++.++|||||||++|+|++|+.||......+        ....+..+....+.
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~  236 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSEPPTLA  236 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSCCCCCS
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCCCC
Confidence            112345699999999998532   2457889999999999999999999997654321        22222333222221


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                          .+..++..+.+|+.+||+.||++|||++|+++
T Consensus       237 ----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 ----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                12345678999999999999999999999876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-54  Score=383.16  Aligned_cols=246  Identities=26%  Similarity=0.426  Sum_probs=200.2

Q ss_pred             cccCCCCcEEEEEEEEc---CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           71 HKLGQGGFGSVYKGQLQ---TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      ++||+|+||+||+|.++   +++.||||+++....+   .+++.+|+.++++++||||++++++|.+ +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999865   3467999999754322   3678999999999999999999999865 457899999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            99999883    346699999999999999999999998   99999999999999999999999999998765443332


Q ss_pred             e-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          225 S-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       225 ~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                      . .....||+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....        ..+...+..+..+..+  
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p--  232 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCP--  232 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCC--
T ss_pred             ccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence            2 2345689999999999764  78899999999999999998 8999875432        2234445555444333  


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                          ..++..+.+|+.+||+.||++|||+++|++.|+.
T Consensus       233 ----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         233 ----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                2345688999999999999999999999998875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=392.00  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=208.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC-C-----ceeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT-G-----GLIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~  135 (373)
                      ..+++.+.||+|+||+||+|++.. +     ..||+|.+.....  ....+.+|+.++.++ +||||+++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            467788999999999999998652 2     2589998865432  236788999999998 899999999999999999


Q ss_pred             EEEEeccCcCCccccccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCC
Q 048542          136 ALVYEYMPNGSLDRHVFPKES-------------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPH  196 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~  196 (373)
                      ++|||||++|+|.+++.....                   ....+++..+..++.|++.||+|||++   +|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence            999999999999999854432                   124589999999999999999999998   9999999999


Q ss_pred             CeeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCc
Q 048542          197 NILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNA  275 (373)
Q Consensus       197 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~  275 (373)
                      |||++.++++||+|||+|+...............||+.|+|||++.+.  .++.++|||||||++|||++ |..||....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999876555444444556689999999998764  78999999999999999997 899987544


Q ss_pred             CccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 048542          276 TRSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLE  339 (373)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~  339 (373)
                      ..       ......+..+..+..+      ..++..+.+|+.+||+.||++|||++||++.|.
T Consensus       272 ~~-------~~~~~~~~~~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD-------ANFYKLIQNGFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS-------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH-------HHHHHHHhcCCCCCCC------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32       1233444444443332      234568999999999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-54  Score=387.84  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=203.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH----HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA----EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|+..+.||+|+||+||+|.+. +|+.||||++.......    +.+.+|+.+++.++||||+++++++.++...|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35777899999999999999865 78899999997654432    46889999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||.+|+|..++    ..+..+++..+..++.||+.||.|||++   +|+||||||+|||++.++++||+|||++.....
T Consensus        95 E~~~~g~l~~~~----~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          95 EYCLGSASDLLE----VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             ECCSEEHHHHHH----HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999987655    2346799999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccc-cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRN-FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      .      ....||+.|+|||++.+. .+.++.++|||||||++|+|++|..||......       . .......+....
T Consensus       168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-------~-~~~~i~~~~~~~  233 (309)
T d1u5ra_         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------S-ALYHIAQNESPA  233 (309)
T ss_dssp             B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------H-HHHHHHHSCCCC
T ss_pred             C------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhCCCCC
Confidence            2      245699999999998653 246889999999999999999999999754321       1 112222222222


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...     ..++..+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 LQS-----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CSC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC-----CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            211     234568999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-54  Score=389.80  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=191.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      ..|++.+.||+|+||+||+|.++ +|+.||||++......  ...+.+|+.+++.++||||+++++++.++...|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45788899999999999999976 7889999999764432  35678999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee---CCCceEEeeccCcccCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~  218 (373)
                      |++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||++.   .++.+||+|||++....
T Consensus        89 ~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          89 VSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             cCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999983    346799999999999999999999998   999999999999994   57899999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC-Cc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG-DL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~  297 (373)
                      ...   .....+||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+..+. ..
T Consensus       162 ~~~---~~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~  228 (307)
T d1a06a_         162 PGS---VLSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEF  228 (307)
T ss_dssp             --------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCC
T ss_pred             CCC---eeeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCC
Confidence            332   22345699999999999875  7899999999999999999999999754321        1222222222 11


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .    ......++..+.+|+.+||+.||++|||++|+++
T Consensus       229 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 D----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1    1222345678999999999999999999999988

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=392.12  Aligned_cols=255  Identities=23%  Similarity=0.327  Sum_probs=202.0

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      ...|++.++||+|+||+||+|.+. +|+.||+|+++....  ..+++.+|+.+++.++||||+++++++.++...|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            456788899999999999999975 788999999876433  24678999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||++|+|.+++.    +...+++..+..++.|++.||.|||+ +   +|+||||||+|||++.++++||+|||+|.....
T Consensus        85 y~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999884    23569999999999999999999996 5   899999999999999999999999999986532


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHH------------
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWV------------  287 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~------------  287 (373)
                      ..    .....||+.|+|||++.+.  .++.++||||+||++|||++|+.||................            
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             Cc----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            21    2345799999999999875  78999999999999999999999997654321100000000            


Q ss_pred             ----------------------HHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          288 ----------------------YDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       288 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                            ............+     ...++.++.+|+.+||+.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP-----SGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCC-----BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                  0000000000000     0123567899999999999999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=383.91  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=202.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCC-----ceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTG-----GLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      ..+++.+.||+|+||.||+|.++++     ..||||.+......  ..++.+|+.++++++||||+++++++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            3456778999999999999987632     36999998764433  3568899999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||.++++.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999887632   346799999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCc-eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC
Q 048542          218 PKENDF-VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD  296 (373)
Q Consensus       218 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (373)
                      ...... .......||+.|+|||++.+.  .++.++|||||||++|||++|..|+......       ..+...+..+..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~~~  231 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR  231 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC
T ss_pred             cCCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhccCC
Confidence            443221 223345689999999998764  7899999999999999999977776543321       224445555544


Q ss_pred             cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          297 LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       297 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      +..+      ..++..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       232 ~~~~------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 LPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCc------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            4333      2345678999999999999999999999999987654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.4e-53  Score=388.87  Aligned_cols=249  Identities=21%  Similarity=0.303  Sum_probs=207.4

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|.++ +|+.||||++...... .+.+.+|+.+++.++||||+++++++.+++..|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46888999999999999999975 7899999999765433 367889999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCCceEEeeccCcccCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ++|+|.+++..   ....+++..+..++.||+.||.|||++   +++||||||+|||++  .++.+||+|||++......
T Consensus       106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999988843   345699999999999999999999998   999999999999996  4678999999999876544


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC-CCccc
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG-GDLEL  299 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  299 (373)
                      ..   .....||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .....+... .... 
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~-  245 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD--------ETLRNVKSCDWNMD-  245 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCSC-
T ss_pred             cc---cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCC-
Confidence            32   2345799999999999875  7889999999999999999999999754321        122222222 1111 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                         ......++..+.+|+.+||+.||++|||++|+++
T Consensus       246 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1222345678999999999999999999999988

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=379.82  Aligned_cols=249  Identities=24%  Similarity=0.285  Sum_probs=207.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-------CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-------SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..|++.+.||+|+||+||+|.++ +|+.||||+++....       ..+.+.+|+.+++.++||||+++++++.++...|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            46888999999999999999975 789999999865322       3578899999999999999999999999999999


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC----ceEEeecc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF----IPKVSDFG  212 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~----~~kl~Dfg  212 (373)
                      +|||||++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++    .+||+|||
T Consensus        90 iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          90 LILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999883    235699999999999999999999998   999999999999998766    59999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++........   .....||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+.
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~  229 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVS  229 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHH
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH--------HHHHHHH
Confidence            9987654332   2345699999999999764  7889999999999999999999999754421        1222222


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+..   ......+..++..+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         230 AVNY---EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             TTCC---CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hcCC---CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2211   1112333456778999999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-53  Score=388.38  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=210.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc-CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF-SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      ..|++.+.||+|+||.||+|... +|+.||||++..... ....+.+|+.+++.++||||+++++++.++...|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            35888999999999999999975 799999999876543 3356789999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee--CCCceEEeeccCcccCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD--HNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~--~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ++|+|.+.+.   ..+.++++..+..++.||+.||+|||++   ||+||||||+|||++  .++.+||+|||++......
T Consensus       109 ~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999988763   2345799999999999999999999998   999999999999998  6789999999999877554


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..   .....||+.|+|||++.+.  .++.++||||+||++|+|++|..||......        .....+..+... . 
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~-~-  247 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWE-F-  247 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCC-C-
T ss_pred             Cc---eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC-C-
Confidence            32   2345699999999999775  7899999999999999999999999754422        122223322211 1 


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcCC
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSI  342 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~~  342 (373)
                       .......++..+.+|+.+||+.||.+|||++|+++.  +++..
T Consensus       248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence             112223456788999999999999999999999873  55433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-52  Score=377.44  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=209.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      .|++.+.||+|+||+||+|+++      ++..||||+++.....  .+++.+|+.+++.++||||+++++++......++
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~   93 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL   93 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence            4677899999999999999864      3468999999765433  3678999999999999999999999999999999


Q ss_pred             EEeccCcCCccccccCCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCC
Q 048542          138 VYEYMPNGSLDRHVFPKE--------------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHN  197 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~N  197 (373)
                      +|||+++|+|.+++....                    .....+++..+..++.|++.||+|||++   +++||||||+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N  170 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  170 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence            999999999999884321                    1234588999999999999999999998   99999999999


Q ss_pred             eeeeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcC
Q 048542          198 ILLDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNAT  276 (373)
Q Consensus       198 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~  276 (373)
                      ||++.++++||+|||+++...............|++.|+|||.+.+.  .++.++|||||||++|||++|.. ||.....
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999865444433334456688999999999875  78999999999999999999964 5554332


Q ss_pred             ccccccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          277 RSSKAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                              ......+..+..+..+      ..++.++.+|+.+||+.||++|||+.||+++|+.+++
T Consensus       249 --------~e~~~~v~~~~~~~~p------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 --------EEVIYYVRDGNILACP------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --------HHHHHHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --------HHHHHHHHcCCCCCCC------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                    2233444554433322      2345678999999999999999999999999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-52  Score=379.46  Aligned_cols=245  Identities=23%  Similarity=0.318  Sum_probs=206.3

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||.||+|+.+ +|+.||||++++.    ....+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            4788899999999999999975 7899999999753    2345778899999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|.+++.    +...+++..++.++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        86 y~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          86 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             CCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             ccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999998883    346789999999999999999999999   9999999999999999999999999999865433


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      ..  .....+||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        ........+. ..  
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~~--------~~~~~i~~~~-~~--  223 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEE-IR--  223 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC--
T ss_pred             Cc--ccccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCHH--------HHHHHHhcCC-CC--
Confidence            22  23456799999999999875  7899999999999999999999999865432        1222333322 11  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                          .+..++..+.+|+.+||+.||.+||+     ++|+++
T Consensus       224 ----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                22345678999999999999999995     788876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=377.77  Aligned_cols=249  Identities=16%  Similarity=0.225  Sum_probs=207.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~  144 (373)
                      +|++.+.||+|+||+||+|.++ +|+.||||+++........+.+|+.+|+.++||||+++++++.+++..|+|||||++
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            5788899999999999999976 788999999988766667788999999999999999999999999999999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC--CCceEEeeccCcccCCCCCC
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH--NFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      |+|.+++..   .+..+++..+..++.||+.||+|||+.   +|+||||||+|||++.  ...+||+|||++........
T Consensus        86 g~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          86 LDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             CBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999998842   345799999999999999999999998   9999999999999984  45899999999987644332


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccCcc
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNV  302 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (373)
                         .....+|+.|+|||.+.+.  .++.++||||+||++|+|++|..||......        .....+..+..   ...
T Consensus       160 ---~~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~~---~~~  223 (321)
T d1tkia_         160 ---FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAEY---TFD  223 (321)
T ss_dssp             ---EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCC---CCC
T ss_pred             ---ccccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC---CCC
Confidence               2345689999999998765  7889999999999999999999999765432        12222222211   111


Q ss_pred             chhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          303 TEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       303 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ......++.++.+|+.+||+.||.+|||++|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2233345778999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=372.05  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC----CceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT----GGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..|++.+.||+|+||.||+|.+..    +..||||.++.....  .+.+.+|+.++++++||||+++++++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            467888999999999999998652    346889988754333  367899999999999999999999986 4678999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      |||+++|+|.+++..   ....+++..+..++.|+++||.|||++   +++||||||+||+++.++.+||+|||+++...
T Consensus        86 ~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          86 MELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999887632   345789999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ..... ......||+.|+|||.+.+.  .++.++|||||||++|||++ |..||......+        +...+..+...
T Consensus       160 ~~~~~-~~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~  228 (273)
T d1mp8a_         160 DSTYY-KASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERL  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCC
T ss_pred             CCcce-eccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            33222 23345689999999999765  78899999999999999998 788887554321        33344444433


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      ..+      ..++..+.+|+.+||+.||++|||++||++.|+.++
T Consensus       229 ~~~------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         229 PMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             CCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            322      345678999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.2e-51  Score=370.90  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEe
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYE  140 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e  140 (373)
                      .|++.+.||+|+||+||+|+++ +|+.||||+++..    ....+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            4788899999999999999975 7899999998753    2345778999999999999999999999999999999999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|..++    ..+..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++......
T Consensus        85 ~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          85 YIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             ecCCccccccc----cccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999998877    3456688999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcccC
Q 048542          221 NDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQ  300 (373)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (373)
                      .     ...+||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .....+..+.. .  
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~i~~~~~-~--  219 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--------KTYEKILNAEL-R--  219 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHCCC-C--
T ss_pred             c-----ccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCHH--------HHHHHHHcCCC-C--
Confidence            2     345799999999999775  7889999999999999999999999764321        12223323221 1  


Q ss_pred             ccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          301 NVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       301 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                          .+..++.++.+++.+||+.||.+||     |++++++
T Consensus       220 ----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 ----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                1223456789999999999999996     8999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=375.69  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=201.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCc----eeEEEEeccC--ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGG----LIAVKMLENS--KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      .|++.+.||+|+||+||+|.+. +|+    +||+|.++..  ....+++.+|+.++++++||||++++++|.++ ..+++
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            4778899999999999999865 444    5888888643  23457899999999999999999999999864 56788


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      +||+.+|+|.+.+..   ....+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          89 TQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            899999999887743   356799999999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          219 KENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ............||+.|+|||.+.+.  .++.++|||||||++|||+| |..||......+        +...+..+..+
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~  232 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL  232 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             cccccccccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC
Confidence            54444334455689999999999775  78999999999999999998 677776543221        33445555444


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                      ..+      ..++..+.+|+.+||+.||.+|||++|+++.|+.+
T Consensus       233 ~~p------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 PQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            332      23456789999999999999999999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=367.93  Aligned_cols=248  Identities=30%  Similarity=0.455  Sum_probs=197.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEEeccCc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYEYMPN  144 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e~~~~  144 (373)
                      .+++.+.||+|+||.||+|.++ |..||||+++.+. ..+++.+|++++++++||||+++++++.+ ....++||||+++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~   85 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK   85 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred             HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence            4677899999999999999986 7899999997643 45789999999999999999999999854 4568999999999


Q ss_pred             CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCCce
Q 048542          145 GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKENDFV  224 (373)
Q Consensus       145 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  224 (373)
                      |+|.+++....  ...+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++......   
T Consensus        86 g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---  157 (262)
T d1byga_          86 GSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  157 (262)
T ss_dssp             EEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC---
Confidence            99999984322  23589999999999999999999998   99999999999999999999999999998643322   


Q ss_pred             eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcCCCcccCccc
Q 048542          225 SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKGGDLELQNVT  303 (373)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (373)
                        ....+|..|+|||.+.+.  .++.++|||||||++|||++ |+.||......        .+...+..+..++.+   
T Consensus       158 --~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~~~~i~~~~~~~~~---  222 (262)
T d1byga_         158 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAP---  222 (262)
T ss_dssp             ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHTTTCCCCCC---
T ss_pred             --ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCC---
Confidence              334588999999999774  78999999999999999998 56666544322        133444444444433   


Q ss_pred             hhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          304 EIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       304 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                         ..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       223 ---~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         223 ---DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               23456789999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-51  Score=366.39  Aligned_cols=250  Identities=21%  Similarity=0.246  Sum_probs=205.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----------HHHHHHHHHHhcccC-CCceeeEeeEeeeC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----------AEEFINEVSTIGRIH-HVNVVQLLGFCSEG  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~  132 (373)
                      ..|++.+.||+|+||+||+|+.. +|+.||||+++.....          .+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            35778899999999999999975 7889999998764321          145789999999997 99999999999999


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      +..|+|||||++|+|.+++.    ....+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence            99999999999999999984    345799999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccc----cCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHH
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRN----FGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~  288 (373)
                      ++........   .....||+.|+|||.+.+.    ...++.++||||+||++|+|++|+.||.....        ....
T Consensus       156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~  224 (277)
T d1phka_         156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLML  224 (277)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHH
T ss_pred             heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHH
Confidence            9987654332   2345699999999998642    23468899999999999999999999975532        1122


Q ss_pred             HHHhcCC-CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          289 DQLNKGG-DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       289 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ..+..+. ....    .....+++.+.+|+.+||+.||++|||++|+++
T Consensus       225 ~~i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGNYQFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTCCCCCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCCCCCCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2223222 2111    122346678999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-52  Score=373.83  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeee-CCe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSE-GSK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~-~~~  134 (373)
                      ..|++.++||+|+||.||+|.+.      +++.||||+++.....  .+.+.+|...+.++ +|+||+.+++++.. +..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            46788899999999999999864      2457999998754432  35677888888777 68999999998765 456


Q ss_pred             eEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC
Q 048542          135 RALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH  202 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~  202 (373)
                      .++|||||++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+||||||+|||++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            8999999999999999854321            234589999999999999999999998   9999999999999999


Q ss_pred             CCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcCccccc
Q 048542          203 NFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKA  281 (373)
Q Consensus       203 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~  281 (373)
                      ++++||+|||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++|.. ||......    
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~----  243 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----  243 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCHH----
Confidence            999999999999876554443334456799999999999875  78999999999999999999754 56543321    


Q ss_pred             cchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          282 YFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                         ......+..+..+..+      ..++.++.+|+.+||+.||++|||++|+++.|+.++
T Consensus       244 ---~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 ---EEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             ---HHHHHHHHHTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHhcCCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               2344445555444333      234567899999999999999999999999998764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=373.25  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=206.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCc--eeEEEEeccCcc--CHHHHHHHHHHhccc-CCCceeeEeeEeeeCCeeEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGG--LIAVKMLENSKF--SAEEFINEVSTIGRI-HHVNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv  138 (373)
                      ..+++.+.||+|+||.||+|.++ +|.  .||||.++....  ..+++.+|+.++.++ +||||+++++++.++...++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            45677899999999999999876 444  477888754322  335789999999999 799999999999999999999


Q ss_pred             EeccCcCCccccccCC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCce
Q 048542          139 YEYMPNGSLDRHVFPK------------ESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIP  206 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~  206 (373)
                      |||+++|+|.+++...            ......+++..+..++.||+.||.|||+.   +++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999998543            23456799999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCC-CCCCCcCccccccchH
Q 048542          207 KVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRR-NSNMNATRSSKAYFPS  285 (373)
Q Consensus       207 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~-p~~~~~~~~~~~~~~~  285 (373)
                      ||+|||+++.......   .....||..|+|||.+.+.  .++.++|||||||++|||++|.. ||....        ..
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~  233 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA  233 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence            9999999975433221   2234589999999999764  78999999999999999999875 454332        12


Q ss_pred             HHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          286 WVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .+...+..+..+..+      ..++..+.+|+.+||+.||++|||++|+++.|+.+.++
T Consensus       234 ~~~~~i~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         234 ELYEKLPQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHGGGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHhcCCCCCC------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            234444444443332      23456899999999999999999999999999887643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-51  Score=368.34  Aligned_cols=257  Identities=22%  Similarity=0.288  Sum_probs=200.5

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC----HHHHHHHHHHhcccCCCceeeEeeEeeeCC----ee
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS----AEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KR  135 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~  135 (373)
                      .+|++.+.||+|+||+||+|.+. +|+.||||+++.....    ...+.+|+.+++.++||||+++++++....    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            45788899999999999999965 7899999999764332    256889999999999999999999986543    47


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+|||||++++|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++..+++|||.+.
T Consensus        87 ~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            89999999999988773    345799999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCC-ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          216 FHPKEND-FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       216 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ....... ........||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......       ......+...
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~  230 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVRED  230 (277)
T ss_dssp             ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcC
Confidence            5543222 1223455799999999999764  7889999999999999999999999754321       1222333332


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcC
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRP-SMTKVLEMLEGS  341 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-s~~ell~~L~~~  341 (373)
                      ....    ......++..+.+++.+||+.||.+|| |++++++.|..+
T Consensus       231 ~~~~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         231 PIPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CCCG----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            2221    112234567899999999999999999 899999888753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=371.56  Aligned_cols=264  Identities=26%  Similarity=0.416  Sum_probs=214.5

Q ss_pred             HHHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC
Q 048542           63 IAMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (373)
Q Consensus        63 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  133 (373)
                      ....|++.++||+|+||.||+|++.      ++..||||+++.....  ..++.+|+.+++.+ +||||+++++++.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3457788899999999999999853      4568999999765433  35688999999999 6999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCee
Q 048542          134 KRALVYEYMPNGSLDRHVFPKE--------------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNIL  199 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil  199 (373)
                      ..+++||||++|+|.+++....              .....+++..+..++.||+.||+|||++   +++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence            9999999999999999885432              1234689999999999999999999998   9999999999999


Q ss_pred             eeCCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccc
Q 048542          200 LDHNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSS  279 (373)
Q Consensus       200 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~  279 (373)
                      ++.++.+|++|||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++++.|+....... 
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999999987665555555667899999999999764  78999999999999999999655544332211 


Q ss_pred             cccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          280 KAYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                           ......+..+..+..+      ...+..+.+|+.+||+.||++|||+++++++|++.+.
T Consensus       255 -----~~~~~~i~~~~~~~~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         255 -----SKFYKMIKEGFRMLSP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             -----HHHHHHHHHTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHhcCCCCCCc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                 2233444444433322      2345679999999999999999999999999987543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-51  Score=371.95  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=198.7

Q ss_pred             Hhhhh-cccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhccc-CCCceeeEeeEeee----CCeeEEE
Q 048542           66 TNHFT-HKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRI-HHVNVVQLLGFCSE----GSKRALV  138 (373)
Q Consensus        66 ~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~----~~~~~lv  138 (373)
                      .|++. +.||+|+||+||+|.+. +++.||||+++..    ..+.+|+.++.++ +||||+++++++.+    +...|+|
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            56666 46999999999999874 7899999998753    4567899887655 89999999999865    4678999


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC---CCceEEeeccCcc
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH---NFIPKVSDFGLAK  215 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~---~~~~kl~Dfg~~~  215 (373)
                      ||||++|+|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   .+.+||+|||+++
T Consensus        88 mEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          88 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceee
Confidence            9999999999998532  235699999999999999999999998   9999999999999985   5679999999998


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      .......   .....||+.|+|||++.+.  .++.++|||||||++|+|++|+.||..........       .......
T Consensus       163 ~~~~~~~---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-------~~~~~i~  230 (335)
T d2ozaa1         163 ETTSHNS---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIR  230 (335)
T ss_dssp             ECCCCCC---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------CCC
T ss_pred             eccCCCc---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-------HHHHHHh
Confidence            6654332   2456799999999999875  78999999999999999999999997554322100       0111111


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .............++.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11112222334567888999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=370.03  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             hcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH------HHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           70 THKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA------EEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        70 ~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .+.||+|+||+||+|.++ +|+.||||+++......      +.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            368999999999999975 78999999997643321      45789999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      .++++....    ..+..+++..+..++.||+.||+|||++   +++||||||+|||++.++.+||+|||++........
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIK----DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHT----TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhh----hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            888776555    3356688899999999999999999998   999999999999999999999999999986544332


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCC------
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGD------  296 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  296 (373)
                        ......||+.|+|||++.+. ..++.++||||+||++|+|++|..||........   + ..+.........      
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l-~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---L-TRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-HHHHHHHCCCCTTTSSST
T ss_pred             --cccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---H-HHHHHhcCCCChhhccch
Confidence              22345799999999998653 4678999999999999999999999875432110   0 000111000000      


Q ss_pred             ------c---ccC--ccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          297 ------L---ELQ--NVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       297 ------~---~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                            .   ...  ........++..+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                  0   000  001122234678999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=365.42  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=195.1

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc--CC--ceeEEEEeccCcc----CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ--TG--GLIAVKMLENSKF----SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRA  136 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~--~~--~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~  136 (373)
                      ..|++.+.||+|+||.||+|++.  ++  ..||||+++....    ..+++.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            35778899999999999999854  22  3689999875432    23678999999999999999999999976 4678


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      +|||||++|++.+.+...   ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            999999999998877432   35699999999999999999999998   999999999999999999999999999997


Q ss_pred             CCCCCCcee-eecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          217 HPKENDFVS-ISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       217 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ......... .....|+..|+|||.+.+.  .++.++|||||||++|||++ |..||......       .........+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-------~~~~~i~~~~  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-------QILHKIDKEG  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTSC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-------HHHHHHHhCC
Confidence            655443322 2344578899999999875  78899999999999999998 89998754322       1122222333


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEG  340 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~  340 (373)
                      ..++.      +..++..+.+|+.+||+.||++|||++||++.|++
T Consensus       232 ~~~~~------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ERLPR------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCC------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            33222      22345679999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=369.72  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=208.6

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcC--------CceeEEEEeccCccC--HHHHHHHHHHhccc-CCCceeeEeeEeeeCC
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQT--------GGLIAVKMLENSKFS--AEEFINEVSTIGRI-HHVNVVQLLGFCSEGS  133 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~  133 (373)
                      ..|++.+.||+|+||.||+|+...        +..||||+++.....  ..++.+|...+.++ +||||++++++|.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            467888999999999999998542        236999999765543  36788899999888 7999999999999999


Q ss_pred             eeEEEEeccCcCCccccccCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee
Q 048542          134 KRALVYEYMPNGSLDRHVFPKES------------RGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD  201 (373)
Q Consensus       134 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~  201 (373)
                      ..++|||||++|+|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence            99999999999999999854421            235689999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHc-CCCCCCCCcCcccc
Q 048542          202 HNFIPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAG-GRRNSNMNATRSSK  280 (373)
Q Consensus       202 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~-g~~p~~~~~~~~~~  280 (373)
                      .++.+||+|||++................||+.|+|||.+.+.  .++.++|||||||++|||++ |..||.....    
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----  243 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  243 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence            9999999999999866544443334456789999999999774  88999999999999999998 5777754332    


Q ss_pred             ccchHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          281 AYFPSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                          ..+...+..+..+..+      ..++..+.+|+.+||+.||.+|||++||++.|++++
T Consensus       244 ----~~~~~~i~~~~~~~~p------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         244 ----EELFKLLKEGHRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             ----HHHHHHHHTTCCCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHcCCCCCCC------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                2344555555544443      234567999999999999999999999999998764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=366.93  Aligned_cols=271  Identities=23%  Similarity=0.268  Sum_probs=201.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeeeCC----eeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv~e  140 (373)
                      .++.+.+.||+|+||.||+|+++ |+.||||+++...........|+..+..++||||+++++++.+..    ..++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            35567789999999999999875 889999999765433333344566666789999999999997643    5789999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC-----DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~-----~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ||++|+|.+++..     ..+++..+..++.|++.||+|||+..     +.+|+||||||+|||++.++++||+|||++.
T Consensus        82 y~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          82 YHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999942     35899999999999999999999631     2499999999999999999999999999998


Q ss_pred             cCCCCCCce--eeecccCCCCccccccccccc----CCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccc-------cc
Q 048542          216 FHPKENDFV--SISATRGTIGYIAPELISRNF----GTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSK-------AY  282 (373)
Q Consensus       216 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~-------~~  282 (373)
                      .........  ......||+.|+|||++.+..    ..++.++|||||||++|||++|..|+.........       ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            765433222  234567999999999986531    13677899999999999999998887543321110       01


Q ss_pred             chHHHHHHHh-cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCC
Q 048542          283 FPSWVYDQLN-KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSI  342 (373)
Q Consensus       283 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~  342 (373)
                      .......... .+..+.++.. .........+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1122222222 2222333221 112345567999999999999999999999999998653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-50  Score=373.85  Aligned_cols=247  Identities=23%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc----CHHHHH---HHHHHhcccCCCceeeEeeEeeeCCeeEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF----SAEEFI---NEVSTIGRIHHVNVVQLLGFCSEGSKRAL  137 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~---~e~~~l~~l~h~ni~~~~~~~~~~~~~~l  137 (373)
                      .|++.+.||+|+||.||+|+.. +|+.||||++.....    ....+.   +++.+++.++||||+++++++.+++..|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            4678899999999999999976 789999999864322    223333   44677788889999999999999999999


Q ss_pred             EEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccC
Q 048542          138 VYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFH  217 (373)
Q Consensus       138 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  217 (373)
                      |||||++|+|.+++.    +...+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        85 vmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          85 ILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999883    345688999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCc
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDL  297 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (373)
                      ....    .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........     .   .........
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~---~~~~~~~~~  224 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----H---EIDRMTLTM  224 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----H---HHHHHSSSC
T ss_pred             CCCc----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----H---HHHHhcccC
Confidence            5432    2345799999999998643 3678999999999999999999999976543221     1   111111111


Q ss_pred             ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          298 ELQNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       298 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                      ..    ..+..++..+.+|+.+||+.||.+|||     ++|+++
T Consensus       225 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CC----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11    112235678999999999999999999     688875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-50  Score=371.09  Aligned_cols=243  Identities=24%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEE
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      ..|++.+.||+|+||.||+|.++ +|+.||||++...    ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            36888899999999999999975 7999999998643    234467899999999999999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      ||+.+|+|...+.    +...+++..+..++.||+.||.|||++   +|+||||||+|||++.++++||+|||+++....
T Consensus       121 e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999988883    335699999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ..     ....||+.|+|||++.+.  .++.++|||||||++|+|++|..||.....        ......+..+...  
T Consensus       194 ~~-----~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~--  256 (350)
T d1rdqe_         194 RT-----WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVR--  256 (350)
T ss_dssp             CB-----CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC--
T ss_pred             cc-----ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCC--
Confidence            22     345699999999999875  788999999999999999999999975432        1222333332211  


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRP-----SMTKVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----s~~ell~  336 (373)
                           .+..++.++.+|+.+||+.||.+|+     |++++++
T Consensus       257 -----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 -----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 1123567899999999999999994     8999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=365.10  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=203.4

Q ss_pred             hhhcccCCCCcEEEEEEEEcCC----ceeEEEEeccCcc--CHHHHHHHHHHhcccCCCceeeEeeEeee-CCeeEEEEe
Q 048542           68 HFTHKLGQGGFGSVYKGQLQTG----GLIAVKMLENSKF--SAEEFINEVSTIGRIHHVNVVQLLGFCSE-GSKRALVYE  140 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~e  140 (373)
                      ++.++||+|+||+||+|.+..+    ..||||.++....  ..+++.+|++++++++||||+++++++.. +...++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999986532    2589999875332  23679999999999999999999999865 568899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ||++|+|.+++..   .....++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       110 ~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         110 YMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             CCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999988743   345678889999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCce--eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCcc
Q 048542          221 NDFV--SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLE  298 (373)
Q Consensus       221 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (373)
                      ....  ......||+.|+|||.+.+.  .++.++||||||+++|||++|+.||........       ....+..+..+.
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-------~~~~i~~g~~~~  254 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLL  254 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCC
T ss_pred             ccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence            2221  12334689999999998764  789999999999999999998888765432211       122333343332


Q ss_pred             cCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCC
Q 048542          299 LQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDD  344 (373)
Q Consensus       299 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~  344 (373)
                      .+      ..++..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       255 ~p------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         255 QP------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             Cc------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            22      23456789999999999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=367.83  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=211.7

Q ss_pred             HHHhhhhcccCCCCcEEEEEEEEc------CCceeEEEEeccCccCH--HHHHHHHHHhcccCCCceeeEeeEeeeCCee
Q 048542           64 AMTNHFTHKLGQGGFGSVYKGQLQ------TGGLIAVKMLENSKFSA--EEFINEVSTIGRIHHVNVVQLLGFCSEGSKR  135 (373)
Q Consensus        64 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~  135 (373)
                      ...+++.++||+|+||.||+|.++      ++..||||+++......  ..+.+|+.++++++||||+++++++..+...
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            356778899999999999999864      35689999997644322  4688999999999999999999999999999


Q ss_pred             EEEEeccCcCCccccccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEe
Q 048542          136 ALVYEYMPNGSLDRHVFPKE------SRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVS  209 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~  209 (373)
                      ++|||||++|+|.+++....      .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence            99999999999998875321      1234578999999999999999999998   99999999999999999999999


Q ss_pred             eccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCC-CCCCCCcCccccccchHHHH
Q 048542          210 DFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGR-RNSNMNATRSSKAYFPSWVY  288 (373)
Q Consensus       210 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~-~p~~~~~~~~~~~~~~~~~~  288 (373)
                      |||+++...............||+.|+|||.+.+.  .++.++|||||||++|||++|. .||.....        ....
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--------~~~~  245 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVL  245 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHH
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            99999866544333333444689999999999775  7888999999999999999986 55543322        2233


Q ss_pred             HHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCC
Q 048542          289 DQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSID  343 (373)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~  343 (373)
                      ..+..+..+..+      ..++..+.+|+.+||+.||++|||+++|++.|+..++
T Consensus       246 ~~i~~~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFVMEGGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHhCCCCCCc------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            444444443322      2345679999999999999999999999999998654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=371.42  Aligned_cols=245  Identities=21%  Similarity=0.291  Sum_probs=202.6

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccC----ccCHHHHHHHHHHhc-ccCCCceeeEeeEeeeCCeeEEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENS----KFSAEEFINEVSTIG-RIHHVNVVQLLGFCSEGSKRALVY  139 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~lv~  139 (373)
                      .|++.+.||+|+||+||+|+++ +|+.||||++++.    ....+.+..|..++. .++||||+++++++.++...|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            4778899999999999999976 7899999999753    233456677777665 689999999999999999999999


Q ss_pred             eccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCC
Q 048542          140 EYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPK  219 (373)
Q Consensus       140 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  219 (373)
                      |||++|+|.+++.    ....+++..+..++.||+.||+|||++   +++||||||+|||++.++++||+|||++.....
T Consensus        83 Ey~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          83 EYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             ECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             eecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999883    345689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCCCccc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGGDLEL  299 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (373)
                      ...  ......||+.|+|||++.+.  .++.++||||+||++|+|++|+.||......        .+...+..+. .. 
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~-~~-  221 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN-PF-  221 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC-CC-
T ss_pred             ccc--cccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-CC-
Confidence            322  23446799999999999875  7889999999999999999999999765432        2333333332 11 


Q ss_pred             CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 048542          300 QNVTEIESMIARKLCMIGLWCIQVKAADRPSMT-KVLE  336 (373)
Q Consensus       300 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~  336 (373)
                           .+..++.++.+|+.+||+.||.+|||+. ++++
T Consensus       222 -----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 -----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -----CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                 2234567899999999999999999996 6753

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=361.55  Aligned_cols=256  Identities=21%  Similarity=0.300  Sum_probs=198.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      .|++.++||+|+||+||+|.+. +|+.||||+++.....   .+++.+|+.++++++||||+++++++.++...|+||||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~   82 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   82 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence            5677899999999999999975 7899999999754332   36788999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +.++.+. ++.  ......+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~~~-~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          83 LHQDLKK-FMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CSEEHHH-HHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             cCCchhh-hhh--hhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9765443 332  12345699999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh---cC----
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN---KG----  294 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~----  294 (373)
                      .  ......||+.|+|||.+... ..++.++|+||+||++|+|++|+.||.......       .......   ..    
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-------QLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHHHCCCCTTT
T ss_pred             c--cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHH-------HHHHHHHhcCCCchhh
Confidence            2  22345699999999987664 456789999999999999999999997543211       0111100   00    


Q ss_pred             ---------CCccc-----CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          295 ---------GDLEL-----QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       295 ---------~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                               .....     .........++..+.+|+.+||+.||++|||++|+++-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                     00000     00011222456789999999999999999999999983

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=363.02  Aligned_cols=239  Identities=23%  Similarity=0.334  Sum_probs=194.7

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC-------HHHHHHHHHHhcccC--CCceeeEeeEeeeCCe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS-------AEEFINEVSTIGRIH--HVNVVQLLGFCSEGSK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l~--h~ni~~~~~~~~~~~~  134 (373)
                      .+|++.+.||+|+||+||+|... +|+.||||+++.....       ..++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            36788899999999999999975 7899999998754321       134568999999986  8999999999999999


Q ss_pred             eEEEEeccCc-CCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-CCceEEeecc
Q 048542          135 RALVYEYMPN-GSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-NFIPKVSDFG  212 (373)
Q Consensus       135 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-~~~~kl~Dfg  212 (373)
                      .++||||+.+ +++.+++.    .+..+++..+..++.|++.||+|||++   +|+||||||+|||++. ++.+||+|||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence            9999999975 56666662    345799999999999999999999998   9999999999999985 5799999999


Q ss_pred             CcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          213 LAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ++.......    .....||+.|+|||++.+. ..++.++||||+||++|+|++|+.||.....              ..
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~  217 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------II  217 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HH
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH--------------Hh
Confidence            998654332    2345799999999998764 2346779999999999999999999964321              11


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .+.. .      .+..++.++.+|+.+||+.||++|||++|+++
T Consensus       218 ~~~~-~------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQV-F------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCC-C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccc-C------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111 1      11234568999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-49  Score=356.61  Aligned_cols=257  Identities=23%  Similarity=0.275  Sum_probs=200.5

Q ss_pred             HhhhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEecc
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      +|++.++||+|+||+||+|++++|+.||||+++.....   .+++.+|+.++++++||||+++++++.+++..+++||++
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            56788999999999999999999999999999764332   378899999999999999999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCCC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEND  222 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  222 (373)
                      .++.+..+.    .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+........
T Consensus        83 ~~~~~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          83 DQDLKKLLD----VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             SEEHHHHHH----TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             hhhhHHHHH----hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            887776655    3356799999999999999999999998   999999999999999999999999999987543322


Q ss_pred             ceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhc---------
Q 048542          223 FVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNK---------  293 (373)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  293 (373)
                        ......+++.|+|||.+.+. ..++.++||||+||++|+|++|+.||........   +.. .......         
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~-i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IFRILGTPNSKNWPNV  228 (286)
T ss_dssp             --------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HHHHHCCCCTTTSTTG
T ss_pred             --ccceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHH-HHHhhCCCChhhccch
Confidence              22344689999999998764 4678999999999999999999999975542110   000 0000000         


Q ss_pred             --C--CCc-----ccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 --G--GDL-----ELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 --~--~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        .  ...     ...........++..+.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0  000     000111222345678999999999999999999999984

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=356.81  Aligned_cols=263  Identities=22%  Similarity=0.274  Sum_probs=196.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC---HHHHHHHHHHhcccCCCceeeEeeEeeeCC------e
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS---AEEFINEVSTIGRIHHVNVVQLLGFCSEGS------K  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~  134 (373)
                      .+|++.++||+|+||+||+|.++ +|+.||||+++....+   .+.+.+|+.+|+.++||||+++++++...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            35778899999999999999975 7899999999865443   356889999999999999999999997654      5


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .|+||||+ +.+|....     +...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++
T Consensus        98 ~~lv~e~~-~~~l~~~~-----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CEEEEECC-SEEHHHHH-----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-cccHHHHH-----HhccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence            69999999 55676655     235699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------ch---
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------FP---  284 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------~~---  284 (373)
                      .......     +...||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||...........       .+   
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eccCCcc-----ccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            8664332     356799999999998764 4578899999999999999999999976542110000       00   


Q ss_pred             ------HHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcCC
Q 048542          285 ------SWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM--LEGSI  342 (373)
Q Consensus       285 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~--L~~~~  342 (373)
                            ........................++..+.+|+.+||+.||++|||++|+++.  ++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                  00000001001111111122223456678999999999999999999999983  55544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=355.95  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=194.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-C-CceeEEEEeccCcc---CHHHHHHHHHHhccc---CCCceeeEeeEeee-----
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-T-GGLIAVKMLENSKF---SAEEFINEVSTIGRI---HHVNVVQLLGFCSE-----  131 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~h~ni~~~~~~~~~-----  131 (373)
                      .+|++.++||+|+||+||+|.+. + ++.||||+++....   ....+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            46788899999999999999974 4 55799999865322   223456777777766   79999999998853     


Q ss_pred             CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeec
Q 048542          132 GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDF  211 (373)
Q Consensus       132 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Df  211 (373)
                      ....+++|||+.++++.....   .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            346789999998877654332   2346689999999999999999999998   9999999999999999999999999


Q ss_pred             cCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHH
Q 048542          212 GLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQL  291 (373)
Q Consensus       212 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  291 (373)
                      |++.......   ......||+.|+|||++.+.  .++.++||||+||++|||++|+.||........   + .......
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~-~~i~~~~  231 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDVI  231 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHH
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---H-HHHHHhh
Confidence            9987543322   23456799999999999775  789999999999999999999999976542210   0 0000100


Q ss_pred             hcC----------------CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          292 NKG----------------GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       292 ~~~----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...                ..............++..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000                000001112223345678899999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-48  Score=353.22  Aligned_cols=263  Identities=18%  Similarity=0.216  Sum_probs=195.0

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccC--HHHHHHHHHHhcccCCCceeeEeeEeeeCC----eeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFS--AEEFINEVSTIGRIHHVNVVQLLGFCSEGS----KRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~lv  138 (373)
                      +|++.++||+|+||+||+|..+ +|+.||||++......  .+++.+|+.+|+.++||||+++++++....    ..+++
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            5778899999999999999865 8999999999764432  367889999999999999999999986543    23455


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHP  218 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  218 (373)
                      ++++.+|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        89 ~~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          89 VTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            56667999999883     23599999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCce-eeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc--------------
Q 048542          219 KENDFV-SISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF--------------  283 (373)
Q Consensus       219 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~--------------  283 (373)
                      ...... ......||+.|+|||++... ..++.++||||+||++|+|++|+.||............              
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            332211 12345699999999998654 46788999999999999999999999765421100000              


Q ss_pred             --hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 048542          284 --PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEM  337 (373)
Q Consensus       284 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~  337 (373)
                        .........................++.++.+|+.+||+.||.+|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000000000000000001112223345678999999999999999999999973

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=344.51  Aligned_cols=260  Identities=20%  Similarity=0.244  Sum_probs=193.9

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeee--------C
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSE--------G  132 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--------~  132 (373)
                      .+|++.++||+|+||+||+|.++ +|+.||||++.....   ...++.+|+.+++.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            47888899999999999999975 789999999865433   23678899999999999999999998854        3


Q ss_pred             CeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeecc
Q 048542          133 SKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFG  212 (373)
Q Consensus       133 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg  212 (373)
                      ...+++|||+.++.+....    .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence            4578999999887765444    3356789999999999999999999998   99999999999999999999999999


Q ss_pred             CcccCCCCCCc--eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHH
Q 048542          213 LAKFHPKENDF--VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQ  290 (373)
Q Consensus       213 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~  290 (373)
                      ++.........  .......||+.|+|||.+.+. ..++.++||||+||++|+|++|+.||.........    ......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~----~~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL----ALISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH----HHHHHh
Confidence            99765432211  112335699999999998764 46789999999999999999999999754321110    000010


Q ss_pred             Hhc--------------------CCCcccCccchh-hHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          291 LNK--------------------GGDLELQNVTEI-ESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       291 ~~~--------------------~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ...                    ............ ....+..+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000                    000000000000 1122456789999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=354.72  Aligned_cols=260  Identities=22%  Similarity=0.246  Sum_probs=193.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCceeeEeeEeee------CCeeEEE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVVQLLGFCSE------GSKRALV  138 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~~lv  138 (373)
                      +|+..++||+|+||+||+|++. +|+.||||++......   ..+|+.++++++||||+++++++..      ..+.++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            4667789999999999999976 7899999999765432   2479999999999999999999843      3357899


Q ss_pred             EeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccC
Q 048542          139 YEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFH  217 (373)
Q Consensus       139 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  217 (373)
                      ||||+++.+. .+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||++...
T Consensus        98 ~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          98 LDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999765433 3322223456799999999999999999999998   999999999999999765 8999999999876


Q ss_pred             CCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc--------chHHHHH
Q 048542          218 PKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY--------FPSWVYD  289 (373)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~--------~~~~~~~  289 (373)
                      .....   .....||..|+|||.+.+. ..++.++||||+||++|||++|+.||........-..        ...+...
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            44332   2345699999999987654 4688999999999999999999999976542210000        0000001


Q ss_pred             HHhcCCCcccCc------cchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          290 QLNKGGDLELQN------VTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       290 ~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      ............      ........+.++.+|+.+||+.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000111110      01112234668999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-47  Score=340.19  Aligned_cols=258  Identities=20%  Similarity=0.273  Sum_probs=202.7

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCcc---CHHHHHHHHHHhcccCCCceeeEeeEeeeCCeeEEEEec
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKF---SAEEFINEVSTIGRIHHVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +|++.++||+|+||+||+|++. +++.||||+++....   ...++.+|+.+++.++||||+++++++.+....++++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            5778899999999999999975 788999999875433   247889999999999999999999999999999999999


Q ss_pred             cCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcccCCCCC
Q 048542          142 MPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKFHPKEN  221 (373)
Q Consensus       142 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  221 (373)
                      +.++++..++    .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.+.......
T Consensus        83 ~~~~~l~~~~----~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          83 CDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CSEEHHHHHH----HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             cccccccccc----ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            9999887776    3456789999999999999999999998   99999999999999999999999999998765433


Q ss_pred             CceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC------
Q 048542          222 DFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG------  295 (373)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  295 (373)
                      ..  .....++..|+|||.+.+. ..++.++||||+||++|+|++|+.||.........  . ..+........      
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--L-KRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--H-HHHHHHHCCCCTTTCTT
T ss_pred             cc--ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--H-HHHHhhcCCCChhhhhh
Confidence            22  2334577889999988764 35688999999999999999999998654322110  0 00000000000      


Q ss_pred             ------------CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          296 ------------DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       296 ------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                                  .............++..+.+|+.+||+.||.+|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        00001112223345678899999999999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.3e-47  Score=345.28  Aligned_cols=256  Identities=19%  Similarity=0.290  Sum_probs=198.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeee--CCeeEEEEe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSE--GSKRALVYE  140 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~--~~~~~lv~e  140 (373)
                      ..|++.++||+|+||+||+|++. +|+.||||+++..  ..+++.+|+.+|+.++ ||||+++++++..  ....++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            46889999999999999999975 7899999998754  3577889999999995 9999999999874  456899999


Q ss_pred             ccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCC-ceEEeeccCcccCCC
Q 048542          141 YMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNF-IPKVSDFGLAKFHPK  219 (373)
Q Consensus       141 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~  219 (373)
                      ||.+++|....       ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+||+|||++.....
T Consensus       113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            99999987654       4589999999999999999999998   999999999999998654 699999999987654


Q ss_pred             CCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-ch-----HHHHHHHhc
Q 048542          220 ENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-FP-----SWVYDQLNK  293 (373)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-~~-----~~~~~~~~~  293 (373)
                      ...   .....+|+.|+|||.+.+. ..++.++|+||+||++|+|++|+.||........... +.     .........
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc---ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            332   2445689999999998764 3578899999999999999999999976543211000 00     000000000


Q ss_pred             C---CCccc--------------CccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          294 G---GDLEL--------------QNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       294 ~---~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                      .   .....              .........++.++.+|+.+||+.||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   00000              0011122345678999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-47  Score=340.80  Aligned_cols=259  Identities=18%  Similarity=0.233  Sum_probs=196.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCCCc-eeeEeeEeeeCCeeEEEEeccC
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN-VVQLLGFCSEGSKRALVYEYMP  143 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~e~~~  143 (373)
                      +|++.+.||+|+||.||+|.+. +|+.||||++..... ..++..|+++++.++|+| |+.+.+++.++...++||||+ 
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-   85 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   85 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence            5788899999999999999875 788999998876432 245788999999998766 555566667888899999999 


Q ss_pred             cCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeee---CCCceEEeeccCcccCCCC
Q 048542          144 NGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLD---HNFIPKVSDFGLAKFHPKE  220 (373)
Q Consensus       144 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~  220 (373)
                      ++++.+.+.   .....+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+||+|||+++.....
T Consensus        86 ~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          86 GPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CCBHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CCchhhhhh---hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            456655542   2346799999999999999999999998   999999999999986   4557999999999876443


Q ss_pred             CCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcCC
Q 048542          221 NDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKGG  295 (373)
Q Consensus       221 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  295 (373)
                      ...     .......||+.|+|||.+.+.  .++.++|||||||++|||++|+.||.....................   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---  234 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  234 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence            221     123345799999999999875  6899999999999999999999999765543221111111111110   


Q ss_pred             CcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcC
Q 048542          296 DLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGS  341 (373)
Q Consensus       296 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~  341 (373)
                          .........++.++.+++.+||+.||++||+++++.+.|+..
T Consensus       235 ----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         235 ----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                011122234567899999999999999999999998888764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=348.51  Aligned_cols=253  Identities=21%  Similarity=0.252  Sum_probs=202.3

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc----CCceeEEEEeccCc-----cCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCe
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ----TGGLIAVKMLENSK-----FSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSK  134 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~  134 (373)
                      ..|++.+.||+|+||+||+|...    +|+.||||+++...     ...+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            45889999999999999999752    57899999986532     234567899999999976 899999999999999


Q ss_pred             eEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCc
Q 048542          135 RALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLA  214 (373)
Q Consensus       135 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~  214 (373)
                      .+++|||+.+|+|.+++.    ....+++..+..++.|++.||+|||++   +++||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            999999999999998883    345678899999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHhcC
Q 048542          215 KFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLNKG  294 (373)
Q Consensus       215 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  294 (373)
                      ......... ......|++.|+|||.+.+....++.++||||+||++|+|++|+.||........    ...+.......
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~~~~~~  251 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRILKS  251 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHHHC
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcccC
Confidence            865433221 2234569999999999976545678899999999999999999999976654321    11122222111


Q ss_pred             CCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 048542          295 GDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPS-----MTKVLE  336 (373)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-----~~ell~  336 (373)
                      . .      ..+..++..+.+|+.+||+.||.+|||     ++|+++
T Consensus       252 ~-~------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 E-P------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C-C------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C-C------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1 1      122345678999999999999999994     789886

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-47  Score=340.35  Aligned_cols=264  Identities=17%  Similarity=0.259  Sum_probs=206.0

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccCC-CceeeEeeEeeeCCeeEEEEecc
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIHH-VNVVQLLGFCSEGSKRALVYEYM  142 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~e~~  142 (373)
                      .+|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++..+...++||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            46788999999999999999976 78899999886543 23456788999999865 89999999999999999999999


Q ss_pred             CcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeC-----CCceEEeeccCcccC
Q 048542          143 PNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDH-----NFIPKVSDFGLAKFH  217 (373)
Q Consensus       143 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~-----~~~~kl~Dfg~~~~~  217 (373)
                       +++|.+++..   .+..+++..+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+++..
T Consensus        84 -~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 -GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             -CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence             6798887732   345799999999999999999999998   9999999999999974     578999999999875


Q ss_pred             CCCCCc-----eeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccchHHHHHHHh
Q 048542          218 PKENDF-----VSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYFPSWVYDQLN  292 (373)
Q Consensus       218 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  292 (373)
                      ......     .......||+.|+|||++.+.  .++.++|||||||++|+|++|..||..........     ....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~i~  229 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIG  229 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHHHH
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHHHH
Confidence            432211     123345799999999999875  78999999999999999999999997554332111     111111


Q ss_pred             cCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcCCCCC
Q 048542          293 KGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLEMLEGSIDDL  345 (373)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~L~~~~~~~  345 (373)
                      ...  ......+....++..+.+++..|++.+|++||+++.+.+.|+.+++..
T Consensus       230 ~~~--~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         230 EKK--QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHH--HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcc--CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            000  001112222345567999999999999999999999999888765433

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=343.76  Aligned_cols=256  Identities=20%  Similarity=0.200  Sum_probs=189.8

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeee------CCee
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSE------GSKR  135 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~------~~~~  135 (373)
                      +|++.++||+|+||+||+|.+. +|+.||||++.....+.   .++.+|+.+++.++||||+++++++..      ....
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~   97 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV   97 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence            5778899999999999999976 79999999998654443   467899999999999999999999853      4678


Q ss_pred             EEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          136 ALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       136 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      |+|||||.++.+. .+      ...+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+|++|||++.
T Consensus        98 ~iv~Ey~~~~l~~-~~------~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          98 YLVMELMDANLCQ-VI------QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEECCSEEHHH-HH------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeccchHHHH-hh------hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence            9999999765554 33      24589999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCcccccc-------------
Q 048542          216 FHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAY-------------  282 (373)
Q Consensus       216 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~-------------  282 (373)
                      ......   ......+|+.|+|||.+.+.  .++.++||||+||++|+|++|+.||...........             
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ----------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccc---ccccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            654332   23445699999999999875  788999999999999999999999975432110000             


Q ss_pred             --chHHHHHHHhcCCC------------cccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 048542          283 --FPSWVYDQLNKGGD------------LELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE  336 (373)
Q Consensus       283 --~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  336 (373)
                        ..............            .............+..+.+|+.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              00000111111100            0111122344567889999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=344.14  Aligned_cols=262  Identities=20%  Similarity=0.241  Sum_probs=195.9

Q ss_pred             HhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCH---HHHHHHHHHhcccCCCceeeEeeEeeeC-----CeeE
Q 048542           66 TNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSA---EEFINEVSTIGRIHHVNVVQLLGFCSEG-----SKRA  136 (373)
Q Consensus        66 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~  136 (373)
                      +|++.++||+|+||+||+|++. +|+.||||++.....+.   +++.+|+.+++.++||||+++++++...     ...+
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            5788899999999999999965 79999999998654443   5678999999999999999999998533     3346


Q ss_pred             EEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          137 LVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       137 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      ++++++.+|+|.+++.     ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||++..
T Consensus        99 ~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence            6777788999999883     34699999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc-------------
Q 048542          217 HPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF-------------  283 (373)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~-------------  283 (373)
                      ....     .....|+..|+|||...+. ..++.++||||+||++|+|++|..||...........+             
T Consensus       171 ~~~~-----~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDDE-----MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTGG-----GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cCcc-----cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4322     2345688999999987654 45688999999999999999999999755422110000             


Q ss_pred             ---hHHHHHHHhcCCCcccCccchhhHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcC
Q 048542          284 ---PSWVYDQLNKGGDLELQNVTEIESMIARKLCMIGLWCIQVKAADRPSMTKVLE--MLEGS  341 (373)
Q Consensus       284 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~--~L~~~  341 (373)
                         .........................++..+.+|+.+||+.||.+|||++|+++  .+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence               00000000000000001111112234677899999999999999999999997  45443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.7e-42  Score=316.18  Aligned_cols=289  Identities=18%  Similarity=0.282  Sum_probs=207.2

Q ss_pred             HHhhhhcccCCCCcEEEEEEEEc-CCceeEEEEeccCccCHHHHHHHHHHhcccC-----------CCceeeEeeEeee-
Q 048542           65 MTNHFTHKLGQGGFGSVYKGQLQ-TGGLIAVKMLENSKFSAEEFINEVSTIGRIH-----------HVNVVQLLGFCSE-  131 (373)
Q Consensus        65 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~ni~~~~~~~~~-  131 (373)
                      .+|++.++||+|+||+||+|+.. +|+.||||+++......+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            35889999999999999999975 7899999999877666677888999888875           5789999988754 


Q ss_pred             -CCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEecCcCCCCeeeeCCC-----
Q 048542          132 -GSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHN-GCDVCILHFDIKPHNILLDHNF-----  204 (373)
Q Consensus       132 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~-~~~~~ivH~dikp~Nil~~~~~-----  204 (373)
                       ....+++++++..+....... .......+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             cccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence             455666777664443322221 12345678999999999999999999997 5   999999999999998655     


Q ss_pred             -ceEEeeccCcccCCCCCCceeeecccCCCCcccccccccccCCcCcccchHHHHHHHHHHHcCCCCCCCCcCccccccc
Q 048542          205 -IPKVSDFGLAKFHPKENDFVSISATRGTIGYIAPELISRNFGTVSCKSDVYGFGMVLLEMAGGRRNSNMNATRSSKAYF  283 (373)
Q Consensus       205 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~~DvwslG~~l~~ll~g~~p~~~~~~~~~~~~~  283 (373)
                       .++++|||.+.......     ....||+.|+|||.+.+.  .++.++|+||+||++++|++|+.||............
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence             38999999987554322     345699999999998764  7889999999999999999999999754432111100


Q ss_pred             hHHHHHHH-----------hcC--------------CCcccC---------ccchhhHHHHHHHHHHHHhhcCCCCCCCC
Q 048542          284 PSWVYDQL-----------NKG--------------GDLELQ---------NVTEIESMIARKLCMIGLWCIQVKAADRP  329 (373)
Q Consensus       284 ~~~~~~~~-----------~~~--------------~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  329 (373)
                       .......           ...              ......         .........+..+.+|+.+||+.||.+||
T Consensus       242 -~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         242 -DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             -HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             -HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence             0000000           000              000000         01122356778899999999999999999


Q ss_pred             CHHHHHHH--HhcC--CCCCCCCCCCccccCCCCCCCCCc
Q 048542          330 SMTKVLEM--LEGS--IDDLQMPPRPFFSSSRHISGTGRE  365 (373)
Q Consensus       330 s~~ell~~--L~~~--~~~~~~~~~p~~~~~~~~~~~~~~  365 (373)
                      |++|+++-  +++.  .++...|.+|.....+.+++..++
T Consensus       321 ta~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  360 (362)
T d1q8ya_         321 DAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE  360 (362)
T ss_dssp             CHHHHHTCGGGTTCTTCTTCCCTTSCTTCBSTTSTTSSSC
T ss_pred             CHHHHhcCcccCCCCCcccCCCCCcccCCCCCCCCchhhh
Confidence            99999983  5543  345567888888777777655443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8.8e-26  Score=188.59  Aligned_cols=160  Identities=18%  Similarity=0.127  Sum_probs=117.7

Q ss_pred             hhhcccCCCCcEEEEEEEEcCCceeEEEEeccCccC-------------------HHHHHHHHHHhcccCCCceeeEeeE
Q 048542           68 HFTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFS-------------------AEEFINEVSTIGRIHHVNVVQLLGF  128 (373)
Q Consensus        68 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~ni~~~~~~  128 (373)
                      -+.++||+|+||+||+|...+|+.||||+++.....                   ......|...+..+.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            357899999999999999888999999987642111                   1234568888999999999988765


Q ss_pred             eeeCCeeEEEEeccCcCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEecCcCCCCeeeeCCCceEE
Q 048542          129 CSEGSKRALVYEYMPNGSLDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCDVCILHFDIKPHNILLDHNFIPKV  208 (373)
Q Consensus       129 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~~~ivH~dikp~Nil~~~~~~~kl  208 (373)
                      ..    .+++|||+++..+.++           +......++.|++.+++|||++   +++||||||+|||++++ .++|
T Consensus        83 ~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             cC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence            32    3799999987655332           2233567899999999999998   99999999999999965 4899


Q ss_pred             eeccCcccCCCCCCceeeecccCCCCccc------ccccccccCCcCcccchHHHHH
Q 048542          209 SDFGLAKFHPKENDFVSISATRGTIGYIA------PELISRNFGTVSCKSDVYGFGM  259 (373)
Q Consensus       209 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~~DvwslG~  259 (373)
                      +|||++.....+...          .|..      .+.+.   ..|+.++|+||+.-
T Consensus       144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~---r~y~~~~d~~s~~~  187 (191)
T d1zara2         144 IDFPQSVEVGEEGWR----------EILERDVRNIITYFS---RTYRTEKDINSAID  187 (191)
T ss_dssp             CCCTTCEETTSTTHH----------HHHHHHHHHHHHHHH---HHHCCCCCHHHHHH
T ss_pred             EECCCcccCCCCCcH----------HHHHHHHHHHHHHHc---CCCCCcccHHHHHH
Confidence            999999755433211          1111      12222   25778899999754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.58  E-value=7.3e-08  Score=82.39  Aligned_cols=137  Identities=14%  Similarity=0.058  Sum_probs=94.4

Q ss_pred             hhcccCCCCcEEEEEEEEcCCceeEEEEeccCc-cCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEeccCcCC
Q 048542           69 FTHKLGQGGFGSVYKGQLQTGGLIAVKMLENSK-FSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEYMPNGS  146 (373)
Q Consensus        69 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~gs  146 (373)
                      ..+..+.++.+.||+.... ++.+++|+..... .....+.+|...+..+. +--+.+++.+..+++..++||++++|.+
T Consensus        18 ~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~   96 (263)
T d1j7la_          18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             EEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence            3344444455789988654 6677888876432 23345677888877764 3346778888888889999999999887


Q ss_pred             ccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----------------------------------------
Q 048542          147 LDRHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGCD-----------------------------------------  185 (373)
Q Consensus       147 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~~-----------------------------------------  185 (373)
                      +.+.....      .   ....++.++++.++.||+...                                         
T Consensus        97 ~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          97 CSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             HHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             cccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            75544111      1   123356667777777875310                                         


Q ss_pred             ---------------CCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          186 ---------------VCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       186 ---------------~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                                     ..++|+|+.|.||++++++...|+||+.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                           137999999999999987777799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=1.2e-06  Score=74.18  Aligned_cols=130  Identities=19%  Similarity=0.187  Sum_probs=89.8

Q ss_pred             ccCCCCc-EEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCC--CceeeEeeEeeeCCeeEEEEeccCcCCcc
Q 048542           72 KLGQGGF-GSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHH--VNVVQLLGFCSEGSKRALVYEYMPNGSLD  148 (373)
Q Consensus        72 ~ig~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~ni~~~~~~~~~~~~~~lv~e~~~~gsL~  148 (373)
                      .+..|.. +.||+....++..+++|.......  ..+..|...++.+..  -.+.+++.+..+++..++||++++|.++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            3444543 679999888788899998765432  345678888777743  33667788888888899999999887664


Q ss_pred             ccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 048542          149 RHVFPKESRGQSLCWEKLHEVALGTARGIEYLHNGC--------------------------------------------  184 (373)
Q Consensus       149 ~~l~~~~~~~~~l~~~~~~~i~~~i~~al~~LH~~~--------------------------------------------  184 (373)
                      +..         ....   ..+.++++.++-||+..                                            
T Consensus        95 ~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          95 SSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            322         1111   23345555566666421                                            


Q ss_pred             -----------CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 -----------DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 -----------~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                                 ...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       0137999999999999987777899999775

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.84  E-value=2.2e-05  Score=68.85  Aligned_cols=136  Identities=14%  Similarity=0.102  Sum_probs=81.9

Q ss_pred             EEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCcee--eEe-----eEeeeCCeeEEEEeccCcCCccccc
Q 048542           79 GSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVNVV--QLL-----GFCSEGSKRALVYEYMPNGSLDRHV  151 (373)
Q Consensus        79 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~ni~--~~~-----~~~~~~~~~~lv~e~~~~gsL~~~l  151 (373)
                      -.||++...+|+.+++|+.+....+.+++..|...+..|....+.  ...     ..+......+.++++++|..+...-
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            479999999999999999988877888899999988887422221  111     1224456778899998765442110


Q ss_pred             ------------------cCC-CCCCCCCC----------------------HHHHHHHHHHHHHHHHHHH-cCCCCCeE
Q 048542          152 ------------------FPK-ESRGQSLC----------------------WEKLHEVALGTARGIEYLH-NGCDVCIL  189 (373)
Q Consensus       152 ------------------~~~-~~~~~~l~----------------------~~~~~~i~~~i~~al~~LH-~~~~~~iv  189 (373)
                                        ... ........                      .......+.++...+.-+- +....+++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                              000 00001111                      1112222333333332221 22245799


Q ss_pred             ecCcCCCCeeeeCCCceEEeeccCccc
Q 048542          190 HFDIKPHNILLDHNFIPKVSDFGLAKF  216 (373)
Q Consensus       190 H~dikp~Nil~~~~~~~kl~Dfg~~~~  216 (373)
                      |+|+.+.|||++++  ..++||+-+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999743  45899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.79  E-value=2.8e-05  Score=70.07  Aligned_cols=75  Identities=16%  Similarity=0.131  Sum_probs=49.2

Q ss_pred             cccCCCCcEEEEEEEEcC-CceeEEEEecc--------CccCHHHHHHHHHHhcccC-C--CceeeEeeEeeeCCeeEEE
Q 048542           71 HKLGQGGFGSVYKGQLQT-GGLIAVKMLEN--------SKFSAEEFINEVSTIGRIH-H--VNVVQLLGFCSEGSKRALV  138 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~--------~~~~~~~~~~e~~~l~~l~-h--~ni~~~~~~~~~~~~~~lv  138 (373)
                      +.||.|....||+....+ ++.+++|.-..        .....++...|.+.++.+. +  ..+++++.+  ++...++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            568999999999998654 56888996432        1223345667888887663 2  345666644  44566899


Q ss_pred             EeccCcCCc
Q 048542          139 YEYMPNGSL  147 (373)
Q Consensus       139 ~e~~~~gsL  147 (373)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.38  E-value=0.00035  Score=62.67  Aligned_cols=73  Identities=15%  Similarity=0.209  Sum_probs=50.8

Q ss_pred             cccCCCCcEEEEEEEEcCC--------ceeEEEEeccCccCHHHHHHHHHHhcccC-CCceeeEeeEeeeCCeeEEEEec
Q 048542           71 HKLGQGGFGSVYKGQLQTG--------GLIAVKMLENSKFSAEEFINEVSTIGRIH-HVNVVQLLGFCSEGSKRALVYEY  141 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~--------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~  141 (373)
                      +.|+.|-.-.+|++...++        ..|.+++... .....+..+|..+++.+. +.-.+++++++.+    .+|+||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef  122 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY  122 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence            5788888899999986532        4577777653 334455678999998885 3334567776643    589999


Q ss_pred             cCcCCcc
Q 048542          142 MPNGSLD  148 (373)
Q Consensus       142 ~~~gsL~  148 (373)
                      ++|.++.
T Consensus       123 i~g~~l~  129 (395)
T d1nw1a_         123 IPSRPLS  129 (395)
T ss_dssp             CCEEECC
T ss_pred             eccccCC
Confidence            9876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.00  E-value=0.0014  Score=56.50  Aligned_cols=143  Identities=10%  Similarity=0.048  Sum_probs=72.4

Q ss_pred             cccCCCCcEEEEEEEEcCCceeEEEEeccCccCHHHHHHHHHHhcccCCCc--eeeEee------EeeeCCeeEEEEecc
Q 048542           71 HKLGQGGFGSVYKGQLQTGGLIAVKMLENSKFSAEEFINEVSTIGRIHHVN--VVQLLG------FCSEGSKRALVYEYM  142 (373)
Q Consensus        71 ~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~n--i~~~~~------~~~~~~~~~lv~e~~  142 (373)
                      +.|..|.--+.|+....+ +.+++|+.... .+.+++..|+.++..+...+  ++....      +.........++.+.
T Consensus        24 ~~i~~G~~N~ny~v~t~~-g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~  101 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTK-DPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  101 (316)
T ss_dssp             EEECC---EEEEEEEESS-CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             ecCCCCcccCeEEEEECC-CcEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence            346677778889988774 46999998653 23344555677777664222  111111      112234556667766


Q ss_pred             CcCCcccccc--------------------CCCCCCCCC-----------------CHHHHHHHHHHHHHHHHHHHc-CC
Q 048542          143 PNGSLDRHVF--------------------PKESRGQSL-----------------CWEKLHEVALGTARGIEYLHN-GC  184 (373)
Q Consensus       143 ~~gsL~~~l~--------------------~~~~~~~~l-----------------~~~~~~~i~~~i~~al~~LH~-~~  184 (373)
                      .+......-.                    .........                 ........+......+...+. ..
T Consensus       102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L  181 (316)
T d2ppqa1         102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  181 (316)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence            5543321100                    000000000                 000111112222222222221 12


Q ss_pred             CCCeEecCcCCCCeeeeCCCceEEeeccCcc
Q 048542          185 DVCILHFDIKPHNILLDHNFIPKVSDFGLAK  215 (373)
Q Consensus       185 ~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~  215 (373)
                      ..+++|+|+.++|++++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3589999999999999988777899999875